Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
while	IN	mark	O
transfection	NN	compound	O
analyses	NNS	nsubj	O
offer	VBP	advcl	O
an	DT	det	O
adequate	JJ	amod	O
approximation	NN	dobj	O
of	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
the	DT	det	O
LS	NN	compound	O
mutations	NNS	nmod	O
,	,	punct	O
the	DT	det	O
analysis	NN	nsubj	O
of	IN	case	O
viral	JJ	amod	O
replication	NN	nmod	O
using	VBG	acl	O
a	DT	det	O
mutant	JJ	amod	O
viral	JJ	amod	O
stock	NN	dobj	O
presents	VBZ	ccomp	O
a	DT	det	O
more	RBR	advmod	O
accurate	JJ	amod	O
picture	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
sometimes	RB	advmod	O
at	IN	case	O
variance	NN	acl:relcl	O
with	IN	case	O
the	DT	det	O
transfection	NN	compound	O
results	NNS	nmod	O
.	.	punct	O

The	DT	det	O
transcriptionally	RB	advmod	B-DNA
regulatory	JJ	amod	I-DNA
regions	NNS	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
lymphomagenic	JJ	amod	O
Akv	NN	nmod	O
and	CC	cc	O
SL3-3	NN	conj	O
murine	JJ	amod	O
leukemia	NN	compound	O
retroviruses	NNS	conj	O
(	-LRB-	punct	O
MLVs	NNS	appos	O
)	-RRB-	punct	O
contain	VBP	ROOT	O
two	CD	nummod	O
types	NNS	dobj	O
of	IN	case	O
E-box	NN	compound	B-DNA
consensus	NN	compound	I-DNA
motifs	NNS	nmod	I-DNA
,	,	punct	O
CAGATG	NN	appos	O
.	.	punct	O

Previously	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
and	CC	cc	O
others	NNS	conj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
regulates	VBZ	ccomp	O
the	DT	det	O
NF-kappa	NN	compound	B-DNA
B1	NN	compound	I-DNA
gene	NN	dobj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
performed	VBD	ROOT	O
an	DT	det	O
analysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
by	IN	case	O
which	WDT	nmod	O
two	CD	nummod	O
PKC	NN	compound	B-protein
inhibitors	NNS	nsubj	O
,	,	punct	O
Calphostin	NN	compound	O
C	NN	appos	O
and	CC	cc	O
Staurosporine	NN	conj	O
,	,	punct	O
prevent	VBP	acl:relcl	O
the	DT	det	O
FN	NN	compound	B-protein
-induced	JJ	amod	O
IL-1beta	NN	compound	B-protein
response	NN	dobj	O
.	.	punct	O

The	DT	det	O
HB9	NN	compound	B-DNA
homeodomain	NN	nsubj	I-DNA
is	VBZ	cop	O
most	RBS	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
Drosophila	FW	compound	B-DNA
melanogaster	FW	compound	I-DNA
homeobox	NN	compound	I-DNA
gene	NN	compound	I-DNA
proboscipedia	NN	nmod	B-DNA
.	.	punct	O

CD45	NN	compound	B-protein
-dependent	JJ	amod	O
events	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
tyrosine	NN	compound	B-protein
phosphorylation	NN	nmod	I-protein
of	IN	case	O
Shc	NN	nmod	B-protein
,	,	punct	O
activation	NN	conj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
activator	NN	compound	B-protein
protein-1	NN	conj	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
interleukin-2	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IL-2	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
of	IN	case	O
CD69	NN	conj	B-protein
and	CC	cc	O
CD25	NN	conj	B-protein
surface	NN	compound	O
expression	NN	dep	O
paralleled	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
tyrosine	NN	compound	B-protein
kinases	NNS	nmod	I-protein
lck	NN	dep	B-protein
and	CC	cc	O
fyn	NN	conj	B-protein
.	.	punct	O

E2a-	NN	compound	O
Pbx1	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
apoptosis	NN	nsubj	O
proceeded	VBD	ROOT	O
through	IN	case	O
a	DT	det	O
BCL2	NN	compound	B-protein
-responsive	JJ	amod	O
checkpoint	NN	nmod	O
eventuating	NN	acl	O
in	IN	case	O
PARP	NN	compound	B-protein
inactivation	NN	nmod	O
but	CC	cc	O
did	VBD	aux	O
require	VB	conj	O
p53	NN	dobj	B-protein
.	.	punct	O

C/EBP	NN	compound	B-protein
beta	NN	compound	I-protein
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-DNA
necrosis	NN	compound	I-DNA
factor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
fetal	JJ	amod	O
liver	NN	nmod	O
of	IN	case	O
PU.1-/-	NN	compound	O
mice	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
lack	VBP	acl:relcl	O
lymphoid	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
myeloid	JJ	conj	I-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
Btk	NN	nmod	B-protein
was	VBD	auxpass	O
reduced	VBN	ROOT	O
two-	CD	dobj	O
to	TO	dep	O
threefold	JJ	dep	O
but	CC	cc	O
not	RB	neg	O
abolished	VBN	conj	O
.	.	punct	O

A	DT	det	O
threonine	NN	compound	O
residue	NN	nsubjpass	O
at	IN	case	O
position	NN	nmod	B-protein
234	CD	nummod	I-protein
,	,	punct	O
previously	RB	advmod	O
shown	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
important	JJ	xcomp	O
for	IN	case	O
CD40	NN	compound	B-protein
association	NN	nmod	O
with	IN	case	O
TNF	NN	compound	B-protein
receptor-associated	JJ	amod	I-protein
factor	NN	nmod	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
TRAF2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
TRAF3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
TRAF5	NN	conj	B-protein
,	,	punct	O
was	VBD	auxpass	O
not	RB	neg	O
required	VBN	ROOT	O
for	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

Exposing	VBG	amod	O
HUVECs	NNS	nsubj	B-cell_line
to	TO	case	O
A/R	NN	nmod	O
induces	VBZ	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
HUVEC	NN	compound	O
nuclei	NNS	nmod	O
within	IN	case	O
4	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
NGFI-B/nur77	NN	compound	B-protein
family	NN	ROOT	I-protein
involved	VBN	acl	O
in	IN	case	O
T-cell	NN	compound	O
apoptosis	NN	nmod	O
]	-RRB-	punct	O

We	PRP	nsubj	O
evaluated	VBD	ROOT	O
49	CD	nummod	O
female	JJ	amod	O
patients	NNS	dobj	O
with	IN	case	O
MPD	NN	nmod	O
and	CC	cc	O
informative	JJ	conj	O
at	IN	case	O
the	DT	det	O
X-linked	JJ	amod	B-DNA
androgen	NN	compound	I-DNA
receptor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
AR	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
locus	NN	nmod	I-DNA
to	TO	mark	O
establish	VB	advcl	O
the	DT	det	O
X	NN	compound	B-DNA
chromosome	NN	compound	I-DNA
inactivation	NN	compound	O
pattern	NN	dobj	O
of	IN	case	O
hemopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Activation	NN	compound	B-protein
protein	NN	compound	I-protein
1	CD	nummod	I-protein
-dependent	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
interleukin	NN	compound	B-DNA
2	CD	nummod	I-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
Ca2+/calmodulin	NN	compound	B-protein
kinase	NN	compound	I-protein
type	NN	compound	I-protein
IV/Gr	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
inability	NN	nsubj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
to	TO	mark	O
suppress	VB	acl	O
its	PRP$	nmod:poss	O
synthesis	NN	dobj	O
in	IN	case	O
macrophages	NNS	nmod	B-cell_type
contrasts	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
tight	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
production	NN	nmod	O
in	IN	case	O
macrophage	NN	compound	O
precursors	NNS	nmod	O
,	,	punct	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	conj	I-cell_type
(	-LRB-	punct	O
PBM	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
nine	CD	nummod	O
different	JJ	amod	O
2.3-kb	JJ	amod	O
cDNA	NN	compound	O
clones	NNS	nmod	O
obtained	VBN	acl	O
from	IN	case	O
NK-derived	JJ	amod	O
polyA+	JJ	amod	O
RNA	NN	nmod	O
confirmed	VBD	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
corresponded	VBD	ccomp	O
to	TO	case	O
an	DT	det	O
unrearranged	JJ	amod	O
TcR	NN	compound	B-DNA
delta	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

High-dose	JJ	amod	O
pulse	NN	compound	O
glucocorticoid	NN	compound	O
therapy	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
successfully	RB	advmod	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
in	IN	case	O
severe	JJ	amod	O
pathological	JJ	amod	O
conditions	NNS	nmod	O
for	IN	case	O
about	RB	advmod	O
20	CD	nummod	O
years	NNS	nmod	O
.	.	punct	O

The	DT	det	O
experiments	NNS	nsubjpass	O
reported	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
were	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
address	VB	xcomp	O
the	DT	det	O
signaling	NN	compound	O
events	NNS	dobj	O
triggered	VBN	acl	O
by	IN	case	O
TCR	NN	compound	B-protein
engagement	NN	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
important	JJ	acl:relcl	O
for	IN	mark	O
regulating	VBG	advcl	O
CD95	NN	compound	B-protein
ligand	NN	compound	I-protein
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

To	TO	mark	O
begin	VB	advcl	O
to	TO	mark	O
elucidate	VB	xcomp	O
the	DT	det	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
wanted	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
which	WDT	mark	O
transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
activated	VBN	ccomp	O
by	IN	case	O
PGN	NN	nmod	O
in	IN	case	O
mouse	NN	compound	B-cell_line
RAW264.7	NN	nmod	I-cell_line
and	CC	cc	O
human	JJ	amod	B-cell_line
THP-1	NN	compound	I-cell_line
macrophage	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

The	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
many	JJ	amod	O
C-11-substituted	JJ	amod	O
1	CD	nummod	O
alpha	NN	compound	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	compound	O
analogs	NNS	nmod	O
on	IN	case	O
HL-60	NN	compound	B-cell_line
cell	NN	compound	O
differentiation	NN	nmod	O
exceeded	VBD	ROOT	O
their	PRP$	nmod:poss	O
activity	NN	dobj	O
on	IN	case	O
calcium	NN	compound	O
metabolism	NN	nmod	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
anergy	NN	nmod	O
by	IN	case	O
high	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
immunodominant	JJ	amod	O
native	JJ	amod	O
peptide	NN	nmod	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
IL-10	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
a	DT	det	O
block	NN	conj	O
in	IN	case	O
JNK	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
these	DT	det	O
observations	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
reactivation	NN	nsubj	O
of	IN	case	O
latent	JJ	amod	O
HIV-1	NN	nmod	O
harbored	VBN	acl	O
in	IN	case	O
chronically	RB	advmod	B-cell_type
infected	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
monocytes	NNS	conj	B-cell_type
,	,	punct	O
or	CC	cc	O
macrophages	NNS	nsubj	B-cell_type
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
AIDS	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubj	O
most	RBS	advmod	O
able	JJ	amod	O
to	TO	aux	O
ingest	VB	xcomp	O
,	,	punct	O
process	NN	conj	O
,	,	punct	O
and	CC	cc	O
present	JJ	amod	O
antigen	NN	nsubj	O
appear	VBP	ROOT	O
to	TO	mark	O
be	VB	cop	O
related	JJ	xcomp	O
to	TO	case	O
the	DT	det	O
mononuclear	JJ	amod	B-cell_type
phagocyte/neutrophil	NN	compound	I-cell_type
series	NN	nmod	I-cell_type
.	.	punct	O

Some	DT	det	O
antioxidants	NNS	nsubj	O
inhibit	VBP	ROOT	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
co-ordinate	JJ	amod	O
fashion	NN	nmod	O
,	,	punct	O
the	DT	det	O
production	NN	appos	O
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
,	,	punct	O
IL-beta	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-6	NN	conj	B-protein
by	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

c-Myc	NN	nsubj	B-protein
and	CC	cc	O
E1A	NN	conj	B-protein
induced	JJ	ROOT	O
cellular	JJ	amod	O
sensitivity	NN	dobj	O
to	TO	case	O
activated	VBN	amod	B-cell_type
NK	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
involves	VBZ	conj	O
cytotoxic	JJ	amod	O
granules	NNS	dobj	O
as	IN	case	O
death	NN	compound	O
effectors	NNS	nmod	O
.	.	punct	O

Additional	JJ	amod	O
work	NN	nsubj	O
,	,	punct	O
employing	VBG	acl	O
sequential	JJ	amod	O
and	CC	cc	O
internal	JJ	conj	O
deletions	NNS	dobj	O
of	IN	case	O
ZEBRA	NN	nmod:poss	B-protein
's	POS	case	O
N-terminal	JJ	amod	B-protein
activation	NN	compound	I-protein
domain	NN	nmod	I-protein
,	,	punct	O
indicates	VBZ	ROOT	O
that	IN	mark	O
its	PRP$	nmod:poss	O
separate	JJ	amod	O
activities	NNS	nsubj	O
are	VBP	cop	O
not	RB	neg	O
attributable	JJ	ccomp	O
to	TO	case	O
specific	JJ	amod	O
subdomains	NNS	nmod	B-protein
but	CC	cc	O
are	VBP	auxpass	O
spread	VBN	conj	O
throughout	IN	case	O
its	PRP$	poss	O
N	NN	compound	B-protein
terminus	NN	nmod	I-protein
and	CC	cc	O
therefore	RB	advmod	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
inactivated	VBN	conj	O
by	IN	mark	O
deleting	VBG	advcl	O
localized	JJ	amod	O
regions	NNS	dobj	O
.	.	punct	O

LysoPC	NN	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
TF	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
Mono	NN	compound	B-cell_line
Mac-6	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
a	DT	det	O
similar	JJ	amod	O
extent	NN	nmod	O
as	IN	case	O
in	IN	case	O
the	DT	det	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
(	-LRB-	punct	I-protein
EBV	NN	appos	I-protein
)	-RRB-	punct	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	compound	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
EBNA-2	NN	compound	B-protein
)	-RRB-	punct	O
protein	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
immortalization	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
primary	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
EBV	NN	nmod	O
.	.	punct	O

This	DT	det	O
investigation	NN	nsubjpass	O
was	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
composition	NN	dobj	O
of	IN	case	O
StatG	NN	nmod	B-protein
in	IN	case	O
mature	JJ	amod	B-cell_type
normal	JJ	amod	I-cell_type
human	JJ	amod	I-cell_type
myeloid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
i.e	NN	appos	O
.	.	punct	O
polymorphonuclear	JJ	amod	B-cell_type
neutrophilic	JJ	amod	I-cell_type
granulocytes	NNS	ROOT	I-cell_type
(	-LRB-	punct	O
PMN	NN	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

63	CD	nummod	O
%	NN	compound	O
nucleotide	NN	compound	O
identity	NN	ROOT	O
with	IN	case	O
a	DT	det	O
more	RBR	advmod	O
conserved	VBN	amod	O
core	NN	nmod	O
of	IN	case	O
169	CD	nummod	B-DNA
base	NN	compound	I-DNA
pairs	NNS	nmod	I-DNA
(	-LRB-	punct	O
86	CD	nummod	O
%	NN	compound	O
identity	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

All	DT	det	O
three	CD	nummod	O
cell	NN	compound	O
lines	NNS	nsubj	O
expressed	VBD	ROOT	O
vitamin	NN	compound	O
D	NN	compound	O
receptor	NN	dobj	O
and	CC	cc	O
had	VBD	conj	O
increased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-1	NN	compound	B-RNA
beta	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
response	NN	dep	O
to	TO	case	O
LPS	NN	nmod	O
.	.	punct	O

Azeptin	NN	nsubj	O
dose-dependently	RB	advmod	O
suppressed	VBD	ROOT	O
both	CC	cc:preconj	O
DNA	NN	dobj	O
and	CC	cc	O
protein	NN	compound	O
synthesis	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
gingival	JJ	amod	I-cell_type
fibroblasts	NNS	nmod	I-cell_type
(	-LRB-	punct	O
HF	NNS	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
also	RB	advmod	O
suppressed	VBD	conj	O
blastogenesis	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBL	NN	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O
Generation	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
,	,	punct	O
interleukin	NN	compound	B-protein
1-beta	NN	conj	I-protein
,	,	punct	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	conj	I-protein
and	CC	cc	O
interleukin-6	NN	conj	B-protein
from	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
Azeptin-treated	JJ	amod	O
PBL	NN	nmod	B-cell_type
and	CC	cc	O
human	JJ	amod	B-cell_type
monocytes	NNS	conj	I-cell_type
(	-LRB-	punct	O
HM	NNS	appos	B-cell_type
)	-RRB-	punct	O
was	VBD	auxpass	O
decreased	VBN	ROOT	O
to	TO	case	O
approximately	RB	advmod	O
1/3	CD	compound	O
to	TO	dep	O
2/3	CD	nmod	O
of	IN	case	O
the	DT	det	O
control	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
do	VB	advcl	O
this	DT	dobj	O
,	,	punct	O
wild-type	JJ	amod	O
and	CC	cc	O
mutant	JJ	conj	O
forms	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
CD4	NN	compound	B-protein
cytoplasmic	JJ	amod	I-protein
tail	NN	nmod	I-protein
were	VBD	auxpass	O
stably	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
lymphoblastoid	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
A2.01	NN	nmod	B-cell_line
.	.	punct	O

These	DT	det	O
clones	NNS	nsubjpass	O
were	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
recognition	NN	nmod	O
of	IN	case	O
BCR1/25	NN	nmod	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ICRF-193	NN	nsubj	O
only	RB	advmod	O
provoked	VBD	ROOT	O
a	DT	det	O
late	JJ	amod	O
activation	NN	dobj	O
(	-LRB-	punct	O
from	IN	case	O
hours	NNS	dep	O
72	CD	nummod	O
to	TO	dep	O
96	CD	nummod	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
total	JJ	amod	O
enzyme	NN	nmod	O
.	.	punct	O

Fos	NN	compound	B-protein
kinase	NN	nsubjpass	I-protein
was	VBD	auxpass	O
purified	VBN	ROOT	O
by	IN	case	O
anion	NN	compound	O
exchange	NN	compound	O
chromatography	NN	nmod	O
and	CC	cc	O
exhibited	VBD	conj	O
an	DT	det	O
apparent	JJ	amod	O
M	NN	dobj	O
(	-LRB-	punct	O
r	NN	appos	O
)	-RRB-	punct	O
=	JJ	amod	O
65	CD	dep	O
,	,	punct	O
000	CD	conj	O
and	CC	cc	O
isoelectric	JJ	amod	O
point	NN	nsubj	O
=	JJ	conj	O
6.1	CD	dobj	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
two	CD	nummod	O
cleavage	NN	compound	O
products	NNS	dobj	O
of	IN	case	O
approximately	RB	advmod	O
68	CD	nummod	B-protein
kDa	NN	nmod	I-protein
and	CC	cc	O
45	CD	nummod	B-protein
kDa	NN	conj	I-protein
after	IN	case	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
stimulates	VBZ	ccomp	O
RNA	NN	compound	B-DNA
polymerase	NN	compound	I-DNA
III-dependent	JJ	amod	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
by	IN	mark	O
accelerating	VBG	advcl	O
the	DT	det	O
rate	NN	dobj	O
and/or	CC	cc	O
extent	NN	conj	O
of	IN	case	O
transcription	NN	compound	B-protein
initiation	NN	compound	I-protein
complex	NN	compound	I-protein
assembly	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
and	CC	cc	O
RA	NN	conj	O
markedly	RB	advmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
p27	NN	compound	B-protein
(	-LRB-	punct	I-protein
KIP1	NN	intj	I-protein
)	-RRB-	punct	I-protein
transcript	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
levels	NNS	nmod	O
induced	VBN	acl	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	dep	O
)	-RRB-	punct	O
2D3	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
IL-2Ralpha	NN	nmod	B-protein
,	,	punct	O
c-myc	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
pim-1	NN	compound	B-DNA
genes	NNS	conj	I-DNA
in	IN	case	O
anti-CD3-activated	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
cdk2	NN	compound	O
inhibitor	NN	nsubj	O
,	,	punct	O
Olomoucine	NN	appos	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
dominant-negative	JJ	amod	B-DNA
cdk2	NN	compound	I-DNA
construct	NN	conj	I-DNA
prevented	VBD	ROOT	O
HLA	NN	compound	B-protein
class	NN	compound	I-protein
I	CD	nummod	I-protein
-mediated	JJ	amod	O
inactivation	NN	dobj	O
of	IN	case	O
Rb	NN	nmod	B-protein
;	:	punct	O
in	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
dominant-negative	JJ	amod	B-DNA
cdk4	NN	nsubj	I-DNA
and	CC	cc	I-DNA
cdk6	NN	compound	I-DNA
constructs	NNS	conj	I-DNA
had	VBD	parataxis	O
no	DT	neg	O
effect	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
paper	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
HCMV	NN	nsubj	O
down	RB	advmod	O
regulates	VBZ	ccomp	O
gamma	NN	nmod:npmod	O
interferon	NN	nmod:npmod	O
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
-induced	JJ	amod	O
HLA-DR	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
U373	NN	compound	B-cell_line
MG	NN	compound	I-cell_line
astrocytoma	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
due	JJ	case	O
to	TO	case	O
a	DT	det	O
defect	NN	nmod	O
downstream	RB	amod	O
of	IN	case	O
STAT1	NN	compound	B-protein
phosphorylation	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
translocation	NN	conj	O
.	.	punct	O

HIV-TF1	NN	nsubj	B-protein
had	VBD	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
weight	NN	dobj	O
of	IN	case	O
39	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
.	.	punct	O

The	DT	det	O
correlation	NN	nsubj	O
is	VBZ	cop	O
specific	JJ	ROOT	O
as	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
other	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
did	VBD	aux	O
not	RB	neg	O
change	VB	advcl	O
.	.	punct	O

Since	IN	mark	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
lines	NNS	conj	I-cell_type
do	VBP	aux	O
not	RB	neg	O
metabolize	VB	advcl	O
arachidonic	JJ	amod	O
acid	NN	dobj	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
ALD	NN	nsubj	O
can	MD	aux	O
protect	VB	ccomp	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	dobj	I-cell_type
against	IN	case	O
a	DT	det	O
metabolite	NN	nmod	O
of	IN	case	O
benzene	NN	nmod	O
by	IN	case	O
induction	NN	nmod	O
of	IN	case	O
QR	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
group	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
receptor	NN	compound	O
levels	NNS	nsubj	O
and	CC	cc	O
morning	NN	compound	O
plasma	NN	compound	O
cortisol	NN	compound	O
values	NNS	conj	O
showed	VBD	ROOT	O
a	DT	det	O
negative	JJ	amod	O
correlation	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
a	DT	det	O
subtle	JJ	amod	O
down-regulatory	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

An	DT	det	O
interleukin-4-induced	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
:	:	punct	O
IL-4	NN	compound	B-protein
Stat	NN	dep	I-protein
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
two	CD	nummod	O
leukemia	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
transient	JJ	amod	O
overexpression	NN	nsubj	O
of	IN	case	O
p16	NN	nmod	B-protein
reestablished	VBD	ROOT	O
the	DT	det	O
normal	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
thymidine	NN	compound	B-protein
kinase	NN	nmod	I-protein
,	,	punct	O
paralleled	VBN	advcl	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
of	IN	case	O
the	DT	det	O
underphosphorylated	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
retinoblastoma	NN	compound	B-protein
protein	NN	nmod	I-protein
and	CC	cc	O
decrease	NN	conj	O
of	IN	case	O
free	JJ	amod	O
E2F	NN	nmod	B-protein
bound	VBN	acl	O
to	TO	case	O
its	PRP$	nmod:poss	O
motif	NN	nmod	O
in	IN	case	O
the	DT	det	O
thymidine	NN	compound	B-DNA
kinase	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

YM268	NN	nsubj	O
facilitated	VBD	ROOT	O
the	DT	det	O
insulin-stimulated	JJ	amod	O
triglyceride	NN	compound	O
accumulation	NN	dobj	O
in	IN	case	O
3T3-L1	NN	compound	B-cell_type
adipocytes	NNS	nmod	I-cell_type
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
mRNA	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
fatty	JJ	amod	B-protein
acid-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

While	IN	mark	O
the	DT	det	O
sera	NN	nsubj	O
of	IN	case	O
EBV-negative	JJ	amod	O
individuals	NNS	nmod	O
(	-LRB-	punct	O
0/3	CD	appos	O
)	-RRB-	punct	O
or	CC	cc	O
healthy	JJ	amod	O
carriers	NNS	conj	O
(	-LRB-	punct	O
0/33	CD	appos	O
)	-RRB-	punct	O
did	VBD	aux	O
not	RB	neg	O
contain	VB	advcl	O
detectable	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
antibodies	NNS	nmod	O
,	,	punct	O
patients	NNS	nsubj	O
with	IN	case	O
mononucleosis	NN	nmod	O
(	-LRB-	punct	O
5/18	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
chronic	JJ	amod	O
EBV	NN	compound	O
infection	NN	conj	O
(	-LRB-	punct	O
2/7	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
EBV	NN	compound	O
reactivation	NN	conj	O
(	-LRB-	punct	O
7/20	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
infection	NN	conj	O
(	-LRB-	punct	O
5/24	CD	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
elevated	JJ	amod	O
antibody	NN	compound	O
titres	NNS	dobj	O
against	IN	case	O
the	DT	det	O
enzyme	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
negative	JJ	amod	O
autoregulation	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nmod	O
seen	VBN	acl	O
in	IN	case	O
most	JJS	amod	O
cells	NNS	nmod	O
and	CC	cc	O
tissues	NNS	conj	O
,	,	punct	O
GR	NN	compound	B-protein
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
positively	RB	advmod	O
autoregulated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
other	JJ	amod	O
cells	NNS	conj	O
sensitive	JJ	amod	O
to	TO	case	O
glucocorticoid-induced	JJ	amod	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O

The	DT	det	O
pattern	NN	nsubj	O
of	IN	case	O
binding	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
restimulated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
pattern	NN	nmod	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
regulate	VB	xcomp	O
T-cell-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
beta	NN	compound	O
chain	NN	conj	O
of	IN	case	O
the	DT	det	O
TcR	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

HIV	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
activity	NN	nsubj	O
perpetuated	VBN	acl	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
induction	NN	nmod	O
on	IN	case	O
infection	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
[	-LRB-	punct	O
see	VB	ROOT	O
comments	NNS	dobj	O
]	-RRB-	punct	O

Recent	JJ	amod	O
reports	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
ionizing	VBG	amod	O
radiation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
dose	NN	compound	O
range	NN	nmod	O
of	IN	case	O
2-50	CD	nummod	O
Gy	NN	nmod	O
results	VBZ	ccomp	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
KG-1	NN	compound	I-cell_line
myeloid	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
human	JJ	amod	B-cell_type
B-lymphocyte	NN	compound	I-cell_type
precursor	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
;	:	punct	O
the	DT	det	O
precise	JJ	amod	O
mechanism	NN	nsubjpass	O
involved	VBN	acl	O
and	CC	cc	O
the	DT	det	O
significance	NN	conj	O
are	VBP	auxpass	O
not	RB	neg	O
yet	RB	advmod	O
known	VBN	parataxis	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
continuous	JJ	amod	O
treatments	NNS	nsubj	O
with	IN	case	O
subcytotoxic	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
etoposide	NN	nmod	O
(	-LRB-	punct	O
0.15	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
ICRF-193	NN	conj	O
(	-LRB-	punct	O
0.3	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
produced	VBD	ROOT	O
several	JJ	amod	O
similar	JJ	amod	O
effects	NNS	dobj	O
,	,	punct	O
namely	RB	advmod	O
decreased	VBD	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
accumulation	NN	appos	O
of	IN	case	O
cells	NNS	nmod	O
at	IN	case	O
G2	NN	nmod	O
,	,	punct	O
increase	NN	conj	O
in	IN	case	O
cell	NN	compound	O
mass	NN	nmod	O
,	,	punct	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
differentiation	NN	nmod	O
.	.	punct	O

These	DT	det	O
compounds	NNS	nsubj	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
beta-galactosidase	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
insertion	NN	nsubj	O
did	VBD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
caps	NNS	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
receptor	NN	compound	O
cross-linking	NN	nmod	O
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
suggestions	NNS	nmod	O
that	IN	mark	O
the	DT	det	O
lymphocyte	NN	nsubj	O
but	CC	cc	O
not	RB	cc	O
macrophage	NN	conj	O
form	NN	dep	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
can	MD	aux	O
associate	VB	ccomp	O
with	IN	case	O
the	DT	det	O
detergent-insoluble	JJ	amod	O
cytoskeleton	NN	nmod	O
.	.	punct	O

Activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
chain	NN	nmod	I-protein
in	IN	case	O
somatic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
hybrids	NNS	nmod	I-cell_line
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
localization	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
leukemia	NN	compound	B-protein
inhibitory	JJ	amod	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
LIF	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
replication	NN	nmod	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
MNP	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
novel	JJ	amod	O
enhancer	NN	compound	O
element	NN	nsubj	O
identified	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
is	VBZ	cop	O
probably	RB	advmod	O
a	DT	det	O
target	NN	compound	O
site	NN	ROOT	O
for	IN	case	O
both	CC	cc:preconj	O
positive	JJ	amod	B-protein
and	CC	cc	I-protein
negative	JJ	conj	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

These	DT	nsubj	O
may	MD	aux	O
partly	RB	advmod	O
account	VB	ROOT	O
for	IN	case	O
the	DT	det	O
differential	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
B7	NN	compound	B-protein
and	CC	cc	O
LFA-3	NN	conj	B-protein
costimulation	NN	nmod	O
on	IN	case	O
IL-2	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

Early	JJ	amod	O
buds	NNS	nsubjpass	O
are	VBP	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
branching	VBG	amod	O
morphogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
ductal	JJ	amod	O
epithelium	NN	nmod	O
from	IN	case	O
which	WDT	nmod	O
endocrine	NN	amod	B-cell_type
and	CC	cc	I-cell_type
exocrine	JJ	conj	I-cell_type
precursor	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
bud	VBP	acl:relcl	O
to	TO	mark	O
eventually	RB	advmod	O
form	VB	xcomp	O
the	DT	det	O
two	CD	nummod	O
other	JJ	amod	O
compartments	NNS	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
problem	NN	nsubj	O
still	RB	advmod	O
remains	VBZ	ROOT	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	dobj	O
of	IN	case	O
leukemic	JJ	amod	O
relapse	NN	nmod	O
following	VBG	case	O
autologous	JJ	amod	O
PBSCT	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
caused	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
reinfusion	NN	nmod	O
of	IN	case	O
PBSC	NN	nmod	B-cell_type
contaminated	VBN	acl	O
by	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
exact	JJ	amod	O
etiology	NN	nsubj	O
of	IN	case	O
multiple	JJ	amod	O
sclerosis	NN	nmod	O
(	-LRB-	punct	O
MS	NN	appos	O
)	-RRB-	punct	O
remains	VBZ	advcl	O
unresolved	JJ	xcomp	O
,	,	punct	O
immune	JJ	amod	O
reactions	NNS	nsubjpass	O
are	VBP	auxpass	O
believed	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
central	JJ	amod	O
pathogenic	JJ	amod	O
mechanisms	NNS	xcomp	O
.	.	punct	O

Induction	NN	ROOT	O
of	IN	case	O
Sp1	NN	compound	B-protein
phosphorylation	NN	nmod	O
and	CC	cc	O
NF-kappa	NN	compound	B-DNA
B-independent	JJ	amod	I-DNA
HIV	NN	compound	I-DNA
promoter	NN	compound	I-DNA
domain	NN	compound	O
activity	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
stimulated	VBN	acl	O
by	IN	case	O
okadaic	JJ	amod	O
acid	NN	nmod	O
.	.	punct	O

The	DT	det	O
IL-1	NN	compound	B-protein
-induced	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
DNA	NN	compound	O
nuclear	JJ	amod	O
localization	NN	nsubj	O
is	VBZ	cop	O
transient	JJ	ROOT	O
and	CC	cc	O
can	MD	aux	O
be	VB	auxpass	O
prolonged	JJ	conj	O
either	CC	cc:preconj	O
by	IN	case	O
an	DT	det	O
antigen	NN	compound	O
receptor-initiated	JJ	amod	O
signal	NN	nmod	O
or	CC	cc	O
by	IN	mark	O
inhibiting	VBG	conj	O
protein	NN	compound	O
synthesis	NN	dobj	O
.	.	punct	O

Increased	VBN	amod	O
turnover	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
constitutive	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
in	IN	case	O
mature	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
a	DT	det	O
decreased	VBN	amod	O
affinity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
sublethal	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
H2O2	NN	nmod	O
actively	RB	advmod	O
suppressed	VBD	ROOT	O
the	DT	det	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
NF-AT	NN	compound	B-protein
and	CC	cc	O
IL-2	NN	conj	B-DNA
reporters	NNS	nmod	I-DNA
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
IL-2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
cells	NNS	nmod	O
stimulated	VBN	acl	O
with	IN	case	O
PHA/PMA	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
USF/c-Myc	NN	nsubj	B-protein
up-regulates	VBZ	ccomp	O
,	,	punct	O
while	IN	mark	O
YY1	NN	nsubj	B-protein
down-regulates	VBZ	advcl	O
the	DT	det	O
promoter	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
CXCR4	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
coreceptor	NN	appos	O
for	IN	case	O
T	NN	compound	O
cell-tropic	JJ	amod	O
HIV-1	NN	compound	O
entry	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
STAT3	NN	compound	B-protein
phosphorylation	NN	nmod	O
is	VBZ	auxpass	O
balanced	JJ	ccomp	O
between	IN	case	O
a	DT	det	O
staurosporine-sensitive	JJ	amod	B-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
PP2A	NN	conj	B-protein
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
mRNA	NN	compound	B-RNA
levels	NNS	dobj	O
of	IN	case	O
various	JJ	amod	O
V-ATPase	NN	compound	B-protein
subunits	NNS	nmod	O
during	IN	case	O
differentiation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
native	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
cell	NN	compound	B-cell_line
line	NN	compound	I-cell_line
THP-1	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
found	VBD	conj	O
that	IN	mark	O
transcriptional	JJ	amod	O
and	CC	cc	O
post-transcriptional	JJ	conj	O
mechanisms	NNS	nsubj	O
could	MD	aux	O
account	VB	ccomp	O
for	IN	case	O
increases	NNS	nmod	O
in	IN	case	O
cell	NN	compound	O
V-ATPase	NN	compound	B-protein
content	NN	nmod	O
.	.	punct	O

NF-IL6	NN	nsubj	B-protein
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
transcriptional	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
genes	NNS	nmod	O
induced	VBN	acl	O
in	IN	case	O
activated	VBN	amod	B-cell_type
monocytes/macrophages	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
NF-IL6	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
only	RB	advmod	O
CCAAT/enhancer-binding	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
C/EBP	NN	compound	I-protein
)	-RRB-	punct	I-protein
family	NN	compound	I-protein
member	NN	conj	O
whose	WP$	nmod:poss	O
steady-state	JJ	amod	O
mRNA	NN	compound	O
levels	NNS	nsubj	O
increase	VBP	conj	O
upon	IN	case	O
activation	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
(	-LRB-	punct	O
1	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

IL-7	NN	nsubj	B-protein
and	CC	cc	O
IL-15	NN	conj	B-protein
induced	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
complexes	NNS	dobj	O
as	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
feature	NN	appos	O
explained	VBN	acl	O
by	IN	case	O
the	DT	det	O
existence	NN	nmod	O
of	IN	case	O
similar	JJ	amod	O
tyrosine-phosphorylated	JJ	amod	B-protein
motifs	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
domains	NNS	nmod	I-protein
of	IN	case	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
and	CC	cc	O
IL-7R	NN	conj	B-protein
that	WDT	nsubj	O
can	MD	aux	O
serve	VB	acl:relcl	O
as	IN	case	O
docking	VBG	amod	O
sites	NNS	nmod	O
for	IN	case	O
Stat	NN	compound	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Hydrogen	NN	compound	O
peroxide	NN	compound	O
and	CC	cc	O
oxygen	NN	conj	O
radicals	NNS	nsubj	O
are	VBP	cop	O
agents	NNS	ROOT	O
commonly	RB	advmod	O
produced	VBN	acl	O
during	IN	case	O
inflammatory	JJ	amod	O
processes	NNS	nmod	O
.	.	punct	O

Proliferation	NN	nsubj	O
to	TO	case	O
tetanus	NN	compound	O
toxoid	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
differ	VB	ROOT	O
significantly	RB	advmod	O
between	IN	case	O
the	DT	det	O
groups	NNS	nmod	O
.	.	punct	O

These	DT	det	O
regulators	NNS	nsubjpass	O
are	VBP	auxpass	O
targeted	VBN	ROOT	O
by	IN	case	O
negative	JJ	amod	O
growth	NN	compound	O
regulatory	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
that	DT	nmod	O
provided	VBN	acl	O
by	IN	case	O
TGF-beta	NN	nmod	B-protein
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
poly	NN	amod	B-RNA
(	-LRB-	punct	I-RNA
A	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
RNA	NN	nmod	I-RNA
purified	VBN	acl	O
from	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
RPMI	NN	nmod	I-cell_line
8226	CD	nummod	I-cell_line
and	CC	cc	O
from	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
revealed	VBD	ROOT	O
a	DT	det	O
major	JJ	amod	B-RNA
mRNA	NN	compound	I-RNA
transcript	NN	dobj	I-RNA
of	IN	case	O
2.2	CD	nummod	O
kilobases	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
recombinant	JJ	amod	O
GHF-1	NN	nsubj	B-protein
interacted	VBD	ROOT	O
directly	RB	advmod	O
with	IN	case	O
c-Jun	NN	nmod	B-protein
but	CC	cc	O
not	RB	cc	O
c-Fos	NN	compound	B-protein
proteins	NNS	conj	I-protein
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
possible	JJ	amod	O
mechanisms	NNS	dobj	O
of	IN	case	O
estradiol	NN	nmod	O
acting	VBG	acl	O
via	IN	case	O
the	DT	det	O
polymorphonuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PMNs	NNS	appos	B-cell_type
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
important	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
Sp1	NN	dep	B-protein
and	CC	cc	O
AP-2	NN	conj	B-protein
mediate	VBP	ROOT	O
induction	NN	dobj	O
of	IN	case	O
acid	NN	compound	B-protein
sphingomyelinase	NN	nmod	I-protein
during	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Characterization	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
interacting	VBG	acl	O
with	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
lymphotropic	JJ	amod	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
I	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
HTLV-I	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
to	TO	mark	O
dissecting	VBG	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
viral	JJ	amod	O
transcription	NN	nmod	O
that	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
pertinent	JJ	acl:relcl	O
to	IN	case	O
the	DT	det	O
oncogenic	JJ	amod	O
and	CC	cc	O
neuropathogenic	JJ	conj	O
processes	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
HTLV-I	NN	compound	O
infection	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
immune	JJ	amod	O
and	CC	cc	O
nervous	JJ	conj	O
systems	NNS	nmod	O
.	.	punct	O

Following	VBG	case	O
EBV	NN	compound	O
infection	NN	nmod	O
,	,	punct	O
Epstein-Barr	JJ	amod	O
nuclear	JJ	amod	O
antigen	NN	compound	O
(	-LRB-	punct	O
EBNA	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
rosetting	NN	compound	I-cell_type
CD4+	JJ	amod	I-cell_type
and	CC	cc	I-cell_type
CD8+	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
absent	JJ	advcl	O
in	IN	case	O
nonexpressing	VBG	amod	B-cell_line
erythroleukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
DNase	NN	compound	B-DNA
I	CD	nummod	I-DNA
site	NN	nsubj	I-DNA
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
uninduced	JJ	amod	B-cell_line
myelomonocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
changed	VBN	conj	O
after	IN	case	O
PMA	NN	compound	O
induction	NN	nmod	O
.	.	punct	O

In	IN	case	O
circulating	VBG	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
RCCs	NNS	nmod	O
,	,	punct	O
the	DT	det	O
suppression	NN	nsubj	O
of	IN	case	O
NFkappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nmod	O
is	VBZ	cop	O
downstream	JJ	ROOT	O
from	IN	case	O
the	DT	det	O
stimulus-induced	JJ	amod	O
degradation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
factor	NN	compound	I-protein
IkappaBalpha	NN	nmod	B-protein
.	.	punct	O

Using	VBG	advcl	O
this	DT	det	O
system	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
CD28	NN	compound	B-protein
stimulation	NN	nsubj	O
by	IN	case	O
B7-transfected	JJ	amod	B-cell_line
CHO	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
induced	VBD	ccomp	O
a	DT	det	O
proliferative	JJ	amod	O
response	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
accompanied	VBN	acl:relcl	O
by	IN	case	O
measurable	JJ	amod	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
dexamethasone	NN	nsubjpass	O
was	VBD	auxpass	O
added	VBN	advcl	O
to	TO	case	O
the	DT	det	O
cultures	NNS	nmod	O
3	CD	nummod	O
hours	NNS	dep	O
after	IN	case	O
the	DT	det	O
stimulators	NNS	pobj	O
,	,	punct	O
it	PRP	nsubj	O
clearly	RB	advmod	O
decreased	VBD	ROOT	O
the	DT	det	O
interleukin-1	NN	compound	B-RNA
beta	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	dobj	O
regardless	RB	advmod	O
of	IN	case	O
the	DT	det	O
stimulator	NN	nmod	O
used	VBN	acl	O
(	-LRB-	punct	O
although	IN	mark	O
the	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
clearly	RB	advmod	O
weaker	JJR	advcl	O
on	IN	case	O
the	DT	det	O
PMA-induced	JJ	amod	B-RNA
mRNA	NN	nmod	I-RNA
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
reporter	NN	compound	B-DNA
gene	NN	compound	I-DNA
analyses	NNS	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
insulin	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
is	VBZ	cop	O
more	RBR	advmod	O
sensitive	JJ	ccomp	O
to	TO	case	O
glycation	NN	nmod	O
than	IN	case	O
the	DT	det	O
control	JJ	amod	O
beta-actin	JJ	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
;	:	punct	O
approximately	RB	advmod	O
50	CD	nummod	O
and	CC	cc	O
80	CD	conj	O
%	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
insulin	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
was	VBD	auxpass	O
lost	VBN	parataxis	O
when	WRB	advmod	O
the	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
kept	VBN	advcl	O
for	IN	case	O
3	CD	nummod	O
d	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
40	CD	nummod	O
and	CC	cc	O
60	CD	conj	O
mM	NN	conj	O
D-ribose	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
even	RB	advmod	O
when	WRB	advmod	O
LMP1	NN	nsubj	B-protein
is	VBZ	cop	O
unable	JJ	ccomp	O
to	TO	mark	O
activate	VB	xcomp	O
NF-kappaB	NN	dobj	B-protein
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
still	RB	advmod	O
capable	JJ	parataxis	O
of	IN	mark	O
inducing	VBG	advcl	O
certain	JJ	amod	O
characteristics	NNS	dobj	O
of	IN	case	O
activated	VBN	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
strongly	RB	advmod	O
suggesting	VBG	advcl	O
that	IN	mark	O
LMP1	NN	nsubj	B-protein
can	MD	aux	O
also	RB	advmod	O
activate	VB	ccomp	O
cells	NNS	dobj	O
independently	RB	advmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
use	VBP	ROOT	O
the	DT	det	O
PIN*POINT	JJ	amod	O
assay	NN	dobj	O
to	TO	mark	O
study	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
on	IN	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
EKLF	NN	nmod	B-protein
to	TO	case	O
5'HS2	NN	nmod	B-DNA
and	CC	cc	O
5'HS3	NN	conj	B-DNA
of	IN	case	O
the	DT	det	O
LCR	NN	nmod	B-DNA
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
simultaneous	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
PKC	NN	nmod	B-protein
and	CC	cc	O
elevation	NN	conj	O
of	IN	case	O
cAMP	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
an	DT	det	O
enhanced	VBN	amod	O
AP-1	NN	compound	B-protein
transcriptional	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
a	DT	det	O
T-leukemia	NN	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
previously	RB	advmod	O
observed	VBN	amod	O
interaction	NN	nsubj	O
between	IN	case	O
the	DT	det	O
parallel	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
may	MD	aux	O
have	VB	ccomp	O
functional	JJ	amod	O
consequences	NNS	dobj	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

All-trans-retinoic	JJ	amod	O
acid	NN	nsubj	O
(	-LRB-	punct	O
ATRA	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
drug	NN	ROOT	O
of	IN	case	O
choice	NN	nmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
APL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

One	CD	nummod	O
clone	NN	nsubj	O
(	-LRB-	punct	O
DEG5	NN	appos	B-cell_line
)	-RRB-	punct	O
also	RB	advmod	O
exerted	VBD	ROOT	O
a	DT	det	O
high	JJ	amod	O
and	CC	cc	O
specific	JJ	conj	O
cytotoxicity	NN	dobj	O
against	IN	case	O
autologous	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
pulsed	VBN	acl	O
with	IN	case	O
BCR1/25	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
with	IN	case	O
IkappaBbeta	NN	nmod	B-protein
provide	VBP	ROOT	O
a	DT	det	O
potential	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
the	DT	det	O
constitutive	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
Tax-expressing	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
precise	JJ	amod	O
factors	NNS	nsubj	O
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
this	DT	det	O
induction	NN	compound	O
mechanism	NN	dobj	O
remain	VBP	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

The	DT	dep	O
AD1	NN	nsubj	B-protein
and	CC	cc	O
AD2	NN	compound	B-protein
transactivation	NN	compound	O
domains	NNS	conj	O
of	IN	case	O
E2A	NN	nmod	B-protein
are	VBP	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
antiapoptotic	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
chimeric	JJ	amod	B-protein
oncoprotein	NN	compound	I-protein
E2A-HLF	NN	nmod	B-protein
.	.	punct	O

Two	CD	nummod	O
interferon-stimulated	JJ	amod	B-DNA
response	NN	compound	I-DNA
elements	NNS	nsubj	I-DNA
(	-LRB-	punct	O
ISRE	NN	appos	B-DNA
)	-RRB-	punct	O
flank	VBP	ROOT	O
a	DT	det	O
multiple	JJ	amod	O
transcription	NN	compound	O
start	NN	compound	O
site	NN	compound	O
region	NN	dobj	O
identifying	VBG	acl	O
MNDA	NN	dobj	B-protein
as	IN	case	O
a	DT	det	O
TATA-less	JJ	amod	B-DNA
interferon-regulated	JJ	amod	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Of	IN	case	O
the	DT	det	O
23	CD	nummod	O
cases	NNS	nmod	O
,	,	punct	O
19	CD	nsubjpass	O
were	VBD	auxpass	O
classified	VBN	ROOT	O
as	IN	case	O
NK-cell	NN	nmod	O
and	CC	cc	O
4	CD	conj	O
as	IN	mark	O
T-cell	NN	nsubj	O
tumours	NNS	advcl	O
.	.	punct	O

The	DT	det	O
chimeric	JJ	amod	B-protein
oncoprotein	NN	compound	I-protein
E2A-HLF	NN	nsubj	B-protein
,	,	punct	O
generated	VBN	acl	O
by	IN	case	O
the	DT	det	O
t	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
17	CD	nummod	I-DNA
;	:	punct	I-DNA
19	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
chromosomal	JJ	amod	I-DNA
translocation	NN	nmod	I-DNA
in	IN	case	O
pro-B-cell	JJ	amod	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
,	,	punct	O
incorporates	VBZ	ROOT	O
the	DT	det	O
transactivation	NN	compound	B-protein
domains	NNS	dobj	I-protein
of	IN	case	O
E2A	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
basic	JJ	amod	B-protein
leucine	NN	compound	I-protein
zipper	NN	compound	I-protein
(	-LRB-	punct	I-protein
bZIP	NN	appos	I-protein
)	-RRB-	punct	I-protein
DNA-binding	JJ	conj	I-protein
and	CC	cc	I-protein
protein	NN	compound	I-protein
dimerization	NN	compound	I-protein
domain	NN	conj	I-protein
of	IN	case	O
HLF	NN	nmod	B-protein
(	-LRB-	punct	O
hepatic	JJ	amod	B-protein
leukemic	JJ	amod	I-protein
factor	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
activator	NN	compound	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
AP	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-1	CD	nummod	I-protein
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	conj	I-protein
by	IN	case	O
CD28	NN	compound	B-protein
stimulation	NN	nmod	O
involves	VBZ	ROOT	O
both	CC	cc:preconj	O
phosphatidylinositol	NN	compound	B-protein
3-kinase	NN	dobj	I-protein
and	CC	cc	O
acidic	JJ	amod	B-protein
sphingomyelinase	NN	compound	I-protein
signals	NNS	conj	O
.	.	punct	O

Phorbol	NN	compound	O
esters	NNS	nsubjpass	O
are	VBP	auxpass	O
required	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
AIM/CD69	NN	compound	B-protein
cell-surface	JJ	amod	O
expression	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
for	IN	mark	O
triggering	VBG	advcl	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
anti-AIM	JJ	amod	B-protein
mAb	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
73	CD	nummod	B-protein
kDa	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
this	DT	det	O
analysis	NN	nmod	O
:	:	punct	O
this	DT	det	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
highly	RB	advmod	O
enriched	VBN	parataxis	O
in	IN	case	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
of	IN	case	I-cell_line
B	NN	compound	I-cell_line
lymphoid	JJ	amod	I-cell_line
origin	NN	nmod	I-cell_line
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
pancreatic	JJ	amod	B-cell_type
beta-cells	NNS	nmod	I-cell_type
and	CC	cc	O
fibroblast	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

NO	NN	nsubj	O
also	RB	advmod	O
decreased	VBD	ROOT	O
the	DT	det	O
endothelial	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
leukocyte	NN	compound	B-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
(	-LRB-	punct	O
E-selectin	NN	dep	B-protein
and	CC	cc	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	conj	O
,	,	punct	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
secretable	JJ	amod	O
cytokines	NNS	conj	B-protein
(	-LRB-	punct	O
IL-6	NN	dep	B-protein
and	CC	cc	O
IL-8	NN	conj	B-protein
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
new	JJ	amod	O
variant	JJ	amod	O
translocation	NN	ROOT	O
in	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukaemia	NN	nmod	O
:	:	punct	O
molecular	JJ	amod	O
characterization	NN	dep	O
and	CC	cc	O
clinical	JJ	amod	O
correlation	NN	conj	O
.	.	punct	O

The	DT	det	O
details	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
regulatory	JJ	amod	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
selects	VBZ	acl:relcl	O
particular	JJ	amod	O
loci	NNS	dobj	B-DNA
for	IN	case	O
rearrangement	NN	nmod	O
are	VBP	auxpass	O
still	RB	advmod	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

An	DT	det	O
unidentified	JJ	amod	O
Ets	NN	compound	B-protein
family	NN	compound	I-protein
protein	NN	nsubj	I-protein
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
EBS	NN	nmod	B-DNA
overlapping	VBG	acl	O
the	DT	det	O
consensus	NN	compound	B-DNA
GAS	NN	compound	I-DNA
motif	NN	dobj	I-DNA
and	CC	cc	O
appears	VBZ	conj	O
to	TO	mark	O
negatively	RB	advmod	O
regulate	VB	xcomp	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

Incubation	NN	nsubjpass	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
1	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
6	CD	nummod	O
)	-RRB-	punct	O
cells/ml	NNS	appos	O
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
natural	JJ	amod	O
thiol	NN	compound	O
antioxidant	NN	dep	O
,	,	punct	O
alpha-lipoic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
prior	JJ	case	O
to	TO	case	O
the	DT	det	O
stimulation	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
25	CD	nummod	O
ng/ml	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
by	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	conj	O
(	-LRB-	punct	O
50	CD	nummod	O
ng/ml	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
basis	NN	nsubj	O
for	IN	case	O
restricted	JJ	amod	O
cytokine	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
1	CD	nummod	I-cell_type
(	-LRB-	punct	I-cell_type
Th1	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
T	NN	compound	I-cell_type
helper	NN	compound	I-cell_type
2	CD	nummod	I-cell_type
(	-LRB-	punct	I-cell_type
Th2	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

Our	PRP$	nmod:poss	O
previous	JJ	amod	O
studies	NNS	nsubj	O
(	-LRB-	punct	O
Chen	NNP	compound	O
,	,	punct	O
H.M.	NNP	compound	O
,	,	punct	O
Ray-Gallet	NNP	compound	O
,	,	punct	O
D.	NNP	conj	O
,	,	punct	O
Zhang	NNP	compound	O
,	,	punct	O
P.	NNP	conj	O
,	,	punct	O
Hetherington	NNP	compound	O
,	,	punct	O
C.J.	NNP	conj	O
,	,	punct	O
Gonzalez	NNP	compound	O
,	,	punct	O
D.A.	NNP	conj	O
,	,	punct	O
Zhang	NNP	compound	O
,	,	punct	O
D.-E.	NNP	conj	O
,	,	punct	O
Moreau-Gachelin	NNP	compound	O
,	,	punct	O
F.	NNP	conj	O
,	,	punct	O
and	CC	cc	O
Tenen	NNP	compound	O
,	,	punct	O
D.G.	NNP	conj	O
(	-LRB-	punct	O
1995	CD	appos	O
)	-RRB-	punct	O
Oncogene	NN	appos	O
11	CD	nummod	O
,	,	punct	O
1549-1560	CD	appos	O
)	-RRB-	punct	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
PU.1	NN	compound	B-DNA
promoter	NN	nsubj	I-DNA
directs	VBZ	ccomp	O
cell	NN	compound	B-DNA
type-specific	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
myeloid	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
PU.1	NN	nsubj	B-protein
activates	VBZ	conj	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
promoter	NN	dobj	O
in	IN	case	O
an	DT	det	O
autoregulatory	JJ	amod	O
loop	NN	nmod	O
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
two	CD	nummod	O
main	JJ	amod	O
goals	NNS	attr	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	appos	O
)	-RRB-	punct	O
to	TO	mark	O
evaluate	VB	advcl	O
whether	IN	mark	O
workers	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
moderately	RB	advmod	O
increased	VBN	amod	O
PCDD/PCDF-body	NN	compound	O
burden	NN	nmod	O
[	-LRB-	punct	O
25-140	CD	dep	O
ppt	NN	dep	O
TCDD	NN	dep	O
or	CC	cc	O
104-522	CD	dep	O
ppt	NN	dep	O
I-TE	NN	conj	O
in	IN	case	O
blood	NN	compound	O
fat	NN	nmod	O
]	-RRB-	punct	O
exhibit	VBP	ccomp	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
surface	NN	compound	B-protein
receptors	NNS	nmod	I-protein
of	IN	case	O
white	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
as	IN	mark	O
observed	VBN	advcl	O
in	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
in	IN	case	O
non-human	JJ	amod	O
primates	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
(	-LRB-	punct	O
2	LS	conj	O
)	-RRB-	punct	O
to	TO	mark	O
clarify	VB	advcl	O
whether	IN	mark	O
persons	NNS	nsubj	O
at	IN	case	O
the	DT	det	O
upper	JJ	amod	O
range	NN	nmod	O
[	-LRB-	punct	O
10-23	CD	nummod	O
ppt	NN	dep	O
TCDD	NN	dep	O
or	CC	cc	O
30-90	CD	conj	O
ppt	NN	dep	O
I-TE	NN	conj	O
in	IN	case	O
blood	NN	compound	O
fat	NN	nmod	O
]	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
body	NN	compound	O
burden	NN	compound	O
reference	NN	compound	O
values	NNS	nmod	O
of	IN	case	O
a	DT	det	O
not	RB	neg	O
particularly	RB	advmod	O
exposed	VBN	amod	O
population	NN	nmod	O
show	VBP	ccomp	O
detectable	JJ	amod	O
deviations	NNS	dobj	O
in	IN	case	O
these	DT	det	O
immunological	JJ	amod	O
variables	NNS	nmod	O
,	,	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
persons	NNS	nmod	O
at	IN	case	O
the	DT	dep	O
lower	JJR	amod	O
and	CC	cc	O
medium	NN	conj	O
range	NN	nmod	O
[	-LRB-	punct	O
1-3	CD	nummod	O
ppt	NN	dep	O
TCDD	NN	dep	O
or	CC	cc	O
9-29	CD	dep	O
ppt	NN	dep	O
I-TE	NN	conj	O
]	-RRB-	punct	O
of	IN	case	O
these	DT	det	O
body	NN	compound	O
burden	NN	compound	O
reference	NN	compound	O
values	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
generally	RB	advmod	O
assumed	VBN	ROOT	O
that	IN	mark	O
most	JJS	amod	O
mammalian	JJ	amod	B-DNA
genes	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
transcribed	VBN	ccomp	O
from	IN	case	O
both	DT	det	O
alleles	NNS	nmod	B-DNA
.	.	punct	O

G-CSF	NN	compound	B-protein
receptors	NNS	nsubj	I-protein
lack	VBP	ROOT	O
intrinsic	JJ	amod	O
tyrosine	NN	compound	B-protein
kinase	NN	compound	I-protein
activity	NN	dobj	O
,	,	punct	O
but	CC	cc	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
results	VBZ	conj	O
in	IN	case	O
the	DT	det	O
rapid	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
tyrosine	NN	compound	O
kinase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
AML1	NN	compound	B-protein
antisense	JJ	amod	O
oligodeoxynucleotide	NN	nsubj	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
sense	NN	amod	O
oligomer	NN	nsubj	O
recovered	VBD	ROOT	O
its	PRP$	nmod:poss	O
differentiation-inducing	JJ	amod	O
capacity	NN	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
butyrate	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
among	IN	case	O
HIV1	NN	compound	B-protein
gene	NN	compound	I-protein
products	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
Tat	NN	compound	B-protein
protein	NN	nsubj	I-protein
appears	VBZ	ccomp	O
to	TO	mark	O
trigger	VB	xcomp	O
monocytic	JJ	amod	O
differentiation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
this	DT	det	O
viral	JJ	amod	B-protein
protein	NN	nsubj	I-protein
directs	VBZ	ccomp	O
progenitors	NNS	dobj	O
of	IN	case	O
the	DT	det	O
monocyte/macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
towards	IN	case	O
a	DT	det	O
differentiation	NN	compound	O
stage	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
production	NN	nsubj	O
of	IN	case	O
viral	JJ	amod	B-protein
antigens	NNS	nmod	I-protein
and	CC	cc	O
virions	NNS	conj	O
might	MD	aux	O
be	VB	cop	O
more	RBR	advmod	O
efficient	JJ	acl:relcl	O
.	.	punct	O

The	DT	det	O
physiological	JJ	amod	O
substrates	NNS	nsubj	O
for	IN	case	O
SHP1	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
have	VBP	aux	O
remained	VBN	ROOT	O
unclear	JJ	xcomp	O
or	CC	cc	O
controversial	JJ	conj	O
.	.	punct	O

Unique	JJ	amod	O
functions	NNS	nsubjpass	O
and	CC	cc	O
disease	NN	compound	O
associations	NNS	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
postulated	VBN	ROOT	O
for	IN	prep	O
such	JJ	amod	O
trans-dimers	NNS	pobj	B-protein
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
different	JJ	acl:relcl	O
from	IN	case	O
cis-encoded	JJ	amod	B-protein
DQ	NN	compound	I-protein
molecules	NNS	nmod	I-protein
encoded	VBN	acl	O
by	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
haplotypes	NNS	nmod	O
.	.	punct	O

By	IN	prep	O
using	VBG	pcomp	O
high	JJ	amod	O
throughput	NN	amod	O
screening	NN	dobj	O
of	IN	case	O
microbial	JJ	amod	O
broths	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
compound	NN	dobj	O
,	,	punct	O
designated	VBN	acl	O
Ro	NN	xcomp	O
09-2210	CD	nummod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
able	JJ	acl:relcl	O
to	TO	mark	O
block	VB	xcomp	O
anti-CD3	NN	nmod:npmod	B-protein
induced	JJ	amod	O
peripheral	JJ	amod	O
blood	NN	compound	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nsubj	O
with	IN	case	O
an	DT	det	O
IC50	NN	nmod	O
=	JJ	conj	O
40	CD	nummod	O
nM	NN	dobj	O
.	.	punct	O

A20	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
activated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
EBV	NN	compound	B-protein
LMP-1	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
cascade	NN	nsubjpass	O
is	VBZ	auxpass	O
blocked	VBN	ccomp	O
when	WRB	advmod	O
anergy	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	advcl	O
to	TO	case	O
high	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
soluble	JJ	amod	O
peptide	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
self	NN	amod	O
and	CC	cc	O
bacterial	JJ	conj	O
peptides	NNS	nsubj	O
equally	RB	advmod	O
were	VBD	cop	O
substantially	RB	advmod	O
less	RBR	advmod	O
effective	JJ	ROOT	O
than	IN	case	O
the	DT	det	O
cognate	JJ	amod	O
viral	JJ	amod	O
peptide	NN	nmod	O
in	IN	mark	O
sensitizing	VBG	advcl	O
target	NN	compound	O
cell	NN	compound	O
lysis	NN	dobj	O
,	,	punct	O
and	CC	cc	O
also	RB	advmod	O
resulted	VBD	conj	O
only	RB	advmod	O
in	IN	case	O
a	DT	det	O
weak	JJ	amod	O
reactivation	NN	nmod	O
of	IN	case	O
memory	NN	compound	B-cell_type
CTLs	NNS	nmod	I-cell_type
in	IN	mark	O
limiting	VBG	advcl	O
dilution	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
cognate	JJ	amod	O
peptide	NN	nsubj	O
was	VBD	cop	O
highly	RB	advmod	O
immunogenic	JJ	parataxis	O
.	.	punct	O

Neutral	JJ	amod	B-protein
sphingomyelinase	NN	nsubjpass	I-protein
(	-LRB-	punct	O
SMase	NN	appos	B-protein
)	-RRB-	punct	O
can	MD	aux	O
be	VB	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
extracellular	JJ	amod	O
signals	NNS	nmod	O
to	TO	mark	O
produce	VB	xcomp	O
ceramide	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
affect	VB	acl:relcl	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
activities	NNS	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
may	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
an	DT	det	O
improvement	NN	nmod	O
of	IN	case	O
antiinflammatory	JJ	amod	O
and	CC	cc	O
immunosuppressive	JJ	conj	O
therapies	NNS	nmod	O
and	CC	cc	O
provide	VBP	conj	O
a	DT	det	O
novel	JJ	amod	O
concept	NN	dobj	O
for	IN	prep	O
drug	NN	compound	O
discovery	NN	pobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
PGE2	NN	nmod	B-protein
vary	VBP	ROOT	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
mode	NN	nmod	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
IL-4	NN	nsubjpass	B-protein
and	CC	cc	O
IL-5	NN	conj	B-protein
are	VBP	auxpass	O
regulated	VBN	conj	O
differently	RB	advmod	O
from	IN	case	O
other	JJ	amod	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

One	CD	nummod	O
type	NN	nsubj	O
,	,	punct	O
EA/S	NN	appos	B-DNA
,	,	punct	O
is	VBZ	cop	O
located	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
region	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
the	DT	det	O
other	JJ	amod	O
,	,	punct	O
E	NN	conj	B-DNA
(	-LRB-	punct	I-DNA
gre	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
,	,	punct	O
is	VBZ	cop	O
located	JJ	conj	O
in	IN	case	O
a	DT	det	O
tandem	JJ	amod	B-DNA
repeat	NN	nmod	I-DNA
with	IN	case	O
enhancer	NN	compound	O
properties	NNS	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
microtitre	NN	compound	O
assay	NN	compound	O
system	NN	dobj	O
for	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
whole-cell	JJ	amod	O
competitive	JJ	amod	O
binding	NN	compound	O
radioassay	NN	acl:relcl	O
using	VBG	acl	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-dexamethasone	NN	dobj	O
as	IN	case	O
radioligand	NN	nmod	O
.	.	punct	O

The	DT	det	O
proteins	NNS	nsubj	O
may	MD	aux	O
prove	VB	ROOT	O
useful	JJ	xcomp	O
in	IN	mark	O
protecting	VBG	advcl	O
adenovirus	NN	compound	B-DNA
gene	NN	compound	I-DNA
therapy	NN	compound	I-DNA
vectors	NNS	dobj	I-DNA
and	CC	cc	O
transplanted	VBN	amod	B-cell_line
cells	NNS	conj	I-cell_line
from	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

The	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
GR	NN	nmod	B-protein
in	IN	case	O
MNL	NN	nmod	B-cell_type
from	IN	case	O
these	DT	det	O
patients	NNS	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
one	CD	nummod	O
month	NN	nmod	O
after	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
prednisolone	JJ	compound	O
therapy	NN	nmod	O
.	.	punct	O

Both	DT	det	O
PPARalpha	NN	compound	B-protein
activators	NNS	nsubj	O
decreased	VBD	ROOT	O
cytokine-induced	JJ	amod	O
VCAM-1	NN	compound	B-protein
mRNA	NN	compound	O
expression	NN	dobj	O
without	IN	mark	O
altering	VBG	advcl	O
its	PRP$	nmod:poss	O
mRNA	NN	compound	O
half-life	NN	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
disclosed	VBD	dep	O
two	CD	nummod	O
specific	JJ	amod	O
complexes	NNS	dobj	O
bound	VBD	acl	O
to	TO	case	O
a	DT	det	O
NF-kappa	NN	nmod:npmod	B-protein
B	NN	nmod:npmod	I-protein
specific	JJ	amod	O
32P-labelled	JJ	amod	O
oligonucleotide	NN	nmod	O
in	IN	case	O
nucleoproteins	NNS	nmod	B-protein
extracted	VBN	acl	O
from	IN	case	O
purified	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
isolated	VBN	acl	O
from	IN	case	O
synovial	JJ	amod	O
fluid	NN	nmod	O
and	CC	cc	O
peripheral	JJ	amod	O
blood	NN	conj	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

Costimulation	NN	nsubj	O
of	IN	case	O
U1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
LPS	NN	nmod	O
plus	CC	cc	O
GM-CSF	NN	conj	B-protein
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
accumulation	NN	nmod	O
of	IN	case	O
steady-state	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
HIV	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
only	RB	advmod	O
a	DT	det	O
weak	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod:npmod	I-DNA
-driven	JJ	amod	O
transcription	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
associated	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	dep	I-protein
,	,	punct	O
was	VBD	auxpass	O
noted	VBN	parataxis	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
neither	DT	nsubj	O
of	IN	case	O
these	DT	det	O
agents	NNS	nmod	O
reduced	VBD	ccomp	O
LPS-stimulated	JJ	amod	O
TF	NN	compound	B-protein
mRNA	NN	compound	O
accumulation	NN	dobj	O
,	,	punct	O
thereby	RB	advmod	O
suggesting	VBG	advcl	O
a	DT	det	O
posttranscriptional	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
the	DT	det	O
effect	NN	nmod	O
.	.	punct	O

Interleukin	NN	nsubj	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
induces	VBZ	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
STATs	NNS	nmod	B-protein
3	CD	dep	I-protein
and	CC	cc	I-protein
5	CD	conj	I-protein
(	-LRB-	punct	O
signal	NN	compound	O
transducer	NN	dep	O
and	CC	cc	O
activator	NN	conj	O
of	IN	amod	O
transcription	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
latter	JJ	amod	O
defect	NN	nsubj	O
may	MD	aux	O
provide	VB	ROOT	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	case	O
many	JJ	nmod	O
of	IN	case	O
the	DT	det	O
XP	NN	nmod	O
and	CC	cc	O
CS	JJ	conj	O
symptoms	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
difficult	JJ	acl:relcl	O
to	TO	mark	O
rationalize	VB	xcomp	O
based	VBN	case	O
solely	RB	advmod	O
on	IN	case	O
an	DT	det	O
NER	NN	compound	O
defect	NN	nmod	O
.	.	punct	O

Control	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
by	IN	case	O
the	DT	det	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	compound	I-protein
inhibitor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
regulatory	JJ	amod	B-protein
Tat	NN	compound	I-protein
protein	NN	nsubj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type-1	NN	nmod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
viral	JJ	amod	O
replication	NN	nmod	O
and	CC	cc	O
also	RB	advmod	O
shows	VBZ	conj	O
pleiotropic	JJ	amod	O
activities	NNS	dobj	O
on	IN	case	O
various	JJ	amod	O
cell	NN	compound	O
functions	NNS	nmod	O
.	.	punct	O

While	IN	mark	O
we	PRP	nsubj	O
can	MD	aux	O
not	RB	neg	O
exclude	VB	advcl	O
that	IN	mark	O
alterations	NNS	nsubj	O
in	IN	case	O
TSG101	NN	nmod	B-DNA
and	CC	cc	O
FHIT	NN	conj	B-DNA
occur	VBP	ccomp	O
during	IN	case	O
cancer	NN	compound	O
development	NN	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
this	DT	det	O
context	NN	nmod	O
the	DT	det	O
commonly	RB	advmod	O
observed	VBN	amod	O
transcript	NN	compound	O
abnormalities	NNS	nsubj	O
are	VBP	aux	O
misleading	JJ	ccomp	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	dobj	O
from	IN	case	O
Fc	NN	compound	B-protein
receptors	NNS	nmod	I-protein
that	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
gene	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
production	NN	conj	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Cis-acting	JJ	amod	B-DNA
elements	NNS	nsubjpass	I-DNA
with	IN	case	O
NFkappaB	NN	nmod	B-DNA
,	,	punct	I-DNA
AP1	NN	conj	I-DNA
and	CC	cc	I-DNA
ETS-like	JJ	amod	I-DNA
binding	NN	compound	I-DNA
motifs	NNS	conj	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
promoter	NN	compound	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
are	VBP	cop	O
important	JJ	conj	O
or	CC	cc	O
essential	JJ	conj	O
for	IN	case	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
following	VBG	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Binding	VBG	amod	B-DNA
sites	NNS	nsubj	I-DNA
at	IN	case	O
the	DT	det	O
core	NN	compound	O
region	NN	nmod	O
show	VBP	ROOT	O
little	JJ	amod	O
conservation	NN	dobj	O
with	IN	case	O
consensus	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
model	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
stimulation	NN	nsubj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
by	IN	case	O
IFN	NN	nmod	B-protein
activates	VBZ	acl:relcl	O
de	FW	amod	O
novo	FW	dep	O
synthesis	NN	dobj	O
of	IN	case	O
an	DT	det	O
inhibitory	JJ	amod	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
possibly	RB	advmod	O
one	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
members	NNS	appos	O
of	IN	case	O
the	DT	det	O
SOCS/	JJ	compound	B-protein
SSI/CIS	NN	compound	I-protein
gene	NN	compound	I-protein
family	NN	nmod	I-protein
,	,	punct	O
capable	JJ	amod	O
of	IN	mark	O
suppressing	VBG	advcl	O
activation	NN	dobj	O
of	IN	case	O
STAT6	NN	nmod	B-protein
by	IN	case	O
IL-4	NN	nmod	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
.	.	punct	O

Molecular	JJ	amod	O
dissection	NN	nsubj	O
of	IN	case	O
the	DT	det	O
B-cell-specific	JJ	amod	O
transcription	NN	compound	O
coactivator	NN	nmod	O
OCA-B	NN	dep	B-protein
has	VBZ	aux	O
revealed	VBN	ROOT	O
distinct	JJ	amod	O
regions	NNS	dobj	O
important	JJ	amod	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
for	IN	case	O
recruitment	NN	nmod	O
to	TO	case	O
immunoglobulin	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
through	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
octamer-bound	JJ	amod	B-protein
Oct-1	NN	nmod	I-protein
and	CC	cc	O
for	IN	case	O
subsequent	JJ	amod	O
coactivator	NN	compound	O
function	NN	conj	O
.	.	punct	O

Analyses	NNS	nsubj	O
of	IN	case	O
mouse	NN	compound	O
strains	NNS	nmod	O
with	IN	case	O
congenital	JJ	amod	O
defects	NNS	nmod	O
in	IN	case	O
different	JJ	amod	O
aspects	NNS	nmod	O
of	IN	case	O
secondary	JJ	amod	O
lymphoid	JJ	amod	O
tissue	NN	compound	O
development	NN	nmod	O
are	VBP	aux	O
beginning	VBG	ROOT	O
to	TO	mark	O
clarify	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
these	DT	det	O
tissues	NNS	nmod	O
in	IN	case	O
immune	JJ	amod	O
responses	NNS	nmod	O
and	CC	cc	O
host	NN	compound	O
defense	NN	conj	O
.	.	punct	O

Second	RB	advmod	O
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
lack	VBP	acl:relcl	O
CD45	NN	dobj	B-protein
and	CC	cc	O
can	MD	aux	O
not	RB	neg	O
signal	VB	conj	O
via	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
,	,	punct	O
supported	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
viral	JJ	amod	O
replication	NN	nmod	O
and	CC	cc	O
gene	NN	compound	O
expression	NN	conj	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
beta-adrenergic	JJ	amod	O
receptor	NN	compound	O
kinase	NN	compound	O
1	CD	nummod	O
carboxyl-terminal	JJ	amod	O
peptide	NN	nmod	O
in	IN	case	O
JY25	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
also	RB	advmod	O
inhibited	VBD	ROOT	O
Raf-1	NN	compound	B-protein
and	CC	cc	O
ERK1	NN	conj	B-protein
activity	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
a	DT	det	O
direct	JJ	amod	O
involvement	NN	dobj	O
of	IN	case	O
G	NN	compound	O
betagamma	NN	compound	O
subunits	NNS	nmod	O
in	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	nmod	O
generated	VBN	acl	O
through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
MAPK	NN	compound	B-protein
pathway	NN	nmod	O
by	IN	case	O
TCC	NN	compound	B-protein
assembly	NN	nmod	O
in	IN	case	O
the	DT	det	O
plasma	NN	compound	O
membrane	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
longer	JJR	amod	O
periods	NNS	nsubjpass	O
of	IN	case	O
incubation	NN	nmod	O
were	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
return	NN	nmod	O
to	TO	case	O
the	DT	det	O
distribution	NN	nmod	O
of	IN	case	O
PKC	NN	nmod	B-protein
in	IN	case	O
control	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
EBV	NN	nsubj	O
is	VBZ	aux	O
using	VBG	ccomp	O
a	DT	det	O
common	JJ	amod	O
pathway	NN	dobj	O
for	IN	case	O
B-cell	NN	compound	O
activation	NN	nmod	O
bypassing	VBG	acl	O
the	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
antigen	NN	nmod	O
,	,	punct	O
T-cell	NN	compound	O
signals	NNS	conj	O
and	CC	cc	O
growth	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
whole	JJ	amod	O
cell	NN	compound	O
dexamethasone	NN	compound	O
binding	NN	compound	O
assay	NN	nmod	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
extent	NN	dobj	O
to	TO	case	O
which	WDT	nmod	O
ALD	NN	nsubj	O
may	MD	aux	O
mimic	VB	acl:relcl	O
mitogenic	JJ	amod	O
stimulation	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
cytoplasmic	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
signaling	NN	compound	O
steps	NNS	dobj	O
in	IN	case	O
ALD-treated	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
detected	VBD	ROOT	O
gangliosides	NNS	dobj	O
in	IN	case	O
supernatants	NNS	nmod	O
from	IN	case	O
RCC	NN	compound	B-cell_type
explants	NNS	nmod	I-cell_type
and	CC	cc	O
not	RB	neg	O
from	IN	case	O
adjacent	JJ	amod	O
normal	JJ	amod	O
kidney	NN	compound	O
tissue	NN	conj	O
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
provided	VBD	ROOT	O
support	NN	dobj	O
for	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
CBF	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
factor	NN	ccomp	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
that	WDT	nsubj	O
is	VBZ	cop	O
responsible	JJ	acl:relcl	O
for	IN	case	O
recognition	NN	nmod	O
of	IN	case	O
the	DT	det	O
SL3	NN	compound	B-DNA
cores	NNS	nmod	I-DNA
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
GATA-1	NN	compound	B-protein
protein	NN	compound	O
level	NN	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
increased	VBN	xcomp	O
in	IN	case	O
ACLA-treated	JJ	nmod	B-cell_line
but	CC	cc	I-cell_line
not	RB	neg	I-cell_line
in	IN	case	I-cell_line
DOX-treated	JJ	amod	I-cell_line
cells	NNS	dep	I-cell_line
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
production	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
Th1	NN	compound	B-protein
cytokine	NN	nmod	I-protein
,	,	punct	O
IFN-gamma	NN	appos	B-protein
,	,	punct	O
by	IN	case	O
HBsAg	NN	compound	B-protein
-reactive	JJ	amod	O
cells	NNS	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
hepatocyte	NN	compound	O
damage	NN	nmod	O
in	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	compound	O
B	NN	nmod	O
,	,	punct	O
while	IN	mark	O
no	DT	neg	O
counteracting	NN	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
Th2	NN	compound	B-protein
cytokines	NNS	nmod	I-protein
produced	VBN	acl	O
by	IN	case	O
those	DT	det	O
cells	NNS	nmod	O
was	VBD	auxpass	O
observed	VBN	advcl	O
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
putative	JJ	amod	O
targets	NNS	nmod	O
of	IN	case	O
calcineurin	NN	nmod	B-protein
is	VBZ	cop	O
the	DT	det	O
pre-existing	JJ	amod	O
,	,	punct	O
cytosolic	JJ	amod	B-protein
component	NN	ROOT	I-protein
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
(	-LRB-	punct	O
NFATp	NN	dep	B-protein
;	:	punct	O
also	RB	advmod	O
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
NFAT1	NN	nmod	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
one	CD	acl:relcl	O
of	IN	case	O
several	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
required	VBN	acl	O
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
interleukin	NN	nmod	B-protein
2	CD	nummod	I-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
B29	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
is	VBZ	cop	O
a	DT	det	O
genetic	JJ	amod	O
target	NN	ccomp	O
for	IN	case	O
EBF	NN	nmod	B-protein
in	IN	case	O
early	JJ	amod	O
B-cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
IFN-alpha	NN	conj	B-protein
,	,	punct	O
IL-12	NN	nsubj	B-protein
induced	VBD	ROOT	O
strong	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
STAT4	NN	nmod	B-protein
and	CC	cc	O
variable	JJ	amod	O
weak	JJ	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
STAT3	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
after	IN	case	O
a	DT	det	O
mutation	NN	nmod	O
of	IN	case	O
Leu122	NN	nmod	O
to	TO	case	O
Arg	NN	nmod	O
the	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
basic	JJ	amod	I-protein
domain	NN	nsubj	I-protein
of	IN	case	O
MyoD	NN	nmod	B-protein
confers	VBZ	ccomp	O
c-myc	NN	nmod:npmod	B-DNA
-like	JJ	amod	O
functional	JJ	amod	O
characteristics	NNS	dobj	O
to	TO	case	O
the	DT	det	O
protein	NN	nmod	O
.	.	punct	O

To	TO	mark	O
define	VB	advcl	O
the	DT	det	O
regions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
required	VBN	acl	O
for	IN	case	O
transcription	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
a	DT	det	O
series	NN	dobj	O
of	IN	case	O
reporter	NN	compound	O
constructs	NNS	nmod	O
containing	VBG	acl	O
different	JJ	amod	O
regions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
IL-3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
5	CD	nummod	I-DNA
'	''	punct	I-DNA
and	CC	cc	I-DNA
3	CD	nummod	I-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
sequences	NNS	conj	I-DNA
.	.	punct	O

Experimentally	RB	advmod	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
progenitors	NNS	nsubj	I-cell_type
do	VBP	aux	O
not	RB	neg	O
tolerate	VB	ROOT	O
constitutive	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
E2a-Pbx1	NN	nmod	B-protein
which	WDT	nsubj	O
contrasts	VBZ	acl:relcl	O
with	IN	case	O
transformation	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
following	VBG	case	O
its	PRP$	nmod:poss	O
stable	JJ	amod	O
expression	NN	nmod	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Molecular	JJ	amod	O
cloning	NN	ROOT	O
of	IN	case	O
SLAP-130	NN	nmod	B-protein
,	,	punct	O
an	DT	det	O
SLP-76-associated	JJ	amod	B-protein
substrate	NN	appos	I-protein
of	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
antigen	NN	compound	I-protein
receptor-stimulated	JJ	amod	I-protein
protein	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
regulatory	JJ	amod	O
role	NN	nsubjpass	O
of	IN	case	O
protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
phosphatases	NNS	nmod	I-protein
(	-LRB-	punct	O
PTPases	NNS	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
was	VBD	auxpass	O
explored	VBN	ROOT	O
by	IN	mark	O
studying	VBG	advcl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
a	DT	det	O
powerful	JJ	amod	O
PTPase	NN	compound	B-protein
inhibitor	NN	nmod	O
,	,	punct	O
vanadate	NN	compound	O
peroxide	NN	appos	O
(	-LRB-	punct	O
pervanadate	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
on	IN	case	O
the	DT	det	O
activation	NN	compound	O
cascade	NN	nmod	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
leukaemic	JJ	amod	I-cell_line
T-cells	NNS	nmod	I-cell_line
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
sustained	JJ	amod	O
high	JJ	amod	O
concentrations	NNS	nsubjpass	O
of	IN	case	O
Ca2+	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
transient	JJ	amod	O
pulses	NNS	conj	O
,	,	punct	O
are	VBP	auxpass	O
required	VBN	ccomp	O
to	TO	mark	O
maintain	VB	xcomp	O
NF-AT	NN	compound	B-protein
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
where	WRB	advmod	O
they	PRP	nsubj	O
participate	VBP	acl:relcl	O
in	IN	case	O
Ca2+-dependent	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	B-DNA
required	VBN	acl	O
for	IN	case	O
lymphocyte	NN	compound	B-cell_type
activation	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
.	.	punct	O

The	DT	det	O
methodology	NN	nsubj	O
employed	VBD	ROOT	O
transient	JJ	amod	O
transfection	NN	dobj	O
of	IN	case	O
HEK	NN	compound	B-cell_line
293	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
a	DT	det	O
cDNA	NN	nmod	O
for	IN	case	O
the	DT	det	O
52-kDa	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
G	NN	compound	B-protein
(	-LRB-	punct	I-protein
S	NN	compound	I-protein
)	-RRB-	punct	I-protein
alpha	NN	nmod	I-protein
under	IN	case	O
regulation	NN	nmod	O
by	IN	case	O
inducible	JJ	amod	B-DNA
metallothionein	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
T3	NN	compound	O
-group	NN	nsubj	O
showed	VBD	ROOT	O
no	DT	neg	O
change	NN	dobj	O
in	IN	case	O
MBC	NN	nmod	O
over	IN	case	O
the	DT	det	O
study	NN	nmod	O
.	.	punct	O

Additional	JJ	amod	O
signaling	VBG	compound	O
molecules	NNS	nsubjpass	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
lymphoid	JJ	amod	O
tissue	NN	compound	O
structure	NN	nmod	O
are	VBP	aux	O
being	VBG	auxpass	O
identified	VBN	ROOT	O
at	IN	prep	O
an	DT	det	O
accelerating	VBG	amod	O
pace	NN	pobj	O
.	.	punct	O

Half-maximal	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
GR	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
protein	NN	conj	O
in	IN	case	O
6TG1.1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
10-100	CD	compound	O
nM	NN	amod	O
dexamethasone	NN	nmod	O
,	,	punct	O
and	CC	cc	O
inclusion	NN	nsubj	O
of	IN	case	O
1	CD	nummod	O
microM	NN	compound	O
RU	NN	nmod	O
38486	CD	nummod	O
completely	RB	advmod	O
blocked	VBD	conj	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
100	CD	compound	O
nM	NN	amod	O
dexamethasone	NN	nmod	O
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
positive	JJ	amod	O
autoregulation	NN	nsubj	O
of	IN	case	O
GR	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
6TG1.1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
a	DT	det	O
receptor-mediated	JJ	amod	O
response	NN	ccomp	O
.	.	punct	O

A-myb	NN	nsubj	B-DNA
was	VBD	cop	O
undetectable	JJ	ROOT	O
in	IN	case	O
4	CD	nummod	O
prolymphocytic	JJ	amod	O
leukemias	NNS	nmod	O
(	-LRB-	punct	O
PLL	NN	appos	O
)	-RRB-	punct	O
but	CC	cc	O
was	VBD	auxpass	O
strongly	RB	advmod	O
expressed	VBN	conj	O
in	IN	case	O
5/20	CD	nmod	O
(	-LRB-	punct	O
25	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	compound	O
(	-LRB-	punct	O
CLL	NN	appos	O
)	-RRB-	punct	O
samples	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
after	IN	case	O
novelty	NN	amod	O
stress	NN	nmod	O
the	DT	det	O
HRBC	NN	compound	B-cell_type
group	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
LPS	NN	compound	B-cell_line
group	NN	conj	I-cell_line
,	,	punct	O
showed	VBD	ROOT	O
increased	VBN	amod	O
ACTH	NN	compound	O
and	CC	cc	O
corticosterone	NN	conj	O
levels	NNS	dobj	O
.	.	punct	O

All	DT	det	O
cases	NNS	nsubj	O
of	IN	case	O
follicular	JJ	pobj	O
,	,	punct	O
mixed	JJ	amod	O
small	JJ	amod	O
and	CC	cc	O
large	JJ	conj	O
cell	NN	compound	O
lymphomas	NNS	nmod	O
showed	VBD	ROOT	O
LAZ3/BCL6	NN	compound	B-protein
expression	NN	dobj	O
confined	VBN	acl	O
to	TO	case	O
the	DT	det	O
neoplastic	JJ	amod	O
follicles	NNS	nmod	O
.	.	punct	O

LPS-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
inhibited	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutant	NN	nmod	O
of	IN	case	O
TRAF2	NN	nmod	B-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
TNF	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
CD40	NN	compound	B-protein
pathway	NN	dobj	O
in	IN	case	O
highly	RB	advmod	O
purified	VBN	amod	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
resting	VBG	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
Ca2+/calmodulin-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
CaMK	NN	compound	I-protein
)	-RRB-	punct	I-protein
type	NN	compound	I-protein
IV/Gr	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
selectively	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
is	VBZ	auxpass	O
activated	VBN	conj	O
after	IN	case	O
signaling	NN	nmod	O
via	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
antigen	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
TCR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
it	PRP	nsubj	O
mediates	VBZ	ccomp	O
some	DT	dobj	O
of	IN	case	O
the	DT	det	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	intj	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
transcriptional	JJ	amod	O
events	NNS	nmod	O
that	WDT	nsubj	O
follow	VBP	acl:relcl	O
TCR	NN	compound	B-protein
engagement	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
characterized	VBD	ROOT	O
Drosophila	NN	dobj	B-protein
and	CC	cc	I-protein
human	JJ	amod	I-protein
TAF	NN	compound	I-protein
subunits	NNS	conj	I-protein
that	WDT	nsubj	O
make	VBP	acl:relcl	O
up	RP	prt	O
the	DT	det	O
core	NN	compound	O
TFIID	NN	compound	B-protein
complex	NN	dobj	I-protein
found	VBN	acl	O
in	IN	case	O
all	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	B-DNA
SP-1	NN	compound	I-DNA
site	NN	nsubj	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin-1	NN	compound	I-DNA
beta	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
confers	VBZ	ROOT	O
preferential	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
keratinocytes	NNS	nmod	B-cell_type
.	.	punct	O

For	IN	case	O
this	DT	det	O
purpose	NN	nmod	O
,	,	punct	O
81	CD	nummod	O
pentadecamer	NN	compound	O
peptides	NNS	nsubjpass	O
covering	VBG	acl	O
the	DT	det	O
complete	JJ	amod	O
491-amino-acid	NN	compound	B-protein
sequence	NN	dobj	I-protein
of	IN	case	O
IE-1	NN	nmod	B-protein
were	VBD	auxpass	O
tested	VBN	ROOT	O
on	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
anti-HCMV	NN	amod	O
immunoglobulin	NN	compound	O
G-seropositive	JJ	amod	O
donors	NNS	nmod	O
.	.	punct	O

The	DT	det	O
IL-4	NN	compound	B-protein
receptor	NN	compound	I-protein
alpha-chain	NN	compound	I-protein
cytoplasmic	JJ	amod	I-protein
domain	NN	nsubj	I-protein
is	VBZ	cop	O
sufficient	JJ	ROOT	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
JAK-1	NN	nmod	B-protein
and	CC	cc	O
STAT6	NN	conj	B-protein
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
IL-4	NN	compound	B-protein
-specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

T-lineage	JJ	amod	O
precursor	NN	compound	O
populations	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
adult	JJ	amod	O
mouse	NN	compound	O
thymus	NN	nmod	O
,	,	punct	O
prior	JJ	case	O
to	TO	mwe	O
T-cell	NN	compound	O
receptor	NN	compound	O
gene	NN	compound	O
rearrangement	NN	nmod	O
,	,	punct	O
display	VBP	ROOT	O
a	DT	det	O
capacity	NN	dobj	O
to	TO	mark	O
produce	VB	acl	O
DC	NNS	dobj	B-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
,	,	punct	O
and	CC	cc	O
are	VBP	cop	O
very	RB	advmod	O
efficient	JJ	amod	O
precursors	NNS	conj	O
of	IN	case	O
DC	NN	nmod	B-cell_type
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

Dose-dependence	JJ	amod	O
studies	NNS	nsubj	O
using	VBG	acl	O
histamine	NN	dobj	O
and	CC	cc	O
dimaprit	NN	conj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
EC50	NN	compound	O
values	NNS	nsubj	O
for	IN	case	O
cAMP	NN	compound	O
production	NN	nmod	O
and	CC	cc	O
c-fos	NN	compound	B-DNA
increase	NN	conj	O
were	VBD	cop	O
similar	JJ	ccomp	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
cAMP	NN	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
c-fos	NN	compound	B-DNA
induction	NN	nmod	O
via	IN	case	O
H2	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Previously	RB	advmod	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
heterologous	JJ	amod	B-protein
activation	NN	compound	I-protein
domains	NNS	nsubj	I-protein
can	MD	aux	O
fully	RB	advmod	O
substitute	VB	ccomp	O
for	IN	case	O
the	DT	det	O
ZEBRA	NN	compound	B-protein
activation	NN	compound	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

IL-10	NN	compound	B-protein
inhibitory	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
exerted	VBN	ROOT	O
on	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Wortmannin	NN	nsubj	O
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
receptor-coupled	JJ	amod	O
PLD	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
blocked	VBD	ROOT	O
the	DT	det	O
anti-CD3	JJ	amod	B-protein
-induced	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
PLD	NN	compound	B-protein
activity	NN	nmod	O
and	CC	cc	O
AP-1	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
activity	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
Bcl-2	NN	compound	B-protein
overexpression	NN	nsubj	O
leads	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
prevention	NN	nmod	O
of	IN	case	O
chemotherapy	NN	compound	O
(	-LRB-	punct	O
paclitaxel	NN	appos	O
)	-RRB-	punct	O
-induced	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
FasL	NN	nmod	B-protein
and	CC	cc	O
blocks	VBZ	conj	O
paclitaxel-induced	JJ	amod	O
apoptosis	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubjpass	O
by	IN	case	O
which	WDT	nmod	O
IFNs	NNS	nsubj	B-protein
mediate	VBP	acl:relcl	O
this	DT	det	O
inhibition	NN	dobj	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
defined	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
should	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
a	DT	det	O
better	JJR	amod	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
IL3	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
isoforms	NNS	nsubj	O
(	-LRB-	punct	O
elf-2a	NN	dep	B-protein
and	CC	cc	O
elf-2b	NN	conj	B-protein
)	-RRB-	punct	O
contain	VBP	ROOT	O
identical	JJ	amod	O
RBTN-2	NN	compound	B-protein
binding	NN	compound	I-protein
regions	NNS	dobj	I-protein
and	CC	cc	O
DNA-binding	JJ	amod	B-protein
domains	NNS	conj	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
assay	NN	dobj	O
to	TO	mark	O
monitor	VB	acl	O
the	DT	det	O
active	JJ	amod	O
,	,	punct	O
GTP-bound	JJ	dep	B-protein
form	NN	dobj	I-protein
of	IN	case	O
Rap1	NN	nmod	B-protein
based	VBN	case	O
on	IN	case	O
the	DT	det	O
differential	JJ	amod	O
affinity	NN	nmod	O
of	IN	case	O
Rap1GTP	NN	nmod	B-protein
and	CC	cc	O
Rap1GDP	NN	conj	B-protein
for	IN	case	O
the	DT	det	O
Rap	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
RalGDS	NN	nmod	B-protein
(	-LRB-	punct	O
RBD	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Loss-	JJ	amod	O
and	CC	cc	O
gain-of-function	JJ	conj	O
mutations	NNS	nsubj	O
reveal	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
BSAP	NN	nmod	B-protein
(	-LRB-	punct	O
Pax-5	NN	appos	B-protein
)	-RRB-	punct	O
at	IN	case	O
the	DT	det	O
start	NN	nmod	O
and	CC	cc	O
end	NN	conj	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
these	DT	det	O
factors	NNS	nsubj	O
cooperate	VBP	ccomp	O
in	IN	case	O
the	DT	det	O
repression	NN	nmod	O
of	IN	case	O
LTR	NN	compound	B-DNA
expression	NN	nmod	O
and	CC	cc	O
viral	JJ	amod	O
replication	NN	conj	O
.	.	punct	O

Many	JJ	amod	O
patients	NNS	nsubj	O
with	IN	case	O
primary	JJ	amod	O
Sjogren	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
(	-LRB-	punct	O
SS	NN	appos	O
)	-RRB-	punct	O
make	VBP	ROOT	O
high	JJ	amod	O
titer	NN	compound	O
IgG	NN	compound	B-protein
autoantibodies	NNS	dobj	I-protein
to	TO	case	O
the	DT	det	O
La	NN	compound	B-protein
(	-LRB-	punct	I-protein
SSB	NN	compound	I-protein
)	-RRB-	punct	I-protein
antigen	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
antigen	NN	compound	O
specific	JJ	amod	O
T	NN	compound	O
cell-B	NN	compound	O
cell	NN	compound	O
interactions	NNS	dobj	O
.	.	punct	O

Five	CD	nummod	O
healthy	JJ	amod	O
human	JJ	amod	O
leukocyte	NN	compound	O
antigen-B8	NN	compound	O
(	-LRB-	punct	O
HLA-B8	NN	compound	O
)	-RRB-	punct	O
-positive	JJ	amod	O
virus	NN	compound	O
carriers	NNS	nsubjpass	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
CD8+	JJ	amod	B-cell_type
cytotoxic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocyte	NN	compound	I-cell_type
(	-LRB-	punct	O
CTL	NN	appos	O
)	-RRB-	punct	O
response	NN	dobj	O
to	TO	case	O
an	DT	det	O
HLA-B8-restricted	JJ	amod	O
peptide	NN	nmod	O
,	,	punct	O
RAKFKQLLQ	NN	appos	O
,	,	punct	O
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
(	-LRB-	punct	I-protein
EBV	NN	compound	I-protein
)	-RRB-	punct	I-protein
immediate-early	JJ	amod	I-protein
trans-activator	NN	compound	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
BZLF1	NN	appos	B-protein
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
Tax	NN	nsubj	B-protein
activates	VBZ	acl:relcl	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
remain	VBP	ROOT	O
unclear	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
findings	NNS	nsubj	O
presented	VBN	acl	O
in	IN	case	O
the	DT	det	O
literature	NN	nmod	O
are	VBP	cop	O
often	RB	advmod	O
controversial	JJ	conj	O
.	.	punct	O

It	PRP	nsubj	O
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
shown	VBN	xcomp	O
which	WDT	mark	O
molecular	JJ	amod	O
events	NNS	nsubj	O
lead	VBP	ccomp	O
to	TO	case	O
the	DT	det	O
specific	JJ	amod	O
'pre-activation	NN	nmod	O
'	''	punct	O
,	,	punct	O
i.e	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
dephosphorylated	VBN	amod	B-protein
(	-LRB-	punct	I-protein
activated	VBN	dep	I-protein
)	-RRB-	punct	I-protein
pRB	NN	nsubj	I-protein
blocks	VBZ	advcl	O
transition	NN	dobj	O
from	IN	case	O
G1	NN	nmod	O
to	TO	case	O
S	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
whereas	IN	mark	O
phosphorylated	VBN	amod	B-protein
(	-LRB-	punct	I-protein
inactivated	VBN	dep	I-protein
)	-RRB-	punct	I-protein
pRB	NN	nsubj	I-protein
releases	VBZ	advcl	O
this	DT	det	O
growth	NN	compound	O
arrest	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
characterized	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
pRB	NN	nmod	B-protein
in	IN	case	O
IL-6	NN	compound	B-protein
-mediated	JJ	amod	O
MM	NN	compound	O
cell	NN	compound	O
growth	NN	nmod	O
.	.	punct	O

Estrogen	NN	compound	O
and	CC	cc	O
progesterone	NN	conj	O
induction	NN	ROOT	O
of	IN	case	O
survival	NN	nmod	O
of	IN	case	O
monoblastoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
undergoing	VBG	acl	O
TNF-alpha	NN	compound	B-protein
-induced	JJ	amod	O
apoptosis	NN	dobj	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
characterized	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
continuous	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
presenting	VBG	acl	O
a	DT	det	O
hierarchical	JJ	amod	O
structure	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
bone	NN	compound	B-cell_line
marrow	NN	compound	I-cell_line
progenitor	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
compartment	NN	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
B-CLL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
bind	VBP	ccomp	O
IL-10	NN	dobj	B-protein
with	IN	case	O
significant	JJ	amod	O
specificity	NN	nmod	O
and	CC	cc	O
express	VBP	conj	O
between	IN	case	O
47	CD	nummod	O
and	CC	cc	O
127	CD	conj	O
IL-10	NN	compound	B-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
dissociation	NN	compound	O
constant	NN	nmod	O
in	IN	case	O
the	DT	det	O
range	NN	nmod	O
of	IN	case	O
168	CD	compound	O
to	TO	dep	O
426	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-12	CD	dep	O
)	-RRB-	punct	O
mol/L	NN	nmod	O
.	.	punct	O

Interaction	NN	nsubj	O
between	IN	case	O
the	DT	det	O
stage	NN	compound	B-DNA
selector	NN	compound	I-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
SSE	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
gamma-globin	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
hypersensitivity	NN	compound	B-DNA
site	NN	conj	I-DNA
2	CD	nummod	I-DNA
in	IN	case	O
the	DT	det	O
locus	NN	compound	B-DNA
control	NN	compound	I-DNA
region	NN	nmod	I-DNA
partly	RB	advmod	O
mediates	VBZ	ROOT	O
the	DT	det	O
competitive	JJ	amod	O
silencing	NN	dobj	O
of	IN	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
fetal	JJ	amod	O
developmental	JJ	amod	O
stage	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
if	IN	mark	O
New	NNP	compound	O
World	NN	compound	O
primates	NNS	nsubj	O
express	VBP	advcl	O
an	DT	det	O
inhibitor	NN	dobj	O
that	WDT	nsubj	O
influences	VBZ	acl:relcl	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
binding	NN	compound	O
characteristics	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
dexamethasone	NN	compound	O
binding	NN	dep	O
in	IN	case	O
cytosol	NN	nmod	O
prepared	VBN	acl	O
from	IN	case	O
B95-8	NN	compound	B-cell_line
lymphoid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
cotton	NN	compound	O
top	NN	amod	O
tamarin	NN	nmod	O
(	-LRB-	punct	O
Saguinus	FW	compound	O
oedipus	FW	appos	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
cytosol	NN	nmod	O
prepared	VBN	acl	O
from	IN	case	O
human	JJ	amod	O
or	CC	cc	O
rat	NN	conj	O
tissues	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
an	DT	det	O
adherent	JJ	amod	O
population	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
,	,	punct	O
with	IN	case	O
preosteoclast/	NN	amod	O
osteoclast	NN	dep	B-cell_type
phenotypic	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
arises	VBZ	ROOT	O
selectively	RB	advmod	O
under	IN	case	O
simple	JJ	amod	O
culture	NN	compound	O
conditions	NNS	nmod	O
from	IN	case	O
normal	JJ	amod	O
PBMC	NN	nmod	B-cell_type
.	.	punct	O

A	DT	det	O
thiol	NN	compound	O
antioxidant	NN	nsubj	O
regulates	VBZ	ROOT	O
IgE	NN	compound	B-protein
isotype	NN	compound	I-protein
switching	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
activation	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
.	.	punct	O

After	IN	case	O
5-day	JJ	amod	O
anti-CD3	NN	amod	B-protein
/IL-2	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
levels	NNS	nsubj	O
of	IN	case	O
p56lck	NN	nmod	B-protein
and	CC	cc	O
p59fyn	NN	conj	B-protein
and	CC	cc	O
protein	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	compound	O
activity	NN	conj	O
increased	VBD	ROOT	O
.	.	punct	O

Contrary	JJ	advmod	O
to	IN	prep	O
the	DT	det	O
idea	NN	pobj	O
that	IN	mark	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
TCR	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
high	JJ	amod	O
doses	NNS	nsubj	O
of	IN	case	O
staurosporine	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
interfere	VB	ROOT	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
by	IN	case	O
PHA	NN	nmod	B-protein
,	,	punct	O
while	IN	mark	O
the	DT	det	O
same	JJ	amod	O
dose	NN	nsubj	O
of	IN	case	O
staurosporine	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	advcl	O
activation	NN	dobj	O
by	IN	case	O
PMA	NN	nmod	O
.	.	punct	O

From	IN	case	O
a	DT	det	O
murine	JJ	amod	B-DNA
B-cell	NN	compound	I-DNA
cDNA-library	NN	nmod	I-DNA
we	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
a	DT	det	O
cDNA	NN	dobj	B-DNA
encoding	VBG	acl	O
the	DT	det	O
murine	JJ	amod	B-protein
B-cell	NN	compound	I-protein
specific	JJ	amod	I-protein
coactivator	NN	dobj	I-protein
mBob1	NN	dep	B-protein
.	.	punct	O

This	DT	det	O
cell	NN	compound	O
line	NN	nsubj	O
stably	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
estrogen	NN	compound	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
an	DT	det	O
IL-1beta	NN	compound	B-DNA
promoter	NN	compound	I-DNA
construct	NN	conj	O
fused	VBN	acl	O
to	TO	case	O
the	DT	det	O
CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
allows	VBZ	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
monitor	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
estrogenic	JJ	amod	O
compounds	NNS	nmod	O
on	IN	case	O
IL-1beta	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
used	VBN	advcl	O
simultaneously	RB	advmod	O
,	,	punct	O
DHEA	NN	nsubj	O
and	CC	cc	O
LPS	NN	compound	O
0.2	CD	nummod	O
ng/ml	NN	conj	O
displayed	VBD	ROOT	O
a	DT	det	O
synergistic	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
monocyte	NN	compound	O
cytotoxicity	NN	nmod	O
against	IN	case	O
cancerous	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
IL-1	NN	compound	B-protein
secretion	NN	appos	O
,	,	punct	O
reactive	JJ	amod	O
nitrogen	NN	compound	O
intermediate	JJ	amod	O
release	NN	conj	O
,	,	punct	O
complement	NN	compound	B-protein
receptor-1	NN	compound	I-protein
cell-surface	JJ	compound	I-protein
protein	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
TNF-alpha	NN	compound	B-protein
protein	NN	conj	I-protein
to	TO	case	O
levels	NNS	nmod	O
comparable	JJ	amod	O
with	IN	case	O
levels	NNS	nmod	O
obtained	VBN	acl	O
using	VBG	xcomp	O
LPS	NN	compound	O
1.0	CD	nummod	O
microgram/ml	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
gp41	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
IL-10	NN	compound	B-protein
up-regulation	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
previously	RB	advmod	O
described	VBN	amod	O
synergistic	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
cAMP	NN	compound	O
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
pathways	NNS	nmod	O
.	.	punct	O

TAL1	NN	nsubj	B-protein
and	CC	cc	O
LIM-only	JJ	amod	B-protein
proteins	NNS	conj	I-protein
synergistically	RB	advmod	O
induce	VBP	ROOT	O
retinaldehyde	NN	compound	B-protein
dehydrogenase	NN	compound	I-protein
2	CD	nummod	I-protein
expression	NN	dobj	O
in	IN	case	O
T-cell	NN	compound	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
by	IN	mark	O
acting	VBG	advcl	O
as	IN	case	O
cofactors	NNS	nmod	O
for	IN	case	O
GATA3	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
effects	NNS	dobj	O
on	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
,	,	punct	O
U937	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
transfected	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
plasmid	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	dobj	I-DNA
(	-LRB-	punct	O
bearing	VBG	advcl	O
two	CD	nummod	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
)	-RRB-	punct	O
coupled	VBN	xcomp	O
to	TO	case	O
a	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
reporter	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
CMV	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
cofactor	NN	ccomp	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
rejection	NN	nmod	O
and	CC	cc	O
infection	NN	conj	O
after	IN	case	O
transplantation	NN	nmod	O
through	IN	case	O
its	PRP$	nmod:poss	O
effects	NNS	nmod	O
on	IN	case	O
IL-6	NN	nmod	B-protein
.	.	punct	O

However	RB	advmod	O
other	JJ	amod	O
possibilities	NNS	nsubjpass	O
,	,	punct	O
such	JJ	amod	O
as	IN	prep	O
altered	JJ	amod	O
distribution	NN	conj	O
of	IN	case	O
lymphocyte	NN	compound	O
subpopulations	NNS	nmod	O
with	IN	case	O
different	JJ	amod	O
receptor	NN	compound	O
concentrations	NNS	nmod	O
and	CC	cc	O
with	IN	case	O
different	JJ	amod	O
cytokine	NN	compound	B-protein
production	NN	conj	O
,	,	punct	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
excluded	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
perivascular	JJ	amod	B-cell_type
DC	NN	nsubj	I-cell_type
migrate	VBP	ROOT	O
across	IN	case	O
the	DT	det	O
activated	VBN	amod	O
endothelium	NN	nmod	O
from	IN	case	O
blood	NN	nmod	O
and	CC	cc	O
receive	VB	conj	O
differentiative	JJ	amod	O
signals	NNS	dobj	O
within	IN	case	O
the	DT	det	O
joint	NN	nmod	O
from	IN	case	O
monocyte-derived	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
and	CC	cc	O
CD40-ligand+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Three	CD	nummod	O
DNA	NN	compound	O
clones	NNS	nsubj	O
containing	VBG	acl	O
HHV-6	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
GS	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
genomic	JJ	amod	I-DNA
fragments	NNS	dobj	I-DNA
transactivated	VBD	ROOT	O
the	DT	det	O
HIV	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
in	IN	case	O
cotransfected	VBN	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
RAW	NN	compound	B-cell_line
264.7	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
an	DT	det	O
E	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
receptor-positive	JJ	amod	O
murine	JJ	amod	O
monocytic	JJ	amod	O
line	NN	appos	O
,	,	punct	O
E	NN	appos	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
downregulates	VBZ	ccomp	O
cytokine-induced	JJ	amod	O
TNF	NN	compound	B-protein
gene	NN	compound	O
expression	NN	dobj	O
by	IN	mark	O
decreasing	VBG	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
Jun	NN	compound	B-protein
NH	NN	compound	I-protein
(	-LRB-	punct	I-protein
2	CD	nummod	I-protein
)	-RRB-	punct	I-protein
-terminal	JJ	amod	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
JNK	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
FK506	NN	nsubj	O
or	CC	cc	O
EGTA	NN	conj	O
(	-LRB-	punct	O
Ca2+	NN	compound	O
chelator	NN	appos	O
)	-RRB-	punct	O
similarly	RB	advmod	O
affected	VBD	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
kappa	NN	compound	B-protein
B-like	JJ	amod	I-protein
site	NN	compound	I-protein
binding	NN	compound	I-protein
complexes	NNS	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
recognized	VBN	acl:relcl	O
by	IN	case	O
any	DT	det	O
antibodies	NNS	nmod	B-protein
against	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
Rel	NN	compound	I-protein
family	NN	compound	I-protein
proteins	NNS	nmod	I-protein
(	-LRB-	punct	O
c-Rel	NN	dep	B-protein
,	,	punct	O
p65	NN	conj	B-protein
,	,	punct	O
p50	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p49	NN	conj	B-protein
)	-RRB-	punct	O
.	.	punct	O

IL-7	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
maintain	VB	ROOT	O
v-Abl	NN	compound	B-protein
-mediated	JJ	amod	O
differentiation	NN	compound	O
arrest	NN	dobj	O
of	IN	case	O
the	DT	det	O
pre-B	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
as	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
and	CC	cc	O
RAG	NN	conj	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
was	VBD	aux	O
unaffected	JJ	advcl	O
by	IN	case	O
IL-7	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
get	VB	advcl	O
further	JJ	amod	O
insights	NNS	dobj	O
into	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
underlying	VBG	acl	O
the	DT	det	O
biological	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Tat	NN	nmod	B-protein
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
endogenous	JJ	amod	O
and	CC	cc	O
exogenous	JJ	conj	O
Tat	NN	compound	B-protein
protein	NN	nmod	I-protein
on	IN	case	O
c-fos	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_line
lymphoblastoid	NN	nmod	I-cell_line
(	-LRB-	punct	I-cell_line
Jurkat	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
and	CC	cc	I-cell_line
monocytic	JJ	amod	I-cell_line
(	-LRB-	punct	I-cell_line
U937	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
primary	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
the	DT	det	O
gene	NN	dobj	O
for	IN	case	O
a	DT	det	O
new	JJ	amod	O
ets-related	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
ERP	NN	appos	B-protein
(	-LRB-	punct	O
ets-related	JJ	amod	B-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
from	IN	case	O
the	DT	det	O
murine	JJ	amod	B-cell_line
pre-B	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
BASC	NN	compound	B-cell_line
6C2	NN	dep	I-cell_line
and	CC	cc	O
from	IN	case	O
mouse	NN	compound	O
lung	NN	compound	O
tissue	NN	conj	O
.	.	punct	O

CD28	NN	compound	B-protein
costimulation	NN	nsubj	O
augments	VBZ	ROOT	O
IL-2	NN	compound	B-protein
secretion	NN	dobj	O
of	IN	case	O
activated	VBN	amod	O
lamina	NN	compound	O
propria	NN	compound	O
T	NN	compound	O
cells	NNS	nmod	O
by	IN	mark	O
increasing	VBG	advcl	O
mRNA	NN	compound	O
stability	NN	dobj	O
without	IN	mark	O
enhancing	VBG	advcl	O
IL-2	NN	compound	B-protein
gene	NN	compound	O
transactivation	NN	dobj	O
.	.	punct	O

This	DT	det	O
CD16	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
FasL	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
suppressed	VBN	ROOT	O
by	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
,	,	punct	O
including	VBG	case	O
thiol	NN	compound	O
deprivation	NN	nmod	O
or	CC	cc	O
treatment	NN	conj	O
with	IN	case	O
hydrogen	NN	compound	O
peroxide	NN	nmod	O
(	-LRB-	punct	O
H2O2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Combined	JJ	amod	O
treatment	NN	nsubj	O
of	IN	case	O
HPCs	NNS	nmod	B-cell_type
with	IN	case	O
alpha-PML	NN	nmod	B-protein
and	CC	cc	O
alpha-Rb	NN	compound	O
oligomers	NNS	conj	O
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
PML	NN	dobj	O
and	CC	cc	O
Rb	NN	conj	O
protein	NN	compound	O
expression	NN	dep	O
and	CC	cc	O
completely	RB	advmod	O
blocked	VBD	conj	O
erythroid	JJ	amod	O
colony	NN	compound	O
development	NN	dobj	O
.	.	punct	O

Lipopolysaccharide	NN	nsubj	O
is	VBZ	ROOT	O
one	CD	attr	O
of	IN	prep	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
trigger	NN	compound	O
substances	NNS	pobj	O
for	IN	case	O
monocytes	NNS	nmod	O
and	CC	cc	O
macrophages	NNS	conj	O
causing	VBG	acl	O
secretion	NN	dobj	O
of	IN	case	O
inflammatory	JJ	amod	B-protein
mediators	NNS	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
interleukin-1	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
the	DT	det	O
constitutive	JJ	amod	O
serine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
STAT1	NN	nmod	B-protein
and	CC	cc	O
STAT3	NN	conj	B-protein
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
CLL	NN	compound	O
samples	NNS	nmod	O
tested	VBN	acl	O
to	TO	case	O
date	NN	nmod	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
physiologic	JJ	amod	O
significance	NN	nsubj	O
of	IN	case	O
this	DT	det	O
modification	NN	nmod	O
remains	VBZ	advcl	O
to	TO	mark	O
be	VB	auxpass	O
determined	VBN	xcomp	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
also	RB	advmod	O
highlight	VBP	ROOT	O
the	DT	det	O
potential	NN	dobj	O
for	IN	case	O
an	DT	det	O
interplay	NN	nmod	O
between	IN	case	O
the	DT	det	O
Notch	NN	nmod	O
and	CC	cc	O
NF-kappaB	NN	compound	O
signaling	NN	compound	O
pathways	NNS	conj	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
action	NN	dobj	O
of	IN	case	O
FGF-1	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
studies	NNS	nsubjpass	O
were	VBD	auxpass	O
initiated	VBN	ROOT	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
that	WDT	nsubj	O
express	VBP	acl:relcl	O
the	DT	det	O
signaling	NN	compound	O
isoform	NN	dobj	O
of	IN	case	O
FGF	NN	compound	B-protein
receptor-1	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
gene	NN	nsubj	O
consists	VBZ	ROOT	O
of	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
exons	NNS	nmod	O
and	CC	cc	O
spans	NNS	conj	O
more	JJR	amod	O
than	IN	quantmod	O
5.6	CD	nummod	B-DNA
kb	NN	dobj	I-DNA
of	IN	case	I-DNA
DNA	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
ras-transformed	JJ	amod	B-cell_line
lymphocytes	NNS	nsubj	I-cell_line
displayed	VBD	ROOT	O
a	DT	det	O
fully	RB	advmod	O
functional	JJ	amod	O
IL-2r	NN	dobj	B-protein
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
c-fos	NN	compound	B-DNA
induction	NN	nmod	O
following	VBG	case	O
treatment	NN	nmod	O
with	IN	case	O
IL-2	NN	nmod	B-protein
;	:	punct	O
nevertheless	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
were	VBD	cop	O
not	RB	neg	O
growth	NN	dep	O
stimulated	VBN	acl	O
by	IN	case	O
this	DT	det	O
lymphokine	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
a	DT	det	O
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
c-myb	NN	compound	B-DNA
5	CD	nummod	I-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
sequence	NN	nmod	I-DNA
that	WDT	nsubj	O
increased	VBD	acl:relcl	O
c-myb	NN	compound	B-DNA
expression	NN	dobj	O
during	IN	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
optimal	JJ	amod	O
agents	NNS	nsubj	O
,	,	punct	O
doses	NNS	conj	O
,	,	punct	O
and/or	CC	cc	O
schedules	NNS	conj	O
have	VBP	ROOT	O
yet	RB	advmod	O
to	TO	mark	O
be	VB	auxpass	O
defined	VBN	xcomp	O
despite	IN	case	O
extensive	JJ	amod	O
clinical	JJ	amod	O
application	NN	nmod	O
.	.	punct	O

After	IN	case	O
stimulation	NN	nmod	O
,	,	punct	O
two	CD	nummod	O
new	JJ	amod	O
kappa	NN	nmod:npmod	B-protein
B-specific	JJ	amod	I-protein
complexes	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
p50-p65	NN	compound	B-protein
heterodimer	NN	nmod	I-protein
and	CC	cc	O
putative	JJ	amod	O
c-Rel	NN	compound	B-protein
homodimer	NN	conj	I-protein
or	CC	cc	O
c-Rel-p65	NN	compound	B-protein
heterodimer	NN	conj	I-protein
.	.	punct	O

Dephosphorylation	NN	ROOT	O
of	IN	case	O
ZAP-70	NN	nmod	B-protein
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
by	IN	case	O
activated	VBN	amod	B-protein
SHP1	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
transient	JJ	amod	O
cotransfection	NN	compound	O
experiments	NNS	nmod	O
,	,	punct	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutants	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
IL-1	NN	compound	B-protein
signaling	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
including	VBG	case	O
MyD88	NN	nmod	B-protein
,	,	punct	O
IRAK	NN	conj	B-protein
,	,	punct	O
IRAK2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
TRAF6	NN	conj	B-protein
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
IL-1	NN	compound	B-protein
-and	NN	compound	O
LPS-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
-luciferase	NN	compound	B-protein
activity	NN	dobj	O
.	.	punct	O

[	-LRB-	punct	O
An	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	nmod	I-protein
blocks	VBZ	ROOT	O
myeloid	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
differentiation	NN	dobj	O
at	IN	case	O
the	DT	det	O
promyelocyte	JJ	amod	O
stage	NN	nmod	O
]	-RRB-	punct	O

Altogether	RB	advmod	O
,	,	punct	O
the	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
evidence	NN	dobj	O
that	IN	mark	O
both	DT	det	O
pathways	NNS	nsubj	O
complement	VBP	ccomp	O
each	DT	det	O
other	JJ	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
,	,	punct	O
conversely	RB	advmod	O
,	,	punct	O
downregulate	VBP	conj	O
the	DT	det	O
TcR	NN	compound	B-protein
transduction	NN	compound	O
mechanisms	NNS	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
in	FW	case	O
vitro-cultured	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
did	VBD	aux	O
not	RB	neg	O
require	VB	ROOT	O
costimulation	NN	dobj	O
for	IN	case	O
cytokine	NN	compound	B-protein
secretion	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
anti-CD3	NN	nmod	B-protein
alone	RB	advmod	O
.	.	punct	O

In	IN	case	O
CsA-treated	JJ	amod	B-cell_line
leukocytes	NNS	nmod	I-cell_line
stimulated	VBN	acl	O
by	IN	case	O
calcium	NN	compound	O
ionophore	NN	nmod	O
,	,	punct	O
the	DT	det	O
degree	NN	nsubjpass	O
of	IN	case	O
reduction	NN	nmod	O
in	IN	case	O
CN	NN	compound	B-protein
activity	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
similar	JJ	amod	O
degree	NN	nmod	O
of	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
each	DT	det	O
event	NN	nmod	O
tested	VBN	acl	O
:	:	punct	O
dephosphorylation	NN	dep	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
nuclear	JJ	amod	O
DNA	NN	compound	O
binding	NN	appos	O
,	,	punct	O
activation	NN	nmod	O
of	IN	case	O
a	DT	det	O
transfected	VBN	amod	B-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
construct	NN	nmod	I-DNA
,	,	punct	O
IFN-gamma	NN	compound	O
and	CC	cc	O
IL-2	NN	conj	O
mRNA	NN	compound	O
accumulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
IFN-gamma	NN	compound	B-protein
production	NN	conj	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
on	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
polycystic	JJ	amod	O
ovary	JJ	amod	O
syndrome	NN	nmod	O
.	.	punct	O

This	DT	det	O
region	NN	nsubj	O
contains	VBZ	ROOT	O
two	CD	nummod	O
binding	VBG	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
the	DT	det	O
Sp1	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

Membrane	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
for	IN	case	O
aldosterone	NN	nmod	O
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
pathway	NN	dep	O
for	IN	case	O
mineralocorticoid	NN	compound	O
action	NN	nmod	O
.	.	punct	O

The	DT	det	O
product	NN	nsubj	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
homolog	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
Drosophila	FW	compound	B-DNA
extra	JJ	amod	I-DNA
sex	NN	compound	I-DNA
combs	NNS	compound	I-DNA
gene	NN	nmod	I-DNA
displays	VBZ	ROOT	O
transcriptional	JJ	amod	B-protein
repressor	NN	compound	I-protein
activity	NN	dobj	O
.	.	punct	O

The	DT	det	O
average	JJ	amod	O
values	NNS	nsubj	O
from	IN	case	O
healthy	JJ	amod	O
volunteers	NNS	nmod	O
did	VBD	aux	O
not	RB	neg	O
differ	VB	ROOT	O
significantly	RB	advmod	O
from	IN	case	O
those	DT	nmod	O
found	VBN	acl	O
in	IN	case	O
these	DT	det	O
children	NNS	nmod	O
,	,	punct	O
though	RB	mark	O
much	RB	amod	O
broader	JJR	amod	O
range	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	advcl	O
in	IN	case	O
patients	NNS	nmod	O
.	.	punct	O

Despite	IN	case	O
differences	NNS	nmod	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
responses	NNS	nmod	O
induced	VBN	acl	O
by	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-2	CD	nummod	I-protein
and	CC	cc	O
IL-7	NN	conj	B-protein
,	,	punct	O
both	DT	det	O
cytokines	NNS	nsubj	B-protein
modulate	VBP	ROOT	O
T	NN	compound	O
cell	NN	compound	O
functions	NNS	dobj	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
signal	NN	compound	B-protein
transducers	NNS	nmod	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	compound	I-protein
(	-LRB-	punct	I-protein
STAT	NN	compound	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	conj	I-protein
.	.	punct	O

[	-LRB-	punct	O
The	DT	det	O
changes	NNS	ROOT	O
in	IN	case	O
glucocorticoid	NN	compound	O
receptors	NNS	nmod	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
asthmatic	JJ	amod	O
subjects	NNS	nmod	O
]	-RRB-	punct	O

Most	JJS	amod	O
patients	NNS	nsubj	O
will	MD	aux	O
respond	VB	ROOT	O
but	CC	cc	O
a	DT	det	O
few	JJ	amod	O
patients	NNS	nsubj	O
respond	VBP	conj	O
less	JJR	advmod	O
to	IN	case	O
these	DT	det	O
drugs	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
for	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
basal	JJ	amod	O
transcription	NN	compound	O
activity	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Using	VBG	ROOT	O
either	CC	cc:preconj	O
a	DT	det	O
p50-	NN	nmod	O
or	CC	cc	O
p65-	NN	conj	O
selected	VBD	amod	O
kappa	NN	compound	O
B	NN	compound	O
motif	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
displayed	VBD	acl:relcl	O
differential	JJ	amod	O
binding	NN	dobj	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
the	DT	det	O
other	JJ	amod	O
protein	NN	nmod	O
,	,	punct	O
little	JJ	appos	O
to	TO	case	O
no	DT	neg	O
binding	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	parataxis	O
with	IN	case	O
the	DT	det	O
heterodimeric	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

Sp	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nsubj	I-protein
preferentially	RB	advmod	O
interact	VBP	ROOT	O
with	IN	case	O
the	DT	det	O
promoter	NN	compound	B-DNA
proximal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
within	IN	case	O
the	DT	det	O
HTLV-I	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

However	RB	advmod	O
,	,	punct	O
more	RBR	advmod	O
recent	JJ	amod	O
studies	NNS	nsubj	O
in	IN	case	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
domain	NN	nsubj	I-protein
is	VBZ	cop	O
not	RB	neg	O
necessary	JJ	ccomp	O
for	IN	case	O
steroid-regulated	JJ	amod	O
apoptosis	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
GR	NN	compound	B-protein
-mediated	JJ	amod	O
transrepression	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
the	DT	det	O
more	RBR	advmod	O
critical	JJ	amod	O
mechanism	NN	conj	O
.	.	punct	O

Peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
atopic	JJ	amod	O
asthma	NN	compound	O
patients	NNS	nmod	O
both	CC	cc:preconj	O
proliferated	VBD	ROOT	O
and	CC	cc	O
produced	VBD	conj	O
IL-5	NN	dobj	B-protein
after	IN	case	O
incubation	NN	nmod	O
with	IN	case	O
mite	JJ	amod	O
allergen	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
mite-specific	JJ	amod	B-cell_type
helper	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
eosinophilic	JJ	amod	O
inflammation	NN	nmod	O
of	IN	case	O
atopic	JJ	amod	O
asthma	NN	nmod	O
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
study	NN	nsubj	O
clearly	RB	advmod	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ccomp	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	O
degradation	NN	dobj	O
or	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	conj	O
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
respond	VBP	acl:relcl	O
to	TO	case	O
IL-2	NN	nmod	B-protein
by	IN	mark	O
entering	VBG	advcl	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	dobj	O
and	CC	cc	O
avoiding	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
these	DT	nmod	O
and	CC	cc	O
other	JJ	amod	O
studies	NNS	conj	O
suggest	VBP	ROOT	O
that	IN	mark	O
additional	JJ	amod	O
C/EBPalpha	NN	compound	B-DNA
target	NN	compound	I-DNA
genes	NNS	nsubj	I-DNA
,	,	punct	O
possibly	RB	advmod	O
other	JJ	amod	O
cytokine	NN	compound	O
receptors	NNS	appos	O
,	,	punct	O
are	VBP	cop	O
also	RB	advmod	O
important	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
block	NN	nmod	O
in	IN	case	O
granulocyte	NN	compound	O
differentiation	NN	nmod	O
observed	VBN	acl	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
C/EBPalpha	NN	compound	B-protein
-deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

This	DT	det	O
site	NN	nsubjpass	O
is	VBZ	auxpass	O
conserved	VBN	ROOT	O
among	IN	case	O
isolates	NNS	nmod	O
of	IN	case	O
HIV-2	NN	nmod	O
and	CC	cc	O
the	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
simian	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	conj	O
,	,	punct	O
and	CC	cc	O
transfection	NN	compound	O
assays	NNS	nsubj	O
show	VBP	conj	O
this	DT	det	O
site	NN	dobj	O
to	TO	mark	O
mediate	VB	xcomp	O
HIV-2	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
activation	NN	dobj	O
following	VBG	case	O
stimulation	NN	nmod	O
of	IN	case	O
monocytic	JJ	nmod	B-cell_line
but	CC	cc	O
not	RB	cc	O
T-cell	NN	compound	B-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

Nuclear	JJ	amod	O
run-on	JJ	amod	O
assays	NNS	nsubj	O
and	CC	cc	O
mRNA	NN	compound	O
stability	NN	compound	O
studies	NNS	conj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
M-CSF	NN	nsubj	B-protein
regulates	VBZ	ccomp	O
c-jun	NN	compound	B-DNA
expression	NN	dobj	O
by	IN	case	O
both	CC	cc:preconj	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
transcription	NN	compound	O
rate	NN	nmod	O
and	CC	cc	O
a	DT	det	O
prolongation	NN	conj	O
in	IN	case	O
the	DT	det	O
half-life	NN	nmod	O
of	IN	case	O
c-jun	NN	compound	B-RNA
transcripts	NNS	nmod	I-RNA
.	.	punct	O

A	DT	det	O
chimeric	JJ	amod	B-DNA
TCR	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
,	,	punct	O
comprising	VBG	acl	O
an	DT	det	O
anti-hapten	JJ	amod	B-protein
single-chain	JJ	amod	I-protein
Ab	NN	compound	I-protein
variable	JJ	amod	I-protein
fragment	NN	dobj	I-protein
fused	VBN	acl	O
to	TO	case	O
the	DT	det	O
transmembrane	NN	amod	B-protein
and	CC	cc	I-protein
cytoplasmic	JJ	conj	I-protein
regions	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
TCR	NN	compound	I-protein
zeta-chain	NN	nmod	I-protein
,	,	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
the	DT	det	O
tetracycline-regulatable	JJ	amod	O
system	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
to	TO	mark	O
regulate	VB	xcomp	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
high	JJ	amod	O
titer	NN	compound	O
anti-38	NN	dobj	O
,	,	punct	O
000-M	NN	compound	O
(	-LRB-	punct	O
r	NN	compound	O
)	-RRB-	punct	O
serum	NN	appos	O
to	TO	mark	O
screen	VB	advcl	O
bacteriophage	NN	compound	B-DNA
lambda	NN	compound	I-DNA
cDNA	NN	compound	I-DNA
expression	NN	compound	O
libraries	NNS	dobj	O
and	CC	cc	O
identified	VBD	conj	O
human	JJ	amod	B-cell_type
islet	NN	dobj	I-cell_type
and	CC	cc	O
placental	JJ	amod	B-cell_line
clones	NNS	conj	I-cell_line
encoding	VBG	acl	O
jun-B	NN	dobj	B-protein
,	,	punct	O
the	DT	det	O
nuclear	JJ	amod	B-protein
transcription	NN	compound	I-protein
protein	NN	appos	I-protein
,	,	punct	O
of	IN	case	O
predicted	VBN	amod	O
38	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
M	NN	nmod	O
(	-LRB-	punct	O
r	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
induction	NN	nsubjpass	O
of	IN	case	O
neutrophil	NN	compound	B-cell_type
binding	NN	nmod	O
by	IN	case	O
LPS	NN	nmod	O
is	VBZ	auxpass	O
actually	RB	advmod	O
suppressed	VBN	ccomp	O
by	IN	case	O
agents	NNS	nmod	O
that	WDT	nsubj	O
elevated	VBD	acl:relcl	O
cAMP	NN	compound	O
levels	NNS	dobj	O
.	.	punct	O

Transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	compound	I-protein
(	-LRB-	punct	I-protein
NFAT	NN	compound	I-protein
)	-RRB-	punct	I-protein
family	NN	nmod	I-protein
regulate	VBP	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
other	JJ	amod	O
inducible	JJ	amod	O
genes	NNS	conj	O
during	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Characterization	NN	nsubjpass	O
of	IN	case	O
HB24	NN	compound	B-DNA
expression	NN	nmod	O
in	IN	case	O
lymphoid	JJ	amod	O
and	CC	cc	O
select	JJ	conj	O
developing	VBG	amod	O
tissues	NNS	nmod	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
.	.	punct	O

The	DT	det	O
effectiveness	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
approach	NN	nmod	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
by	IN	mark	O
immunizing	VBG	advcl	O
mice	NNS	dobj	O
with	IN	case	O
human	JJ	amod	O
group	NN	compound	O
C	NN	compound	O
adenoviruses	NNS	nmod	O
.	.	punct	O

B-1	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
are	VBP	cop	O
self-renewing	JJ	ROOT	O
,	,	punct	O
CD5+	JJ	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
that	WDT	nsubj	O
display	VBP	acl:relcl	O
a	DT	det	O
propensity	NN	dobj	O
for	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
and	CC	cc	O
are	VBP	cop	O
the	DT	det	O
normal	JJ	amod	O
counterpart	NN	conj	O
to	TO	case	O
human	JJ	amod	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemias	NNS	nmod	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
by	IN	case	O
beta-amyloid	NN	amod	O
peptides	NNS	nmod	O
and	CC	cc	O
interferon-gamma	NN	conj	B-protein
in	IN	case	O
murine	JJ	amod	O
microglia	NNS	nmod	O
.	.	punct	O

Using	VBG	advcl	O
tetanus	NN	compound	B-cell_type
toxoid	NN	amod	I-cell_type
specific	JJ	dep	I-cell_type
and	CC	cc	I-cell_type
HLA-DR-restricted	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	dobj	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
polarized	VBN	amod	B-cell_type
intestinal	JJ	amod	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
directed	VBN	acl	O
to	TO	mark	O
express	VB	xcomp	O
HLA-DR	NN	compound	B-protein
molecules	NNS	dobj	I-protein
are	VBP	cop	O
able	JJ	ccomp	O
to	TO	mark	O
initiate	VB	xcomp	O
class	NN	compound	O
II	CD	nummod	O
processing	NN	dobj	O
only	RB	advmod	O
after	IN	case	O
internalization	NN	nmod	O
of	IN	case	O
antigen	NN	nmod	O
from	IN	case	O
their	PRP$	nmod:poss	O
apical	JJ	amod	O
surface	NN	nmod	O
.	.	punct	O

The	DT	det	O
SRG3	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
about	RB	case	O
three	CD	nummod	O
times	NNS	nmod	O
higher	JJR	amod	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
than	IN	case	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	nsubj	I-protein
specific	JJ	amod	O
to	TO	case	O
the	DT	det	O
glycosphingolipid	NN	compound	O
lactosylceramide	NN	nmod	O
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
NF-kappaB-like	JJ	amod	B-protein
factor	NN	nmod	I-protein
by	IN	case	O
PGG-Glucan	NN	nmod	O
,	,	punct	O
and	CC	cc	O
ligand	NN	compound	O
binding	NN	compound	O
data	NNS	conj	O
,	,	punct	O
including	VBG	case	O
polysaccharide	NN	compound	O
specificity	NN	nmod	O
,	,	punct	O
suggested	VBD	advcl	O
that	IN	mark	O
the	DT	det	O
PGG-Glucan	NN	compound	O
binding	NN	compound	O
moiety	NN	nsubj	O
was	VBD	cop	O
lactosylceramide	NN	ccomp	O
.	.	punct	O

Incubation	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
MM-LDL	NN	nmod	B-protein
caused	VBD	ROOT	O
a	DT	det	O
173	CD	compound	O
%	NN	amod	O
increase	NN	dobj	O
in	IN	case	O
intracellular	JJ	amod	O
cAMP	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
therefore	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
exclusive	JJ	amod	O
Tax	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
VCAM-1	NN	nmod	B-protein
on	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
may	MD	aux	O
represent	VB	ccomp	O
a	DT	det	O
pivotal	JJ	amod	O
event	NN	dobj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
HTLV-1-associated	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Together	RB	advmod	O
the	DT	det	O
Act-1	NN	compound	B-DNA
and	CC	cc	O
CBF	NN	conj	B-DNA
sites	NNS	nsubj	I-DNA
form	VBP	ROOT	O
a	DT	det	O
functional	JJ	amod	B-DNA
unit	NN	dobj	I-DNA
(	-LRB-	punct	O
AC	NN	compound	B-DNA
unit	NN	appos	I-DNA
)	-RRB-	punct	O
with	IN	case	O
dual	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

These	DT	det	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
Epstein-Barr	JJ	conj	B-cell_line
virus-immortalized	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
compared	VBN	conj	O
with	IN	case	O
1	CD	compound	B-cell_line
alpha	NN	compound	I-cell_line
,	,	punct	I-cell_line
25-	CD	compound	I-cell_line
(	-LRB-	punct	I-cell_line
OH	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
2D3-responsive	JJ	compound	I-cell_line
cells	NNS	nmod	I-cell_line
of	IN	case	O
the	DT	det	O
T	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
monocytic	JJ	conj	I-cell_type
lineages	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
pigment	NN	nsubj	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
dexamethasone-treated	JJ	amod	B-cell_line
rat	NN	compound	I-cell_line
thymocytes	NNS	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
UV-irradiated	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
DNA	NN	compound	O
ladder	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
cellular	JJ	amod	O
morphological	JJ	amod	O
changes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
flow	NN	compound	O
cytometry	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

Triplex	NN	compound	O
formation	NN	nsubj	O
by	IN	case	O
GM3	NN	nmod	O
blocked	VBD	ROOT	O
recombinant	JJ	amod	B-protein
and	CC	cc	I-protein
nuclear	JJ	conj	I-protein
NF-kappaB	NN	compound	I-protein
proteins	NNS	dobj	I-protein
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
element	NN	nmod	I-DNA
.	.	punct	O

IL-13	NN	nsubj	B-protein
induces	VBZ	ROOT	O
phosphorylation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
JAK2	NN	compound	B-protein
Janus	NN	compound	I-protein
kinase	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
colon	NN	compound	I-cell_line
carcinoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
:	:	punct	O
similarities	NNS	dep	O
between	IN	case	O
IL-4	NN	compound	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
signaling	NN	nmod	O
.	.	punct	O

HIV-1	NN	compound	B-DNA
proviral	JJ	amod	I-DNA
DNA	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
two	CD	nummod	O
binding	VBG	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
danazol	NN	nsubj	O
has	VBZ	ccomp	O
an	DT	det	O
anti-estrogenic	JJ	amod	O
action	NN	dobj	O
to	TO	case	O
the	DT	det	O
monocytes	NNS	nmod	O
through	IN	case	O
the	DT	det	O
competition	NN	nmod	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
estrogen	NN	compound	O
binding	NN	compound	O
sites	NNS	nmod	O
as	IN	mark	O
seen	VBN	advcl	O
in	IN	case	O
the	DT	det	O
estrogen	NN	compound	O
target	NN	compound	O
organ	NN	nmod	O
.	.	punct	O

The	DT	det	O
half-life	NN	nsubj	O
of	IN	case	O
c-jun	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
was	VBD	cop	O
similar	JJ	ROOT	O
(	-LRB-	punct	O
45-50	CD	nummod	O
min	NN	dep	O
)	-RRB-	punct	O
in	IN	case	O
both	CC	cc:preconj	O
untreated	JJ	amod	O
and	CC	cc	O
okadaic	JJ	conj	B-cell_line
acid-induced	JJ	conj	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Programmed	VBN	amod	O
cell	NN	compound	O
death	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
process	NN	ROOT	O
required	VBN	acl	O
for	IN	case	O
the	DT	det	O
normal	JJ	amod	O
development	NN	nmod	O
of	IN	case	O
an	DT	det	O
organism	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
M.	FW	compound	O
tuberculosis	FW	nsubj	O
can	MD	aux	O
upregulate	VB	ccomp	O
HIV-1	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
could	MD	aux	O
thus	RB	advmod	O
have	VB	conj	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
influence	VB	acl	O
the	DT	det	O
pathogenesis	NN	dobj	O
of	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
unlike	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
constitutively	RB	advmod	O
phosphorylated	VBN	ccomp	O
and	CC	cc	O
resynthesized	VBD	conj	O
as	IN	case	O
a	DT	det	O
hypophosphorylated	JJ	amod	B-protein
form	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
differential	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
Ca2+-independent	JJ	amod	B-protein
isoforms	NNS	nmod	I-protein
in	IN	case	O
alveolar	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
compared	VBN	case	O
with	IN	case	O
monocytes	NNS	advcl	B-cell_type
.	.	punct	O

Estrogen	NN	compound	B-protein
receptor	NN	nsubj	I-protein
diminishes	VBZ	ROOT	O
DNA-binding	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
chicken	NN	compound	B-protein
GATA-1	NN	nmod	I-protein
and	CC	cc	O
CACCC-binding	JJ	amod	B-protein
proteins	NNS	conj	I-protein
.	.	punct	O

NF-kB	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
eukaryotic	JJ	amod	B-protein
transcription	NN	compound	I-protein
regulatory	JJ	amod	I-protein
factor	NN	ROOT	I-protein
.	.	punct	O

No	DT	neg	O
difference	NN	nsubjpass	O
in	IN	case	O
plasma	NN	compound	O
cortisol	NN	compound	O
level	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
asthmatics	NNS	nmod	O
and	CC	cc	O
healthy	JJ	amod	O
subjects	NNS	conj	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	B-DNA
Sp1	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
(	-LRB-	punct	O
-110	CD	nummod	B-DNA
bp	NN	appos	I-DNA
)	-RRB-	punct	O
decreased	VBD	ROOT	O
tissue-specific	JJ	amod	O
promoter	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
these	DT	det	O
results	NNS	conj	O
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
transactivation	NN	compound	O
experiments	NNS	nmod	O
,	,	punct	O
demonstrate	VBP	conj	O
that	IN	mark	O
Sp1	NN	nsubj	B-protein
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
tissue-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
CD14	NN	nmod	B-protein
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
by	IN	case	O
PBMC	NN	nmod	B-cell_type
was	VBD	auxpass	O
observed	VBN	ROOT	O
also	RB	advmod	O
when	WRB	advmod	O
other	JJ	amod	O
inducers	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	advcl	O
(	-LRB-	punct	O
staphylococci	NNS	dep	O
,	,	punct	O
silica	NN	conj	O
,	,	punct	O
zymosan	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
locus	NN	compound	B-DNA
control	NN	compound	I-DNA
region	NN	nmod	I-DNA
(	-LRB-	punct	O
LCR	NN	appos	B-DNA
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
locus	NN	nmod	I-DNA
,	,	punct	O
in	FW	amod	O
vivo	FW	dep	O
footprints	NNS	appos	O
on	IN	case	O
NF-E2	NN	nmod	B-protein
(	-LRB-	punct	O
or	CC	cc	O
AP-1	NN	conj	B-protein
)	-RRB-	punct	O
and	CC	cc	O
GATA-1	NN	compound	B-DNA
motifs	NNS	conj	I-DNA
remained	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
regardless	RB	advmod	O
of	IN	mark	O
whether	IN	mark	O
the	DT	det	O
fetal	JJ	nsubjpass	O
or	CC	cc	O
the	DT	det	O
adult	JJ	amod	B-DNA
globin	NN	compound	I-DNA
genes	NNS	conj	I-DNA
are	VBP	auxpass	O
expressed	VBN	advcl	O
.	.	punct	O

Some	DT	det	O
pulmonary	JJ	amod	O
diseases	NNS	nsubjpass	O
like	IN	case	O
bronchitis	NN	nmod	O
or	CC	cc	O
asthma	NN	compound	O
bronchiale	NN	conj	O
are	VBP	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
inflammatory	JJ	amod	O
mechanisms	NNS	nmod	O
in	IN	case	O
bronchial	JJ	amod	B-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
an	DT	det	O
AP-1	NN	compound	B-protein
protein	NN	nmod	O
in	IN	case	O
the	DT	det	O
NF-AT	NN	compound	B-protein
protein	NN	compound	O
complex	NN	nmod	O
may	MD	aux	O
regulate	VB	ROOT	O
NF-AT	NN	compound	B-protein
-binding	JJ	amod	O
activity	NN	dobj	O
through	IN	case	O
protein-protein	JJ	amod	O
interaction	NN	nmod	O
.	.	punct	O

In	IN	case	O
transient	JJ	amod	O
transfectin	NN	compound	O
experiments	NNS	nmod	O
,	,	punct	O
BCL6	NN	nsubj	B-protein
can	MD	aux	O
repress	VB	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
promoters	NNS	nmod	B-DNA
linked	VBN	acl	O
to	TO	case	O
its	PRP$	nmod:poss	O
DNA	NN	compound	B-DNA
target	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
and	CC	cc	O
this	DT	det	O
activity	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	conj	O
upon	IN	case	O
specific	JJ	amod	O
DNA-binding	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
an	DT	det	O
intact	JJ	amod	O
N-terminal	JJ	amod	B-protein
half	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
mobility	NN	compound	O
shift	NN	nsubj	O
and	CC	cc	O
sequence	NN	compound	O
specificity	NN	conj	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
were	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
NF	NN	nmod	B-protein
(	-LRB-	punct	I-protein
P	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
only	RB	advmod	O
a	DT	det	O
small	JJ	amod	O
amount	NN	nsubjpass	O
of	IN	case	O
P65	NN	nmod	B-protein
was	VBD	auxpass	O
detected	VBN	conj	O
in	IN	case	O
NF	NN	nmod	B-protein
(	-LRB-	punct	I-protein
P	NN	appos	I-protein
)	-RRB-	punct	I-protein
in	IN	case	O
crude	JJ	amod	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
.	.	punct	O

NF-kappa	NN	nmod:npmod	B-protein
B	NN	nmod:npmod	I-protein
-directed	JJ	amod	O
luciferase	NN	compound	B-protein
activity	NN	nsubj	O
increased	VBD	ROOT	O
approximately	RB	advmod	O
3-fold	RB	advmod	O
when	WRB	advmod	O
cells	NNS	nsubjpass	O
transfected	VBN	acl	O
with	IN	case	O
the	DT	det	O
plasmid	NN	compound	B-DNA
pNF-kappa	NN	compound	I-DNA
BLUC	NN	nmod	I-DNA
containing	VBG	acl	O
five	CD	nummod	O
copies	NNS	dobj	O
of	IN	case	O
consensus	NN	compound	B-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
minimal	JJ	amod	O
adenovirus	NN	compound	B-DNA
E1B	NN	compound	I-DNA
promoter-luciferase	JJ	amod	I-DNA
gene	NN	nmod	I-DNA
were	VBD	auxpass	O
exposed	VBN	advcl	O
to	TO	case	O
thrombin	NN	nmod	B-protein
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
was	VBD	cop	O
essential	JJ	ccomp	O
for	IN	case	O
thrombin	NN	compound	B-protein
response	NN	nmod	O
.	.	punct	O

Incubation	NN	nsubj	O
with	IN	case	O
40	CD	compound	O
%	NN	amod	O
MCM	NN	nmod	O
caused	VBD	ROOT	O
a	DT	det	O
50	CD	compound	O
%	NN	amod	O
reduction	NN	dobj	O
in	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
this	DT	det	O
evidence	NN	nmod	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
BSAP	NN	nsubj	B-protein
may	MD	aux	O
not	RB	neg	O
only	RB	advmod	O
play	VB	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
neural	JJ	amod	O
development	NN	conj	O
and	CC	cc	O
spermatogenesis	NN	conj	O
.	.	punct	O

Fibrinogen	NN	nsubj	B-protein
also	RB	advmod	O
caused	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
SP1	NN	conj	B-protein
or	CC	cc	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
CREB	NN	compound	I-protein
)	-RRB-	punct	I-protein
factors	NNS	conj	I-protein
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor-1	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
CSF-1R	NN	appos	B-protein
)	-RRB-	punct	O
confers	VBZ	ROOT	O
long-lasting	JJ	amod	O
CSF-1	NN	compound	B-protein
-dependent	JJ	amod	O
proliferation	NN	dobj	O
to	TO	case	O
mouse	NN	compound	B-cell_line
myeloid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
macrophage	NN	compound	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
PU.1	NN	nsubj	O
binds	VBZ	ROOT	O
the	DT	det	O
CD11b	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
close	RB	advmod	O
to	TO	case	O
the	DT	det	O
Sp1	NN	compound	B-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Antibody	NN	compound	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
HUVECs	NNS	nmod	B-cell_type
at	IN	case	O
least	JJS	nmod:npmod	O
75	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
response	NN	nmod	O
is	VBZ	auxpass	O
VCAM-1	NN	nmod:npmod	B-protein
mediated	VBN	ccomp	O
.	.	punct	O

C5a	NN	nsubj	B-protein
induced	JJ	amod	O
kappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
15	CD	nummod	O
min	NN	dobj	O
after	IN	case	O
agonist	NN	compound	O
stimulation	NN	nmod	O
,	,	punct	O
peaked	VBD	conj	O
at	IN	case	O
30-40	CD	nummod	O
min	NN	nmod	O
,	,	punct	O
and	CC	cc	O
remained	VBD	conj	O
detectable	JJ	xcomp	O
at	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

The	DT	det	O
conserved	VBN	amod	O
TRAF3	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubj	I-DNA
in	IN	case	O
LMP1	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
CD30	NN	compound	B-protein
Hodgkin	NN	nmod:poss	I-protein
's	POS	case	I-protein
disease	NN	compound	I-protein
marker	NN	conj	I-protein
provides	VBZ	ROOT	O
further	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
a	DT	det	O
TRAF3	NN	compound	B-protein
-mediated	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	ccomp	O
in	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Stimulation	NN	ROOT	O
of	IN	case	O
interferon	NN	compound	B-DNA
beta	NN	compound	I-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	case	O
purified	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
a	DT	det	O
novel	JJ	amod	O
TH	NN	compound	B-protein
protein	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
identification	NN	nsubj	O
of	IN	case	O
allelic	JJ	amod	O
nucleotides	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-4	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
provides	VBZ	ROOT	O
specific	JJ	amod	O
targets	NNS	dobj	O
for	IN	case	O
a	DT	det	O
comprehensive	JJ	amod	O
screening	NN	nmod	O
of	IN	case	O
atopic	JJ	nmod	O
and	CC	cc	O
nonatopic	JJ	conj	O
individuals	NNS	dep	O
and	CC	cc	O
may	MD	aux	O
provide	VB	conj	O
a	DT	det	O
clue	NN	dobj	O
for	IN	case	O
genetic	JJ	amod	O
predisposition	NN	nmod	O
for	IN	case	O
atopy	NN	nmod	O
.	.	punct	O

Is	VBZ	cop	O
celiac	JJ	amod	O
disease	NN	ROOT	O
due	JJ	case	O
to	TO	case	O
molecular	JJ	amod	O
mimicry	NN	nmod	O
between	IN	case	O
gliadin	NN	compound	O
peptide	NN	compound	O
-HLA	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
molecule	NN	dep	I-protein
-T	NN	nummod	O
cell	NN	compound	O
interactions	NNS	nmod	O
and	CC	cc	O
those	DT	conj	O
of	IN	case	O
some	DT	det	O
unidentified	JJ	amod	B-protein
superantigen	NN	nmod	I-protein
?	.	punct	O

Interferons	NNS	nsubjpass	B-protein
(	-LRB-	punct	O
IFNs	NNS	appos	B-protein
)	-RRB-	punct	O
are	VBP	auxpass	O
well	RB	advmod	O
known	VBN	ROOT	O
both	CC	cc:preconj	O
as	IN	case	O
antiviral	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
as	IN	case	O
potent	JJ	amod	O
regulators	NNS	conj	O
of	IN	case	O
cell	NN	nmod	O
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Positive	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	O
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
composite	JJ	amod	B-DNA
octamer	NN	compound	I-DNA
motif	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
interleukin	NN	compound	B-DNA
2	CD	nummod	I-DNA
enhancer	NN	nmod	I-DNA
by	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
Oct-2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	conj	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
emphasize	VBP	ROOT	O
the	DT	det	O
multiple	JJ	amod	O
levels	NNS	dobj	O
at	IN	case	O
which	WDT	nmod	O
NFAT-dependent	JJ	amod	O
transactivation	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
,	,	punct	O
and	CC	cc	O
predict	VB	conj	O
significant	JJ	amod	O
differences	NNS	dobj	O
in	IN	case	O
the	DT	det	O
architecture	NN	nmod	O
of	IN	case	O
cooperative	JJ	amod	O
transcription	NN	compound	B-protein
complexes	NNS	nmod	I-protein
containing	VBG	acl	O
different	JJ	amod	O
NFAT-family	NN	compound	B-protein
proteins	NNS	dobj	I-protein
.	.	punct	O

Human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
I	CD	nummod	O
Tax	NN	nsubj	B-protein
associates	VBZ	ROOT	O
with	IN	prep	O
and	CC	cc	O
is	VBZ	auxpass	O
negatively	RB	advmod	O
regulated	VBN	conj	O
by	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B2	NN	compound	I-protein
p100	NN	compound	I-protein
gene	NN	compound	I-protein
product	NN	nmod	I-protein
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
viral	JJ	amod	O
latency	NN	nmod	O
.	.	punct	O

Cell	NN	compound	O
cycle	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
E2F	NN	nmod	B-protein
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
reveals	VBZ	ROOT	O
novel	JJ	amod	B-protein
E2F	NN	compound	I-protein
complexes	NNS	dobj	I-protein
and	CC	cc	O
biochemically	RB	advmod	O
distinct	JJ	amod	O
forms	NNS	conj	O
of	IN	case	O
free	JJ	amod	O
E2F	NN	nmod	B-protein
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
cJun	NN	nmod	B-protein
or	CC	cc	O
JunD	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
JunB	NN	conj	B-protein
,	,	punct	O
also	RB	advmod	O
eliminates	VBZ	ROOT	O
the	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
PMA	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
many	JJ	amod	O
but	CC	cc	O
not	RB	cc	O
all	DT	conj	O
Jun-	NN	dep	B-protein
and	CC	cc	I-protein
Fos-related	JJ	conj	I-protein
proteins	NNS	nsubj	I-protein
functionally	RB	advmod	O
activate	VBP	ccomp	O
NF-AT	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	O
component	NN	nmod	O
.	.	punct	O

Neutrophil	NN	compound	O
accumulation	NN	nsubjpass	O
and	CC	cc	O
development	NN	conj	O
of	IN	case	O
lung	NN	compound	O
injury	NN	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
substantially	RB	advmod	O
diminished	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
factors	NNS	nsubj	O
control	VBP	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
regulatory	JJ	amod	B-DNA
immediate-early	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
,	,	punct	O
in	IN	case	O
addition	NN	nmod	O
,	,	punct	O
lytic	JJ	amod	O
and	CC	cc	O
latent	JJ	conj	O
cycle	NN	compound	O
regulatory	JJ	amod	O
genes	NNS	nsubj	O
negatively	RB	advmod	O
interfere	VBP	conj	O
with	IN	case	O
each	DT	det	O
other	JJ	nmod	O
and	CC	cc	O
thus	RB	advmod	O
link	VBP	conj	O
cellular	JJ	amod	O
and	CC	cc	O
viral	JJ	conj	B-DNA
gene	NN	compound	I-DNA
regulatory	JJ	amod	O
mechanisms	NNS	dobj	O
.	.	punct	O

Tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nsubj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
stimulated	VBD	ROOT	O
the	DT	det	O
terminal	JJ	amod	O
differentiation	NN	dobj	O
of	IN	case	O
the	DT	det	O
DC	NN	nmod	B-cell_type
by	IN	mark	O
downregulating	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
M-CSF	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
cfms	VBD	compound	B-RNA
mRNA	NN	conj	I-RNA
,	,	punct	O
and	CC	cc	O
aborting	VBG	conj	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
convert	VB	acl	O
to	TO	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
progesterone	NN	compound	B-protein
receptor	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
analysed	VBN	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
an	DT	det	O
enzyme	NN	compound	O
linked	JJ	amod	O
immunosorbent	JJ	amod	O
assay	NN	dobj	O
(	-LRB-	punct	O
Abbott	NN	compound	O
PgR-EIA	NN	appos	O
monoclonal	JJ	amod	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
evaluate	VB	advcl	O
its	PRP$	nmod:poss	O
prognostic	JJ	amod	O
character	NN	dobj	O
in	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
spontaneous	JJ	amod	O
abortion	NN	nmod	O
.	.	punct	O

Low	JJ	amod	O
dose	NN	compound	O
dexamethasone	NN	compound	O
therapy	NN	nsubj	O
(	-LRB-	punct	O
1-1.5	CD	nummod	O
mg/day	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
of	IN	case	O
clinical	JJ	amod	O
benefit	NN	ROOT	O
in	IN	case	O
these	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

When	WRB	advmod	O
PR	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
incubated	VBN	advcl	O
in	IN	case	O
rabbit	NN	compound	O
reticulocyte	NN	compound	O
lysate	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
association	NN	nsubjpass	O
with	IN	case	O
hsp90	NN	nmod	B-protein
,	,	punct	O
hsp70	NN	appos	B-protein
,	,	punct	O
the	DT	det	O
three	CD	nummod	O
immunophilins	NNS	appos	B-protein
FKBP54	NN	dep	B-protein
,	,	punct	O
FKBP52	NN	conj	B-protein
and	CC	cc	O
CyP-40	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
with	IN	case	O
p23	NN	conj	B-protein
is	VBZ	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
truncated	VBN	amod	B-RNA
TSG101	NN	compound	I-RNA
and	CC	cc	I-RNA
FHIT	NN	conj	I-RNA
transcripts	NNS	nsubjpass	I-RNA
are	VBP	auxpass	O
commonly	RB	advmod	O
detected	VBN	ccomp	O
in	IN	case	O
both	CC	cc:preconj	O
normal	JJ	nmod	O
and	CC	cc	O
malignant	JJ	conj	O
tissues	NNS	dep	O
and	CC	cc	O
that	IN	mark	O
a	DT	det	O
significant	JJ	amod	O
fraction	NN	nsubj	O
of	IN	case	O
these	DT	nmod	O
are	VBP	cop	O
likely	JJ	conj	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
result	NN	xcomp	O
of	IN	case	O
aberrant	JJ	amod	O
splicing	NN	nmod	O
.	.	punct	O

The	DT	det	O
relative	JJ	amod	O
low	JJ	amod	O
binding	NN	compound	O
affinity	NN	nsubj	O
of	IN	case	O
cleavage	NN	compound	B-protein
stimulation	NN	compound	I-protein
factor	NN	compound	I-protein
CstF-64	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
polyA	NN	compound	I-DNA
site	NN	nmod	I-DNA
seems	VBZ	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
its	PRP$	nmod:poss	O
neglect	NN	nmod	O
in	IN	case	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

As	IN	mark	O
expected	VBN	advcl	O
,	,	punct	O
these	DT	det	O
transgenic	JJ	amod	O
mice	NNS	nsubj	O
developed	VBD	ROOT	O
splenomegaly	NN	dobj	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
massive	JJ	amod	O
amplification	NN	nmod	O
of	IN	case	O
Ter	NN	compound	B-cell_line
119	CD	nummod	I-cell_line
positive	JJ	amod	I-cell_line
erythroid	JJ	amod	I-cell_line
nucleated	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
expressing	VBG	acl	O
T	NN	compound	B-protein
antigen	NN	dobj	I-protein
.	.	punct	O

Interaction	NN	nsubj	O
between	IN	case	O
immunoglobulin-like	JJ	amod	B-protein
transcript-2/leukocyte	NN	compound	I-protein
Ig-like	JJ	amod	I-protein
receptor	NN	nmod	I-protein
1	CD	nummod	I-protein
on	IN	case	O
NKL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
HLA-B27	NN	conj	B-protein
on	IN	case	O
target	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
leads	VBZ	ROOT	O
to	TO	case	O
an	DT	det	O
impairment	NN	nmod	O
of	IN	case	O
NKL	NN	compound	O
natural	JJ	amod	O
cytotoxicity	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
correlates	VBZ	acl:relcl	O
with	IN	case	O
an	DT	det	O
absence	NN	nmod	O
of	IN	case	O
JunB	NN	nmod	O
,	,	punct	O
FosB	NN	conj	O
,	,	punct	O
and	CC	cc	O
c-Fos	NN	conj	O
transcription	NN	dep	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
an	DT	det	O
absence	NN	conj	O
of	IN	case	O
their	PRP$	nmod:poss	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Preliminary	JJ	amod	O
observations	NNS	nsubj	O
tend	VBP	ROOT	O
to	TO	mark	O
correlate	VB	xcomp	O
this	DT	det	O
CREF	NN	compound	O
cell	NN	compound	O
killing	NN	dobj	O
with	IN	case	O
the	DT	det	O
accumulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
early	JJ	amod	B-protein
viral	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
and/or	CC	cc	O
viral	JJ	amod	B-DNA
DNA	NN	conj	I-DNA
in	IN	case	O
the	DT	det	O
infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
method	NN	nsubjpass	O
developed	VBN	acl	O
can	MD	aux	O
be	VB	auxpass	O
adapted	VBN	ROOT	O
to	TO	mark	O
characterize	VB	xcomp	O
and	CC	cc	O
identify	VB	conj	O
other	JJ	amod	O
composite	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
as	RB	advmod	O
well	RB	mwe	O
.	.	punct	O

oriP	NN	nsubj	B-DNA
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
EBNA	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
Epstein-Barr	JJ	amod	B-cell_line
virus-immortalized	JJ	amod	I-cell_line
lymphoblastoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
have	VBP	ROOT	O
an	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
inflammatory	JJ	amod	O
and	CC	cc	O
immune	JJ	conj	O
responses	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	nsubj	O
may	MD	aux	O
be	VB	cop	O
through	IN	case	O
the	DT	det	O
modulation	NN	conj	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
binding	VBG	acl	O
to	TO	case	O
DNA	NN	nmod	O
.	.	punct	O

Curcumin	NN	nsubjpass	O
(	-LRB-	punct	O
diferuoylmethane	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
yellow	JJ	amod	O
pigment	NN	appos	O
in	IN	case	O
the	DT	det	O
rhizome	NN	nmod	O
of	IN	case	O
tumeric	NN	amod	O
(	-LRB-	punct	O
Curcuma	NN	amod	O
longa	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
ingredient	NN	appos	O
of	IN	prep	O
curry	JJ	compound	O
spice	NN	pobj	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
exhibit	VB	xcomp	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
pharmacological	JJ	amod	O
effects	NNS	nmod	O
including	VBG	case	O
antitumor	NN	nmod	O
,	,	punct	O
antiinflammatory	JJ	conj	O
,	,	punct	O
and	CC	cc	O
antiinfectious	JJ	amod	O
activities	NNS	conj	O
.	.	punct	O

The	DT	det	O
first	JJ	amod	O
step	NN	nsubj	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
import	NN	compound	O
process	NN	nmod	O
is	VBZ	cop	O
recognition	NN	ROOT	O
of	IN	case	O
a	DT	det	O
nuclear	JJ	amod	B-protein
localization	NN	compound	I-protein
sequence	NN	nmod	I-protein
(	-LRB-	punct	O
NLS	NN	appos	B-protein
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
karyophilic	JJ	amod	B-protein
protein	NN	nmod	I-protein
by	IN	case	O
a	DT	det	O
cytoplasmic	JJ	amod	B-protein
receptor	NN	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
importin	NN	compound	B-protein
(	-LRB-	punct	I-protein
karyopherin	NN	compound	I-protein
)	-RRB-	punct	I-protein
-alpha	NN	compound	I-protein
subunit	NN	nmod	I-protein
.	.	punct	O

Gene	NN	nsubj	O
for	IN	case	O
a	DT	det	O
tissue-specific	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
activator	NN	nmod	I-protein
(	-LRB-	punct	O
EBF	NN	dep	B-protein
or	CC	cc	O
Olf-1	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
expressed	VBN	acl	O
in	IN	case	O
early	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
adipocytes	NNS	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
olfactory	JJ	amod	B-cell_type
neurons	NNS	conj	I-cell_type
,	,	punct	O
is	VBZ	cop	O
located	JJ	ROOT	O
on	IN	case	O
human	JJ	amod	B-DNA
chromosome	NN	nmod	I-DNA
5	CD	nummod	I-DNA
,	,	punct	O
band	NN	compound	B-DNA
q34	NN	conj	I-DNA
,	,	punct	O
and	CC	cc	O
proximal	JJ	amod	B-DNA
mouse	NN	compound	I-DNA
chromosome	NN	conj	I-DNA
11	CD	nummod	I-DNA
.	.	punct	O

ngal	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
at	IN	case	O
moderate	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
only	RB	advmod	O
2	CD	compound	O
of	IN	advmod	O
17	CD	nummod	O
human	JJ	amod	O
tissues	NNS	nmod	O
examined	VBN	acl	O
,	,	punct	O
breast	NN	conj	O
and	CC	cc	O
lung	NN	conj	O
.	.	punct	O

In	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
HIV	NN	compound	O
transcription	NN	nsubjpass	O
is	VBZ	auxpass	O
poorly	RB	advmod	O
detected	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
any	DT	det	O
event	NN	nsubj	O
that	WDT	nsubj	O
enables	VBZ	acl:relcl	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
to	TO	mark	O
become	VB	xcomp	O
less	RBR	advmod	O
responsive	JJ	xcomp	O
to	TO	case	O
IFN-	NN	amod	B-protein
gamma	NN	nmod	I-protein
may	MD	aux	O
potentially	RB	advmod	O
alter	VB	ROOT	O
immune	JJ	amod	O
responsiveness	NN	dobj	O
to	TO	case	O
Ag	NN	nmod	B-protein
.	.	punct	O

B	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
prestimulated	VBN	ROOT	O
with	IN	case	O
SAC	NN	nmod	O
for	IN	case	O
48	CD	nummod	O
hrs	NNS	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TCL1	NN	nmod	B-protein
also	RB	advmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
preleukaemic	JJ	amod	B-cell_type
clone	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
A-T	NN	compound	O
patients	NNS	nmod	O
containing	VBG	acl	O
the	DT	det	O
primary	JJ	amod	O
translocation	NN	dobj	O
alone	RB	advmod	O
.	.	punct	O

Their	PRP$	nmod:poss	O
effects	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
src-family	NN	compound	B-DNA
tyrosine	NN	compound	I-DNA
kinase	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
were	VBD	cop	O
different	JJ	ROOT	O
:	:	punct	O
hck	NN	compound	B-DNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
similarly	RB	advmod	O
induced	VBN	parataxis	O
by	IN	case	O
these	DT	det	O
agents	NNS	nmod	O
but	CC	cc	O
lyn	NN	compound	O
expression	NN	nsubj	O
was	VBD	cop	O
stronger	JJR	conj	O
and	CC	cc	O
more	RBR	advmod	O
rapid	JJ	conj	O
after	IN	case	O
RA	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
present	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
IL-6	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
binding	NN	compound	I-protein
factor	NN	nsubj	I-protein
II	CD	nummod	I-protein
functions	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
repressor	NN	nmod	O
specific	JJ	amod	O
for	IN	case	O
IL-6	NN	nmod:npmod	B-DNA
kappa	NN	nmod:npmod	I-DNA
B-related	JJ	amod	I-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
motifs	NNS	nmod	I-DNA
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
an	DT	det	O
unchanged	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
active	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
the	DT	det	O
cytosolic	JJ	amod	B-protein
inhibitor	NN	compound	I-protein
protein	NN	compound	I-protein
IkappaB-alpha	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
NB4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
two	CD	nummod	O
other	JJ	amod	O
synthetic	JJ	amod	O
nonselective	JJ	amod	O
RAR	NN	compound	O
ligands	NNS	nsubj	O
are	VBP	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
inducing	VBG	advcl	O
LAP	NN	dobj	B-protein
as	RB	advmod	O
much	JJ	nmod	O
as	IN	case	O
AM580	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
RAR	NN	compound	O
beta-	NN	nsubj	O
or	CC	cc	O
RAR	NN	nmod:npmod	O
gamma-specific	JJ	amod	O
ligands	NNS	dep	O
are	VBP	cop	O
totally	RB	advmod	O
ineffective	JJ	parataxis	O
.	.	punct	O

Transient	JJ	amod	O
transfection	NN	compound	O
analysis	NN	nsubj	O
with	IN	case	O
target	NN	compound	B-DNA
plasmids	NNS	nmod	I-DNA
containing	VBG	acl	O
either	CC	cc:preconj	O
DRA	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
(	-LRB-	punct	O
wild-type	JJ	dep	O
or	CC	cc	O
mutated	VBN	conj	O
)	-RRB-	punct	O
or	CC	cc	O
TPA	NN	compound	B-DNA
response	NN	compound	I-DNA
elements	NNS	conj	I-DNA
demonstrated	VBD	ROOT	O
that	IN	mark	O
pretreatment	NN	nsubj	O
with	IN	case	O
the	DT	det	O
selective	JJ	amod	O
PKC	NN	compound	B-protein
inhibitor	NN	compound	O
GF	NN	compound	O
109203X	NN	nmod	O
repressed	VBD	ccomp	O
TPA-mediated	JJ	amod	O
activation	NN	dobj	O
.	.	punct	O

This	DT	det	O
technique	NN	nsubjpass	O
was	VBD	auxpass	O
successfully	RB	advmod	O
applied	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
differences	NNS	dobj	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
expression	NN	nmod	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
before	IN	nmod	O
and	CC	cc	O
after	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
potent	JJ	amod	O
differentiation	NN	compound	O
inducers	NNS	nmod	O
:	:	punct	O
12-O-tetradecanoylphorbol	NN	compound	O
13-acetate	NN	dep	O
(	-LRB-	punct	O
TPA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
combination	NN	conj	O
of	IN	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D2	NN	conj	O
(	-LRB-	punct	O
VD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
proteolytic	JJ	amod	O
event	NN	nsubj	O
liberates	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
,	,	punct	O
permitting	VBG	advcl	O
its	PRP$	nmod:poss	O
rapid	JJ	amod	O
translocation	NN	dobj	O
into	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
where	WRB	advmod	O
it	PRP	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
its	PRP$	nmod:poss	O
cognate	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
major	JJ	amod	O
side	JJ	amod	O
effects	NNS	nsubj	O
severely	RB	advmod	O
limit	VBP	ROOT	O
their	PRP$	nmod:poss	O
therapeutic	JJ	amod	O
use	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
HL-60	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
transduced	VBN	acl	O
with	IN	case	O
a	DT	det	O
bcl-2	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
showed	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
differentiation	NN	compound	O
response	NN	dobj	O
to	TO	case	O
retinoids	NNS	nmod	O
as	IN	mark	O
did	VBD	advcl	O
parental	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
even	RB	advmod	O
though	IN	mark	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	advcl	O
in	IN	case	O
these	DT	det	O
bcl-2-transduced	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
differentiation	NN	nsubjpass	O
and	CC	cc	O
apoptosis	NN	conj	O
are	VBP	auxpass	O
regulated	VBN	ccomp	O
independently	RB	advmod	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
these	DT	nmod	O
,	,	punct	O
designated	VBN	acl	O
Rhom-2	NN	xcomp	B-DNA
,	,	punct	O
is	VBZ	cop	O
located	JJ	ROOT	O
on	IN	case	O
human	JJ	amod	B-DNA
chromosome	NN	nmod	I-DNA
11	CD	nummod	I-DNA
at	IN	case	O
band	NN	compound	B-DNA
11p13	NN	nmod	I-DNA
,	,	punct	O
where	WRB	advmod	O
a	DT	det	O
cluster	NN	nsubj	O
of	IN	case	O
T-cell	NN	compound	B-DNA
leukemia-specific	JJ	amod	I-DNA
translocations	NNS	nmod	I-DNA
occur	VBP	acl:relcl	O
;	:	punct	O
all	DT	det	O
translocation	NN	compound	O
breakpoints	NNS	nsubj	O
at	IN	case	O
11p13	NN	nmod	B-DNA
are	VBP	cop	O
upstream	JJ	parataxis	O
of	IN	case	O
the	DT	det	O
Rhom-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activity	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
increase	VB	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
HER-2/neu	NN	compound	B-protein
overexpression	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
nuclear	JJ	amod	O
run-on	JJ	amod	O
assay	NN	dobj	O
,	,	punct	O
IL-4	NN	compound	B-protein
stimulation	NN	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
enhance	VB	xcomp	O
transcription	NN	dobj	O
by	IN	case	O
two-	CD	nmod	O
to	TO	dep	O
threefold	RB	dep	O
.	.	punct	O

Helenalin	NN	nsubj	O
inhibits	VBZ	ROOT	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
four	CD	nummod	O
different	JJ	amod	O
stimuli	NNS	nmod	O
in	IN	case	O
T-cells	NNS	nmod	B-cell_type
,	,	punct	O
B-cells	NNS	conj	B-cell_type
and	CC	cc	O
epithelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
abrogates	VBZ	conj	O
kappaB	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
elevated	JJ	amod	O
IFN	NN	compound	B-protein
alpha	NN	compound	I-protein
levels	NNS	nsubj	O
in	IN	case	O
AIDS-GR	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
the	DT	det	O
lack	NN	ROOT	O
of	IN	case	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
cortisol	NN	nmod	O
on	IN	case	O
IFN	NN	compound	B-protein
alpha	NN	compound	I-protein
production	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
cortisol	NN	compound	O
resistance	NN	nmod	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
p45	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
the	DT	det	O
neutrophils	NNS	nmod	B-cell_type
declined	VBD	ROOT	O
rapidly	RB	advmod	O
after	IN	case	O
transfer	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
to	TO	case	O
in	FW	amod	O
vitro	FW	dep	O
culture	NN	nmod	O
and	CC	cc	O
G-CSF	NN	conj	B-protein
could	MD	aux	O
not	RB	neg	O
sustain	VB	conj	O
the	DT	det	O
expression	NN	dobj	O
from	IN	case	O
the	DT	det	O
down-regulation	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
E2	NN	dobj	B-protein
may	MD	aux	O
also	RB	advmod	O
participate	VB	conj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
neutrophil-specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

1	LS	ROOT	O
.	.	punct	O

From	IN	case	O
these	DT	det	O
results	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
can	MD	aux	O
conclude	VB	ROOT	O
that	IN	mark	O
electrostatic	JJ	amod	O
interactions	NNS	nsubj	O
of	IN	case	O
retinoids	NNS	nmod	O
with	IN	case	O
the	DT	det	O
RAR	NN	compound	B-protein
alpha-LBD	NN	nmod	I-protein
play	VBP	ccomp	O
a	DT	det	O
significant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
ligand	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

NF-kB	NN	compound	B-protein
levels	NNS	nsubj	O
were	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
unstimulated	JJ	amod	B-cell_line
U1	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
parent	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
U937	NN	nmod	B-cell_line
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
IL-4	NN	compound	B-protein
costimulation	NN	nsubj	O
with	IN	case	O
IL-2	NN	nmod	B-protein
or	CC	cc	O
IL-12	NN	conj	B-protein
does	VBZ	aux	O
not	RB	neg	O
alter	VB	ROOT	O
their	PRP$	nmod:poss	O
own	JJ	amod	O
preferential	JJ	amod	O
GAS	NN	compound	B-DNA
-like	JJ	amod	O
DNA	NN	compound	O
binding	NN	compound	O
patterns	NNS	dobj	O
when	WRB	advmod	O
C	NN	compound	B-DNA
epsilon-	NN	nsubjpass	I-DNA
,	,	punct	I-DNA
Fc	NN	compound	I-DNA
gamma	NN	compound	I-DNA
RI-	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
SIE	NN	compound	I-DNA
GAS	NN	compound	I-DNA
motif	NN	conj	I-DNA
containing	VBG	acl	O
oligonucleotide	NN	compound	O
probes	NNS	dobj	O
are	VBP	auxpass	O
compared	VBN	advcl	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
induction	NN	nsubj	O
of	IN	case	O
GAS-like	JJ	amod	B-protein
DNA-protein	JJ	amod	I-protein
binding	NN	compound	I-protein
complexes	NNS	nmod	I-protein
by	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
IL-4	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-12	NN	conj	B-protein
is	VBZ	cop	O
highly	RB	advmod	O
selective	JJ	ccomp	O
and	CC	cc	O
represents	VBZ	conj	O
one	CD	nummod	O
important	JJ	amod	O
factor	NN	dobj	O
in	IN	mark	O
determining	VBG	acl	O
specific	JJ	amod	O
gene	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
AM580	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
effective	JJ	ROOT	O
as	IN	case	O
ATRA	NN	nmod	O
in	IN	mark	O
modulating	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
these	DT	det	O
differentiation	NN	compound	B-protein
markers	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
HL-60	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
granulocytes	NNS	conj	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	compound	O
patients	NNS	nmod	O
during	IN	case	O
the	DT	det	O
stable	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
LTB4	NN	nsubj	O
induces	VBZ	ccomp	O
synthesis	NN	dobj	O
of	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-6	CD	nummod	I-protein
by	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
through	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Repression	NN	nsubj	O
by	IN	case	O
Ikaros	NN	compound	B-protein
proteins	NNS	nmod	I-protein
correlates	VBZ	ROOT	O
with	IN	case	O
hypo-acetylation	NN	nmod	O
of	IN	case	O
core	NN	compound	B-protein
histones	NNS	nmod	I-protein
at	IN	case	O
promoter	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
and	CC	cc	O
is	VBZ	auxpass	O
relieved	VBN	conj	O
by	IN	case	O
histone	NN	compound	B-protein
deacetylase	NN	compound	I-protein
inhibitors	NNS	nmod	O
.	.	punct	O

Cloning	NN	ROOT	O
and	CC	cc	O
functional	JJ	amod	O
characterization	NN	conj	O
of	IN	case	O
early	JJ	amod	B-protein
B-cell	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
regulator	NN	appos	O
of	IN	case	O
lymphocyte-specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Signals	NNS	ROOT	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factors	NNS	conj	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
interleukin-4	NN	nmod	B-DNA
and	CC	cc	I-DNA
interleukin-5	NN	conj	I-DNA
genes	NNS	dep	I-DNA
in	IN	case	O
helper	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
mutants	NNS	nmod	O
to	TO	mark	O
activate	VB	acl	O
a	DT	det	O
reporter	NN	compound	O
gene	NN	dobj	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
conserved	JJ	amod	O
W-X-Y	NN	nmod	B-DNA
or	CC	cc	I-DNA
X-Y	NN	compound	I-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	conj	I-DNA
was	VBD	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	dep	O
GR	NN	nmod	B-protein
and	CC	cc	O
mineralocorticoid	NN	compound	B-protein
receptor	NN	conj	I-protein
(	-LRB-	punct	O
MR	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
CRH	NN	compound	O
regulation	NN	nmod	O
in	IN	case	O
the	DT	det	O
FMS	NN	compound	O
patients	NNS	nmod	O
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
solved	VBN	xcomp	O
.	.	punct	O

The	DT	det	O
transmembrane	JJ	compound	O
domains	NNS	nsubjpass	O
are	VBP	auxpass	O
well	RB	advmod	O
conserved	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
there	EX	expl	O
is	VBZ	conj	O
striking	JJ	amod	O
sequence	NN	compound	O
divergence	NN	nsubj	O
of	IN	case	O
the	DT	det	O
carboxy-terminal	JJ	amod	B-protein
cytoplasmic	JJ	amod	I-protein
domain	NN	nmod	I-protein
essential	JJ	amod	O
for	IN	case	O
B-cell	NN	compound	B-cell_type
immortalization	NN	nmod	O
and	CC	cc	O
interaction	NN	conj	O
with	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptor	NN	compound	I-protein
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Fibrinogen	NN	nsubj	B-protein
activates	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	dobj	I-protein
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
.	.	punct	O

NFAT	NN	compound	B-protein
activation	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
induced	VBN	amod	O
nuclear	JJ	amod	O
import	NN	nmod	O
.	.	punct	O

To	TO	mark	O
extend	VB	advcl	O
these	DT	det	O
initial	JJ	amod	O
observations	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
antioxidant	JJ	amod	O
treatment	NN	nmod	O
on	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinases	NNS	nmod	I-protein
erk1	NN	dep	B-protein
and	CC	cc	O
erk2	NN	conj	B-protein
,	,	punct	O
as	IN	case	O
members	NNS	advcl	O
of	IN	case	O
a	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
known	VBN	acl	O
to	TO	mark	O
directly	RB	advmod	O
regulate	VB	xcomp	O
transcription	NN	compound	O
factor	NN	compound	O
function	NN	dobj	O
.	.	punct	O

Reciprocally	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
by	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
peptide	NN	compound	O
inhibitor	NN	nmod	O
or	CC	cc	O
a	DT	det	O
dominant	JJ	amod	O
form	NN	conj	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
inhibitor	NN	nmod	O
,	,	punct	O
IkappaB	NN	appos	B-protein
,	,	punct	O
makes	VBZ	ROOT	O
the	DT	det	O
cells	NNS	nsubj	O
more	RBR	advmod	O
susceptible	JJ	xcomp	O
to	TO	case	O
Fas-mediated	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
PML-RAR	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
synthetic	JJ	amod	O
retinoid	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
much	RB	advmod	O
better	JJR	amod	O
transactivator	NN	nsubj	O
of	IN	case	O
retinoic	JJ	amod	B-DNA
acid-responsive	JJ	amod	I-DNA
element-containing	JJ	amod	I-DNA
promoters	NNS	nmod	I-DNA
than	IN	case	O
the	DT	det	O
natural	JJ	amod	O
retinoid	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
RAR	NN	compound	B-protein
alpha	NN	conj	I-protein
,	,	punct	O
AM580	NN	conj	O
and	CC	cc	O
ATRA	NN	conj	O
have	VBP	ROOT	O
similar	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

TSC2	NN	compound	B-RNA
messenger	NN	compound	I-RNA
RNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
widely	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
various	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
throughout	IN	case	O
the	DT	det	O
body	NN	nmod	O
,	,	punct	O
including	VBG	case	O
epithelia	NN	nmod	O
,	,	punct	O
lymphocytes	NNS	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
cells	NNS	conj	O
with	IN	case	O
endocrine	JJ	amod	O
functions	NNS	nmod	O
,	,	punct	O
e.g.	FW	advmod	O
,	,	punct	O
adrenal	JJ	amod	O
cortex	NN	conj	O
and	CC	cc	O
anterior	JJ	amod	O
pituitary	NN	conj	O
.	.	punct	O

The	DT	det	O
differences	NNS	nsubj	O
between	IN	case	O
wild-type	JJ	amod	B-protein
and	CC	cc	I-protein
mutated	VBN	conj	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
were	VBD	cop	O
not	RB	neg	O
related	JJ	ROOT	O
to	TO	case	O
levels	NNS	nmod	O
of	IN	case	O
p56	NN	nmod	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
or	CC	cc	O
NF-	NN	compound	B-protein
kappaB	NN	compound	I-protein
activation	NN	conj	O
.	.	punct	O

At	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
distinct	JJ	amod	O
domains	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod:npmod	O
mediated	JJ	amod	O
interaction	NN	nmod	O
with	IN	case	O
hsp90	NN	nmod	B-protein
:	:	punct	O
the	DT	det	O
ligand-binding	JJ	amod	B-protein
domain	NN	dep	I-protein
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
PAS	NN	compound	B-protein
region	NN	nmod	I-protein
and	CC	cc	O
,	,	punct	O
surprisingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
bHLH	JJ	amod	B-protein
domain	NN	appos	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	compound	O
signals	NNS	nmod	O
by	IN	case	O
PGE2	NN	nmod	B-protein
is	VBZ	cop	O
selective	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
sodium	NN	compound	O
salicylate	NN	nsubj	O
and	CC	cc	O
additional	JJ	amod	O
NSAIDs	NNS	conj	O
used	VBN	acl	O
at	IN	case	O
concentrations	NNS	nmod	O
that	WDT	nsubj	O
activate	VBP	acl:relcl	O
HSF1	NN	dobj	B-protein
also	RB	advmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
monocytic	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
(	-LRB-	punct	O
TNF-alpha	NN	dep	B-DNA
,	,	punct	O
IL-1beta	NN	conj	B-DNA
,	,	punct	O
IL-6	NN	conj	B-DNA
,	,	punct	O
IL-8	NN	conj	B-DNA
,	,	punct	O
IL-10	NN	conj	B-DNA
,	,	punct	O
ICAM-1	NN	appos	B-DNA
)	-RRB-	punct	O
activated	VBN	acl	O
by	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
a	DT	det	O
pro-inflammatory	JJ	amod	O
stimulus	NN	nmod	O
(	-LRB-	punct	O
lipopolysaccharide	NN	dep	O
,	,	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
ALG-4	NN	nsubj	B-protein
is	VBZ	cop	O
necessary	JJ	ccomp	O
and	CC	cc	O
sufficient	JJ	conj	O
for	IN	case	O
FasL	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
previously	RB	advmod	O
described	VBN	amod	O
isoform	NN	compound	B-protein
NF-ATc/A	NN	nsubj	I-protein
contains	VBZ	advcl	O
a	DT	det	O
relatively	RB	advmod	O
short	JJ	amod	O
C	NN	compound	B-protein
terminus	NN	dobj	I-protein
,	,	punct	O
the	DT	det	O
longer	JJR	amod	O
isoforms	NNS	nsubj	O
,	,	punct	O
B	NN	appos	B-protein
and	CC	cc	O
C	NN	conj	B-protein
,	,	punct	O
span	VBP	ROOT	O
extra	JJ	amod	O
C-terminal	JJ	amod	O
peptides	NNS	dobj	O
of	IN	case	O
128	CD	nummod	O
and	CC	cc	O
246	CD	conj	O
aa	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

A	DT	det	O
characteristic	NN	nsubj	O
of	IN	case	O
HTLV-I-transformed	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
the	DT	det	O
constitutive	JJ	amod	O
nuclear	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
NF-kappaB/Rel	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
essential	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
these	DT	det	O
transformed	VBN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
PMA	NN	nmod	O
plus	CC	cc	O
ionomycin	NN	conj	O
(	-LRB-	punct	O
P/I	NN	appos	O
)	-RRB-	punct	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
Fas	NN	compound	B-protein
Ligand	NN	nmod	I-protein
(	-LRB-	punct	O
FasL	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
RA	NN	nsubj	O
directly	RB	advmod	O
inhibits	VBZ	ccomp	O
the	DT	det	O
erythroid	JJ	amod	O
differentiation	NN	compound	O
program	NN	dobj	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
adult	JJ	amod	O
HPC	NN	nmod	B-cell_type
,	,	punct	O
and	CC	cc	O
may	MD	aux	O
lead	VB	conj	O
to	TO	case	O
a	DT	det	O
shift	NN	nmod	O
from	IN	case	O
the	DT	det	O
erythroid	JJ	amod	O
to	TO	dep	O
granulocytic	JJ	dep	O
differentiation	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Differential	JJ	amod	O
binding	NN	compound	O
affinities	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
obtained	VBN	ROOT	O
with	IN	case	O
p50-	NN	amod	B-DNA
and	CC	cc	I-DNA
c-Rel-selected	JJ	conj	I-DNA
sequences	NNS	nmod	I-DNA
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
glucocorticoid	NN	compound	O
hormone	NN	compound	O
inhibition	NN	nsubj	O
of	IN	case	O
neutrophil	NN	compound	B-cell_type
-mediated	JJ	amod	O
tumor	NN	compound	O
cell	NN	compound	O
cytostasis	NN	nmod	O
is	VBZ	cop	O
at	IN	advmod	O
least	JJS	mwe	O
partially	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
a	DT	det	O
lowering	NN	ccomp	O
of	IN	case	O
the	DT	det	O
ligand	NN	compound	O
binding	NN	compound	O
avidity	NN	nmod	O
of	IN	case	O
beta2	NN	compound	B-protein
integrin	NN	nmod	I-protein
on	IN	case	O
the	DT	det	O
neutrophil	NN	compound	B-cell_type
surface	NN	nmod	O
.	.	punct	O

Interleukin-12	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
produced	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
infection	NN	nmod	O
with	IN	case	O
bacteria	NNS	nmod	O
or	CC	cc	O
parasites	NNS	conj	O
or	CC	cc	O
to	TO	case	O
bacterial	JJ	amod	O
constituents	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
LPS	NN	nmod	O
in	IN	case	O
monocytes/macrophages	NNS	nmod	B-cell_type
and	CC	cc	O
dendritic	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
also	RB	advmod	O
generated	VBN	conj	O
by	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
antigen-presenting	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
via	IN	case	O
CD40-CD40	NN	compound	B-protein
ligand	NN	nmod	I-protein
(	-LRB-	punct	O
CD40L	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

After	IN	case	O
stimulation	NN	nmod	O
by	IN	case	O
PMA	NN	nmod	O
,	,	punct	O
RXR	NN	compound	B-protein
alpha	NN	compound	I-protein
expression	NN	nsubj	O
increased	VBD	ROOT	O
in	IN	case	O
H9	NN	nmod	B-cell_line
and	CC	cc	O
U937	NN	conj	B-cell_line
cells	NNS	dep	I-cell_line
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
CEM	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

The	DT	det	O
relationship	NN	ROOT	O
between	IN	case	O
Ca2+-ATPase	NN	nmod	B-protein
and	CC	cc	O
freely	RB	advmod	O
exchangeable	JJ	conj	O
Ca2+	NN	conj	O
in	IN	case	O
the	DT	det	O
dense	JJ	amod	O
tubules	NNS	nmod	O
:	:	punct	O
a	DT	det	O
study	NN	dep	O
in	IN	case	O
platelets	NNS	nmod	B-cell_type
from	IN	case	O
women	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
both	DT	det	O
childrens	NNS	nmod:poss	O
'	POS	case	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
were	VBD	cop	O
unable	JJ	ROOT	O
to	TO	mark	O
produce	VB	xcomp	O
the	DT	det	O
cytokines	NNS	dobj	B-protein
IL-2	NN	dep	B-protein
,	,	punct	O
interferon-gamma	NN	conj	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
IL-4	NN	conj	B-protein
and	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Both	DT	det	O
groups	NNS	nsubj	O
showed	VBD	ROOT	O
substantial	JJ	amod	O
decreases	NNS	dobj	O
in	IN	case	O
mineralocorticoid	NN	compound	O
(	-LRB-	punct	O
MR	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
glucocorticoid	NN	compound	O
receptor	NN	conj	O
(	-LRB-	punct	O
GR	NN	appos	O
)	-RRB-	punct	O
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
hippocampus	NN	nmod	O
,	,	punct	O
a	DT	det	O
limbic	JJ	amod	O
brain	NN	compound	O
structure	NN	appos	O
critical	JJ	amod	O
for	IN	case	O
HPA	NN	amod	O
axis	NN	compound	O
regulation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
GR	NN	compound	B-protein
concentrations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
hypothalamus	NN	nmod	O
were	VBD	cop	O
unchanged	JJ	parataxis	O
and	CC	cc	O
in	IN	case	O
anterior	JJ	amod	O
pituitary	NN	conj	O
were	VBD	auxpass	O
slightly	RB	advmod	O
increased	VBN	conj	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
studies	NNS	nmod	O
defining	VBG	acl	O
recently	RB	advmod	O
identified	VBN	amod	O
crucial	JJ	amod	O
signals	NNS	dobj	O
for	IN	case	O
the	DT	det	O
biogenesis	NN	nmod	O
of	IN	case	O
secondary	JJ	amod	O
lymphoid	JJ	amod	O
organs	NNS	nmod	O
and	CC	cc	O
for	IN	case	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
their	PRP$	nmod:poss	O
proper	JJ	amod	O
microarchitecture	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
STAT6	NN	compound	B-protein
activation	NN	nsubj	O
plays	VBZ	advcl	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
IL-4	NN	nmod:npmod	B-protein
/	:	punct	O
IL-13	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
the	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
IFN-beta	NN	nmod	B-protein
and	CC	cc	O
IFN-gamma	NN	conj	B-protein
to	TO	mark	O
inhibit	VB	acl	O
STAT6	NN	compound	B-protein
activity	NN	dobj	O
provides	VBZ	ROOT	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	mark	O
how	WRB	advmod	O
IFNs	NNS	nsubj	B-protein
can	MD	aux	O
suppress	VB	acl	O
IL-4	NN	nmod:npmod	B-protein
/	:	punct	O
IL-13	NN	nmod:npmod	B-protein
-inducible	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
pocket	NN	compound	B-protein
protein-E2F	JJ	amod	I-protein
complexes	NNS	nsubj	I-protein
are	VBP	cop	O
convergence	NN	compound	O
points	NNS	ROOT	O
for	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
signaling	NN	nmod	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
regulation	NN	nmod	O
,	,	punct	O
YY1	NN	nsubj	B-protein
and	CC	cc	O
LSF	NN	conj	B-protein
could	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
establishment	NN	nmod	O
and	CC	cc	O
maintenance	NN	conj	O
of	IN	case	O
a	DT	det	O
population	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
stably	RB	advmod	O
but	CC	advmod	O
nonproductively	RB	advmod	O
infected	VBN	conj	O
with	IN	case	O
HIV-1	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PWM	NN	nsubj	B-protein
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
initiate	VB	xcomp	O
an	DT	det	O
intracytoplasmic	JJ	amod	O
signalling	NN	amod	O
cascade	NN	dobj	O
and	CC	cc	O
EGR-1	NN	compound	B-DNA
induction	NN	conj	O
in	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

When	WRB	advmod	O
freshly	RB	advmod	O
isolated	VBN	advcl	O
,	,	punct	O
highly	RB	advmod	O
enriched	VBN	amod	O
(	-LRB-	punct	O
>	NN	intj	O
98	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
IFN-gamma	NN	compound	B-protein
responsiveness	NN	nmod	O
;	:	punct	O
these	DT	det	O
cells	NNS	nsubj	O
can	MD	aux	O
respond	VB	parataxis	O
to	TO	case	O
IFN-gamma	NN	nmod	B-protein
and	CC	cc	O
express	VB	conj	O
beta-chain	NN	dobj	B-protein
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
induction	NN	nsubj	O
and	CC	cc	O
IL-2	NN	compound	B-protein
receptor	NN	compound	O
expression	NN	conj	O
occurred	VBD	ROOT	O
even	RB	advmod	O
with	IN	case	O
the	DT	det	O
smaller	JJR	amod	O
second	JJ	dep	O
messenger	NN	compound	O
response	NN	nmod	O
generated	VBN	acl	O
by	IN	case	O
OKT3	NN	nmod	B-protein
.	.	punct	O

Protein	NN	compound	O
synthesis	NN	compound	O
inhibitors	NNS	nsubj	O
and	CC	cc	O
corticosteroids	NNS	conj	O
,	,	punct	O
which	WDT	nsubj	O
suppress	VBP	acl:relcl	O
arachidonate	NN	compound	O
release	NN	dobj	O
and	CC	cc	O
the	DT	det	O
synthesis	NN	conj	O
of	IN	case	O
proinflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
,	,	punct	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
translocation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
CHO/	NN	amod	O
CD14	NN	nmod	B-protein
or	CC	cc	O
RAW	NN	compound	B-cell_line
264.7	CD	nummod	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
early	JJ	amod	O
event	NN	ccomp	O
.	.	punct	O

Signals	NNS	nsubj	O
transduced	VBN	acl	O
through	IN	case	O
the	DT	det	O
CD4	NN	compound	B-protein
molecule	NN	nmod	I-protein
on	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
activate	VBP	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
antiapoptotic	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
Notch-1	NN	nmod	B-protein
,	,	punct	O
providing	VBG	advcl	O
evidence	NN	dobj	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
addition	NN	dep	O
to	TO	mark	O
regulating	VBG	advcl	O
cell	NN	compound	O
fate	NN	compound	O
decisions	NNS	dobj	O
,	,	punct	O
Notch-1	NN	nsubj	B-protein
can	MD	aux	O
play	VB	acl:relcl	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
controlling	VBG	advcl	O
levels	NNS	dobj	O
of	IN	case	O
cell	NN	compound	O
death	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
the	DT	det	O
modulation	NN	nsubj	O
of	IN	case	O
corticosensitivity	NN	nmod	O
in	IN	case	O
TNFalpha-	NN	amod	B-cell_line
and	CC	cc	I-cell_line
IL-10-pretreated	JJ	conj	I-cell_line
U937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	cop	O
related	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
change	NN	nmod	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentration	NN	nmod	O
and	CC	cc	O
affinity	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
endogenous	JJ	amod	O
IKK	NN	compound	O
enzymatic	JJ	amod	O
activity	NN	nsubj	O
was	VBD	aux	O
significantly	RB	advmod	O
elevated	JJ	ROOT	O
in	IN	case	O
HTLV-1-infected	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
Tax-expressing	JJ	conj	I-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

An	DT	det	O
11-base-pair	JJ	amod	O
DNA	NN	compound	O
sequence	NN	compound	O
motif	NN	nsubj	O
apparently	RB	advmod	O
unique	JJ	amod	O
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin	NN	compound	I-DNA
4	CD	nummod	I-DNA
gene	NN	nmod	I-DNA
confers	VBZ	ROOT	O
responsiveness	NN	dobj	O
to	TO	case	O
T-cell	NN	compound	O
activation	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
the	DT	det	O
NK	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
NK92	NN	dobj	I-cell_line
to	TO	mark	O
define	VB	xcomp	O
the	DT	det	O
molecular	JJ	amod	O
and	CC	cc	O
cellular	JJ	conj	O
basis	NN	dobj	O
of	IN	case	O
NK	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
EC	NN	compound	B-cell_type
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
initial	JJ	amod	O
infection	NN	nsubj	O
with	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
most	JJS	amod	O
individuals	NNS	nmod	O
usually	RB	advmod	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
establishment	NN	nmod	O
of	IN	case	O
a	DT	det	O
latent	JJ	amod	O
or	CC	cc	O
chronic	JJ	conj	O
infection	NN	nmod	O
before	IN	case	O
eventual	JJ	amod	O
progression	NN	nmod	O
toward	IN	case	O
acquired	VBN	amod	O
immunodeficiency	NN	compound	O
syndrome	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
the	DT	det	O
response	NN	nsubj	O
of	IN	case	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
HMBA	NN	nmod	O
may	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
useful	JJ	amod	O
experimental	JJ	amod	O
system	NN	dobj	O
for	IN	mark	O
studying	VBG	acl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
responsible	JJ	amod	O
for	IN	case	O
downmodulation	NN	nmod	O
of	IN	case	O
lineage-restricted	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
during	IN	case	O
hemopoietic	JJ	amod	O
lineage	NN	compound	O
commitment	NN	nmod	O
.	.	punct	O

Oct2	NN	compound	B-protein
expression	NN	nsubj	O
was	VBD	cop	O
unable	JJ	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
a	DT	det	O
multimerized	JJ	amod	B-DNA
octamer	NN	compound	I-DNA
enhancer	NN	compound	I-DNA
element	NN	dobj	I-DNA
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
however	RB	advmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
(	-LRB-	punct	O
EMSAs	NNS	appos	O
)	-RRB-	punct	O
indicated	VBD	ROOT	O
that	IN	mark	O
pyrrolidine	NN	compound	O
DTC	NN	nsubj	O
(	-LRB-	punct	O
PDTC	NN	appos	O
)	-RRB-	punct	O
prevented	VBD	ccomp	O
NF-kappaB	NN	dobj	B-protein
,	,	punct	O
and	CC	cc	O
NFAT	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
stimulated	VBN	acl	O
with	IN	case	O
either	CC	cc:preconj	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	nmod	O
plus	CC	cc	O
ionophore	NN	conj	O
or	CC	cc	O
antibodies	NNS	conj	O
against	IN	case	O
the	DT	det	O
CD3-T-cell	NN	compound	B-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
and	CC	cc	O
simultaneously	RB	advmod	O
activated	VBD	conj	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
AP-1	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
TLR2	NN	nsubj	B-protein
associates	VBZ	ccomp	O
with	IN	case	O
the	DT	det	O
high-affinity	JJ	amod	B-protein
LPS	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	compound	I-protein
membrane	NN	compound	O
CD14	NN	nmod	B-protein
to	TO	mark	O
serve	VB	xcomp	O
as	IN	case	O
an	DT	det	O
LPS	NN	compound	B-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
LPS	NN	compound	O
treatment	NN	nsubj	O
enhances	VBZ	conj	O
the	DT	det	O
oligomerization	NN	dobj	O
of	IN	case	O
TLR2	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
human	JJ	amod	O
toll	NN	compound	O
signaling	NN	compound	O
pathway	NN	ROOT	O
:	:	punct	O
divergence	NN	dep	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappaB	NN	nmod	I-protein
and	CC	cc	O
JNK	NN	compound	B-protein
/SAPK	NN	conj	B-protein
activation	NN	dep	O
upstream	RB	amod	O
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptor-associated	JJ	amod	I-protein
factor	NN	nmod	I-protein
6	CD	nummod	I-protein
(	-LRB-	punct	O
TRAF6	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
set	VBN	ROOT	O
out	RP	prt	O
to	TO	aux	O
test	VB	xcomp	O
a	DT	det	O
model	NN	dobj	O
for	IN	case	O
tissue-specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
that	WDT	nsubj	O
relies	VBZ	acl:relcl	O
on	IN	case	O
the	DT	det	O
early	JJ	amod	O
replication	NN	nmod	O
of	IN	case	O
expressed	VBN	amod	O
genes	NNS	nmod	O
to	TO	mark	O
sequester	VB	xcomp	O
limiting	VBG	amod	O
activating	VBG	amod	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
supernatants	NNS	nsubj	O
from	IN	case	O
DEP-PAH-activated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
controls	NNS	nmod	O
,	,	punct	O
exhibited	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
enhanced	VBN	amod	O
chemotactic	JJ	amod	O
activity	NN	dobj	O
for	IN	case	O
neutrophils	NNS	nmod	B-cell_type
and	CC	cc	O
eosinophils	NNS	conj	B-cell_type
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
inhibited	VBN	acl:relcl	O
by	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
anti-IL-8	NN	nmod	B-protein
and	CC	cc	O
anti-RANTES	JJ	conj	B-protein
neutralizing	NN	compound	O
antibodies	NNS	dep	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Examination	NN	nsubj	O
of	IN	case	O
activation-induced	JJ	amod	O
phosphorylation	NN	nmod	O
and	CC	cc	O
ubiquitination	NN	conj	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
did	VBD	aux	O
not	RB	neg	O
demonstrate	VB	ROOT	O
any	DT	det	O
significant	JJ	amod	O
age-related	JJ	amod	O
alterations	NNS	dobj	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
stimuli	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
translocation	NN	nmod	O
of	IN	case	O
the	DT	det	O
active	JJ	amod	O
p65-50	NN	compound	B-protein
heterodimer	NN	nmod	I-protein
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
albeit	IN	mark	O
at	IN	case	O
a	DT	det	O
lower	JJR	amod	O
level	NN	advcl	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
the	DT	det	O
elderly	JJ	nmod	O
.	.	punct	O

EBNA-2	NN	nsubj	B-protein
trans-activates	VBZ	ROOT	O
cellular	JJ	amod	B-DNA
and	CC	cc	I-DNA
viral	JJ	conj	I-DNA
genes	NNS	dobj	I-DNA
like	IN	case	O
CD23	NN	nmod	B-DNA
,	,	punct	O
c-fgr	NN	conj	B-DNA
,	,	punct	O
latent	JJ	amod	B-protein
membrane	NN	compound	I-protein
protein	NN	conj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
LMP1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
terminal	JJ	amod	B-protein
protein	NN	conj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
TP1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
no	DT	neg	O
upregulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
lipoxygenase	NN	compound	B-protein
activity	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
when	WRB	advmod	O
the	DT	det	O
macrophages	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
prepared	VBN	advcl	O
from	IN	case	O
homozygous	JJ	amod	O
STAT6	NN	nmod:npmod	B-protein
-deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

This	DT	det	O
cytoplasmic	JJ	amod	O
inhibitor	NN	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
phosphorylated	VBN	ROOT	O
and	CC	cc	O
degraded	VBN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
a	DT	det	O
diverse	JJ	amod	O
set	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B-inducing	JJ	amod	I-protein
agents	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
T-cell	NN	compound	B-protein
mitogens	NNS	nmod	I-protein
,	,	punct	I-protein
proinflammatory	JJ	amod	B-protein
cytokines	NNS	conj	I-protein
,	,	punct	O
and	CC	cc	O
viral	JJ	amod	B-protein
transactivators	NNS	conj	I-protein
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
Tax	NN	compound	B-protein
protein	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
.	.	punct	O

Variation	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
vitamin	NN	compound	B-DNA
D	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
typed	VBN	ROOT	O
in	IN	case	O
2015	CD	nummod	O
subjects	NNS	nmod	O
from	IN	case	O
large	JJ	amod	O
case-control	JJ	amod	O
studies	NNS	nmod	O
of	IN	case	O
three	CD	nummod	O
major	JJ	amod	O
infectious	JJ	amod	O
diseases	NNS	nmod	O
:	:	punct	O
tuberculosis	NN	dep	O
,	,	punct	O
malaria	NN	conj	O
,	,	punct	O
and	CC	cc	O
hepatitis	NN	compound	O
B	NN	compound	O
virus	NN	conj	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
SRF	NN	nmod	B-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
causes	VBZ	ROOT	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
enhancer	NN	dobj	I-DNA
to	TO	mark	O
function	VB	xcomp	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
it	PRP	nsubj	O
does	VBZ	dep	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
high	JJ	amod	O
level	NN	nsubj	O
of	IN	case	O
SRF	NN	compound	B-protein
binding	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
functionally	RB	advmod	O
important	JJ	ccomp	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
stromal-derived	JJ	amod	B-protein
cytokine	NN	compound	I-protein
interleukin-7	NN	nmod	I-protein
(	-LRB-	punct	O
IL-7	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
IL-2-gene	JJ	compound	B-DNA
regulation	NN	nmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
IL-5	NN	nsubj	B-protein
activated	VBD	ccomp	O
the	DT	det	O
Jak	NN	compound	B-protein
2	CD	nummod	I-protein
-STAT	NN	amod	B-protein
1	CD	nummod	I-protein
signaling	NN	compound	O
pathway	NN	dobj	O
in	IN	case	O
eosinophils	NNS	nmod	B-cell_type
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
(	-LRB-	punct	O
GC	NN	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
potent	JJ	amod	O
anti-inflammatory	JJ	amod	O
and	CC	cc	O
immunosuppressive	JJ	conj	O
agents	NNS	ROOT	O
that	WDT	nsubj	O
act	VBP	acl:relcl	O
on	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
immune	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
including	VBG	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

STAT-1	NN	nsubjpass	B-protein
was	VBD	auxpass	O
tyrosine	NN	nmod:npmod	O
phosphorylated	VBN	ROOT	O
within	IN	case	O
15	CD	nummod	O
min	NN	nmod	O
of	IN	case	O
IL-5	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
genome	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
erythroid-specific	JJ	amod	B-DNA
hypersensitive	JJ	amod	I-DNA
site	NN	compound	I-DNA
HS2	NN	compound	I-DNA
enhancer	NN	nsubj	I-DNA
regulates	VBZ	ROOT	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
downstream	JJ	amod	B-DNA
beta-like	JJ	amod	I-DNA
globin	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
10-50	CD	nummod	B-DNA
kilobases	NNS	nmod:npmod	I-DNA
away	RB	advmod	O
.	.	punct	O

The	DT	det	O
Fc	NN	compound	B-protein
epsilon	NN	compound	I-protein
RI-gamma	NN	compound	I-protein
chains	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
where	WRB	advmod	O
they	PRP	nsubj	O
play	VBP	acl:relcl	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
binding	NN	nmod	O
,	,	punct	O
reconstitution	NN	conj	O
and	CC	cc	O
cotransfection	NN	conj	O
experiments	NNS	dep	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
occurs	VBZ	ccomp	O
in	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
stages	NNS	nmod	O
:	:	punct	O
a	DT	det	O
CsA-sensitive	JJ	amod	O
stage	NN	dep	O
involving	VBG	acl	O
modification	NN	dobj	O
and/or	CC	cc	O
translocation	NN	conj	O
of	IN	case	O
the	DT	det	O
pre-existing	JJ	amod	O
NF-AT	NN	compound	B-protein
complex	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
CsA-insensitive	JJ	amod	O
stage	NN	conj	O
involving	VBG	acl	O
the	DT	det	O
addition	NN	dobj	O
of	IN	case	O
newly	RB	advmod	O
synthesized	VBN	amod	O
Fos	NN	compound	B-protein
or	CC	cc	O
Fos/Jun	NN	conj	B-protein
proteins	NNS	nmod	I-protein
to	TO	case	O
the	DT	det	O
pre-existing	JJ	amod	B-protein
complex	NN	nmod	I-protein
.	.	punct	O

MTIIa	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubj	O
increased	VBD	ROOT	O
significantly	RB	advmod	O
.	.	punct	O

Truncation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
beta	NN	compound	B-DNA
globin	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
led	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
2-3	CD	compound	O
fold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
promoter	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
disruption	NN	nsubj	O
of	IN	case	O
a	DT	det	O
membrane-proximal	JJ	amod	B-protein
proline-rich	JJ	amod	I-protein
sequence	NN	compound	I-protein
motif	NN	nmod	I-protein
(	-LRB-	punct	O
'	``	punct	O
box1	NN	appos	B-protein
'	''	punct	O
)	-RRB-	punct	O
in	IN	case	O
either	DT	det	O
subunit	NN	nmod	O
of	IN	case	O
the	DT	det	O
bipartite	JJ	amod	B-protein
IL-4R	NN	nmod	I-protein
abolished	VBD	ROOT	O
not	RB	neg	O
only	RB	cc:preconj	O
ligand-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
Janus	NN	compound	B-protein
kinases	NNS	nmod	I-protein
JAK1	NN	dep	B-protein
and	CC	cc	O
JAK3	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
IL-4	NN	nmod:npmod	B-protein
-triggered	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
STAT5	NN	nmod	B-protein
and	CC	cc	O
concomitant	JJ	amod	O
cell	NN	compound	O
proliferation	NN	conj	O
.	.	punct	O

Functional	JJ	amod	O
analyses	NNS	nsubj	O
of	IN	case	O
DNA	NN	compound	B-DNA
fragments	NNS	nmod	I-DNA
containing	VBG	acl	O
the	DT	det	O
TATA	NN	compound	B-DNA
element	NN	dobj	I-DNA
and	CC	cc	O
the	DT	det	O
identification	NN	conj	O
of	IN	case	O
a	DT	det	O
DNase	NN	compound	B-DNA
I-hypersensitive	JJ	amod	I-DNA
chromatin	NN	compound	I-DNA
site	NN	nmod	I-DNA
(	-LRB-	punct	O
HS	NN	appos	B-DNA
1	CD	nummod	I-DNA
)	-RRB-	punct	O
in	IN	case	O
close	JJ	amod	O
proximity	NN	nmod	O
to	TO	case	O
the	DT	det	O
TATA	NN	compound	B-DNA
box	NN	nmod	I-DNA
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
identified	VBN	amod	O
TATA	NN	compound	B-DNA
motif	NN	nsubj	I-DNA
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
elk-1	NN	compound	B-DNA
transcription	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
now	RB	advmod	O
investigated	VBN	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
a	DT	det	O
new	JJ	amod	O
analogue	NN	nmod	O
of	IN	case	O
UP	NN	nmod	O
,	,	punct	O
PNU156804	NN	appos	O
,	,	punct	O
which	WDT	nsubj	O
shows	VBZ	acl:relcl	O
a	DT	det	O
more	RBR	advmod	O
favorable	JJ	amod	O
activity	NN	compound	O
profile	NN	dobj	O
than	IN	case	O
UP	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Mutated	VBN	amod	B-DNA
human	JJ	amod	I-DNA
CIITA	NN	compound	I-DNA
constructs	NNS	nsubj	I-DNA
are	VBP	cop	O
potent	JJ	amod	O
suppressors	NNS	appos	O
of	IN	case	O
porcine	NN	compound	O
MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
expression	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
CD45-	NN	amod	B-cell_line
or	CC	cc	I-cell_line
CD3-negative	JJ	conj	I-cell_line
variants	NNS	dobj	I-cell_line
of	IN	case	O
the	DT	det	O
Jurkat	NN	compound	B-cell_line
leukemic	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
different	JJ	amod	O
biochemical	JJ	amod	O
events	NNS	nsubj	O
induced	VBN	acl	O
by	IN	case	O
pervanadate	NN	nmod	O
appeared	VBD	ccomp	O
to	TO	mark	O
be	VB	cop	O
dependent	JJ	xcomp	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
CD45	NN	nmod	B-protein
or	CC	cc	O
CD3	NN	conj	B-protein
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
MyD88	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
component	NN	ccomp	O
in	IN	case	O
the	DT	det	O
signaling	NN	compound	O
cascade	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	acl:relcl	O
by	IN	case	O
IL-1	NN	compound	B-protein
receptor	NN	nmod	I-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
IL-18	NN	compound	B-protein
receptor	NN	conj	I-protein
.	.	punct	O

T	NN	compound	O
cell	NN	compound	O
responses	NNS	nsubjpass	O
to	TO	case	O
some	DT	det	O
nuclear	JJ	amod	O
antigens	NNS	nmod	O
,	,	punct	O
particularly	RB	advmod	O
U1RNP	NN	appos	B-protein
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	nmod	O
(	-LRB-	punct	O
SLE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
in	IN	case	O
healthy	JJ	amod	O
subjects	NNS	conj	O
.	.	punct	O

BHA	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
suppress	VB	xcomp	O
not	RB	neg	O
only	RB	cc:preconj	O
PMA-	NN	amod	O
or	CC	cc	O
TNF-induced	JJ	conj	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
constitutive	JJ	conj	O
,	,	punct	O
HIV-enhancer	NN	dep	O
activity	NN	dobj	O
concomitant	JJ	amod	O
to	TO	case	O
an	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
lymphoblastoid	JJ	amod	B-cell_line
T	NN	nmod	I-cell_line
(	-LRB-	punct	O
J.Jhan	NN	appos	B-cell_line
)	-RRB-	punct	O
and	CC	cc	O
monocytic	JJ	amod	B-cell_line
(	-LRB-	punct	I-cell_line
U937	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
PLB-IIIB	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
constitutive	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complex	NN	nmod	I-protein
was	VBD	auxpass	O
detected	VBN	ROOT	O
,	,	punct	O
composed	VBN	xcomp	O
of	IN	case	O
proteins	NNS	nmod	O
ranging	VBG	acl	O
between	IN	case	O
70	CD	nummod	O
and	CC	cc	O
110	CD	conj	O
kD	NN	nmod	O
.	.	punct	O

Dissociation	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
from	IN	case	O
Ig	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
by	IN	case	O
cytokine	NN	compound	O
and	CC	cc	O
LPS	NN	conj	O
stimulation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
possibly	RB	advmod	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
common	JJ	amod	O
pathway	NN	dobj	O
to	TO	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
TF	NN	nmod	B-DNA
and	CC	cc	I-DNA
other	JJ	amod	I-DNA
inflammatory	JJ	amod	I-DNA
genes	NNS	conj	I-DNA
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
high	JJ	amod	O
lymphocytic	JJ	amod	O
infiltration	NN	nmod	O
(	-LRB-	punct	O
2.5	CD	nummod	O
points	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
low	JJ	amod	O
body	NN	compound	O
mass	NN	conj	O
and	CC	cc	O
fat	NN	conj	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
increased	VBN	amod	O
number	NN	nsubjpass	O
and	CC	cc	O
apparent	JJ	amod	O
dissociation	NN	compound	O
constant	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
are	VBP	auxpass	O
closely	RB	advmod	O
associated	VBN	dep	O
with	IN	case	O
the	DT	det	O
effectiveness	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

As	RB	advmod	O
far	RB	advmod	O
as	IN	mark	O
we	PRP	nsubj	O
know	VBP	parataxis	O
,	,	punct	O
these	DT	det	O
myb-transformed	JJ	amod	B-cell_line
hemopoi-etic	JJ	amod	I-cell_line
cells	NNS	nsubj	I-cell_line
(	-LRB-	punct	O
MTHC	NN	appos	B-cell_line
)	-RRB-	punct	O
differ	VBP	ROOT	O
from	IN	case	O
normal	JJ	nmod	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
unregulated	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
myb	NN	nmod	O
,	,	punct	O
a	DT	det	O
gene	NN	appos	O
whose	WP$	nmod:poss	O
expression	NN	nsubj	O
is	VBZ	cop	O
obligatory	JJ	acl:relcl	O
for	IN	case	O
proliferation	NN	nmod	O
of	IN	case	O
hemopoietic	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

This	DT	det	O
nuclear	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
was	VBD	cop	O
still	RB	advmod	O
present	JJ	ROOT	O
when	WRB	advmod	O
contaminant	JJ	amod	O
LPS	NN	nsubjpass	O
was	VBD	auxpass	O
removed	VBN	advcl	O
by	IN	case	O
ultrafiltration	NN	nmod	O
and	CC	cc	O
when	WRB	advmod	O
serum	NN	nsubjpass	O
was	VBD	auxpass	O
omitted	VBN	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
addition	NN	dep	O
to	TO	case	O
its	PRP$	nmod:poss	O
established	JJ	amod	O
role	NN	nmod	O
as	IN	case	O
a	DT	det	O
hormone-dependent	JJ	amod	B-protein
trans-activator	NN	nmod	I-protein
,	,	punct	O
VDR	NN	nsubj	B-protein
may	MD	aux	O
influence	VB	ccomp	O
gene	NN	compound	O
expression	NN	dobj	O
by	IN	case	O
ligand-independent	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
UV-induced	JJ	amod	O
CYP1A1	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nsubjpass	O
in	IN	case	O
mammalian	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
an	DT	det	O
Ah	NN	compound	B-protein
receptor	NN	compound	I-protein
ligand	NN	nmod	O
formed	VBN	acl	O
from	IN	case	O
tryptophan	NN	nmod	O
.	.	punct	O

A	DT	det	O
wide	JJ	amod	O
spectrum	NN	nsubjpass	O
of	IN	case	O
levels	NNS	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
expression	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
various	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
both	CC	cc:preconj	O
in	IN	case	O
cell	NN	compound	O
culture	NN	nmod	O
and	CC	cc	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
jagged1	NN	compound	B-protein
transcripts	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
also	RB	advmod	O
upregulated	VBN	ROOT	O
by	IN	case	O
endogenous	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
and	CC	cc	O
this	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
mutant	NN	nmod	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
physiological	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

Full-length	JJ	amod	O
ERP	NN	nsubj	B-protein
expresses	VBZ	ROOT	O
only	RB	advmod	O
negligible	JJ	amod	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
by	IN	case	O
itself	PRP	nmod	O
.	.	punct	O

Antioxidant-mediated	JJ	amod	O
inhibition	NN	nsubjpass	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
low	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
messenger	NN	compound	B-RNA
RNAs	NNS	nmod	I-RNA
.	.	punct	O

One	CD	nummod	O
major	JJ	nsubjpass	B-DNA
and	CC	cc	I-DNA
one	CD	nummod	I-DNA
minor	JJ	amod	I-DNA
transcription	NN	compound	I-DNA
start	NN	compound	I-DNA
site	NN	conj	I-DNA
were	VBD	auxpass	O
identified	VBN	ROOT	O
101	CD	nmod:npmod	B-DNA
and	CC	cc	I-DNA
130	CD	conj	I-DNA
base	NN	compound	I-DNA
pairs	NNS	dep	I-DNA
(	-LRB-	punct	I-DNA
bp	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
upstream	RB	advmod	I-DNA
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
from	IN	case	O
the	DT	det	O
protein	NN	compound	B-DNA
translation	NN	compound	I-DNA
start	NN	compound	I-DNA
ATG	NN	nmod	I-DNA
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
NF-kappaB	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
main	JJ	amod	O
transcription	NN	compound	O
factor	NN	dep	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
of	IN	case	O
CD23	NN	nmod	B-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Forty	CD	nummod	O
animals	NNS	nsubjpass	O
were	VBD	auxpass	O
inoculated	VBN	ROOT	O
intranasally	RB	advmod	O
with	IN	case	O
10	CD	pobj	O
(	-LRB-	punct	O
7.0	CD	dep	O
)	-RRB-	punct	O
pfu	NN	nmod	O
of	IN	case	O
Ad5/animal	NN	nmod	O
,	,	punct	O
and	CC	cc	O
15	CD	nummod	O
animals	NNS	conj	O
inoculated	VBN	acl	O
with	IN	case	O
sterile	JJ	amod	O
culture	NN	compound	O
media	NNS	nmod	O
served	VBD	acl	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
mass	NN	nsubj	O
of	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
is	VBZ	cop	O
approximately	RB	advmod	O
28	CD	nummod	O
kDa	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
DNA	NN	compound	O
binding	NN	compound	O
characteristics	NNS	nsubj	O
are	VBP	cop	O
indistinguishable	JJ	conj	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
novel	JJ	amod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
MS-2	NN	nmod	B-protein
.	.	punct	O

Gel	NN	compound	O
retardation	NN	compound	O
assays	NNS	nsubj	O
,	,	punct	O
using	VBG	acl	O
a	DT	det	O
32P-probe	NN	dobj	O
containing	VBG	acl	O
the	DT	det	O
HIV-1	NN	compound	O
NF-kB	NN	compound	B-protein
probe	NN	dobj	O
and	CC	cc	O
nuclear	JJ	amod	O
extracts	NNS	conj	O
from	IN	case	O
PMA-treated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
showed	VBD	ROOT	O
significantly	RB	advmod	O
reduced	VBN	amod	O
induction	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
NF-kB	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
these	DT	det	O
two	CD	nummod	O
subclones	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
wild	JJ	amod	B-protein
type	NN	compound	I-protein
CEM	NN	nmod	I-protein
and	CC	cc	O
a	DT	det	O
control	NN	compound	O
subclone	NN	conj	O
.	.	punct	O

In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
Western	NN	nsubj	O
,	,	punct	O
supershift	NN	conj	O
,	,	punct	O
and	CC	cc	O
promoter	NN	compound	O
deletion	NN	compound	O
analyses	NNS	conj	O
suggested	VBD	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
CCAAT/enhancer-binding	JJ	amod	B-DNA
protein-beta	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
C/EBP-beta	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
between	IN	case	O
-2010	CD	nmod	B-DNA
and	CC	cc	I-DNA
-1954	CD	conj	I-DNA
in	IN	mark	O
regulating	VBG	acl	O
transcription	NN	dobj	O
of	IN	case	O
collagenase-1	NN	nmod	B-protein
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Except	IN	case	O
for	IN	case	O
PGF2	NN	compound	O
alpha	NN	nmod	O
,	,	punct	O
HHT	NN	conj	O
and	CC	cc	O
15-HETE	NN	conj	O
no	DT	neg	O
detectable	JJ	amod	O
quantities	NNS	nsubjpass	O
of	IN	case	O
eicosanoids	NNS	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
non-tumor	JJ	amod	O
material	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
in	IN	case	O
the	DT	det	O
malignant	JJ	amod	O
tumor	NN	compound	O
material	NN	amod	O
substantial	JJ	amod	O
quantities	NNS	nsubj	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
eicosanoid	NN	compound	O
metabolites	NNS	nmod	O
were	VBD	cop	O
present	JJ	parataxis	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
NFKB2	NN	compound	B-protein
precursor	NN	nsubjpass	O
is	VBZ	auxpass	O
physically	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
c-Rel	NN	nmod	B-protein
and	CC	cc	O
with	IN	case	O
Tax	NN	conj	B-protein
in	IN	case	O
HTLV-I	NN	compound	B-cell_type
infected	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
present	JJ	amod	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
clearly	RB	advmod	O
that	IN	mark	O
mycoplasma	NN	compound	B-protein
products	NNS	nsubj	I-protein
can	MD	aux	O
have	VB	ccomp	O
a	DT	det	O
profound	JJ	amod	O
impact	NN	dobj	O
on	IN	case	O
the	DT	det	O
activation	NN	compound	O
status	NN	nmod	O
of	IN	case	O
eukaryotic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
semiquantitative	JJ	amod	O
reverse	JJ	amod	B-protein
transcriptase	NN	compound	I-protein
-linked	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubjpass	O
(	-LRB-	punct	O
RT-PCR	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
for	IN	case	O
analysis	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
treated	VBN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
mean	NN	compound	O
dissociation	NN	compound	O
constant	NN	nsubj	O
(	-LRB-	punct	O
KD	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
of	IN	case	O
patients	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
healthy	JJ	amod	O
women	NNS	conj	O
(	-LRB-	punct	O
A-CRF	NN	appos	O
:	:	punct	O
0.7	CD	nummod	O
+/-	CC	cc	O
0.5	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
;	:	punct	O
M-CRF	NN	appos	O
:	:	punct	O
1.1	CD	nummod	O
+/-	CC	cc	O
0.9	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
;	:	punct	O
controls	NNS	dep	O
:	:	punct	O
1.0	CD	nummod	O
+/-	CC	cc	O
0.6	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
are	VBP	ROOT	O
four	CD	nummod	O
putative	JJ	amod	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubj	I-DNA
(	-LRB-	punct	O
kappa	NN	compound	B-DNA
B-1	NN	appos	I-DNA
,	,	punct	O
kappa	NN	compound	B-DNA
B-2	NN	appos	I-DNA
,	,	punct	O
kappa	NN	compound	B-DNA
B-3	NN	conj	I-DNA
,	,	punct	O
kappa	NN	compound	B-DNA
B-4	NN	appos	I-DNA
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-DNA
TNF-alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
interaction	NN	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	xcomp	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
transactivation	NN	nmod	O
.	.	punct	O

Chlorinated	VBN	amod	O
dibenzo-p-dioxins	NNS	ROOT	O
and	CC	cc	O
dibenzofurans	NNS	conj	O
and	CC	cc	O
the	DT	det	O
human	JJ	amod	O
immune	JJ	amod	O
system	NN	conj	O
.	.	punct	O

Surface	NN	compound	O
marker	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
HMBA-induced	JJ	amod	B-cell_line
cells	NNS	nsubj	I-cell_line
expressed	VBD	ccomp	O
reduced	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
glycophorin	NN	compound	B-protein
A	NN	nmod	I-protein
,	,	punct	O
CD5	NN	conj	B-protein
,	,	punct	O
CD7	NN	conj	B-protein
and	CC	cc	O
CD11b	NN	conj	B-protein
.	.	punct	O

DMDTC	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
alter	VB	xcomp	O
NF-kappaB	NN	dobj	B-protein
directly	RB	advmod	O
as	IN	case	O
pre-incubation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
with	IN	case	O
DMDTC	NN	nmod	O
does	VBZ	aux	O
not	RB	neg	O
diminish	VB	conj	O
binding	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
.	.	punct	O

This	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
C/EBP	NN	compound	B-RNA
epsilon	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
is	VBZ	auxpass	O
transcriptionally	RB	advmod	O
mediated	VBN	ROOT	O
and	CC	cc	O
occurs	VBZ	conj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
synthesis	NN	nmod	O
of	IN	case	O
additional	JJ	amod	O
protein	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Blockade	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
intracellular	JJ	amod	O
signalling	NN	amod	O
event	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
transendothelial	JJ	amod	O
migration	NN	compound	O
response	NN	nmod	O
towards	IN	case	O
MCP-1	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
localized	VBD	ROOT	O
the	DT	det	O
LAM-	NN	amod	O
,	,	punct	O
lipopolysaccharide	NN	conj	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
,	,	punct	O
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
-inducible	JJ	conj	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
to	TO	case	O
a	DT	det	O
-131/+15	CD	amod	O
(	-LRB-	punct	O
positions	NNS	dep	O
-131	CD	dep	O
to	TO	dep	O
+15	CD	dep	O
)	-RRB-	punct	O
DNA	NN	compound	O
fragment	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-1	NN	compound	B-DNA
beta	NN	compound	I-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
deletion	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
chloramphenicol	NN	compound	B-protein
acetyltransferase	NN	compound	I-protein
assay	NN	conj	O
.	.	punct	O

The	DT	det	O
monomeric	JJ	amod	O
polypeptide	NN	compound	O
Flexi-12	NN	nsubj	B-protein
is	VBZ	cop	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
phytohemagglutinin	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
PHA	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
blasts	NNS	nmod	I-cell_line
,	,	punct	O
induce	VBP	advcl	O
PHA	NN	compound	B-cell_line
blasts	NNS	dobj	I-cell_line
to	TO	mark	O
secrete	VB	xcomp	O
interferon-gamma	NN	dobj	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
additionally	RB	advmod	O
,	,	punct	O
by	IN	case	O
preincubation	NN	nmod	O
,	,	punct	O
enhance	VBP	conj	O
the	DT	det	O
killing	NN	dobj	O
of	IN	case	O
K562	NN	compound	O
targets	NNS	nmod	O
by	IN	case	O
PBLs	NNS	nmod	B-cell_type
.	.	punct	O

It	PRP	nsubjpass	O
had	VBD	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
thought	VBN	ROOT	O
that	IN	mark	O
ZEBRA	NN	nmod:poss	B-protein
's	POS	case	O
capacity	NN	ccomp	O
to	TO	mark	O
disrupt	VB	acl	O
EBV	NN	compound	O
latency	NN	dobj	O
resided	VBD	acl	O
primarily	RB	advmod	O
in	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
activate	VB	acl	O
transcription	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubj	O
encode	VBP	acl:relcl	O
products	NNS	dobj	O
required	VBN	acl	O
for	IN	case	O
lytic	JJ	amod	O
replication	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
these	DT	det	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
as	IN	case	O
a	DT	det	O
model	NN	nmod	O
of	IN	case	O
IL-12	NN	compound	B-protein
signal	NN	compound	O
transduction	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
confirmed	VBD	ROOT	O
that	IN	mark	O
these	DT	det	O
events	NNS	nsubj	O
involve	VBP	ccomp	O
members	NNS	dobj	O
of	IN	case	O
the	DT	det	O
Janus	NN	compound	B-protein
kinase	NN	compound	I-protein
family	NN	nmod	I-protein
of	IN	case	O
nonreceptor	JJ	amod	B-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
JAK2	NN	dep	B-protein
,	,	punct	O
TYK2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
signal	NN	compound	B-protein
transducer	NN	conj	I-protein
and	CC	cc	I-protein
activator	NN	conj	I-protein
of	IN	case	I-protein
transcription	NN	nmod	I-protein
4	CD	nummod	I-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
assay	NN	nsubj	O
of	IN	case	O
PBMC	NN	nmod	B-cell_type
by	IN	case	O
the	DT	det	O
adenovirus-specific	JJ	amod	O
PCR	NN	nmod	O
may	MD	aux	O
help	VB	ROOT	O
detect	VB	xcomp	O
early	JJ	amod	O
invasive	JJ	amod	O
disease	NN	dobj	O
and	CC	cc	O
warrants	VBZ	conj	O
further	JJ	amod	O
evaluation	NN	dobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
CD2	NN	compound	B-protein
and	CC	cc	O
CD3	NN	compound	B-protein
receptor	NN	compound	I-protein
-mediated	JJ	conj	O
signalling	NN	dobj	O
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
chickens	NNS	nmod	O
,	,	punct	O
estrogens	NNS	nsubj	O
stimulate	VBP	ROOT	O
outgrowth	NN	dobj	O
of	IN	case	O
bone	NN	nmod:npmod	B-cell_type
marrow-derived	JJ	amod	I-cell_type
erythroid	JJ	amod	I-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
delay	VBP	conj	O
their	PRP$	nmod:poss	O
maturation	NN	dobj	O
.	.	punct	O

Preliminary	JJ	amod	O
observations	NNS	nsubj	O
also	RB	advmod	O
indicate	VBP	ROOT	O
possible	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
clinical	JJ	amod	O
variables	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
stage	NN	nmod	O
in	IN	case	O
selected	VBN	amod	O
instances	NNS	nmod	O
.	.	punct	O

MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Lymphocyte	NN	compound	B-cell_type
samples	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	dep	O
by	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
mitogen	NN	compound	B-protein
phytohemagglutinin	NN	nmod	I-protein
(	-LRB-	punct	O
PHA	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
the	DT	det	O
monoclonal	JJ	amod	O
antibody	NN	compound	O
alphaCD3	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
magnitude	NN	nsubj	O
of	IN	case	O
responsiveness	NN	nmod	O
is	VBZ	cop	O
cell	NN	nmod:npmod	O
type	NN	nmod:npmod	O
dependent	JJ	ROOT	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
.	.	punct	O

The	DT	det	O
glucocorticoid-induced	JJ	amod	O
reduction	NN	nsubjpass	O
of	IN	case	O
IL-12	NN	compound	B-protein
production	NN	nmod	O
was	VBD	auxpass	O
antagonized	VBN	ROOT	O
by	IN	case	O
RU	NN	nmod	O
486	CD	nummod	O
,	,	punct	O
a	DT	det	O
glucocorticoid-receptor	JJ	amod	O
antagonist	NN	appos	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
herpes	NN	compound	B-protein
simplex	NN	amod	I-protein
tegument	NN	amod	I-protein
proteins	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
processed	VBN	ccomp	O
for	IN	case	O
antigen	NN	compound	O
presentation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
are	VBP	cop	O
possible	JJ	amod	O
candidate	NN	compound	O
compounds	NNS	conj	O
for	IN	case	O
herpes	NN	compound	O
simplex	NN	compound	O
vaccines	NNS	nmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
possible	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
normal	JJ	amod	B-DNA
allele	NN	nsubjpass	I-DNA
may	MD	aux	O
be	VB	auxpass	O
functionally	RB	advmod	O
inactivated	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
nonmutational	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

Dexamethasone	NN	nsubj	O
prevented	VBD	ROOT	O
IL-8	NN	dobj	B-protein
and	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	compound	I-protein
secretion	NN	conj	O
in	IN	case	O
ventilated	VBN	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
CD28	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	nsubj	I-DNA
(	-LRB-	punct	O
CD28RE	NN	appos	B-DNA
)	-RRB-	punct	O
does	VBZ	aux	O
not	RB	neg	O
function	VB	ccomp	O
independently	RB	advmod	O
but	CC	cc	O
works	VBZ	conj	O
instead	RB	advmod	O
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
the	DT	det	O
adjacent	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
proximal	JJ	amod	I-DNA
AP-1-binding	JJ	amod	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
this	DT	det	O
hypothesis	NN	nsubjpass	O
is	VBZ	auxpass	O
confirmed	VBN	conj	O
here	RB	advmod	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
E2A-HLF	NN	nmod	B-protein
to	TO	mark	O
prolong	VB	acl	O
the	DT	det	O
survival	NN	dobj	O
of	IN	case	O
interleukin-3	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
IL-3	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-dependent	JJ	amod	I-cell_line
murine	JJ	amod	I-cell_line
pro-B	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
after	IN	case	O
IL-3	NN	compound	B-protein
withdrawal	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
disrupts	VBZ	ccomp	O
signaling	NN	compound	O
pathways	NNS	dobj	O
normally	RB	advmod	O
responsible	JJ	amod	O
for	IN	case	O
cell	NN	compound	O
suicide	NN	nmod	O
,	,	punct	O
allowing	VBG	advcl	O
the	DT	det	O
cells	NNS	dobj	O
to	TO	mark	O
accumulate	VB	acl	O
as	IN	case	O
transformed	VBN	amod	B-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

Apoptosis-resistant	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
have	VBP	ROOT	O
a	DT	det	O
deficiency	NN	dobj	O
in	IN	case	O
NF-kappaB	NN	compound	B-protein
-mediated	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
Fas	NN	compound	B-protein
ligand	NN	compound	I-protein
transcription	NN	nmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
dose	NN	nmod:npmod	O
dependent	JJ	ROOT	O
and	CC	cc	O
appeared	VBD	conj	O
relatively	RB	advmod	O
late	JJ	xcomp	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
association	NN	nsubjpass	O
of	IN	case	O
phosphoinositide	NN	compound	B-protein
3-kinase	NN	nmod	I-protein
with	IN	case	O
CD28	NN	nmod	B-protein
and	CC	cc	O
enhanced	VBN	conj	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
phospholipase	NN	compound	O
Cgamma	NN	nmod	O
were	VBD	auxpass	O
seen	VBN	ROOT	O
after	IN	case	O
anti-CD28	JJ	amod	O
mAb	NN	nmod	O
and	CC	cc	O
CHO-CD80	NN	compound	O
stimulation	NN	conj	O
but	CC	cc	O
to	TO	case	O
a	DT	det	O
much	RB	advmod	O
lesser	JJR	amod	O
extent	NN	conj	O
after	IN	case	O
CHO-CD86	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
progressive	JJ	amod	O
decline	NN	nsubj	O
in	IN	case	O
the	DT	det	O
heat	NN	compound	O
shock	NN	compound	O
response	NN	nmod	O
of	IN	case	O
cultured	VBN	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
correlates	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
percent	JJ	amod	O
proliferative	JJ	amod	O
life	NN	compound	O
span	NN	nmod	O
completed	VBN	acl	O
rather	RB	advmod	O
than	IN	mwe	O
with	IN	prep	O
the	DT	det	O
actual	JJ	amod	O
proliferative	JJ	amod	O
activity	NN	pobj	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
a	DT	det	O
human	JJ	amod	O
T-lymphotropic	JJ	amod	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HTLV-1	NN	appos	O
)	-RRB-	punct	O
model	NN	dobj	O
of	IN	case	O
cAMP	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	compound	I-DNA
(	-LRB-	punct	O
CRE	NN	appos	B-DNA
)	-RRB-	punct	O
transcription	NN	nmod	O
to	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
influence	NN	dobj	O
of	IN	case	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
on	IN	case	O
transcription	NN	nmod	O
from	IN	case	O
homologous	JJ	amod	O
regions	NNS	nmod	O
in	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
Sp1	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
had	VBD	ROOT	O
the	DT	det	O
most	RBS	advmod	O
dramatic	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
SIVmac	NN	compound	O
replication	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-cell_line
macrophage	NN	compound	I-cell_line
cultures	NNS	nmod	I-cell_line
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
restimulation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_line
Th2	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
clones	NNS	conj	O
in	IN	case	O
the	DT	det	O
presence	NN	intj	O
of	IN	case	O
IFN-alpha	NN	nmod	B-protein
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
.	.	punct	O

While	IN	mark	O
the	DT	det	O
maternally	RB	advmod	B-DNA
derived	VBN	amod	I-DNA
X	NN	compound	I-DNA
chromosome	NN	nsubj	I-DNA
was	VBD	cop	O
preferentially	RB	advmod	O
active	JJ	advcl	O
in	IN	case	O
the	DT	det	O
asymptomatic	JJ	amod	O
twin	NN	nmod	O
,	,	punct	O
the	DT	det	O
paternal	JJ	amod	B-DNA
X	NN	compound	I-DNA
chromosome	NN	nsubj	I-DNA
was	VBD	cop	O
active	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
,	,	punct	O
affected	VBN	dep	O
twin	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
found	VBN	conj	O
in	IN	case	O
her	PRP$	nmod:poss	O
hemizygotic	JJ	amod	O
nephew	NN	nmod	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
underlying	VBG	acl	O
the	DT	det	O
sustained	JJ	amod	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
observed	VBN	acl	O
in	IN	case	O
U937	NN	compound	B-cell_line
monocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
chronically	RB	advmod	O
infected	VBN	acl	O
with	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
SLAP-130	NN	nsubj	B-protein
is	VBZ	cop	O
hematopoietic	JJ	amod	O
cell-specific	JJ	ccomp	O
and	CC	cc	O
associates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
SH2	NN	compound	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
SLP-76	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
AP-1	NN	compound	B-protein
-dependent	JJ	amod	O
luciferase	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
two	CD	nummod	O
specific	JJ	amod	O
inhibitors	NNS	dobj	O
of	IN	case	O
serine/threonine	NN	compound	B-protein
phosphatases-1	NN	nmod	I-protein
and	CC	cc	I-protein
-2A	NN	conj	I-protein
:	:	punct	O
okadaic	JJ	amod	O
acid	NN	dobj	O
and	CC	cc	O
calyculin	NN	compound	O
A	NN	conj	O
.	.	punct	O

Recently	RB	advmod	O
we	PRP	nsubj	O
reported	VBD	ROOT	O
that	IN	mark	O
all-trans-retinoic	JJ	amod	O
acid	NN	nsubj	O
(	-LRB-	punct	O
ATRA	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
and	CC	cc	O
highly	RB	advmod	O
specific	JJ	conj	O
inducer	NN	ccomp	O
of	IN	case	O
CD38	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
promyelocytic	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
elevated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
zinc	NN	nmod	O
containing	VBG	acl	O
trace	NN	compound	O
element	NN	compound	O
preparation	NN	dobj	O
.	.	punct	O

Wild-type	JJ	nsubj	O
and	CC	cc	O
chimeric	JJ	conj	B-protein
HLF	NN	compound	I-protein
proteins	NNS	dep	I-protein
also	RB	advmod	O
bound	VBD	ROOT	O
closely	RB	advmod	O
related	JJ	amod	O
sites	NNS	dobj	O
identified	VBN	acl	O
previously	RB	advmod	O
for	IN	case	O
bZIP	NN	compound	B-protein
proteins	NNS	nmod	I-protein
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
proline	NN	compound	B-protein
-and	NN	compound	O
acidic	JJ	amod	O
amino	NN	compound	O
acid-rich	JJ	nmod	O
(	-LRB-	punct	O
PAR	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
C/EBP	NN	conj	B-protein
subfamilies	NNS	dep	I-protein
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
E2A-HLF	JJ	compound	B-protein
proteins	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
less	RBR	advmod	O
tolerant	JJ	parataxis	O
of	IN	case	O
certain	JJ	amod	O
deviations	NNS	nmod	O
from	IN	case	O
the	DT	det	O
HLF	NN	compound	B-DNA
consensus	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Maximal	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
c-fos	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
that	DT	nmod	O
for	IN	case	O
the	DT	det	O
fos-B	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
the	DT	det	O
adult	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
lymphoid	JJ	amod	B-cell_type
lineages	NNS	nsubj	I-cell_type
rely	VBP	ROOT	O
on	IN	case	O
Ikaros	NN	nmod	B-DNA
at	IN	case	O
distinct	JJ	amod	O
phases	NNS	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
development	NN	nmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
whether	IN	mark	O
this	DT	det	O
putative	JJ	amod	O
function	NN	nsubjpass	O
of	IN	case	O
CD28	NN	nmod	B-protein
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
via	IN	case	O
a	DT	det	O
particular	JJ	amod	O
signaling	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
early	JJ	amod	O
signaling	NN	compound	O
events	NNS	dobj	O
initiated	VBN	acl	O
in	IN	case	O
resting	VBG	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
the	DT	det	O
stimulatory	JJ	amod	B-protein
mAb	NN	compound	I-protein
BW	NN	nmod	I-protein
828	CD	nummod	I-protein
with	IN	case	O
signals	NNS	nmod	O
triggered	VBN	acl	O
by	IN	case	O
the	DT	det	O
nonstimulating	JJ	amod	B-protein
CD28	NN	compound	I-protein
mAb	NN	nmod	I-protein
9.3	CD	nummod	I-protein
.	.	punct	O

The	DT	det	O
signaling	NN	compound	O
pathways	NNS	nsubj	O
involving	VBG	acl	O
PKC	NN	compound	B-protein
activation	NN	dobj	O
,	,	punct	O
calcium	NN	compound	O
mobilization	NN	conj	O
and	CC	cc	O
ras	NN	compound	B-protein
activation	NN	conj	O
combine	VBP	ROOT	O
to	TO	mark	O
provide	VB	xcomp	O
the	DT	det	O
necessary	JJ	amod	O
components	NNS	dobj	O
for	IN	case	O
production	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-protein
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

STAT3	NN	compound	B-protein
expression	NN	nsubjpass	O
in	IN	case	O
particular	JJ	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
Abl	NN	nmod	B-protein
,	,	punct	O
Src	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
HTLV-1	NN	compound	O
transformation	NN	conj	O
of	IN	case	O
normal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
Id3	NN	nmod	B-protein
completely	RB	advmod	O
blocks	VBZ	ROOT	O
development	NN	dobj	O
of	IN	case	O
CD34+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
into	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
a	DT	det	O
fetal	JJ	amod	O
thymic	JJ	amod	O
organ	NN	compound	O
culture	NN	nmod	O
(	-LRB-	punct	O
FTOC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
growth-regulated	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
mammalian	JJ	amod	B-DNA
MCM5	NN	nmod	I-DNA
and	CC	cc	I-DNA
MCM6	NN	conj	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
and	CC	cc	O
presumably	RB	advmod	O
other	JJ	amod	O
MCM	NN	compound	O
members	NNS	conj	O
,	,	punct	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
regulated	VBN	ccomp	O
by	IN	case	O
E2F	NN	nmod	B-protein
through	IN	mark	O
binding	NN	advcl	O
to	TO	case	O
multiple	JJ	amod	B-DNA
E2F	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
.	.	punct	O

The	DT	det	O
cDNA	NN	nsubj	O
contains	VBZ	ROOT	O
a	DT	det	O
546-nucleotide	JJ	amod	B-DNA
(	-LRB-	punct	I-DNA
nt	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
open	JJ	amod	I-DNA
reading	NN	compound	I-DNA
frame	NN	dobj	I-DNA
(	-LRB-	punct	O
ORF	NN	appos	B-DNA
)	-RRB-	punct	O
that	WDT	nsubj	O
codes	VBZ	acl:relcl	O
for	IN	case	O
the	DT	det	O
carboxyl-terminal	JJ	amod	B-protein
180	CD	nummod	I-protein
amino	NN	compound	I-protein
acids	NNS	nmod	I-protein
(	-LRB-	punct	O
aa	NNS	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
recently	RB	advmod	O
identified	VBN	amod	O
fkhrl1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
catalytic	JJ	amod	B-protein
domain	NN	nsubj	I-protein
of	IN	case	O
pp56	NN	nmod	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
its	PRP$	nmod:poss	O
regulatory	JJ	amod	B-protein
domain	NN	conj	I-protein
,	,	punct	O
is	VBZ	cop	O
sufficient	JJ	ROOT	O
for	IN	mark	O
inducing	VBG	advcl	O
IL-2	NN	compound	B-protein
production	NN	dobj	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C-zeta	NN	nmod	I-protein
stimulates	VBZ	ROOT	O
leukemic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
differentiation	NN	dobj	O
.	.	punct	O

Bruton	NNP	nmod:poss	B-protein
's	POS	case	I-protein
agammaglobulinemia	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	nsubj	I-protein
(	-LRB-	punct	O
Btk	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
cytoplasmic	JJ	amod	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	ROOT	I-protein
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	O
disease	NN	compound	O
X-linked	JJ	amod	O
agammaglobulinemia	NN	nmod	O
(	-LRB-	punct	O
XLA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

PROBLEM	NN	ROOT	O
:	:	punct	O
The	DT	det	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
immunosuppressive	JJ	amod	O
and	CC	cc	O
immunosuppression-inducing	JJ	conj	O
capacities	NNS	nmod	O
of	IN	case	O
Jeg-3	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
choriocarcinoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
supernatants	NNS	nmod	O
(	-LRB-	punct	O
HCSs	NNS	appos	O
)	-RRB-	punct	O
are	VBP	auxpass	O
not	RB	neg	O
yet	RB	advmod	O
completely	RB	advmod	O
understood	VBN	appos	O
.	.	punct	O

Co-treatment	NN	nsubj	O
of	IN	case	O
RBCs	NNS	nmod	B-cell_type
with	IN	case	O
TCDD	NN	nmod	O
and	CC	cc	O
NaOV	NN	conj	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
the	DT	det	O
TCDD-induced	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
parasitemia	NN	nmod	O
.	.	punct	O

ER	NN	compound	B-protein
variants	NNS	nsubjpass	O
,	,	punct	O
generated	VBN	acl	O
by	IN	case	O
alternative	JJ	amod	O
splicing	NN	nmod	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
normal	JJ	amod	O
mammary	JJ	amod	O
glands	NNS	conj	O
,	,	punct	O
therefore	RB	advmod	O
their	PRP$	nmod:poss	O
role	NN	nsubjpass	O
in	IN	case	O
tumorigenesis	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
questioned	VBN	parataxis	O
.	.	punct	O

Distinctive	JJ	amod	O
gene	NN	compound	O
expression	NN	compound	O
patterns	NNS	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
mammary	JJ	amod	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
breast	NN	compound	O
cancers	NNS	conj	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
phytohemagglutinin	NN	nmod	B-protein
further	RB	advmod	O
enhanced	VBD	advcl	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
AP1	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
PMA	NN	nmod	O
inhibited	VBD	ROOT	O
it	PRP	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
profound	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
deficit	NN	nsubj	O
of	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
thymus	NN	nsubj	O
is	VBZ	cop	O
by	IN	case	O
far	RB	mwe	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
site	NN	ccomp	O
for	IN	mark	O
inducing	VBG	acl	O
the	DT	det	O
expansion	NN	dobj	O
per	FW	compound	O
se	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
if	IN	mark	O
other	JJ	amod	O
sites	NNS	nsubj	O
can	MD	aux	O
induce	VB	advcl	O
some	DT	det	O
response	NN	compound	O
acquisition	NN	dobj	O
.	.	punct	O

Reconstitution	NN	nsubj	O
of	IN	case	O
Jak1	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
E1C3	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
restored	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
IL-4	NN	nmod	B-protein
to	TO	mark	O
induce	VB	acl	O
IRS	NN	compound	B-DNA
and	CC	cc	O
Stat6	NN	conj	B-protein
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
.	.	punct	O

The	DT	det	O
immunodominant	JJ	amod	O
,	,	punct	O
CD8	NN	appos	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cytotoxic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocyte	NN	compound	I-cell_type
(	-LRB-	punct	O
CTL	NN	appos	O
)	-RRB-	punct	O
response	NN	nsubjpass	O
to	TO	case	O
the	DT	det	O
HLA-B8-restricted	JJ	amod	O
peptide	NN	nmod	O
,	,	punct	O
RAKFKQLL	NN	appos	O
,	,	punct	O
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
immediate-early	JJ	amod	I-protein
antigen	NN	nmod	I-protein
,	,	punct	O
BZLF1	NN	appos	B-protein
,	,	punct	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
diverse	JJ	amod	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TCR	NN	compound	I-protein
)	-RRB-	punct	I-protein
repertoire	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
NF-kappaB	NN	nsubjpass	B-protein
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
human	JJ	amod	O
CD34	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
clonogenic	JJ	amod	O
function	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

Yet	RB	advmod	O
,	,	punct	O
for	IN	case	O
many	JJ	amod	O
pathogens	NNS	nmod	O
,	,	punct	O
the	DT	det	O
molecules	NNS	nsubj	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
IL-12	NN	compound	B-protein
production	NN	dobj	O
by	IN	case	O
macrophages	NNS	nmod	B-cell_type
and	CC	cc	O
the	DT	det	O
mechanisms	NNS	conj	O
by	IN	case	O
which	WDT	nmod	O
they	PRP	nsubj	O
do	VBP	acl:relcl	O
so	RB	advmod	O
remain	VB	ROOT	O
undefined	JJ	acomp	O
.	.	punct	O

Promoter	NN	compound	O
sequences	NNS	nsubjpass	O
responsive	JJ	amod	O
to	TO	case	O
cyclic	JJ	amod	O
AMP	NN	nmod	O
(	-LRB-	punct	O
cAMP	NN	appos	O
)	-RRB-	punct	O
are	VBP	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
bind	VBP	conj	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
CREB	NN	compound	B-protein
)	-RRB-	punct	I-protein
/activating	VBG	amod	I-protein
transcription	NN	compound	I-protein
factor-1	NN	compound	I-protein
(	-LRB-	punct	I-protein
ATF-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
family	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
objective	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
develop	VB	xcomp	O
U937	NN	compound	B-cell_line
transfectants	NNS	dobj	O
expressing	VBG	acl	O
antisense	JJ	amod	O
VDR	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
use	VB	conj	O
these	DT	dobj	O
to	TO	mark	O
examine	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	compound	O
-VDR	NN	compound	B-protein
interaction	NN	nmod	O
in	IN	case	O
this	DT	det	O
lineage	NN	nmod	O
.	.	punct	O

LIF	NN	nsubj	B-protein
increased	VBD	ROOT	O
steady-state	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
HIV	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
at	IN	case	O
2.0	CD	nummod	O
,	,	punct	O
4.3	CD	conj	O
,	,	punct	O
and	CC	cc	O
9.2	CD	conj	O
kB	NN	nmod	O
.	.	punct	O

Binding	NN	compound	O
assays	NNS	nsubj	O
using	VBG	acl	O
125I-labeled	JJ	amod	B-protein
C-C	JJ	compound	I-protein
chemokines	NNS	dobj	I-protein
in	IN	case	O
mammalian	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
indicated	VBD	ROOT	O
that	IN	mark	O
CHEMR1	NN	nsubj	B-DNA
did	VBD	aux	O
not	RB	neg	O
bind	VB	ccomp	O
MIP-1alpha	NN	dobj	O
,	,	punct	O
RANTES	NN	conj	O
,	,	punct	O
or	CC	cc	O
MIP-1beta	NN	conj	O
,	,	punct	O
whereas	IN	dep	O
CCR-1	NN	nsubj	B-protein
binds	VBZ	parataxis	O
MIP-1alpha	NN	dobj	B-protein
and	CC	cc	O
RANTES	NN	conj	B-protein
.	.	punct	O

One	CD	nummod	O
transformation	NN	compound	B-protein
effector	NN	compound	I-protein
site	NN	nsubj	I-protein
(	-LRB-	punct	O
TES1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
membrane	NN	compound	B-protein
proximal	JJ	amod	I-protein
45	CD	nummod	I-protein
residues	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	O
tail	NN	nmod	O
,	,	punct	O
constitutively	RB	advmod	O
engages	VBZ	ROOT	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptor-associated	JJ	amod	I-protein
factors	NNS	dobj	I-protein
.	.	punct	O

Although	IN	mark	O
prior	JJ	amod	O
studies	NNS	nsubj	O
suggest	VBP	advcl	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
and	CC	cc	O
phosphatases	NNS	conj	O
in	IN	case	O
Fas	NN	compound	B-protein
signaling	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
Fas	NN	compound	O
ligation	NN	nsubj	O
induces	VBZ	ccomp	O
apoptosis	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
deficient	JJ	amod	O
in	IN	case	O
either	CC	cc:preconj	O
CD45	NN	nmod	B-protein
or	CC	cc	O
Lck	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
IL-4	NN	compound	B-protein
receptor	NN	nsubjpass	I-protein
(	-LRB-	punct	O
IL-4R	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
two	CD	nummod	O
chains	NNS	nmod	O
,	,	punct	O
the	DT	det	O
IL-4-binding	JJ	amod	B-protein
IL-4Ralpha	NN	compound	I-protein
chain	NN	appos	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
shared	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
IL-13R	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
IL-2Rgamma	NN	compound	B-protein
(	-LRB-	punct	I-protein
gammac	NN	compound	I-protein
)	-RRB-	punct	I-protein
chain	NN	conj	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
shared	VBN	acl:relcl	O
with	IN	case	O
IL-7R	NN	nmod	B-protein
,	,	punct	O
IL-9R	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-15R	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
multidrug-resistant	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
,	,	punct	O
designated	VBN	acl	O
HL-60/vinc	NN	xcomp	O
,	,	punct	O
fail	VBP	ccomp	O
to	TO	mark	O
respond	VB	xcomp	O
to	TO	case	O
TPA	NN	nmod	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
c-jun	NN	compound	B-RNA
transcripts	NNS	nmod	I-RNA
or	CC	cc	O
other	JJ	amod	O
phenotypic	JJ	amod	O
characteristics	NNS	conj	O
of	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

In	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
IL-1beta	NN	compound	B-protein
treatment	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
production	NN	nmod	O
of	IN	case	O
ROIs	NNS	nmod	O
which	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
of	IN	case	O
the	DT	det	O
5-LOX	NN	compound	B-protein
enzyme	NN	nmod	I-protein
but	CC	cc	O
requires	VBZ	conj	O
the	DT	det	O
NADPH	NN	compound	O
oxidase	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
implicated	VBD	ROOT	O
c-Rel	NN	dobj	B-protein
as	IN	case	O
an	DT	det	O
IL-2	NN	compound	B-protein
promoter	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
for	IN	case	O
which	WDT	nmod	O
experimental	JJ	amod	O
support	NN	nsubjpass	O
was	VBD	auxpass	O
obtained	VBN	acl:relcl	O
from	IN	case	O
transient	JJ	amod	O
transfection	NN	compound	O
experiments	NNS	nmod	O
.	.	punct	O

Restoration	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
ZEBRA	NN	compound	I-protein
protein	NN	nmod:poss	I-protein
's	POS	case	O
capacity	NN	nmod	O
to	TO	mark	O
disrupt	VB	acl	O
latency	NN	dobj	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
heterologous	JJ	amod	B-protein
activation	NN	compound	I-protein
regions	NNS	nmod	I-protein
.	.	punct	O

MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Peptides	NNS	nsubjpass	O
derived	VBN	acl	O
from	IN	case	O
oncogenic	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
were	VBD	auxpass	O
screened	VBN	dep	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
HLA	NN	compound	B-protein
binding	NN	compound	I-protein
motifs	NNS	nmod	I-protein
;	:	punct	O
actual	JJ	amod	O
binding	NN	nsubjpass	O
were	VBD	auxpass	O
evaluated	VBN	dep	O
by	IN	case	O
HLA	NN	compound	O
stabilization	NN	compound	O
experiments	NNS	nmod	O
using	VBG	acl	O
transfectants	NNS	dobj	O
and	CC	cc	O
specific	JJ	amod	O
anti-HLA	JJ	amod	B-protein
antibodies	NNS	conj	I-protein
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
in	IN	case	O
CIITA-transfected	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
hybrids	NNS	nmod	I-cell_line
,	,	punct	O
cell	NN	compound	O
surface	NN	compound	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
HLA-DQ	NN	compound	I-protein
heterodimer	NN	nmod	I-protein
was	VBD	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
.	.	punct	O

Hormones	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
1	CD	compound	O
alpha	NN	nmod	O
,	,	punct	O
25-dihydroxy	NN	compound	O
vitamin	NN	compound	O
D3	NN	appos	O
(	-LRB-	punct	O
D3	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	conj	O
,	,	punct	O
and	CC	cc	O
9-cis	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	conj	O
stimulate	VBP	ROOT	O
differentiation	NN	dobj	O
of	IN	case	O
myeloid	JJ	amod	B-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
via	IN	case	O
their	PRP$	nmod:poss	O
interaction	NN	nmod	O
with	IN	case	O
specific	JJ	amod	O
hormone	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Similar	JJ	amod	O
repeat	NN	compound	B-protein
motifs	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
diverse	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
but	CC	cc	O
the	DT	det	O
motifs	NNS	nsubj	O
of	IN	case	O
Bcl-3	NN	nmod	B-protein
are	VBP	cop	O
most	RBS	advmod	O
closely	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
those	DT	nmod	O
found	VBN	acl	O
in	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
ankyrin	NN	compound	B-protein
repeat	NN	compound	I-protein
domain	NN	nsubjpass	O
is	VBZ	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
directly	RB	advmod	O
involved	VBN	xcomp	O
in	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
one	CD	nummod	O
or	CC	cc	O
more	RBR	conj	O
cytoplasmic	JJ	amod	B-protein
serine	NN	compound	I-protein
kinases	NNS	nsubj	I-protein
also	RB	advmod	O
phosphorylate	VBP	ccomp	O
STAT3	NN	dobj	B-protein
and	CC	cc	O
are	VBP	cop	O
necessary	JJ	conj	O
for	IN	case	O
maximal	JJ	amod	O
gene	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Spi-1/PU.1	NN	compound	B-DNA
proto-oncogene	NN	nsubj	B-DNA
induces	VBZ	ROOT	O
opposite	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
monocytic	JJ	nmod	O
and	CC	cc	O
erythroid	JJ	conj	O
differentiation	NN	dep	O
of	IN	case	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Redox	NN	compound	O
status	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
influences	VBZ	ROOT	O
constitutive	JJ	amod	O
or	CC	cc	O
induced	VBN	conj	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	dobj	O
and	CC	cc	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
activity	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_line
T	NN	nmod	I-cell_line
and	CC	cc	I-cell_line
monocytic	JJ	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

Furthermore	RB	ROOT	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	amod	O
trans-acting	JJ	amod	B-protein
factors	NNS	intj	I-protein
of	IN	case	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
B	NN	conj	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
e.g	NN	dep	O
.	.	punct	O
NF-kB	NN	nsubjpass	B-protein
,	,	punct	O
NF-AT	NN	conj	B-protein
and	CC	cc	O
STAT	NN	conj	B-protein
families	NNS	conj	I-protein
)	-RRB-	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
functional	JJ	amod	O
importance	NN	conj	O
are	VBP	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
component	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
has	VBZ	ccomp	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
reconstitute	VB	acl	O
NF	NN	dobj	B-protein
(	-LRB-	punct	I-protein
P	NN	appos	I-protein
)	-RRB-	punct	I-protein
whereas	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
alone	RB	advmod	O
can	MD	aux	O
not	RB	neg	O
account	VB	advcl	O
for	IN	case	O
NF	NN	nmod	B-protein
(	-LRB-	punct	I-protein
P	NN	appos	I-protein
)	-RRB-	punct	I-protein
in	IN	case	O
crude	JJ	amod	O
extracts	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
we	PRP	nsubj	O
explored	VBD	ROOT	O
the	DT	det	O
possible	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
5-hydroxyeicosatetraenoic	JJ	amod	O
acid	NN	nmod	O
as	IN	case	O
a	DT	det	O
regulator	NN	nmod	O
of	IN	case	O
arachidonic	JJ	amod	O
acid	NN	compound	O
liberation	NN	nmod	O
demonstrating	VBG	xcomp	O
that	IN	mark	O
endogenous	JJ	amod	O
5-lipoxygenase	NN	compound	B-protein
activity	NN	nsubj	O
modulates	VBZ	ccomp	O
platelet-activating	JJ	amod	B-protein
factor	NN	nmod:npmod	I-protein
induced	JJ	amod	O
arachidonic	JJ	amod	O
acid	NN	compound	O
release	NN	dobj	O
perhaps	RB	advmod	O
acting	VBG	advcl	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
phospholipase	NN	compound	B-protein
A2	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
complex	NN	nmod	O
would	MD	aux	O
increase	VB	ROOT	O
,	,	punct	O
independently	RB	advmod	O
of	IN	case	O
an	DT	nmod	O
in	IN	case	O
synergy	NN	nmod	O
with	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
low	JJ	amod	O
basal	JJ	amod	O
activity	NN	appos	O
of	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
observed	VBN	acl	O
in	IN	case	O
normal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Interleukin	NN	nsubj	B-protein
2	CD	nummod	I-protein
and	CC	cc	I-protein
15	CD	conj	I-protein
activate	VBP	ROOT	O
Stat3alpha	NN	dobj	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
and	CC	cc	I-cell_type
B	NN	conj	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
demonstrate	VBP	ROOT	O
an	DT	det	O
early	JJ	amod	O
and	CC	cc	O
transient	JJ	conj	O
hyperpolarization	NN	dobj	O
after	IN	case	O
ligand	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
at	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	O
and	CC	cc	O
T-cell	NN	conj	O
differentiation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
therefore	RB	advmod	O
investigated	VBN	ROOT	O
the	DT	det	O
changes	NNS	dobj	O
in	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
activity	NN	nmod	O
upon	IN	case	O
exposure	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
to	TO	case	O
M-CSF	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
peptide	NN	compound	O
vaccination	NN	nmod	O
,	,	punct	O
immunization	NN	nsubj	O
with	IN	case	O
adenovirus	NN	nmod	O
,	,	punct	O
expressing	VBG	acl	O
Ad5E1A	NN	dobj	B-protein
,	,	punct	O
induced	VBD	ROOT	O
Ad5E1A	JJ	compound	B-protein
-specific	JJ	amod	O
immunity	NN	dobj	O
and	CC	cc	O
prevented	VBD	conj	O
the	DT	det	O
outgrowth	NN	dobj	O
of	IN	case	O
Ad5E1A	JJ	compound	B-protein
-expressing	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
add	VBP	ROOT	O
to	IN	case	O
our	PRP$	nmod:poss	O
knowledge	NN	nmod	O
about	IN	case	O
the	DT	det	O
molecules	NNS	nmod	O
implicated	VBN	acl	O
along	IN	case	O
the	DT	det	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
growth	NN	compound	O
arrest	NN	conj	O
of	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
provide	VBP	conj	O
a	DT	det	O
first	JJ	amod	O
step	NN	dobj	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
roles	NNS	nmod	O
.	.	punct	O

Adhesion	NN	compound	O
assays	NNS	nsubj	O
under	IN	case	O
physiological	JJ	amod	O
shear	NN	compound	O
flow	NN	compound	O
conditions	NNS	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
firm	JJ	compound	O
arrest	NN	nsubjpass	O
,	,	punct	O
spreading	NN	conj	O
,	,	punct	O
and	CC	cc	O
transmigration	NN	conj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
on	IN	case	O
TNF-alpha	NN	compound	B-protein
-activated	JJ	amod	O
endothelium	NN	nmod	O
was	VBD	auxpass	O
markedly	RB	advmod	O
inhibited	VBN	ccomp	O
by	IN	case	O
IkappaB-alpha	NN	compound	B-protein
overexpression	NN	nmod	O
.	.	punct	O

The	DT	det	O
combination	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	B-protein
costimulatory	JJ	amod	I-protein
molecule	NN	compound	I-protein
B7.1	NN	nmod	B-protein
and	CC	cc	O
IL-12	NN	conj	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
synergistic	JJ	xcomp	O
for	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
immunodeficiency	NN	compound	I-protein
virus	NN	compound	I-protein
(	-LRB-	punct	I-protein
HIV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
Nef	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	compound	O
pathways	NNS	nmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
Jurkat	NN	compound	B-cell_line
CD4+	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
stably	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
Nef	NN	compound	O
expression	NN	compound	O
vector	NN	nmod	O
.	.	punct	O

To	TO	mark	O
find	VB	advcl	O
new	JJ	amod	O
regulatory	JJ	amod	B-DNA
regions	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
8.5	CD	nummod	O
kb	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
5	CD	nummod	O
'	''	punct	O
end	VB	compound	O
noncoding	JJ	compound	O
sequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
sequenced	VBN	ROOT	O
.	.	punct	O

Nuclear	JJ	amod	O
run-off	NN	amod	O
assays	NNS	nsubj	O
and	CC	cc	O
half-life	JJ	amod	O
studies	NNS	conj	O
showed	VBD	ROOT	O
that	IN	mark	O
accumulation	NN	nsubj	O
of	IN	case	O
C/EBP	NN	compound	B-RNA
epsilon	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
9-cis	JJ	amod	O
RA	NN	nmod	O
was	VBD	cop	O
due	JJ	ccomp	O
to	TO	case	O
enhanced	VBN	amod	O
transcription	NN	nmod	O
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
alterations	NNS	nmod	O
observed	VBN	acl	O
are	VBP	cop	O
of	IN	case	O
medical	JJ	amod	O
relevance	NN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
direct	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
K+	NN	compound	B-protein
channels	NNS	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
progesterone	NN	nmod	O
contributes	VBZ	ccomp	O
to	TO	case	O
progesterone-induced	JJ	amod	O
immunosuppression	NN	nmod	O
.	.	punct	O

Aggregation	NN	nsubjpass	O
was	VBD	auxpass	O
likely	RB	advmod	O
caused	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
up-regulated	VBN	amod	O
surface	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
including	VBG	case	O
integrin	NN	compound	B-protein
alpha	NN	nmod	I-protein
,	,	punct	O
L-selectin	NN	conj	B-protein
,	,	punct	O
ICAM-3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
H-CAM	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
3H-PGG-Glucan	NN	nmod	O
to	TO	case	O
human	JJ	amod	O
leukocyte	NN	compound	O
membranes	NNS	nmod	O
was	VBD	cop	O
specific	JJ	ROOT	O
,	,	punct	O
concentration-dependent	JJ	conj	O
,	,	punct	O
saturable	JJ	conj	O
,	,	punct	O
and	CC	cc	O
high	JJ	amod	O
affinity	NN	conj	O
(	-LRB-	punct	O
Kd	NN	dep	O
approximately	RB	advmod	O
6	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
0.1-0.5	CD	dep	O
microM	NN	compound	O
DMDTC	NN	nsubj	O
inhibits	VBZ	ccomp	O
intracellular	JJ	amod	O
IL-2	NN	compound	B-protein
production	NN	dobj	O
and	CC	cc	O
decreases	VBZ	conj	O
surface	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
CD25	NN	nmod	B-protein
(	-LRB-	punct	O
the	DT	det	O
alpha	NN	compound	B-protein
subunit	NN	dep	I-protein
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-protein
receptor	NN	nmod	I-protein
)	-RRB-	punct	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
stimulated	VBN	acl	O
with	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
CMV	NN	nsubj	O
induced	VBD	ccomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
cytokine	NN	nsubj	B-protein
may	MD	aux	O
modulate	VB	ccomp	O
foam	NN	compound	O
cell	NN	compound	O
formation	NN	dobj	O
during	IN	case	O
atherogenesis	NN	nmod	O
.	.	punct	O

While	IN	mark	O
dexamethasone	NN	nsubj	O
(	-LRB-	punct	O
0.1	CD	nummod	O
nmol/L	NN	dep	O
to	TO	case	O
100	CD	nummod	O
mumol/L	NN	nmod	O
)	-RRB-	punct	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
expression	NN	dobj	O
of	IN	case	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
on	IN	case	O
resting	VBG	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
,	,	punct	O
it	PRP	nsubj	O
attenuated	VBD	ROOT	O
the	DT	det	O
PAF	NN	compound	B-protein
-induced	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
L-selectin	NN	nmod	B-protein
and	CC	cc	O
CD18	NN	conj	B-protein
expression	NN	dep	O
in	IN	case	O
a	DT	det	O
time-	NN	amod	O
and	CC	cc	O
concentration-dependent	JJ	conj	O
fashion	NN	nmod	O
with	IN	case	O
IC50	NN	compound	O
values	NNS	nmod	O
of	IN	case	O
31	CD	nummod	O
and	CC	cc	O
13	CD	conj	O
nmol/L	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Whereas	IN	mark	O
in	IN	case	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	compound	O
(	-LRB-	punct	O
CML	NN	appos	O
)	-RRB-	punct	O
the	DT	det	O
granulocytes	NNS	nsubj	B-cell_type
(	-LRB-	punct	O
PMN	NN	appos	B-cell_type
)	-RRB-	punct	O
were	VBD	cop	O
uniformly	RB	advmod	O
of	IN	case	O
monoclonal	JJ	amod	O
origin	NN	advcl	O
,	,	punct	O
a	DT	det	O
striking	JJ	amod	O
heterogeneity	NN	nsubjpass	O
of	IN	case	O
clonal	JJ	amod	O
development	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
PMN	NN	nmod	B-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
other	JJ	amod	O
MPD	NN	nmod	O
,	,	punct	O
with	IN	case	O
up	RB	advmod	O
to	TO	dep	O
50	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
them	PRP	nmod	O
expressing	VBG	acl	O
a	DT	det	O
polyclonal	JJ	amod	O
pattern	NN	dobj	O
of	IN	case	O
X	NN	compound	O
inactivation	NN	nmod	O
.	.	punct	O

The	DT	det	O
1311-base	JJ	compound	B-DNA
pair	NN	compound	I-DNA
human	JJ	amod	I-DNA
tumor	NN	compound	I-DNA
necrosis	NN	compound	I-DNA
factor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TNF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
region	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
fused	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
luciferase	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
Luc	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
studied	VBN	conj	O
in	IN	case	O
a	DT	det	O
transient	JJ	amod	O
transfection	NN	compound	O
system	NN	nmod	O
in	IN	case	O
three	CD	nummod	O
TNF	NN	compound	B-cell_line
producing	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
U937	NN	compound	B-cell_line
macrophage	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
,	,	punct	O
the	DT	det	O
MLA	NN	compound	B-cell_line
144	CD	nummod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
,	,	punct	O
and	CC	cc	O
the	DT	det	O
729-6	CD	nummod	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
MIP-1alpha-R	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
suggests	VBZ	ROOT	O
an	DT	det	O
autocrine	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
chemokine	NN	nmod	B-protein
in	IN	case	O
HTLV-I	NN	compound	B-cell_type
infected	JJ	amod	I-cell_type
T-cells	NNS	nmod	I-cell_type
.	.	punct	O

Subsequently	RB	advmod	O
,	,	punct	O
such	JJ	amod	O
primed	VBN	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
can	MD	aux	O
undergo	VB	ROOT	O
switch	NN	compound	O
recombination	NN	dobj	O
to	TO	mark	O
express	VB	xcomp	O
the	DT	det	O
selected	VBN	amod	O
new	JJ	amod	O
isotype	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
intracellular	JJ	amod	O
mechanisms	NNS	nsubj	O
for	IN	case	O
these	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
ethanol	NN	nmod	O
are	VBP	auxpass	O
yet	RB	advmod	O
to	TO	mark	O
be	VB	auxpass	O
understood	VBN	ROOT	O
.	.	punct	O

Further	RB	advmod	O
deletional	JJ	amod	O
and	CC	cc	O
alanine	NN	conj	O
mutagenesis	NN	compound	O
analyses	NNS	nsubj	O
and	CC	cc	O
comparison	NN	conj	O
with	IN	case	O
TRAF	NN	compound	B-DNA
binding	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
CD40	NN	nmod	O
,	,	punct	O
in	IN	case	O
CD30	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
LMP1	NN	conj	B-protein
of	IN	case	O
other	JJ	amod	O
lymphycryptoviruses	NNS	nmod	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
PXQXT/S	NN	nsubj	B-DNA
is	VBZ	cop	O
a	DT	det	O
core	NN	ccomp	O
TRAF	NN	compound	B-DNA
binding	NN	compound	I-DNA
motif	NN	dobj	I-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
several	JJ	amod	O
novel	JJ	amod	O
KRAB-containing	JJ	amod	B-DNA
zinc	NN	compound	I-DNA
finger	NN	compound	I-DNA
genes	NNS	nsubjpass	I-DNA
and	CC	cc	O
a	DT	det	O
novel	JJ	amod	O
conserved	VBN	amod	B-DNA
sequence	NN	compound	I-DNA
element	NN	conj	I-DNA
were	VBD	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

Both	CC	cc:preconj	O
CHO-CD80	NN	nsubj	B-protein
and	CC	cc	O
CHO-CD86	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
the	DT	dep	O
presence	NN	dep	O
of	IN	case	O
anti-CD3	JJ	amod	B-protein
mAb	NN	nmod	I-protein
,	,	punct	O
costimulated	VBD	amod	O
NFAT	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	ROOT	O
.	.	punct	O

Rapid	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
key	JJ	amod	O
cellular	JJ	amod	O
proteins	NNS	nmod	O
is	VBZ	cop	O
a	DT	det	O
crucial	JJ	amod	O
event	NN	ROOT	O
in	IN	case	O
the	DT	det	O
transduction	NN	nmod	O
of	IN	case	O
activation	NN	compound	O
signals	NNS	nmod	O
to	TO	case	O
T-lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

This	DT	nsubj	O
may	MD	aux	O
occur	VB	ROOT	O
through	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
IL-10	NN	nmod	B-protein
to	TO	mark	O
induce	VB	acl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
,	,	punct	O
suppressor	NN	appos	O
of	IN	case	O
cytokine	NN	compound	B-protein
signaling	NN	nmod	I-protein
3	CD	nummod	I-protein
(	-LRB-	punct	O
SOCS3	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
an	DT	det	O
EBNA2	NN	nmod:npmod	B-DNA
dependent	JJ	amod	I-DNA
cis-acting	JJ	amod	I-DNA
element	NN	dobj	I-DNA
,	,	punct	O
various	JJ	amod	O
TP1	NN	compound	B-DNA
promoter-reporter	JJ	compound	I-DNA
gene	NN	compound	I-DNA
constructs	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
transfected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
and	CC	cc	O
presence	NN	conj	O
of	IN	case	O
an	DT	det	O
EBNA2	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
into	IN	case	O
the	DT	det	O
established	JJ	amod	O
B-cell	NN	compound	B-cell_line
line	NN	compound	I-cell_line
BL41-P3HR1	NN	nmod	I-cell_line
.	.	punct	O

Direct	JJ	amod	O
suppression	NN	ROOT	O
of	IN	case	O
Stat1	NN	compound	B-protein
function	NN	nmod	O
during	IN	case	O
adenoviral	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
NO	NN	nmod:poss	O
's	POS	case	O
ability	NN	nsubj	O
to	TO	mark	O
limit	VB	acl	O
endothelial	JJ	amod	O
activation	NN	dobj	O
and	CC	cc	O
inhibit	VBP	ccomp	O
monocyte	NN	compound	O
adhesion	NN	dobj	O
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
some	DT	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
antiatherogenic	JJ	amod	O
and	CC	cc	O
antiinflammatory	JJ	conj	O
properties	NNS	nmod	O
within	IN	case	O
the	DT	det	O
vessel	NN	compound	O
wall	NN	nmod	O
.	.	punct	O

The	DT	det	O
S.	FW	compound	O
cerevisiae	FW	nsubj	O
and	CC	cc	O
Sch.	FW	compound	O
pombe	FW	compound	O
systems	NNS	nsubj	O
support	VBP	ROOT	O
effects	NNS	dobj	O
of	IN	case	O
acidic	JJ	amod	B-protein
activator	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
provided	VBD	conj	O
a	DT	det	O
further	JJ	amod	O
protein	NN	compound	O
fraction	NN	nsubjpass	O
from	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
is	VBZ	auxpass	O
supplied	VBN	conj	O
.	.	punct	O

A	DT	det	O
second	JJ	amod	O
translocation	NN	nsubjpass	O
adjacent	JJ	amod	O
to	TO	case	O
rhombotin	NN	nmod	B-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
and	CC	cc	O
at	IN	case	O
the	DT	det	O
same	JJ	amod	O
position	NN	conj	O
as	IN	case	O
in	IN	case	O
the	DT	det	O
previous	JJ	amod	O
example	NN	nmod	O
.	.	punct	O

Activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
CBF	NN	compound	B-DNA
site	NN	nmod	I-DNA
is	VBZ	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
critically	RB	advmod	O
dependent	JJ	xcomp	O
on	IN	case	O
the	DT	det	O
adjacent	JJ	amod	B-DNA
activator	NN	compound	I-DNA
site	NN	nmod	I-DNA
Act-1	NN	dep	I-DNA
.	.	punct	O

This	DT	det	O
ANG	NN	compound	B-protein
II	CD	nummod	I-protein
effect	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
angiotensin	NN	compound	O
AT1	NN	compound	O
receptor	NN	compound	O
antagonist	NN	compound	O
losartan	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nsubjpass	O
of	IN	case	O
HIV	NN	compound	O
inhibition	NN	nmod	O
by	IN	case	O
ascorbate	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
mediated	VBN	ccomp	O
via	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
inhibition	NN	nmod	O
,	,	punct	O
unlike	IN	case	O
that	DT	nmod	O
seen	VBN	acl	O
with	IN	case	O
other	JJ	amod	O
antioxidants	NNS	nmod	O
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
by	IN	case	O
lipopolysaccharide	NN	nmod	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
prevented	VBN	ROOT	O
by	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
cytosolic	JJ	amod	B-protein
phospholipase	NN	compound	I-protein
A2	NN	nmod	I-protein
.	.	punct	O

Binding	NN	nsubjpass	O
of	IN	case	O
1	CD	nummod	O
nM	NN	nmod	O
[	-LRB-	punct	O
125I	NN	nummod	O
]	-RRB-	punct	O
-aldosterone	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
at	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
weight	NN	nmod	O
of	IN	case	O
approximately	RB	advmod	O
50	CD	nummod	O
kDa	NN	nmod	O
which	WDT	nsubj	O
was	VBD	cop	O
absent	JJ	acl:relcl	O
with	IN	case	O
1	CD	nummod	O
microM	NN	amod	O
cold	JJ	amod	O
aldosterone	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
cortisol	NN	conj	O
in	IN	case	O
the	DT	det	O
binding	VBG	amod	O
media	NNS	nmod	O
.	.	punct	O

This	DT	det	O
function	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
result	NN	ROOT	O
of	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
EBV	NN	nmod	O
with	IN	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
,	,	punct	O
CD21	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
caused	VBN	conj	O
by	IN	case	O
infection	NN	nmod	O
rather	RB	cc	O
than	IN	mwe	O
surface	NN	compound	O
signaling	NN	conj	O
,	,	punct	O
because	IN	mark	O
neither	CC	cc:preconj	O
specific	JJ	amod	B-protein
mAb	NN	nsubj	I-protein
nor	CC	cc	O
the	DT	det	O
P3HR-1	NN	compound	O
strain	NN	conj	O
of	IN	case	O
virus	NN	nmod	O
mimicked	VBD	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
B95-8	NN	nmod	O
.	.	punct	O

DNA-protein	JJ	amod	O
crosslinking	NN	compound	O
studies	NNS	nsubj	O
have	VBP	aux	O
revealed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
more	RBR	advmod	O
rapidly	RB	advmod	O
migrating	VBG	amod	O
B2	NN	compound	B-protein
complex	NN	nsubj	I-protein
contains	VBZ	ccomp	O
both	CC	cc:preconj	O
p50	NN	dobj	B-protein
and	CC	cc	O
p55	NN	conj	B-protein
while	IN	mark	O
the	DT	det	O
more	RBR	advmod	O
slowly	RB	advmod	O
migrating	VBG	amod	O
B1	NN	compound	B-protein
complex	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
composed	VBN	advcl	O
of	IN	case	O
p50	NN	nmod	B-protein
,	,	punct	O
p55	NN	conj	B-protein
,	,	punct	O
p75	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p85	NN	conj	B-protein
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
PBMCs	NNS	nsubjpass	B-cell_type
and	CC	cc	O
sera	NNS	conj	O
from	IN	case	O
8	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
extrinsic	JJ	amod	O
asthma	NN	nmod	O
(	-LRB-	punct	O
mean	JJ	amod	O
IgE	NN	compound	B-protein
,	,	punct	O
285+/-100	CD	nummod	O
IU/mL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
3	CD	nummod	O
patients	NNS	conj	O
with	IN	case	O
HIE	NN	nmod	O
(	-LRB-	punct	O
mean	JJ	amod	O
IgE	NN	dep	B-protein
,	,	punct	O
7050+/-1122	CD	nummod	O
IU/mL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
14	CD	nummod	O
nonatopic	JJ	amod	O
control	JJ	amod	O
subjects	NNS	conj	O
(	-LRB-	punct	O
mean	JJ	amod	O
IgE	NN	nsubjpass	B-protein
,	,	punct	O
112+/-28	CD	nummod	O
IU/mL	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
analyzed	VBN	dep	O
.	.	punct	O

Similar	JJ	amod	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
c-fos	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
transfected	VBN	amod	O
IFN-beta	NN	compound	O
promoter	NN	nsubj	O
responded	VBD	ROOT	O
to	TO	case	O
EBNA2	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
sequence	NN	nsubjpass	O
closely	RB	advmod	O
resembling	VBG	acl	O
a	DT	det	O
RBP-Jkappa	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
was	VBD	auxpass	O
pinpointed	VBN	conj	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
target	NN	nmod	O
of	IN	case	O
EBNA2	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

Late	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubj	O
follows	VBZ	ROOT	O
and	CC	cc	O
is	VBZ	cop	O
dependent	JJ	conj	O
upon	IN	case	O
lytic	JJ	amod	O
replication	NN	nmod	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
genome	NN	nmod	I-DNA
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
vincristine	NN	compound	O
resistance	NN	nsubj	O
confers	VBZ	ccomp	O
insensitivity	NN	dobj	O
to	TO	case	O
TPA-induced	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
can	MD	aux	O
include	VB	conj	O
defects	NNS	dobj	O
in	IN	case	O
PKC	NN	compound	B-protein
-mediated	JJ	amod	O
signaling	NN	compound	O
events	NNS	nmod	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
jun/fos	NN	compound	B-DNA
early	JJ	amod	I-DNA
response	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Changes	NNS	nsubj	O
in	IN	case	O
MNDA	NN	compound	B-protein
expression	NN	nmod	O
occurred	VBD	ROOT	O
slowly	RB	advmod	O
(	-LRB-	punct	O
hours	NNS	dep	O
to	TO	case	O
days	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
MNDA	NN	nsubj	B-protein
could	MD	aux	O
mediate	VB	ccomp	O
changes	NNS	dobj	O
realized	VBN	acl	O
over	IN	prep	O
a	DT	det	O
long	JJ	amod	O
period	NN	pobj	O
.	.	punct	O

Engagement	NN	nsubj	O
of	IN	case	O
natural	JJ	amod	O
cytotoxicity	NN	compound	O
programs	NNS	nmod	O
regulates	VBZ	ROOT	O
AP-1	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
NKL	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
NK	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Analyses	NNS	nsubj	O
of	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
by	IN	case	O
electrophoretic	JJ	amod	O
DNA	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
decreased	VBN	amod	O
IL-2	NN	compound	B-protein
production	NN	nsubjpass	O
by	IN	case	O
stimulated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
elderly	JJ	amod	O
individuals	NNS	nmod	O
was	VBD	auxpass	O
closely	RB	advmod	O
associated	VBN	ccomp	O
with	IN	case	O
impairments	NNS	nmod	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
AP-1	NN	nmod	B-protein
and	CC	cc	O
NF-AT	NN	conj	B-protein
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
zinc	NN	compound	O
addition	NN	nsubj	O
in	IN	case	O
a	DT	det	O
serum-	NN	amod	O
and	CC	cc	O
lipopolysaccharide-free	JJ	conj	O
cell	NN	compound	O
culture	NN	compound	O
system	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
significantly	RB	advmod	O
enhanced	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
interleukin	NN	compound	B-protein
1	CD	nummod	I-protein
beta	NN	nmod	I-protein
(	-LRB-	punct	O
IL-1	NN	compound	B-protein
beta	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
to	TO	case	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
mRNA	NN	nmod	B-RNA
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
wide	JJ	amod	O
range	NN	dobj	O
of	IN	case	O
TCR	NN	compound	B-protein
affinities	NNS	nmod	O
among	IN	case	O
the	DT	det	O
different	JJ	amod	O
clonotypes	NNS	nmod	O
that	WDT	nsubj	O
segregated	VBD	acl:relcl	O
with	IN	case	O
Vbeta	NN	compound	O
usage	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
helper	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
results	VBZ	ROOT	O
in	IN	case	O
coordinate	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
involved	VBN	acl	O
in	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
haematopoietic	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
CN	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
coordinated	VBN	amod	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
and	CC	cc	I-DNA
IL-2	NN	conj	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
CLE0	NN	compound	B-DNA
sequence	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
is	VBZ	cop	O
a	DT	det	O
functional	JJ	amod	O
analogue	NN	conj	O
of	IN	case	O
the	DT	det	O
NF-AT-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
signals	NNS	dobj	O
downstream	RB	amod	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
exposed	VBN	ROOT	O
to	TO	case	O
UV	NN	compound	O
light	NN	nmod	O
delivered	VBN	acl	O
by	IN	case	O
a	DT	det	O
bank	NN	nmod	O
of	IN	case	O
6	CD	nummod	O
Philips	NN	compound	O
TL20/12RS	NN	compound	O
sun	NN	compound	O
lamps	NNS	nmod	O
emitting	VBG	acl	O
primarily	RB	advmod	O
in	IN	case	O
the	DT	det	O
UVB	NN	compound	O
range	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
and	CC	cc	O
presence	NN	conj	O
of	IN	case	O
tryptophan	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
phospholipase	NN	compound	B-protein
C	NN	compound	I-protein
gamma	NN	nmod	I-protein
1	CD	nummod	I-protein
,	,	punct	O
ligation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
receptor	NN	nmod	O
also	RB	advmod	O
seems	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
a	DT	det	O
calcium-independent	JJ	amod	O
,	,	punct	O
CD28	NN	nmod:npmod	B-protein
-specific	JJ	dep	O
pathway	NN	dobj	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
c-jun	NN	compound	B-DNA
transcription	NN	nmod	O
by	IN	case	O
okadaic	JJ	amod	O
acid	NN	nmod	O
is	VBZ	auxpass	O
controlled	VBN	ccomp	O
primarily	RB	advmod	O
by	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

3BP2	NN	nsubjpass	B-protein
was	VBD	auxpass	O
selectively	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
hematopoietic/lymphoid	JJ	amod	O
tissues	NNS	nmod	O
and	CC	cc	O
bound	VBD	conj	O
via	IN	case	O
its	PRP$	nmod:poss	O
SH2	NN	compound	B-protein
domain	NN	compound	I-protein
activated	VBN	amod	I-protein
Syk-family	JJ	amod	I-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
mammalian	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
including	VBG	case	O
in	IN	case	O
antigen	NN	compound	B-cell_type
receptor-stimulated	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
endogenous	JJ	amod	O
thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	nsubj	I-protein
(	-LRB-	punct	O
c-erbA/TR-alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	conj	I-protein
(	-LRB-	punct	O
RAR-alpha	NN	appos	B-protein
)	-RRB-	punct	O
play	VBP	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
examine	VBP	ROOT	O
the	DT	det	O
biochemical	JJ	amod	O
basis	NN	dobj	O
for	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
HIV	NN	nmod	O
by	IN	case	O
NFKB2	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
all	DT	det	O
other	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
/I	JJ	compound	O
kappa	NN	compound	O
B	NN	compound	O
molecules	NNS	nsubj	O
tested	VBN	acl	O
are	VBP	cop	O
relatively	RB	advmod	O
stable	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
cell-types	NNS	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
no	DT	neg	O
primary	JJ	amod	O
and	CC	cc	O
general	JJ	conj	O
impairment	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	O
metabolism	NN	nmod	O
in	IN	case	O
the	DT	det	O
asthmatics	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
GCR	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
asthmatics	NNS	nmod	O
is	VBZ	cop	O
lower	JJR	conj	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
healthy	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

Specific	JJ	amod	O
nuclear	JJ	amod	O
translocation	NN	nsubjpass	O
of	IN	case	O
[	-LRB-	punct	B-protein
3H	NN	compound	I-protein
]	-RRB-	punct	I-protein
calcitriol/VDR	NN	nmod	I-protein
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
time	NN	nmod:npmod	O
dependent	JJ	xcomp	O
reaching	VBG	xcomp	O
a	DT	det	O
maximum	NN	dobj	O
of	IN	case	O
approximately	RB	advmod	O
2100	CD	nummod	O
binding	VBG	amod	O
sites/nucleus	NNS	nmod	O
after	IN	case	O
3	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
incubation	NN	nmod	O
in	IN	case	O
HL60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
whereas	IN	dep	O
a	DT	det	O
maximum	NN	nsubjpass	O
of	IN	case	O
approximately	RB	advmod	O
310	CD	nummod	O
binding	VBG	amod	O
sites/nucleus	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	parataxis	O
after	IN	case	O
3	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
PBL	NN	nmod	B-cell_type
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
M-CSF	NN	nsubj	B-protein
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
gene	NN	nmod	O
.	.	punct	O

The	DT	det	O
lymphocytes	NNS	nsubj	B-cell_type
exhibited	VBD	ROOT	O
lipid	NN	compound	O
peroxidation	NN	dobj	O
only	RB	advmod	O
upon	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
the	DT	det	O
lowest	JJS	amod	O
level	NN	nmod	O
of	IN	case	O
hydrogen	NN	compound	O
peroxide	NN	nmod	O
used	VBN	acl	O
(	-LRB-	punct	O
20	CD	nummod	O
microM	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
changes	NNS	dobj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
this	DT	det	O
variable	JJ	amod	O
VDR	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
three	CD	nummod	O
copies	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
GC-box	NN	nmod	B-DNA
can	MD	aux	O
functionally	RB	advmod	O
compensate	VB	ccomp	O
for	IN	case	O
the	DT	det	O
GM-kappa	NN	compound	B-DNA
B/GC-box	NN	compound	I-DNA
region	NN	nmod	I-DNA
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
GC-motif	NN	nsubj	O
can	MD	aux	O
function	VB	ccomp	O
independently	RB	advmod	O
of	IN	case	O
the	DT	det	O
GM-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
motif	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
replacement	NN	nsubj	O
of	IN	case	O
p50	NN	compound	B-protein
homodimers	NNS	nmod	I-protein
with	IN	case	O
transcriptionally	RB	advmod	O
active	JJ	amod	O
heterodimers	NNS	nmod	O
following	VBG	case	O
time	NN	nmod	O
in	IN	case	O
culture	NN	nmod	O
may	MD	aux	O
partially	RB	advmod	O
explain	VB	ROOT	O
the	DT	det	O
progressive	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
susceptibility	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
to	TO	case	O
HIV	NN	compound	O
infection	NN	nmod	O
during	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
culture	NN	nmod	O
.	.	punct	O

The	DT	det	O
DNA-binding	JJ	amod	B-protein
domain	NN	nsubjpass	I-protein
(	-LRB-	punct	O
amino	NN	compound	B-protein
acids	NNS	appos	I-protein
421-486	CD	nummod	I-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
completely	RB	advmod	O
conserved	VBN	ROOT	O
among	IN	case	O
human	JJ	amod	B-protein
,	,	punct	I-protein
squirrel	NN	compound	I-protein
monkey	NN	nmod	I-protein
,	,	punct	I-protein
owl	JJ	amod	I-protein
monkey	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
cotton-top	NN	amod	I-protein
tamarin	NN	compound	I-protein
receptors	NNS	conj	I-protein
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
and	CC	cc	O
prevention	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
in	IN	case	O
eosinophils	NNS	nmod	B-cell_type
.	.	punct	O

IFN	NN	compound	B-protein
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
binding	NN	nmod	O
of	IN	case	O
IFNs	NNS	nmod	B-protein
to	TO	case	O
their	PRP$	nmod:poss	O
receptors	NNS	nmod	O
and	CC	cc	O
subsequent	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
Janus	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	compound	O
(	-LRB-	punct	O
JAK	NN	appos	B-protein
)	-RRB-	punct	O
-	:	punct	O
STAT	NN	compound	B-protein
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
TPA	NN	nmod	B-protein
,	,	punct	O
bryostatin	NN	conj	B-protein
1	CD	nummod	I-protein
,	,	punct	O
and	CC	cc	O
retinoic	JJ	amod	O
acid	NN	conj	O
on	IN	case	O
PO-B	NN	nmod	B-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
AP-2	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	conj	O
during	IN	case	O
HL-60	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Basement	NN	compound	O
membrane	NN	compound	O
immunoreactivity	NN	nsubj	O
for	IN	case	O
type	NN	compound	B-protein
IV	CD	nummod	I-protein
collagen	NN	nmod	I-protein
and	CC	cc	O
laminin	NN	conj	B-protein
was	VBD	cop	O
discontinuous	JJ	ROOT	O
in	IN	case	O
most	JJS	amod	O
examples	NNS	nmod	O
of	IN	case	O
IDC	NN	nmod	O
regardless	RB	advmod	O
of	IN	case	O
type	NN	nmod	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
trend	NN	nmod	O
toward	IN	case	O
more	RBR	advmod	O
intense	JJ	amod	O
staining	NN	nmod	O
in	IN	case	O
comedo	NN	nmod	O
than	IN	case	O
in	IN	case	O
noncomedo	JJ	amod	O
carcinomas	NNS	nmod	O
.	.	punct	O

Aspirin	NN	nsubj	O
appeared	VBD	ROOT	O
to	TO	mark	O
prevent	VB	xcomp	O
VCAM-1	NN	compound	B-protein
transcription	NN	dobj	O
,	,	punct	O
since	IN	mark	O
it	PRP	nsubj	O
dose-dependently	RB	advmod	O
inhibited	VBD	advcl	O
induction	NN	dobj	O
of	IN	case	O
VCAM-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
TNF	NN	nmod	B-protein
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
Western	NN	compound	O
blotting	NN	compound	O
experiments	NNS	nmod	O
using	VBG	acl	O
antibodies	NNS	dobj	B-protein
to	TO	case	O
kappa	NN	compound	B-protein
B/Rel	NN	compound	I-protein
family	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
kappa	NN	compound	O
B-binding	JJ	amod	O
activity	NN	nsubjpass	O
constitutively	RB	advmod	O
expressed	VBN	acl	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
RCC	NN	compound	O
patients	NNS	nmod	O
is	VBZ	auxpass	O
composed	VBN	ROOT	O
mostly	RB	advmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B1	NN	compound	I-protein
(	-LRB-	punct	I-protein
p50	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	nmod	I-protein
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
therefore	RB	advmod	O
can	MD	aux	O
become	VB	ROOT	O
competent	JJ	xcomp	O
for	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
by	IN	case	O
control	NN	nmod	O
of	IN	case	O
regulated	VBN	amod	B-protein
host	NN	compound	I-protein
factors	NNS	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
NFATc	NN	compound	B-protein
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
of	IN	case	O
functional	JJ	amod	O
synergy	NN	nmod	O
between	IN	case	O
TAL1	NN	nmod	B-protein
and	CC	cc	O
LMO	NN	conj	B-protein
in	IN	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
transcriptional	JJ	amod	O
regulation	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
tried	VBD	ROOT	O
to	TO	mark	O
identify	VB	xcomp	O
downstream	JJ	amod	B-DNA
target	NN	compound	I-DNA
genes	NNS	dobj	I-DNA
regulated	VBN	acl	O
by	IN	case	O
TAL1	NN	nmod	B-protein
and	CC	cc	O
LMO	NN	conj	B-protein
by	IN	case	O
a	DT	det	O
subtractive	JJ	amod	O
PCR	NN	compound	O
method	NN	nmod	O
.	.	punct	O

IEF-1	NN	nsubjpass	B-protein
,	,	punct	O
a	DT	det	O
pancreatic	JJ	amod	O
beta-cell	NN	nmod:npmod	O
type-specific	JJ	amod	O
complex	NN	appos	O
believed	VBN	acl	O
to	TO	mark	O
regulate	VB	xcomp	O
insulin	NN	compound	O
expression	NN	dobj	O
,	,	punct	O
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
consist	VB	xcomp	O
of	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
distinct	JJ	amod	O
species	NNS	nmod	O
,	,	punct	O
one	CD	nsubj	O
of	IN	case	O
which	WDT	nmod	O
does	VBZ	aux	O
not	RB	neg	O
contain	VB	parataxis	O
Pan	NN	compound	B-protein
molecules	NNS	dobj	I-protein
.	.	punct	O

This	DT	det	O
element	NN	nsubj	O
includes	VBZ	ROOT	O
binding	VBG	amod	O
sites	NNS	dobj	O
for	IN	case	O
NF-E2	NN	nmod	B-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
GATA-1	NN	conj	B-protein
and	CC	cc	O
Sp-1	NN	conj	B-protein
.	.	punct	O

CD38	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
leukocyte	NN	compound	B-protein
differentiation	NN	compound	I-protein
antigen	NN	ROOT	I-protein
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
phenotypic	JJ	amod	O
marker	NN	xcomp	O
of	IN	case	O
different	JJ	amod	O
subpopulations	NNS	nmod	O
of	IN	case	O
T-	NN	compound	B-cell_type
and	CC	cc	I-cell_type
B-	NN	conj	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Whereas	IN	mark	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
following	VBG	case	O
T-cell	NN	compound	O
stimulation	NN	nmod	O
is	VBZ	auxpass	O
mediated	VBN	advcl	O
largely	RB	advmod	O
through	IN	case	O
binding	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
to	TO	case	O
two	CD	nummod	O
adjacent	JJ	amod	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
,	,	punct	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
four	CD	nummod	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
:	:	punct	O
a	DT	det	O
single	JJ	amod	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	dep	I-DNA
,	,	punct	O
two	CD	nummod	O
purine-rich	JJ	amod	B-DNA
binding	VBG	amod	I-DNA
sites	NNS	appos	I-DNA
,	,	punct	O
PuB1	NN	appos	B-DNA
and	CC	cc	O
PuB2	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
a	DT	det	O
pets	NN	compound	B-DNA
site	NN	conj	I-DNA
.	.	punct	O

IL-7	NN	nsubj	B-protein
also	RB	advmod	O
delayed	VBD	ROOT	O
the	DT	det	O
decreases	NNS	dobj	O
in	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
c-Myc	NN	nmod	B-protein
,	,	punct	O
Bcl-2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Bcl-xL	NN	conj	B-protein
that	WDT	nsubj	O
occur	VBP	acl:relcl	O
upon	IN	case	O
loss	NN	nmod	O
of	IN	case	O
v-Abl	NN	compound	B-protein
kinase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
tiny	JJ	amod	O
ring	NN	compound	O
X	NN	compound	B-DNA
chromosomes	NNS	nsubjpass	I-DNA
studied	VBN	acl	O
with	IN	case	O
an	DT	det	O
antibody	NN	nmod	B-protein
specific	JJ	amod	O
for	IN	case	O
the	DT	det	O
acetylated	VBN	amod	O
isoforms	NNS	nmod	O
of	IN	case	O
histone	NN	compound	B-protein
H4	NN	nmod	I-protein
marking	VBG	acl	O
transcribed	VBN	amod	B-DNA
chromatin	NN	compound	I-DNA
domains	NNS	dobj	I-DNA
were	VBD	auxpass	O
labeled	VBN	ROOT	O
at	IN	case	O
a	DT	det	O
level	NN	nmod	O
consistent	JJ	amod	O
with	IN	case	O
their	PRP$	nmod:poss	O
being	VBG	cop	O
active	JJ	nmod	O
.	.	punct	O

Under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
HUVEC	NN	compound	B-protein
adhesion	NN	compound	I-protein
molecules	NNS	nsubjpass	I-protein
,	,	punct	O
E-selectin	NN	appos	B-protein
,	,	punct	O
VCAM-1	NN	conj	B-protein
and	CC	cc	O
ICAM-1	NN	conj	B-protein
,	,	punct	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
at	IN	case	O
3	CD	nummod	O
h	NN	nmod	O
with	IN	mark	O
only	JJ	advmod	O
ICAM-1	NN	compound	B-protein
remaining	VBG	nmod	O
overexpressed	VBN	acl	O
at	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Intracellular	JJ	amod	O
signals	NNS	nsubj	O
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
differentiation	NN	dobj	O
of	IN	case	O
pluripotent	JJ	amod	B-cell_type
hemopoietic	JJ	amod	I-cell_type
progenitors	NNS	nmod	I-cell_type
to	TO	case	O
dendritic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
DC	NN	appos	B-cell_type
)	-RRB-	punct	O
are	VBP	auxpass	O
largely	RB	advmod	O
undefined	JJ	ROOT	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
inhibitors	NNS	nsubj	I-protein
blocked	VBD	ROOT	O
SP-A	NN	compound	B-protein
-dependent	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
tumor	NN	compound	B-RNA
necrosis	NN	compound	I-RNA
factor-alpha	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin-2	NN	compound	I-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
the	DT	det	O
alpha	NN	compound	B-protein
and	CC	cc	I-protein
beta	NN	conj	I-protein
isoforms	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
express	VBP	ROOT	O
interleukin-1beta	NN	dobj	B-protein
(	-LRB-	punct	O
IL-1beta	NN	appos	B-protein
)	-RRB-	punct	O
when	WRB	advmod	O
stimulated	VBN	advcl	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-protein
matrix	NN	compound	I-protein
glycoprotein	NN	nmod	I-protein
,	,	punct	O
fibronectin	NN	appos	B-protein
(	-LRB-	punct	O
FN	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Heparin	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
polyanionic	JJ	amod	O
glycosaminoglycan	NN	ROOT	O
(	-LRB-	punct	O
GAG	NN	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
can	MD	aux	O
bind	VB	acl:relcl	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
to	TO	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
including	VBG	case	O
interferon-gamma	NN	nmod	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
members	NNS	conj	O
of	IN	case	O
the	DT	det	O
chemokine	NN	compound	B-protein
superfamily	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
Jurkat	NN	compound	B-cell_line
T-cells	NNS	nmod	I-cell_line
,	,	punct	O
PG490	NN	nsubj	O
inhibits	VBZ	ROOT	O
PMA/Iono-stimulated	JJ	amod	O
IL-2	NN	compound	B-protein
transcription	NN	dobj	O
.	.	punct	O

SHP2-interacting	JJ	amod	B-protein
transmembrane	JJ	amod	I-protein
adaptor	NN	compound	I-protein
protein	NN	ROOT	I-protein
(	-LRB-	punct	O
SIT	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
disulfide-linked	JJ	amod	B-protein
dimer	NN	appos	I-protein
regulating	VBG	acl	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

In	IN	case	O
light	NN	nmod	O
of	IN	case	O
the	DT	det	O
evidence	NN	nmod	O
showing	VBG	acl	O
physical	JJ	amod	O
and	CC	cc	O
functional	JJ	conj	O
interactions	NNS	dobj	O
between	IN	case	O
Oct	NN	compound	B-protein
factors	NNS	nmod	I-protein
and	CC	cc	O
OCA-B	NN	conj	B-protein
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
for	IN	case	O
OCA-B	NN	nmod	B-protein
and	CC	cc	O
discuss	VBP	conj	O
the	DT	det	O
implications	NNS	dobj	O
of	IN	case	O
OCA-B	NN	nmod	B-protein
for	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
tissue-specific	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
TNF-alpha	NN	compound	B-protein
bioavailability	NN	nsubj	O
from	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
isolated	VBN	acl	O
from	IN	case	O
10	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
thalassaemia	NN	nmod	O
or	CC	cc	O
sickle	JJ	amod	O
cell	NN	compound	O
anaemia	NN	conj	O
given	VBN	ROOT	O
DFX	NN	dobj	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
10	CD	nummod	O
untreated	JJ	amod	O
subjects	NNS	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
evaluated	VBN	conj	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
IL-4	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
,	,	punct	O
of	IN	case	O
10	CD	nummod	O
kilobases	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
four	CD	nummod	O
exons	NNS	nmod	B-DNA
and	CC	cc	O
three	CD	nummod	O
introns	NNS	conj	B-DNA
.	.	punct	O

Further	JJ	amod	O
characterization	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
should	MD	aux	O
identify	VB	ROOT	O
factors	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
,	,	punct	O
terminal	JJ	amod	O
differentiation	NN	conj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
osteoclasts	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
remaining	VBG	amod	O
86	CD	nummod	O
%	NN	nsubj	O
correspond	VBP	ROOT	O
to	TO	case	O
unknown	JJ	amod	O
genes	NNS	nmod	B-DNA
of	IN	case	O
which	WDT	nmod	O
92	CD	nummod	O
%	NN	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
confirmed	VBN	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
differentially	RB	advmod	O
expressed	VBN	xcomp	O
.	.	punct	O

It	PRP	nsubj	O
also	RB	advmod	O
suggests	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
specificity-conferring	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
mineralocorticoid	NN	compound	O
action	NN	nmod	O
at	IN	case	O
the	DT	det	O
membrane	NN	compound	O
level	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nsubj	O
was	VBD	cop	O
insufficient	JJ	ROOT	O
for	IN	case	O
CD40	NN	compound	B-protein
-mediated	JJ	amod	O
up-regulation	NN	nmod	O
of	IN	case	O
B7-1	NN	nmod	B-protein
,	,	punct	O
Fas	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
CD23	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
E-proteins	NNS	nmod	B-protein
in	IN	case	O
B-	NN	nmod	O
and	CC	cc	O
T-lymphocyte	NN	conj	O
development	NN	dep	O
.	.	punct	O

constitutive	JJ	amod	O
nuclear	JJ	amod	O
translocation	NN	ROOT	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	conj	O
,	,	punct	O
of	IN	case	O
these	DT	det	O
members	NNS	nmod	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
,	,	punct	O
NF-kB	NN	conj	B-protein
and	CC	cc	O
AP-1	NN	compound	B-protein
factor	NN	compound	I-protein
families	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
small	JJ	amod	B-protein
GTP-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
Rho	NN	nsubj	I-protein
potentiates	VBZ	ROOT	O
AP-1	NN	compound	B-protein
transcription	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

HIV-1	NN	compound	O
replication	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
dopamine	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
correlated	VBD	acl:relcl	O
with	IN	case	O
the	DT	det	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
transactivation	NN	nmod	O
.	.	punct	O

Associated	VBN	advcl	O
with	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
,	,	punct	O
IL-10	NN	nsubj	B-protein
suppressed	VBD	ROOT	O
SEB	NN	compound	B-protein
induction	NN	dobj	O
of	IN	case	O
interleukin-2	NN	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
by	IN	case	O
phagocytic	JJ	amod	O
stimuli	NNS	nmod	O
in	IN	case	O
human	JJ	amod	O
neutrophils	NNS	nmod	O
.	.	punct	O

Two	CD	nummod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
NF-IL6	NN	nsubj	I-protein
(	-LRB-	punct	O
positions	NNS	dep	O
-153	CD	compound	B-DNA
to	TO	dep	I-DNA
-145	CD	nummod	I-DNA
and	CC	cc	O
-83	CD	compound	O
to	TO	dep	O
-75	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
one	CD	nummod	O
nuclear	JJ	amod	B-DNA
factor	NN	compound	I-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
positions	NNS	compound	I-DNA
-72	CD	compound	I-DNA
to	TO	dep	I-DNA
-63	CD	nmod	I-DNA
)	-RRB-	punct	I-DNA
motifs	NNS	conj	I-DNA
are	VBP	cop	O
present	JJ	ROOT	O
within	IN	case	O
this	DT	det	O
fragment	NN	nmod	O
.	.	punct	O

Membrane-associated	JJ	amod	B-protein
lymphotoxin	NN	nsubj	I-protein
on	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
activates	VBZ	ROOT	O
endothelial	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
via	IN	case	O
an	DT	det	O
NF-kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
IL-12	NN	nsubj	B-protein
also	RB	advmod	O
failed	VBD	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
STAT4-containing	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
these	DT	det	O
Th2	NN	compound	B-cell_line
clones	NNS	nmod	I-cell_line
.	.	punct	O

Nitric	JJ	amod	O
oxide-stimulated	JJ	amod	O
guanine	NN	compound	O
nucleotide	NN	compound	O
exchange	NN	ROOT	O
on	IN	case	O
p21ras	NN	nmod	B-protein
.	.	punct	O

5'-Rapid	JJ	compound	O
amplification	NN	nsubj	O
of	IN	case	O
cDNA	NN	compound	B-DNA
ends	NNS	nmod	I-DNA
(	-LRB-	punct	O
5'-RACE	JJ	appos	B-DNA
)	-RRB-	punct	O
analysis	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
transcription	NN	compound	O
initiation	NN	nsubj	O
occurred	VBD	ccomp	O
at	IN	case	O
several	JJ	amod	O
closely	RB	advmod	O
spaced	VBN	amod	O
nearby	JJ	amod	O
sites	NNS	nmod	O
originating	VBG	acl	O
approximately	RB	advmod	O
204	CD	nummod	B-DNA
bp	NN	nmod:npmod	I-DNA
upstream	JJ	advmod	I-DNA
from	IN	case	O
the	DT	det	O
translation	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Human	JJ	amod	B-protein
neutrophil	NN	compound	I-protein
elastase	NN	nsubj	I-protein
proteolytically	RB	advmod	O
activates	VBZ	ROOT	O
the	DT	det	O
platelet	NN	compound	B-protein
integrin	NN	dobj	I-protein
alphaIIbbeta3	NN	dep	B-protein
through	IN	case	O
cleavage	NN	nmod	O
of	IN	case	O
the	DT	det	O
carboxyl	NN	compound	B-protein
terminus	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
alphaIIb	NN	compound	B-protein
subunit	NN	compound	I-protein
heavy	JJ	amod	I-protein
chain	NN	nmod	I-protein
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Allelic	JJ	amod	O
variations	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
vitamin	NN	compound	B-DNA
D	NN	compound	I-DNA
receptor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
VDR	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
risk	NN	nmod	O
of	IN	mark	O
developing	VBG	acl	O
prostate	NN	compound	O
cancer	NN	dobj	O
in	IN	case	O
men	NNS	nmod	O
and	CC	cc	O
osteoporosis	NN	conj	O
in	IN	case	O
postmenopausal	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

PHA	NN	nsubj	B-protein
stimulates	VBZ	ROOT	O
IL-2R	NN	compound	O
alpha-	NN	amod	O
,	,	punct	O
beta-	NN	conj	O
,	,	punct	O
and	CC	cc	O
gamma-chain	NN	conj	O
expression	NN	dobj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
signaling	NN	compound	B-protein
pathway	NN	compound	I-protein
molecules	NNS	conj	I-protein
Jak1	NN	dep	B-protein
,	,	punct	O
Jak3	NN	conj	B-protein
,	,	punct	O
Stat1	NN	conj	O
,	,	punct	O
Stat3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Stat5	NN	conj	B-protein
.	.	punct	O

Only	RB	advmod	O
the	DT	det	O
catalytic	JJ	amod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
NH2	NN	nmod:npmod	B-protein
regulatory	JJ	conj	O
,	,	punct	O
domain	NN	nsubj	O
of	IN	case	O
pp56	NN	nmod	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
NF-AT	NN	compound	B-protein
region	NN	compound	O
transactivation	NN	dobj	O
on	IN	case	O
its	PRP$	nmod:poss	O
own	JJ	nmod	O
and	CC	cc	O
to	TO	mark	O
cooperate	VB	conj	O
with	IN	case	O
other	JJ	amod	O
intracellular	JJ	amod	O
signals	NNS	nmod	O
to	TO	mark	O
trigger	VB	xcomp	O
this	DT	det	O
response	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
secretion	NN	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
by	IN	case	O
anti-CD3-stimulated	JJ	amod	B-cell_line
cord	NN	compound	I-cell_line
blood	NN	compound	I-cell_line
mononuclear	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
still	RB	advmod	O
blunted	VBN	ROOT	O
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
adults	NNS	nmod	O
.	.	punct	O

The	DT	det	O
L	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
produces	VBZ	ROOT	O
the	DT	det	O
erythroid	JJ	dobj	B-protein
(	-LRB-	punct	O
R-PK	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
the	DT	det	O
hepatic	JJ	conj	B-protein
(	-LRB-	punct	I-protein
L-PK	JJ	appos	I-protein
)	-RRB-	punct	I-protein
isozymes	NNS	dep	I-protein
by	IN	case	O
the	DT	det	O
alternative	JJ	amod	O
use	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
promoters	NNS	nmod	B-DNA
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
virus	NN	compound	O
reactivation	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
following	VBG	case	O
CD4	NN	compound	B-protein
oligomerization	NN	nmod	O
by	IN	case	O
antibodies	NNS	nmod	B-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
other	JJ	amod	O
epitopes	NNS	dobj	O
in	IN	case	O
D1	NN	nmod	B-protein
,	,	punct	O
including	VBG	case	O
the	DT	det	O
D1/CDR3-loop	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
comparison	NN	nsubj	O
with	IN	case	O
protease-treated	JJ	amod	O
extracts	NNS	nmod	O
prepared	VBN	acl	O
from	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
the	DT	det	O
band	NN	compound	O
1pk	NN	compound	O
activity	NN	nmod	O
despite	IN	case	O
an	DT	det	O
absence	NN	nmod	O
of	IN	case	O
the	DT	det	O
native	JJ	amod	O
RFX	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	nsubj	O
requires	VBZ	ROOT	O
a	DT	det	O
complex	JJ	amod	B-DNA
upstream	JJ	amod	I-DNA
element	NN	dobj	I-DNA
,	,	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
contain	VB	xcomp	O
binding	VBG	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
both	CC	cc:preconj	O
positive	JJ	amod	B-protein
and	CC	cc	I-protein
negative	JJ	conj	I-protein
regulatory	JJ	amod	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
chromosome	NN	compound	B-DNA
14	CD	nummod	I-DNA
region	NN	nsubj	I-DNA
translocated	VBN	acl	O
or	CC	cc	O
rearranged	VBN	conj	O
involves	VBZ	ROOT	O
approximately	RB	advmod	O
350	CD	nummod	O
kb	NN	dobj	O
of	IN	case	O
DNA	NN	nmod	O
at	IN	case	O
chromosome	NN	compound	O
band	NN	compound	O
14q32.1	NN	nmod	O
.	.	punct	O

The	DT	det	O
murine	JJ	amod	B-DNA
fra-1	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
,	,	punct	O
encoding	VBG	acl	O
Fos-related	JJ	amod	B-protein
Ag	NN	dobj	I-protein
1	CD	nummod	I-protein
,	,	punct	O
was	VBD	auxpass	O
isolated	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
splenic	JJ	amod	B-DNA
cDNA	NN	compound	I-DNA
library	NN	nmod	I-DNA
and	CC	cc	O
sequenced	VBN	conj	O
.	.	punct	O

T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
express	VBP	ROOT	O
several	JJ	amod	O
low	JJ	amod	B-protein
molecular	JJ	amod	I-protein
weight	NN	compound	I-protein
transmembrane	JJ	compound	I-protein
adaptor	NN	compound	I-protein
proteins	NNS	dobj	I-protein
that	WDT	nsubj	O
recruit	VBP	acl:relcl	O
src	NN	compound	B-protein
homology	NN	compound	I-protein
(	-LRB-	punct	I-protein
SH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2	CD	nummod	I-protein
domain-containing	JJ	amod	I-protein
intracellular	JJ	amod	I-protein
molecules	NNS	dobj	I-protein
to	TO	case	O
the	DT	det	O
cell	NN	compound	O
membrane	NN	nmod	O
via	IN	case	O
tyrosine-based	JJ	amod	O
signaling	NN	compound	O
motifs	NNS	nmod	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
and	CC	cc	O
others	NNS	conj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
thrombopoietin	NN	nsubj	B-protein
induces	VBZ	ccomp	O
rapid	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
Jak2	NN	nmod	B-protein
and	CC	cc	O
other	JJ	amod	O
proteins	NNS	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
platelets	NNS	nmod	I-cell_type
and	CC	cc	O
BaF3	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
genetically	RB	advmod	O
engineered	VBN	advcl	O
to	TO	mark	O
express	VB	xcomp	O
c-Mpl	NN	dobj	B-protein
,	,	punct	O
a	DT	det	O
receptor	NN	appos	O
for	IN	case	O
thrombopoietin	NN	nmod	B-protein
.	.	punct	O

In-vitro	FW	compound	O
transcription/translation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
cDNA	NN	nmod	B-DNA
expressed	VBD	ROOT	O
a	DT	det	O
protein	NN	dobj	O
of	IN	case	O
approximately	RB	advmod	O
20	CD	nummod	O
kDa	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
CD40	NN	compound	B-protein
cytoplasmic	JJ	amod	I-protein
domain	NN	compound	I-protein
truncation	NN	nmod	O
and	CC	cc	O
point	NN	compound	O
mutants	NNS	conj	O
defined	VBD	ROOT	O
a	DT	det	O
10-amino	JJ	amod	B-protein
acid	NN	compound	I-protein
CD40	NN	compound	I-protein
cytoplasmic	JJ	amod	I-protein
signaling	NN	compound	I-protein
determinant	NN	dobj	I-protein
required	VBN	acl	O
for	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
Fy	NN	compound	O
(	-LRB-	punct	O
a-b-	JJ	compound	O
)	-RRB-	punct	O
phenotype	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
predominant	JJ	amod	O
one	CD	ROOT	O
in	IN	case	O
populations	NNS	nmod	O
of	IN	case	O
black	JJ	amod	O
people	NNS	nmod	O
and	CC	cc	O
also	RB	advmod	O
occurs	VBZ	conj	O
in	IN	case	O
other	JJ	amod	O
populations	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
some	DT	det	O
non-Ashkenazi	JJ	amod	O
Jewish	JJ	amod	O
groups	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
activated	VBN	amod	O
STAT5a	NN	nsubj	B-protein
and	CC	cc	O
STAT5b	NN	conj	B-protein
proteins	NNS	dep	O
form	VBP	ccomp	O
distinct	JJ	amod	O
Fc	NN	compound	O
gamma	NN	compound	O
RI	NN	compound	O
GAS	NN	compound	O
binding	NN	compound	O
patterns	NNS	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
NK	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
they	PRP	nsubj	O
might	MD	aux	O
have	VB	ccomp	O
different	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
gene	NN	compound	O
regulation	NN	nmod	O
.	.	punct	O

Avian	JJ	amod	B-cell_type
erythroblasts	NNS	nsubj	I-cell_type
expressing	VBG	acl	O
the	DT	det	O
activated	VBN	amod	B-protein
mouse	NN	compound	I-protein
EpoR	NN	compound	I-protein
(	-LRB-	punct	I-protein
R129C	NN	dobj	I-protein
)	-RRB-	punct	I-protein
differentiated	VBD	ROOT	O
into	IN	case	O
erythrocytes	NNS	nmod	B-cell_type
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
hEpo	NN	nmod	B-protein
.	.	punct	O

Emphasis	NN	nsubjpass	O
is	VBZ	auxpass	O
given	VBN	ROOT	O
to	TO	case	O
recent	JJ	amod	O
information	NN	nmod	O
about	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
prolactin	NN	compound	O
receptor	NN	compound	O
signal	NN	compound	O
transduction	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
signaling	VBG	compound	B-protein
molecules	NNS	conj	I-protein
and	CC	cc	O
prolactin-inducible	JJ	amod	B-DNA
target	NN	compound	I-DNA
genes	NNS	conj	I-DNA
that	WDT	nsubj	O
participate	VBP	acl:relcl	O
in	IN	case	O
these	DT	det	O
responses	NNS	nmod	O
.	.	punct	O

A/R	NN	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
an	DT	det	O
oxidant	JJ	amod	O
stress	NN	dobj	O
in	IN	case	O
naive	JJ	amod	O
HUVECs	NNS	nmod	B-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
A/R-tolerant	JJ	amod	B-cell_line
HUVECs	NNS	conj	I-cell_line
.	.	punct	O

Five	CD	nummod	O
patients	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
with	IN	case	O
repeated	VBN	amod	O
maximal	JJ	amod	O
responses	NNS	nmod	O
to	TO	case	O
adenovirus	NN	compound	B-protein
antigen	NN	nmod	I-protein
;	:	punct	O
in	IN	case	O
one	CD	nsubj	O
of	IN	case	O
these	DT	det	O
adenovirus	NN	compound	B-DNA
nucleotide	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
were	VBD	cop	O
present	JJ	parataxis	O
in	IN	case	O
a	DT	det	O
synovial	JJ	amod	O
biopsy	NN	compound	O
specimen	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
wild-type	JJ	amod	B-protein
hGR	NN	nsubjpass	I-protein
and	CC	cc	O
hGR-Ile	NN	conj	B-protein
729	CD	nummod	I-protein
were	VBD	auxpass	O
expressed	VBN	advcl	O
in	IN	case	O
COS-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
assayed	VBN	conj	O
for	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
-Dexamethasone	NN	nummod	O
binding	NN	nmod	O
,	,	punct	O
the	DT	det	O
dissociation	NN	compound	O
constants	NNS	nsubj	O
were	VBD	cop	O
0.799	CD	nummod	O
+/-	CC	cc	O
0.068	CD	conj	O
and	CC	cc	O
1.54	CD	conj	O
+/-	CC	cc	O
0.06	CD	conj	O
nM	NN	ROOT	O
(	-LRB-	punct	O
mean	NN	dep	O
+/-	CC	cc	O
SEM	NN	conj	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	amod	O
0.01	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

In	IN	case	O
support	NN	nmod	O
of	IN	case	O
this	DT	det	O
interpretation	NN	nmod	O
,	,	punct	O
mutation	NN	nsubj	O
of	IN	case	O
putative	JJ	amod	O
nuclear	JJ	amod	B-protein
localization	NN	compound	I-protein
sequences	NNS	nmod	I-protein
decreased	VBD	ROOT	O
nuclear	JJ	amod	O
localization	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
transcriptional	JJ	amod	O
activation	NN	conj	O
by	IN	case	O
membrane-bound	JJ	amod	B-protein
DeltaE	NN	nmod	I-protein
.	.	punct	O

CIITA	NN	nsubj	B-protein
and	CC	cc	O
Bob1	NN	conj	B-protein
interact	VBP	ROOT	O
with	IN	case	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
conserved	VBN	amod	B-DNA
upstream	JJ	amod	I-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
major	JJ	amod	I-DNA
histocompatibility	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
octamer-binding	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	conj	I-protein
Oct-1	NN	dep	B-protein
and	CC	cc	O
Oct-2	NN	conj	B-protein
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Although	IN	mark	O
under	IN	case	O
standard	JJ	amod	O
culture	NN	compound	O
conditions	NNS	nmod	O
,	,	punct	O
bovine	JJ	amod	O
brain	NN	compound	O
gangliosides	NNS	nsubj	O
(	-LRB-	punct	O
100	CD	nummod	O
micrograms/ml	NNS	appos	O
)	-RRB-	punct	O
suppressed	VBD	advcl	O
LPS-stimulated	JJ	amod	O
TNF	NN	compound	B-protein
production	NN	dobj	O
5-fold	RB	advmod	O
in	IN	case	O
PBMC	NN	nmod	B-cell_type
and	CC	cc	O
10-fold	RB	conj	O
in	IN	case	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
suppression	NN	nsubj	O
was	VBD	cop	O
more	RBR	advmod	O
efficient	JJ	ROOT	O
under	IN	case	O
serum-free	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

In	IN	case	O
chloramphenicol	NN	compound	B-protein
acetyltransferase	NN	compound	I-protein
assays	NNS	nmod	O
,	,	punct	O
utilizing	VBG	acl	O
the	DT	det	O
transient	JJ	amod	O
transfection	NN	dobj	O
of	IN	case	O
a	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
plasmid	NN	nmod	I-DNA
containing	VBG	acl	O
the	DT	det	O
IL-6	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
,	,	punct	O
IL-4	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
IL-10	NN	conj	B-protein
,	,	punct	O
suppressed	VBD	ROOT	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-6	NN	compound	O
gene	NN	compound	O
promoter	NN	nmod	O
stimulated	VBN	acl	O
by	IN	case	O
PMA	NN	nmod	O
and	CC	cc	O
LPS	NN	conj	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF-kappa	NN	compound	I-protein
B	NN	compound	I-protein
)	-RRB-	punct	I-protein
/Rel	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nsubjpass	I-protein
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
atherosclerosis	NN	nmod	O
,	,	punct	O
as	IN	mark	O
is	VBZ	auxpass	O
suggested	VBN	advcl	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
activated	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	O
atherosclerotic	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
a	DT	det	O
truncated	JJ	amod	O
form	NN	nsubj	O
of	IN	case	O
NFAT1	NN	nmod	B-protein
acts	VBZ	ROOT	O
as	IN	case	O
a	DT	det	O
dominant-negative	JJ	nmod	O
,	,	punct	O
reducing	VBG	xcomp	O
IL-4	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
in	IN	case	O
primed	VBN	amod	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
confirming	VBG	conj	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
endogenous	JJ	amod	B-protein
NFAT	NN	nmod	I-protein
to	TO	case	O
increased	VBN	amod	O
IL-4	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
effector	NN	compound	O
T	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
three	CD	nummod	O
cases	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
did	VBD	aux	O
not	RB	neg	O
find	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
difference	NN	dobj	O
in	IN	case	O
stability	NN	nmod	O
.	.	punct	O

The	DT	det	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
CD28-responsive	JJ	amod	I-protein
complex	NN	nsubj	I-protein
contains	VBZ	ROOT	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
members	NNS	dobj	O
of	IN	case	O
the	DT	det	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
family	NN	nmod	I-protein
:	:	punct	O
c-Rel	NN	dep	B-protein
,	,	punct	O
p50	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p65	NN	conj	B-protein
.	.	punct	O

Immunohistochemical	JJ	amod	O
and	CC	cc	O
ultrastructural	JJ	conj	O
studies	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
support	VB	xcomp	O
the	DT	det	O
diagnosis	NN	dobj	O
.	.	punct	O

These	DT	det	O
phenomena	NNS	nsubj	O
are	VBP	cop	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	ROOT	O
comparable	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
seen	VBN	acl	O
with	IN	prep	O
rIL-12	NN	pobj	B-protein
.	.	punct	O

A	DT	det	O
nonlinear	JJ	amod	O
relationship	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
splenocyte	NN	compound	B-cell_type
proliferation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
concentration	NN	conj	O
of	IN	case	O
bound	VBN	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
spleen	NN	nmod	O
.	.	punct	O

No	DT	neg	O
virus	NN	compound	O
replication	NN	nsubjpass	O
and	CC	cc	O
no	DT	neg	O
transcription	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Ad2	NN	compound	B-DNA
early	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
either	DT	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
NF-kappa	NN	compound	B-protein
B/Rel	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
Sp1	NN	conj	B-protein
proteins	NNS	dep	O
in	IN	case	O
uninduced	JJ	amod	O
and	CC	cc	O
lipopolysaccharide-induced	JJ	conj	O
expression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
purified	VBN	ROOT	O
these	DT	det	O
activities	NNS	dobj	O
and	CC	cc	O
found	VBD	conj	O
that	IN	mark	O
the	DT	det	O
principal	JJ	amod	O
IL-2-inducible	JJ	amod	B-protein
component	NN	nsubj	I-protein
bears	VBZ	ccomp	O
significant	JJ	amod	O
relatedness	NN	dobj	O
to	TO	case	O
a	DT	det	O
prolactin-induced	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
first	RB	advmod	O
identified	VBN	acl	O
in	IN	case	O
sheep	NN	compound	B-cell_type
mammary	JJ	amod	I-cell_type
gland	NN	compound	I-cell_type
tissue	NN	nmod	I-cell_type
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
infection	NN	nsubj	O
of	IN	case	O
mature	JJ	amod	O
,	,	punct	O
resting	VBG	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
drives	VBZ	ROOT	O
them	PRP	dobj	O
to	TO	aux	O
become	VB	xcomp	O
lymphoblasts	NNS	dobj	O
expressing	VBG	acl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
cell	NN	compound	O
surface	NN	compound	O
molecules	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
CD48	NN	nmod	B-protein
,	,	punct	O
characteristically	RB	advmod	O
expressed	VBN	advcl	O
on	IN	case	O
normal	JJ	amod	B-cell_type
activated	VBN	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
protein	NN	compound	B-protein
products	NNS	nsubj	I-protein
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
contain	VBP	ROOT	O
the	DT	det	O
basic-helix-loop-helix	JJ	amod	B-protein
motif	NN	dobj	I-protein
characteristic	JJ	amod	O
of	IN	case	O
a	DT	det	O
large	JJ	amod	O
family	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
canonical	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
sequence	NN	compound	I-DNA
CANNTG	NN	nmod	I-DNA
as	IN	case	O
protein	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
.	.	punct	O

Cells	NNS	nsubjpass	O
were	VBD	auxpass	O
separated	VBN	ROOT	O
from	IN	case	O
blood	NN	compound	O
samples	NNS	nmod	O
on	IN	case	O
a	DT	det	O
Ficoll	NN	compound	O
gradient	NN	nmod	O
and	CC	cc	O
incubated	VBN	conj	O
with	IN	case	O
different	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
testosterone	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
a	DT	det	O
400-fold	JJ	amod	O
excess	NN	nmod	O
of	IN	case	O
unlabelled	JJ	amod	O
testosterone	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
using	VBG	advcl	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
herpes	NN	compound	I-DNA
thymidine	NN	compound	I-DNA
kinase	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
construct	NN	dobj	I-DNA
containing	VBG	acl	O
the	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
consensus	NN	compound	I-DNA
sequence	NN	dobj	I-DNA
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	nsubj	O
by	IN	case	O
an	DT	det	O
IL-2-induced	JJ	amod	B-protein
monocyte-derived	JJ	amod	I-protein
nuclear	JJ	amod	I-protein
protein	NN	nmod	I-protein
confers	VBZ	ccomp	O
reporter	NN	compound	O
gene	NN	compound	O
(	-LRB-	punct	O
human	JJ	amod	O
growth	NN	compound	O
hormone	NN	appos	O
)	-RRB-	punct	O
activity	NN	dobj	O
.	.	punct	O

Correlations	NNS	nsubjpass	O
of	IN	case	O
TCRzeta	NN	nmod	B-protein
or	CC	cc	O
p56	NN	conj	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
levels	NNS	nmod	O
with	IN	case	O
response	NN	nmod	O
or	CC	cc	O
disease	NN	conj	O
variables	NNS	dep	O
,	,	punct	O
except	IN	case	O
for	IN	case	O
lower	JJR	amod	O
TCRzeta	NN	compound	B-protein
levels	NNS	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	compound	O
0.001	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
bone	NN	compound	O
metastases	NNS	nmod	O
,	,	punct	O
were	VBD	auxpass	O
not	RB	neg	O
found	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
complex	NN	nmod	O
,	,	punct	O
promoter	NN	compound	O
specificity	NN	nsubjpass	O
is	VBZ	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
domain	NN	nmod	O
of	IN	case	O
RFX5	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
general	JJ	amod	O
transcription	NN	compound	O
apparatus	NN	nsubjpass	O
is	VBZ	auxpass	O
recruited	VBN	conj	O
by	IN	case	O
the	DT	det	O
acidic	JJ	amod	B-protein
activation	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
CIITA	NN	nmod	B-protein
.	.	punct	O

Endothelial	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
EC	NN	appos	B-cell_type
)	-RRB-	punct	O
act	VBP	ROOT	O
as	IN	case	O
APC	NN	nmod	O
for	IN	case	O
resting	VBG	amod	B-cell_type
PBL	NN	nmod	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
important	JJ	amod	O
roles	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
allograft	NN	compound	O
rejection	NN	nmod	O
and	CC	cc	O
delayed	VBN	amod	O
hypersensitivity	NN	conj	O
.	.	punct	O

Out	IN	advmod	O
current	JJ	amod	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
further	JJ	amod	O
investigations	NNS	nsubjpass	O
are	VBP	auxpass	O
warranted	VBN	ccomp	O
to	TO	mark	O
elucidate	VB	xcomp	O
the	DT	det	O
possible	JJ	amod	O
linkage	NN	dobj	O
of	IN	case	O
ER	NN	compound	B-DNA
codon	NN	compound	I-DNA
10	CD	nummod	I-DNA
polymorphism	NN	nmod	O
to	TO	case	O
physiological	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
conditions	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
an	DT	det	O
abnormality	NN	compound	O
of/or	NN	nsubj	O
influencing	VBG	acl	O
NF-AT	NN	dobj	B-protein
may	MD	aux	O
underlie	VB	ccomp	O
the	DT	det	O
multiple	JJ	amod	O
lymphokine	NN	compound	B-protein
deficiency	NN	dobj	O
in	IN	case	O
this	DT	det	O
patient	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
increasing	VBG	amod	O
evidence	NN	nsubj	O
that	IN	mark	O
lipoproteins	NNS	nsubj	B-protein
of	IN	case	O
Treponema	FW	compound	O
pallidum	FW	nmod	O
and	CC	cc	O
Borrelia	FW	compound	O
burgdorferi	FW	conj	O
are	VBP	cop	O
key	JJ	amod	O
inflammatory	JJ	amod	O
mediators	NNS	ccomp	O
during	IN	case	O
syphilis	NN	nmod	O
and	CC	cc	O
Lyme	NN	compound	O
disease	NN	conj	O
.	.	punct	O

Oleic	JJ	amod	O
acid	NN	nsubj	O
inhibits	VBZ	ROOT	O
endothelial	JJ	amod	O
activation	NN	dobj	O
:	:	punct	O
A	DT	det	O
direct	JJ	amod	O
vascular	JJ	amod	O
antiatherogenic	JJ	amod	O
mechanism	NN	dep	O
of	IN	case	O
a	DT	det	O
nutritional	JJ	amod	O
component	NN	nmod	O
in	IN	case	O
the	DT	det	O
mediterranean	JJ	amod	O
diet	NN	nmod	O
.	.	punct	O

Jak	NN	nsubjpass	B-protein
2	CD	nummod	I-protein
was	VBD	auxpass	O
tyrosine	NN	nmod:npmod	O
phosphorylated	VBN	ROOT	O
within	IN	case	O
1	CD	compound	O
to	TO	dep	O
3	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
eosinophils	NNS	nmod	B-cell_type
with	IN	case	O
IL-5	NN	nmod	B-protein
.	.	punct	O

1	LS	ROOT	O
.	.	punct	O

Soluble	JJ	amod	B-protein
tumor	NN	compound	I-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptors	NNS	nsubj	I-protein
inhibit	VBP	ROOT	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	dobj	O
and	CC	cc	O
cytokine-induced	JJ	amod	O
HIV-1	NN	compound	O
expression	NN	conj	O
chronically	RB	advmod	O
infected	JJ	amod	B-cell_type
U1	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
CD4	NN	compound	B-protein
triggering	NN	nmod	O
on	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activating	NN	compound	O
signals	NNS	nmod	O
in	IN	case	O
a	DT	det	O
lymphoma	NN	compound	O
model	NN	nmod	O
using	VBG	acl	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	dobj	I-protein
(	-LRB-	punct	O
mAb	NN	appos	B-protein
)	-RRB-	punct	O
which	WDT	nsubj	O
recognize	VBP	acl:relcl	O
different	JJ	amod	O
CD4	NN	compound	B-protein
epitopes	NNS	dobj	I-protein
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
T3	NN	nsubj	O
strongly	RB	advmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
action	NN	dobj	O
of	IN	case	O
RA	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
cooperative	JJ	amod	O
action	NN	dobj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
receptors	NNS	nmod	O
in	IN	mark	O
modulating	VBG	acl	O
erythroid	JJ	amod	O
differentiation	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
CaMKIV/Gr	NN	nsubj	B-protein
reconstitutes	VBZ	ccomp	O
the	DT	det	O
capacity	NN	dobj	O
of	IN	case	O
the	DT	det	O
cytosolic	JJ	amod	O
component	NN	nmod	O
of	IN	case	O
NFAT	NN	nmod	B-protein
to	TO	mark	O
direct	VB	advcl	O
transcription	NN	dobj	O
from	IN	case	O
NFAT	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
non-	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Fas	NN	compound	B-protein
ligand	NN	nsubj	I-protein
(	-LRB-	punct	O
FasL	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
cytotoxic	JJ	amod	O
lymphocytes	NNS	nmod	O
is	VBZ	cop	O
important	JJ	ROOT	O
for	IN	mark	O
mediating	VBG	advcl	O
apoptosis	NN	dobj	O
of	IN	case	O
activated	VBN	amod	O
lymphocytes	NNS	nmod	O
and	CC	cc	O
other	JJ	amod	O
target	NN	compound	O
cells	NNS	conj	O
.	.	punct	O

Infection	NN	nsubj	O
with	IN	case	O
a	DT	det	O
variant	NN	nmod	O
of	IN	case	O
simian	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
SIVsmmPBj14	NN	appos	O
,	,	punct	O
leads	VBZ	ROOT	O
to	TO	case	O
severe	JJ	amod	O
acute	JJ	amod	O
disease	NN	nmod	O
in	IN	case	O
macaques	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
describe	VBP	ROOT	O
an	DT	det	O
enhancer	NN	compound	O
site	NN	dobj	O
in	IN	case	O
the	DT	det	O
third	JJ	amod	B-DNA
intron	NN	nmod	I-DNA
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Recently	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
Pax5	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
is	VBZ	cop	O
subject	JJ	ccomp	O
to	TO	case	O
allele	VB	compound	B-DNA
-specific	JJ	amod	O
regulation	NN	nmod	O
during	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
first	JJ	amod	O
approach	NN	nmod	O
,	,	punct	O
stable	JJ	amod	O
clones	NNS	nsubjpass	O
of	IN	case	O
two	CD	nummod	O
B-cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
carrying	VBG	acl	O
an	DT	det	O
LMP1	NN	compound	B-protein
gene	NN	dobj	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
an	DT	det	O
inducible	JJ	amod	O
metallothionein	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
were	VBD	auxpass	O
induced	VBN	ROOT	O
to	TO	mark	O
express	VB	xcomp	O
LMP1	NN	dobj	B-protein
in	IN	case	O
all	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

DNA-binding	JJ	amod	O
and	CC	cc	O
transcriptional	JJ	conj	O
regulatory	JJ	amod	O
properties	NNS	ROOT	O
of	IN	case	O
hepatic	JJ	amod	B-protein
leukemia	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
HLF	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
t	NN	conj	O
(	-LRB-	punct	O
17	CD	nummod	O
;	:	punct	O
19	CD	dep	O
)	-RRB-	punct	O
acute	JJ	amod	B-protein
lymphoblastic	JJ	amod	I-protein
leukemia	NN	compound	I-protein
chimera	NN	compound	I-protein
E2A-HLF	NN	dep	I-protein
.	.	punct	O

These	DT	det	O
cellular	JJ	amod	B-protein
gene	NN	compound	I-protein
regulatory	JJ	amod	I-protein
molecules	NNS	nsubj	I-protein
induced	VBN	acl	O
with	IN	case	O
anti-Ig	NN	nmod	O
may	MD	aux	O
cooperatively	RB	advmod	O
play	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
part	NN	dobj	O
in	IN	mark	O
achieving	VBG	advcl	O
efficient	JJ	amod	O
EBV	NN	compound	O
activation	NN	dobj	O
as	IN	mark	O
seen	VBN	advcl	O
with	IN	case	O
anti-Ig	JJ	compound	B-protein
treatment	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
GATA-1	NN	nmod	B-protein
,	,	punct	O
SCL	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
developing	VBG	amod	O
brain	NN	nmod	O
.	.	punct	O

TCF-1	NN	compound	B-protein
alpha	NN	nsubj	I-protein
is	VBZ	cop	O
currently	RB	advmod	O
unique	JJ	ROOT	O
among	IN	case	O
the	DT	det	O
newly	RB	advmod	O
emerging	VBG	amod	O
family	NN	nmod	O
of	IN	case	O
DNA-binding	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
that	WDT	nsubj	O
share	VBP	acl:relcl	O
the	DT	det	O
HMG	NN	compound	B-protein
motif	NN	dobj	I-protein
in	IN	case	O
that	IN	nmod	O
it	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
highly	RB	advmod	B-protein
tissue-specific	JJ	amod	I-protein
RNA	NN	compound	I-protein
polymerase	NN	compound	I-protein
II	CD	nummod	I-protein
transcription	NN	compound	B-protein
factor	NN	acl:relcl	I-protein
.	.	punct	O

Phorbol	NN	compound	O
esters	NNS	nsubj	O
induce	VBP	ROOT	O
expression	NN	dobj	O
of	IN	case	O
CD69	NN	nmod	B-protein
whereas	IN	mark	O
none	NN	nsubj	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	B-protein
PKC	NN	compound	I-protein
isotypes	NNS	nmod	I-protein
tested	VBN	acl	O
were	VBD	cop	O
able	JJ	advcl	O
to	TO	mark	O
have	VB	xcomp	O
this	DT	det	O
effect	NN	dobj	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
adaptive	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
depends	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
co-stimulatory	JJ	amod	B-protein
molecules	NNS	nmod	I-protein
and	CC	cc	O
cytokines	NNS	conj	B-protein
by	IN	case	O
antigen-presenting	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

SOCS-3	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
tyrosine	NN	nmod:npmod	O
phosphorylated	JJ	ROOT	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
interleukin-2	NN	nmod	B-protein
and	CC	cc	O
suppresses	VBZ	conj	O
STAT5	NN	compound	B-protein
phosphorylation	NN	dobj	O
and	CC	cc	O
lymphocyte	NN	compound	O
proliferation	NN	conj	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
Rel-A	NN	compound	I-protein
and	CC	cc	I-protein
c-Rel	NN	conj	I-protein
protein	NN	compound	I-protein
complexes	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
differentially	RB	advmod	O
distributed	VBN	ROOT	O
within	IN	case	O
human	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

HTLV-I	NN	nsubj	O
encodes	VBZ	ROOT	O
a	DT	det	O
potent	JJ	amod	O
transactivator	NN	compound	B-protein
protein	NN	dobj	O
termed	VBN	acl	O
Tax	NN	xcomp	B-protein
that	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
T-cell	NN	compound	O
immortalization	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
leukocyte-mediated	JJ	amod	O
tissue	NN	compound	O
damage	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	advcl	O
of	IN	case	O
the	DT	det	O
pathologic	JJ	amod	O
picture	NN	nmod	O
in	IN	case	O
ischemia/reperfusion	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
sought	VBN	ROOT	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
PMNs	NNS	nsubjpass	B-cell_type
are	VBP	auxpass	O
directed	VBN	acl:relcl	O
into	IN	case	O
hypoxic	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
basis	NN	pobj	O
of	IN	case	O
cross-linking	JJ	amod	O
results	NNS	nmod	O
with	IN	case	O
21	CD	nummod	O
different	JJ	amod	O
EMCV	NN	compound	B-DNA
IRES	NN	compound	I-DNA
fragments	NNS	nmod	I-DNA
and	CC	cc	O
cytoplasmic	JJ	amod	O
HeLa	NN	compound	O
extract	NN	conj	O
or	CC	cc	O
rabbit	NN	compound	O
reticulocyte	NN	compound	O
lysate	NN	conj	O
as	IN	case	O
the	DT	det	O
source	NN	nmod	O
of	IN	case	O
polypeptides	NNS	nmod	O
,	,	punct	O
consensus	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubjpass	I-DNA
for	IN	case	O
p52	NN	nmod	B-protein
,	,	punct	O
p57	NN	conj	B-protein
,	,	punct	O
p70	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p100	NN	conj	B-protein
are	VBP	auxpass	O
proposed	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
immediate	JJ	amod	B-DNA
early	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
is	VBZ	cop	O
critical	JJ	ROOT	O
to	TO	mark	O
determining	VBG	advcl	O
the	DT	det	O
ultimate	JJ	amod	O
outcome	NN	dobj	O
of	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
antigen	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
multiple	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nmod:npmod	I-protein
related	JJ	amod	I-protein
polypeptides	NNS	nsubjpass	I-protein
ranging	VBG	acl	O
from	IN	case	O
85	CD	compound	O
to	TO	dep	O
45	CD	nummod	O
kDa	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
capacity	NN	nmod	O
to	TO	mark	O
interact	VB	acl	O
with	IN	case	O
the	DT	det	O
PRDII	NN	compound	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
of	IN	case	O
interferon	NN	compound	B-DNA
beta	NN	nmod	I-DNA
and	CC	cc	O
were	VBD	auxpass	O
shown	VBN	conj	O
to	TO	mark	O
possess	VB	xcomp	O
distinct	JJ	amod	O
intrinsic	JJ	amod	O
DNA	NN	compound	O
binding	NN	compound	O
affinities	NNS	dobj	O
for	IN	case	O
this	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
form	VB	conj	O
multiple	JJ	amod	B-protein
DNA	NN	compound	I-protein
binding	NN	nmod:npmod	I-protein
homo-	JJ	dobj	I-protein
and	CC	cc	I-protein
heterodimer	NN	conj	I-protein
complexes	NNS	dep	I-protein
in	IN	case	O
co-renaturation	NN	compound	O
experiments	NNS	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
PGE2	NN	nsubj	B-protein
or	CC	cc	O
di-butyryl	NN	compound	O
(	-LRB-	punct	O
Bt2	NN	compound	O
)	-RRB-	punct	O
cAMP	NN	conj	O
abolished	VBD	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
(	-LRB-	punct	I-protein
p50/p65	NN	compound	I-protein
)	-RRB-	punct	I-protein
heterodimer	NN	nmod	I-protein
to	TO	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
in	IN	case	O
cells	NNS	nmod	O
stimulated	VBN	acl	O
with	IN	case	O
anti-CD3	JJ	amod	B-protein
mAb	NN	nmod	I-protein
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
PMA/A23187	NN	conj	O
.	.	punct	O

Differential	JJ	amod	O
induction	NN	ROOT	O
of	IN	case	O
the	DT	det	O
NF-AT	NN	compound	B-protein
complex	NN	nmod	I-protein
during	IN	case	O
restimulation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
T-cell	NN	compound	O
anergy	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
sequence	NN	nmod	O
immediately	RB	advmod	O
upstream	JJ	advmod	O
from	IN	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
(	-LRB-	punct	O
TIS	NN	appos	B-DNA
)	-RRB-	punct	O
showed	VBD	ROOT	O
no	DT	neg	O
canonical	JJ	amod	O
TATA	NN	dobj	B-DNA
or	CC	cc	O
CAAT	NN	conj	B-DNA
elements	NNS	dep	I-DNA
,	,	punct	O
however	RB	advmod	O
an	DT	det	O
initiator	NN	compound	O
element	NN	nsubj	O
commonly	RB	advmod	O
found	VBN	acl	O
in	IN	case	O
TATA-less	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
encompassed	VBD	parataxis	O
the	DT	det	O
TIS	NN	dobj	B-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
monocytes	NNS	nsubj	B-cell_type
and	CC	cc	O
IFN-U937	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
both	DT	dep	O
responded	VBD	ROOT	O
to	TO	case	O
red	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
sensitized	VBN	acl	O
with	IN	case	O
antibodies	NNS	nmod	B-protein
against	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
specificities	NNS	nmod	O
of	IN	case	O
assumed	VBN	amod	O
(	-LRB-	punct	O
although	IN	mark	O
not	RB	neg	O
documented	VBN	dep	O
)	-RRB-	punct	O
clinical	JJ	amod	O
significance	NN	nmod	O
for	IN	case	O
blood	NN	compound	O
transfusion	NN	compound	O
recipients	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
weak	JJ	amod	O
but	CC	cc	O
significant	JJ	conj	O
negative	JJ	dep	O
correlation	NN	nsubj	O
between	IN	case	O
body	NN	compound	O
temperature	NN	nmod	O
and	CC	cc	O
the	DT	det	O
number	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
patient	NN	compound	O
group	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
modifications	NNS	dobj	O
imposed	VBN	acl	O
on	IN	case	O
NF-kappa	NN	compound	B-protein
B/I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
components	NNS	nmod	I-protein
following	VBG	case	O
stimulation	NN	nmod	O
and	CC	cc	O
show	VBP	conj	O
that	IN	mark	O
the	DT	det	O
final	JJ	amod	O
step	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
induction	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
involves	VBZ	ccomp	O
phosphorylation	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B/I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
protein	NN	compound	I-protein
families	NNS	nmod	I-protein
.	.	punct	O

Immuno-histochemical	JJ	amod	O
analysis	NN	nsubj	O
confirmed	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
NGAL	NN	nmod	B-protein
within	IN	case	O
breast	NN	compound	B-cell_type
carcinoma	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
detected	VBD	conj	O
only	RB	advmod	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
ductal	JJ	amod	O
epithelium	NN	nmod	O
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	ROOT	I-protein
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
and	CC	cc	O
is	VBZ	auxpass	O
selectively	RB	advmod	O
activated	VBN	conj	O
following	VBG	case	O
HIV	NN	compound	O
infection	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Pervanadate	NN	nsubj	O
induced	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
tyrosine	NN	compound	B-protein
kinases	NNS	nmod	I-protein
lck	NN	dep	B-protein
and	CC	cc	O
fyn	NN	conj	B-protein
(	-LRB-	punct	O
4-	CD	dep	O
and	CC	cc	O
3-fold	JJ	conj	O
respectively	RB	advmod	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
dramatic	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
notably	RB	advmod	O
phospholipase	NN	compound	B-protein
C	NN	compound	I-protein
gamma	NN	appos	I-protein
1	CD	nummod	I-protein
.	.	punct	O

Both	CC	cc:preconj	O
r-hTBP-1	NN	nsubj	B-protein
and	CC	cc	O
rhu	JJ	amod	B-protein
TNFR	NN	compound	I-protein
:	:	punct	I-protein
Fc	NN	conj	I-protein
blocked	VBD	ROOT	O
PMA	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NK	NN	compound	I-protein
)	-RRB-	punct	I-protein
-	:	punct	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
U1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
decreases	NNS	nmod	O
in	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
.	.	punct	O

This	DT	det	O
loss	NN	nsubjpass	O
of	IN	case	O
STAT1	NN	nmod	B-protein
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	ROOT	O
in	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
patients	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
fludarabine	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

E3	NN	compound	B-protein
transcripts	NNS	nsubj	I-protein
are	VBP	cop	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
myeloid	JJ	amod	B-cell_type
,	,	punct	I-cell_type
B-lymphoid	JJ	conj	I-cell_type
,	,	punct	I-cell_type
and	CC	cc	I-cell_type
erythroid	JJ	conj	I-cell_type
lineages	NNS	nmod	I-cell_type
,	,	punct	O
absent	JJ	advcl	O
in	IN	case	O
nonhematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
encode	VBP	conj	O
a	DT	det	O
highly	RB	advmod	O
hydrophobic	JJ	amod	O
,	,	punct	O
potentially	RB	advmod	O
phosphorylated	VBN	dep	O
polypeptide	NN	dobj	O
of	IN	case	O
unknown	JJ	amod	O
function	NN	nmod	O
with	IN	case	O
significant	JJ	amod	O
homology	NN	nmod	O
to	TO	case	O
a	DT	det	O
putative	JJ	amod	O
protein	NN	nmod	O
expressed	VBN	acl	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Transactivation	NN	nsubjpass	O
of	IN	case	O
PTHrP	NN	nmod	B-protein
by	IN	case	O
Tax	NN	nmod	B-protein
was	VBD	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
B-cell	NN	compound	B-cell_line
lines	NNS	conj	I-cell_line
or	CC	cc	O
fibroblasts	NNS	conj	B-cell_line
.	.	punct	O

We	PRP	nsubj	O
postulate	VBP	ROOT	O
that	IN	mark	O
MBP	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
release	NN	nsubj	O
of	IN	case	O
IL-8	NN	nmod	B-protein
by	IN	case	O
neutrophils	NNS	nmod	B-cell_type
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
the	DT	det	O
pathophysiology	NN	nmod	O
of	IN	case	O
acute	JJ	amod	O
asthma	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
inflammatory	JJ	amod	O
lung	NN	compound	O
diseases	NNS	conj	O
.	.	punct	O

The	DT	det	O
work	NN	nsubj	O
reported	VBN	ROOT	O
here	RB	advmod	O
resolves	VBZ	dobj	O
,	,	punct	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
regulation	NN	nmod	O
,	,	punct	O
the	DT	det	O
controversy	NN	nsubj	O
as	IN	cc	O
to	TO	prep	O
whether	IN	pobj	O
or	CC	cc	O
not	RB	cc	O
human	JJ	amod	B-cell_type
monocytes/macrophages	NNS	conj	I-cell_type
can	MD	aux	O
produce	VB	parataxis	O
nitric	JJ	amod	O
oxide	NN	dobj	O
(	-LRB-	punct	O
NO	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
stimulated	VBN	advcl	O
with	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	case	O
or	CC	cc	O
without	IN	conj	O
co-stimulation	NN	nmod	O
by	IN	case	O
interferon-gamma	NN	nmod	O
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Thiol	NN	compound	O
modulation	NN	nsubj	O
inhibits	VBZ	ROOT	O
the	DT	det	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	compound	I-protein
)	-RRB-	punct	I-protein
-1	CD	nummod	I-protein
-mediated	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
an	DT	det	O
IL-1	NN	compound	B-protein
receptor-associated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
.	.	punct	O

Overall	RB	advmod	O
,	,	punct	O
TSH-R	NN	compound	B-protein
transcript	NN	compound	O
levels	NNS	nsubj	O
were	VBD	cop	O
low	JJ	ROOT	O
or	CC	cc	O
absent	JJ	conj	O
in	IN	case	O
those	DT	det	O
thyroids	NNS	nmod	O
in	IN	case	O
which	WDT	nmod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	B-protein
histocompatibility	NN	compound	I-protein
complex	NN	compound	I-protein
class	NN	nmod	I-protein
I	CD	dep	I-protein
or	CC	cc	I-protein
II	CD	conj	I-protein
(	-LRB-	punct	O
MHC	NN	appos	B-protein
I	CD	dep	I-protein
or	CC	cc	I-protein
II	CD	conj	I-protein
)	-RRB-	punct	O
was	VBD	cop	O
high	JJ	acl:relcl	O
,	,	punct	O
thus	RB	advmod	O
establishing	VBG	advcl	O
an	DT	det	O
inverse	JJ	amod	O
relation	NN	dobj	O
(	-LRB-	punct	O
MHC	NN	appos	B-protein
I	NN	nummod	I-protein
,	,	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
-0.791	CD	dobj	O
;	:	punct	O
P	NN	dep	O
<	ADD	dep	O
0.01	CD	dep	O
;	:	punct	O
MHC	NN	dep	B-protein
II	CD	nummod	I-protein
,	,	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
-0.784	NN	dobj	O
;	:	punct	O
P	NN	dep	O
<	ADD	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
human	JJ	amod	B-DNA
homeobox	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
distantly	RB	advmod	O
related	JJ	amod	O
to	TO	case	O
proboscipedia	NN	nmod	B-DNA
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
lymphoid	JJ	nmod	O
and	CC	cc	O
pancreatic	JJ	conj	O
tissues	NNS	dep	O
.	.	punct	O

E1A	NN	nmod:poss	B-DNA
's	POS	case	O
inhibition	NN	nsubj	O
of	IN	case	O
IFN	NN	compound	B-protein
-MCP	NN	nmod	O
has	VBZ	ROOT	O
the	DT	det	O
net	JJ	amod	O
effect	NN	dobj	O
of	IN	mark	O
promoting	VBG	acl	O
the	DT	det	O
selective	JJ	amod	O
NK	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
clearance	NN	dobj	O
of	IN	case	O
Ad-infected	JJ	amod	O
or	CC	cc	O
Ad-transformed	JJ	conj	B-cell_line
human	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
the	DT	det	O
response	NN	dobj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
T3	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
NT3R	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
this	DT	det	O
condition	NN	nmod	O
,	,	punct	O
binding	NN	compound	O
characteristics	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
MNL	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
4-h	JJ	amod	O
NK	NN	compound	O
cytolysis	NN	compound	O
assays	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
on	IN	case	O
IFN-gamma-treated	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
infected	VBN	acl	O
with	IN	case	O
an	DT	det	O
Ad5	NN	compound	O
E1A	NN	compound	B-DNA
deletion	NN	compound	O
mutant	NN	nmod	O
,	,	punct	O
dl343	NN	appos	O
,	,	punct	O
or	CC	cc	O
transfected	VBN	conj	O
with	IN	case	O
the	DT	det	O
Ad5	NN	compound	B-DNA
E1A	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
T-cell	NN	compound	B-DNA
receptor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TCR	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
beta-chain	NN	compound	I-DNA
promoters	NNS	nsubjpass	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
characterized	VBN	ROOT	O
as	IN	case	O
nonstructured	JJ	amod	B-DNA
basal	JJ	amod	I-DNA
promoters	NNS	nmod	I-DNA
that	WDT	nsubj	O
carry	VBP	acl:relcl	O
a	DT	det	O
single	JJ	amod	O
conserved	VBN	amod	O
ubiquitous	JJ	amod	B-DNA
cyclic	JJ	amod	I-DNA
AMP-responsive	JJ	amod	I-DNA
element	NN	dobj	I-DNA
.	.	punct	O

From	IN	case	O
the	DT	det	O
present	JJ	amod	O
and	CC	cc	O
previous	JJ	conj	O
data	NNS	nmod	O
,	,	punct	O
eighteen	CD	nummod	O
different	JJ	amod	O
KOX	NN	compound	B-DNA
genes	NNS	nsubj	I-DNA
have	VBP	aux	O
been	VBN	cop	O
located	JJ	ROOT	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	dobj	O
by	IN	case	O
two	CD	nmod	O
within	IN	case	O
nine	CD	nummod	O
DNA	NN	compound	B-DNA
fragments	NNS	nmod	I-DNA
of	IN	case	O
200	CD	compound	O
to	TO	dep	O
580	CD	nummod	O
kb	NN	nmod	O
.	.	punct	O

The	DT	det	O
ZR-75-1	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubj	I-cell_line
showed	VBD	ROOT	O
an	DT	det	O
expression	NN	dobj	O
of	IN	case	O
642	CD	nummod	O
fmol/mg	NN	nmod	O
whereas	IN	mark	O
lymphocytes	NNS	nsubj	O
of	IN	case	O
pregnant	JJ	amod	O
women	NNS	nmod	O
showed	VBD	advcl	O
an	DT	det	O
expression	NN	compound	O
<	''	dobj	O
or	CC	cc	O
=	JJ	conj	O
4	CD	nummod	O
fmol/mg	NN	conj	O
.	.	punct	O

A	DT	det	O
key	JJ	amod	O
cytokine	NN	nsubj	B-protein
induced	VBN	acl	O
during	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
is	VBZ	cop	O
IL-2	NN	ROOT	B-protein
.	.	punct	O

HLA	NN	compound	B-protein
class	NN	compound	I-protein
I	CD	nummod	I-protein
Ags	NNS	nsubjpass	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
,	,	punct	O
since	IN	mark	O
signaling	VBG	nsubj	O
via	IN	case	O
HLA	NN	compound	B-protein
class	NN	compound	I-protein
I	CD	nummod	I-protein
molecules	NNS	nmod	I-protein
can	MD	aux	O
induce	VB	advcl	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
aortic	JJ	amod	B-cell_type
endothelial	NN	nmod	I-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
smooth	JJ	amod	B-cell_type
muscle	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
co-operative	JJ	amod	O
interactions	NNS	nsubjpass	O
between	IN	case	O
all-trans	JJ	nmod	O
and	CC	cc	O
9-cis	JJ	conj	O
RA	NN	dep	O
and	CC	cc	O
D3	NN	conj	O
which	WDT	nsubj	O
promote	VBP	acl:relcl	O
neutrophil	NN	compound	O
and	CC	cc	O
monocyte	NN	conj	O
differentiation	NN	dobj	O
of	IN	case	O
HL60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
have	VBP	aux	O
been	VBN	auxpass	O
analysed	VBN	ROOT	O
in	IN	case	O
detail	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nsubj	I-protein
(	-LRB-	punct	O
TNF	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
interleukin-7	NN	conj	B-protein
(	-LRB-	punct	O
IL-7	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
secreted	VBN	acl	O
during	IN	case	O
this	DT	det	O
interaction	NN	nmod	O
,	,	punct	O
are	VBP	cop	O
critical	JJ	amod	O
cytokines	NNS	ROOT	O
for	IN	case	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
transactivation	NN	nmod	O
through	IN	case	O
NF-kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
cyclosporin	NN	compound	O
A	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
rapamycin	NN	conj	O
,	,	punct	O
blocked	VBD	ROOT	O
the	DT	det	O
synergistic	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
IL-8	NN	compound	B-protein
expression	NN	nmod	O
achieved	VBN	acl	O
with	IN	case	O
anti-CD3	NN	nmod	B-protein
and	CC	cc	O
anti-	NN	conj	O
CD28	NN	compound	B-protein
costimulation	NN	dep	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
data	NNS	nsubj	O
,	,	punct	O
along	IN	case	O
with	IN	case	O
other	JJ	amod	O
findings	NNS	nmod	O
of	IN	case	O
HPA	JJ	amod	O
abnormalities	NNS	nmod	O
in	IN	case	O
PTSD	NN	nmod	O
,	,	punct	O
support	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	case	O
a	DT	det	O
greater	JJR	amod	O
negative	JJ	amod	O
feedback	NN	compound	O
sensitivity	NN	nmod	O
at	IN	case	O
one	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
HPA	JJ	amod	O
axis	NN	nmod	O
.	.	punct	O

PtdIns	NN	nsubjpass	O
binding	VBG	acl	O
to	TO	case	O
mCD14	NN	nmod	B-protein
can	MD	aux	O
be	VB	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
anti-CD14	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibodies	NNS	nmod	I-protein
that	WDT	nsubj	O
inhibit	VBP	acl:relcl	O
LPS	NN	compound	O
-mCD14	NNS	dep	B-protein
binding	NN	dobj	O
,	,	punct	O
and	CC	cc	O
PtdIns	NN	nsubj	O
can	MD	aux	O
inhibit	VB	conj	O
both	CC	cc:preconj	O
LPS	NN	compound	O
-mCD14	NNS	dep	B-protein
binding	NN	dobj	O
and	CC	cc	O
LPS-induced	JJ	amod	O
responses	NNS	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Specific	JJ	amod	O
staining	NN	nsubj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
electron	NN	compound	O
microscopic	JJ	amod	O
examinations	NNS	conj	O
revealed	VBD	ROOT	O
the	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
metal	NN	amod	O
gold	NN	nmod	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
supporting	VBG	advcl	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
hypothesis	NN	dobj	O
that	IN	mark	O
gold	NN	compound	O
ions	NNS	nsubj	O
could	MD	aux	O
block	VB	ccomp	O
NF-kappaB	NN	compound	B-protein
-DNA	NN	compound	O
binding	NN	dobj	O
by	IN	case	O
a	DT	det	O
redox	NN	compound	O
mechanism	NN	nmod	O
.	.	punct	O

Repertoire	JJ	compound	O
selection	NN	nsubjpass	O
was	VBD	auxpass	O
monitored	VBN	ROOT	O
by	IN	mark	O
determining	VBG	advcl	O
the	DT	det	O
TCR	NN	compound	B-protein
beta	NN	compound	I-protein
chain	NN	compound	I-protein
sequences	NNS	dobj	I-protein
of	IN	case	O
RAKFKQLLQ-specific	JJ	amod	B-cell_line
CTL	NN	nmod	I-cell_line
established	VBN	acl	O
from	IN	case	O
primary	JJ	amod	O
infected	JJ	amod	O
and	CC	cc	O
healthy	JJ	conj	O
virus	NN	compound	O
carriers	NNS	nmod	O
.	.	punct	O

Anti-E.	NN	amod	B-protein
chaffeensis	NN	compound	I-protein
antibody	NN	nsubj	I-protein
complexed	VBN	acl	O
with	IN	case	O
E.	FW	compound	O
chaffeensis	NN	nmod	O
significantly	RB	advmod	O
enhanced	VBD	ROOT	O
mRNA	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
IL-1beta	NN	nmod	B-protein
in	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
HIV-infected	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
protein	NN	compound	O
levels	NNS	nsubjpass	O
are	VBP	auxpass	O
decreased	VBN	ROOT	O
secondary	JJ	xcomp	O
to	TO	case	O
enhanced	VBN	amod	O
protein	NN	compound	O
degradation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
selenium	NN	nmod	O
,	,	punct	O
an	DT	det	O
integral	JJ	amod	O
component	NN	appos	O
of	IN	case	O
glutathione	NN	compound	B-protein
peroxidase	NN	nmod	I-protein
(	-LRB-	punct	O
GPX	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
on	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

AML	NN	nsubj	B-protein
and	CC	cc	I-protein
Ets	NN	conj	I-protein
proteins	NNS	dep	I-protein
regulate	VBP	ROOT	O
the	DT	det	O
I	NN	compound	B-DNA
alpha1	NN	compound	I-DNA
germ-line	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

Chicken	NN	compound	O
IL2	NN	nsubj	B-protein
contains	VBZ	ROOT	O
five	CD	nummod	O
repeats	NNS	dobj	O
of	IN	case	O
the	DT	det	O
``	``	punct	O
instability	NN	compound	O
''	''	punct	O
motif	NN	compound	O
ATTTA	NN	nmod	O
in	IN	case	O
the	DT	det	O
3'untranslated	JJ	amod	B-DNA
region	NN	nmod	I-DNA
in	IN	case	O
exon	NN	nmod	B-DNA
4	CD	nummod	I-DNA
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
PPARgamma	NN	nmod	B-protein
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
to	TO	case	O
foam	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
atherosclerotic	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O

Scatchard	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
-	:	punct	O
GRE	NN	compound	B-DNA
binding	NN	nmod	O
showed	VBD	ROOT	O
no	DT	neg	O
change	NN	dobj	O
in	IN	case	O
binding	NN	compound	O
affinity	NN	nmod	O
but	CC	cc	O
did	VBD	aux	O
show	VB	conj	O
a	DT	det	O
reduced	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
receptors	NNS	nmod	B-protein
available	JJ	amod	O
for	IN	case	O
DNA	NN	compound	O
binding	NN	nmod	O
in	IN	case	O
the	DT	det	O
steroid-resistant	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

Protein	NN	compound	O
latency	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
immunocytochemistry	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
two	CD	nummod	O
cases	NNS	nsubj	O
expressed	VBD	advcl	O
CD4	NN	dobj	B-protein
,	,	punct	O
no	DT	neg	O
case	NN	nsubj	O
expressed	VBD	ROOT	O
CD2	NN	dobj	B-protein
,	,	punct	O
CD3	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
CD8	NN	conj	B-protein
and	CC	cc	O
no	DT	neg	O
case	NN	nsubj	O
showed	VBD	conj	O
clonal	JJ	amod	O
rearrangement	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
T-cell	NN	compound	B-protein
receptor	NN	dobj	I-protein
(	-LRB-	punct	O
TCR	NN	compound	B-protein
beta	NN	dep	I-protein
,	,	punct	I-protein
gamma	NN	conj	I-protein
,	,	punct	I-protein
delta	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
oxidized	VBN	amod	B-protein
LDL	NN	nmod	I-protein
(	-LRB-	punct	O
oxLDL	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
system	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
THP-1	NN	compound	B-cell_line
monocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
adherent	JJ	amod	B-cell_type
monocytes	NNS	conj	I-cell_type
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
culture	NN	nmod	O
of	IN	case	O
leukemia	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
dopamine	NN	compound	O
system	NN	nmod	O
,	,	punct	O
cytokine	NN	compound	B-protein
signaling	NN	compound	O
pathway	NN	conj	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
via	IN	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
PBMC	NN	conj	B-cell_type
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus	NN	nsubj	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
infects	VBZ	ROOT	O
B	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
outgrowth	NN	nmod	O
of	IN	case	O
immortalised	JJ	amod	B-cell_line
lymphoblastoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
LCLs	NNS	appos	B-cell_line
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
myricetin	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
NFkappaB	NN	compound	B-protein
activity	NN	dobj	O
correlated	VBD	acl	O
with	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
monocyte	NN	compound	O
adhesion	NN	nmod	O
to	TO	case	O
ECV304	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
c-Raf	NN	nsubj	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
at	IN	case	O
the	DT	det	O
helm	NN	acl:relcl	O
of	IN	case	O
the	DT	det	O
classic	JJ	amod	O
MAP-	NN	amod	O
Erk	NN	compound	B-protein
cascade	NN	nmod	O
,	,	punct	O
contributes	VBZ	ccomp	O
to	TO	case	O
IL-2	NN	compound	B-protein
induction	NN	nmod	O
through	IN	case	O
a	DT	det	O
distal	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
element	NN	nmod	I-DNA
spanning	VBG	acl	O
the	DT	det	O
nucleotides	NNS	dobj	O
from	IN	case	O
positions	NNS	nmod	O
-502	CD	compound	O
to	TO	dep	O
-413	CD	nummod	O
in	IN	case	O
front	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
start	NN	compound	O
site	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
HTLV-I	NN	compound	B-protein
TaxI	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
up-regulation	NN	nmod	O
of	IN	case	O
ICAM-I	NN	nmod	B-protein
and	CC	cc	O
LFA-3	NN	conj	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
transformed	VBN	acl	O
with	IN	case	O
HTLV-I	NN	nmod	O
and	CC	cc	O
the	DT	det	O
mechanism	NN	conj	O
of	IN	case	O
down-regulation	NN	nmod	O
of	IN	case	O
ICAM-I	NN	nmod	B-protein
and	CC	cc	O
LFA-I	NN	conj	B-protein
in	IN	case	O
ATL-derived	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Implications	NNS	ROOT	O
for	IN	case	O
immunity	NN	nmod	O
and	CC	cc	O
vaccine	NN	compound	O
design	NN	conj	O
.	.	punct	O

The	DT	det	O
poly	NN	compound	B-protein
(	-LRB-	punct	I-protein
I	NN	compound	I-protein
)	-RRB-	punct	I-protein
-poly	JJ	compound	I-protein
(	-LRB-	punct	I-protein
C	NN	compound	I-protein
)	-RRB-	punct	I-protein
-induced	JJ	amod	I-protein
IFN	NN	compound	I-protein
alpha	NN	compound	I-protein
production	NN	nsubjpass	O
by	IN	case	O
monocytes	NNS	nmod	B-cell_type
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
the	DT	det	O
C	NN	compound	O
and	CC	cc	O
AIDS-C	NN	conj	O
groups	NNS	nmod	O
(	-LRB-	punct	O
approximately	RB	advmod	O
80	CD	nummod	O
%	NN	amod	O
inhibition	NN	dobj	O
in	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
)	-RRB-	punct	O
;	:	punct	O
the	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
reversed	VBN	parataxis	O
by	IN	case	O
the	DT	det	O
receptor	NN	compound	O
antagonist	NN	compound	O
RU-38486	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
SR-BP	NN	nsubj	B-protein
represents	VBZ	ccomp	O
the	DT	det	O
molecular	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
SR	JJ	amod	O
31747A	NN	nmod	O
in	IN	case	O
mammalian	JJ	amod	O
tissues	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
could	MD	aux	O
be	VB	cop	O
critical	JJ	acl:relcl	O
for	IN	case	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
while	IN	mark	O
NE	NNS	nsubj	B-protein
by	IN	case	O
itself	PRP	nmod	O
does	VBZ	aux	O
not	RB	neg	O
activate	VB	advcl	O
human	JJ	amod	B-cell_type
platelets	NNS	dobj	I-cell_type
,	,	punct	O
it	PRP	nsubj	O
strongly	RB	advmod	O
enhances	VBZ	ccomp	O
the	DT	det	O
weak	JJ	amod	O
aggregation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
a	DT	det	O
threshold	NN	compound	O
concentration	NN	nmod	O
of	IN	case	O
cathepsin	NN	compound	B-protein
G	NN	nmod	I-protein
(	-LRB-	punct	O
threshold	NN	dep	O
of	IN	case	O
cathepsin	NN	compound	B-protein
G	NN	nmod	I-protein
)	-RRB-	punct	O
(	-LRB-	punct	O
Renesto	NNP	compound	O
,	,	punct	O
P.	NNP	conj	O
,	,	punct	O
and	CC	cc	O
Chignard	NNP	compound	O
,	,	punct	O
M.	NNP	conj	O
(	-LRB-	punct	O
1993	CD	appos	O
)	-RRB-	punct	O
Blood	NNP	conj	O
82	CD	nummod	O
,	,	punct	O
139-144	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
IL-1	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
IL-1R	NN	compound	B-protein
)	-RRB-	punct	O
-	:	punct	O
and	CC	cc	O
TCR	NN	nmod:npmod	B-protein
-initiated	JJ	amod	O
signals	NNS	nsubj	O
can	MD	aux	O
interact	VB	ccomp	O
synergistically	RB	advmod	O
to	TO	mark	O
increase	VB	xcomp	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
lymphokine	NN	nmod	B-DNA
and	CC	cc	I-DNA
lymphokine	NN	compound	I-DNA
receptor	NN	compound	I-DNA
genes	NNS	dep	I-DNA
during	IN	case	O
the	DT	det	O
competence	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
activation	NN	compound	O
program	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Dendritic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
DC	NN	appos	B-cell_type
)	-RRB-	punct	O
are	VBP	cop	O
potent	JJ	amod	O
APCs	NNS	ROOT	B-cell_type
that	WDT	nsubj	O
enter	VBP	acl:relcl	O
resting	VBG	amod	O
tissues	NNS	dobj	O
as	IN	case	O
precursors	NNS	nmod	O
and	CC	cc	O
,	,	punct	O
after	IN	case	O
Ag	NN	compound	O
exposure	NN	nmod	O
,	,	punct	O
differentiate	VBP	conj	O
and	CC	cc	O
migrate	VB	conj	O
to	TO	mark	O
draining	VBG	advcl	O
lymph	NN	compound	O
nodes	NNS	dobj	O
.	.	punct	O

U1	NN	compound	B-cell_line
lines	NNS	nsubj	I-cell_line
overexpressing	VBG	acl	O
C/EBP	NN	compound	B-protein
activator	NN	compound	I-protein
NF-IL-6	NN	dobj	B-protein
produced	VBD	ROOT	O
more	RBR	amod	O
viral	JJ	amod	B-RNA
mRNA	NN	dobj	I-RNA
and	CC	cc	O
virus	NN	compound	O
particles	NNS	conj	O
following	VBG	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
than	IN	case	O
control	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
are	VBP	aux	O
limiting	VBG	ccomp	O
for	IN	case	O
virus	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

Complications	NNS	nsubj	O
after	IN	case	O
lung	NN	compound	O
transplantation	NN	nmod	O
include	VBP	ROOT	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
rejection	NN	nmod	O
and	CC	cc	O
an	DT	det	O
increased	VBN	amod	O
incidence	NN	conj	O
of	IN	case	O
infection	NN	nmod	O
,	,	punct	O
particularly	RB	advmod	O
with	IN	case	O
cytomegalovirus	NN	nmod	O
(	-LRB-	punct	O
CMV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Synthesis	NN	nsubjpass	O
and	CC	cc	O
biological	JJ	conj	O
evaluation	NN	dep	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
dicarba-closo-dodecaborane	NN	compound	O
(	-LRB-	punct	O
carborane	NN	appos	O
)	-RRB-	punct	O
derivatives	NNS	nmod	O
of	IN	case	O
retinoids	NNS	nmod	O
are	VBP	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

Further	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
general	JJ	amod	O
coactivator	NN	compound	O
requirements	NNS	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
selective	JJ	amod	O
removal	NN	nsubj	O
of	IN	case	O
PC4	NN	nmod	B-protein
from	IN	case	O
the	DT	det	O
essential	JJ	amod	O
USA	NN	compound	O
fraction	NN	nmod	O
severely	RB	advmod	O
impairs	VBZ	ccomp	O
Oct-1	NN	dobj	O
and	CC	cc	O
OCA-B	NN	conj	O
function	NN	dep	O
in	IN	case	O
a	DT	det	O
cell-free	JJ	amod	O
system	NN	nmod	O
reconstituted	VBN	acl	O
with	IN	case	O
partially	RB	advmod	O
purified	VBN	amod	O
factors	NNS	nmod	O
.	.	punct	O

An	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
ratio	NN	nmod	O
of	IN	case	O
memory	NN	nmod	B-cell_type
to	TO	case	I-cell_type
naive	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
has	VBZ	aux	O
been	VBN	auxpass	O
postulated	VBN	ROOT	O
to	TO	mark	O
underlie	VB	xcomp	O
immune	JJ	amod	O
hyporesponsiveness	NN	dobj	O
accompanying	VBG	acl	O
aging	NN	dobj	O
.	.	punct	O

Incubation	NN	nsubj	O
of	IN	case	O
B-chronic	JJ	amod	B-cell_line
lymphocytic	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
B-CLL	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
major	JJ	amod	O
PKC	NN	compound	B-protein
substrates	NNS	nmod	I-protein
,	,	punct	O
MARCKS	NN	appos	B-protein
(	-LRB-	punct	O
myristoylated	VBN	amod	B-protein
,	,	punct	I-protein
alanine-rich	JJ	dep	I-protein
C	NN	compound	I-protein
kinase	NN	compound	I-protein
substrate	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
MRP	NN	conj	B-protein
(	-LRB-	punct	O
MARCKS-related	JJ	amod	B-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
of	IN	case	O
a	DT	det	O
third	JJ	amod	O
protein	NN	conj	O
,	,	punct	O
with	IN	case	O
an	DT	det	O
apparent	JJ	amod	O
m.w.	NN	nmod	O
of	IN	case	O
60	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
that	WDT	nsubj	O
was	VBD	cop	O
the	DT	det	O
most	RBS	advmod	O
prominent	JJ	amod	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
substrate	NN	acl:relcl	I-protein
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
this	DT	det	O
short	JJ	amod	O
t1/2	NN	nmod	O
,	,	punct	O
accumulation	NN	nsubj	O
of	IN	case	O
1	CD	nummod	B-RNA
,	,	punct	I-RNA
25	CD	conj	I-RNA
(	-LRB-	punct	I-RNA
OH	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
2D3	NN	compound	I-RNA
receptor	NN	compound	I-RNA
RNA	NN	nmod	I-RNA
increased	VBD	csubjpass	O
in	IN	case	O
cells	NNS	nmod	O
as	IN	case	O
their	PRP$	nmod:poss	O
protein	NN	compound	O
synthesis	NN	nmod	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
are	VBP	cop	O
perfectly	RB	advmod	O
compatible	JJ	ROOT	O
with	IN	case	O
major	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
steroidal	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
the	DT	det	O
sodium-proton-antiport	NN	nmod	B-protein
in	IN	case	O
HML	NN	nmod	B-cell_type
and	CC	cc	O
thus	RB	advmod	O
very	RB	advmod	O
likely	RB	advmod	O
represent	VBP	conj	O
membrane	NN	compound	B-protein
receptors	NNS	dobj	I-protein
for	IN	case	O
aldosterone	NN	nmod	O
.	.	punct	O

Tax1	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
bind	VB	ROOT	O
DNA	NN	dobj	O
directly	RB	advmod	O
but	CC	cc	O
regulates	VBZ	conj	O
transcription	NN	dobj	O
through	IN	case	O
protein-protein	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
sequence-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

To	TO	mark	O
characterize	VB	ROOT	O
mechanisms	NNS	dobj	O
responsible	JJ	amod	O
for	IN	case	O
these	DT	det	O
LIF	NN	compound	B-protein
effects	NNS	nmod	O
,	,	punct	O
levels	NNS	dobj	O
of	IN	case	O
HIV	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
activation	NN	appos	O
of	IN	case	O
the	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
protein	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	B-protein
NF	NN	appos	I-protein
)	-RRB-	punct	I-protein
-kB	NN	punct	I-protein
,	,	punct	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
potential	JJ	amod	O
interactions	NNS	nsubjpass	O
with	IN	case	O
other	JJ	amod	O
cytokines	NNS	nmod	B-protein
were	VBD	auxpass	O
analyzed	VBN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
--	:	punct	O
Reactions	NNS	nsubj	O
in	IN	case	O
comedo	NN	compound	O
carcinomas	NNS	nmod	O
were	VBD	cop	O
significantly	RB	advmod	O
negative	JJ	appos	O
for	IN	case	O
estrogen	NN	compound	B-protein
receptor	NN	nmod	I-protein
and	CC	cc	O
progesterone	NN	compound	B-protein
receptor	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
positive	JJ	conj	O
for	IN	case	O
p53	NN	nmod	B-protein
and	CC	cc	O
HER-2/neu	NN	conj	B-protein
more	RBR	advmod	O
often	RB	advmod	O
than	IN	case	O
the	DT	det	O
noncomedo	JJ	amod	O
variant	NN	nmod	O
.	.	punct	O

Both	DT	det	O
pathways	NNS	nsubjpass	O
were	VBD	auxpass	O
fully	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
Bcl-2	NN	nmod	B-protein
or	CC	cc	O
Bcl-X	NN	conj	B-protein
(	-LRB-	punct	I-protein
L	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Resistance	NN	nsubj	O
to	TO	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
induced	VBD	amod	O
apoptosis	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
high	JJ	amod	O
metastatic	JJ	amod	O
capacity	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
antagonists	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
phorbol	NN	nmod:npmod	O
ester-induced	JJ	amod	O
up-regulation	NN	nmod	O
of	IN	case	O
HB-EGF	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
kappa	NN	compound	O
B	NN	compound	O
binding	NN	compound	O
activity	NN	conj	O
.	.	punct	O

Interleukin-6	NN	nsubj	B-protein
promotes	VBZ	ROOT	O
multiple	JJ	amod	O
myeloma	NN	compound	O
cell	NN	compound	O
growth	NN	dobj	O
via	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
retinoblastoma	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

DNase	NN	compound	O
I	CD	nummod	O
footprinting	NN	compound	O
assays	NNS	nsubj	O
revealed	VBD	ROOT	O
four	CD	nummod	O
distinct	JJ	amod	O
sites	NNS	dobj	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
myeloid	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
proteins	NNS	dobj	I-protein
(	-LRB-	punct	O
-408	CD	nummod	B-DNA
to	TO	dep	I-DNA
-386	CD	dep	I-DNA
,	,	punct	O
-293	CD	compound	B-DNA
to	TO	dep	I-DNA
-254	CD	conj	I-DNA
,	,	punct	O
-76	CD	compound	B-DNA
to	TO	dep	I-DNA
-65	CD	conj	I-DNA
,	,	punct	O
and	CC	cc	O
-34	CD	conj	B-DNA
to	TO	dep	I-DNA
+3	JJ	conj	I-DNA
)	-RRB-	punct	O
.	.	punct	O

By	IN	case	O
Northern	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
UT-7	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
expressed	VBD	ROOT	O
detectable	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
beta-	NN	nmod	B-protein
and	CC	cc	I-protein
gamma-globin	NN	conj	I-protein
but	CC	cc	O
not	RB	cc	O
alpha-globin	NN	conj	B-protein
.	.	punct	O

Transactivation	NN	nsubj	O
by	IN	case	O
CIITA	NN	nmod	B-protein
was	VBD	cop	O
extremely	RB	advmod	O
sensitive	JJ	ROOT	O
to	TO	case	O
a	DT	det	O
mutation	NN	nmod	O
in	IN	case	O
TBP	NN	nmod	B-protein
that	WDT	nsubjpass	O
in	IN	case	O
yeast	NN	nmod	O
is	VBZ	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
abolish	VB	xcomp	O
VP16	NN	compound	B-protein
-mediated	JJ	amod	O
transcription	NN	dobj	O
but	CC	cc	O
leaves	VBZ	conj	O
basal	JJ	amod	O
transcription	NN	dobj	O
unaffected	JJ	acl	O
.	.	punct	O

In	IN	case	O
agreement	NN	nmod	O
with	IN	case	O
this	DT	det	O
finding	NN	nmod	O
,	,	punct	O
Northern	NN	compound	O
experiments	NNS	nsubj	O
where	WRB	advmod	O
p65	NN	compound	O
and	CC	cc	O
p105	NN	conj	O
mRNA	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	acl:relcl	O
,	,	punct	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	O
factor	NN	nmod	O
were	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ccomp	O
by	IN	case	O
IL-10	NN	nmod	B-protein
or	CC	cc	O
IL-4	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
NF-kappaB	NN	compound	B-protein
nuclear	JJ	amod	O
translocation	NN	nsubjpass	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
virus	NN	compound	O
production	NN	nmod	O
by	IN	case	O
iHIV-1	NN	nmod	O
were	VBD	auxpass	O
strictly	RB	advmod	O
linked	VBN	ccomp	O
to	TO	case	O
the	DT	det	O
concentrations	NNS	nmod	O
of	IN	case	O
viral	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
used	VBN	acl	O
as	IN	case	O
exogenous	JJ	amod	O
stimuli	NNS	nmod	O
.	.	punct	O

Ad5	NN	compound	B-DNA
E1A	NN	compound	I-DNA
DNA	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
in	IN	case	O
five	CD	nmod	O
of	IN	case	O
six	CD	nummod	O
animals	NNS	nmod	O
20	CD	nummod	O
days	NNS	conj	O
after	IN	case	O
infection	NN	nmod	O
and	CC	cc	O
in	IN	case	O
five	CD	conj	O
of	IN	case	O
five	CD	nummod	O
animals	NNS	nmod	O
47	CD	nummod	O
days	NNS	dep	O
after	IN	case	O
infection	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
identify	VBP	ROOT	O
the	DT	det	O
gene	NN	dobj	O
encoding	VBG	acl	O
the	DT	det	O
lymphocyte	NN	compound	B-protein
homing	JJ	dobj	I-protein
and	CC	cc	I-protein
migration	NN	compound	I-protein
protein	NN	conj	I-protein
CD44	NN	dep	B-protein
as	IN	case	O
a	DT	det	O
target	NN	nmod	O
of	IN	case	O
EGR1	NN	compound	B-protein
regulation	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

NF-E1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
encoded	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
same	JJ	amod	O
gene	NN	nmod	O
as	IN	case	O
the	DT	det	O
YY-1	NN	compound	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
adeno-associated	JJ	amod	B-DNA
virus	NN	compound	I-DNA
P5	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
mean	JJ	amod	O
IL-4	NN	compound	B-protein
level	NN	nsubj	O
detected	VBN	acl	O
by	IN	case	O
ELISA	NN	nmod	O
was	VBD	cop	O
much	RB	advmod	O
greater	JJR	dep	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
HIE	NN	nmod	O
than	IN	case	O
control	JJ	amod	O
subjects	NNS	nmod	O
(	-LRB-	punct	O
88.6+/-11.5	CD	nummod	O
pg/mL	NN	dep	O
vs	CC	cc	O
11.5+/-7.1	CD	nummod	O
pg/mL	NN	conj	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
.005	NN	dobj	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
IL-4	NN	compound	B-protein
levels	NNS	nsubj	O
among	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
both	CC	cc:preconj	O
asthma	NN	nmod	O
and	CC	cc	O
HIE	NN	conj	O
correlated	VBD	conj	O
with	IN	case	O
the	DT	det	O
increased	VBN	amod	O
IgE	NN	compound	B-protein
levels	NNS	nmod	O
.	.	punct	O

Activated	VBN	amod	B-cell_type
macrophages	NNS	nsubj	I-cell_type
contribute	VBP	ROOT	O
to	TO	case	O
chronic	JJ	amod	O
inflammation	NN	nmod	O
by	IN	case	O
the	DT	det	O
secretion	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
proteinases	NNS	conj	B-protein
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
weight	NN	nmod	O
,	,	punct	O
DNA-binding	JJ	amod	O
characteristics	NNS	conj	O
,	,	punct	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
transactivation	NN	compound	O
activity	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
previously	RB	advmod	O
identified	VBN	amod	O
DRE	NN	compound	B-DNA
1	CD	nummod	I-DNA
-binding	JJ	amod	O
protein	NN	nsubj	O
,	,	punct	O
p37	NN	appos	B-protein
,	,	punct	O
is	VBZ	cop	O
YB-1	NN	ccomp	B-protein
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
two	CD	nummod	O
members	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
NSAIDs	NNS	nmod	O
,	,	punct	O
sodium	NN	compound	O
salicylate	NN	appos	O
and	CC	cc	O
sulindac	NN	conj	O
repress	VBP	ccomp	O
the	DT	det	O
IL1B	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
to	TO	case	O
similar	JJ	amod	O
degree	NN	nmod	O
to	TO	case	O
heat	NN	compound	O
shock	NN	nmod	O
or	CC	cc	O
HSF1	NN	compound	B-protein
overexpression	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
for	IN	case	O
the	DT	det	O
clonal	JJ	amod	O
expansion	NN	nmod	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
characteristic	JJ	amod	O
result	NN	acl:relcl	O
of	IN	case	O
HTLV-I	NN	compound	O
infection	NN	nmod	O
,	,	punct	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	dep	O
CREB/ATF	NN	nmod	O
and	CC	cc	O
SRF	NN	conj	O
pathways	NNS	dep	O
is	VBZ	auxpass	O
also	RB	advmod	O
required	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
IL-4-induced	JJ	amod	B-protein
complex	NN	nsubj	I-protein
reacted	VBD	ROOT	O
with	IN	case	O
anti-STAT	NN	nmod	B-protein
(	-LRB-	punct	I-protein
signal	NN	compound	I-protein
transducers	NNS	dep	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
)	-RRB-	punct	I-protein
6	CD	nummod	I-protein
,	,	punct	O
resulting	VBG	xcomp	O
in	IN	case	O
a	DT	det	O
supershift	NN	nmod	O
whereas	IN	mark	O
the	DT	det	O
formation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
IFN-gamma-induced	JJ	amod	B-protein
complex	NN	nmod	I-protein
was	VBD	auxpass	O
inhibited	VBN	advcl	O
by	IN	case	O
anti-STAT	NN	nmod	B-protein
1	CD	nummod	I-protein
.	.	punct	O

Intratracheal	JJ	amod	O
instillation	NN	nsubj	O
of	IN	case	O
IL-6	NN	nmod	B-protein
alone	RB	advmod	O
into	IN	case	O
normal	JJ	amod	O
rats	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
PMN	NN	compound	O
infiltration	NN	nmod	O
into	IN	case	O
lung	NN	compound	O
interstitium	NN	nmod	O
and	CC	cc	O
alveoli	NNS	conj	O
,	,	punct	O
marked	JJ	amod	O
elevation	NN	dobj	O
of	IN	case	O
bronchoalveolar	JJ	amod	O
lavage	NN	compound	O
cellularity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
wet-to-dry	JJ	amod	O
ratio	NN	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
suppression	NN	nsubj	O
of	IN	case	O
T	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
by	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
CyA	NN	appos	O
)	-RRB-	punct	O
enhanced	VBD	ccomp	O
atherosclerotic	JJ	amod	O
lesion	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
new	JJ	amod	O
evidence	NN	dobj	O
for	IN	case	O
a	DT	det	O
possible	JJ	amod	O
relationship	NN	nmod	O
between	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
electron-transport	JJ	amod	O
system	NN	nmod	O
at	IN	case	O
the	DT	det	O
plasma	NN	compound	O
membrane	NN	nmod	O
by	IN	case	O
ascorbate	NN	nmod	O
or	CC	cc	O
its	PRP$	nmod:poss	O
free	JJ	amod	O
radical	NN	amod	O
and	CC	cc	O
redox-dependent	JJ	conj	O
gene	NN	compound	O
transcription	NN	conj	O
in	IN	case	O
T-cells	NNS	nmod	B-cell_type
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Oct1	NN	nsubjpass	B-protein
,	,	punct	O
YY1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
octamer-like	JJ	amod	B-protein
factors	NNS	conj	I-protein
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
-90/-79	CD	nummod	B-DNA
sequence	NN	nmod	I-DNA
within	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
IL-5	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
are	VBP	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
IL-5	NN	compound	B-protein
transcription	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Sublethal	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
stimulate	VBP	ROOT	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
c-jun	NN	nmod	B-DNA
and	CC	cc	O
suppress	VBP	conj	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activation	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

TS	NN	nsubj	O
activated	VBD	ROOT	O
HSF	NN	dobj	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
Hsp70	NN	compound	B-protein
overexpression	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
NFkappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
TNFalpha	NN	compound	B-protein
release	NN	conj	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	B-protein
nuclear	JJ	amod	I-protein
proteins	NNS	nsubj	I-protein
NF-kappa	NN	compound	B-protein
B	NN	dep	I-protein
(	-LRB-	punct	O
consisting	VBG	acl	O
of	IN	case	O
subunits	NNS	nmod	O
p50	VBP	dep	B-protein
an	DT	det	O
dp65	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
subunit	NN	conj	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
p50	NN	appos	B-protein
)	-RRB-	punct	O
by	IN	case	O
itself	PRP	nmod	O
,	,	punct	O
also	RB	advmod	O
called	VBN	advcl	O
KBF1	NN	xcomp	B-protein
,	,	punct	O
are	VBP	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	ROOT	O
and	CC	cc	O
localized	JJ	conj	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
IARC	NN	nmod	B-cell_line
301.5	CD	nummod	I-cell_line
.	.	punct	O

Anti-Ehrlichia	NN	compound	B-protein
chaffeensis	NN	compound	I-protein
antibody	NN	nsubj	I-protein
complexed	VBN	acl	O
with	IN	case	O
E.	FW	compound	O
chaffeensis	NN	nmod	O
induces	VBZ	ROOT	O
potent	JJ	amod	O
proinflammatory	JJ	amod	B-RNA
cytokine	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
through	IN	case	O
sustained	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
IkappaB-alpha	NN	nmod	B-protein
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

Elucidation	NN	nsubj	O
of	IN	case	O
IL-5	NN	compound	B-protein
-specific	JJ	amod	O
regulatory	JJ	amod	O
mechanisms	NNS	nmod	O
may	MD	aux	O
facilitate	VB	ROOT	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
novel	JJ	amod	O
treatments	NNS	nmod	O
for	IN	case	O
allergic	JJ	amod	O
diseases	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
eosinophilic	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

Synergy	NN	nsubj	O
between	IN	case	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
is	VBZ	cop	O
obligatory	JJ	ROOT	O
for	IN	case	O
expression	NN	nmod	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
in	IN	case	O
B	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
T	NN	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
:	:	punct	O
implication	NN	dep	O
for	IN	case	O
c-fos	NN	compound	B-DNA
control	NN	nmod	O
via	IN	case	O
surface	NN	compound	B-protein
immunoglobulin	NN	nmod	I-protein
and	CC	cc	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
antigen	NN	compound	I-protein
receptors	NNS	conj	I-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Zp	NN	nsubj	B-DNA
responds	VBZ	ccomp	O
directly	RB	advmod	O
to	TO	case	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
PKC	NN	nmod	B-protein
and	CC	cc	O
calcium/calmodulin-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	conj	I-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
CD40	NN	compound	B-protein
-mediated	JJ	amod	O
cell	NN	compound	O
survival	NN	nsubj	O
proceeds	VBZ	ccomp	O
through	IN	case	O
NF-kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
up-regulation	NN	nmod	O
of	IN	case	O
Bcl-2	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
As2O3	NN	nmod	O
on	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
to	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
growth-inhibitory	JJ	amod	O
and	CC	cc	O
apoptotic	JJ	conj	O
effects	NNS	nsubjpass	O
of	IN	case	O
As2O3	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
observed	VBN	ccomp	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
at	IN	case	O
clinically	RB	advmod	O
achievable	JJ	amod	O
concentrations	NNS	nmod	O
.	.	punct	O

The	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
family	NN	nsubj	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
proteins	NNS	nmod	I-protein
represents	VBZ	ROOT	O
multiple	JJ	amod	O
DNA	NN	compound	O
binding	NN	dobj	O
,	,	punct	O
rel	NN	nmod:npmod	B-protein
related	JJ	amod	I-protein
polypeptides	NNS	conj	I-protein
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
regulation	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
immune	JJ	amod	O
responsiveness	NN	nmod	O
and	CC	cc	O
inflammation	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
.	.	punct	O

NF-kappaB	NN	compound	B-protein
activation	NN	nsubj	O
by	IN	case	O
LMP1	NN	nmod	B-protein
(	-LRB-	punct	O
1-231	CD	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
TRAF1	NN	compound	B-protein
/TRAF2	NN	compound	B-protein
heteroaggregates	VBZ	nmod	O
since	IN	mark	O
TRAF1	NN	nsubj	B-protein
is	VBZ	cop	O
unique	JJ	advcl	O
among	IN	case	O
the	DT	det	O
TRAFs	NNS	nmod	B-protein
in	IN	mark	O
coactivating	VBG	advcl	O
NF-kappaB	NN	dobj	B-protein
with	IN	case	O
LMP1	NN	nmod	B-protein
(	-LRB-	punct	O
1-231	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
TRAF2	NN	compound	B-protein
dominant-negative	JJ	amod	O
mutant	NN	nsubj	O
can	MD	aux	O
block	VB	parataxis	O
LMP1	NN	compound	B-protein
(	-LRB-	punct	O
1-231	CD	dep	O
)	-RRB-	punct	O
-mediated	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
TRAF1	NN	compound	B-protein
coactivation	NN	conj	O
,	,	punct	O
and	CC	cc	O
30	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
TRAF2	NN	nmod	B-protein
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
TRAF1	NN	nmod	B-protein
in	IN	case	O
EBV-transformed	JJ	amod	O
B	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

These	DT	det	O
two	CD	nummod	O
anthracyclines	NNS	nsubj	O
,	,	punct	O
although	IN	mark	O
closely	RB	advmod	O
related	JJ	advcl	O
in	IN	case	O
their	PRP$	nmod:poss	O
structures	NNS	nmod	O
,	,	punct	O
appeared	VBD	ROOT	O
to	TO	mark	O
act	VB	xcomp	O
as	IN	case	O
differentiation	NN	compound	O
inducers	NNS	nmod	O
by	IN	case	O
distinct	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
unexpectedly	RB	advmod	O
by	IN	case	O
immunohistochemical	JJ	intj	O
,	,	punct	O
Western	NN	compound	O
blotting	NN	nmod	O
(	-LRB-	punct	O
immunoblotting	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
Northern	NN	compound	O
(	-LRB-	punct	O
RNA	NN	compound	O
)	-RRB-	punct	O
blotting	NN	compound	O
assays	NNS	conj	O
that	IN	mark	O
CD14	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
at	IN	case	O
high	JJ	amod	O
density	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
gingival	JJ	amod	I-cell_type
fibroblasts	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
neither	CC	cc:preconj	O
NF-kappa	NN	compound	B-protein
B	NN	nsubjpass	I-protein
nor	CC	cc	O
AP-1	NN	conj	B-protein
activation	NN	conj	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
survival	NN	nmod	O
or	CC	cc	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	conj	O
in	IN	case	O
activated	VBN	amod	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
extracellular	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
released	VBN	acl	O
by	IN	case	O
X-ray-treated	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
colonic	JJ	amod	I-cell_line
carcinoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
(	-LRB-	punct	O
HT29	NN	appos	B-cell_line
)	-RRB-	punct	O
might	MD	aux	O
activate	VB	ROOT	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	dobj	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
of	IN	case	O
HIV-1	NN	nmod	O
in	IN	case	O
non-irradiated	JJ	amod	B-cell_line
HT29	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
amounts	NNS	nsubj	O
of	IN	case	O
transcriptionally	RB	advmod	O
active	JJ	amod	O
phosphorylated	VBN	amod	B-protein
CREB	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
P-CREB	NN	appos	B-protein
)	-RRB-	punct	O
differ	VBP	ccomp	O
between	IN	case	O
activated	VBN	amod	O
PBMC	NN	nmod	B-cell_type
and	CC	cc	O
Jurkat	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Erythroid	JJ	amod	B-protein
Kruppel-like	JJ	amod	I-protein
factor	NN	nsubj	I-protein
(	-LRB-	punct	O
EKLF	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
red	JJ	amod	B-protein
cell-specific	JJ	amod	I-protein
transcriptional	JJ	amod	I-protein
activator	NN	ROOT	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
crucial	JJ	acl:relcl	O
for	IN	mark	O
consolidating	VBG	advcl	O
the	DT	det	O
switch	NN	dobj	O
to	TO	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
adult	JJ	amod	O
beta-globin	NN	compound	B-protein
expression	NN	nmod	O
during	IN	case	O
erythroid	JJ	amod	O
ontogeny	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
CIF	NN	nsubj	B-protein
blocks	NNS	ccomp	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
IL2	NN	compound	B-protein
transcription	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
introduced	VBD	ROOT	O
reporter	NN	compound	O
plasmids	NNS	dobj	O
into	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Jurkat	NN	nmod	I-cell_line
by	IN	case	O
transient	JJ	amod	O
transfection	NN	nmod	O
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
display	VBP	ROOT	O
constitutively	RB	advmod	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
p59fyn	NN	nmod	B-protein
and	CC	cc	O
CD3	NN	compound	B-protein
zeta	NN	compound	I-protein
tyrosine	NN	compound	O
phosphorylation	NN	conj	O
.	.	punct	O

The	DT	det	O
other	JJ	amod	O
glucocorticoids	NNS	nsubj	O
tested	VBN	acl	O
,	,	punct	O
methylprednisolone	NN	conj	O
and	CC	cc	O
corticosterone	NN	conj	O
,	,	punct	O
were	VBD	cop	O
also	RB	advmod	O
effective	JJ	ROOT	O
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	appos	O
)	-RRB-	punct	O
M	NN	nmod	O
or	CC	cc	O
greater	JJR	conj	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
soluble	JJ	amod	O
TN	NN	nsubj	B-protein
inhibits	VBZ	ccomp	O
proliferation	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
response	NN	dep	O
to	TO	case	O
alpha	NN	compound	B-protein
CD3	NN	compound	I-protein
Ab	NN	nmod	I-protein
co-immobilized	VBN	acl	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-protein
matrix	NN	compound	I-protein
protein	NN	compound	I-protein
fibronectin	NN	nmod	B-protein
(	-LRB-	punct	O
FN	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

For	IN	case	O
example	NN	nmod	O
dendritic	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
(	-LRB-	punct	O
DC	NN	appos	B-cell_type
)	-RRB-	punct	O
can	MD	aux	O
be	VB	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
colonies	NNS	nmod	O
of	IN	case	O
GM-CSF-responsive	JJ	amod	B-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
under	IN	case	O
experimental	JJ	amod	O
conditions	NNS	conj	O
are	VBP	auxpass	O
routinely	RB	advmod	O
expanded	VBN	conj	O
as	IN	case	O
a	DT	det	O
population	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
from	IN	case	O
GM-CSF-responsive	JJ	amod	B-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
warrant	VBP	ROOT	O
prudence	NN	dobj	O
in	IN	case	O
the	DT	det	O
design	NN	nmod	O
of	IN	case	O
antioxidant-based	JJ	amod	O
therapies	NNS	nmod	O
aimed	VBN	acl	O
at	IN	mark	O
suppressing	VBG	advcl	O
HIV	NN	compound	O
replication	NN	dobj	O
.	.	punct	O

Recognition	NN	ROOT	O
of	IN	case	O
herpes	NN	compound	B-protein
simplex	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
2	CD	nummod	I-protein
tegument	NN	amod	I-protein
proteins	NNS	nmod	I-protein
by	IN	case	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
infiltrating	VBG	acl	O
human	JJ	amod	O
genital	JJ	amod	O
herpes	NN	compound	O
lesions	NNS	dobj	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
A/R	NN	nsubj	O
elicits	VBZ	ccomp	O
a	DT	det	O
two-phase	JJ	amod	O
neutrophil-endothelial	JJ	amod	O
cell	NN	compound	O
adhesion	NN	compound	O
response	NN	dobj	O
that	WDT	nsubj	O
involves	VBZ	acl:relcl	O
transcription-independent	JJ	amod	O
and	CC	cc	O
transcription-dependent	JJ	conj	O
surface	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
endothelial	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
.	.	punct	O

First	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
gives	VBZ	ROOT	O
no	DT	neg	O
information	NN	dobj	O
on	IN	case	O
memory	NN	nmod	O
to	TO	case	O
lytic	JJ	amod	B-protein
cycle	NN	compound	I-protein
antigens	NNS	nmod	I-protein
;	:	punct	O
second	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
preferentially	RB	advmod	O
amplifies	VBZ	parataxis	O
the	DT	det	O
dominant	JJ	amod	O
components	NNS	dobj	O
of	IN	case	O
latent	JJ	amod	O
antigen-specific	JJ	amod	O
memory	NN	nmod	O
at	IN	case	O
the	DT	det	O
expense	NN	nmod	O
of	IN	case	O
key	JJ	amod	O
subdominant	JJ	amod	O
reactivities	NNS	nmod	O
.	.	punct	O

In	IN	case	O
fact	NN	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
NH2	NN	compound	B-protein
regulatory	JJ	amod	B-protein
domain	NN	nsubj	I-protein
is	VBZ	cop	O
sufficient	JJ	advcl	O
to	TO	mark	O
mediate	VB	xcomp	O
CD4	NN	compound	B-protein
accessory	JJ	compound	O
function	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
catalytic	JJ	amod	B-protein
domain	NN	nsubj	I-protein
of	IN	case	O
pp56	NN	nmod	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
is	VBZ	cop	O
sufficient	JJ	ccomp	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
,	,	punct	O
mimicking	VBG	xcomp	O
TCR	NN	compound	B-protein
ligation	NN	dobj	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
diminished	VBN	amod	O
T	NN	compound	O
cell	NN	compound	O
response	NN	dobj	O
to	TO	case	O
activation	NN	compound	O
signals	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
measured	VBD	ROOT	O
nucleoprotein	NN	compound	O
DNA-binding	JJ	amod	O
activities	NNS	dobj	O
regulating	VBG	acl	O
gene	NN	compound	O
expression	NN	dobj	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
using	VBG	xcomp	O
the	DT	det	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

Restriction	NN	compound	O
enzyme	NN	compound	O
analysis	NN	nsubj	O
followed	VBN	acl	O
by	IN	case	O
Southern	NN	compound	O
blot	NN	compound	O
hybridization	NN	nmod	O
identified	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
fused	VBN	amod	O
fragment	NN	nmod	O
encompassing	VBG	acl	O
both	DT	det	O
ends	NNS	dobj	O
of	IN	case	O
EBV	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
hematopoietic	JJ	amod	O
cell-specific	JJ	amod	O
pattern	NN	nsubjpass	O
of	IN	case	O
MNDA	NN	compound	B-protein
expression	NN	nmod	O
was	VBD	auxpass	O
elucidated	VBN	ROOT	O
through	IN	case	O
a	DT	det	O
comprehensive	JJ	amod	O
analysis	NN	nmod	O
of	IN	case	O
normal	JJ	nmod	O
and	CC	cc	O
neoplastic	JJ	conj	O
tissues	NNS	dep	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
results	NNS	nsubj	O
provide	VBP	conj	O
further	JJ	amod	O
evidence	NN	dobj	O
of	IN	case	O
the	DT	det	O
coexpression	NN	nmod	O
of	IN	case	O
B-	NN	amod	B-protein
and	CC	cc	I-protein
myeloid	JJ	conj	I-protein
cell	NN	compound	I-protein
markers	NNS	nmod	I-protein
in	IN	case	O
neoplastic	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
identify	VBP	conj	O
a	DT	det	O
normal	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
population	NN	dobj	I-cell_type
that	WDT	nsubj	O
might	MD	aux	O
be	VB	cop	O
related	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
cell	NN	nmod	O
of	IN	case	O
origin	NN	nmod	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
neoplasms	NNS	nmod	I-cell_type
.	.	punct	O

Coordination	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
injury	NN	nmod	O
or	CC	cc	O
disease	NN	conj	O
in	IN	case	O
the	DT	det	O
brain	NN	nmod	O
is	VBZ	auxpass	O
postulated	VBN	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
bi-directional	JJ	amod	O
discourse	NN	dobj	O
between	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
the	DT	det	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
CYP1A1	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
level	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
UV	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
tryptophan	NN	nmod	O
was	VBD	cop	O
higher	JJR	ccomp	O
than	IN	case	O
that	DT	nmod	O
induced	VBN	acl	O
by	IN	case	O
UV	NN	nmod	O
alone	RB	advmod	O
in	IN	case	O
both	CC	cc:preconj	O
HaCaT	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
after	IN	case	O
3	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
incubation	NN	compound	O
post-UV	JJ	amod	O
irradiation	NN	nmod	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
patients	NNS	nmod	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	nsubj	O
in	IN	case	O
IL-2-producing	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
well-differentiated	JJ	amod	O
Th1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
produced	VBD	acl:relcl	O
IFN-gamma	NN	dobj	B-protein
but	CC	cc	O
not	RB	cc	O
IL-2	NN	conj	B-protein
were	VBD	cop	O
evident	JJ	ROOT	O
after	IN	mark	O
priming	VBG	advcl	O
with	IN	case	O
anti-CD3	JJ	nmod	B-protein
and	CC	cc	O
anti-CD28	NN	conj	B-protein
.	.	punct	O

Activated	VBN	amod	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
died	VBD	ROOT	O
by	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
only	RB	advmod	O
cells	NNS	nsubj	O
with	IN	case	O
mutated	VBN	amod	O
nef	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
expressing	VBG	acl	O
truncated	VBN	amod	O
Nefs	NNS	dobj	B-protein
survived	VBD	conj	O
,	,	punct	O
which	WDT	nsubj	O
rendered	VBD	dep	O
Nef	NN	compound	B-protein
nonfunctional	JJ	dobj	O
.	.	punct	O

These	DT	nsubj	O
differ	VBP	ROOT	O
in	IN	case	O
the	DT	det	O
length	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
C	NN	compound	O
terminal	JJ	amod	O
peptides	NNS	nmod	O
and	CC	cc	O
mode	NN	conj	O
of	IN	case	O
synthesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
single	JJ	amod	O
point	NN	compound	O
assay	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
also	RB	advmod	O
applied	VBN	ROOT	O
for	IN	case	O
determination	NN	nmod	O
of	IN	case	O
GH	NN	nmod	O
in	IN	case	O
10	CD	nummod	O
children	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
large	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
prednisone	NN	nmod	O
.	.	punct	O

Concerning	VBG	amod	O
tumor-infiltrating	JJ	amod	B-cell_type
lymphocytes	NNS	ROOT	I-cell_type
,	,	punct	O
the	DT	det	O
rate	NN	nsubj	O
of	IN	case	O
moderate	JJ	amod	O
or	CC	cc	O
remarkable	JJ	conj	O
grades	NNS	nmod	O
of	IN	case	O
c-fos-positive	JJ	amod	B-protein
lymphocytes	NNS	nmod	I-protein
before	IN	case	O
radiotherapy	NN	nmod	O
and	CC	cc	O
at	IN	case	O
radiation	NN	compound	O
doses	NNS	conj	O
of	IN	case	O
4	CD	nummod	O
,	,	punct	O
10	CD	nmod	O
,	,	punct	O
and	CC	cc	O
20	CD	nummod	O
Gy	NN	conj	O
was	VBD	cop	O
8.0	CD	nummod	O
,	,	punct	O
29.2	CD	conj	O
,	,	punct	O
4.8	CD	appos	O
,	,	punct	O
and	CC	cc	O
0	CD	nummod	O
%	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
tyloxapol	NN	nsubj	O
is	VBZ	cop	O
potentially	RB	advmod	O
useful	JJ	ccomp	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
antiinflammatory	JJ	amod	O
therapy	NN	nmod	O
for	IN	case	O
CF	NN	compound	O
lung	NN	compound	O
disease	NN	nmod	O
,	,	punct	O
and	CC	cc	O
could	MD	aux	O
possibly	RB	advmod	O
promote	VB	conj	O
clearance	NN	dobj	O
of	IN	case	O
secretions	NNS	nmod	O
in	IN	case	O
the	DT	det	O
CF	NN	compound	O
airway	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
resting	VBG	amod	O
tonsillar	JJ	amod	O
B	NN	compound	O
cells	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
express	VB	advcl	O
VDR	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
activation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
interleukin-4	NN	nmod	B-protein
induced	VBD	ROOT	O
VDR	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
exogenously	RB	advmod	O
supplemented	VBN	amod	O
1	CD	nummod	O
alpha	NN	compound	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
HNF-3alpha	NN	nsubjpass	B-protein
,	,	punct	I-protein
-3beta	NN	conj	I-protein
,	,	punct	I-protein
-3gamma	NN	conj	I-protein
,	,	punct	I-protein
-4gamma	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
-6	CD	conj	I-protein
are	VBP	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
pancreatic	JJ	amod	B-cell_type
beta-cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
transfection	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
TRADD	NN	nsubj	B-protein
and	CC	cc	O
TES2	NN	conj	B-protein
synergistically	RB	advmod	O
mediated	VBD	ROOT	O
high-level	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
.	.	punct	O

IFN-gamma	NN	nsubjpass	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
induction	NN	dobj	O
of	IN	case	O
CD23	NN	nmod	B-protein
and	CC	cc	O
15-lipoxygenase	NN	conj	B-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
on	IN	case	O
type	NN	compound	O
I	CD	nummod	O
and	CC	cc	O
type	NN	compound	O
II	CD	nummod	O
IL-1R	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
defined	VBN	parataxis	O
.	.	punct	O

This	DT	det	O
paper	NN	nsubj	O
reviews	VBZ	ROOT	O
the	DT	det	O
considerable	JJ	amod	O
data	NNS	dobj	O
available	JJ	amod	O
relating	VBG	acl	O
ROS	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
antioxidant	JJ	amod	O
defence	NN	conj	O
to	TO	case	O
inflammatory	JJ	amod	O
diseases	NNS	nmod	O
and	CC	cc	O
attempts	VBZ	conj	O
to	TO	mark	O
draw	VB	xcomp	O
parallels	NNS	dobj	O
with	IN	case	O
periodontitis	NN	nmod	O
,	,	punct	O
in	IN	case	O
an	DT	det	O
effort	NN	nmod	O
to	TO	mark	O
stimulate	VB	acl	O
more	RBR	advmod	O
periodontal	JJ	amod	O
research	NN	dobj	O
in	IN	prep	O
this	DT	det	O
important	JJ	amod	O
area	NN	pobj	O
.	.	punct	O

The	DT	det	O
restricted	JJ	amod	O
pattern	NN	nsubj	O
of	IN	case	O
SCL	NN	compound	B-protein
protein	NN	compound	I-protein
synthesis	NN	nmod	O
is	VBZ	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
restricted	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
SCL	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
documented	VBN	acl	O
previously	RB	advmod	O
.	.	punct	O

After	IN	case	O
dexamethasone	NN	compound	O
suppression	NN	ROOT	O
(	-LRB-	punct	O
1	CD	nummod	O
mg	NN	dep	O
at	IN	case	O
11	CD	nummod	O
p.m.	NN	nmod	O
)	-RRB-	punct	O
Type	NN	compound	B-protein
I	CD	nummod	I-protein
receptors	NNS	nsubj	I-protein
always	RB	advmod	O
decrease	VBP	ROOT	O
in	IN	case	O
controls	NNS	nmod	O
while	IN	mark	O
the	DT	det	O
response	NN	nsubj	O
of	IN	case	O
Type	NN	nmod	B-protein
II	CD	nummod	I-protein
is	VBZ	cop	O
not	RB	neg	O
homogeneous	JJ	advcl	O
.	.	punct	O

Biological	JJ	amod	O
markers	NNS	nsubjpass	O
of	IN	case	O
ovulation	NN	nmod	O
,	,	punct	O
after	IN	prep	O
a	DT	det	O
great	JJ	pobj	O
in	IN	prep	O
the	DT	det	O
past	NN	pobj	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
fallen	VBN	ROOT	O
into	IN	prep	O
disuse	NN	pobj	O
for	IN	prep	O
the	DT	det	O
large	JJ	amod	O
diffusion	NN	pobj	O
of	IN	prep	O
biochemical	JJ	amod	O
and	CC	cc	O
biophysical	JJ	conj	O
ones	NNS	pobj	O
.	.	punct	O

After	IN	case	O
4	CD	nummod	O
hours	NNS	nsubj	O
,	,	punct	O
IL-1	NN	compound	B-protein
beta	NN	compound	I-protein
and	CC	cc	O
IL-8	NN	conj	B-protein
concentration	NN	appos	O
of	IN	case	O
the	DT	det	O
cell-free	JJ	amod	O
supernatant	NN	nmod	O
had	VBD	aux	O
increased	VBN	ROOT	O
by	IN	case	O
268	CD	nummod	O
+/-	CC	cc	O
36	CD	conj	O
%	NN	nmod	O
and	CC	cc	O
210	CD	nummod	O
+/-	CC	cc	O
7	CD	conj	O
%	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
and	CC	cc	O
cellular	JJ	amod	O
MCP-1	NN	compound	B-protein
content	NN	nsubj	O
had	VBD	aux	O
increased	VBN	conj	O
by	IN	case	O
170	CD	nummod	O
+/-	CC	cc	O
8	CD	conj	O
%	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubj	I-protein
,	,	punct	O
fibromyalgia	NN	appos	O
and	CC	cc	O
low	JJ	amod	O
back	JJ	amod	O
pain	NN	ROOT	O
.	.	punct	O

The	DT	det	O
repetitive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
priming	NN	appos	O
)	-RRB-	punct	O
enhances	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
many	JJ	amod	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
IL-4	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
others	NNS	conj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
IL-2	NN	nmod	B-protein
.	.	punct	O

All	DT	det	O
tissues	NNS	nsubj	O
and	CC	cc	O
cells	NNS	conj	O
studied	VBN	acl	O
were	VBD	cop	O
homozygous	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
wild-type	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
were	VBD	cop	O
heterozygous	JJ	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
homozygous	JJ	conj	O
for	IN	case	O
the	DT	det	O
codon-10-variant	JJ	amod	B-DNA
type	NN	nmod	I-DNA
.	.	punct	O

Latent	JJ	amod	B-protein
membrane	NN	compound	I-protein
protein	NN	nsubj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
LMP1	NN	appos	B-protein
)	-RRB-	punct	O
acts	VBZ	ROOT	O
like	IN	case	O
a	DT	det	O
permanently	RB	advmod	B-protein
activated	VBN	amod	I-protein
receptor	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TNF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-receptor	NN	amod	I-protein
superfamily	NN	nmod	I-protein
and	CC	cc	O
is	VBZ	auxpass	O
absolutely	RB	advmod	O
required	VBN	conj	O
for	IN	case	O
B	NN	compound	O
cell	NN	compound	O
immortalization	NN	nmod	O
by	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
there	EX	expl	O
has	VBZ	aux	O
been	VBN	ROOT	O
some	DT	det	O
progress	NN	attr	O
in	IN	case	O
the	DT	det	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
activated	VBN	acl	O
by	IN	case	O
these	DT	det	O
cytokines	NNS	nmod	B-protein
in	IN	case	O
eosinophils	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
NAC	NN	nmod	O
were	VBD	cop	O
not	RB	neg	O
due	JJ	case	O
to	TO	mwe	O
nonspecific	JJ	amod	O
toxicity	NN	nsubjpass	O
as	IN	case	O
neither	CC	cc:preconj	O
the	DT	det	O
viability	NN	nsubjpass	O
of	IN	case	O
DC	NN	nmod	B-cell_type
nor	CC	cc	O
their	PRP$	nmod:poss	O
mannose	NN	nmod:npmod	O
receptor-mediated	JJ	amod	O
endocytosis	NN	conj	O
were	VBD	auxpass	O
modified	VBN	ROOT	O
by	IN	case	O
NAC	NN	nmod	O
.	.	punct	O

This	DT	det	O
immunosuppressive	JJ	amod	O
drug	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
prevent	VB	xcomp	O
T-cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
precise	JJ	amod	O
point	NN	nsubj	O
at	IN	case	O
which	WDT	nmod	O
rapamycin	NN	nsubj	O
regulates	VBZ	acl:relcl	O
T-cell	NN	compound	O
cycle	NN	compound	O
progression	NN	dobj	O
has	VBZ	conj	O
yet	RB	advmod	O
to	TO	mark	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O

ATRA	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
activate	VB	ROOT	O
nuclear	JJ	amod	O
factor	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
or	CC	cc	O
signal	NN	compound	O
transducer	NN	conj	O
and	CC	cc	O
activator	NN	conj	O
of	IN	amod	O
transcription	NN	dep	O
(	-LRB-	punct	O
STAT	NN	compound	O
)	-RRB-	punct	O
activation	NN	compound	O
pathways	NNS	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
an	DT	det	O
alternate	JJ	amod	O
mechanism	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
IRF-1	NN	compound	B-DNA
gene	NN	compound	I-DNA
activation	NN	nmod	O
.	.	punct	O

Results	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
sustained	JJ	amod	O
elevated	JJ	ccomp	O
[	-LRB-	punct	O
Ca2+	NN	dep	O
]	-RRB-	punct	O
i	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
significant	JJ	amod	O
factor	NN	dep	O
in	IN	case	O
oxidant-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
.	.	punct	O

Dexamethasone	NN	nsubj	O
induced	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
rapid	JJ	dep	O
and	CC	cc	O
sustained	JJ	conj	O
twofold	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
GRE	NN	compound	B-DNA
binding	NN	nmod	O
in	IN	case	O
PBMCs	NNS	nmod	B-cell_type
from	IN	case	O
steroid-sensitive	JJ	amod	O
asthmatic	JJ	amod	O
patients	NNS	nmod	O
and	CC	cc	O
nonasthmatic	JJ	amod	O
individuals	NNS	conj	O
,	,	punct	O
but	CC	cc	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
markedly	RB	advmod	O
reduced	VBN	conj	O
in	IN	case	O
steroid-resistant	JJ	amod	O
asthmatic	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	O
receptors	NNS	nsubj	O
are	VBP	cop	O
also	RB	advmod	O
able	JJ	ROOT	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
transcriptional	JJ	amod	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
AP-1	NN	nmod	B-protein
(	-LRB-	punct	O
activator	NN	compound	B-protein
protein-1	NN	appos	I-protein
)	-RRB-	punct	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
data	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
concluded	VBD	ROOT	O
that	IN	mark	O
interdomain	NN	compound	B-protein
B	NN	nsubj	I-protein
regulates	VBZ	ccomp	O
but	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	conj	O
for	IN	case	O
ZAP-70	NN	compound	B-protein
signaling	NN	compound	O
function	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
cellular	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
studies	NNS	nmod	O
described	VBN	acl	O
in	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
physical	JJ	amod	O
interaction	NN	dobj	O
between	IN	case	O
multiple	JJ	amod	O
Ets	NN	nmod	B-protein
and	CC	cc	I-protein
NF-kappaB/NFAT	NN	conj	I-protein
proteins	NNS	dep	I-protein
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	IN	case	O
activated	VBN	amod	B-cell_type
normal	JJ	amod	I-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Alveolar	JJ	amod	B-cell_type
macrophages	NNS	nsubj	I-cell_type
are	VBP	cop	O
located	JJ	ROOT	O
directly	RB	advmod	O
in	IN	case	O
the	DT	det	O
surrounding	NN	nmod	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
so	IN	mark	O
that	IN	mark	O
we	PRP	nsubj	O
suppose	VBP	advcl	O
an	DT	det	O
interaction	NN	dobj	O
between	IN	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
regarding	VBG	case	O
to	TO	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	B-protein
mediators	NNS	nmod	I-protein
.	.	punct	O

Copyright	NN	ROOT	O
1998	CD	nummod	O
by	IN	prep	O
The	NNP	det	O
American	NNP	compound	O
Society	NNP	pobj	O
of	IN	prep	O
Hematology	NNP	pobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
compared	VBN	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
to	TO	mark	O
bind	VB	acl	O
to	TO	case	O
their	PRP$	nmod:poss	O
appropriate	JJ	amod	O
site	NN	nmod	O
on	IN	case	O
DNA	NN	nmod	O
.	.	punct	O

In	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
the	DT	det	O
cytokine	NN	nsubj	B-protein
that	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
by	IN	case	O
DEX	NN	nmod	O
,	,	punct	O
also	RB	advmod	O
rescues	VBZ	ROOT	O
these	DT	det	O
cells	NNS	dobj	O
from	IN	case	O
DEX-induced	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
rescue	NN	compound	O
cytokine	NN	nsubj	O
is	VBZ	cop	O
different	JJ	advcl	O
in	IN	case	O
Th1	NN	compound	B-cell_type
and	CC	cc	I-cell_type
Th2	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Interleukin-6	NN	compound	B-protein
levels	NNS	nsubjpass	O
are	VBP	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
lung	NN	compound	O
transplant	JJ	amod	O
patients	NNS	nmod	O
clinically	RB	advmod	O
diagnosed	VBN	acl	O
with	IN	case	O
CMV	NN	compound	O
pneumonitis	NN	nmod	O
.	.	punct	O

An	DT	det	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nsubj	O
(	-LRB-	punct	O
EMSA	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
nuclear	JJ	amod	O
extract	NN	nmod	O
from	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
an	DT	det	O
oligonucleotide	NN	conj	O
of	IN	case	O
this	DT	det	O
binding	VBG	amod	O
site	NN	nmod	O
demonstrated	VBD	ROOT	O
a	DT	det	O
new	JJ	amod	O
protein-DNA	JJ	amod	B-protein
complex	NN	dobj	I-protein
,	,	punct	O
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
CMAT	NN	nmod	B-protein
for	IN	case	O
c-myb	NN	nmod	B-protein
in	IN	case	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
;	:	punct	O
this	DT	det	O
complex	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
present	JJ	parataxis	O
in	IN	case	O
unactivated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
protects	VBZ	ccomp	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
clones	NNS	dobj	I-cell_line
from	IN	case	O
IL-2	NN	compound	B-protein
deprivation	NN	compound	O
apoptosis	NN	nmod	O
accompanying	VBG	acl	O
active	JJ	amod	O
proliferation	NN	dobj	O
and	CC	cc	O
enhanced	VBN	amod	O
expression	NN	conj	O
of	IN	case	O
P53	NN	nmod	B-protein
,	,	punct	O
Rb	NN	conj	B-protein
and	CC	cc	O
Bcl-xL	NN	conj	B-protein
proteins	NNS	dep	I-protein
.	.	punct	O

Selective	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
IL-5	NN	compound	B-protein
gene	NN	compound	O
transcription	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
for	IN	mark	O
treating	VBG	advcl	O
eosinophlic	JJ	amod	O
inflammation	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
AP-1	NN	dep	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
may	MD	aux	O
be	VB	cop	O
important	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
modulatory	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
activated	VBN	amod	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Initiation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
lytic	JJ	amod	O
cycle	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
BZLF1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

At	IN	case	O
low	JJ	amod	O
GSSG	NN	compound	O
levels	NNS	nmod	O
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
can	MD	aux	O
not	RB	neg	O
optimally	RB	advmod	O
activate	VB	ROOT	O
the	DT	det	O
immunologically	RB	advmod	O
important	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	dobj	I-protein
,	,	punct	O
whereas	IN	dep	O
high	JJ	amod	O
GSSG	NN	compound	O
levels	NNS	nsubj	O
inhibit	VBP	parataxis	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

Molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
leading	VBG	acl	O
to	TO	case	O
restricted	JJ	amod	O
HIV-1	NN	compound	O
replication	NN	nmod	O
may	MD	aux	O
differ	VB	ROOT	O
between	IN	case	O
certain	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
stimulation	NN	nsubj	O
with	IN	case	O
a	DT	det	O
synthetic	JJ	amod	O
ceramide	NN	compound	O
analog	NN	nmod	O
results	VBZ	ccomp	O
in	IN	case	O
JNK	NN	compound	B-protein
activation	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
apoptosis	NN	conj	O
,	,	punct	O
suggesting	VBG	xcomp	O
ceramide	NN	compound	O
release	NN	nsubj	O
occurs	VBZ	ccomp	O
proximal	JJ	xcomp	O
to	TO	case	O
JNK	NN	compound	B-protein
activation	NN	nmod	O
in	IN	case	O
Fas	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
TNF-alpha	NN	compound	B-protein
production	NN	nmod	O
by	IN	case	O
THP-1-hGH-transfected	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
cultured	VBN	acl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
LPS	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
a	DT	det	O
selective	JJ	amod	O
pathway	NN	nmod	O
,	,	punct	O
since	IN	mark	O
no	DT	neg	O
inhibition	NN	nsubjpass	O
of	IN	case	O
TNF-alpha	NN	compound	B-protein
production	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	advcl	O
when	WRB	advmod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
cultured	VBN	advcl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
PMA	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
Ets	NN	compound	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
that	WDT	nsubj	O
regulated	VBD	acl:relcl	O
GPIX	NN	compound	B-DNA
promoter	NN	compound	I-DNA
expression	NN	dobj	O
was	VBD	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
microenvironment-directed	JJ	amod	O
,	,	punct	O
two-step	JJ	dep	O
model	NN	dobj	O
for	IN	case	O
GATA-1	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
differentiating	VBG	amod	B-cell_type
hematopoietic	JJ	amod	I-cell_type
progenitors	NNS	nmod	I-cell_type
that	WDT	nsubj	O
involves	VBZ	acl:relcl	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
cycle-dependent	JJ	amod	O
initiation	NN	dobj	O
and	CC	cc	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
lineage-dependent	JJ	amod	O
maintenance	NN	conj	O
or	CC	cc	O
suppression	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
are	VBP	cop	O
in	IN	case	O
striking	JJ	amod	O
contrast	NN	ROOT	O
to	TO	case	O
the	DT	det	O
increase	NN	nmod	O
in	IN	case	O
nuclear	JJ	amod	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
HIV-1	NN	compound	O
replication	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
in	IN	case	O
promonocytic	JJ	amod	B-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
U937	NN	dep	I-cell_line
and	CC	cc	O
HL-60	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
emphasize	VBP	conj	O
the	DT	det	O
importance	NN	dobj	O
of	IN	mark	O
studying	VBG	acl	O
cytokine	NN	compound	B-protein
regulation	NN	dobj	O
of	IN	case	O
HIV-1	NN	nmod	O
in	IN	case	O
normal	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
LMP1	NN	nsubj	B-protein
appropriates	VBZ	ccomp	O
TRADD	NN	dobj	B-protein
to	TO	mark	O
enable	VB	xcomp	O
efficient	JJ	amod	O
long-term	JJ	amod	O
lymphoblastoid	JJ	amod	O
cell	NN	compound	O
outgrowth	NN	dobj	O
.	.	punct	O

G	NN	compound	O
(	-LRB-	punct	O
Anh	NN	compound	O
)	-RRB-	punct	O
MTetra	NN	nsubj	O
,	,	punct	O
a	DT	det	O
natural	JJ	amod	O
bacterial	JJ	amod	O
cell	NN	compound	O
wall	NN	compound	O
breakdown	NN	compound	O
product	NN	appos	O
,	,	punct	O
induces	VBZ	ROOT	O
interleukin-1	NN	compound	B-protein
beta	NN	compound	I-protein
and	CC	cc	O
interleukin-6	NN	conj	B-protein
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
sequence	NN	nsubj	O
shows	VBZ	ROOT	O
high	JJ	amod	O
homology	NN	dobj	O
with	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
FOSB	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
a	DT	det	O
component	NN	dobj	O
of	IN	case	O
the	DT	det	O
AP1	NN	compound	B-protein
transcriptional	JJ	amod	I-protein
regulator	NN	nmod	I-protein
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cdc2	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
the	DT	det	O
5'-flanking	JJ	amod	B-DNA
sequence	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
cdc2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
found	VBD	conj	O
the	DT	det	O
putative	JJ	amod	O
E2F	NN	compound	O
binding	NN	compound	B-DNA
site	NN	dobj	I-DNA
at	IN	case	O
the	DT	det	O
position	NN	nmod	O
of	IN	case	O
nucleotides	NNS	nmod	B-DNA
-124	CD	nummod	I-DNA
to	TO	dep	I-DNA
-117	CD	nummod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
distinguish	VBP	ROOT	O
the	DT	det	O
stimuli-specific	JJ	amod	O
pathways	NNS	dobj	O
by	IN	mark	O
showing	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
oxidative	JJ	amod	O
stimuli	NNS	nsubj	O
trigger	VBP	ccomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
in	IN	case	O
only	RB	advmod	O
one	CD	nmod	O
of	IN	case	O
two	CD	nummod	O
human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
Wurzburg	NN	dep	B-cell_line
but	CC	cc	O
not	RB	cc	O
Jurkat	NN	conj	B-cell_line
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nsubj	I-protein
and	CC	cc	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	conj	O
readily	RB	advmod	O
stimulate	VBP	advcl	O
in	IN	case	O
both	DT	det	O
lines	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
these	DT	det	O
immature	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
differentiated	VBD	ROOT	O
terminally	RB	advmod	O
into	IN	case	O
mature	JJ	amod	O
granulocytes	NNS	nmod	O
by	IN	mark	O
adding	VBG	advcl	O
with	IN	case	O
RA	NN	nmod	O
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-6	CD	appos	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Of	IN	case	O
86	CD	nummod	O
patients	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
chronic	JJ	amod	O
MPD	NN	nmod	O
,	,	punct	O
71	CD	nummod	O
(	-LRB-	punct	O
82	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
exhibited	VBD	ROOT	O
an	DT	det	O
allele	NN	compound	B-DNA
ratio	NN	dobj	O
greater	JJR	amod	O
than	IN	case	O
3	CD	nmod	O
:	:	punct	O
1	CD	dep	O
,	,	punct	O
whereas	IN	mark	O
only	RB	advmod	O
10	CD	nsubj	O
(	-LRB-	punct	O
12	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
86	CD	nummod	O
age-matched	JJ	amod	O
control	JJ	compound	O
subjects	NNS	nmod	O
showed	VBD	advcl	O
a	DT	det	O
skewed	JJ	amod	O
XCI	NN	compound	O
pattern	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
detected	VBN	ROOT	O
ER	NN	compound	B-DNA
codon	NN	compound	I-DNA
10	CD	nummod	I-DNA
polymorphism	NN	dobj	O
in	IN	case	O
these	DT	det	O
samples	NNS	nmod	O
and	CC	cc	O
have	VBP	aux	O
compared	VBN	conj	O
them	PRP	dobj	O
to	TO	case	O
those	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
samples	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
E29.1	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
hybridoma	NN	compound	I-cell_line
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nsubjpass	I-protein
and	CC	cc	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	conj	I-protein
are	VBP	auxpass	O
equally	RB	advmod	O
associated	VBN	ccomp	O
with	IN	case	O
p65	NN	nmod	B-protein
and	CC	cc	O
that	IN	mark	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
degraded	VBN	conj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
TNF	NN	compound	B-protein
alpha	NN	nmod	I-protein
in	IN	case	O
contrast	NN	nmod	O
to	TO	mark	O
what	WP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
originally	RB	advmod	O
published	VBN	advcl	O
.	.	punct	O

A	DT	det	O
candidate	NN	compound	O
gene	NN	nsubj	O
to	TO	mark	O
control	VB	acl	O
thymocyte	NN	compound	B-cell_type
differentiation	NN	dobj	O
,	,	punct	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
factor-1	NN	conj	I-protein
(	-LRB-	punct	O
TCF-1	NN	appos	B-protein
)	-RRB-	punct	O
*	SYM	punct	O
encodes	VBZ	ROOT	O
a	DT	det	O
DNA-binding	JJ	amod	B-protein
protein	NN	dobj	I-protein
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
a	DT	det	O
DNA-binding	JJ	amod	B-protein
factor	NN	nsubj	I-protein
containing	VBG	acl	O
STAT1	NN	dobj	B-protein
also	RB	advmod	O
becomes	VBZ	ccomp	O
activated	VBN	xcomp	O
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
or	CC	cc	O
Jurkat	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
although	IN	mark	O
not	RB	neg	O
until	IN	case	O
1-2	CD	nummod	O
h	NN	advcl	O
after	IN	case	O
stimulation	NN	nmod	O
.	.	punct	O

DNase	NN	compound	B-protein
I	CD	nummod	I-protein
mapping	NN	nsubj	O
of	IN	case	O
genomic	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
identified	VBD	ROOT	O
a	DT	det	O
hypersensitive	JJ	amod	B-DNA
element	NN	dobj	I-DNA
near	IN	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
although	IN	mark	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	advcl	O
that	IN	mark	O
EBNA3C	NN	nsubj	B-protein
can	MD	aux	O
upregulate	VB	ccomp	O
CD21	NN	dobj	B-protein
in	IN	case	O
some	DT	det	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
were	VBD	cop	O
unable	JJ	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
any	DT	det	O
effect	NN	dobj	O
of	IN	case	O
EBNA3C	NN	nmod	B-protein
on	IN	case	O
reporter	NN	compound	B-DNA
plasmids	NNS	nmod	I-DNA
which	WDT	nsubj	O
contain	VBP	acl:relcl	O
the	DT	det	O
CD21	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

A	DT	det	O
recent	JJ	amod	O
sib-pair	JJ	amod	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
tight	JJ	amod	O
linkage	NN	dobj	O
between	IN	case	O
markers	NNS	nmod	O
on	IN	case	O
5q31.1	NN	nmod	B-DNA
and	CC	cc	O
a	DT	det	O
major	JJ	amod	B-DNA
susceptibility	NN	compound	I-DNA
gene	NN	conj	I-DNA
controlling	VBG	acl	O
total	JJ	amod	O
serum	NN	compound	O
IgE	NN	compound	B-protein
levels	NNS	dobj	O
.	.	punct	O

A	DT	det	O
mammalian	JJ	amod	B-protein
histone	NN	compound	I-protein
deacetylase	NN	nsubj	I-protein
related	JJ	amod	O
to	TO	case	O
the	DT	det	O
yeast	NN	compound	B-protein
transcriptional	JJ	amod	I-protein
regulator	NN	nmod	I-protein
Rpd3p	NN	dep	B-protein
[	-LRB-	punct	O
see	VB	ROOT	O
comments	NNS	dobj	O
]	-RRB-	punct	O

In	IN	case	O
agreement	NN	nmod	O
with	IN	case	O
the	DT	det	O
results	NNS	nmod	O
of	IN	case	O
gel	NN	compound	O
retardation	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
tandem	JJ	amod	O
copies	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
E6	NN	compound	B-DNA
motif	NN	nmod	I-DNA
stimulated	VBD	ROOT	O
transcription	NN	dobj	O
in	IN	case	O
ARH77	NN	compound	B-cell_line
and	CC	cc	O
Raji	NN	conj	B-cell_line
cells	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
or	CC	cc	O
HeLa	NN	conj	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
mutagenesis	NN	nsubj	O
and	CC	cc	O
transient	JJ	amod	O
transfection	NN	compound	O
experiments	NNS	conj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
C-terminal	JJ	amod	B-protein
serine/threonine/proline-rich	JJ	amod	I-protein
region	NN	nsubj	I-protein
of	IN	case	O
BSAP	NN	nmod	B-protein
contains	VBZ	ccomp	O
a	DT	det	O
potent	JJ	amod	O
transactivation	NN	compound	B-protein
domain	NN	dobj	I-protein
of	IN	case	O
55	CD	nummod	O
amino	NN	compound	O
acids	NNS	nmod	O
which	WDT	nsubj	O
is	VBZ	cop	O
active	JJ	acl:relcl	O
from	IN	case	O
promoter	NN	nmod	B-DNA
and	CC	cc	I-DNA
enhancer	NN	conj	I-DNA
positions	NNS	dep	I-DNA
.	.	punct	O

We	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
slide	NN	compound	O
assay	NN	dobj	O
that	WDT	nsubj	O
allows	VBZ	acl:relcl	O
the	DT	det	O
demonstration	NN	dobj	O
of	IN	case	O
antigens	NNS	nmod	B-protein
localized	JJ	acl	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
from	IN	case	O
isolated	VBN	amod	B-cell_type
white	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
from	IN	case	O
single	JJ	amod	B-cell_type
tumor	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
derived	VBN	acl	O
from	IN	case	O
malignant	JJ	amod	O
effusions	NNS	nmod	O
.	.	punct	O

Deletion	NN	compound	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
CD95L	NN	compound	B-DNA
proximal	JJ	amod	I-DNA
promoter	NN	compound	I-DNA
sequence	NN	nsubj	I-DNA
from	IN	case	O
-220	CD	nmod	B-DNA
to	TO	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	case	O
T	NN	nmod:npmod	O
cell	NN	nmod:npmod	O
stimulation-induced	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
CD95L	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
gel	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
hT86	NN	nsubj	O
attenuated	VBD	ROOT	O
the	DT	det	O
intensity	NN	dobj	O
of	IN	case	O
the	DT	det	O
retarded	VBN	amod	O
band	NN	nmod	O
composed	VBN	acl	O
of	IN	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
probe	NN	nmod	I-DNA
and	CC	cc	O
Oct-2	NN	conj	B-protein
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
Oct-2	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
POU	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nsubj	I-protein
Oct-1	NN	dep	B-protein
and	CC	cc	O
Oct-2	NN	conj	B-protein
regulate	VBP	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
octamer-dependent	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
that	WDT	nsubj	O
direct	VBP	acl:relcl	O
transcription	NN	dobj	O
from	IN	case	O
rearranged	VBN	amod	O
immunoglobulin	NN	compound	B-protein
genes	NNS	nmod	I-protein
.	.	punct	O

Probucol	NN	nsubj	O
(	-LRB-	punct	O
50	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
N-acetylcysteine	NN	conj	O
(	-LRB-	punct	O
20	CD	nummod	O
mM	NN	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
agonist-induced	JJ	amod	O
monocytic	JJ	amod	O
cell	NN	compound	O
adhesion	NN	dobj	O
;	:	punct	O
whereas	IN	dep	O
,	,	punct	O
several	JJ	amod	O
other	JJ	amod	O
antioxidants	NNS	nsubj	O
had	VBD	parataxis	O
no	DT	neg	O
significant	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
also	RB	advmod	O
stimulates	VBZ	ROOT	O
nuclear	JJ	amod	O
export	NN	dobj	O
in	IN	case	O
cells	NNS	nmod	O
that	WDT	nsubjpass	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
preincubated	VBN	acl:relcl	O
with	IN	case	O
RanQ69L	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
either	CC	cc:preconj	O
freshly	RB	advmod	O
isolated	VBN	acl	O
from	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBL	NN	appos	B-cell_type
)	-RRB-	punct	O
or	CC	cc	O
long-term	JJ	amod	B-cell_line
cultured	VBN	amod	I-cell_line
NK	NN	compound	I-cell_line
clones	NNS	conj	I-cell_line
,	,	punct	O
with	IN	case	O
specific	JJ	amod	O
cell	NN	compound	O
targets	NNS	nmod	O
results	VBZ	ccomp	O
in	IN	case	O
an	DT	det	O
increased	VBN	amod	O
binding	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
transcription	NN	compound	B-protein
factors	NNS	dep	I-protein
measured	VBN	acl	O
by	IN	case	O
gel	NN	compound	O
retardation	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
was	VBD	cop	O
also	RB	advmod	O
true	JJ	ROOT	O
for	IN	case	O
KBF	NN	compound	O
(	-LRB-	punct	O
p50	NN	compound	O
homodimer	NN	appos	O
)	-RRB-	punct	O
binding	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	compound	O
levels	NNS	nsubj	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
(	-LRB-	punct	O
ICAM-1	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
adult	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
leukemia	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
ATL	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
are	VBP	cop	O
high	JJ	ccomp	O
,	,	punct	O
whereas	IN	dep	O
those	DT	nsubj	O
in	IN	case	O
T-lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
are	VBP	advcl	O
not	RB	neg	O
.	.	punct	O

Estrone	NN	nsubj	O
potentiates	VBZ	ROOT	O
myeloid	JJ	amod	O
cell	NN	compound	O
differentiation	NN	dobj	O
:	:	punct	O
a	DT	det	O
role	NN	dep	O
for	IN	case	O
17	CD	nummod	B-protein
beta-hydroxysteroid	NN	compound	I-protein
dehydrogenase	NN	nmod	I-protein
in	IN	mark	O
modulating	VBG	acl	O
hemopoiesis	NN	dobj	O
.	.	punct	O

Progesterone	NN	nsubj	O
had	VBD	ROOT	O
little	JJ	amod	O
or	CC	cc	O
no	DT	conj	O
effect	NN	dobj	O
on	IN	case	O
a	DT	det	O
cloned	VBN	amod	B-protein
voltage-gated	JJ	amod	I-protein
Na+	NN	compound	I-protein
channel	NN	nmod	I-protein
,	,	punct	O
an	DT	det	O
inward	JJ	amod	O
rectifier	NN	compound	O
K+	NN	compound	B-protein
channel	NN	appos	I-protein
,	,	punct	O
or	CC	cc	O
on	IN	case	O
lymphocyte	NN	compound	B-protein
Ca2+	NN	compound	I-protein
and	CC	cc	I-protein
Cl-	NN	conj	I-protein
channels	NNS	conj	I-protein
.	.	punct	O

This	DT	det	O
phenotype	NN	nsubj	O
is	VBZ	cop	O
distinct	JJ	ROOT	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
G-CSF	NN	compound	O
receptor-/-	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
other	JJ	amod	O
genes	NNS	nsubj	O
are	VBP	cop	O
likely	JJ	ccomp	O
to	TO	mark	O
be	VB	auxpass	O
adversely	RB	advmod	O
affected	VBN	xcomp	O
by	IN	case	O
loss	NN	nmod	O
of	IN	case	O
C/EBPalpha	NN	nmod	B-protein
.	.	punct	O

gamma	NN	compound	B-protein
B*CaM-K	NN	nsubjpass	I-protein
and	CC	cc	O
delta	NN	conj	B-protein
CaM-AI	NN	amod	I-protein
,	,	punct	O
known	VBN	acl	O
to	TO	mark	O
exhibit	VB	xcomp	O
constitutive	JJ	amod	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	appos	O
)	-RRB-	punct	O
-independent	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
were	VBD	auxpass	O
cotransfected	VBN	ROOT	O
(	-LRB-	punct	O
alone	RB	advmod	O
or	CC	cc	O
in	IN	case	O
combination	NN	conj	O
)	-RRB-	punct	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
a	DT	det	O
plasmid	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
intact	JJ	amod	O
IL-2	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
driving	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
three	CD	nummod	O
compartments	NNS	nsubjpass	O
are	VBP	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
of	IN	case	O
common	JJ	amod	O
endodermal	JJ	amod	O
origin	NN	xcomp	O
;	:	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
earlier	JJR	amod	O
hypotheses	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
suggested	VBD	acl:relcl	O
that	IN	mark	O
the	DT	det	O
endocrine	JJ	amod	O
compartment	NN	nsubj	O
was	VBD	cop	O
of	IN	case	O
neuroectodermal	JJ	amod	O
origin	NN	ccomp	O
.	.	punct	O

The	DT	det	O
3H-thymidine	JJ	amod	O
uptake	NN	compound	O
procedure	NN	nsubjpass	O
was	VBD	auxpass	O
employed	VBN	ROOT	O
,	,	punct	O
incorporating	VBG	xcomp	O
multiple	JJ	amod	O
microbiological	JJ	amod	B-protein
antigens	NNS	dobj	I-protein
.	.	punct	O

Recent	JJ	amod	O
development	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	B-cell_line
cultures	NNS	nmod	I-cell_line
of	IN	case	O
human	JJ	amod	B-cell_line
megakaryocytes	NNS	nmod	I-cell_line
and	CC	cc	O
the	DT	det	O
molecular	JJ	amod	O
cloning	NN	conj	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
specific	JJ	acl:relcl	O
to	TO	case	O
this	DT	det	O
lineage	NN	nmod	O
offer	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	mark	O
getting	VBG	acl	O
some	DT	det	O
insights	NNS	dobj	O
into	IN	case	O
the	DT	det	O
genetic	JJ	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
control	VBP	acl:relcl	O
megakaryocytopoiesis	NN	dobj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
PPARgamma	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
heterodimer	NN	compound	O
partner	NN	appos	O
of	IN	case	O
RXR	NN	nmod	B-protein
,	,	punct	O
is	VBZ	auxpass	O
also	RB	advmod	O
markedly	RB	advmod	O
induced	VBN	ROOT	O
by	IN	case	O
RA	NN	nmod	O
in	IN	case	O
THP-1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

OBJECTIVE	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
DEP-PAHs	NNS	nmod	O
on	IN	case	O
the	DT	det	O
release	NN	nmod	O
and	CC	cc	O
mRNA	NN	compound	B-RNA
expression	NN	conj	O
of	IN	case	O
IL-8	NN	nmod	B-protein
,	,	punct	O
MCP-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
RANTES	NN	conj	B-protein
by	IN	case	O
PBMCs	NNS	nmod	B-cell_type
obtained	VBN	acl	O
from	IN	case	O
healthy	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

Seventeen	CD	nummod	O
microsatellite	NN	compound	B-DNA
markers	NNS	nsubjpass	I-DNA
that	WDT	nsubj	O
span	VBP	acl:relcl	O
the	DT	det	O
common	JJ	amod	O
deleted	VBN	amod	O
region	NN	dobj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
search	VB	xcomp	O
for	IN	case	O
loss	NN	nmod	O
of	IN	case	O
heterozygosity	NN	nmod	O
in	IN	case	O
granulocyte	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
cysteine	NN	nmod	O
and	CC	cc	O
related	JJ	amod	O
thiols	NNS	conj	O
on	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
expression	NN	conj	O
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
dihydropyrimidine	NN	compound	B-protein
dehydrogenase	NN	nmod	I-protein
(	-LRB-	punct	O
DPD	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
initial	JJ	amod	O
enzyme	NN	appos	B-protein
of	IN	case	O
pyrimidine	NN	nmod	O
(	-LRB-	punct	O
and	CC	cc	O
FUra	NN	conj	O
)	-RRB-	punct	O
catabolism	NN	nmod	O
,	,	punct	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
each	DT	det	O
subject	NN	nmod	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
radiometric	JJ	amod	O
assay	NN	nmod	O
using	VBG	acl	O
FUra	NN	dobj	O
as	IN	case	O
the	DT	det	O
substrate	NN	nmod	O
.	.	punct	O

The	DT	det	O
intracellular	JJ	amod	O
signal	NN	compound	O
transduction	NN	nsubj	O
of	IN	case	O
IL-5	NN	nmod	B-protein
in	IN	case	O
eosinophils	NNS	nmod	B-cell_type
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
activity	NN	nsubj	O
was	VBD	cop	O
heat	NN	nmod:npmod	O
labile	JJ	ROOT	O
and	CC	cc	O
trypsin	NN	compound	B-protein
sensitive	JJ	conj	O
.	.	punct	O

p60	NN	nsubjpass	B-protein
was	VBD	auxpass	O
purified	VBN	ROOT	O
from	IN	case	O
CESS	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
peptide	NN	compound	O
microsequencing	NN	conj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
revealed	VBD	conj	O
that	IN	mark	O
it	PRP	nsubj	O
was	VBD	cop	O
lymphocyte-specific	JJ	amod	B-protein
protein	NN	ccomp	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
LSP1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
here	RB	advmod	O
characterized	VBN	acl:relcl	O
as	IN	case	O
the	DT	det	O
most	RBS	advmod	O
prominent	JJ	amod	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
substrate	NN	nmod	I-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
activity	NN	nsubj	O
of	IN	case	O
plasma	NN	compound	O
IL-1	NN	nmod	B-protein
in	IN	case	O
aged	JJ	amod	O
long-distance	JJ	amod	O
runner	NN	nmod	O
was	VBD	cop	O
209	CD	nummod	O
%	NN	ccomp	O
,	,	punct	O
223	CD	nummod	O
%	NN	conj	O
and	CC	cc	O
145	CD	nummod	O
%	NN	conj	O
of	IN	case	O
the	DT	det	O
control	NN	nmod	O
at	IN	case	O
14.7-18.7	CD	amod	O
,	,	punct	O
3.8-7.0	CD	conj	O
and	CC	cc	O
1.5-2.6	CD	conj	O
KD	NN	conj	O
fractions	NNS	nmod	O
.	.	punct	O

Under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
dexamethasone	NN	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
minimal	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
cell	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
elicited	VBD	conj	O
little	JJ	amod	O
internucleosomal	JJ	amod	O
DNA	NN	compound	O
fragmentation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
induced	VBD	conj	O
no	DT	neg	O
cell	NN	compound	O
cycle	NN	compound	O
perturbation	NN	dobj	O
.	.	punct	O

The	DT	det	O
adult	JJ	amod	B-cell_type
globin	NN	compound	I-cell_type
expressing	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
displayed	VBD	ROOT	O
more	RBR	advmod	O
extensive	JJ	amod	O
footprints	NNS	dobj	O
than	IN	case	O
the	DT	det	O
fetal	JJ	amod	B-cell_type
globin	NN	compound	I-cell_type
expressing	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
3	CD	nummod	B-DNA
'	``	punct	I-DNA
regulatory	JJ	amod	I-DNA
sequences	NNS	nmod	I-DNA
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
Agamma-	NN	nmod	B-DNA
and	CC	cc	I-DNA
the	DT	det	I-DNA
beta-globin	NN	compound	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
role	NN	dobj	O
of	IN	case	O
these	DT	det	O
3	CD	nummod	B-DNA
'	''	punct	I-DNA
elements	NNS	nmod	I-DNA
in	IN	case	O
beta-globin	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

All	DT	nsubjpass	O
of	IN	case	O
procedure	NN	nmod	O
were	VBD	auxpass	O
done	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
lipopolysaccharide	NN	nsubj	O
induces	VBZ	ROOT	O
synthesis	NN	dobj	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
the	DT	det	O
85-kDa	JJ	amod	O
cytosolic	JJ	amod	B-protein
phospholipase	NN	compound	I-protein
A2	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
SH3	NN	compound	B-protein
domains	NNS	nsubj	I-protein
of	IN	case	O
Grb2	NN	nmod	B-protein
form	VBP	ROOT	O
a	DT	det	O
stable	JJ	amod	O
complex	NN	dobj	O
with	IN	case	O
SOS1	NN	nmod	B-protein
and	CC	cc	O
two	CD	nummod	O
proteins	NNS	conj	O
of	IN	case	O
75	CD	nummod	B-protein
kD	NN	nmod	I-protein
and	CC	cc	O
120	CD	nummod	B-protein
kD	NN	conj	I-protein
,	,	punct	O
which	WDT	nsubj	O
undergo	VBP	acl:relcl	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
in	IN	case	O
Fc	NN	compound	B-cell_line
gamma	NN	compound	I-cell_line
RIIA	NN	compound	I-cell_line
stimulated	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

When	WRB	advmod	O
expressed	VBN	advcl	O
in	IN	prep	O
the	DT	det	O
TNT	NNP	compound	O
System	NNP	pobj	O
,	,	punct	O
squirrel	NN	compound	O
monkey	NN	nsubj	O
and	CC	cc	O
human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	conj	I-protein
had	VBD	ROOT	O
similar	JJ	amod	O
,	,	punct	O
high	JJ	dep	O
affinity	NN	compound	O
binding	NN	dobj	O
for	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
apparent	JJ	amod	O
Kd	NN	dep	O
,	,	punct	O
5.9	CD	nummod	O
+/-	CC	cc	O
1.2	CD	conj	O
and	CC	cc	O
4.3	CD	conj	O
+/-	CC	cc	O
0.5	CD	conj	O
nmol/L	NN	appos	O
,	,	punct	O
respectively	RB	advmod	O
;	:	punct	O
n	NN	nsubj	O
=	JJ	dep	O
3	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
squirrel	NN	compound	B-protein
monkey	NN	compound	I-protein
F774L	NN	compound	I-protein
receptor	NN	nsubj	I-protein
had	VBD	parataxis	O
lower	JJR	amod	O
affinity	NN	compound	O
binding	NN	dobj	O
(	-LRB-	punct	O
apparent	JJ	amod	O
Kd	NN	dobj	O
,	,	punct	O
20.4	CD	nummod	O
+/-	CC	cc	O
2.0	CD	conj	O
nmol/L	NN	appos	O
;	:	punct	O
n	NN	nsubj	O
=	JJ	dep	O
3	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
transcription	NN	compound	O
start	NN	compound	O
site	NN	nsubj	O
is	VBZ	cop	O
located	JJ	ROOT	O
approximately	RB	advmod	O
4	CD	nummod	O
kilobases	NNS	nmod	O
5	CD	nummod	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
translation	NN	compound	B-DNA
initiation	NN	compound	I-DNA
codon	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
an	DT	det	O
RNA	NN	compound	O
splice	NN	nsubj	O
of	IN	case	O
3863	CD	nummod	O
bases	NNS	nmod	O
occurs	VBZ	conj	O
in	IN	case	O
the	DT	det	O
5'-untranslated	JJ	amod	B-DNA
region	NN	nmod	I-DNA
to	TO	mark	O
generate	VB	xcomp	O
mature	JJ	amod	B-RNA
HeLa	NN	compound	I-RNA
cell	NN	compound	I-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Bcl-3	NN	nsubj	B-protein
can	MD	aux	O
aid	VB	ccomp	O
kappa	NN	nmod:npmod	B-DNA
B	NN	nmod:npmod	I-DNA
site	NN	nmod:npmod	I-DNA
-dependent	JJ	amod	O
transcription	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
counteracting	VBG	advcl	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
p50/NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
homodimers	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
partially	RB	advmod	O
overlapping	VBG	amod	O
CD40L	NN	compound	B-DNA
and	CC	cc	I-DNA
IL-4	NN	conj	I-DNA
responsive	JJ	amod	I-DNA
elements	NNS	nsubj	I-DNA
are	VBP	cop	O
functionally	RB	advmod	O
cooperative	JJ	ROOT	O
as	IN	case	O
the	DT	det	O
disruption	NN	nsubj	O
of	IN	case	O
one	CD	nmod	O
of	IN	case	O
them	PRP	nmod	O
prevents	VBZ	parataxis	O
synergistic	JJ	amod	O
promoter	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
CD4	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
and	CC	cc	O
their	PRP$	nmod:poss	O
immediate	JJ	amod	O
precursors	NNS	nsubjpass	O
is	VBZ	auxpass	O
detected	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
because	IN	mark	O
these	DT	det	O
cells	NNS	nsubj	O
lack	VBP	advcl	O
markers	NNS	dobj	O
that	WDT	nsubj	O
correlate	VBP	acl:relcl	O
with	IN	case	O
positive	JJ	amod	O
selection	NN	nmod	O
,	,	punct	O
a	DT	det	O
deregulation	NN	nsubjpass	O
in	IN	case	O
their	PRP$	nmod:poss	O
maturation	NN	compound	O
process	NN	nmod	O
is	VBZ	auxpass	O
suggested	VBN	conj	O
.	.	punct	O

Paternal	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
WT1	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
fibroblasts	NNS	nmod	I-cell_type
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
.	.	punct	O

Using	VBG	advcl	O
various	JJ	amod	O
constructs	NNS	dobj	O
expressing	VBG	acl	O
a	DT	det	O
lacZ	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	dobj	I-DNA
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
intact	JJ	nmod	O
or	CC	cc	O
three	CD	nummod	O
deleted	JJ	amod	O
forms	NNS	dep	O
of	IN	case	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
obtained	VBD	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
the	DT	det	O
kappaB	NN	compound	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nsubjpass	I-DNA
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
U3	NN	compound	B-DNA
region	NN	nmod	I-DNA
are	VBP	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
cell-to-cell	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
cepharanthine	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
highly	RB	advmod	O
potent	JJ	amod	O
inhibitor	NN	ccomp	O
of	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
in	IN	case	O
a	DT	det	O
chronically	RB	advmod	B-cell_line
infected	JJ	amod	I-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
approach	NN	nsubj	O
allows	VBZ	ROOT	O
the	DT	det	O
convenient	JJ	amod	O
generation	NN	dobj	O
of	IN	case	O
RNA	NN	compound	B-protein
polymerase	NN	compound	I-protein
II	CD	nummod	I-protein
transcription	NN	compound	O
systems	NNS	nmod	O
from	IN	case	O
Saccharomyces	FW	compound	O
cerevisiae	FW	nmod	O
,	,	punct	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
Schizosaccharomyces	FW	compound	O
pombe	FW	conj	O
.	.	punct	O

In	IN	case	O
21	CD	compound	O
of	IN	advmod	O
27	CD	nummod	O
informative	JJ	amod	O
female	JJ	amod	O
patients	NNS	nmod	O
the	DT	det	O
majority	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
granulocytes	NNS	nmod	B-cell_type
were	VBD	auxpass	O
clonally	RB	advmod	O
derived	VBN	ROOT	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
LITAF	NN	nsubj	B-protein
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
TNF-alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
proposes	VBZ	conj	O
a	DT	det	O
new	JJ	amod	O
mechanism	NN	dobj	O
to	TO	mark	O
control	VB	acl	O
TNF-alpha	NN	compound	B-protein
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

In-situ	FW	compound	O
detection	NN	nsubjpass	O
of	IN	case	O
fragmented	JJ	amod	O
DNA	NN	nmod	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
identify	VB	xcomp	O
apoptotic	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
LPS	NN	compound	O
activation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
results	VBZ	ROOT	O
in	IN	case	O
nuclear	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
c-Rel/p50	NN	nmod	B-protein
and	CC	cc	O
p50/p65	NN	conj	B-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
induces	VBZ	conj	O
phosphorylation	NN	dobj	O
of	IN	case	O
MAD3	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
TNFRp55-deficient	JJ	amod	O
mice	NNS	nsubj	O
are	VBP	cop	O
severely	RB	advmod	O
impaired	JJ	ROOT	O
to	TO	mark	O
clear	VB	xcomp	O
L.	FW	compound	O
monocytogenes	FW	dobj	O
and	CC	cc	O
readily	RB	advmod	O
succumb	VBP	conj	O
to	TO	case	O
infection	NN	nmod	O
.	.	punct	O

4.	LS	dep	O
Danazol	NN	nsubj	O
may	MD	aux	O
release	VB	ROOT	O
estrogen	NN	compound	O
predominance	NN	dobj	O
via	IN	case	O
the	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
transcription	NN	nmod	O
for	IN	case	O
ER	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
ER	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
ER	NN	compound	B-protein
expressions	NNS	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

In	IN	case	O
vertebrates	NNS	nmod	O
,	,	punct	O
five	CD	nummod	O
distinct	JJ	amod	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
subunits	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
currently	RB	advmod	O
known	VBN	ROOT	O
which	WDT	nsubj	O
might	MD	aux	O
extensively	RB	advmod	O
heterodimerize	VB	ccomp	O
,	,	punct	O
thereby	RB	advmod	O
forming	VBG	advcl	O
complexes	NNS	dobj	O
with	IN	case	O
distinct	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
DNA	NN	compound	O
sequence	NN	compound	O
specificity	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	O
type-	NN	amod	O
and	CC	cc	O
cell	NN	nmod:npmod	O
stage-specific	JJ	conj	O
distribution	NN	conj	O
.	.	punct	O

Studies	NNS	nsubj	O
on	IN	case	O
RA	NN	compound	O
time-response	JJ	amod	O
or	CC	cc	O
pulse	NN	conj	O
treatment	NN	nmod	O
in	IN	case	O
semisolid	JJ	amod	O
or	CC	cc	O
liquid	JJ	conj	O
culture	NN	nmod	O
show	VBP	ROOT	O
that	IN	mark	O
early	JJ	amod	O
RA	NN	compound	O
addition	NN	nsubj	O
is	VBZ	cop	O
most	RBS	advmod	O
effective	JJ	ccomp	O
,	,	punct	O
thus	RB	advmod	O
indicating	VBG	advcl	O
that	IN	mark	O
early	JJ	amod	O
but	CC	cc	O
not	RB	cc	O
late	JJ	conj	O
HPC	NN	nsubj	B-cell_type
are	VBP	cop	O
sensitive	JJ	ccomp	O
to	TO	case	O
its	PRP$	nmod:poss	O
action	NN	nmod	O
.	.	punct	O

Functional	JJ	amod	O
roles	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
Oct-2A	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
high	JJ	amod	B-protein
mobility	NN	compound	I-protein
group	NN	compound	I-protein
protein	NN	conj	I-protein
I/Y	NN	dep	B-protein
in	IN	case	O
HLA-DRA	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
cover	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
utilized	VBN	acl:relcl	O
by	IN	case	O
mammalian	JJ	amod	O
oncogenic	JJ	amod	O
viruses	NNS	nmod	O
to	TO	mark	O
affect	VB	xcomp	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
Rel/NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
role	NN	conj	O
of	IN	case	O
Rel/NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
viral	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
replication	NN	conj	O
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
calcium	NN	compound	O
ionophore	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	advcl	O
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
TPA	NN	nmod	O
,	,	punct	O
a	DT	det	O
PKC	NN	compound	B-protein
activator	NN	appos	O
,	,	punct	O
the	DT	det	O
Zp	NN	compound	B-DNA
induction	NN	nsubjpass	O
was	VBD	auxpass	O
synergistically	RB	advmod	O
enhanced	VBN	ROOT	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Protein	NN	compound	O
production	NN	nsubjpass	O
in	IN	case	O
supernatants	NNS	nmod	O
was	VBD	auxpass	O
assessed	VBN	dep	O
by	IN	case	O
ELISA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
mRNA	NN	compound	B-RNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
evaluated	VBN	conj	O
by	IN	case	O
semiquantitative	JJ	amod	O
RT-PCR	NN	nmod	O
.	.	punct	O

Preclinical	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
potential	JJ	amod	O
use	NN	dobj	O
of	IN	case	O
TPO	NN	nmod	B-protein
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
contexts	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
is	VBZ	cop	O
too	RB	advmod	O
early	JJ	conj	O
to	TO	mark	O
evaluate	VB	xcomp	O
its	PRP$	nmod:poss	O
benefit	NN	dobj	O
in	IN	mark	O
reducing	VBG	advcl	O
platelet	NN	compound	O
transfusion	NN	dobj	O
.	.	punct	O

The	DT	det	O
``	``	punct	O
natural	JJ	ROOT	O
''	''	punct	O
PPAR	NN	compound	O
activator	NN	compound	O
15d-PGJ	NN	nsubj	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
had	VBD	ROOT	O
the	DT	det	O
greatest	JJS	amod	O
potency	NN	dobj	O
and	CC	cc	O
was	VBD	cop	O
the	DT	det	O
only	RB	amod	O
tested	VBN	amod	O
molecule	NN	conj	O
capable	JJ	amod	O
of	IN	mark	O
partially	RB	advmod	O
inhibiting	VBG	advcl	O
the	DT	det	O
induced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
E-selectin	NN	nmod	B-protein
and	CC	cc	O
neutrophil-like	JJ	amod	O
HL60	NN	compound	B-cell_line
cell	NN	conj	I-cell_line
binding	VBG	acl	O
to	TO	case	O
PMA-activated	JJ	amod	O
HAECs	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
p50	NN	compound	B-protein
and	CC	cc	I-protein
p65	NN	conj	I-protein
proteins	NNS	nsubjpass	I-protein
,	,	punct	O
constituents	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
prototypic	JJ	amod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappaB	NN	nmod	I-protein
,	,	punct	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
DNA-protein	JJ	amod	O
complexes	NNS	nmod	O
by	IN	case	O
anti-peptide	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
in	IN	case	O
gel	NN	compound	O
supershift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
ADP-activated	JJ	amod	B-cell_type
platelets	NNS	nsubj	I-cell_type
induced	VBD	ROOT	O
MCP-1	NN	compound	O
and	CC	cc	O
ICAM-1	NN	conj	O
promoter-dependent	JJ	amod	O
transcription	NN	dobj	O
.	.	punct	O

New	JJ	compound	O
knowledge	NN	nsubj	O
on	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
steroid	NN	compound	O
resistance	NN	nmod	O
may	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
implications	NNS	dobj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
asthma	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
diseases	NNS	conj	O
.	.	punct	O

As	IN	prep	O
a	DT	det	O
first	JJ	amod	O
step	NN	pobj	O
toward	IN	mark	O
elucidating	VBG	acl	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
Cbl	NN	nmod	B-protein
in	IN	case	O
TCR	NN	nmod:npmod	B-protein
-initiated	JJ	amod	O
signaling	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
wild-type	JJ	amod	B-protein
Cbl	NN	nmod	I-protein
or	CC	cc	O
a	DT	det	O
transforming	VBG	amod	O
Cbl	NN	compound	B-protein
mutant	NN	conj	I-protein
(	-LRB-	punct	O
70Z/3	NN	appos	O
)	-RRB-	punct	O
to	TO	mark	O
induce	VB	acl	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
a	DT	det	O
nuclear	JJ	amod	B-DNA
factor	NN	compound	I-DNA
of	IN	amod	I-DNA
activated	VBN	amod	I-DNA
T	NN	compound	I-DNA
cells	NNS	compound	I-DNA
(	-LRB-	punct	I-DNA
NFAT	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
element	NN	nmod	I-DNA
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
interleukin	NN	compound	B-DNA
2	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
IL2	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
transiently	RB	advmod	O
cotransfected	VBN	amod	O
Jurkat-TAg	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
lack	NN	nsubj	O
of	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
selective	JJ	amod	O
defects	NNS	conj	O
in	IN	case	O
gamma	NN	compound	B-cell_type
delta	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
dendritic	JJ	amod	B-cell_type
antigen-presenting	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
point	VBP	ROOT	O
to	TO	case	O
Ikaros	NN	nmod	B-protein
as	IN	case	O
an	DT	det	O
essential	JJ	amod	O
factor	NN	nmod	O
for	IN	case	O
the	DT	det	O
establishment	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
branchpoints	NNS	nmod	O
of	IN	case	O
the	DT	det	O
T	NN	compound	O
cell	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

EMS	NN	compound	O
analyses	NNS	nsubj	O
performed	VBN	acl	O
with	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
Tax-expressing	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
HTLV-I-transformed	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
demonstrate	VBP	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
prevents	VBZ	ccomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
U1	NN	nmod	B-DNA
(	-LRB-	punct	O
U1A/U1B	NN	appos	B-DNA
)	-RRB-	punct	O
and	CC	cc	O
U2	NN	compound	B-DNA
DNA-protein	JJ	amod	B-protein
complexes	NNS	conj	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
could	MD	aux	O
not	RB	neg	O
prove	VB	ROOT	O
that	IN	mark	O
Th2	NN	compound	B-protein
type	NN	compound	I-protein
cytokines	NNS	nsubj	I-protein
had	VBD	ccomp	O
a	DT	det	O
protective	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
hepatocytes	NNS	nmod	B-cell_type
.	.	punct	O

A	DT	det	O
particular	JJ	amod	O
allele	NN	nsubj	O
has	VBZ	ROOT	O
an	DT	det	O
unusually	RB	advmod	O
high	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
recovery	NN	nsubjpass	O
of	IN	case	O
proteins	NNS	nmod	O
mediating	VBG	acl	O
signal	NN	compound	O
transduction	NN	dobj	O
through	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor/CD3	NN	compound	I-protein
complex	NN	nmod	I-protein
in	IN	case	O
LN	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
activated	VBD	acl	O
ex	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
antitumor	JJ	compound	O
function	NN	nmod	O
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
using	VBG	acl	O
protein	NN	compound	O
extracts	NNS	dobj	O
from	IN	case	O
EBV-B	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
the	DT	det	O
IL-2	NN	compound	B-protein
NF-chi	NN	compound	B-protein
B	NN	compound	I-protein
probe	NN	conj	O
revealed	VBD	ROOT	O
the	DT	det	O
constitutive	JJ	amod	O
generation	NN	dobj	O
of	IN	case	O
chi	NN	compound	B-protein
B	NN	compound	I-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
IL-2-secreting	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
consisting	VBG	acl	O
mainly	RB	advmod	O
of	IN	case	O
heterodimeric	JJ	amod	B-protein
p50/p65	NN	compound	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

Kappa	NN	compound	B-protein
B	NN	compound	I-protein
(	-LRB-	punct	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
)	-RRB-	punct	I-protein
enhancer	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
isolated	VBN	acl	O
from	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
activated	VBN	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
produce	VBP	ROOT	O
two	CD	nummod	O
distinct	JJ	amod	O
nucleoprotein	NN	compound	B-protein
complexes	NNS	dobj	I-protein
when	WRB	advmod	O
incubated	VBN	advcl	O
with	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
element	NN	nmod	I-DNA
from	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
receptor-alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
described	VBN	amod	O
conditions	NNS	nsubj	O
which	WDT	nsubj	O
inhibited	VBD	acl:relcl	O
or	CC	cc	O
prevented	VBD	conj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-1RI-associated	JJ	amod	B-protein
kinase	NN	nmod	I-protein
similarly	RB	advmod	O
impaired	VBD	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
EL4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
best	JJS	advmod	O
understood	VBN	amod	O
apoptotic	JJ	amod	O
pathways	NNS	nmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
Fas	NN	compound	B-protein
/Fas	NN	compound	B-protein
ligand	NN	compound	I-protein
(	-LRB-	punct	O
FasL	NN	appos	B-protein
)	-RRB-	punct	O
interaction	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	dep	O
that	IN	mark	O
LPS-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nsubj	O
and	CC	cc	O
TNF-alpha	NN	compound	B-protein
release	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
are	VBP	cop	O
independent	JJ	ccomp	O
of	IN	case	O
PKC	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

Cell	NN	compound	O
adhesion	NN	nsubj	O
to	TO	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
stimulated	VBN	acl	B-protein
by	IN	case	I-protein
tumor	NN	compound	I-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
due	JJ	ROOT	O
to	TO	case	O
induction	NN	nmod	O
of	IN	case	O
surface	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
vascular	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
(	-LRB-	punct	O
VCAM-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

If	IN	mark	O
they	PRP	nsubj	O
can	MD	aux	O
not	RB	neg	O
,	,	punct	O
chimeric	JJ	amod	B-protein
proteins	NNS	nsubjpass	I-protein
can	MD	aux	O
be	VB	auxpass	O
tested	VBN	ROOT	O
to	TO	mark	O
identify	VB	xcomp	O
which	WDT	mark	O
amino	NN	compound	O
acids	NNS	nsubj	O
distinguish	VBP	ccomp	O
the	DT	det	O
different	JJ	amod	O
family	NN	compound	O
members	NNS	dobj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunosuppressive	JJ	amod	O
drug	NN	nmod	O
cyclosporin	NN	compound	O
A	NN	dep	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
inactivation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Ca2+/calmodulin-dependent	JJ	amod	B-protein
serine-threonine	NN	compound	I-protein
phosphatase	NN	compound	I-protein
calcineurin	NN	nmod	B-protein
by	IN	case	O
the	DT	det	O
drug-immunophilin	JJ	amod	B-protein
complex	NN	nmod	I-protein
.	.	punct	O

For	IN	case	O
most	JJS	amod	O
lymphokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
a	DT	det	O
combination	NN	nsubjpass	O
of	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
(	-LRB-	punct	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13	CD	nummod	O
acetate	NN	dep	O
,	,	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
calcium	NN	compound	O
ionophores	NNS	conj	O
(	-LRB-	punct	O
A23187	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
maximal	JJ	amod	O
induction	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
potentiation	NN	nsubj	O
of	IN	case	O
nonphlogistic	JJ	amod	O
clearance	NN	nmod	O
of	IN	case	O
apoptotic	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
by	IN	case	O
phagocytes	NNS	nmod	B-cell_type
is	VBZ	cop	O
a	DT	det	O
hitherto	RB	advmod	O
unrecognized	JJ	amod	O
property	NN	ccomp	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
that	WDT	nsubj	O
has	VBZ	acl:relcl	O
potential	JJ	amod	O
implications	NNS	dobj	O
for	IN	case	O
therapies	NNS	nmod	O
aimed	VBN	acl	O
at	IN	mark	O
promoting	VBG	advcl	O
the	DT	det	O
resolution	NN	dobj	O
of	IN	case	O
inflammatory	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
Rhom-2	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
is	VBZ	cop	O
such	PDT	case	O
a	DT	det	O
common	JJ	amod	O
site	NN	advcl	O
of	IN	case	O
chromosomal	JJ	amod	O
damage	NN	nmod	O
in	IN	case	O
T-cell	NN	compound	B-cell_type
tumors	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
consistency	NN	nsubjpass	O
of	IN	case	O
translocations	NNS	nmod	O
near	IN	case	O
the	DT	det	O
rhombotin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
further	RB	advmod	O
examined	VBN	ROOT	O
.	.	punct	O

Using	VBG	advcl	O
purified	VBN	amod	O
recombinant	JJ	amod	O
p50	NN	dobj	B-protein
,	,	punct	O
p65	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
c-Rel	NN	compound	B-protein
proteins	NNS	conj	I-protein
,	,	punct	O
optimal	JJ	amod	O
DNA-binding	JJ	amod	O
motifs	NNS	nsubjpass	O
were	VBD	auxpass	O
selected	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
pool	NN	nmod	O
of	IN	case	O
random	JJ	amod	O
oligonucleotides	NNS	nmod	O
.	.	punct	O

In	IN	case	O
lymphoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
only	RB	advmod	O
,	,	punct	O
the	DT	det	O
E	NN	compound	B-protein
(	-LRB-	punct	I-protein
gre	NN	compound	I-protein
)	-RRB-	punct	I-protein
-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
complexes	NNS	nsubj	I-protein
included	VBD	ROOT	O
ALF1	NN	compound	B-protein
or	CC	cc	O
HEB	NN	conj	B-protein
and	CC	cc	O
E2A	NN	conj	B-protein
basic	JJ	amod	I-protein
helix-loop-helix	JJ	amod	I-protein
proteins	NNS	dobj	I-protein
.	.	punct	O

CD19	NN	compound	B-protein
expression	NN	nsubj	O
begins	VBZ	ROOT	O
at	IN	case	O
the	DT	det	O
pro-B	JJ	amod	O
cell	NN	compound	O
stage	NN	nmod	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
EBF	NN	nmod	B-protein
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
activated	VBD	ROOT	O
a	DT	det	O
B29	NN	nmod:npmod	B-DNA
promoter-controlled	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
construct	NN	dobj	I-DNA
13-fold	RB	advmod	O
and	CC	cc	O
induced	VBD	conj	O
a	DT	det	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
from	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
B29	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Reinsertion	NN	nsubj	O
of	IN	case	O
these	DT	det	O
sequences	NNS	nmod	O
into	IN	case	O
zeta-luciferase	NN	compound	B-DNA
constructs	NNS	nmod	I-DNA
missing	VBG	acl	O
the	DT	det	O
-417	CD	compound	O
to	TO	dep	O
-207	CD	nummod	O
region	NN	dobj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
sequences	NNS	nsubj	O
lack	VBP	ccomp	O
classical	JJ	amod	O
enhancer	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

The	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nsubj	I-protein
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
regulates	VBZ	ROOT	O
cytokine	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
through	IN	case	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
several	JJ	amod	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Mental	JJ	amod	O
retardation	NN	nsubjpass	O
and	CC	cc	O
a	DT	det	O
constellation	NN	conj	O
of	IN	case	O
congenital	JJ	amod	O
malformations	NNS	nmod	O
not	RB	neg	O
usually	RB	advmod	O
associated	VBN	nsubjpass	O
with	IN	case	O
Turner	NN	compound	O
syndrome	NN	nmod	O
are	VBP	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
some	DT	det	O
females	NNS	nmod	O
with	IN	case	O
a	DT	det	O
mosaic	JJ	amod	O
45	CD	nmod	O
,	,	punct	O
X/46	NN	conj	O
,	,	punct	O
X	NN	conj	O
,	,	punct	O
r	NN	compound	O
(	-LRB-	punct	O
X	NN	compound	O
)	-RRB-	punct	O
karyotype	NN	dep	O
.	.	punct	O

Abnormal	JJ	amod	O
T	NN	compound	B-cell_type
lymphocyte	NN	compound	I-cell_type
development	NN	ROOT	O
induced	VBN	acl	O
by	IN	case	O
targeted	VBN	amod	O
overexpression	NN	nmod	O
of	IN	case	O
IkappaB	NN	compound	B-protein
alpha	NN	nmod	I-protein
.	.	punct	O

MBP	NN	nsubj	B-protein
stimulated	VBD	ROOT	O
2-fold	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
IL-8	NN	compound	B-RNA
messenger	NN	compound	I-RNA
RNA	NN	nmod	I-RNA
(	-LRB-	punct	O
mRNA	NN	appos	B-RNA
)	-RRB-	punct	O
after	IN	case	O
1	CD	nummod	O
and	CC	cc	O
3	CD	conj	O
h	NN	nmod	O
of	IN	case	O
incubation	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
actinomycin	NN	compound	O
D	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	dep	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
at	IN	case	O
clinically	RB	advmod	O
relevant	JJ	amod	O
concentrations	NNS	nmod	O
exert	VBP	ccomp	O
specific	JJ	amod	O
actions	NNS	dobj	O
on	IN	case	O
expression	NN	nmod	O
of	IN	case	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
on	IN	case	O
activated	VBN	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
mediated	VBN	acl:relcl	O
through	IN	case	O
ligation	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
anti-inflammatory	JJ	amod	O
corticosteroids	NNS	nsubj	O
may	MD	aux	O
inhibit	VB	acl:relcl	O
leukocyte	NN	compound	O
accumulation	NN	dobj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
mitogen	NN	compound	B-protein
activation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
induces	VBZ	ccomp	O
nuclear	JJ	amod	O
factors	NNS	dobj	O
that	WDT	nsubj	O
form	VBP	acl:relcl	O
complexes	NNS	dobj	O
with	IN	case	O
cyclic	JJ	amod	B-protein
AMP	NN	compound	I-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
CREB	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
LMP-1	NN	nsubj	B-protein
upregulates	VBZ	acl:relcl	O
these	DT	det	O
proteins	NNS	dobj	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
is	VBZ	cop	O
plausible	JJ	conj	O
that	IN	mark	O
LMP-1	NN	nsubj	B-protein
modifies	VBZ	ccomp	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	dobj	O
that	WDT	nsubj	O
result	VBP	acl:relcl	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
one	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
ultimately	RB	advmod	O
regulate	VBP	acl:relcl	O
transcription	NN	dobj	O
of	IN	case	O
oncogenic	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

SRC-related	JJ	amod	B-DNA
proto-oncogenes	NNS	ROOT	I-DNA
and	CC	cc	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
modulation	NN	dep	O
by	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
and	CC	cc	O
FK506	NN	conj	O
.	.	punct	O

C/EBP	NN	compound	B-protein
beta	NN	ROOT	I-protein
in	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
:	:	punct	O
correlation	NN	dep	O
with	IN	case	O
inflammation	NN	nmod	O
,	,	punct	O
not	RB	neg	O
disease	NN	compound	O
specificity	NN	conj	O
.	.	punct	O

Proliferation	NN	nsubjpass	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
immobilized	VBN	amod	O
anti-CD3	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nmod	I-protein
(	-LRB-	punct	O
mAb	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
an	DT	det	O
additional	JJ	amod	O
costimulatory	JJ	amod	O
signal	NN	nmod	O
delivered	VBN	acl	O
by	IN	case	O
anti-CD28	JJ	amod	B-protein
mAb	NN	nmod	I-protein
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
mutations	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
androgen	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
are	VBP	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
androgen	NN	compound	O
insensitivity	NN	compound	O
syndromes	NNS	nmod	O
,	,	punct	O
a	DT	det	O
heterogeneous	JJ	amod	O
group	NN	appos	O
of	IN	case	O
related	JJ	amod	O
disorders	NNS	nmod	O
involving	VBG	acl	O
defective	JJ	amod	O
sexual	JJ	amod	O
differentiation	NN	dobj	O
in	IN	case	O
karyotypic	JJ	amod	O
males	NNS	nmod	O
.	.	punct	O

The	DT	det	O
immunomodulatory	JJ	amod	O
cytokine	NN	compound	B-protein
IL-4	NN	nsubj	B-protein
affects	VBZ	ROOT	O
cells	NNS	dobj	O
of	IN	case	O
most	JJS	advmod	O
hemopoietic	JJ	amod	B-cell_type
lineages	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
enhancer	NN	nsubj	B-DNA
for	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
mu	NN	compound	I-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
IgH	NN	appos	B-protein
)	-RRB-	punct	O
activates	VBZ	ROOT	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
gene	NN	dobj	I-DNA
at	IN	case	O
the	DT	det	O
pre-B	JJ	amod	O
cell	NN	compound	O
stage	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
lymphocyte	NN	compound	I-cell_type
differentiation	NN	nmod	O
.	.	punct	O

Some	DT	det	O
mice	NNS	nsubj	O
showed	VBD	ROOT	O
marked	JJ	amod	O
splenic	JJ	amod	O
lymphocyte	NN	compound	O
depletion	NN	dobj	O
.	.	punct	O

Highly	RB	advmod	O
purified	VBN	amod	O
monocytes	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
IL-10	NN	nmod	B-protein
for	IN	case	O
60	CD	compound	O
to	TO	dep	O
90	CD	nummod	O
minutes	NNS	nmod	O
before	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
IFNgamma	NN	nmod	B-protein
or	CC	cc	O
IFNalpha	NN	conj	B-protein
.	.	punct	O

Tal-1	NN	compound	B-protein
rearrangements	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
nearly	RB	advmod	O
30	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
T	NN	compound	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
presented	VBN	acl	O
below	IN	advmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
Notch-1	NN	compound	B-protein
expression	NN	nsubj	O
provides	VBZ	ccomp	O
significant	JJ	amod	O
protection	NN	dobj	O
to	TO	case	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
from	IN	case	O
TCR	NN	compound	B-protein
-mediated	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
supported	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
observation	NN	nmod	O
that	IN	mark	O
the	DT	det	O
down-regulatory	JJ	amod	O
capacity	NN	nsubj	O
of	IN	case	O
IL-4	NN	nmod	B-protein
appeared	VBD	ccomp	O
to	TO	mark	O
be	VB	cop	O
dependent	JJ	xcomp	O
on	IN	case	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

Attenuation	NN	nsubj	O
of	IN	case	O
HLA-DR	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
infected	VBN	acl	O
with	IN	case	O
Mycobacterium	NN	compound	O
tuberculosis	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
intracellular	JJ	amod	O
sequestration	NN	nmod	O
of	IN	case	O
immature	JJ	amod	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
heterodimers	NNS	nmod	I-protein
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
IL-4	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
JunB	NN	nmod	B-protein
during	IN	case	O
T	NN	compound	O
helper	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

This	DT	det	O
sequence	NN	compound	B-DNA
element	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
referred	VBN	ROOT	O
to	TO	nmod	O
as	IN	case	O
the	DT	det	O
BAT	NN	compound	B-DNA
box	NN	nmod	I-DNA
and	CC	cc	O
its	PRP$	nmod:poss	O
deletion	NN	nsubj	O
significantly	RB	advmod	O
reduced	VBD	conj	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
a	DT	det	O
CD20	NN	compound	O
promoter-CAT	JJ	amod	O
construct	NN	nmod	O
in	IN	case	O
B	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

Among	IN	case	O
upstream	JJ	amod	B-protein
signaling	VBG	amod	I-protein
molecules	NNS	nmod	I-protein
of	IN	case	O
ERK	NN	nmod	B-protein
,	,	punct	O
Shc	NN	nsubjpass	B-protein
was	VBD	auxpass	O
constitutively	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
Grb2	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
tyrosine-phosphorylated	VBN	conj	O
by	IN	case	O
GM-CSF	NN	nmod	B-protein
and	CC	cc	O
FMLP	NN	conj	O
,	,	punct	O
and	CC	cc	O
Sos1	NN	nsubjpass	B-protein
and	CC	cc	O
c-Raf-1	NN	conj	B-protein
were	VBD	auxpass	O
not	RB	neg	O
phosphorylated	VBN	conj	O
by	IN	case	O
GM-CSF	NN	nmod	B-protein
,	,	punct	O
IL-3	NN	conj	O
,	,	punct	O
TNF	NN	conj	O
,	,	punct	O
and	CC	cc	O
FMLP	NN	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
whereas	IN	dep	O
all	PDT	det:predet	O
these	DT	det	O
signaling	VBG	amod	O
molecules	NNS	nsubjpass	O
were	VBD	auxpass	O
affected	VBN	parataxis	O
and/or	CC	cc	O
utilized	VBN	conj	O
by	IN	case	O
GM-CSF	NN	nmod	B-protein
in	IN	case	O
MO7e	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
nuclear	JJ	amod	O
factor	NN	nsubj	O
of	IN	case	O
kappaB	NN	nmod	O
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
ubiquitous	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
key	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
and	CC	cc	O
inflammation	NN	conj	O
.	.	punct	O

The	DT	det	O
activating	VBG	amod	O
and	CC	cc	O
inhibitory	JJ	conj	O
domains	NNS	nsubj	O
function	VBP	ROOT	O
together	RB	advmod	O
as	IN	case	O
an	DT	det	O
independent	JJ	amod	O
regulatory	JJ	amod	O
module	NN	nmod	O
in	IN	case	O
different	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
fusion	NN	nmod	O
to	TO	case	O
the	DT	det	O
GAL4	NN	compound	B-protein
DNA	NN	compound	I-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
some	DT	nsubj	O
of	IN	case	O
the	DT	det	O
genes	NNS	nmod	O
displayed	VBD	ROOT	O
a	DT	det	O
restricted	JJ	amod	O
expression	NN	compound	O
pattern	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
they	PRP	nsubj	O
represent	VBP	ccomp	O
potential	JJ	amod	O
regulators	NNS	dobj	O
of	IN	case	O
monocyte	NN	compound	O
differentiation	NN	nmod	O
or	CC	cc	O
proliferation	NN	conj	O
.	.	punct	O

Both	DT	det	O
compounds	NNS	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
mixed	JJ	amod	O
lymphocyte	NN	compound	O
reaction	NN	dobj	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
reversed	VBN	conj	O
by	IN	case	O
exogenous	JJ	amod	O
IL-2	NN	nmod	B-protein
.	.	punct	O

Given	VBN	case	O
the	DT	det	O
important	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
the	DT	det	O
estrogen	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
and	CC	cc	O
physiology	NN	conj	O
of	IN	case	O
the	DT	det	O
breast	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
essential	JJ	ROOT	O
to	TO	mark	O
delineate	VB	xcomp	O
the	DT	det	O
mechanisms	NNS	dobj	O
responsible	JJ	amod	O
for	IN	case	O
its	PRP$	nmod:poss	O
failed	VBN	amod	O
expression	NN	nmod	O
in	IN	case	O
some	DT	det	O
breast	NN	compound	O
tumors	NNS	nmod	O
.	.	punct	O

HTLV-1-transformed	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
expressed	VBD	ROOT	O
higher	JJR	amod	O
amounts	NNS	dobj	O
of	IN	case	O
STAT1	NN	nmod	B-RNA
,	,	punct	I-RNA
STAT3	NN	conj	I-RNA
and	CC	cc	I-RNA
STAT5	NN	conj	I-RNA
RNA	NN	dep	I-RNA
and	CC	cc	O
proteins	NNS	conj	O
than	IN	case	O
virus-negative	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
pattern	NN	nsubjpass	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
was	VBD	auxpass	O
suggested	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
clones	NNS	nmod	O
in	IN	case	O
each	DT	det	O
group	NN	nmod	O
at	IN	case	O
neutrophil	NN	nmod	O
commitment	NN	dep	O
and	CC	cc	O
maturation	NN	conj	O
.	.	punct	O

Severe	JJ	amod	O
5-fluorouracil	NN	compound	O
toxicity	NN	ROOT	O
secondary	JJ	amod	O
to	TO	case	O
dihydropyrimidine	NN	compound	B-protein
dehydrogenase	NN	compound	I-protein
deficiency	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
corticosteroid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
as	IN	case	O
a	DT	det	O
possible	JJ	amod	O
marker	NN	nmod	O
of	IN	case	O
brain	NN	compound	O
involution	NN	nmod	O
.	.	punct	O

An	DT	det	O
interferon-gamma	NN	compound	B-DNA
activation	NN	compound	I-DNA
sequence	NN	nsubj	I-DNA
mediates	VBZ	ROOT	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
IgG	NN	compound	B-DNA
Fc	NN	compound	I-DNA
receptor	NN	compound	I-DNA
type	NN	compound	I-DNA
IC	NN	compound	I-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
interferon-gamma	NN	nmod	B-protein
.	.	punct	O

Serum-equilibrated	JJ	amod	B-cell_type
PtdIns	NN	nsubj	I-cell_type
also	RB	advmod	I-cell_type
binds	VBZ	ROOT	I-cell_type
to	TO	case	I-cell_type
mCD14-expressing	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
raising	VBG	advcl	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
endogenous	JJ	amod	O
PtdIns	NN	nsubj	O
may	MD	aux	O
modulate	VB	ccomp	O
cellular	JJ	amod	O
responses	NNS	dobj	O
to	TO	case	O
LPS	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
mCD14	NN	compound	B-protein
ligands	NNS	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
to	TO	mark	O
activate	VB	acl	O
NF-kappaB	NN	dobj	B-protein
is	VBZ	cop	O
crucial	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
intense	JJ	amod	O
self-perpetuated	JJ	amod	O
viral	JJ	amod	O
transcription	NN	nmod	O
observed	VBN	acl	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
monocytic	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
extent	NN	nsubjpass	O
to	TO	case	O
which	WDT	nmod	O
peptides	NNS	nsubjpass	O
containing	VBG	acl	O
chemically	RB	advmod	O
and	CC	cc	O
post-translationally	RB	advmod	O
modified	VBN	amod	O
amino	NN	compound	B-protein
acid	NN	compound	I-protein
side	NN	compound	I-protein
chains	NNS	dobj	I-protein
are	VBP	auxpass	O
recognized	VBN	acl:relcl	O
by	IN	case	O
primed	VBN	amod	B-cell_line
CTL	NN	nmod	I-cell_line
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O

ZEBRA	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
bZIP	NN	compound	B-protein
transcriptional	JJ	amod	I-protein
activator	NN	ROOT	I-protein
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
as	IN	case	O
a	DT	det	O
dimer	NN	nmod	O
to	TO	case	O
7-bp	JJ	amod	B-DNA
response	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
within	IN	case	O
EBV	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
and	CC	cc	O
is	VBZ	auxpass	O
directly	RB	advmod	O
involved	VBN	conj	O
in	IN	case	O
the	DT	det	O
stimulation	NN	nmod	O
of	IN	case	O
virus	NN	compound	O
replication	NN	nmod	O
at	IN	case	O
the	DT	det	O
EBV	NN	compound	B-DNA
lytic	JJ	amod	I-DNA
origin	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
GM-CSF	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
M-TAT/EPO	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
culture	NN	nmod	I-cell_line
decreased	VBD	ROOT	O
the	DT	det	O
amount	NN	dobj	O
of	IN	case	O
hemoglobin	NN	nmod	O
,	,	punct	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	advcl	O
of	IN	case	O
EPO	NN	nmod	B-protein
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
EPO	NN	compound	B-protein
signal	NN	nsubjpass	O
for	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
is	VBZ	auxpass	O
suppressed	VBN	ccomp	O
by	IN	case	O
GM-CSF	NN	nmod	B-protein
.	.	punct	O

Whereas	IN	mark	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
young	JJ	amod	O
subjects	NNS	nmod	O
stimulated	VBN	acl	O
with	IN	case	O
cross-linked	JJ	amod	B-protein
anti-CD3epsilon	NN	compound	I-protein
mAb	NN	nmod	I-protein
OKT3	NN	dep	B-protein
plus	CC	cc	O
PMA	NN	conj	O
or	CC	cc	O
with	IN	case	O
the	DT	det	O
lectin	NN	compound	B-protein
PHA	NN	conj	B-protein
plus	CC	cc	O
PMA	NN	conj	O
demonstrated	VBD	advcl	O
considerable	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
c-Fos	NN	compound	B-protein
protein	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
c-Fos	NN	nmod	B-protein
but	CC	cc	O
not	RB	cc	O
c-Jun	NN	conj	B-protein
was	VBD	auxpass	O
markedly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
stimulated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
certain	JJ	amod	O
elderly	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

Is	VBZ	ROOT	O
GATA-1	NN	nsubj	B-protein
necessary	JJ	amod	O
for	IN	case	O
globin	NN	compound	O
gene	NN	compound	O
switching	NN	nmod	O
?	.	punct	O
GATA-1	NN	nsubjpass	B-protein
may	MD	aux	O
be	VB	auxpass	O
modified	VBN	ROOT	O
differently	RB	advmod	O
during	IN	case	O
development	NN	nmod	O
so	IN	mark	O
that	IN	mark	O
the	DT	det	O
locus	NN	compound	O
control	NN	compound	O
region	NN	nsubj	O
can	MD	aux	O
interact	VB	advcl	O
with	IN	case	O
different	JJ	amod	O
globin	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
combined	VBN	advcl	O
with	IN	case	O
unstimulated	JJ	amod	O
B	NN	nmod	O
or	CC	cc	O
T	NN	conj	O
cell	NN	compound	O
extracts	NNS	dep	O
,	,	punct	O
full-length	JJ	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
truncated	VBN	conj	O
,	,	punct	O
Jun/Fos	NN	compound	O
heterodimers	NNS	nsubj	O
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
form	VB	xcomp	O
an	DT	det	O
NFAT	NN	compound	B-protein
complex	NN	dobj	I-protein
,	,	punct	O
indicating	VBG	xcomp	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
a	DT	det	O
constitutively	RB	advmod	B-protein
expressed	VBN	amod	I-protein
nuclear	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
in	IN	case	O
B	NN	compound	B-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
necessary	JJ	amod	O
for	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NFAT	NN	compound	B-protein
complex	NN	nmod	I-protein
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
described	VBN	ROOT	O
an	DT	det	O
inherited	VBN	amod	O
over-expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
macrophage	NN	compound	B-protein
scavenger	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
SR	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
blood	NN	compound	B-cell_type
monocytes	NNS	nmod	I-cell_type
from	IN	case	O
members	NNS	nmod	O
of	IN	case	O
a	DT	det	O
kindred	NN	nmod	O
,	,	punct	O
only	RB	advmod	O
two	CD	nsubj	O
of	IN	case	O
whom	WP	nmod	O
displayed	VBD	advcl	O
extensive	JJ	amod	O
xanthomatosis	NN	dobj	O
.	.	punct	O

Clonality	NN	compound	O
analysis	NN	ROOT	O
of	IN	case	O
granulocytes	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
lymphocytes	NNS	conj	I-cell_type
in	IN	case	O
healthy	JJ	amod	O
females	NNS	nmod	O
by	IN	case	O
the	DT	det	O
PCR-based	JJ	amod	O
HUMARA	NN	compound	B-DNA
method	NN	nmod	O
.	.	punct	O

Restoration	NN	nsubj	O
of	IN	case	O
terminal	JJ	amod	O
differentiation	NN	nmod	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	B-cell_line
erythroleukemia	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
MEL	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	nmod	I-cell_line
requires	VBZ	ROOT	O
a	DT	det	O
decline	NN	dobj	O
in	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
PU.1	NN	nmod	B-protein
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
PU.1	NN	nsubj	B-protein
can	MD	aux	O
block	VB	ccomp	O
erythroid	JJ	amod	O
differentiation	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
hemin	NN	nmod	O
or	CC	cc	O
TPA	NN	compound	O
induction	NN	conj	O
on	IN	case	O
the	DT	dep	O
binding	NN	nmod	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
at	IN	case	O
a	DT	det	O
regulatory	JJ	amod	B-DNA
element	NN	nmod	I-DNA
found	VBN	acl	O
within	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
sequences	NNS	nmod	I-DNA
of	IN	case	O
many	JJ	amod	O
erythroid-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Tepoxalin	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
dual	JJ	amod	O
enzyme	NN	compound	O
inhibitor	NN	nsubjpass	O
of	IN	case	O
cyclooxygenase	NN	nmod	B-protein
and	CC	cc	O
5-lipoxygenase	NN	conj	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
T-cell	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	nsubjpass	I-protein
was	VBD	auxpass	O
not	RB	neg	O
activated	VBN	ROOT	O
by	IN	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
induced	VBD	acl:relcl	O
morphological	JJ	amod	O
differentiation	NN	dobj	O
of	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
neuroblastoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
used	VBN	acl	O
in	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
.	.	punct	O

MRP14	NN	nsubj	B-DNA
(	-LRB-	punct	O
Macrophage	NN	compound	B-protein
migration	NN	compound	I-protein
inhibitory	JJ	amod	I-protein
related	JJ	amod	I-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
MRP8	NN	conj	B-protein
,	,	punct	O
two	CD	nummod	O
S-100	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
contained	VBN	acl	O
in	IN	case	O
high	JJ	amod	O
concentrations	NNS	nmod	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
are	VBP	cop	O
obviously	RB	advmod	O
essential	JJ	ROOT	O
for	IN	case	O
adhesion	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
granulocytes	NNS	conj	B-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
,	,	punct	O
the	DT	det	O
GR	NN	nsubj	B-protein
in	IN	case	O
MNL	NN	nmod	B-cell_type
did	VBD	aux	O
not	RB	neg	O
demonstrate	VB	ROOT	O
circadian	JJ	amod	O
variation	NN	dobj	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
concentrations	NNS	nmod	O
of	IN	case	O
plasma	NN	compound	O
cortisol	NN	nmod	O
.	.	punct	O

Thapsigargin	NN	nsubj	O
(	-LRB-	punct	O
TG	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
Ca	NN	compound	B-protein
(	-LRB-	punct	I-protein
2+	NN	nummod	I-protein
)	-RRB-	punct	I-protein
-ATPase	NN	nmod	I-protein
,	,	punct	O
depletes	VBZ	ROOT	O
intracellular	JJ	amod	O
Ca2+	NN	compound	O
stores	NNS	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
a	DT	det	O
sustained	JJ	amod	O
Ca2+	NN	compound	O
influx	NN	dobj	O
without	IN	mark	O
altering	VBG	advcl	O
phosphatidyl	NN	compound	O
inositol	NN	compound	O
levels	NNS	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
other	JJ	amod	O
X1	NN	nmod:npmod	O
box-specific	JJ	amod	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
all	PDT	det:predet	O
these	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
bcl-6	JJ	compound	B-protein
protein	NN	nmod	I-protein
on	IN	case	O
normal	JJ	amod	O
epidermis	JJ	nmod	O
,	,	punct	O
benign	JJ	conj	O
,	,	punct	O
and	CC	cc	O
malignant	JJ	amod	O
tumors	NNS	conj	O
originating	VBG	acl	O
from	IN	case	O
epidermal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
squamous	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
carcinoma	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
SCC	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
are	VBP	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

Group	NN	nsubj	O
1	CD	nummod	O
contains	VBZ	ROOT	O
G0S24	NN	dobj	B-DNA
and	CC	cc	O
the	DT	det	O
rat	NN	compound	B-DNA
and	CC	cc	I-DNA
mouse	NN	conj	I-DNA
TIS11	NN	compound	I-DNA
genes	NNS	conj	I-DNA
(	-LRB-	punct	O
also	RB	advmod	O
known	VBN	dep	O
as	IN	case	O
TTP	NN	nmod	B-DNA
,	,	punct	O
Nup475	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
Zfp36	NN	conj	B-DNA
)	-RRB-	punct	O
.	.	punct	O

Bandshift	NN	compound	O
experiments	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
an	DT	det	O
early	JJ	amod	O
stage	NN	nmod	O
of	IN	case	O
both	CC	det	O
differentiation	NN	compound	O
pathways	NNS	nmod	O
(	-LRB-	punct	O
14	CD	nummod	O
days	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
94	CD	nummod	O
kDa	NN	compound	O
STAT5B	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
activated	VBN	ccomp	O
by	IN	case	O
both	CC	cc:preconj	O
IL-5	NN	nmod	B-protein
(	-LRB-	punct	O
eosinophil	NN	compound	B-cell_type
lineage	NN	appos	I-cell_type
)	-RRB-	punct	O
and	CC	cc	O
GM-CSF	NN	conj	B-protein
(	-LRB-	punct	O
neutrophil	NN	compound	B-cell_type
lineage	NN	appos	I-cell_type
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IL-2	NN	compound	B-DNA
NF-chi	NN	compound	I-DNA
B	NN	compound	I-DNA
site	NN	nsubj	I-DNA
is	VBZ	cop	O
indispensable	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
EBV-transformed	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
whereas	IN	mark	O
other	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
appear	VBP	advcl	O
to	TO	mark	O
be	VB	cop	O
less	RBR	advmod	O
important	JJ	xcomp	O
for	IN	case	O
IL-2	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

A	DT	det	O
truncated	VBN	amod	O
version	NN	nsubj	O
of	IN	case	O
430-444	CD	nmod	O
,	,	punct	O
i.e.	FW	conj	O
,	,	punct	O
VP16	NN	appos	O
433-442	CD	nummod	O
,	,	punct	O
binds	VBZ	ROOT	O
with	IN	case	O
an	DT	det	O
affinity	NN	nmod	O
10-fold	RB	advmod	O
lower	JJR	amod	O
compared	VBN	case	O
to	TO	case	O
430-444	CD	nmod	O
at	IN	case	O
acidic	JJ	amod	O
pH	NN	nmod	O
,	,	punct	O
and	CC	cc	O
binding	NN	nsubj	O
at	IN	case	O
neutral	JJ	amod	O
pH	NN	nmod	O
was	VBD	cop	O
barely	RB	advmod	O
detectable	JJ	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
may	MD	aux	O
provide	VB	ROOT	O
new	JJ	amod	O
insights	NNS	dobj	O
into	IN	case	O
the	DT	det	O
slow	JJ	amod	O
rate	NN	nmod	O
of	IN	case	O
HCMV	NN	compound	O
DNA	NN	compound	O
replication	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
possible	JJ	amod	O
involvement	NN	conj	O
of	IN	case	O
HCMV	NN	nmod	O
in	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
find	VBP	ROOT	O
also	RB	advmod	O
that	IN	mark	O
the	DT	det	O
interaction	NN	nsubjpass	O
between	IN	case	O
SLP-76	NN	nmod	B-protein
and	CC	cc	O
Vav	NN	conj	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	ccomp	O
for	IN	case	O
their	PRP$	nmod:poss	O
cooperation	NN	nmod	O
in	IN	mark	O
augmenting	VBG	acl	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
,	,	punct	O
as	IN	mark	O
the	DT	det	O
two	CD	nummod	O
molecules	NNS	nsubj	O
appear	VBP	advcl	O
to	TO	mark	O
function	VB	xcomp	O
in	IN	case	O
different	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
upstream	RB	advmod	O
of	IN	case	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Subcloning	NN	nsubj	O
of	IN	case	O
the	DT	det	O
variant	JJ	amod	B-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
segments	NNS	nmod	I-DNA
into	IN	case	O
LTR-driven	JJ	amod	B-DNA
CAT	NN	compound	I-DNA
expression	NN	compound	I-DNA
vectors	NNS	nmod	I-DNA
confirmed	VBD	ROOT	O
a	DT	det	O
correlation	NN	dobj	O
between	IN	case	O
promoter	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
replicative/cytopathic	JJ	amod	O
capacity	NN	conj	O
.	.	punct	O

The	DT	det	O
distribution	NN	nsubj	O
of	IN	case	O
this	DT	det	O
integral	JJ	amod	B-protein
membrane	NN	compound	I-protein
protein	NN	nmod	I-protein
is	VBZ	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
certain	JJ	amod	O
tissues	NNS	nmod	O
where	WRB	advmod	O
its	PRP$	nmod:poss	O
level	NN	nsubjpass	O
of	IN	case	O
expression	NN	nmod	O
is	VBZ	auxpass	O
modulated	VBN	acl:relcl	O
by	IN	case	O
multiple	JJ	amod	O
exogenous	JJ	amod	O
stimuli	NNS	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
IL-10	NN	nsubj	B-protein
enhanced	VBD	ROOT	O
the	DT	det	O
degradation	NN	dobj	O
of	IN	case	O
IL-6	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
a	DT	det	O
mRNA	NN	compound	O
stability	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
activation	NN	nsubj	O
in	IN	case	O
THP-1	NN	compound	B-protein
cells	NNS	nmod	I-protein
occurred	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
vanadate	NN	nmod	O
and	CC	cc	O
was	VBD	cop	O
unaffected	JJ	conj	O
by	IN	case	O
catalase	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
purified	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
peripheral-blood	JJ	amod	I-cell_type
granulocytes	NNS	nsubj	I-cell_type
express	VBP	ccomp	O
constitutively	RB	advmod	O
significant	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
proto-oncogenes	NNS	amod	B-DNA
c-jun	NN	compound	B-RNA
,	,	punct	I-RNA
jun	NN	compound	I-RNA
B	NN	conj	I-RNA
and	CC	cc	I-RNA
jun	NN	compound	I-RNA
D	NN	conj	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
Spi-C	NN	nsubj	B-protein
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
novel	JJ	amod	O
subgroup	NN	dobj	O
within	IN	case	O
the	DT	det	O
Ets	NN	compound	B-protein
protein	NN	compound	I-protein
family	NN	nmod	I-protein
,	,	punct	O
as	IN	mark	O
it	PRP	nsubj	O
differed	VBD	advcl	O
significantly	RB	advmod	O
from	IN	case	O
Spi-B	NN	nmod	B-protein
and	CC	cc	O
PU.1	NN	conj	B-protein
within	IN	case	O
helix	NN	nmod	B-protein
1	CD	nummod	I-protein
of	IN	case	O
the	DT	det	O
Ets	NN	compound	B-protein
domain	NN	nmod	I-protein
.	.	punct	O

Deletion	NN	nsubj	O
and	CC	cc	O
base	NN	compound	O
substitution	NN	compound	O
mutations	NNS	conj	O
along	IN	case	O
with	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
studies	NNS	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
enhancer	NN	nsubj	O
contained	VBD	ccomp	O
a	DT	det	O
minimum	NN	dobj	O
of	IN	case	O
three	CD	nummod	O
functional	JJ	amod	O
protein	NN	compound	B-DNA
binding	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
,	,	punct	O
two	CD	nsubj	O
of	IN	case	O
which	WDT	nmod	O
appeared	VBD	parataxis	O
to	TO	mark	O
be	VB	cop	O
important	JJ	xcomp	O
for	IN	case	O
gene	NN	compound	O
induction	NN	nmod	O
.	.	punct	O

Protein	NN	compound	O
kinase	NN	compound	O
C	NN	compound	O
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
depletion	NN	nsubj	O
generated	VBN	acl	O
by	IN	case	O
a	DT	det	O
long-term	JJ	amod	O
phorbol	NN	compound	O
12	CD	nummod	O
myristate	NN	compound	O
13-acetate	NN	compound	O
treatment	NN	nmod	O
had	VBD	ROOT	O
weak	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
proliferation	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	compound	O
genistein	NN	dobj	O
(	-LRB-	punct	O
10	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
a	DT	det	O
complete	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
IL-10	NN	nmod	B-protein
induced	JJ	amod	O
c-fos	NN	compound	B-DNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

ICSAT	NN	nsubj	B-protein
is	VBZ	cop	O
structurally	RB	advmod	O
most	RBS	advmod	O
closely	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
previously	RB	advmod	O
cloned	VBN	amod	O
ICSBP	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
IFN	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IRF	NN	compound	I-protein
)	-RRB-	punct	I-protein
family	NN	nmod	I-protein
of	IN	case	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
interferon	NN	compound	B-DNA
consensus	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
(	-LRB-	punct	O
ICSs	NNS	appos	B-DNA
)	-RRB-	punct	O
found	VBN	acl	O
in	IN	case	O
many	JJ	amod	O
promoters	NNS	nmod	O
of	IN	case	O
the	DT	det	O
IFN-regulated	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
secreted	VBN	amod	O
IL-1beta	NN	nmod	B-protein
,	,	punct	O
TNF-alpha	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-6	NN	conj	B-protein
during	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
stimulation	NN	nmod	O
were	VBD	cop	O
comparable	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
induced	VBN	acl	O
by	IN	case	O
Escherichia	FW	compound	O
coli	FW	compound	O
lipopolysaccharide	NN	nmod	O
at	IN	case	O
1	CD	nummod	O
microg/ml	NN	nmod	O
.	.	punct	O

The	DT	det	O
appearance	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
fusion	NN	compound	B-protein
transcript	NN	nmod	I-protein
(	-LRB-	punct	O
RAZ	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
comprised	VBD	acl:relcl	O
regions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
BZLF-1	NN	compound	B-DNA
locus	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
adjacent	JJ	amod	O
BRLF-1	NN	compound	B-DNA
locus	NN	conj	I-DNA
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
RT-PCR	NN	nmod	O
.	.	punct	O

Inefficient	JJ	amod	O
DNA	NN	compound	O
replication	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
another	DT	det	O
monocyte	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
THP-1	NN	appos	B-cell_line

HIV-1	NN	compound	O
harboring	NN	compound	O
mutations	NNS	nsubjpass	O
within	IN	case	O
two	CD	nummod	O
C/EBP	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
were	VBD	auxpass	O
crippled	VBN	ROOT	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
replicate	VB	acl	O
in	IN	case	O
U937	NN	compound	B-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
these	DT	det	O
sites	NNS	nsubjpass	O
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
replication	NN	nmod	O
.	.	punct	O

Retinoids	NNS	nsubjpass	O
,	,	punct	O
including	VBG	case	O
all-trans-retinoic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
isomers	NNS	conj	O
,	,	punct	O
and	CC	cc	O
fifty	CD	nummod	O
synthetic	JJ	amod	O
retinoids	NNS	conj	O
(	-LRB-	punct	O
retinobenzoic	JJ	amod	O
acids	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
were	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
differentiation-inducing	JJ	amod	O
activity	NN	nmod	O
on	IN	case	O
human	JJ	amod	B-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
HL-60	NN	dep	B-cell_line
and	CC	cc	O
NB4	NN	conj	B-cell_line
.	.	punct	O

Very	RB	advmod	O
little	JJ	amod	O
information	NN	nsubj	O
exists	VBZ	ROOT	O
linking	VBG	xcomp	O
these	DT	det	O
two	CD	nummod	O
important	JJ	amod	O
classes	NNS	dobj	O
of	IN	case	O
signaling	VBG	amod	B-protein
molecules	NNS	nmod	I-protein
.	.	punct	O

RXR-alpha	NN	compound	B-RNA
mRNA	NN	nsubj	I-RNA
was	VBD	cop	O
present	JJ	ROOT	O
in	IN	case	O
untreated	JJ	amod	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
levels	NNS	nsubj	O
increased	VBD	conj	O
after	IN	case	O
induction	NN	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
with	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
recognition	NN	dobj	O
by	IN	case	O
ovarian	JJ	amod	B-cell_type
tumor	NN	compound	I-cell_type
associated	JJ	amod	I-cell_type
lymphocyte	NN	nmod	I-cell_type
(	-LRB-	punct	O
OVTAL	NN	appos	B-cell_type
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
breast	NN	compound	B-cell_type
tumor	NN	compound	I-cell_type
associated	JJ	amod	I-cell_type
lymphocytes	NNS	conj	I-cell_type
(	-LRB-	punct	O
BRTAL	NNS	appos	B-cell_type
)	-RRB-	punct	O
,	,	punct	O
of	IN	case	O
peptides	NNS	nmod	O
corresponding	VBG	acl	O
to	TO	case	O
the	DT	det	O
sequence	NN	compound	O
125-135	CD	nmod	B-protein
of	IN	case	I-protein
the	DT	det	I-protein
Aminoenhancer	NNP	compound	I-protein
of	IN	amod	I-protein
split	JJ	amod	I-protein
(	-LRB-	punct	I-protein
AES	NN	compound	I-protein
)	-RRB-	punct	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

P-LPS-induced	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
monocyte	NN	compound	B-DNA
chemoattractant	NN	compound	I-DNA
protein	NN	compound	I-DNA
1	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
MCP-1	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
markedly	RB	advmod	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
anti-human	JJ	amod	O
CD14	NN	compound	B-protein
antibody	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
completely	RB	advmod	O
inhibited	VBN	conj	O
by	IN	case	O
herbimycin	NN	compound	O
A	NN	nmod	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
tyrosine	NN	compound	B-protein
kinase	NN	nmod	I-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
shed	VBP	ROOT	O
light	NN	dobj	O
on	IN	case	O
the	DT	dep	O
biochemical	JJ	nmod	O
and	CC	cc	O
molecular	JJ	conj	O
mechanisms	NNS	dep	O
regulating	VBG	acl	O
human	JJ	amod	O
granulocyte	NN	compound	O
apoptosis	NN	dobj	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
indicate	VBP	conj	O
that	IN	mark	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nsubj	B-protein
plays	VBZ	ccomp	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
physiological	JJ	amod	O
cell	NN	compound	O
death	NN	compound	O
pathway	NN	dobj	O
in	IN	case	O
granulocytes	NNS	nmod	B-cell_type
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
nucleotide	NN	compound	B-DNA
sequences	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
CD11a	NN	nmod	B-DNA
,	,	punct	I-DNA
CD11b	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
CD11c	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoters	NNS	conj	I-DNA
to	TO	mark	O
identify	VB	xcomp	O
common	JJ	amod	O
elements	NNS	dobj	O
that	WDT	nsubj	O
might	MD	aux	O
contribute	VB	acl:relcl	O
to	TO	case	O
inducible	JJ	amod	O
expression	NN	nmod	O
.	.	punct	O

Evidence	NN	nsubjpass	O
is	VBZ	auxpass	O
provided	VBN	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
nuclear	JJ	amod	O
component	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-protein
NF-AT	NN	nmod	I-protein
contains	VBZ	ccomp	O
the	DT	det	O
phorbol	NN	compound	B-protein
ester-inducible	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
AP1	NN	dobj	I-protein
(	-LRB-	punct	O
Jun/Fos	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
simian	JJ	amod	O
EBV	NN	nsubj	O
share	VBP	ROOT	O
considerable	JJ	amod	O
genetic	JJ	amod	O
,	,	punct	O
biologic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
epidemiologic	JJ	conj	O
features	NNS	dobj	O
with	IN	case	O
human	JJ	amod	O
EBV	NN	nmod	O
,	,	punct	O
including	VBG	case	O
virus-induced	JJ	amod	O
tumorigenesis	NN	nmod	O
.	.	punct	O

Stimulation	NN	nsubjpass	O
of	IN	case	O
interleukin-1	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
caused	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
stimulation	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
activities	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
of	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
by	IN	case	O
these	DT	det	O
protein	NN	compound	B-protein
phosphatase	NN	compound	I-protein
inhibitors	NNS	nmod	O
.	.	punct	O

ATRA	NN	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
C/EBP	NN	compound	B-protein
epsilon	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
NB4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
Western	NN	compound	O
blotting	NN	nmod	O
.	.	punct	O

Given	VBN	case	O
the	DT	det	O
reported	VBN	amod	O
long-range	JJ	amod	O
cis-inactivating	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
the	DT	det	O
XIST	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
early	JJ	amod	O
embryonic	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
the	DT	det	O
lack	NN	conj	O
of	IN	case	O
requirement	NN	nmod	O
of	IN	case	O
X-chromosome-specific	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
for	IN	mark	O
propagating	VBG	acl	O
the	DT	det	O
inactive	JJ	amod	O
state	NN	dobj	O
,	,	punct	O
there	EX	expl	O
exists	VBZ	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	case	O
cis	JJ	compound	O
inactivation	NN	nmod	O
of	IN	case	O
autosomal	JJ	amod	O
material	NN	nmod	O
after	IN	case	O
de	FW	amod	O
novo	FW	dep	O
translocation	NN	nmod	O
to	TO	case	O
an	DT	det	O
inactive	JJ	amod	B-DNA
X	NN	compound	I-DNA
chromosome	NN	nmod	I-DNA
(	-LRB-	punct	O
Xi	NN	appos	B-DNA
)	-RRB-	punct	O
in	IN	case	O
differentiated	VBN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
IL-12	NN	compound	B-protein
induction	NN	nsubj	O
of	IN	case	O
IFN-gamma	NN	compound	B-RNA
cytoplasmic	JJ	amod	I-RNA
mRNA	NN	nmod	I-RNA
appears	VBZ	ROOT	O
to	TO	mark	O
only	RB	advmod	O
partially	RB	advmod	O
depend	VB	xcomp	O
on	IN	case	O
activation	NN	nmod	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
.	.	punct	O

These	DT	det	O
blast	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
express	VBP	ROOT	O
lineage-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	dobj	I-protein
such	JJ	case	O
as	IN	mwe	O
GATA-1	NN	nmod	B-protein
common	JJ	amod	O
to	TO	case	O
these	DT	det	O
lineages	NNS	nmod	O
and	CC	cc	O
frequently	RB	advmod	O
express	VBP	conj	O
erythroid-specific	JJ	amod	B-RNA
mRNAs	NNS	dobj	I-RNA
such	JJ	case	O
as	IN	mwe	O
gamma-globin	NN	nmod	B-protein
and	CC	cc	O
erythroid	JJ	amod	B-protein
delta-aminolevulinate	JJ	amod	I-protein
synthase	NN	conj	I-protein
(	-LRB-	punct	O
ALAS-E	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
most	JJS	nsubj	O
of	IN	case	O
the	DT	det	O
blasts	NNS	nmod	O
in	IN	case	O
M7	NN	compound	O
and	CC	cc	O
TMD	NN	conj	O
cases	NNS	nmod	O
have	VBP	ccomp	O
erythroid	JJ	amod	O
and	CC	cc	O
megakaryocytic	JJ	conj	O
phenotypes	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
non-abortive	JJ	amod	O
maternal	JJ	amod	O
infections	NNS	nsubj	O
would	MD	aux	O
compromise	VB	ccomp	O
fetal	JJ	amod	O
brain	NN	compound	O
development	NN	dobj	O
and	CC	cc	O
alter	VB	conj	O
hypothalamic-pituitary-adrenocortical	JJ	amod	O
(	-LRB-	punct	O
HPA	JJ	appos	O
)	-RRB-	punct	O
axis	NN	dobj	O
functioning	VBG	acl	O
when	WRB	advmod	O
adult	JJ	advcl	O
.	.	punct	O

The	DT	det	O
extracellular	JJ	amod	O
domain	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-protein
G-CSF	NN	compound	I-protein
receptor	NN	nmod	I-protein
was	VBD	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
SB	NN	nmod	O
247464	CD	nummod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
compound	NN	nsubj	O
acts	VBZ	ccomp	O
by	IN	mark	O
oligomerizing	VBG	advcl	B-protein
receptor	NN	compound	I-protein
chains	NNS	dobj	I-protein
.	.	punct	O

The	DT	det	O
finding	NN	nsubj	O
that	IN	mark	O
patients	NNS	nsubj	O
with	IN	case	O
PTSD	NN	nmod	O
had	VBD	ccomp	O
a	DT	det	O
substantially	RB	advmod	O
greater	JJR	amod	O
number	NN	dobj	O
of	IN	case	O
lymphocyte	NN	compound	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
than	IN	case	O
normal	JJ	amod	O
comparison	NN	compound	O
subjects	NNS	nmod	O
is	VBZ	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
authors	NNS	nmod:poss	O
'	POS	case	O
previous	JJ	amod	O
observations	NNS	nmod	O
of	IN	case	O
low	JJ	amod	O
24-hour	JJ	amod	O
urinary	JJ	amod	O
cortisol	NN	compound	O
excretion	NN	nmod	O
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
PTSD	NN	nmod	O
.	.	punct	O

Periductal	JJ	amod	O
angiogenesis	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
significantly	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
type	NN	nmod	O
of	IN	case	O
IDC	NN	nmod	O
but	CC	cc	O
was	VBD	cop	O
more	RBR	advmod	O
pronounced	JJ	conj	O
with	IN	case	O
comedo	NN	compound	O
carcinomas	NNS	nmod	O
.	.	punct	O

This	DT	det	O
selective	JJ	amod	O
inhibition	NN	nsubj	O
by	IN	case	O
IL-10	NN	nmod	B-protein
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	nmod	O
occurs	VBZ	ROOT	O
rapidly	RB	advmod	O
and	CC	advmod	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	conj	O
and	CC	cc	O
correlates	VBZ	conj	O
well	RB	advmod	O
with	IN	case	O
IL-10	NN	nmod:poss	B-protein
's	POS	case	O
cytokine	NN	compound	B-protein
synthesis	NN	compound	O
inhibitory	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
kinetics	NNS	nmod	O
and	CC	cc	O
dose	NN	compound	O
responsiveness	NN	conj	O
.	.	punct	O

StatG	NN	ROOT	B-protein
in	IN	case	O
normal	JJ	amod	B-cell_type
immature	JJ	amod	I-cell_type
human	JJ	amod	I-cell_type
myeloid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
i.e	NN	appos	O
.	.	punct	O
adult	JJ	amod	B-cell_type
CD34+	JJ	amod	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
,	,	punct	O
was	VBD	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
Stat3beta	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
T	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
immune	JJ	amod	O
response	NN	nsubj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
an	DT	det	O
endotoxic	JJ	amod	O
challenge	NN	conj	O
during	IN	case	O
pregnancy	NN	nmod	O
can	MD	aux	O
induce	VB	ccomp	O
anomalies	NNS	dobj	O
in	IN	case	O
HPA	NN	amod	O
axis	NN	compound	O
function	NN	nmod	O
in	IN	case	O
adulthood	NN	nmod	O
.	.	punct	O

Neither	CC	cc:preconj	O
FMLP	NN	nsubj	B-protein
nor	CC	cc	O
PAF	NN	conj	B-protein
activated	VBD	ROOT	O
c-jun	NN	compound	B-protein
NH2-terminal	JJ	amod	I-protein
MAPk	NN	dobj	I-protein
(	-LRB-	punct	O
JNKs	NNS	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Administration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cytokine	NN	nmod	B-protein
interleukin-2	NN	dep	I-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
can	MD	aux	O
result	VB	ROOT	O
in	IN	case	O
therapeutic	JJ	amod	O
benefits	NNS	nmod	O
for	IN	case	O
individuals	NNS	nmod	O
with	IN	case	O
renal	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
and	CC	cc	O
melanoma	NN	conj	O
.	.	punct	O

Composite	JJ	amod	B-DNA
elements	NNS	nsubj	I-DNA
are	VBP	cop	O
regulatory	JJ	amod	B-DNA
modules	NNS	ROOT	I-DNA
of	IN	case	O
promoters	NNS	nmod	B-DNA
or	CC	cc	O
enhancers	NNS	conj	B-DNA
that	WDT	nsubj	O
consist	VBP	acl:relcl	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
of	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
but	CC	cc	O
synergizing	VBG	conj	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
values	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
clinical	JJ	amod	O
symptoms	NNS	nmod	O
of	IN	case	O
PIH	NN	nmod	O
.	.	punct	O

Overall	RB	advmod	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
transactivation	NN	nmod	O
by	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
B-cell-specific	JJ	amod	I-protein
CIITA	NN	nmod	I-protein
is	VBZ	cop	O
very	RB	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
mediated	VBN	acl	O
by	IN	case	O
the	DT	det	O
herpes	NN	compound	B-protein
virus	NN	compound	I-protein
transactivator	NN	compound	I-protein
VP16	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
ways	NNS	nmod	O
that	WDT	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
tested	VBN	acl:relcl	O
.	.	punct	O

In	IN	case	O
4	CD	nummod	O
cases	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
3	CD	nummod	O
AML	NN	nmod	O
with	IN	case	O
immature	JJ	amod	O
morphology	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
AML-M0	NN	dep	O
and	CC	cc	O
2	CD	nummod	O
AML-M1	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
1	CD	nummod	O
ALL	NN	conj	O
,	,	punct	O
the	DT	det	O
signals	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
CALM	NN	compound	B-DNA
YACS	NNS	nmod	I-DNA
were	VBD	auxpass	O
separated	VBN	ROOT	O
in	IN	case	O
interphase	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
indicating	VBG	xcomp	O
a	DT	det	O
translocation	NN	compound	O
breakpoint	NN	dobj	O
within	IN	case	O
the	DT	det	O
CALM	NN	compound	B-DNA
region	NN	nmod	I-DNA
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
Ara-C	NN	nmod	O
on	IN	case	O
neutral	JJ	amod	B-protein
sphingomyelinase	NN	nmod	I-protein
and	CC	cc	O
mitogen-	NN	amod	B-protein
and	CC	cc	I-protein
stress-	NN	conj	I-protein
activated	VBN	amod	I-protein
protein	NN	compound	I-protein
kinases	NNS	conj	I-protein
in	IN	case	O
T-lymphocyte	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
IFN-gamma	NN	nsubj	B-protein
enhanced	VBD	ROOT	O
the	DT	det	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Stat1alpha	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
IL-13	NN	nsubj	B-protein
phosphorylated	VBD	ROOT	O
insulin	NN	compound	B-protein
response	NN	compound	I-protein
substrate-1	NN	dobj	I-protein
,	,	punct	O
IL-4R	NN	compound	B-protein
p140	NN	conj	I-protein
,	,	punct	O
JAK1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Tyk2	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
JAK3	NN	compound	B-protein
kinase	NN	conj	I-protein
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
novel	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
AG-490	NN	nsubj	O
potently	RB	advmod	O
inhibits	VBZ	ccomp	O
the	DT	det	O
autokinase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
JAK3	NN	nmod	B-protein
and	CC	cc	O
tyrosine	NN	compound	O
phosphorylation	NN	conj	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	conj	O
of	IN	case	O
signal	NN	compound	B-protein
transducer	NN	nmod	I-protein
and	CC	cc	I-protein
activator	NN	conj	I-protein
of	IN	case	I-protein
transcription	NN	compound	I-protein
5a	NN	nmod	I-protein
and	CC	cc	I-protein
5b	NN	conj	I-protein
(	-LRB-	punct	I-protein
STAT5a/b	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Various	JJ	amod	O
extracellular	JJ	amod	O
signals	NNS	nsubj	O
,	,	punct	O
often	RB	advmod	O
converging	VBG	acl	O
in	IN	case	O
common	JJ	amod	O
intracellular	JJ	amod	O
pathways	NNS	nmod	O
,	,	punct	O
can	MD	aux	O
induce	VB	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
a	DT	det	O
cell-type-specific	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
indicates	VBZ	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
either	CC	cc:preconj	O
episomal	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
or	CC	cc	O
concatameric	JJ	amod	B-DNA
linear	JJ	amod	I-DNA
DNA	NN	conj	I-DNA
.	.	punct	O

Further	JJ	amod	O
evidence	NN	nsubjpass	O
that	IN	mark	O
the	DT	det	O
action	NN	nsubjpass	O
of	IN	case	O
dexamethasone	NN	nmod	O
was	VBD	auxpass	O
mediated	VBN	ccomp	O
through	IN	case	O
ligation	NN	nmod	O
of	IN	case	O
corticosteroid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
[	-LRB-	punct	O
human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	dep	I-protein
(	-LRB-	punct	O
hGRs	NNS	appos	B-protein
)	-RRB-	punct	O
]	-RRB-	punct	O
was	VBD	auxpass	O
provided	VBN	ROOT	O
by	IN	case	O
experiments	NNS	nmod	O
utilizing	VBG	acl	O
the	DT	det	O
steroid	NN	compound	O
antagonist	NN	compound	O
RU-486	NN	dobj	O
.	.	punct	O

Due	IN	case	O
to	TO	mwe	O
its	PRP$	nmod:poss	O
location	NN	nmod	O
within	IN	case	O
this	DT	det	O
cluster	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
biologic	JJ	amod	O
role	NN	conj	O
in	IN	case	O
Ig	NN	compound	O
class	NN	compound	O
switching	NN	nmod	O
and	CC	cc	O
Th2	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
differentiation	NN	conj	O
,	,	punct	O
the	DT	det	O
IL-4	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
has	VBZ	aux	O
emerged	VBN	ROOT	O
as	IN	case	O
one	CD	nummod	O
major	JJ	amod	O
candidate	NN	nmod	O
for	IN	case	O
the	DT	det	O
atopy	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Following	VBG	case	O
culture	NN	nmod	O
with	IN	case	O
ATRA	NN	nmod	O
,	,	punct	O
increased	VBN	amod	O
CD38	NN	compound	B-protein
protein	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
normal	JJ	amod	B-cell_type
CD34+	JJ	amod	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
on	IN	case	O
normal	JJ	amod	B-cell_type
circulating	VBG	amod	I-cell_type
granulocytes	NNS	conj	I-cell_type
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
binding	NN	compound	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
TF	NN	compound	B-DNA
site	NN	nsubj	I-DNA
bound	VBD	ccomp	O
translated	VBN	amod	O
c-Rel	NN	dobj	B-protein
and	CC	cc	I-protein
p65	NN	conj	I-protein
homodimers	NNS	dep	I-protein
but	CC	cc	O
not	RB	cc	O
p50/p65	NN	compound	B-protein
heterodimers	NNS	conj	I-protein
or	CC	cc	O
p50	NN	compound	B-protein
homodimers	NNS	conj	I-protein
.	.	punct	O

Implications	NNS	ROOT	O
for	IN	case	O
replication	NN	nmod	O
of	IN	case	O
HIV-1	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
further	RBR	advmod	O
,	,	punct	O
we	PRP	nsubj	O
then	RB	advmod	O
purified	VBD	ROOT	O
a	DT	det	O
number	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
kinases	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
PKC	NN	nmod	B-protein
,	,	punct	O
PhK	NN	conj	B-protein
,	,	punct	O
ZAP-70	NN	conj	B-protein
,	,	punct	O
ERK	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
MEK	NN	conj	B-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
a	DT	det	O
MKK	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
showed	VBD	conj	O
that	IN	mark	O
Ro	NN	nsubj	O
09-2210	CD	nsubj	O
was	VBD	cop	O
a	DT	det	O
selective	JJ	amod	O
inhibitor	NN	dep	O
of	IN	case	O
MEK1	NN	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	ccomp	O
59	CD	nummod	O
nM	NN	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
hydrocortisone	NN	nsubj	O
induces	VBZ	ccomp	O
IkappaB	NN	dobj	B-protein
and	CC	cc	O
suppresses	VBZ	conj	O
NF-kappaB	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
MNC	NN	nmod	B-cell_type
in	IN	case	O
parallel	NN	nmod	O
.	.	punct	O

Lymphoid	JJ	amod	O
cell	NN	compound	O
differentiation	NN	nsubj	O
relies	VBZ	ROOT	O
on	IN	case	O
precisely	RB	advmod	O
orchestrated	VBN	amod	O
gene	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
repression	NN	compound	O
events	NNS	conj	O
.	.	punct	O

The	DT	det	O
hormone	NN	nsubj	O
delayed	VBD	ROOT	O
terminal	JJ	amod	O
differentiation	NN	dobj	O
into	IN	case	O
erythrocytes	NNS	nmod	B-cell_type
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
assayed	VBN	acl:relcl	O
by	IN	case	O
morphology	NN	nmod	O
,	,	punct	O
hemoglobin	NN	compound	B-protein
accumulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
genes	NNS	nmod	O
characteristic	JJ	amod	O
for	IN	case	O
immature	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
result	NN	nsubj	O
of	IN	case	O
this	DT	det	O
activation	NN	compound	O
process	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
induction	NN	ROOT	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
encoding	VBG	acl	O
cytokines	NNS	dobj	B-protein
such	JJ	case	O
as	IN	mwe	O
interleukin-2	NN	nmod	B-protein
,	,	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
interferon	NN	compound	B-protein
(	-LRB-	punct	I-protein
IFN	NN	compound	I-protein
)	-RRB-	punct	I-protein
-gamma	NN	conj	I-protein
which	WDT	nsubj	O
have	VBP	acl:relcl	O
important	JJ	amod	O
immunoregulatory	JJ	amod	B-protein
effects	NNS	dobj	O
.	.	punct	O

Involvement	NN	ROOT	O
in	IN	case	O
the	DT	det	O
potentiation	NN	nmod	O
of	IN	case	O
platelet	NN	compound	O
aggregation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	compound	I-protein
signaling	NN	compound	O
pathway	NN	nmod	O
may	MD	aux	O
inhibit	VB	ccomp	O
NF-kappaB	NN	compound	B-protein
-mediated	JJ	amod	O
transcription	NN	dobj	O
by	IN	mark	O
phosphorylating	VBG	advcl	O
proteins	NNS	dobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
CREB	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
compete	VBP	acl:relcl	O
for	IN	case	O
limiting	VBG	amod	O
amounts	NNS	nmod	O
of	IN	case	O
the	DT	det	O
coactivator	NN	nmod	O
CBP	NN	dep	B-protein
.	.	punct	O

PNU156804	NN	compound	O
inhibition	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
is	VBZ	cop	O
due	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
degradation	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	nmod	I-protein
and	CC	cc	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-beta	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
EGR1	NN	compound	B-DNA
binding	NN	compound	I-DNA
motif	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
necessary	JJ	xcomp	O
for	IN	case	O
stimulus-induced	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
CD44	NN	compound	B-protein
promoter-chloramphenicol	JJ	amod	B-DNA
acetyltransferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
in	IN	case	O
nontransformed	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
was	VBD	auxpass	O
required	VBN	conj	O
for	IN	case	O
transactivation	NN	nmod	O
by	IN	case	O
an	DT	det	O
EGR1	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
B-cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

To	TO	mark	O
address	VB	advcl	O
potential	JJ	amod	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
estrogens	NNS	nsubj	O
suppress	VBP	acl:relcl	O
erythropoiesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
on	IN	case	O
GATA-1	NN	nmod	B-protein
,	,	punct	O
an	DT	det	O
erythroid	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	appos	I-protein
that	WDT	nsubj	O
participates	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
majority	NN	nmod	O
of	IN	case	O
erythroid	JJ	amod	B-DNA
cell-specific	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
is	VBZ	cop	O
necessary	JJ	conj	O
for	IN	case	O
full	JJ	amod	O
maturation	NN	nmod	O
of	IN	case	O
erythrocytes	NNS	nmod	B-cell_type
.	.	punct	O

Although	IN	mark	O
both	DT	det	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
well	RB	advmod	O
expressed	VBN	advcl	O
,	,	punct	O
the	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
recognized	VBN	ROOT	O
by	IN	case	O
E1A-	NN	amod	B-cell_type
or	CC	cc	I-cell_type
E1B-specific	JJ	conj	I-cell_type
CTLs	NNS	nmod	I-cell_type
unless	IN	mark	O
the	DT	det	O
relevant	JJ	amod	O
epitope	NN	nsubjpass	O
was	VBD	auxpass	O
either	CC	cc:preconj	O
provided	VBN	advcl	O
exogenously	RB	advmod	O
as	IN	case	O
a	DT	det	O
synthetic	JJ	amod	O
peptide	NN	nmod	O
or	CC	cc	O
targeted	VBN	conj	O
to	TO	case	O
the	DT	det	O
ER	NN	nmod	O
in	IN	case	O
a	DT	det	O
TAP-independent	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
its	PRP$	nmod:poss	O
expression	NN	dobj	O
.	.	punct	O

This	DT	nsubj	O
yields	VBZ	ROOT	O
a	DT	det	O
fusion	NN	compound	O
transcript	NN	dobj	O
,	,	punct	O
PML/RARalpha	NN	appos	B-protein
,	,	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	appos	I-protein
with	IN	case	O
reported	VBN	amod	O
dominant	JJ	amod	O
negative	JJ	amod	O
functions	NNS	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
hormone	NN	nmod	O
.	.	punct	O

Through	IN	case	O
systematic	JJ	amod	O
DNA	NN	compound	O
footprinting	NN	nmod	O
of	IN	case	O
the	DT	det	O
TNF	NN	nmod	O
(	-LRB-	punct	O
encoding	VBG	dep	O
tumour	NN	compound	O
necrosis	NN	compound	O
factor	NN	compound	O
,	,	punct	O
TNF	NN	compound	O
)	-RRB-	punct	O
promoter	NN	compound	O
region	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
single	JJ	amod	O
nucleotide	NN	compound	O
polymorphism	NN	dobj	O
(	-LRB-	punct	O
SNP	NN	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
causes	VBZ	acl:relcl	O
the	DT	det	O
helix-turn-helix	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
OCT-1	NN	dobj	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
a	DT	det	O
novel	JJ	amod	O
region	NN	nmod	O
of	IN	case	O
complex	JJ	amod	O
protein-DNA	JJ	amod	O
interactions	NNS	nmod	O
and	CC	cc	O
alters	VBZ	conj	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
neither	CC	cc:preconj	O
ascorbate	NN	nsubj	O
nor	CC	cc	O
AZT	NN	conj	O
affected	VBD	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	dobj	O
under	IN	case	O
all	DT	det	O
three	CD	nummod	O
induction	NN	compound	O
conditions	NNS	nmod	O
in	IN	case	O
the	DT	det	O
ACH-2	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Copyright	NN	dep	O
1998	CD	ROOT	O
Academic	NNP	compound	O
Press	NNP	dep	O
.	.	punct	O

Transient	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
p16	NN	nmod	B-protein
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
lymphocytes	NNS	nmod	O
caused	VBD	ROOT	O
arrest	NN	dobj	O
in	IN	case	O
G1	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	cop	O
without	IN	case	O
effect	NN	conj	O
on	IN	case	O
the	DT	det	O
cell	NN	compound	O
growth	NN	nmod	O
of	IN	case	O
MOLT-4	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
CEM	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
although	IN	mark	O
all	DT	nsubj	O
of	IN	case	O
them	PRP	nmod	O
express	VBP	advcl	O
functional	JJ	amod	O
retinoblastoma	NN	compound	B-protein
protein	NN	dobj	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubjpass	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
receptor	NN	compound	O
down-regulation	NN	nmod	O
due	JJ	case	O
to	TO	case	O
higher	JJR	amod	O
level	NN	nmod	O
of	IN	case	O
mineralocorticoids	NNS	nmod	O
of	IN	case	O
the	DT	det	O
zona	NN	compound	O
glomerulosa	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
contributes	VBZ	ROOT	O
to	TO	case	O
virus-induced	JJ	amod	O
erythroleukemia	NN	nmod	O
by	IN	mark	O
efficiently	RB	advmod	O
arresting	VBG	advcl	O
differentiation	NN	dobj	O
of	IN	case	O
red	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
progenitors	NNS	nmod	I-cell_type
and	CC	cc	O
by	IN	mark	O
suppressing	VBG	conj	O
transcription	NN	dobj	O
of	IN	case	O
erythrocyte-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

METHOD	NN	nsubj	O
:	:	punct	O
They	PRP	nsubj	O
measured	VBD	ROOT	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
lymphocyte	NN	compound	B-protein
cytosolic	JJ	amod	I-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentrations	NNS	conj	O
in	IN	case	O
15	CD	nummod	O
consecutively	RB	advmod	O
admitted	VBN	amod	O
male	JJ	amod	O
combat	NN	compound	O
Vietnam	NN	compound	O
veterans	NNS	nmod	O
with	IN	case	O
PTSD	NN	nmod	O
and	CC	cc	O
in	IN	case	O
a	DT	det	O
normal	JJ	amod	O
comparison	NN	compound	O
group	NN	conj	O
of	IN	case	O
11	CD	nummod	O
subjects	NNS	nmod	O
.	.	punct	O

Human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
clones	NNS	nsubjpass	I-cell_line
reactive	JJ	amod	O
with	IN	case	O
gC	NN	nmod	B-protein
and	CC	cc	O
VP16	NN	conj	B-protein
are	VBP	auxpass	O
reported	VBN	ROOT	O
here	RB	advmod	O
for	IN	prep	O
the	DT	det	O
first	JJ	amod	O
time	NN	pobj	O
.	.	punct	O

The	DT	det	O
mRNA	NN	compound	O
levels	NNS	nsubj	O
for	IN	case	O
fkhrl1	NN	nmod	B-DNA
is	VBZ	aux	O
elevated	JJ	ROOT	O
in	IN	case	O
T	NN	nmod:npmod	B-cell_type
helper-induced	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
comparison	NN	nmod	O
to	TO	case	O
PHA-stimulated	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Based	VBN	case	O
upon	IN	case	O
these	DT	det	O
results	NNS	nmod	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
alpha-interferon	NN	nsubj	B-protein
through	IN	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
initiates	VBZ	ccomp	O
phosphatidic	JJ	amod	O
acid	NN	nmod:npmod	O
dependent	JJ	amod	O
signalling	NN	dobj	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
regulates	VBZ	acl:relcl	O
the	DT	det	O
affinity	NN	dobj	O
of	IN	case	O
47	CD	compound	B-protein
kDa	NN	compound	I-protein
sterol	NN	compound	I-protein
regulatory	JJ	amod	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
factor	NN	nmod	I-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
LDL-receptor	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	conj	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
CML	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
two	CD	nummod	O
NF-IL6	NN	compound	B-DNA
sites	NNS	nsubj	I-DNA
mediate	VBP	ccomp	O
induction	NN	dobj	O
of	IN	case	O
IL-1	NN	compound	B-protein
beta	NN	nmod	I-protein
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
the	DT	det	O
stimuli	NNS	nmod	O
LAM	NN	dep	O
,	,	punct	O
LPS	NN	conj	O
,	,	punct	O
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
these	DT	det	O
results	NNS	nmod	O
,	,	punct	O
the	DT	det	O
attachment	NN	nsubjpass	O
of	IN	case	O
monocytes	NNS	nmod	O
to	TO	case	O
MVEC	NNS	nmod	B-cell_line
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
PTPase	NN	compound	B-protein
inhibitors	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
this	DT	det	O
analysis	NN	nsubj	O
suggests	VBZ	ROOT	O
a	DT	det	O
common	JJ	amod	O
step	NN	dobj	O
in	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathways	NNS	nmod	O
that	WDT	nsubj	O
trigger	VBP	acl:relcl	O
I	CD	compound	B-protein
kappaB	NN	compound	I-protein
alpha	NN	dobj	I-protein
,	,	punct	O
I	NN	compound	B-protein
kappaB	NN	compound	I-protein
beta	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
I	NN	compound	B-protein
kappaB	NN	compound	I-protein
epsilon	NN	compound	I-protein
degradation	NN	conj	O
.	.	punct	O

Ten-day	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
Epo	NN	nmod	B-protein
induced	VBD	ROOT	O
mature	JJ	amod	B-cell_type
erythroblasts	NNS	dobj	I-cell_type
and	CC	cc	O
red	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

It	PRP	nsubj	O
also	RB	advmod	O
elevated	VBD	ROOT	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
neutrophil	NN	compound	I-cell_type
counts	VBZ	dobj	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
ISGF3	NN	nmod	B-protein
(	-LRB-	punct	O
IFN-stimulated	JJ	amod	B-protein
gene	NN	compound	I-protein
factor	NN	appos	I-protein
3	CD	nummod	I-protein
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
conserved	VBN	amod	O
IFN-stimulated	JJ	amod	B-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
ISRE	NN	appos	B-DNA
)	-RRB-	punct	O
results	VBZ	ROOT	O
in	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

While	IN	mark	O
ICN	NN	nsubj	B-protein
appeared	VBD	advcl	O
primarily	RB	advmod	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
DeltaE	NN	nsubj	B-protein
localized	VBD	ROOT	O
to	TO	case	O
cytoplasmic	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
membranes	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
intranuclear	JJ	amod	O
localization	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
essential	JJ	ccomp	O
for	IN	case	O
oncogenesis	NN	nmod	O
or	CC	cc	O
transcriptional	JJ	amod	O
activation	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
p53	NN	compound	B-protein
molecule	NN	nsubj	I-protein
appears	VBZ	ccomp	O
in	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
forms	NNS	nmod	O
:	:	punct	O
the	DT	det	O
mutant	JJ	amod	B-protein
p53	NN	ccomp	I-protein
that	WDT	nsubj	O
stimulates	VBZ	acl:relcl	O
tumor	NN	compound	O
progression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
wild	JJ	amod	B-protein
type	NN	compound	I-protein
p53	NN	conj	I-protein
that	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
tumor	NN	compound	O
progression	NN	dobj	O
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
show	VB	xcomp	O
an	DT	det	O
alpha-tcp-induced	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
this	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
after	IN	case	O
cytokine	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Down-regulation	NN	nsubjpass	O
of	IN	case	O
17beta-HSD	NN	compound	B-protein
IV	CD	nummod	I-protein
mRNA	NN	compound	O
expression	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
enhanced	VBN	amod	O
estradiol	NN	compound	O
inactivation	NN	nmod	O
by	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
suggesting	VBG	xcomp	O
a	DT	det	O
link	NN	dobj	O
between	IN	case	O
estrogenic	JJ	amod	O
pathways	NNS	nmod	O
and	CC	cc	O
cell	NN	compound	O
proliferation	NN	conj	O
.	.	punct	O

MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
macrophages	NNS	nmod	B-cell_type
infected	VBN	acl	O
with	IN	case	O
Mycobacterium	NN	compound	O
tuberculosis	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
concomitant	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
nuclear	JJ	amod	O
NF-kappaB	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
and	CC	cc	O
endogenous	JJ	amod	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
transcriptional	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
analysed	VBD	ROOT	O
FHIT	NN	dobj	B-DNA
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
RNA	NN	compound	B-RNA
samples	NNS	nmod	I-RNA
and	CC	cc	O
detected	VBD	conj	O
truncated	VBN	amod	O
FHIT	NN	compound	B-RNA
transcripts	NNS	dobj	I-RNA
frequently	RB	advmod	O
in	IN	case	O
both	CC	cc:preconj	O
tumour	NN	nmod	O
and	CC	cc	O
normal	JJ	conj	O
tissues	NNS	dep	O
.	.	punct	O

Degenerate	NN	compound	O
primers	NNS	nsubjpass	O
corresponding	VBG	acl	O
to	TO	case	O
the	DT	det	O
TFIIIA	NN	compound	B-DNA
zinc-finger	NN	compound	I-DNA
consensus	NN	compound	I-DNA
amino	NN	compound	I-DNA
acid	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
and	CC	cc	O
to	TO	case	O
the	DT	det	O
POU-homeodomain	NN	conj	B-protein
and	CC	cc	O
POU-specific	JJ	amod	B-protein
domain	NN	conj	I-protein
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
amplify	VB	xcomp	O
genes	NNS	dobj	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
that	IN	mark	O
they	PRP	nsubj	O
contained	VBD	ccomp	O
similarities	NNS	dobj	O
in	IN	case	O
structural	JJ	amod	O
motifs	NNS	nmod	O
shared	VBN	acl	O
within	IN	case	O
these	DT	det	O
families	NNS	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Because	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
contributes	VBZ	advcl	O
to	TO	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
numerous	JJ	amod	O
inflammatory	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
molecular	JJ	amod	O
target	NN	xcomp	O
of	IN	case	O
antiinflammatory	JJ	amod	O
drugs	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	mark	O
characterize	VB	xcomp	O
the	DT	det	O
functional	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
protein	NN	compound	I-protein
complex	NN	nmod	I-protein
in	IN	case	O
lupus	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Over-expression	NN	nsubj	O
of	IN	case	O
both	DT	det	O
genes	NNS	nmod	O
was	VBD	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
monocytes	NNS	nmod	B-cell_type
from	IN	case	O
II-2	NN	nmod	B-cell_line
and	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
observed	VBN	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
from	IN	case	O
the	DT	det	O
clinically	RB	advmod	O
unaffected	JJ	amod	O
family	NN	compound	O
members	NNS	nmod	O
,	,	punct	O
unlike	IN	case	O
that	DT	nmod	O
of	IN	case	O
SR	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
flies	NNS	nmod	O
,	,	punct	O
this	DT	det	O
pathway	NN	nsubj	O
controls	VBZ	ROOT	O
segment	NN	compound	O
polarity	NN	dobj	O
;	:	punct	O
in	IN	prep	O
Xenopus	NN	pobj	O
it	PRP	nsubj	O
controls	VBZ	parataxis	O
the	DT	det	O
definition	NN	dobj	O
of	IN	case	O
the	DT	det	O
body	NN	compound	O
axis	NN	nmod	O
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
do	VBP	aux	O
not	RB	neg	O
see	VB	ROOT	O
particularly	RB	advmod	O
strong	JJ	amod	O
transcription	NN	dobj	O
when	WRB	advmod	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
kappa	NN	compound	I-DNA
enhancer	NN	nsubjpass	I-DNA
(	-LRB-	punct	O
or	CC	cc	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
enhancer	NN	conj	I-DNA
)	-RRB-	punct	O
is	VBZ	auxpass	O
used	VBN	advcl	O
to	TO	mark	O
activate	VB	xcomp	O
a	DT	det	O
kappa	NN	compound	O
gene	NN	compound	O
promoter	NN	dobj	B-DNA
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
tumor-derived	JJ	amod	O
gangliosides	NNS	nsubj	O
may	MD	aux	O
blunt	VB	ccomp	O
antitumor	JJ	amod	O
immune	JJ	amod	O
responses	NNS	dobj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
RCCs	NNS	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
recombinant	JJ	amod	O
EBF	NN	nmod	B-protein
in	IN	case	O
transfected	VBN	amod	B-cell_line
nonlymphoid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
strongly	RB	advmod	O
activated	VBD	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
reporter	NN	compound	O
plasmids	NNS	nmod	O
containing	VBG	acl	O
functional	JJ	amod	O
EBF-binding	JJ	amod	B-DNA
sites	NNS	dobj	I-DNA
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
differentiation	NN	nsubj	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
IL-6	NN	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
recapitulates	VBZ	ROOT	O
the	DT	det	O
hallmarks	NNS	dobj	O
of	IN	case	O
terminal	JJ	amod	O
B	NN	compound	O
differentiation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
;	:	punct	O
Oct-2	NN	nsubj	B-protein
may	MD	aux	O
have	VB	parataxis	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
undertook	VBD	ROOT	O
a	DT	det	O
detailed	JJ	amod	O
analysis	NN	dobj	O
of	IN	case	O
E2F	NN	compound	B-protein
DNA-binding	JJ	amod	O
activities	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
cell	NN	compound	O
cycle	NN	compound	O
behavior	NN	conj	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
ETS1	NN	nsubj	B-protein
can	MD	aux	O
transactivate	VB	ccomp	O
a	DT	det	O
GM-CSF	NN	compound	B-DNA
reporter	NN	compound	I-DNA
construct	NN	dobj	I-DNA
in	IN	case	O
unstimulated	JJ	amod	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
providing	VBG	advcl	O
that	IN	mark	O
either	CC	cc:preconj	O
NFkappaB	NN	nsubjpass	B-protein
or	CC	cc	O
AP1	NN	compound	B-protein
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
are	VBP	auxpass	O
supplied	VBN	ccomp	O
by	IN	case	O
co-transfection	NN	nmod	O
.	.	punct	O

Appearance	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
STAT1	NN	compound	B-protein
factor	NN	nmod	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
,	,	punct	O
and	CC	cc	O
blocked	VBN	conj	O
by	IN	case	O
cycloheximide	NN	nmod	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
its	PRP$	nmod:poss	O
activation	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ccomp	O
upon	IN	case	O
a	DT	det	O
protein	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
synthesized	VBN	acl	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
initial	JJ	amod	O
signaling	NN	compound	O
events	NNS	nmod	O
.	.	punct	O

The	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
cell	NN	nmod:npmod	O
type-specific	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
TNF	NN	compound	B-protein
alpha	NN	nmod	I-protein
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
unwanted	JJ	amod	O
and	CC	cc	O
potentially	RB	advmod	O
hazardous	JJ	conj	O
specificities	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
elicited	VBN	ROOT	O
when	WRB	advmod	O
using	VBG	advcl	O
synthetic	JJ	amod	O
peptides	NNS	dobj	O
in	IN	case	O
subunit	NN	compound	O
vaccines	NNS	nmod	O
in	IN	case	O
which	WDT	nmod	O
succinimide	NN	compound	O
residues	NNS	nsubj	O
may	MD	aux	O
form	VB	acl:relcl	O
spontaneously	RB	advmod	O
during	IN	case	O
storage	NN	nmod	O
or	CC	cc	O
chemical	JJ	conj	O
synthesis	NN	dep	O
.	.	punct	O

Like	IN	case	O
the	DT	det	O
105-kDa	JJ	amod	O
precursor	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
contains	VBZ	ROOT	O
an	DT	det	O
amino-terminal	JJ	amod	B-protein
Rel-related	JJ	amod	I-protein
domain	NN	dobj	I-protein
of	IN	case	O
about	IN	advmod	O
300	CD	nummod	O
amino	NN	compound	O
acids	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
carboxy-terminal	JJ	amod	B-protein
domain	NN	conj	I-protein
containing	VBG	acl	O
six	CD	nummod	O
full	JJ	amod	B-protein
cell	NN	compound	I-protein
cycle	NN	compound	I-protein
or	CC	cc	O
ankyrin	NN	conj	B-protein
repeats	NNS	dobj	I-protein
.	.	punct	O

New	JJ	amod	O
data	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
pharmacokinetics	NNS	nmod	O
,	,	punct	O
pharmacodynamics	NNS	conj	O
,	,	punct	O
and	CC	cc	O
molecular	JJ	amod	O
mechanisms	NNS	conj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
have	VBP	aux	O
suggested	VBN	ROOT	O
alternative	JJ	amod	O
approaches	NNS	dobj	O
in	IN	case	O
ALL	NN	nmod	O
.	.	punct	O

The	DT	det	O
rate	NN	nsubj	O
of	IN	case	O
LTR	NN	compound	B-DNA
-directed	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
increased	VBD	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
a	DT	det	O
phorbol	NN	compound	O
ester	NN	nmod	O
or	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	conj	I-protein
if	IN	mark	O
either	CC	cc:preconj	O
the	DT	det	O
NFAT-1	NN	compound	B-protein
or	CC	cc	O
NF	NN	compound	B-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
deleted	VBN	advcl	O
,	,	punct	O
but	CC	cc	O
failed	VBD	conj	O
to	TO	mark	O
respond	VB	xcomp	O
to	TO	case	O
these	DT	det	O
mitogenic	JJ	amod	O
stimuli	NNS	nmod	O
if	IN	mark	O
both	DT	det	O
sequences	NNS	nsubj	O
were	VBD	cop	O
absent	JJ	advcl	O
.	.	punct	O

Ascorbate	NN	nsubj	O
and	CC	cc	O
AZT	NN	conj	O
also	RB	advmod	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
following	VBG	case	O
TNF-alpha-	NN	amod	O
or	CC	cc	O
PMA-induced	JJ	conj	O
stimulation	NN	nmod	O
of	IN	case	O
U1	NN	compound	O
promonocytic	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Maximal	JJ	amod	O
accumulation	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
c-fos	NN	nmod	B-RNA
and	CC	cc	I-RNA
c-jun	NN	conj	I-RNA
messenger	NN	compound	I-RNA
RNA	NN	dep	I-RNA
(	-LRB-	punct	O
mRNA	NN	appos	O
)	-RRB-	punct	O
occurred	VBD	ROOT	O
30	CD	nummod	O
minutes	NNS	dobj	O
after	IN	case	O
LPS	NN	compound	O
addition	NN	nmod	O
.	.	punct	O

AR	NNS	nsubjpass	B-protein
can	MD	aux	O
be	VB	auxpass	O
visualized	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
anti-AR	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
of	IN	case	O
permeabilized	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	mark	O
using	VBG	advcl	O
CLSM	NN	dobj	O
,	,	punct	O
though	IN	mark	O
AR	NNS	nsubj	B-protein
are	VBP	cop	O
not	RB	neg	O
detectable	JJ	advcl	O
in	IN	case	O
cytosol	NN	compound	O
fractions	NNS	nmod	O
when	WRB	advmod	O
using	VBG	advcl	O
the	DT	det	O
charcoal	NN	compound	O
binding	NN	compound	O
assay	NN	dobj	O
with	IN	case	O
3H-R1881	NN	nmod	O
as	IN	case	O
ligand	NN	nmod	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
Jun	NN	compound	B-protein
proteins	NNS	nmod	I-protein
to	TO	mark	O
cooperate	VB	acl	O
with	IN	case	O
GR	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
has	VBZ	aux	O
been	VBN	auxpass	O
investigated	VBN	ROOT	O
after	IN	case	O
transfection	NN	nmod	O
of	IN	case	O
c-jun	NN	nmod	B-DNA
,	,	punct	I-DNA
jun-B	NN	conj	I-DNA
,	,	punct	I-DNA
or	CC	cc	I-DNA
jun-D	NN	conj	I-DNA
expression	NN	compound	I-DNA
vectors	NNS	dep	I-DNA
,	,	punct	O
which	WDT	nsubj	O
augmented	VBD	acl:relcl	O
GR	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	dobj	O
from	IN	case	O
either	CC	cc:preconj	O
MMTV	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
or	CC	cc	O
GRE	NN	conj	B-DNA
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
this	DT	det	O
phenotype	NN	nmod	O
,	,	punct	O
the	DT	det	O
myeloid	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
PU.1	NN	nsubjpass	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
erythroid	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
GATA-1	NN	conj	I-protein
,	,	punct	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
47.10	CD	nummod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Despite	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
LPS	NN	nmod	O
,	,	punct	O
disruption	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
signaling	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
precursor	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
inducible	JJ	amod	O
Oct-2	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
the	DT	det	O
suppression	NN	conj	O
of	IN	case	O
Oct-2	NN	compound	B-protein
-directed	JJ	amod	O
transcription	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
expression	NN	ROOT	O
of	IN	case	O
physiological	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
Bcl-x	NN	compound	B-cell_type
protected	VBD	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
Fas-mediated	JJ	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

Adenovirus	NN	compound	O
E1A	NN	nsubj	O
inhibits	VBZ	ROOT	O
IFN	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
resistance	NN	dobj	O
to	TO	case	O
cytolysis	NN	nmod	O
by	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Human	JJ	amod	B-DNA
interferon	NN	compound	I-DNA
regulatory	JJ	amod	I-DNA
factor	NN	compound	I-DNA
2	CD	nummod	I-DNA
gene	NN	ROOT	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubj	I-cell_line
,	,	punct	I-cell_line
B104	NN	appos	I-cell_line
,	,	punct	O
expressed	VBD	ccomp	O
surface	NN	compound	B-protein
IgM	NN	dobj	I-protein
(	-LRB-	punct	O
sIgM	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
surface	NN	compound	B-protein
IgD	NN	conj	I-protein
(	-LRB-	punct	O
sIgD	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
crosslinking	NN	nsubj	O
of	IN	case	O
sIgM	NN	nmod	B-protein
and	CC	cc	O
sIgD	NN	conj	B-protein
by	IN	case	O
anti-IgM	JJ	amod	B-protein
antibody	NN	nmod	I-protein
(	-LRB-	punct	I-protein
Ab	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
anti-IgD	JJ	amod	B-protein
Ab	NN	conj	I-protein
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
induced	VBD	conj	O
Ca2+	NN	compound	O
influx	NN	dobj	O
to	TO	case	O
almost	RB	advmod	O
the	DT	det	O
same	JJ	amod	O
degree	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
only	RB	advmod	O
sIgM	NN	compound	B-protein
-crosslinking	NN	nsubj	O
caused	VBD	advcl	O
B104	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
death	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TRAMP	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
any	DT	nmod	O
of	IN	case	O
the	DT	det	O
known	JJ	amod	O
apoptosis-inducing	JJ	amod	B-protein
ligands	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
TNF	NN	compound	B-protein
family	NN	nmod	I-protein
.	.	punct	O

Negative	JJ	amod	O
selection	NN	nsubj	O
refers	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
deletion	NN	nmod	O
or	CC	cc	O
inactivation	NN	conj	O
of	IN	case	O
potentially	RB	advmod	O
autoreactive	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

Several	JJ	amod	O
methods	NNS	nsubjpass	O
for	IN	case	O
specific	JJ	amod	O
down-regulation	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
are	VBP	auxpass	O
shown	VBN	ROOT	O
that	IN	nsubj	O
may	MD	aux	O
be	VB	cop	O
relevant	JJ	ccomp	O
to	TO	case	O
treatment	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O

The	DT	det	O
potencies	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
transactivation	NN	compound	B-protein
domains	NNS	nmod	I-protein
of	IN	case	O
Stat5	NN	nmod	B-protein
,	,	punct	O
Stat6	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
viral	JJ	amod	B-protein
protein	NN	compound	I-protein
VP16	NN	conj	I-protein
were	VBD	auxpass	O
compared	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
homodimerization	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IL-4Ralpha	NN	compound	B-protein
chain	NN	nmod	I-protein
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
transduce	VB	xcomp	O
Jak1	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
intracellular	JJ	amod	O
signals	NNS	dobj	O
that	WDT	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
IgE	NN	compound	B-protein
isotype	NN	compound	I-protein
switching	NN	nmod	O
.	.	punct	O

Circularization	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
EBV	NN	compound	B-DNA
genome	NN	nmod	I-DNA
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
VDR	NN	compound	B-protein
concentration	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
in	IN	case	O
A-CRF	NN	compound	O
(	-LRB-	punct	O
0.8	CD	nummod	O
+/-	CC	cc	O
0.5	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nmod	O
vs.	CC	cc	O
2.3	CD	nummod	O
+/-	CC	cc	O
0.9	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	conj	O
in	IN	case	O
controls	NNS	nmod	O
,	,	punct	O
p	NN	dep	O
<	-LRB-	parataxis	O
0.001	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
seen	VBN	parataxis	O
in	IN	case	O
M-CRF	NN	nmod	O
(	-LRB-	punct	O
1.7	CD	nummod	O
+/-	CC	cc	O
0.7	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nmod	O
vs.	CC	cc	O
2.3	CD	nummod	O
+/-	CC	cc	O
0.9	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	conj	O
in	IN	case	O
controls	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
the	DT	det	O
immunoprecipitated	VBN	amod	B-protein
Jak	NN	nsubj	I-protein
2	CD	nummod	I-protein
obtained	VBN	acl	O
from	IN	case	O
IL-5-stimulated	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
underwent	VBD	ROOT	O
autophosphorylation	NN	dobj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
interleukin	NN	compound	B-protein
1beta	NN	nmod	I-protein
and	CC	cc	O
other	JJ	amod	O
cytokines	NNS	conj	B-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
interleukin	NN	nmod	B-protein
6	CD	nummod	I-protein
and	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	conj	I-protein
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
dependent	JJ	xcomp	O
on	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
NFkappaB	NN	appos	B-protein
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor-kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NFkappaB	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
impaired	JJ	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
renal	JJ	amod	O
cell	NN	compound	O
carcinomas	NNS	nmod	O
(	-LRB-	punct	O
RCCs	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
CF	NN	compound	O
individuals	NNS	nmod	O
,	,	punct	O
7	CD	compound	O
of	IN	advmod	O
52	CD	nummod	O
(	-LRB-	punct	O
13	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
detectable	JJ	amod	O
E1a	NN	compound	B-DNA
sequences	NNS	dobj	I-DNA
in	IN	case	O
the	DT	det	O
respiratory	JJ	amod	O
epithelium	NN	nmod	O
,	,	punct	O
with	IN	case	O
E1a	NN	compound	O
copy	NN	compound	O
number	NN	nmod	O
in	IN	case	O
the	DT	det	O
positive	JJ	amod	O
samples	NNS	nmod	O
of	IN	case	O
80	CD	intj	O
+/-	CC	cc	O
21/10	CD	conj	O
(	-LRB-	punct	O
3	CD	dep	O
)	-RRB-	punct	O
recovered	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
soluble	JJ	amod	B-protein
CD4	NN	nsubj	I-protein
(	-LRB-	punct	O
sCD4	NN	appos	B-protein
)	-RRB-	punct	O
prevented	VBD	ROOT	O
virus	NN	compound	O
reactivation	NN	dobj	O
by	IN	case	O
D1/CDR2-loop	NN	compound	B-protein
ligands	NNS	nmod	I-protein
.	.	punct	O

More	RBR	advmod	O
extensive	JJ	amod	O
deletion	NN	nsubj	O
of	IN	case	O
sequences	NNS	nmod	O
upstream	JJ	amod	O
of	IN	case	O
Cp	NN	nmod	B-DNA
,	,	punct	O
including	VBG	case	O
the	DT	det	O
EBNA2-dependent	JJ	amod	B-DNA
enhancer	NN	nmod	I-DNA
,	,	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
nearly	RB	advmod	O
complete	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
Cp	NN	compound	B-DNA
activity	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
monocytes	NNS	nsubj	B-cell_type
express	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
IL-10-stimulated	JJ	amod	B-protein
STAT	NN	compound	I-protein
protein	NN	dobj	I-protein
with	IN	case	O
an	DT	det	O
M	NN	nmod	O
(	-LRB-	punct	O
r	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
70	CD	nummod	B-protein
kDa	NN	nmod	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
recognized	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
anti-STAT3	JJ	amod	B-protein
Ab	NN	nmod	I-protein
but	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
observed	VBN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Recombinant	JJ	amod	B-protein
murine	JJ	amod	I-protein
and	CC	cc	I-protein
human	JJ	conj	I-protein
TCF-1	NN	nsubj	I-protein
recognized	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
sequence	NN	compound	O
motif	NN	dobj	O
in	IN	case	O
the	DT	det	O
CD3-epsilon	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
gel	NN	compound	O
retardation	NN	nmod	O
and	CC	cc	O
methylation	NN	compound	O
interference	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

Visceral	JJ	amod	O
TSC2	NN	compound	B-DNA
expression	NN	nsubj	O
was	VBD	cop	O
comparable	JJ	ROOT	O
in	IN	case	O
autopsy	JJ	compound	O
tissues	NNS	nmod	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	nmod	O
and	CC	cc	O
without	IN	case	O
TSC	NN	nmod	O
;	:	punct	O
TSC2	NN	compound	B-DNA
messenger	NN	compound	O
RNA	NN	compound	O
expression	NN	nsubj	O
was	VBD	cop	O
most	RBS	advmod	O
prominent	JJ	parataxis	O
in	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
a	DT	det	O
rapid	JJ	amod	O
mitotic	JJ	amod	O
rate	NN	nmod	O
and	CC	cc	O
turnover	NN	conj	O
,	,	punct	O
e.g.	FW	advmod	O
,	,	punct	O
epithelia	NN	conj	O
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
,	,	punct	O
with	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
pyramidal	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
and	CC	cc	O
other	JJ	amod	O
neurons	NNS	conj	O
being	VBG	cop	O
an	DT	det	O
obvious	JJ	amod	O
exception	NN	nmod	O
,	,	punct	O
and/or	CC	cc	O
in	IN	case	O
cells	NNS	conj	O
with	IN	case	O
important	JJ	amod	O
secretory/transport	NN	compound	O
functions	NNS	nmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
important	JJ	acomp	O
to	TO	aux	O
note	VB	xcomp	O
that	IN	mark	O
the	DT	det	O
effector	NN	compound	O
response	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
self-limiting	JJ	ccomp	O
in	IN	case	O
RA	NN	compound	O
autoimmune	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

Neither	CC	cc:preconj	O
Bt2cAMP	NN	nsubj	O
nor	CC	cc	O
PMA	NN	conj	O
individually	RB	advmod	O
mediated	VBD	ROOT	O
these	DT	det	O
sustained	JJ	amod	O
effects	NNS	dobj	O
,	,	punct	O
which	WDT	nsubj	O
therefore	RB	advmod	O
appear	VBP	acl:relcl	O
as	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
interplay	NN	nmod	O
between	IN	case	O
both	DT	det	O
metabolic	JJ	amod	O
stimuli	NNS	nmod	O
.	.	punct	O

Shared	JJ	amod	O
gamma	NN	compound	B-protein
(	-LRB-	punct	I-protein
c	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	ROOT	I-protein
within	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
interleukin-7	NN	compound	I-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

Activity	NN	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
core	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

Extracellular-regulated	JJ	amod	B-protein
kinase	NN	nsubjpass	I-protein
1/2	CD	nummod	I-protein
,	,	punct	O
Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
c-Jun	NN	conj	B-protein
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
-dependent	JJ	amod	O
IL-6	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
monocytes	NNS	nmod	O
.	.	punct	O

An	DT	det	O
antiserum	NN	nsubjpass	O
to	TO	case	O
this	DT	det	O
enzyme	NN	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
isolate	VB	xcomp	O
a	DT	det	O
cDNA	NN	compound	B-DNA
clone	NN	dobj	I-DNA
.	.	punct	O

In	IN	case	O
this	DT	det	O
investigation	NN	nmod	O
an	DT	det	O
enhanced	VBN	amod	O
and	CC	cc	O
prolonged	JJ	conj	O
IL-2	NN	compound	B-protein
and	CC	cc	O
IL-2	NN	conj	B-RNA
mRNA	NN	compound	I-RNA
response	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
stimulated	VBN	amod	O
(	-LRB-	punct	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
mitogens	NNS	dep	I-protein
or	CC	cc	O
alloantigens	NNS	conj	B-protein
)	-RRB-	punct	O
murine	JJ	amod	B-cell_type
splenocytes	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
the	DT	det	O
stimulated	VBN	amod	O
murine	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
EL-4	NN	conj	I-cell_line
in	IN	case	O
the	DT	det	O
presence	NN	intj	O
of	IN	case	O
ciprofloxacin	NN	nmod	O
(	-LRB-	punct	O
5-80	CD	nummod	O
micrograms/ml	NNS	appos	O
)	-RRB-	punct	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
control	JJ	amod	O
cells	NNS	nmod	O
without	IN	case	O
antibiotics	NNS	nmod	O
.	.	punct	O

These	DT	det	O
pathways	NNS	nsubjpass	O
are	VBP	auxpass	O
disrupted	VBN	ROOT	O
by	IN	case	O
agonists	NNS	nmod	O
that	WDT	nsubj	O
utilize	VBP	acl:relcl	O
adenylate	NN	compound	B-protein
cyclase	NN	dobj	I-protein
and	CC	cc	O
cAMP-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
A	NN	conj	I-protein
(	-LRB-	punct	O
PKA	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
switch	NN	nmod	O
from	IN	case	O
the	DT	det	O
membrane	NN	compound	B-RNA
forms	NNS	nmod	I-RNA
of	IN	case	O
mu	NN	nmod	B-RNA
and	CC	cc	O
gamma	NN	conj	B-RNA
to	TO	case	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
secreted	JJ	amod	B-RNA
forms	NNS	nmod	I-RNA
was	VBD	auxpass	O
noted	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
TGF-beta	NN	nmod	B-protein
.	.	punct	O

One	CD	nummod	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
describe	VB	xcomp	O
the	DT	det	O
profile	NN	dobj	O
of	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
these	DT	det	O
different	JJ	amod	O
populations	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
assess	VB	conj	O
whether	IN	mark	O
the	DT	det	O
patterns	NNS	nsubj	O
observed	VBN	acl	O
correlated	VBD	ccomp	O
with	IN	case	O
functional	JJ	amod	O
differences	NNS	nmod	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Coexpression	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
PEBP2betaMYH11	NN	nmod	B-protein
and	CC	cc	O
activated	VBN	amod	B-protein
NRAS	NNS	conj	I-protein
induced	VBD	ROOT	O
a	DT	det	O
more	RBR	advmod	O
severe	JJ	amod	O
phenotype	NN	dobj	O
characterized	VBN	acl	O
by	IN	case	O
abnormal	JJ	amod	O
nuclear	JJ	amod	O
morphology	NN	nmod	O
indicative	JJ	amod	O
of	IN	case	O
granulocytic	JJ	amod	O
dysplasia	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
investigated	VBD	ROOT	O
the	DT	det	O
MTCP1	NN	compound	B-DNA
locus	NN	compound	I-DNA
configuration	NN	dobj	O
by	IN	case	O
Southern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Compared	VBN	case	O
to	TO	case	O
benign	JJ	amod	O
tumor	NN	nmod	O
or	CC	cc	O
mammary	JJ	amod	O
reduction	NN	compound	O
test	NN	compound	O
material	NN	conj	O
the	DT	det	O
eicosanoid	NN	compound	O
profile	NN	nsubj	O
of	IN	case	O
tissue	NN	nmod	O
obtained	VBN	acl	O
from	IN	case	O
malignant	JJ	amod	O
mammary	JJ	amod	O
tumors	NNS	nmod	O
showed	VBD	ROOT	O
important	JJ	amod	O
differences	NNS	dobj	O
.	.	punct	O

In	IN	case	O
hematopoietic	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
RA	NN	nsubj	O
and	CC	cc	O
RARs	NNS	conj	B-protein
,	,	punct	O
predominantly	RB	advmod	O
RAR	NN	compound	B-protein
alpha	NN	appos	I-protein
may	MD	aux	O
play	VB	ROOT	O
key	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
progenitors	NNS	nmod	I-cell_type
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
SOX9	NN	compound	B-DNA
coding	NN	compound	I-DNA
sequence	NN	compound	I-DNA
polymorphism	NN	dobj	I-DNA
,	,	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
SOX9	NN	compound	B-DNA
alleles	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
reverse	JJ	amod	B-protein
transcriptase	NN	compound	I-protein
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
in	IN	case	O
lymphoblastoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
translocation	NN	compound	O
cases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
PAX-5	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
recently	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
participate	VB	xcomp	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
locus	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
chromosomal	JJ	amod	O
translocation	NN	compound	O
t	NN	nmod	B-DNA
(	-LRB-	punct	I-DNA
9	CD	dep	I-DNA
;	:	punct	I-DNA
14	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
(	-LRB-	punct	I-DNA
p13	NN	dep	I-DNA
;	:	punct	I-DNA
q32	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Epo	NN	nsubj	B-protein
acts	VBZ	ccomp	O
at	IN	case	O
both	CC	cc:preconj	O
transcriptional	JJ	amod	O
and	CC	cc	O
posttranscriptional	JJ	conj	O
levels	NNS	nmod	O
on	IN	case	O
the	DT	det	O
TAL1	NN	compound	B-protein
locus	NN	nmod	O
in	IN	case	O
Friend	NN	compound	B-cell_line
virus-induced	JJ	amod	I-cell_line
erythroblasts	NNS	nmod	I-cell_line
and	CC	cc	O
establish	VB	conj	O
a	DT	det	O
link	NN	dobj	O
between	IN	case	O
Epo	NN	compound	B-protein
signaling	NN	compound	O
mechanisms	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
member	NN	conj	O
of	IN	case	O
a	DT	det	O
family	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
diverse	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
lineages	NNS	nmod	I-cell_type
.	.	punct	O

Murine	JJ	amod	B-protein
and	CC	cc	I-protein
human	JJ	conj	I-protein
TCF-1	NN	nsubj	I-protein
displayed	VBD	ROOT	O
a	DT	det	O
95.5	CD	compound	O
%	NN	compound	O
overall	JJ	amod	O
amino	NN	compound	O
acid	NN	compound	O
homology	NN	dobj	O
.	.	punct	O

IL-4	NN	nsubjpass	B-protein
,	,	punct	O
a	DT	det	O
product	NN	appos	O
of	IN	case	O
the	DT	det	O
T-helper	NN	nmod	B-cell_type
0	CD	nummod	I-cell_type
(	-LRB-	punct	I-cell_type
Th0	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
2	CD	nummod	I-cell_type
(	-LRB-	punct	I-cell_type
Th2	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
subset	NN	conj	I-cell_type
,	,	punct	O
was	VBD	auxpass	O
originally	RB	advmod	O
described	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
B-cell	NN	compound	B-protein
stimulatory	JJ	amod	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
has	VBZ	aux	O
subsequently	RB	advmod	O
been	VBN	auxpass	O
found	VBN	conj	O
to	TO	mark	O
suppress	VB	xcomp	O
IL-1	NN	compound	O
alpha	NN	dobj	O
,	,	punct	O
IL-1	NN	compound	O
beta	NN	conj	O
,	,	punct	O
IL-6	NN	conj	O
,	,	punct	O
IL-8	NN	conj	O
,	,	punct	O
and	CC	cc	O
TNF-alpha	NN	compound	O
gene	NN	compound	O
expression	NN	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
stimulated	VBN	acl	O
with	IN	case	O
LPS	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
upregulate	VB	conj	O
IL-1	NN	compound	B-DNA
receptor	NN	compound	I-DNA
antagonist	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL1-RA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
.	.	punct	O

Both	DT	det	O
forms	NNS	nsubj	O
have	VBP	ROOT	O
DNA-binding	JJ	amod	B-protein
domain	NN	dobj	I-protein
,	,	punct	O
but	CC	cc	O
AML1a	NN	nsubj	B-protein
lacks	VBZ	conj	O
a	DT	det	O
putative	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	compound	O
domain	NN	dobj	O
which	WDT	dobj	O
AML1b	NNS	nsubj	B-protein
has	VBZ	acl:relcl	O
.	.	punct	O

This	DT	det	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3-induced	JJ	nummod	O
G1	NN	compound	O
arrest	NN	nsubjpass	O
is	VBZ	auxpass	O
enhanced	VBN	ROOT	O
by	IN	case	O
all-trans	JJ	amod	O
RA	NN	nmod	O
.	.	punct	O

These	DT	det	O
transcripts	NNS	nsubj	O
can	MD	aux	O
encode	VB	ROOT	O
three	CD	nummod	O
proteins	NNS	dobj	O
of	IN	case	O
calculated	VBN	amod	O
molecular	JJ	amod	O
mass	NN	compound	O
32.2	CD	nummod	B-RNA
kDa	NN	nmod	I-RNA
,	,	punct	O
27.8	CD	nummod	B-RNA
kDa	NN	conj	I-RNA
,	,	punct	O
and	CC	cc	O
14.3	CD	nummod	B-RNA
kDa	NN	conj	I-RNA
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
all	DT	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	acl:relcl	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
adherent	JJ	amod	B-cell_type
monocytes	NNS	nsubj	I-cell_type
regulate	VBP	ccomp	O
nuclear	JJ	amod	O
processing	NN	dobj	O
(	-LRB-	punct	O
or	CC	cc	O
decay	NN	conj	O
)	-RRB-	punct	O
of	IN	case	O
I	NN	compound	B-RNA
kappa	NN	compound	I-RNA
B	NN	compound	I-RNA
alpha/MAD-3	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
thereby	RB	advmod	O
increasing	VBG	advcl	O
mRNA	NN	compound	O
levels	NNS	dobj	O
without	IN	mark	O
stimulating	VBG	advcl	O
I	NN	compound	B-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
alpha/MAD-3	NN	compound	I-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
.	.	punct	O

Glucocorticoid-resistance	NN	nsubj	O
in	IN	case	O
peripheral-blood	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
does	VBZ	aux	O
not	RB	neg	O
correlate	VB	ROOT	O
with	IN	case	O
number	NN	nmod	O
of	IN	case	O
affinity	NN	nmod	O
of	IN	case	O
glucocorticoid-receptors	NNS	nmod	B-protein
in	IN	case	O
chronic	JJ	amod	O
renal	JJ	amod	O
failure	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

A	DT	det	O
new	JJ	amod	O
approach	NN	nsubjpass	O
to	TO	mark	O
facilitate	VB	acl	O
immobilization	NN	dobj	O
and	CC	cc	O
affinity	NN	compound	O
purification	NN	conj	O
of	IN	case	O
recombinant	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
selected	VBN	amod	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
has	VBZ	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
secretion	NN	nsubj	O
of	IN	case	O
PGE2	NN	nmod	O
by	IN	case	O
macrophages	NNS	nmod	B-cell_type
in	IN	case	O
response	NN	dep	O
to	TO	case	O
infection	NN	nmod	O
or	CC	cc	O
inflammatory	JJ	amod	O
activators	NNS	conj	O
could	MD	aux	O
induce	VB	ccomp	O
signaling	NN	compound	O
events	NNS	dobj	O
resulting	VBG	acl	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
proviral	JJ	amod	O
DNA	NN	nmod	O
present	JJ	amod	O
into	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
latently	RB	advmod	O
infected	VBN	acl	O
with	IN	case	O
HIV-1	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
EBF	NN	nsubj	B-protein
and	CC	cc	O
E47	NN	conj	B-protein
synergize	VBP	ccomp	O
to	TO	mark	O
activate	VB	xcomp	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubj	O
define	VBP	acl:relcl	O
an	DT	det	O
early	JJ	amod	O
stage	NN	dobj	O
of	IN	case	O
the	DT	det	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
second	JJ	amod	O
alteration	NN	nsubj	O
,	,	punct	O
at	IN	case	O
threonine	NN	nmod	O
78	CD	nummod	O
,	,	punct	O
also	RB	advmod	O
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	dobj	O
,	,	punct	O
although	IN	mark	O
more	RBR	advmod	O
indirect	JJ	advcl	O
,	,	punct	O
role	NN	dep	O
:	:	punct	O
alteration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
sequence	NN	nmod	O
at	IN	case	O
threonine	NN	nmod	O
78	CD	nummod	O
such	JJ	case	O
that	IN	mark	O
it	PRP	nsubj	O
resembles	VBZ	ccomp	O
that	DT	nmod	O
of	IN	case	O
c-erb	NN	compound	B-protein
A	NN	nmod	I-protein
can	MD	aux	O
act	VB	parataxis	O
as	IN	case	O
an	DT	det	O
intragenic	JJ	amod	O
suppressor	NN	nmod	O
and	CC	cc	O
can	MD	aux	O
partially	RB	advmod	O
restore	VB	conj	O
function	NN	dobj	O
to	TO	case	O
a	DT	det	O
v-erb	NN	compound	B-protein
A	NN	compound	I-protein
protein	NN	nmod	I-protein
rendered	VBN	acl	O
defective	JJ	xcomp	O
due	JJ	case	O
to	TO	mwe	O
a	DT	det	O
mutation	NN	nmod	O
at	IN	case	O
position	NN	nmod	B-protein
61	CD	nummod	I-protein
.	.	punct	O

The	DT	det	O
thrombin	NN	compound	B-protein
-generating	JJ	amod	O
potential	NN	nsubj	O
of	IN	case	O
the	DT	det	O
apoptotic	JJ	amod	B-cell_line
VSMC-myc	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	cop	O
greater	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
unactivated	JJ	amod	B-cell_type
platelets	NNS	nmod	I-cell_type
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.003	CD	dep	O
for	IN	case	O
AUC	NN	nmod	O
;	:	punct	O
P	NN	dep	O
=	JJ	amod	O
.0002	NN	dep	O
for	IN	case	O
PT	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
similar	JJ	conj	O
to	TO	case	O
calcium-ionophore	JJ	amod	O
activated	VBN	amod	B-cell_type
platelets	NNS	nmod	I-cell_type
(	-LRB-	punct	O
AUC	NN	dep	O
of	IN	case	O
332	CD	nummod	O
+/-	CC	cc	O
15	CD	conj	O
nmol	NN	compound	O
x	NN	compound	O
min/L	NN	nmod	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	amod	O
.3	NN	dobj	O
;	:	punct	O
PT	NN	dep	O
of	IN	case	O
172	CD	nummod	O
+/-	CC	cc	O
8	CD	conj	O
nmol/L	NN	nmod	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	amod	O
.2	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Immunoblot	NN	nsubj	O
and	CC	cc	O
flow	NN	compound	O
cytometry	NN	compound	O
analysis	NN	conj	O
revealed	VBD	ROOT	O
a	DT	det	O
limited	JJ	amod	O
proteolysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
carboxyl	NN	compound	B-protein
terminus	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
alphaIIb	NN	compound	B-protein
subunit	NN	compound	I-protein
heavy	JJ	amod	I-protein
chain	NN	nmod	I-protein
(	-LRB-	punct	O
alphaIIbH	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
the	DT	det	O
disappearance	NN	nmod	O
of	IN	case	O
the	DT	det	O
epitope	NN	nmod	O
for	IN	case	O
the	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	compound	I-protein
PMI-1	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
cDNA	NN	compound	B-DNA
library	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
screened	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
patients	NNS	compound	O
own	JJ	amod	O
autoimmune	JJ	amod	O
serum	NN	nsubj	O
being	VBG	cop	O
monospecific	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
autoantigen	NN	compound	I-protein
La/SS-B	NN	nmod	I-protein
.	.	punct	O

Cortivazol	NN	nsubj	O
significantly	RB	advmod	O
induced	VBD	ROOT	O
GR	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
in	IN	case	O
the	DT	det	O
normal	JJ	amod	B-cell_line
CEM-C7	NN	nmod	I-cell_line
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
two	CD	nummod	O
classes	NNS	conj	O
of	IN	case	O
dex-resistant	JJ	amod	B-cell_line
clones	NNS	nmod	I-cell_line
,	,	punct	O
although	IN	mark	O
the	DT	det	O
dex-resistant	JJ	amod	B-cell_line
clones	NNS	nsubj	I-cell_line
needed	VBD	advcl	O
at	IN	case	O
least	JJS	nmod:npmod	O
10	CD	compound	O
times	NNS	nmod:npmod	O
more	JJR	amod	O
cortivazol	NN	dobj	O
than	IN	case	O
the	DT	det	O
normal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
for	IN	case	O
significant	JJ	amod	O
GR	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
induction	NN	nmod	O
.	.	punct	O

The	DT	det	O
NFAT	NN	compound	B-protein
protein	NN	nsubj	O
migrated	VBD	ROOT	O
more	RBR	advmod	O
slowly	RB	advmod	O
in	IN	case	O
a	DT	det	O
sodium	NN	compound	O
dodecyl	NN	compound	O
sulfate-polyacrylamide	JJ	amod	O
gel	NN	nmod	O
than	IN	case	O
the	DT	det	O
CMAT	NN	compound	B-protein
protein	NN	nsubj	I-protein
did	VBD	advcl	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
focused	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
study	NN	nmod	O
of	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
triggered	VBN	acl	O
by	IN	case	O
CD23	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
promonocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
U937	NN	conj	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
mineralocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
MR	NN	appos	B-protein
)	-RRB-	punct	O
count	NN	dobj	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
2	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

The	DT	det	O
NB	NN	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
a	DT	det	O
target	NN	ROOT	O
of	IN	case	O
antibodies	NNS	nmod	B-protein
in	IN	case	O
the	DT	det	O
serum	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
the	DT	det	O
autoimmune	JJ	amod	O
disease	NN	compound	O
primary	JJ	amod	O
biliary	JJ	amod	O
cirrhosis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
BRL49653	NN	nsubj	O
,	,	punct	O
a	DT	det	O
PPARgamma	NN	compound	B-protein
ligand	NN	appos	O
,	,	punct	O
failed	VBD	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
MCP-1	NN	compound	B-protein
secretion	NN	dobj	O
either	CC	advmod	O
alone	RB	advmod	O
or	CC	cc	O
to	TO	mark	O
modify	VB	conj	O
the	DT	det	O
expression	NN	compound	O
level	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
RA	NN	nmod	O
.	.	punct	O

A	DT	det	O
mutant	NN	nsubjpass	O
of	IN	case	O
KBF1/p50	NN	compound	B-protein
(	-LRB-	punct	O
delta	NN	compound	B-protein
SP	NN	nmod	I-protein
)	-RRB-	punct	O
,	,	punct	O
unable	JJ	amod	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
DNA	NN	nmod	O
but	CC	cc	O
able	JJ	conj	O
to	TO	mark	O
form	VB	xcomp	O
homo-	JJ	dobj	O
or	CC	cc	O
heterodimers	NNS	conj	B-protein
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
constructed	VBN	ROOT	O
.	.	punct	O

Role	NN	ROOT	O
for	IN	case	O
a	DT	det	O
novel	JJ	amod	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
palindromic	JJ	amod	I-DNA
octamer	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
TPO	NN	nsubj	B-protein
has	VBZ	ccomp	O
a	DT	det	O
distinct	JJ	amod	O
action	NN	dobj	O
on	IN	case	O
erythropoiesis	NN	nmod	O
.	.	punct	O

BSAP	NN	nsubj	B-protein
is	VBZ	cop	O
unique	JJ	ROOT	O
among	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
epsilon	NN	compound	O
germline	NN	compound	B-DNA
expression	NN	dobj	O
,	,	punct	O
because	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
B	NN	nmod:npmod	O
cell	NN	nmod:npmod	O
specific	JJ	advcl	O
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
at	IN	case	O
the	DT	det	O
merging	JJ	amod	O
point	NN	conj	O
of	IN	case	O
two	CD	nummod	O
signalling	NN	amod	O
pathways	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
critical	JJ	acl:relcl	O
for	IN	case	O
IgE	NN	compound	B-protein
switching	NN	nmod	O
.	.	punct	O

The	DT	det	O
NR2	NN	compound	B-cell_line
hybrid	NN	nsubj	I-cell_line
allowed	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
exclude	VB	xcomp	O
three	CD	nummod	O
candidate	NN	compound	B-DNA
genes	NNS	dobj	I-DNA
for	IN	case	O
AGS	NN	nmod	O
:	:	punct	O
hepatic	JJ	amod	B-DNA
nuclear	JJ	amod	I-DNA
factor	NN	compound	I-DNA
3	CD	nummod	I-DNA
beta	NN	dobj	I-DNA
(	-LRB-	punct	O
HNF3	NN	compound	B-DNA
beta	NN	appos	I-DNA
)	-RRB-	punct	O
,	,	punct	O
paired	JJ	amod	B-DNA
box	NN	conj	I-DNA
1	CD	nummod	I-DNA
(	-LRB-	punct	O
PAX1	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
cystatin	NN	compound	B-DNA
C	NN	conj	I-DNA
(	-LRB-	punct	O
CST3	NN	appos	B-DNA
)	-RRB-	punct	O
as	IN	mark	O
shown	VBN	dep	O
by	IN	case	O
their	PRP$	nmod:poss	O
localization	NN	nmod	O
outside	IN	amod	O
of	IN	case	O
the	DT	det	O
deletion	NN	nmod	O
.	.	punct	O

In	IN	case	O
THP-1	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
TPA	NN	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
a	DT	det	O
new	JJ	amod	O
,	,	punct	O
faster-migrating	JJ	dep	B-protein
NF	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
species	NNS	dobj	I-protein
not	RB	neg	O
induced	VBN	acl	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Interleukin-10	NN	nsubj	B-protein
(	-LRB-	punct	O
IL-10	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
beta	NN	conj	I-protein
(	-LRB-	punct	O
TGF-beta	NN	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
inhibitory	JJ	ROOT	O
for	IN	case	O
B	NN	compound	B-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
IgE	NN	compound	B-protein
production	NN	conj	O
,	,	punct	O
and	CC	cc	O
mast	NN	compound	O
cell	NN	compound	O
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
they	PRP	nsubj	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
eosinophils	NNS	nmod	B-cell_type
.	.	punct	O

Various	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
expression	NN	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
on	IN	case	O
seborrheic	JJ	amod	O
keratoses	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
expression	NN	compound	O
level	NN	nsubj	O
on	IN	case	O
basal	JJ	amod	O
cell	NN	compound	O
epitheliomas	NNS	nmod	O
was	VBD	cop	O
low	JJ	advcl	O
.	.	punct	O

This	DT	det	O
activation	NN	compound	B-protein
domain	NN	nsubj	I-protein
of	IN	case	O
CIITA	NN	nmod	B-protein
interacts	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
32	CD	nummod	B-protein
kDa	NN	compound	I-protein
subunit	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
general	JJ	amod	B-protein
transcription	NN	compound	I-protein
complex	NN	compound	I-protein
TFIID	NN	nmod	B-protein
,	,	punct	O
TAFII32	NN	appos	B-protein
.	.	punct	O

Cross-linking	NN	nsubj	O
of	IN	case	O
this	DT	det	O
lymphocyte-specific	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
designated	VBN	acl	O
TACI	NN	xcomp	B-protein
(	-LRB-	punct	O
transmembrane	JJ	amod	B-protein
activator	NN	dep	I-protein
and	CC	cc	I-protein
CAML-interactor	NN	conj	I-protein
)	-RRB-	punct	O
,	,	punct	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
transfected	VBN	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
TACI-specific	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
led	VBD	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
NF-AT	NN	dep	B-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
NFkappaB	NN	conj	B-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
while	IN	mark	O
ligand-activated	JJ	amod	O
c-erbA/TR	NN	nsubj	B-protein
accelerated	VBD	advcl	O
differentiation	NN	dobj	O
,	,	punct	O
unliganded	JJ	amod	O
c-erbA/TR	NN	nsubj	B-protein
effectively	RB	advmod	O
blocked	VBD	ROOT	O
differentiation	NN	dobj	O
and	CC	cc	O
supported	VBD	conj	O
sustained	JJ	amod	O
progenitor	NN	compound	O
growth	NN	dobj	O
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

Functional	JJ	amod	O
B-cell	NN	compound	O
response	NN	ROOT	O
in	IN	case	O
intrahepatic	JJ	amod	O
lymphoid	JJ	amod	O
follicles	NNS	nmod	O
in	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	compound	O
C	NN	nmod	O
.	.	punct	O

These	DT	det	O
biochemical	JJ	amod	O
findings	NNS	nsubj	O
correlate	VBP	ROOT	O
perfectly	RB	advmod	O
with	IN	case	O
the	DT	det	O
selective	JJ	amod	O
ability	NN	nmod	O
of	IN	case	O
c-ErbB	NN	nmod	B-protein
to	TO	mark	O
cause	VB	acl	O
sustained	JJ	amod	O
self	NN	compound	O
renewal	NN	dobj	O
in	IN	case	O
erythroid	JJ	amod	B-cell_type
progenitors	NNS	nmod	I-cell_type
.	.	punct	O

Bcl-3	NN	nsubj	B-protein
may	MD	aux	O
therefore	RB	advmod	O
aid	VB	ROOT	O
activation	NN	dobj	O
of	IN	case	O
select	JJ	amod	O
NF-kappa	NN	nmod:npmod	B-DNA
B-regulated	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
using	VBG	advcl	O
ATL-16T	JJ	compound	O
nuclear	JJ	amod	O
extract	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
GATA-4	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
only	JJ	advmod	O
GATA-binding	JJ	amod	B-protein
protein	NN	ccomp	I-protein
that	WDT	nsubj	O
forms	VBZ	acl:relcl	O
specific	JJ	amod	O
DNA-protein	JJ	amod	B-protein
complex	NN	dobj	I-protein
with	IN	case	O
the	DT	det	O
-70	CD	nummod	B-DNA
GATA	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
CD36	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
phagocytosis	NN	nmod	O
of	IN	case	O
apoptotic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
foam	NN	compound	O
cell	NN	compound	O
formation	NN	conj	O
by	IN	case	O
uptake	NN	nmod	O
of	IN	case	O
oxidized	VBN	amod	B-protein
low	JJ	amod	I-protein
density	NN	compound	I-protein
lipoprotein	NN	nmod	I-protein
.	.	punct	O

IL-2	NN	nsubj	B-protein
induced	VBD	ROOT	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
STAT3	NN	nmod	B-protein
and	CC	cc	O
STAT5	NN	conj	B-protein
of	IN	case	O
a	DT	det	O
HTLV-1-transformed	JJ	amod	O
cell	NN	compound	O
line	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
stimulated	VBD	conj	O
its	PRP$	nmod:poss	O
proliferation	NN	dobj	O
.	.	punct	O

Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
protein	NN	compound	I-protein
2	CD	nummod	I-protein
transactivation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
latent	JJ	amod	B-DNA
membrane	NN	compound	I-DNA
protein	NN	compound	I-DNA
1	CD	nummod	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
J	NN	compound	B-protein
kappa	NN	nmod	I-protein
and	CC	cc	O
PU.1	NN	conj	B-protein
.	.	punct	O

These	DT	det	O
properties	NNS	nsubj	O
of	IN	case	O
NF-ATc/B	NN	nmod	B-protein
and	CC	cc	I-protein
-C	NN	conj	I-protein
might	MD	aux	O
be	VB	cop	O
of	IN	case	O
importance	NN	ROOT	O
for	IN	case	O
gene	NN	compound	O
regulation	NN	nmod	O
in	IN	case	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
which	WDT	nmod	O
NF-ATc/B	NN	nsubjpass	B-protein
and	CC	cc	I-protein
-C	NN	conj	I-protein
are	VBP	auxpass	O
predominantly	RB	advmod	O
synthesized	VBN	acl:relcl	O
.	.	punct	O

The	DT	det	O
IRF-2	NN	compound	B-protein
promoter	NN	compound	B-DNA
region	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
a	DT	det	O
CpG	NN	compound	O
island	NN	dobj	O
,	,	punct	O
with	IN	case	O
several	JJ	amod	O
GC	NN	compound	B-DNA
boxes	NNS	nmod	I-DNA
,	,	punct	O
a	DT	det	O
putative	JJ	amod	O
NF-kappa	NN	compound	B-DNA
B-binding	JJ	amod	I-DNA
site	NN	appos	I-DNA
,	,	punct	O
and	CC	cc	O
a	DT	det	O
CAAT	NN	compound	B-DNA
box	NN	conj	I-DNA
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
TATA	NN	compound	B-DNA
box	NN	conj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
a	DT	det	O
physical	JJ	amod	O
interaction	NN	dobj	O
between	IN	case	O
Tax	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
HsN3	NN	compound	B-protein
subunit	NN	conj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
proteasome	NN	nmod	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
reduced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
was	VBD	cop	O
not	RB	neg	O
the	DT	det	O
result	NN	ROOT	O
of	IN	case	O
a	DT	det	O
global	JJ	amod	O
TCR/CD3	JJ	compound	B-protein
-signaling	JJ	amod	O
defect	NN	nmod	O
because	IN	mark	O
CD3	NN	compound	B-protein
cross-linking	NN	nsubj	O
induced	VBD	advcl	O
an	DT	det	O
equivalent	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
intracellular-free	JJ	amod	O
calcium	NN	compound	O
ions	NNS	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
NFATp	NN	compound	B-protein
dephosphorylation	NN	conj	O
,	,	punct	O
translocation	NN	dobj	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	conj	O
in	IN	case	O
both	CC	cc:preconj	O
normal	JJ	amod	B-cell_type
and	CC	cc	O
anergic	JJ	conj	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Ciprofloxacin	NN	nsubj	O
increased	VBD	ROOT	O
CAT	NN	compound	B-protein
activity	NN	dobj	O
in	IN	case	O
stimulated	VBN	amod	O
lymphocytes	NNS	nmod	O
transfected	VBN	acl	O
with	IN	case	O
plasmids	NNS	nmod	B-cell_type
containing	VBG	acl	O
either	CC	cc:preconj	O
the	DT	det	O
IL-2	NN	compound	B-protein
or	CC	cc	O
metallothionein	NN	conj	B-DNA
enhancer	NN	dobj	I-DNA
.	.	punct	O

SR	JJ	amod	O
31747A	NN	nsubj	O
,	,	punct	O
defined	VBN	acl	O
as	IN	case	O
a	DT	det	O
sigma	NN	compound	O
ligand	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
immunosuppressive	JJ	amod	O
agent	NN	ROOT	O
that	WDT	nsubj	O
blocks	VBZ	acl:relcl	O
proliferation	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
mouse	NN	conj	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
decrease	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
levels	NNS	nmod	O
in	IN	case	O
cell	NN	nmod	O
may	MD	aux	O
involve	VB	ccomp	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
climacteric	JJ	amod	O
syndrome	NN	nmod	O
.	.	punct	O

In	IN	case	O
response	NN	dep	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
Wnt	NN	compound	O
signaling	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
beta-catenin	NN	nsubj	B-protein
accumulates	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
where	WRB	advmod	O
it	PRP	nsubj	O
cooperates	VBZ	advcl	O
with	IN	case	O
LEF/TCF	NN	compound	B-protein
(	-LRB-	punct	O
for	IN	case	O
lymphoid	JJ	amod	B-protein
enhancer	NN	compound	I-protein
factor	NN	dep	I-protein
and	CC	cc	I-protein
T-cell	NN	compound	I-protein
factor	NN	conj	I-protein
)	-RRB-	punct	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
to	TO	mark	O
activate	VB	xcomp	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Cotransfection	NN	nsubj	O
of	IN	case	O
a	DT	det	O
CD44	NN	compound	B-DNA
promoter-chloramphenicol	JJ	amod	I-DNA
acetyltransferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
with	IN	case	O
an	DT	det	O
egr-1	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
6.5-	CD	dep	O
to	TO	dep	O
8.5-fold	JJ	dep	O
induction	NN	nmod	O
of	IN	case	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
relative	JJ	case	O
to	TO	case	O
an	DT	det	O
empty	JJ	amod	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
.	.	punct	O

Pyrrolidine	NN	compound	O
dithiocarbamate	NN	nsubj	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
activation	NN	nmod	O
,	,	punct	O
prevents	VBZ	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
promyelocytic	JJ	amod	B-cell_line
leukemia	NN	compound	I-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
thymocytes	NNS	conj	B-cell_type
.	.	punct	O

The	DT	det	O
simplest	JJS	amod	O
model	NN	nsubj	O
to	TO	mark	O
explain	VB	acl	O
these	DT	det	O
results	NNS	dobj	O
is	VBZ	ROOT	O
that	IN	mark	O
anergy	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
complex	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
exert	VBP	acl:relcl	O
a	DT	det	O
cis-acting	JJ	amod	O
dominant	JJ	amod	O
negative	JJ	amod	O
regulatory	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
trans-activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
program	NN	nsubj	O
for	IN	case	O
recognition	NN	compound	O
NFAT	NN	compound	B-DNA
composite	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
is	VBZ	cop	O
available	JJ	ROOT	O
through	IN	case	O
the	DT	det	O
World	NNP	compound	O
Wide	NN	compound	O
Web	NN	nmod	O
(	-LRB-	punct	O
http	NN	appos	O
:	:	punct	O
//compel.bionet.nsc.ru/FunSite/CompelScan.html	NN	punct	O
and	CC	cc	O
http	NN	conj	O
:	:	punct	O
//transfac.gbf.de/dbsearch/funsitep/s_comp.html	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
showing	VBG	acl	O
that	IN	mark	O
15	CD	nummod	O
amino	NN	compound	O
acids	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
carboxyl-terminal	JJ	amod	B-protein
end	NN	nmod	I-protein
of	IN	case	O
NFATx1	NN	nmod	B-protein
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
its	PRP$	nmod:poss	O
maximum	JJ	compound	O
transactivation	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
cell	NN	compound	O
line	NN	dobj	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
stably	RB	advmod	O
transfected	VBN	acl:relcl	O
with	IN	case	O
a	DT	det	O
trimer	NN	nmod	O
of	IN	case	O
the	DT	det	O
NFAT-1	NN	compound	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
lac-Z	JJ	amod	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
screened	VBD	ROOT	O
for	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
NFAT	NN	compound	B-protein
-1-mediated	JJ	amod	O
beta-galactosidase	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Allergen-specific	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
clones	NNS	nsubjpass	I-cell_line
and	CC	cc	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
hybridomas	NNS	conj	I-cell_line
were	VBD	auxpass	O
established	VBN	dep	O
from	IN	case	O
the	DT	det	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
asthma	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
responses	NNS	nsubjpass	O
to	TO	case	O
various	JJ	amod	O
stimuli	NNS	nmod	O
were	VBD	auxpass	O
determined	VBN	conj	O
.	.	punct	O

Molecular	JJ	amod	O
,	,	punct	O
biochemical	JJ	conj	O
and	CC	cc	O
epidemiological	JJ	conj	O
evidence	NN	nsubj	O
implicate	VBP	ROOT	O
HTLV-I	NN	dobj	O
as	IN	case	O
an	DT	det	O
etiologic	JJ	amod	O
agent	NN	nmod	O
of	IN	case	O
adult	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
ATL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Immunoblot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
p50	NN	compound	O
subunit	NN	nsubjpass	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
MDMs	NNS	conj	B-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
wild-type	JJ	amod	B-protein
ZAP-70	NN	nmod	I-protein
induced	VBD	ROOT	O
constitutive	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
JNK1	NN	nmod	B-protein
was	VBD	auxpass	O
also	RB	advmod	O
significantly	RB	advmod	O
induced	VBN	ROOT	O
,	,	punct	O
with	IN	mark	O
JNK1	NN	compound	B-protein
protein	NN	compound	O
levels	NNS	nsubj	O
increasing	VBG	advcl	O
moderately	RB	advmod	O
during	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
TPA	NN	nmod	O
.	.	punct	O

Mobilization	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
activates	VBZ	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
encoding	VBG	acl	O
endothelial	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecules	NNS	dobj	I-protein
and	CC	cc	O
chemokines	NNS	conj	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
monocyte	NN	compound	O
infiltration	NN	nmod	O
critical	JJ	amod	O
in	IN	case	O
atherogenesis	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
reports	NNS	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
a	DT	det	O
previously	RB	advmod	O
unexpected	JJ	amod	O
variability	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
dominant	JJ	amod	B-cell_line
neoplastic	JJ	amod	I-cell_line
clone	NN	nmod	I-cell_line
in	IN	case	O
myeloproliferative	JJ	amod	O
disorders	NNS	nmod	O
(	-LRB-	punct	O
MPD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
intracellular	JJ	amod	O
parasite	NN	nsubj	O
Theileria	FW	compound	O
parva	FW	dep	O
secures	VBZ	ROOT	O
its	PRP$	poss	O
propagation	NN	dobj	O
and	CC	cc	O
spreads	VBZ	conj	O
through	IN	case	O
the	DT	det	O
infected	JJ	amod	O
animal	NN	nmod	O
by	IN	mark	O
infecting	VBG	advcl	O
and	CC	cc	O
transforming	VBG	conj	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
inducing	VBG	advcl	O
their	PRP$	nmod:poss	O
continuous	JJ	amod	O
proliferation	NN	dobj	O
and	CC	cc	O
rendering	VBG	conj	O
them	PRP	nsubj	O
metastatic	JJ	ccomp	O
.	.	punct	O

Specific	JJ	amod	O
complex	NN	compound	O
formation	NN	ROOT	O
between	IN	case	O
the	DT	det	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
bare	JJ	amod	I-protein
lymphocyte	NN	compound	I-protein
syndrome-associated	JJ	amod	I-protein
transactivators	NNS	nmod	I-protein
CIITA	NN	dep	B-protein
and	CC	cc	O
RFX5	NN	conj	B-protein
.	.	punct	O

Small-bowel	JJ	amod	O
resection	NN	nsubj	O
in	IN	case	O
ileostomized	JJ	amod	O
patients	NNS	nmod	O
causes	VBZ	ROOT	O
excessive	JJ	amod	O
fecal	JJ	amod	O
sodium	NN	compound	O
losses	NNS	dobj	O
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
chronic	JJ	amod	O
sodium	NN	compound	O
depletion	NN	nmod	O
with	IN	case	O
contraction	NN	nmod	O
of	IN	case	O
the	DT	det	O
plasma	NN	compound	O
volume	NN	nmod	O
and	CC	cc	O
severe	JJ	amod	O
secondary	JJ	amod	O
hyperaldosteronism	NN	conj	O
.	.	punct	O

In	IN	case	O
FCS-	JJ	amod	B-cell_line
liquid-suspension	NN	compound	I-cell_line
culture	NN	nmod	I-cell_line
supplemented	VBN	acl	O
with	IN	case	O
saturating	JJ	amod	O
Ep	NN	compound	B-protein
level	NN	nmod	O
and	CC	cc	O
low-dose	JJ	amod	B-protein
IL-3/GM-CSF	NN	conj	I-protein
,	,	punct	O
adult	JJ	amod	O
HPC	NN	nsubj	B-cell_type
undergo	VBP	ROOT	O
unilineage	JJ	amod	O
erythropoietic	JJ	amod	O
differentiation	NN	dobj	O
:	:	punct	O
Here	RB	advmod	O
again	RB	advmod	O
,	,	punct	O
treatment	NN	nsubj	O
with	IN	case	O
high-dose	JJ	amod	O
RA	NN	nmod	O
induces	VBZ	parataxis	O
a	DT	det	O
shift	NN	dobj	O
from	IN	case	O
the	DT	det	O
erythroid	JJ	amod	O
to	TO	dep	O
granulocytic	JJ	dep	O
differentiation	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Apoptosis	NN	nsubj	O
is	VBZ	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
removal	NN	nmod	O
of	IN	case	O
potentially	RB	advmod	O
autoreactive	JJ	amod	O
or	CC	cc	O
useless	JJ	conj	O
T	NN	compound	O
cells	NNS	nmod	O
during	IN	case	O
thymic	JJ	amod	O
selection	NN	nmod	O
and	CC	cc	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
in	IN	case	O
the	DT	det	O
periphery	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
within	IN	case	O
the	DT	det	O
B-cell	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
ERP	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ROOT	O
primarily	RB	advmod	O
at	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
B-lymphocyte	NN	compound	B-cell_type
development	NN	nmod	O
,	,	punct	O
and	CC	cc	O
expression	NN	compound	O
declines	VBZ	conj	O
drastically	RB	advmod	O
upon	IN	case	O
B-cell	NN	compound	O
maturation	NN	nmod	O
,	,	punct	O
correlating	VBG	advcl	O
with	IN	case	O
the	DT	det	O
enhancer	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
pi	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
UCSD-AML1	NN	nmod	B-cell_line
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
also	RB	advmod	O
identified	VBN	ROOT	O
fusion	NN	compound	B-RNA
transcripts	NNS	dobj	I-RNA
between	IN	case	O
the	DT	det	O
ecotropic	JJ	amod	B-DNA
viral	JJ	amod	I-DNA
insertion	NN	compound	I-DNA
site	NN	compound	I-DNA
I	CD	compound	I-DNA
(	-LRB-	punct	I-DNA
EVI1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
3q26	NN	nmod	B-DNA
and	CC	cc	O
GR6	NN	conj	B-DNA
and	CC	cc	O
between	IN	case	O
EVI1	NN	conj	B-DNA
and	CC	cc	O
Ribophorin	NN	conj	B-DNA
I	NNP	nummod	I-DNA
that	WDT	nsubj	O
maps	VBZ	acl:relcl	O
30	CD	nummod	O
kb	NN	nmod:npmod	O
telomeric	JJ	xcomp	O
to	TO	prep	O
GR6	NN	pobj	B-DNA
in	IN	case	O
3q21	NN	nmod	B-DNA
.	.	punct	O

Two	CD	nsubj	O
of	IN	case	O
these	DT	det	O
motifs	NNS	nmod	O
are	VBP	cop	O
part	NN	ROOT	O
of	IN	case	O
a	DT	det	O
highly	RB	advmod	O
conserved	VBN	amod	O
and	CC	cc	O
inducible	JJ	conj	O
dyad	NN	compound	B-DNA
symmetry	NN	compound	I-DNA
element	NN	nmod	I-DNA
shown	VBN	acl	O
previously	RB	advmod	O
to	TO	mark	O
control	VB	xcomp	O
a	DT	det	O
remote	JJ	amod	O
IL-2	NN	compound	B-DNA
enhancer	NN	dobj	I-DNA
and	CC	cc	O
the	DT	det	O
CD18	NN	compound	B-DNA
promoter	NN	conj	I-DNA
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
adhesive	JJ	amod	O
response	NN	nsubjpass	O
was	VBD	auxpass	O
elicited	VBN	ROOT	O
by	IN	case	O
TNF	NN	compound	O
alpha	NN	nmod	O
(	-LRB-	punct	O
100	CD	nummod	O
U/ml	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
inducers	NNS	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
adhesive	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
here	RB	advmod	O
used	VBN	advcl	O
as	IN	case	O
positive	JJ	amod	O
control	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
cloned	VBN	advcl	O
in	IN	case	O
multiple	JJ	amod	O
copies	NNS	nmod	O
this	DT	det	O
so-called	JJ	amod	O
TCEd	NN	nsubj	B-DNA
(	-LRB-	punct	O
distal	JJ	amod	B-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
element	NN	appos	I-DNA
)	-RRB-	punct	O
acts	VBZ	ROOT	O
as	IN	case	O
an	DT	det	O
inducible	JJ	amod	O
proto-enhancer	NN	compound	B-DNA
element	NN	nmod	I-DNA
in	IN	case	O
E14	NN	compound	B-cell_line
T	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Being	VBG	cop	O
compatible	JJ	advcl	O
with	IN	case	O
those	DT	det	O
results	NNS	nmod	O
,	,	punct	O
Azeptin	NN	nsubj	O
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	nummod	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
suppressed	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
PBL	NN	nmod	B-cell_type
,	,	punct	O
HM	NNS	conj	O
and	CC	cc	O
HF	NNS	conj	B-cell_type
.	.	punct	O

Altogether	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
atypical	JJ	amod	B-protein
PKC	NN	compound	I-protein
isoenzymes	NNS	nsubj	I-protein
,	,	punct	O
including	VBG	case	O
PKC-zeta	NN	nmod	B-protein
,	,	punct	O
participate	VBP	ccomp	O
in	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
by	IN	case	O
which	WDT	nmod	O
HIV	NN	compound	O
infection	NN	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

The	DT	det	O
strong	JJ	amod	O
association	NN	nsubj	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
with	IN	case	O
an	DT	det	O
epitope	NN	nmod	B-protein
within	IN	case	O
the	DT	det	O
HLA-DR	NN	compound	B-protein
chain	NN	nmod	I-protein
shared	VBN	acl	O
between	IN	case	O
various	JJ	amod	O
alleles	NNS	nmod	O
of	IN	case	O
HLA-DR4	NN	nmod	B-protein
and	CC	cc	O
DR1	NN	conj	B-protein
emphasizes	VBZ	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
antigen	NN	compound	O
presentation	NN	nmod	O
.	.	punct	O

Thrombin	NN	nsubj	B-protein
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
platelet	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
hemostasis	NN	conj	O
,	,	punct	O
and	CC	cc	O
thrombosis	NN	conj	O
.	.	punct	O

Where	WRB	advmod	O
this	DT	det	O
function	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
suppressor	NN	compound	I-protein
proteins	NNS	nmod	I-protein
is	VBZ	cop	O
impaired	JJ	advcl	O
,	,	punct	O
the	DT	det	O
capacity	NN	nsubjpass	O
for	IN	case	O
differentiation	NN	nmod	O
is	VBZ	auxpass	O
lost	VBN	ROOT	O
,	,	punct	O
which	WDT	nsubj	O
leads	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
sustained	JJ	amod	O
proliferation	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
characteristic	JJ	acl:relcl	O
of	IN	case	O
the	DT	det	O
cancer	NN	compound	B-cell_type
cell	NN	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
HePTP	NN	nsubj	B-protein
had	VBD	ROOT	O
no	DT	neg	O
effects	NNS	dobj	O
on	IN	case	O
N-terminal	JJ	amod	B-protein
c-Jun	NN	compound	I-protein
kinase	NN	nmod	I-protein
or	CC	cc	O
on	IN	case	O
events	NNS	conj	O
upstream	RB	amod	O
of	IN	case	O
the	DT	det	O
MAP	NN	compound	O
kinases	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
PU.1	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
is	VBZ	auxpass	O
upregulated	VBN	ccomp	O
during	IN	case	O
myeloid	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_line
purified	VBN	amod	I-cell_line
CD34+	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
murine	JJ	amod	B-cell_line
multipotential	JJ	amod	I-cell_line
FDCP-mix	NN	compound	I-cell_line
A4	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
PU.1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
upregulated	VBN	ccomp	O
as	IN	case	O
an	DT	det	O
early	JJ	amod	O
event	NN	nmod	O
during	IN	case	O
differentiation	NN	nmod	O
of	IN	case	O
multipotential	JJ	amod	B-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubjpass	O
of	IN	case	O
HS2	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
function	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
binding	VBG	amod	B-protein
sites	NNS	nmod	I-protein
determined	VBN	advcl	O
using	VBG	xcomp	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
dihydrotestosterone	NN	dobj	O
,	,	punct	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
RU-1881	NN	conj	O
,	,	punct	O
or	CC	cc	O
[	-LRB-	punct	O
3H	NN	conj	O
]	-RRB-	punct	O
testosterone	NN	nsubj	O
were	VBD	cop	O
comparable	JJ	ROOT	O
.	.	punct	O

Although	IN	mark	O
TR55	NN	compound	B-protein
expression	NN	nsubj	O
was	VBD	cop	O
unaltered	JJ	advcl	O
during	IN	case	O
TNF-alpha	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
HIV	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
this	DT	det	O
receptor	NN	nsubjpass	O
was	VBD	auxpass	O
still	RB	advmod	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
viral	JJ	amod	O
activation	NN	compound	O
process	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
a	DT	det	O
T-lymphocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
with	IN	case	O
micromolar	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
HOCl	NN	nmod	O
promoted	VBD	ROOT	O
the	DT	det	O
appearance	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	B-protein
(	-LRB-	punct	O
the	DT	det	O
heterodimer	NN	compound	B-protein
p50/p65	NN	appos	I-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
was	VBD	ROOT	O
prominently	RB	advmod	O
and	CC	cc	O
selectively	RB	advmod	O
(	-LRB-	punct	O
within	IN	case	O
the	DT	det	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	attr	O
)	-RRB-	punct	O
expressed	VBN	advcl	O
in	IN	case	O
pyramidal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
the	DT	det	O
cerebral	JJ	amod	O
cortex	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
motor	NN	compound	B-cell_type
neurons	NNS	conj	I-cell_type
,	,	punct	O
e.g.	FW	advmod	O
,	,	punct	O
in	IN	case	O
spinal	JJ	amod	O
cord	NN	compound	O
and	CC	cc	O
brainstem	NN	conj	O
nuclei	NNS	nmod	O
.	.	punct	O

Increases	NNS	nsubjpass	O
in	IN	case	O
CAT	NN	compound	B-protein
activity	NN	nmod	O
during	IN	case	O
transient	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
these	DT	det	O
constructs	NNS	nmod	O
in	IN	case	O
TPA-treated	JJ	amod	B-cell_line
U-937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
could	MD	aux	O
be	VB	auxpass	O
assigned	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
region	NN	nmod	O
(	-LRB-	punct	O
-97	CD	compound	O
to	TO	dep	O
-20	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
promoter	NN	nmod	B-DNA
that	WDT	nsubj	O
contains	VBZ	acl:relcl	O
the	DT	det	O
AP-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
hormone-dependent	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
Tax	NN	nmod	B-protein
promotes	VBZ	ccomp	O
an	DT	det	O
enhanced	VBN	amod	O
prooxidant	JJ	amod	O
state	NN	dobj	O
in	IN	case	O
stably	RB	advmod	B-cell_line
transfected	VBN	amod	I-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
intracellular	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
glutathione	NN	nmod	O
and	CC	cc	O
H2O2	NN	conj	O
;	:	punct	O
these	DT	det	O
changes	NNS	nsubjpass	O
are	VBP	auxpass	O
followed	VBN	parataxis	O
by	IN	case	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O

Rather	RB	advmod	O
,	,	punct	O
squirrel	NN	compound	O
monkeys	NNS	nsubj	O
express	VBP	ROOT	O
a	DT	det	O
soluble	JJ	amod	O
factor	NN	dobj	O
that	WDT	nsubj	O
,	,	punct	O
in	IN	case	O
mixing	JJ	amod	O
studies	NNS	nmod	O
of	IN	case	O
cytosol	NN	nmod	O
from	IN	case	O
squirrel	NN	compound	B-cell_type
monkey	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
SML	NNS	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
mouse	NN	compound	O
L929	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
reduced	VBD	acl:relcl	O
GR	NN	compound	O
binding	NN	compound	O
affinity	NN	dobj	O
by	IN	case	O
11-fold	JJ	nmod	O
.	.	punct	O

Lipopolysaccharide	NN	compound	O
induction	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-DNA
necrosis	NN	compound	I-DNA
factor-alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
LPS	NN	compound	O
activation	NN	nsubj	O
of	IN	case	O
JNK	NN	nmod	B-protein
in	IN	case	O
monocyte/macrophage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
a	DT	det	O
CD14-	NN	amod	O
and	CC	cc	O
protein	NN	nmod:npmod	O
tyrosine	NN	nmod:npmod	O
phosphorylation-dependent	JJ	conj	O
event	NN	ccomp	O
that	WDT	nsubj	O
may	MD	aux	O
mediate	VB	acl:relcl	O
the	DT	det	O
early	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
AP-1	NN	nmod	B-protein
in	IN	mark	O
regulating	VBG	acl	O
LPS-triggered	JJ	amod	O
gene	NN	compound	O
induction	NN	dobj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	IN	case	O
JAK-1-deficient	JJ	amod	B-cell_line
HeLa	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
STAT6	NN	compound	B-protein
activation	NN	nsubjpass	O
by	IN	case	O
IL-4	NN	nmod	B-protein
is	VBZ	auxpass	O
completely	RB	advmod	O
abolished	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
enforced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
Bcl-2	NN	nmod	B-protein
inhibited	VBD	ROOT	O
triptolide-induced	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
PARP	NN	nmod	B-protein
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

In	IN	case	O
pre-B	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
Ba/F3	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
transactivation	NN	compound	O
domain	NN	nsubj	O
of	IN	case	O
Stat6	NN	nmod	B-protein
was	VBD	auxpass	O
IL-4	NN	nmod:npmod	B-protein
regulated	VBN	ROOT	O
,	,	punct	O
independently	RB	advmod	O
from	IN	case	O
its	PRP$	nmod:poss	O
DNA	NN	compound	O
binding	NN	compound	O
function	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
JunB	NN	nsubjpass	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
other	JJ	amod	O
Jun	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	conj	I-protein
,	,	punct	O
was	VBD	auxpass	O
selectively	RB	advmod	O
induced	VBN	ccomp	O
in	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
not	RB	neg	O
in	IN	case	O
Th1	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
during	IN	case	O
differentiation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
generated	VBN	ROOT	O
rabbit	NN	compound	O
antisera	NNS	dobj	O
against	IN	case	O
this	DT	det	O
putative	JJ	amod	O
p13MTCP1	NN	compound	B-protein
protein	NN	nmod	I-protein
and	CC	cc	O
screened	VBN	conj	O
for	IN	case	O
expression	NN	nmod	O
of	IN	case	O
p13MTCP1	NN	compound	B-protein
normal	JJ	amod	O
lymphoid	JJ	amod	O
tissues	NNS	nmod	O
and	CC	cc	O
33	CD	nummod	O
cases	NNS	conj	O
of	IN	case	O
immature	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
mature	JJ	conj	I-cell_type
lymphoid	JJ	amod	I-cell_type
T-cell	NN	compound	I-cell_type
proliferations	NNS	nmod	I-cell_type
using	VBG	acl	O
a	DT	det	O
sensitive	JJ	amod	O
Western	NN	compound	O
blot	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

6.	LS	cc	O
Partitioning	NN	nsubj	O
of	IN	case	O
SMX-NHOH	NN	nmod	O
into	IN	case	O
red	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	cop	O
significantly	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	amod	O
0.05	CD	nummod	O
)	-RRB-	punct	O
lower	JJR	ROOT	O
than	IN	case	O
with	IN	case	O
the	DT	det	O
hydroxylamine	NN	nmod	O
of	IN	case	O
dapsone	NN	nmod	O
.	.	punct	O

The	DT	det	O
GS	NN	compound	O
strain	NN	nsubj	O
transactivated	VBD	ROOT	O
the	DT	det	O
promoter	NN	dobj	B-DNA
in	IN	case	O
both	CC	cc:preconj	O
stimulated	VBN	amod	O
and	CC	cc	O
resting	VBG	conj	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
while	IN	mark	O
the	DT	det	O
Z29	NN	compound	O
strain	NN	nsubj	O
increased	VBD	advcl	O
HIV	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
only	RB	advmod	O
in	IN	case	O
stimulated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
reasoned	VBD	ROOT	O
that	IN	mark	O
selective	JJ	amod	O
IFN	NN	compound	B-protein
responsiveness	NN	nsubj	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
STAT	NN	compound	B-protein
family	NN	compound	I-protein
member	NN	nmod	I-protein
(	-LRB-	punct	O
Stat1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
Stat1-dependent	JJ	amod	B-DNA
immune-response	JJ	amod	I-DNA
genes	NNS	conj	I-DNA
such	JJ	case	O
as	IN	mwe	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
(	-LRB-	punct	O
ICAM-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
IFN	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor-1	NN	conj	I-protein
(	-LRB-	punct	O
IRF-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
Stat1	NN	compound	B-protein
itself	PRP	conj	O
in	IN	case	O
airway	NN	compound	B-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
provides	VBZ	ccomp	O
a	DT	det	O
basis	NN	dobj	O
for	IN	mark	O
detecting	VBG	acl	O
cytokine	NN	compound	B-protein
signaling	NN	compound	O
abnormalities	NNS	dobj	O
in	IN	case	O
inflammatory	JJ	amod	O
airway	NN	compound	O
disease	NN	nmod	O
.	.	punct	O

One	CD	nummod	O
interpretation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
data	NNS	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
model	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
peak	NN	nsubj	O
in	IN	case	O
GATA-1	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	nmod	O
amplifies	VBZ	acl:relcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
replication	NN	nmod	O
on	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
erythroid-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
at	IN	case	O
the	DT	det	O
same	JJ	amod	O
time	NN	nmod	O
as	IN	mark	O
preventing	VBG	advcl	O
activation	NN	dobj	O
of	IN	case	O
non-erythroid	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
containing	VBG	acl	O
GATA-responsive	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
.	.	punct	O

In	IN	case	O
a	DT	det	O
previous	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
bufalin	NN	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
an	DT	det	O
active	JJ	amod	O
principle	NN	acl:relcl	O
of	IN	case	O
Chinese	JJ	amod	O
medicine	NN	nmod	O
,	,	punct	O
chan'su	NN	appos	O
,	,	punct	O
caused	VBD	ccomp	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_line
leukemia	NN	compound	I-cell_line
U937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
anomalous	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
via	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
of	IN	case	O
Ras	NN	nmod	B-protein
,	,	punct	O
Raf-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
MAPK	NN	compound	B-protein
kinase-1	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
levels	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
increases	NNS	nmod	O
in	IN	case	O
the	DT	det	O
amounts	NNS	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
mRNAs	NNS	nmod	B-RNA
during	IN	case	O
LPS	NN	compound	O
activation	NN	nmod	O
of	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
all	DT	det	O
cells	NNS	nmod	O
tested	VBN	acl	O
,	,	punct	O
ER	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
expressed	VBN	dep	O
without	IN	case	O
prior	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
stimulation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
argue	VBP	ROOT	O
that	IN	mark	O
in	FW	amod	O
vivo	FW	dep	O
RelA	NN	compound	B-protein
homodimers	NNS	nsubj	I-protein
are	VBP	cop	O
likely	JJ	ccomp	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
dominant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
TNF-alpha	NN	compound	B-protein
-induced	JJ	amod	O
ICAM-1	NN	compound	B-protein
transcription	NN	nmod	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
cellular	JJ	amod	O
or	CC	cc	O
molecular	JJ	conj	B-protein
factors	NNS	nsubj	I-protein
responsible	JJ	amod	O
for	IN	case	O
a	DT	det	O
delay	NN	nmod	O
in	IN	case	O
B-CLL	NN	compound	O
cell	NN	compound	O
death	NN	nmod	O
are	VBP	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
p38alpha	NN	compound	B-protein
MAPk	NN	nmod	I-protein
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
transient	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
TNF-alpha	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
accumulation	NN	nmod	O
but	CC	cc	O
persistent	JJ	amod	O
loss	NN	conj	O
of	IN	case	O
TNF-alpha	NN	compound	B-protein
synthesis	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
IL-2	NN	nsubj	B-protein
and	CC	cc	O
IL-7	NN	conj	B-protein
induced	VBD	ROOT	O
substantial	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
STAT5A	NN	compound	B-protein
/STAT5B	NN	compound	B-protein
heterodimerization	NN	nmod	O
.	.	punct	O

These	DT	det	O
two	CD	nummod	O
related	JJ	amod	O
genes	NNS	nsubj	O
share	VBP	ROOT	O
the	DT	det	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
region	NN	dobj	O
encoding	VBG	acl	O
the	DT	det	O
Runt	NN	compound	B-protein
domain	NN	dobj	I-protein
.	.	punct	O

ZEBRA	NN	nsubj	B-protein
,	,	punct	O
a	DT	det	O
transcriptional	JJ	amod	O
activator	NN	appos	O
,	,	punct	O
initiates	VBZ	ROOT	O
the	DT	det	O
EBV	NN	compound	O
lytic	JJ	amod	O
cascade	NN	dobj	O
by	IN	mark	O
activating	VBG	advcl	O
viral	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Concomitant	JJ	advcl	O
with	IN	case	O
receptor	NN	compound	O
oligomerization	NN	nmod	O
,	,	punct	O
the	DT	det	O
IL-1R-associated	JJ	amod	B-protein
kinase	NN	nsubjpass	I-protein
(	-LRB-	punct	I-protein
IRAK	NN	appos	I-protein
)	-RRB-	punct	I-protein
is	VBZ	auxpass	O
recruited	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
TLR2	NN	compound	B-protein
complex	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
the	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
IL-10	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
protooncogene	NN	compound	B-DNA
c-fos	NN	nmod	I-DNA
was	VBD	auxpass	O
investigated	VBN	ROOT	O
,	,	punct	O
because	IN	mark	O
Fos	NN	nsubj	O
plays	VBZ	advcl	O
a	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
B	NN	compound	O
cell	NN	nmod	O
proliferation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
cycloheximide	NN	nsubj	O
prevented	VBD	ROOT	O
the	DT	det	O
p65	NN	compound	B-protein
and	CC	cc	O
c-rel	NN	conj	B-protein
translocation	NN	dobj	O
and	CC	cc	O
consequent	JJ	amod	O
formation	NN	conj	O
of	IN	case	O
active	JJ	amod	O
binding	NN	compound	O
heterodimers	NNS	nmod	O
,	,	punct	O
at	IN	case	O
early	JJ	amod	O
and	CC	cc	O
late	JJ	conj	O
times	NNS	nmod	O
.	.	punct	O

As	IN	case	O
a	DT	det	O
result	NN	nmod	O
,	,	punct	O
G1-S-associated	JJ	amod	B-DNA
DNA	NN	nsubjpass	I-DNA
and	CC	cc	O
mRNA	NN	compound	O
synthesis	NN	conj	O
is	VBZ	auxpass	O
inhibited	VBN	ROOT	O
,	,	punct	O
growth	NN	conj	O
uncoupled	VBD	acl	O
from	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
maturation	NN	nsubj	O
enabled	VBD	conj	O
to	TO	mark	O
proceed	VB	xcomp	O
.	.	punct	O

p38	NN	nsubj	B-protein
and	CC	cc	O
p63	NN	conj	B-protein
may	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
docking	VBG	amod	O
site	NN	dobj	O
for	IN	case	O
Grb2	NN	nmod	B-protein
,	,	punct	O
thereby	RB	advmod	O
linking	VBG	advcl	O
Grb2	NN	compound	B-protein
SH3-binding	JJ	amod	I-protein
proteins	NNS	dobj	I-protein
SOS1	NN	dep	B-protein
,	,	punct	O
SLP-76	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p120	NN	conj	B-protein
to	TO	case	O
downstream	JJ	amod	O
signalling	NN	amod	O
events	NNS	nmod	O
.	.	punct	O

The	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
events	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
gp120	NN	compound	B-protein
-mediated	JJ	amod	O
enhancement	NN	nmod	O
of	IN	case	O
ICAM-1	NN	nmod	B-protein
appear	VBP	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
activation	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
and	CC	cc	O
tyrosine	NN	compound	B-protein
kinase	NN	conj	I-protein
,	,	punct	O
because	IN	mark	O
inhibitors	NNS	nsubj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
and	CC	cc	O
tyrosine	NN	compound	B-protein
kinase	NN	conj	I-protein
abrogate	VBP	advcl	O
gp120	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
ICAM-1	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
astrocytes	NNS	nmod	B-cell_type
and	CC	cc	O
microglia	NNS	conj	B-cell_type
.	.	punct	O

To	TO	mark	O
interpret	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
EBV	NN	nsubj	O
activates	VBZ	acl:relcl	O
the	DT	det	O
cell	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
assayed	VBN	ROOT	O
many	JJ	amod	O
proteins	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
G0	NN	compound	O
and	CC	cc	O
G1	NN	conj	O
phases	NNS	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Major	JJ	amod	O
recent	JJ	amod	O
developments	NNS	nsubjpass	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
identification	NN	nmod	O
of	IN	case	O
novel	JJ	amod	O
families	NNS	nmod	O
of	IN	case	O
transcription	NN	compound	B-DNA
factors	NNS	nmod	I-DNA
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
multiple	JJ	amod	O
T-cell	NN	compound	B-DNA
genes	NNS	dobj	I-DNA
during	IN	case	O
thymocyte	NN	compound	O
ontogeny	NN	nmod	O
and	CC	cc	O
T-cell	NN	compound	B-cell_type
activation	NN	conj	O
,	,	punct	O
are	VBP	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
this	DT	det	O
domain	NN	nsubj	O
conferred	VBD	ROOT	O
enhancing	NN	compound	O
activity	NN	dobj	O
when	WRB	advmod	O
fused	VBN	advcl	O
to	TO	case	O
the	DT	det	O
Oct1	NN	compound	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
by	IN	case	O
itself	PRP	nmod	O
was	VBD	cop	O
unable	JJ	acl:relcl	O
to	TO	mark	O
stimulate	VB	xcomp	O
from	IN	case	O
a	DT	det	O
remote	JJ	amod	O
position	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
it	PRP	nsubj	O
acts	VBZ	ROOT	O
as	IN	case	O
a	DT	det	O
dehydratase	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
regeneration	NN	nmod	O
of	IN	case	O
tetrahydrobiopterin	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
cofactor	NN	appos	O
for	IN	case	O
aromatic	JJ	amod	B-protein
amino	NN	compound	I-protein
acid	NN	compound	I-protein
hydroxylases	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
female	JJ	amod	O
steroid	NN	compound	O
hormones	NNS	nsubjpass	O
estrogen	NN	dep	O
(	-LRB-	punct	O
E2	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
progesterone	NN	conj	O
(	-LRB-	punct	O
Prog	NN	appos	O
)	-RRB-	punct	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
modulate	VB	xcomp	O
the	DT	det	O
reactivity	NN	dobj	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
;	:	punct	O
recently	RB	advmod	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	parataxis	O
that	IN	mark	O
they	PRP	nsubj	O
can	MD	aux	O
regulate	VB	ccomp	O
induction	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
osteoblasts	NNS	conj	B-cell_type
.	.	punct	O

Induction	NN	ROOT	O
of	IN	case	O
interleukin-12	NN	compound	B-protein
p40	NN	compound	B-RNA
transcript	NN	nmod	I-RNA
by	IN	case	O
CD40	NN	compound	B-protein
ligation	NN	nmod	O
via	IN	case	O
activation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
.	.	punct	O

Requirements	NNS	ROOT	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D-mediated	JJ	amod	O
gene	NN	compound	O
regulation	NN	nmod	O
in	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
this	DT	det	O
complex	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
cyclosporin-sensitive	JJ	advcl	O
,	,	punct	O
promoter	NN	compound	O
induction	NN	nsubjpass	O
is	VBZ	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
cyclosporin	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

The	DT	det	O
CCAAT	NN	compound	B-DNA
element	NN	nsubj	I-DNA
present	JJ	amod	O
in	IN	case	O
reverse	JJ	amod	O
orientation	NN	nmod	O
in	IN	case	O
this	DT	det	O
promoter	NN	compound	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
ferritin	NN	compound	B-DNA
H-chain	NN	compound	I-DNA
gene	NN	nmod	I-DNA
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	case	O
binding	VBG	nmod	O
and	CC	cc	O
for	IN	case	O
gene	NN	compound	O
activity	NN	conj	O
,	,	punct	O
since	IN	mark	O
a	DT	det	O
single	JJ	amod	O
point	NN	compound	O
mutation	NN	nsubj	O
is	VBZ	cop	O
able	JJ	advcl	O
to	TO	mark	O
abolish	VB	xcomp	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
HRF	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	conj	O
in	IN	case	O
transfected	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Further	JJ	amod	O
studies	NNS	nsubjpass	O
were	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	advmod	O
using	VBG	xcomp	O
differential	JJ	amod	O
RNA	NN	compound	O
display	NN	dobj	O
(	-LRB-	punct	O
DD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
PNU156804	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
inhibit	VB	ccomp	O
c-myc	NN	dobj	O
and	CC	cc	O
bcl-2	NN	conj	O
mRNA	NN	compound	O
induction	NN	dep	O
.	.	punct	O

Partial	JJ	amod	O
cortisol	NN	compound	O
receptor	NN	compound	O
resistance	NN	nsubj	O
might	MD	aux	O
be	VB	cop	O
less	RBR	advmod	O
rare	JJ	ROOT	O
than	IN	mark	O
previously	RB	advmod	O
thought	VBN	advcl	O
.	.	punct	O

Escape	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	O
cytomegalovirus	NN	nmod	O
from	IN	case	O
HLA-DR	NN	compound	B-protein
-restricted	JJ	amod	O
CD4	NN	nmod	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
T-cell	NN	compound	O
response	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
repression	NN	nmod	O
of	IN	case	O
gamma	NN	compound	B-protein
interferon	NN	compound	I-protein
-induced	JJ	amod	O
class	NN	compound	B-protein
II	CD	nummod	I-protein
transactivator	NN	compound	I-protein
expression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediates	NNS	nmod	O
(	-LRB-	punct	O
ROIs	NNS	appos	O
)	-RRB-	punct	O
in	IN	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
by	IN	case	O
proinflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
was	VBD	cop	O
cell	NN	nmod:npmod	O
specific	JJ	ccomp	O
.	.	punct	O

In	IN	case	O
cells	NNS	nmod	O
that	WDT	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
preincubated	VBN	acl:relcl	O
to	TO	mark	O
lower	JJR	amod	O
mRNA	NN	compound	O
levels	NNS	dobj	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
transient	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
G0S2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
peaking	VBG	advcl	O
between	IN	case	O
1-2	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
Concanavalin-A	NN	nmod	O
(	-LRB-	punct	O
ConA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
to	TO	case	O
the	DT	det	O
combination	NN	conj	O
of	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
(	-LRB-	punct	O
TPA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
calcium	NN	compound	O
ionophore	NN	conj	O
,	,	punct	O
ionomycin	NN	appos	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
C26	NN	compound	B-DNA
element	NN	nsubjpass	I-DNA
itself	PRP	dep	O
was	VBD	auxpass	O
profoundly	RB	advmod	O
activated	VBN	ROOT	O
upon	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
12-O-tetradecanoylphorbol-13-acetate	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
luciferase	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
stimulated	VBN	ROOT	O
after	IN	case	O
IFN-gamma	NN	compound	B-protein
treatment	NN	nmod	O
when	WRB	advmod	O
the	DT	det	O
construct	NN	nsubjpass	O
was	VBD	auxpass	O
transfected	VBN	advcl	O
in	IN	case	O
macrophage	NN	nmod	O
or	CC	cc	O
in	IN	case	O
epithelial	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
these	DT	det	O
sites	NNS	nmod	O
is	VBZ	cop	O
TRAF2	NN	ROOT	B-protein
,	,	punct	O
a	DT	det	O
signal	NN	compound	B-protein
transduction	NN	compound	I-protein
molecule	NN	appos	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
utilized	VBN	acl:relcl	O
by	IN	case	O
TNFR1	NN	nmod	B-protein
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
downstream	JJ	amod	O
kinases	NNS	nmod	B-protein
and	CC	cc	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
is	VBZ	auxpass	O
induced	VBN	advcl	O
by	IN	case	O
the	DT	det	O
same	JJ	amod	O
stimuli	NNS	nmod	O
that	WDT	nsubj	O
stimulate	VBP	acl:relcl	O
IL-2	NN	compound	B-protein
production	NN	dobj	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
immunosuppressant	JJ	amod	O
action	NN	nsubjpass	O
of	IN	case	O
CsA	NN	nmod	O
and	CC	cc	O
FK506	NN	conj	O
is	VBZ	auxpass	O
exerted	VBN	ccomp	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
these	DT	det	O
trans-activating	JJ	amod	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Glucocorticoid-induced	JJ	amod	O
apoptosis	NN	ROOT	O
of	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Transient-transfection	JJ	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
bcl-x	NN	compound	B-DNA
promoter	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
transactivated	VBN	ccomp	O
by	IN	case	O
wild-type	JJ	amod	B-protein
Tax	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
binding	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
AP-1	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
consists	VBZ	acl:relcl	O
of	IN	case	O
dimers	NNS	nmod	O
of	IN	case	O
Fos	NN	compound	B-protein
and	CC	cc	I-protein
Jun	NN	conj	I-protein
family	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
gel	NN	compound	O
shift	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
IgE	NN	compound	B-protein
switching	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
requires	VBZ	ROOT	O
several	JJ	amod	O
signals	NNS	dobj	O
given	VBN	acl	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
cell	NN	nmod:npmod	O
contact-delivered	JJ	amod	O
signals	NNS	conj	O
.	.	punct	O

Because	IN	mark	O
HIV-1	NN	nsubj	O
requires	VBZ	advcl	O
active	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
for	IN	case	O
efficient	JJ	amod	O
transcription	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
on	IN	case	O
the	DT	det	O
processing	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
105K	CD	nummod	I-protein
precursor	NN	nmod	I-protein
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
factors	NNS	dobj	O
controlling	VBG	acl	O
vascular-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
PECAM-1	NN	nmod	B-protein
,	,	punct	O
we	PRP	nsubj	O
cloned	VBD	ROOT	O
the	DT	det	O
5'-flanking	JJ	amod	B-DNA
region	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
PECAM-1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
analyzed	VBD	conj	O
its	PRP$	nmod:poss	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

By	IN	case	O
promoter	NN	compound	O
function	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
SAA	NN	compound	B-DNA
promoter	NN	compound	I-DNA
sequence	NN	nsubj	I-DNA
between	IN	case	O
-280	CD	nmod	O
and	CC	cc	O
-226	CD	conj	O
can	MD	aux	O
confer	VB	ccomp	O
LPS	NN	compound	O
responsiveness	NN	dobj	O
.	.	punct	O

From	IN	case	O
AML1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
two	CD	nummod	O
representative	JJ	amod	O
forms	NNS	nsubjpass	O
of	IN	case	O
proteins	NNS	nmod	O
,	,	punct	O
AML1a	NNS	appos	B-protein
and	CC	cc	O
AML1b	NNS	conj	B-protein
,	,	punct	O
are	VBP	auxpass	O
produced	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
alternative	JJ	amod	O
splicing	NN	nmod	O
.	.	punct	O

Mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
relevant	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
AP-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
eliminated	VBD	ROOT	O
these	DT	det	O
responses	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
their	PRP$	nmod:poss	O
activity	NN	dobj	O
after	IN	case	O
transfection	NN	nmod	O
into	IN	case	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
an	DT	det	O
erythroleukemia	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
with	IN	case	O
an	DT	det	O
embryonic-fetal	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
cotransfection	NN	nsubj	O
with	IN	case	O
a	DT	det	O
combination	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
significantly	RB	advmod	O
augmented	VBD	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
containing	VBG	acl	O
the	DT	det	O
GM-kappa	NN	compound	B-DNA
B/GC-box	NN	dobj	I-DNA
and	CC	cc	O
the	DT	det	O
CLE0	NN	conj	B-DNA
(	-LRB-	punct	O
AP-1/NF-AT	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Therefore	RB	advmod	O
we	PRP	nsubj	O
first	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
participation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
germline	NN	compound	B-cell_line
C	NN	compound	I-cell_line
epsilon	NN	compound	I-cell_line
transcription	NN	nmod	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
Burkitt	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
DND39	NN	appos	B-cell_line
.	.	punct	O

The	DT	det	O
sites	NNS	nsubj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
corresponding	JJ	amod	O
nuclear	JJ	amod	O
binding	NN	compound	O
factors	NNS	conj	O
include	VBP	ROOT	O
:	:	punct	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
AP-3	NN	conj	B-protein
,	,	punct	O
OCT-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
NF-AT	NN	conj	B-protein
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
majority	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
were	VBD	auxpass	O
expressed	VBN	ccomp	O
at	IN	case	O
comparable	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
U-937	NN	compound	B-cell_line
and	CC	cc	O
HeLa	NN	conj	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
T	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
with	IN	case	O
IL-12	NN	nmod	B-protein
induces	VBZ	ccomp	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
Janus	NN	compound	B-protein
family	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
JAK2	NN	nmod	B-protein
and	CC	cc	O
Tyk2	NN	conj	B-protein
,	,	punct	O
implicating	VBG	advcl	O
these	DT	det	O
kinases	NNS	dobj	B-protein
in	IN	case	O
the	DT	det	O
immediate	JJ	amod	O
biochemical	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
IL-12	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
MAPk	NN	compound	B-protein
kinase	NN	dobj	I-protein
(	-LRB-	punct	O
MKK	NN	appos	B-protein
)	-RRB-	punct	O
that	WDT	nsubj	O
activates	VBZ	acl:relcl	O
p38	NN	compound	B-protein
MAPk	NN	dobj	I-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
LPS	NN	nmod	O
,	,	punct	O
the	DT	det	O
p38	NN	compound	B-protein
MAPk	NN	compound	I-protein
isoforms	NNS	appos	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	acl:relcl	O
as	IN	case	O
part	NN	nmod	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
responses	NNS	conj	O
affected	VBN	acl	O
by	IN	case	O
p38	NN	compound	B-protein
MAPk	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
basis	NN	dobj	O
for	IN	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
in	IN	case	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
leukemic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
ATL	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

DNase	NN	compound	B-protein
I	CD	nummod	I-protein
footprinting	NN	nsubj	O
identified	VBD	ROOT	O
several	JJ	amod	O
protected	VBN	amod	O
areas	NNS	dobj	O
including	VBG	case	O
Sp1	NN	nmod	B-DNA
,	,	punct	I-DNA
Sp1/AP-2	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
cAMP	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	conj	I-DNA
(	-LRB-	punct	I-DNA
CRE	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
within	IN	case	O
the	DT	det	O
201-bp	JJ	amod	O
core	NN	compound	O
promoter	NN	compound	O
region	NN	nmod	O
and	CC	cc	O
Sp1	NN	conj	B-DNA
,	,	punct	I-DNA
NRE-2a	NN	conj	I-DNA
,	,	punct	I-DNA
TCF-1/LEF-1	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
Sp1/NF-AT	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
in	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
immunosuppressive	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
are	VBP	cop	O
largely	RB	advmod	O
due	JJ	case	O
to	TO	case	O
transcriptional	JJ	amod	O
inhibition	NN	ROOT	O
of	IN	case	O
immunologically	RB	advmod	B-DNA
relevant	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IL-2	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Transcription	NN	nsubjpass	O
from	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
when	WRB	advmod	O
either	CC	cc:preconj	O
the	DT	det	O
Elf-1	NN	nsubjpass	B-DNA
or	CC	cc	I-DNA
the	DT	det	I-DNA
HMG-I	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
Y	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
binding	NN	compound	I-DNA
site	NN	conj	I-DNA
was	VBD	auxpass	O
mutated	VBN	advcl	O
.	.	punct	O

B	NN	compound	B-cell_type
lymphocytes	NNS	nsubjpass	I-cell_type
from	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukaemia	NN	nmod	O
(	-LRB-	punct	O
CLL	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
analysed	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
presence	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	conj	O
of	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
which	WDT	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
gene	NN	compound	O
control	NN	nmod	O
of	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Monocyte-macrophage	JJ	amod	O
differentiation	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
model	NN	compound	O
system	NN	nmod	O
for	IN	mark	O
studying	VBG	acl	O
gene	NN	compound	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
vacuolar	NN	compound	I-protein
H	NN	nmod	I-protein
(	-LRB-	punct	I-protein
+	CC	cc	I-protein
)	-RRB-	punct	I-protein
-ATPase	NN	dep	I-protein
(	-LRB-	punct	O
V-ATPase	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Jak	NN	compound	B-protein
-Stat	NN	compound	B-protein
pathway	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
proliferative	JJ	amod	O
signaling	NN	nmod	O
by	IN	case	O
the	DT	det	O
G-CSFR	NN	nmod	B-protein
and	CC	cc	O
requires	VBZ	conj	O
the	DT	det	O
membrane-proximal	JJ	amod	B-protein
box	NN	compound	I-protein
1	CD	nummod	I-protein
PXP	NN	compound	I-protein
motif	NN	dobj	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
conserved	VBN	acl:relcl	O
in	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
receptor	NN	compound	I-protein
superfamily	NN	nmod	I-protein
.	.	punct	O

CD40	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
functional	JJ	amod	O
activation	NN	compound	B-protein
antigen	NN	ROOT	I-protein
and	CC	cc	O
B7-independent	JJ	amod	B-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
costimulatory	JJ	amod	I-protein
molecule	NN	conj	I-protein
on	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
lung	NN	compound	I-cell_type
fibroblasts	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
the	DT	det	O
PI3-K	NN	compound	B-protein
inhibitor	NN	nsubj	O
,	,	punct	O
wortmannin	NN	appos	O
,	,	punct	O
interferes	VBZ	ccomp	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
kinase	NN	nmod	I-protein
,	,	punct	O
Erk2	NN	appos	B-protein
,	,	punct	O
after	IN	case	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
TcR	NN	appos	B-protein
)	-RRB-	punct	O
stimulation	NN	nmod	O
.	.	punct	O

Cell-mediated	JJ	amod	O
immunity	NN	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
infection	NN	nmod	O
with	IN	case	O
the	DT	det	O
human	JJ	amod	O
cytomegalovirus	NN	nmod	O
(	-LRB-	punct	O
HCMV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
predominance	NN	nsubjpass	O
of	IN	case	O
p50	NN	compound	B-protein
NF-kappa	NN	compound	I-protein
B	NN	compound	I-protein
moieties	NNS	nmod	I-protein
and	CC	cc	O
possibly	RB	advmod	O
p50	NN	compound	B-protein
homodimers	NNS	conj	I-protein
or	CC	cc	O
closely	RB	advmod	O
related	JJ	amod	O
species	NNS	conj	O
,	,	punct	O
rather	RB	cc	O
than	IN	mwe	O
the	DT	det	O
p50-p56	NN	compound	B-protein
heterodimer	NN	conj	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
the	DT	det	O
predominant	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
species	NNS	acl:relcl	O
in	IN	case	O
most	JJS	amod	O
T	NN	nmod:npmod	B-cell_type
lymphocytic	JJ	amod	I-cell_type
and	CC	cc	I-cell_type
monocytic	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
U1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Overall	RB	advmod	O
therefore	RB	advmod	O
,	,	punct	O
exposure	NN	nsubj	O
to	TO	case	O
NSAIDs	NNS	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
profound	JJ	amod	O
switch	NN	nmod	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
with	IN	case	O
suppression	NN	nsubj	O
of	IN	case	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
macrophage	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
stress	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
HSF1	NN	conj	B-protein
appears	VBZ	parataxis	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
regulatory	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
these	DT	det	O
effects	NNS	nmod	O
.	.	punct	O

By	IN	mark	O
assaying	VBG	advcl	O
CAT	NN	compound	B-protein
enzyme	NN	compound	I-protein
activity	NN	dobj	O
across	IN	case	O
a	DT	det	O
24-h	JJ	amod	O
PRL	NN	compound	B-protein
induction	NN	compound	O
time	NN	compound	O
course	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
assign	VB	xcomp	O
G1	NN	compound	O
vs.	CC	cc	O
S	NN	conj	O
phase	NN	compound	O
PRL	NN	compound	B-protein
responses	NNS	dobj	O
of	IN	case	O
the	DT	det	O
IRF-1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
to	TO	case	O
different	JJ	amod	O
regions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
IRF-1	NN	intj	B-protein
5'-flanking	JJ	dep	B-DNA
and	CC	cc	O
promoter	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
organized	VBN	amod	O
structure	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
secondary	JJ	amod	O
lymphoid	JJ	amod	O
tissues	NNS	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
enhance	VB	xcomp	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
antigen	NN	compound	O
recognition	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
support	VB	conj	O
proper	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
activation	NN	nmod	O
and	CC	cc	O
maturation	NN	conj	O
of	IN	case	O
the	DT	det	O
antigen-responsive	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
ALY	NN	nmod	B-protein
stimulates	VBZ	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
TCR	NN	compound	B-protein
alpha	NN	compound	I-protein
enhancer	NN	compound	I-protein
complex	NN	nmod	I-protein
reconstituted	VBN	acl	O
in	IN	case	O
transfected	VBN	amod	B-cell_line
nonlymphoid	JJ	amod	I-cell_line
HeLa	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
whereas	IN	mark	O
down-regulation	NN	nsubj	O
of	IN	case	O
ALY	NN	nmod	B-protein
by	IN	case	O
anti-sense	JJ	amod	O
oligonucleotides	NNS	nmod	O
virtually	RB	advmod	O
eliminates	VBZ	advcl	O
TCR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
enhancer	NN	compound	I-DNA
activity	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
the	DT	det	O
DNA-binding	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-2	NN	nmod	B-protein
was	VBD	auxpass	O
slightly	RB	advmod	O
reduced	VBN	ROOT	O
by	IN	case	O
TPA	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
HL-60	NN	compound	O
differentiation	NN	nmod	O
but	CC	cc	O
unchanged	JJ	conj	O
during	IN	case	O
granulocyte	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

DNA	NN	compound	O
accessibility	NN	nsubj	O
to	TO	case	O
restriction	NN	compound	B-protein
enzymes	NNS	nmod	I-protein
within	IN	case	O
the	DT	det	O
chromosomal	JJ	amod	O
copy	NN	nmod	O
of	IN	case	O
the	DT	det	O
vitellogenin	NN	compound	B-DNA
gene	NN	compound	I-DNA
B1	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
shows	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
estrogen	NN	compound	B-DNA
responsive	JJ	amod	I-DNA
unit	NN	nsubj	I-DNA
and	CC	cc	O
the	DT	det	O
promoter	NN	compound	B-DNA
proximal	JJ	amod	I-DNA
region	NN	conj	I-DNA
are	VBP	cop	O
sensitive	JJ	ccomp	O
to	TO	case	O
digestion	NN	nmod	O
in	IN	case	O
uninduced	JJ	amod	O
and	CC	cc	O
estrogen-induced	JJ	conj	B-cell_type
hepatocytes	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
erythrocyte	NN	compound	O
nuclei	NNS	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
using	VBG	acl	O
specific	JJ	amod	B-protein
antibodies	NNS	dobj	I-protein
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
RXR	NN	compound	B-protein
alpha	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
blood	NN	compound	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
acute	JJ	amod	O
myeloid	JJ	amod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
AML	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
10	CD	nummod	O
cases	NNS	appos	O
)	-RRB-	punct	O
and	CC	cc	O
from	IN	case	O
myelomonocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
arrested	VBN	acl	O
at	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
.	.	punct	O

PU.1	NN	nsubjpass	B-protein
(	-LRB-	punct	O
spi-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
Ets	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
,	,	punct	O
is	VBZ	auxpass	O
predominantly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
myeloid	JJ	intj	B-cell_type
and	CC	cc	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
activates	VBZ	conj	O
many	JJ	amod	O
B	NN	compound	B-DNA
cell	NN	dobj	I-DNA
and	CC	cc	I-DNA
myeloid	JJ	amod	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
critical	JJ	conj	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
both	DT	nmod	O
of	IN	case	O
these	DT	det	O
lineages	NNS	nmod	O
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
B	NN	compound	B-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
activates	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
and	CC	cc	I-protein
differentiation	NN	conj	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Binding	NN	ROOT	O
of	IN	case	O
YY1	NN	nmod	B-protein
and	CC	cc	O
Oct1	NN	conj	B-protein
to	TO	case	O
a	DT	det	O
novel	JJ	amod	O
element	NN	nmod	O
that	WDT	nsubj	O
downregulates	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
IL-5	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Monocytes	NNS	nsubj	O
and	CC	cc	O
transformed	VBN	amod	B-cell_line
B-cells	NNS	conj	I-cell_line
normally	RB	advmod	O
express	VBP	ROOT	O
MNP-1	NN	dobj	B-protein
strongly	RB	advmod	O
and	CC	cc	O
MNP-2	NN	conj	B-protein
weakly	RB	advmod	O
,	,	punct	O
while	IN	mark	O
T-cells	NNS	nsubj	O
strongly	RB	advmod	O
express	VBP	advcl	O
only	RB	advmod	O
MNP-2	NN	dobj	B-protein
.	.	punct	O

Transcriptional	JJ	amod	O
targeting	NN	ROOT	O
of	IN	case	O
retroviral	JJ	amod	O
vectors	NNS	nmod	O
to	TO	case	O
the	DT	det	O
erythroblastic	JJ	amod	B-cell_type
progeny	NN	nmod	I-cell_type
of	IN	case	O
transduced	VBN	amod	B-cell_line
hematopoietic	JJ	amod	I-cell_line
stem	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Functional	JJ	amod	O
characterization	NN	ROOT	O
of	IN	case	O
novel	JJ	amod	O
IL-2	NN	compound	B-protein
transcriptional	JJ	amod	O
inhibitors	NNS	nmod	O
.	.	punct	O

Before	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
low	JJ	amod	O
shear	NN	nmod	O
(	-LRB-	punct	O
2	CD	nummod	O
dyn/cm2	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
6	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
HAEC	NNS	nsubjpass	B-cell_line
were	VBD	auxpass	O
preincubated	VBN	ROOT	O
with	IN	nmod	O
or	CC	cc	O
without	IN	case	O
the	DT	det	O
antioxidants	NNS	compound	O
pyrrolidine	NN	compound	O
dithiocarbamate	NN	nmod	O
(	-LRB-	punct	O
PDTC	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
N-acetyl-L-cysteine	NN	conj	O
(	-LRB-	punct	O
NAC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
EC	NN	compound	B-cell_type
costimulation	NN	nsubj	O
causes	VBZ	ccomp	O
increased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
as	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
increased	VBN	amod	O
IL-2	NN	compound	B-protein
transcription	NN	nmod	O
in	IN	case	O
PBL	NN	nmod	B-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
12-O-tetradecanoyl	NN	compound	O
phorbol	NN	compound	O
13-acetate	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
synergized	VBD	acl:relcl	O
to	TO	mark	O
fully	RB	advmod	O
activate	VB	xcomp	O
c-Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	dobj	I-protein
,	,	punct	O
was	VBD	cop	O
also	RB	advmod	O
sensitive	JJ	ROOT	O
to	TO	case	O
inhibition	NN	nmod	O
by	IN	case	O
forskolin	NN	nmod	O
.	.	punct	O

Stability	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
c-fos	NN	compound	B-DNA
and	CC	cc	O
c-jun	NN	conj	B-RNA
mRNA	NN	nmod	I-RNA
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
LTB4	NN	nmod	O
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
after	IN	case	O
actinomycin	NN	compound	O
D	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Estrogen	NN	nsubj	O
decreases	VBZ	ROOT	O
TNF	NN	compound	B-protein
gene	NN	compound	O
expression	NN	dobj	O
by	IN	mark	O
blocking	VBG	advcl	O
JNK	NN	compound	B-protein
activity	NN	dobj	O
and	CC	cc	O
the	DT	det	O
resulting	VBG	amod	O
production	NN	conj	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
and	CC	cc	O
JunD	NN	conj	B-protein
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
to	TO	mark	O
adverse	JJ	amod	O
environmental	JJ	amod	O
conditions	NNS	nmod	O
invokes	VBZ	ROOT	O
a	DT	det	O
genetically	RB	advmod	O
programmed	VBN	amod	O
series	NN	dobj	O
of	IN	case	O
events	NNS	nmod	O
resulting	VBG	acl	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
neutrophil	NN	compound	O
stimulation	NN	nsubj	O
with	IN	case	O
GM-CSF	NN	nmod	B-protein
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
a	DT	det	O
STAT5	NN	compound	B-protein
-containing	JJ	amod	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
normal	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
:	:	punct	O
effects	NNS	dep	O
of	IN	case	O
age	NN	nmod	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
season	NN	conj	O
,	,	punct	O
and	CC	cc	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentrations	NNS	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
detectable	JJ	amod	O
activation	NN	nsubj	O
in	IN	case	O
neutrophils	NNS	nmod	B-cell_type
of	IN	case	O
the	DT	det	O
recently	RB	advmod	O
cloned	VBN	amod	O
Jak3	NN	compound	B-protein
kinase	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
expressed	VBN	xcomp	O
at	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
as	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
undergo	VBP	conj	O
terminal	JJ	amod	O
neutrophilic	JJ	amod	O
maturation	NN	dobj	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
PKC-epsilon	NN	nsubj	B-protein
and	CC	cc	O
,	,	punct	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	appos	O
PKC-alpha	NN	dep	B-protein
but	CC	cc	O
not	RB	cc	O
-zeta	NN	conj	B-protein
,	,	punct	O
can	MD	aux	O
regulate	VB	ccomp	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
AP-1	NN	dep	B-protein
and	CC	cc	O
nuclear	JJ	amod	O
factor	NN	compound	B-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	conj	I-protein
(	-LRB-	punct	O
NF-AT-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
IL-2	NN	nsubj	B-protein
neither	CC	cc:preconj	O
activates	VBZ	ROOT	O
JNK	NN	dobj	B-protein
nor	CC	cc	O
increases	VBZ	conj	O
AP-1	NN	compound	B-protein
binding	NN	compound	O
activity	NN	dobj	O
to	TO	case	O
a	DT	det	O
consensus	NN	compound	O
o-tetradecanoylphorbol	NN	compound	B-DNA
13-acetate	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TPA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Three	CD	nummod	O
mouse	NN	compound	O
strains	NNS	nsubjpass	O
(	-LRB-	punct	O
C57BL/10SnJ	NN	dep	O
[	-LRB-	punct	O
H-2b	NN	appos	O
]	-RRB-	punct	O
,	,	punct	O
C3HeB/FeJ	NN	appos	O
[	-LRB-	punct	O
H-2k	NN	appos	O
]	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
BALB/cByJ	NN	conj	O
[	-LRB-	punct	O
H-2d	NN	appos	O
]	-RRB-	punct	O
)	-RRB-	punct	O
were	VBD	auxpass	O
immunized	VBN	ROOT	O
with	IN	case	O
wild-type	JJ	amod	O
Ad	NN	nmod	O
or	CC	cc	O
Ad	NN	compound	O
vectors	NNS	conj	O
lacking	VBG	acl	O
the	DT	det	O
immunodominant	JJ	amod	B-protein
antigen	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
CTL	NN	compound	B-cell_type
responses	NNS	nsubjpass	O
were	VBD	auxpass	O
measured	VBN	conj	O
.	.	punct	O

The	DT	det	O
change	NN	nsubj	O
in	IN	case	O
NF-kappaB	NN	compound	B-protein
components	NNS	nmod	I-protein
with	IN	case	O
monocyte	NN	compound	O
differentiation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
may	MD	aux	O
also	RB	advmod	O
explain	VB	ROOT	O
the	DT	det	O
different	JJ	amod	O
transcriptional	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	O
populations	NNS	nmod	O
in	IN	case	O
HIV-infected	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
BLPs	NNS	nsubj	B-protein
stimulated	VBD	ROOT	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	dobj	I-protein
,	,	punct	O
a	DT	det	O
transcriptional	JJ	amod	B-protein
activator	NN	appos	I-protein
of	IN	case	O
multiple	JJ	amod	B-DNA
host	NN	compound	I-DNA
defense	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
activated	VBD	conj	O
the	DT	det	O
respiratory	JJ	amod	O
burst	NN	dobj	O
through	IN	case	O
hTLR2	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
phenotypic	JJ	amod	O
drift	NN	nsubjpass	O
from	IN	case	O
latency	NN	nmod	O
I	NN	nummod	O
to	TO	case	O
latency	NN	nmod	O
III	CD	nummod	O
has	VBZ	aux	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
previously	RB	advmod	O
in	IN	case	O
some	DT	det	O
BL	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
model	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
isolated	VBN	amod	O
lung	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
can	MD	aux	O
be	VB	auxpass	O
submitted	VBN	acl:relcl	O
to	TO	case	O
a	DT	det	O
prolonged	JJ	amod	B-cell_line
cyclic	JJ	amod	I-cell_line
pressure-stretching	JJ	amod	I-cell_line
strain	NN	nmod	I-cell_line
resembling	VBG	acl	O
that	DT	dobj	O
of	IN	case	O
conventional	JJ	amod	O
mechanical	JJ	amod	O
ventilation	NN	nmod	O
.	.	punct	O

A	DT	det	O
human	JJ	amod	O
IL-5	NN	compound	B-DNA
promoter/enhancer	NN	compound	I-DNA
luciferase	NN	compound	I-DNA
gene	NN	compound	I-DNA
construct	NN	nsubjpass	I-DNA
transfected	VBN	acl	O
into	IN	case	O
IL-5-producing	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
was	VBD	auxpass	O
clearly	RB	advmod	O
transcribed	VBN	ROOT	O
after	IN	case	O
stimulation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
515	CD	nummod	O
base	NN	compound	O
pair	NN	compound	O
IL-5	NN	compound	B-DNA
gene	NN	compound	I-DNA
segment	NN	nsubj	I-DNA
upstream	JJ	advmod	O
of	IN	case	O
the	DT	det	O
coding	VBG	amod	O
region	NN	nmod	O
was	VBD	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
respond	VB	xcomp	O
to	TO	mark	O
activating	VBG	xcomp	O
signals	NNS	dobj	O
in	IN	case	O
human	JJ	amod	O
helper	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

SDS-PAGE	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	compound	B-protein
protein	NN	nmod	I-protein
has	VBZ	aux	O
shown	VBN	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
weight	NN	dobj	O
of	IN	case	O
approximately	RB	advmod	O
50	CD	nummod	O
kD	NN	nmod	O
.	.	punct	O

The	DT	det	O
BZLF1	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
(	-LRB-	punct	O
Zp	NN	appos	B-DNA
)	-RRB-	punct	O
was	VBD	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
crosslinking	VBG	nmod	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
immunoglobulin	NN	nmod	I-protein
(	-LRB-	punct	O
Ig	NN	appos	B-protein
)	-RRB-	punct	O
with	IN	case	O
anti-Ig	JJ	amod	B-protein
antibody	NN	nmod	I-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
other	JJ	amod	O
viral	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

DNA	NN	compound	O
band-shift	NN	compound	O
analysis	NN	nsubj	O
reveals	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
glial	JJ	amod	O
cells	NNS	nmod	O
that	WDT	nsubj	O
differs	VBZ	acl:relcl	O
from	IN	case	O
that	DT	nmod	O
present	JJ	amod	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Lipopolysaccharide	NN	nmod:npmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
-prestimulated	JJ	amod	O
and	CC	cc	O
untreated	JJ	conj	O
THP-1	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
cocultured	VBN	ROOT	O
with	IN	case	O
resting	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
umbilical	JJ	amod	I-cell_type
vein	NN	compound	I-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
HUVEC	NN	appos	B-cell_type
)	-RRB-	punct	O
for	IN	case	O
3	CD	nummod	O
and	CC	cc	O
24	CD	conj	O
h	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
colimycin	NN	nmod	O
to	TO	mark	O
neutralize	VB	xcomp	O
LPS	NN	compound	O
traces	NNS	dobj	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
patients	NNS	nmod	O
who	WP	nsubj	O
have	VBP	aux	O
received	VBN	acl:relcl	O
anti-estrogen	JJ	amod	O
therapy	NN	dobj	O
show	VBP	ROOT	O
similar	JJ	amod	O
enhancement	NN	dobj	O
of	IN	case	O
Ig-secreting	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
after	IN	case	O
PWM	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

ATRA	NN	nsubj	O
induces	VBZ	ROOT	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
differentiation	NN	dobj	O
of	IN	case	O
APL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
into	IN	case	O
mature	JJ	amod	B-cell_type
granulocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
MAD-3	NN	compound	B-DNA
cDNA	NN	nsubj	I-DNA
encodes	VBZ	ROOT	O
an	DT	det	O
I	NN	nmod:npmod	B-protein
kappa	NN	nmod:npmod	I-protein
B-like	JJ	amod	I-protein
protein	NN	dobj	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
likely	JJ	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
transcriptional	JJ	amod	O
responses	NNS	nmod	O
to	TO	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
including	VBG	case	O
adhesion-dependent	JJ	amod	O
pathways	NNS	nmod	O
of	IN	case	O
monocyte	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Human	JJ	amod	O
neutrophils	NNS	nsubjpass	B-cell_type
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	ROOT	O
to	TO	mark	O
actively	RB	advmod	O
transcribe	VB	xcomp	O
a	DT	det	O
number	NN	dobj	O
of	IN	case	O
early-response	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
in	IN	case	O
particular	JJ	amod	O
those	DT	nmod	O
encoding	VBG	acl	O
cytokines	NNS	dobj	B-protein
,	,	punct	O
chemokines	NNS	conj	B-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
high-affinity	JJ	amod	O
surface	NN	compound	O
receptor	NN	conj	O
for	IN	case	O
IgG	NN	nmod	B-protein
,	,	punct	O
FcgammaRI	NN	appos	B-protein
.	.	punct	O

The	DT	det	O
balance	NN	nsubj	O
between	IN	case	O
repression	NN	nmod	O
by	IN	case	O
ZEB	NN	nmod	B-protein
and	CC	cc	O
transcriptional	JJ	amod	O
activation	NN	conj	O
by	IN	case	O
c-Myb	NN	compound	B-protein
/Ets	NN	nmod	B-protein
provides	VBZ	ROOT	O
a	DT	det	O
flexible	JJ	amod	O
regulatory	JJ	amod	O
mechanism	NN	dobj	O
for	IN	mark	O
controlling	VBG	acl	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Among	IN	case	O
the	DT	det	O
20	CD	nummod	O
selected	VBN	amod	O
oligonucleotides	NNS	nmod	O
,	,	punct	O
two	CD	nummod	O
potent	JJ	amod	O
15-mer	JJ	amod	O
AS	JJ	amod	O
oligonucleotides	NNS	nsubj	O
(	-LRB-	punct	O
C-JUN	NN	compound	O
AS	JJ	amod	O
oligonucleotides	NNS	appos	O
)	-RRB-	punct	O
exhibited	VBD	ROOT	O
significant	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
cell	NN	compound	O
growth	NN	nmod	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
between	IN	case	O
2	CD	nummod	O
and	CC	cc	O
10	CD	conj	O
microM	NN	nmod	O
.	.	punct	O

Mean	NN	compound	O
values	NNS	nsubj	O
for	IN	case	O
plasma	NN	compound	O
aldosterone	NN	nmod	O
were	VBD	cop	O
not	RB	neg	O
different	JJ	ROOT	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	conj	O
for	IN	case	O
MR	NN	nmod	B-protein
(	-LRB-	punct	O
preeclampsia	NN	dep	O
,	,	punct	O
81	CD	nummod	O
+/-	CC	cc	O
44	CD	conj	O
receptors/cell	NNS	appos	O
;	:	punct	O
controls	NNS	dep	O
,	,	punct	O
306	CD	dep	O
+/-	CC	cc	O
168	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
SPD	NN	conj	O
(	-LRB-	punct	O
preeclampsia	NN	dep	O
,	,	punct	O
65	CD	nummod	O
+/-	CC	cc	O
7	CD	conj	O
mV	NN	appos	O
;	:	punct	O
controls	NNS	dep	O
,	,	punct	O
12	CD	nummod	O
+/-	CC	cc	O
5	CD	conj	O
mV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
single	JJ	amod	O
EGR1	NN	compound	B-protein
binding	NN	compound	O
motif	NN	nsubjpass	O
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
at	IN	case	O
bp	NN	nmod	O
-301	CD	nummod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
CD44	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
mRNA	NN	nmod	B-RNA
for	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
in	IN	case	O
eosinophils	NNS	nmod	B-cell_type
and	CC	cc	O
basophils	NNS	conj	B-cell_type
suggests	VBZ	ROOT	O
that	IN	mark	O
gene	NN	compound	O
transcription	NN	nsubjpass	O
in	IN	case	O
these	DT	det	O
lineages	NNS	nmod	O
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
GATA-binding	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Transcriptional	JJ	amod	O
basis	NN	ROOT	O
for	IN	case	O
hyporesponsiveness	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
inducible	JJ	amod	I-DNA
nitric	JJ	amod	I-DNA
oxide	NN	compound	I-DNA
synthase	NN	compound	I-DNA
gene	NN	nmod	I-DNA
to	TO	case	O
lipopolysaccharide/interferon-gamma	NN	nmod	O
.	.	punct	O

Correspondingly	RB	advmod	O
,	,	punct	O
transfection	NN	nsubj	O
of	IN	case	O
p50	NN	nmod	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
provided	VBD	ROOT	O
considerable	JJ	amod	O
protection	NN	dobj	O
from	IN	case	O
TCR-mediated	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Human	JJ	amod	O
immunodeficiency	NN	compound	O
virus-type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
infection	NN	nsubjpass	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
chronic	JJ	amod	O
state	NN	nmod	O
of	IN	case	O
immune	JJ	amod	O
hyperactivation	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	O
therapy	NN	nsubj	O
resolves	VBZ	ROOT	O
clinical	JJ	amod	O
symptoms	NNS	dobj	O
within	IN	case	O
hours	NNS	nmod	O
to	TO	case	O
days	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
therapy	NN	nsubj	O
has	VBZ	conj	O
to	TO	mark	O
be	VB	auxpass	O
continued	VBN	xcomp	O
over	IN	case	O
several	JJ	amod	O
years	NNS	nmod	O
to	TO	mark	O
prevent	VB	xcomp	O
disease	NN	compound	O
relapses	NNS	dobj	O
.	.	punct	O

Despite	IN	case	O
this	DT	det	O
effect	NN	nmod	O
,	,	punct	O
steady	JJ	amod	O
state	NN	compound	O
levels	NNS	nsubj	O
of	IN	case	O
HLA-DRalpha	NN	compound	B-protein
,	,	punct	O
HLA-DRbeta	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
invariant	JJ	amod	B-protein
(	-LRB-	punct	I-protein
Ii	NN	compound	I-protein
)	-RRB-	punct	I-protein
chains	NNS	conj	I-protein
were	VBD	cop	O
equivalent	JJ	ROOT	O
in	IN	case	O
control	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
infected	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

Uncontrolled	JJ	amod	O
replication	NN	nsubj	O
of	IN	case	O
a	DT	det	O
virus	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
harmful	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
host	NN	nmod	O
is	VBZ	cop	O
also	RB	advmod	O
disadvantageous	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
virus	NN	nmod	O
.	.	punct	O

A	DT	det	O
second	JJ	amod	O
transcript	NN	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	mark	O
encoding	VBG	advcl	O
the	DT	det	O
recently	RB	advmod	O
characterized	VBN	amod	O
RAZ	NN	dobj	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
also	RB	advmod	O
is	VBZ	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
replicative	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

NAC	NN	nsubj	O
caused	VBD	ROOT	O
an	DT	det	O
expected	VBN	amod	O
dramatic	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
reduced	VBN	amod	O
glutathione	NN	compound	O
(	-LRB-	punct	O
GSH	NN	appos	O
)	-RRB-	punct	O
levels	NNS	nmod	O
in	IN	case	O
EC	NN	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
appearance	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
CMAT	NN	compound	B-protein
binding	NN	compound	I-protein
complex	NN	nmod	I-protein
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
both	CC	cc:preconj	O
cyclosporin	NN	compound	O
A	NN	nmod	O
and	CC	cc	O
rapamycin	NN	conj	O
.	.	punct	O

Such	JJ	amod	O
markers	NNS	nsubj	O
will	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
for	IN	case	O
linkage	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
screening	NN	conj	O
of	IN	case	O
cDNA	NN	compound	B-DNA
libraries	NNS	nmod	I-DNA
.	.	punct	O

Association	NN	ROOT	O
of	IN	case	O
TRAF1	NN	nmod	B-protein
,	,	punct	O
TRAF2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
TRAF3	NN	conj	B-protein
with	IN	case	O
an	DT	det	O
Epstein-Barr	JJ	amod	B-DNA
virus	NN	compound	I-DNA
LMP1	NN	compound	I-DNA
domain	NN	nmod	I-DNA
important	JJ	amod	O
for	IN	case	O
B-lymphocyte	NN	compound	B-cell_type
transformation	NN	nmod	O
:	:	punct	O
role	NN	dep	O
in	IN	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
.	.	punct	O

Potential	JJ	amod	O
phosphorylation	NN	compound	B-protein
sites	NNS	nsubj	I-protein
include	VBP	ROOT	O
the	DT	det	O
sequence	NN	compound	O
PSPTSPT	NN	dobj	B-protein
,	,	punct	O
which	WDT	nsubj	O
resembles	VBZ	acl:relcl	O
an	DT	det	O
RNA	NN	compound	B-protein
polymerase	NN	compound	I-protein
II	CD	nummod	I-protein
repeat	NN	dobj	I-protein
reported	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
target	NN	xcomp	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-protein
cycle	NN	compound	I-protein
control	NN	compound	I-protein
kinase	NN	compound	I-protein
cdc2	NN	nmod	I-protein
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
IFN-alpha	NN	nmod	B-protein
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
assembly	NN	nmod	O
of	IN	case	O
IFN-stimulated	JJ	amod	B-protein
gene	NN	compound	I-protein
factor	NN	compound	I-protein
3	CD	nummod	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
complex	NN	nmod	I-protein
formed	VBN	acl	O
by	IN	case	O
STAT1	NN	nmod	B-protein
,	,	punct	O
STAT2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p48	NN	compound	B-protein
protein	NN	conj	I-protein
.	.	punct	O

Active	JJ	amod	O
suppression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
transactivator-encoding	JJ	amod	I-DNA
AIR-1	NN	compound	I-DNA
locus	NN	nmod	I-DNA
is	VBZ	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
lack	NN	nmod	O
of	IN	case	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
observed	VBN	acl	O
during	IN	case	O
differentiation	NN	nmod	O
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
plasma	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
model	NN	nsubjpass	O
of	IN	case	O
adenovirus	NN	compound	O
5	CD	nummod	O
(	-LRB-	punct	O
Ad5	NN	appos	O
)	-RRB-	punct	O
infection	NN	nmod	O
was	VBD	auxpass	O
developed	VBN	ROOT	O
in	IN	case	O
guinea	NN	compound	O
pigs	NNS	nmod	O
to	TO	mark	O
begin	VB	xcomp	O
to	TO	mark	O
study	VB	xcomp	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
peripheral	JJ	amod	O
lung	NN	compound	O
inflammation	NN	nmod	O
.	.	punct	O

A	DT	det	O
third	JJ	amod	O
tyrosine	NN	nsubj	O
within	IN	case	O
the	DT	det	O
amino-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
(	-LRB-	punct	O
Y145	NN	appos	O
)	-RRB-	punct	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	xcomp	O
for	IN	case	O
optimal	JJ	amod	O
SLP-76	NN	compound	B-protein
function	NN	nmod	O
,	,	punct	O
as	IN	mark	O
altering	VBG	csubj	O
it	PRP	dobj	O
alone	RB	advmod	O
to	TO	case	O
phenylalanine	NN	nmod	O
has	VBZ	advcl	O
a	DT	det	O
potent	JJ	amod	O
impact	NN	dobj	O
on	IN	case	O
SLP-76	NN	compound	B-protein
augmentation	NN	nmod	O
of	IN	case	O
NFAT	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
recognizing	VBG	acl	O
antigens	NNS	dobj	O
encoded	VBN	acl	O
within	IN	case	O
map	NN	compound	O
units	NNS	nmod	O
0.67	CD	compound	O
to	TO	dep	O
0.73	CD	dep	O
of	IN	case	O
HSV	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
are	VBP	auxpass	O
frequently	RB	advmod	O
recovered	VBN	ROOT	O
from	IN	case	O
herpetic	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O

Specific	JJ	amod	O
lymphocytes	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
peptide	NN	compound	O
sensitization	NN	nmod	O
and	CC	cc	O
screened	VBN	conj	O
by	IN	case	O
thymidine	NN	compound	O
uptake	NN	nmod	O
or	CC	cc	O
cellular	JJ	amod	O
cytotoxic	JJ	amod	O
assays	NNS	conj	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
peptide	NN	compound	O
matches	NNS	nmod	O
covering	VBG	acl	O
more	JJR	advmod	O
than	IN	advmod	O
10	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
the	DT	det	O
TBP7	NN	compound	B-protein
sequence	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
fact	NN	conj	O
that	IN	mark	O
the	DT	det	O
migration	NN	nsubj	O
of	IN	case	O
S6	NN	nmod	B-protein
on	IN	case	O
SDS-PAGE	NN	nmod	O
is	VBZ	cop	O
consistent	JJ	ccomp	O
with	IN	case	O
the	DT	det	O
estimated	VBN	amod	O
molecular	JJ	amod	O
mass	NN	nmod	O
for	IN	case	O
TBP7	NN	nmod	B-protein
,	,	punct	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
subunit	NN	nsubj	B-protein
6	CD	nummod	I-protein
of	IN	case	O
the	DT	det	O
26S	NN	compound	B-protein
protease	NN	nmod	I-protein
is	VBZ	cop	O
TBP7	NN	ccomp	B-protein
.	.	punct	O

Like	IN	prep	O
Drosophila	FW	compound	O
Toll	NN	pobj	B-protein
,	,	punct	O
human	JJ	amod	B-protein
Toll	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
type	NN	compound	O
I	CD	nummod	O
transmembrane	JJ	compound	O
protein	NN	ROOT	O
with	IN	case	O
an	DT	det	O
extracellular	JJ	amod	O
domain	NN	nmod	O
consisting	VBG	acl	O
of	IN	case	O
a	DT	det	O
leucine-rich	JJ	amod	B-protein
repeat	NN	compound	I-protein
(	-LRB-	punct	I-protein
LRR	NN	compound	I-protein
)	-RRB-	punct	I-protein
domain	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
cytoplasmic	JJ	amod	O
domain	NN	conj	O
homologous	JJ	amod	O
to	TO	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
interleukin	NN	compound	I-protein
(	-LRB-	punct	I-protein
IL	NN	compound	I-protein
)	-RRB-	punct	I-protein
-1	CD	nummod	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
remarkable	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
genomic	JJ	amod	O
footprinting	NN	compound	O
data	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
mutagenesis	NN	compound	O
results	NNS	conj	O
also	RB	advmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
erythroid	JJ	amod	O
lineage-	NN	amod	O
and	CC	cc	O
developmental	JJ	amod	O
stage-specific	JJ	conj	O
regulation	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-DNA
alpha-like	JJ	amod	I-DNA
globin	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
is	VBZ	auxpass	O
indeed	RB	advmod	O
modulated	VBN	ccomp	O
by	IN	case	O
stable	JJ	amod	O
binding	NN	nmod	O
of	IN	case	O
specific	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
factors	NNS	nmod	I-protein
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
mediator	NN	ROOT	O
of	IN	case	O
specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
monocytes	NNS	nmod	O
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	conj	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	O
genome	NN	nmod	O
in	IN	case	O
promonocytic	JJ	amod	O
leukemias	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
characterize	VBP	ROOT	O
the	DT	det	O
putative	JJ	amod	B-protein
human	JJ	amod	I-protein
homolog	NN	dobj	I-protein
of	IN	case	O
NRL	NN	nmod	B-protein
,	,	punct	O
neutrophil	NN	compound	B-protein
gelatinase-associated	JJ	amod	I-protein
lipocalin	NN	conj	I-protein
(	-LRB-	punct	O
NGAL	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

In	FW	amod	O
situ	FW	dep	O
hybridisation	NN	nsubj	O
revealed	VBD	ROOT	O
musculin	NN	compound	B-protein
expression	NN	nsubj	O
in	IN	case	O
embryos	NNS	nmod	O
was	VBD	cop	O
largely	RB	advmod	O
restricted	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
embryonic	JJ	amod	B-cell_type
skeletal	JJ	amod	I-cell_type
muscle	NN	compound	I-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
a	DT	det	O
differential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
Spi-1	NN	nmod	B-DNA
on	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
Ets	NN	compound	B-DNA
motifs	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
preferentially	RB	advmod	O
bound	VBN	ROOT	O
by	IN	case	O
PU-1	NN	nmod	B-protein
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
extracts	NNS	nmod	O
from	IN	case	O
all	DT	det	O
stages	NNS	nmod	O
of	IN	case	O
development	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
a	DT	det	O
different	JJ	amod	O
Ets	NN	compound	B-protein
family	NN	compound	I-protein
member	NN	nsubj	I-protein
reacts	VBZ	parataxis	O
with	IN	case	O
these	DT	det	O
motifs	NNS	nmod	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
extracts	NNS	nmod	O
.	.	punct	O

Using	VBG	advcl	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	compound	O
information	NN	dobj	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
DNA	NN	compound	B-protein
affinity-purified	JJ	amod	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
now	RB	advmod	O
isolated	VBN	ROOT	O
cDNA	NN	compound	B-DNA
clones	NNS	dobj	I-DNA
encoding	VBG	acl	O
TCF-1	NN	compound	B-protein
alpha	NN	dobj	I-protein
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
germline	NN	compound	B-DNA
Cepsilon	NN	compound	O
transcription	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
two	CD	nummod	O
human	JJ	amod	B-cell_line
Burkitt	NN	nmod:poss	I-cell_line
's	POS	case	I-cell_line
lymphoma	NN	compound	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
,	,	punct	O
DND39	NN	appos	B-cell_line
and	CC	cc	O
DG75	NN	conj	B-cell_line
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
3q21	NN	nmod	B-DNA
and	CC	cc	O
identification	NN	conj	O
of	IN	case	O
intergenic	JJ	amod	O
fusion	NN	compound	O
transcripts	NNS	nmod	O
with	IN	case	O
ecotropic	JJ	amod	B-DNA
viral	JJ	amod	I-DNA
insertion	NN	compound	I-DNA
site	NN	nmod	I-DNA
I	CD	nummod	I-DNA
in	IN	case	O
leukemia	NN	nmod	O
.	.	punct	O

One	CD	nummod	O
base	NN	compound	O
pair	NN	compound	O
change	NN	nsubj	O
abolishes	VBZ	ROOT	O
the	DT	det	O
T	NN	nmod:npmod	O
cell-restricted	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
a	DT	det	O
kB-like	JJ	amod	B-DNA
proto-enhancer	NN	compound	I-DNA
element	NN	nmod	I-DNA
from	IN	case	O
the	DT	det	O
interleukin	NN	compound	B-DNA
2	CD	nummod	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Second	NNP	advmod	O
is	VBZ	cop	O
a	DT	det	O
controlled	JJ	amod	O
phase	NN	ROOT	O
of	IN	case	O
TCR	NN	compound	B-DNA
gene	NN	compound	I-DNA
rearrangement	NN	nmod	O
.	.	punct	O

These	DT	det	O
TRAF	NN	compound	B-protein
binding	NN	compound	I-protein
domains	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
functionally	RB	advmod	O
important	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
RANK	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
and	CC	cc	O
c-Jun	NN	conj	B-protein
NH2-terminal	JJ	amod	B-protein
kinase	NN	compound	I-protein
activities	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
the	DT	det	O
first	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	nmod	I-cell_type
by	IN	case	O
antigen	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
the	DT	det	O
shaping	NN	nmod	O
of	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
specificity	NN	compound	O
repertoire	NN	nmod	O
and	CC	cc	O
maintenance	NN	conj	O
of	IN	case	O
self-tolerance	NN	nmod	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
yeast	NN	compound	O
two-hybrid	JJ	amod	O
system	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
EVI1	NN	nsubj	B-protein
(	-LRB-	punct	O
contained	VBN	acl	O
in	IN	case	O
its	PRP$	nmod:poss	O
entirety	NN	nmod	O
in	IN	case	O
MDS1/EVI1	NN	nmod	B-DNA
and	CC	cc	O
AML1/MDS1/EVI1	NN	conj	B-protein
)	-RRB-	punct	O
physically	RB	advmod	O
interacts	VBZ	ccomp	O
with	IN	case	O
SMAD3	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
an	DT	det	O
intracellular	JJ	amod	O
mediator	NN	acl:relcl	O
of	IN	case	O
TGF-beta1	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
occurs	VBZ	ROOT	O
after	IN	case	O
its	PRP$	nmod:poss	O
induced	VBN	amod	O
dissociation	NN	nmod	O
from	IN	case	O
its	PRP$	nmod:poss	O
cytoplasmic	JJ	amod	O
inhibitor	NN	compound	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

Exogenous	JJ	amod	O
IL-2	NN	nsubj	B-protein
,	,	punct	O
which	WDT	nsubj	O
restitutes	VBZ	acl:relcl	O
the	DT	det	O
proliferative	JJ	amod	O
response	NN	dobj	O
of	IN	case	O
the	DT	dep	O
anti-CD3-	JJ	nmod	B-cell_line
and	CC	cc	I-cell_line
anti-CD28-treated	JJ	conj	I-cell_line
Rel-/-	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	dep	I-cell_line
,	,	punct	O
restores	VBZ	ROOT	O
production	NN	dobj	O
of	IN	case	O
IL-5	NN	compound	O
,	,	punct	O
TNF-alpha	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IFN-gamma	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
IL-3	NN	conj	B-protein
and	CC	cc	O
GM-CSF	NN	conj	B-protein
expression	NN	nmod	O
to	TO	case	O
approximately	RB	advmod	O
normal	JJ	amod	O
levels	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
functional	JJ	amod	O
outcome	NN	nsubj	O
of	IN	case	O
the	DT	det	O
VDR	NN	compound	B-protein
antisense	JJ	amod	O
transfection	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
in	IN	case	O
the	DT	det	O
myelomonocytic	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
VDR	NN	compound	B-protein
expression	NN	nsubj	O
may	MD	aux	O
act	VB	ccomp	O
as	IN	case	O
a	DT	det	O
protective	JJ	amod	O
mechanism	NN	nmod	O
against	IN	case	O
programmed	VBN	amod	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
analyze	VB	advcl	O
potential	JJ	amod	O
cross	NN	compound	O
points	NNS	dobj	O
between	IN	mark	O
positively	RB	advmod	O
and	CC	advmod	O
negatively	RB	advmod	O
regulating	VBG	advcl	O
signaling	NN	compound	O
pathways	NNS	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
activators	NNS	nmod	O
of	IN	case	O
the	DT	det	O
adenylate	NN	compound	B-protein
cyclase	NN	nmod	I-protein
or	CC	cc	O
PKA	NN	conj	B-protein
on	IN	case	O
two	CD	nummod	O
parallel	JJ	amod	O
mitogen-activated	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
signaling	NN	compound	O
pathways	NNS	nmod	O
mediated	VBN	acl	O
by	IN	case	O
extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
ERK	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
c-Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	conj	I-protein
.	.	punct	O

Immunoprecipitation	NN	compound	O
experiments	NNS	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
an	DT	det	O
association	NN	dobj	O
between	IN	case	O
nuclear	JJ	amod	O
I	NN	compound	B-protein
(	-LRB-	punct	I-protein
kappa	NN	compound	I-protein
)	-RRB-	punct	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	I-protein
alpha	NN	nmod	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
NF-kappaB	NN	compound	B-protein
proteins	NNS	conj	O
.	.	punct	O

Convergence	NN	ROOT	O
of	IN	case	O
costimulatory	JJ	amod	O
signals	NNS	nmod	O
and	CC	cc	O
differences	NNS	conj	O
from	IN	case	O
transformed	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
B29	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
controlled	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
complex	JJ	amod	O
interplay	NN	nmod	O
of	IN	case	O
positive	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

High	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
cytokine	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
also	RB	advmod	O
required	VBD	ROOT	O
both	CC	cc:preconj	O
TCR	NN	dobj	B-protein
and	CC	cc	O
costimulatory	JJ	amod	O
signals	NNS	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
interferon	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor	NN	nsubj	I-protein
1	CD	nummod	I-protein
not	RB	neg	O
only	RB	cc:preconj	O
triggers	VBZ	ccomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
interferon	NN	compound	B-protein
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
may	MD	aux	O
play	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
limiting	VBG	advcl	O
the	DT	det	O
duration	NN	dobj	O
of	IN	case	O
this	DT	det	O
response	NN	nmod	O
by	IN	mark	O
activating	VBG	advcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
IRF-2	NN	nmod	B-protein
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
p105	NN	compound	B-protein
processing	NN	nmod	O
by	IN	case	O
NF-kappaB	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
transiently	RB	advmod	B-cell_line
transfected	VBN	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
IgE	NN	compound	B-protein
production	NN	nsubjpass	O
in	IN	case	O
asthma	NN	nmod	O
and	CC	cc	O
HIE	NN	conj	O
usually	RB	advmod	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
elevated	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
IL-4	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
IL-13	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
blood	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
increased	VBN	amod	O
sera	NN	compound	O
IL-4	NN	compound	B-protein
levels	NNS	nsubj	O
in	IN	case	O
asthma	NN	nmod	O
and	CC	cc	O
HIE	NN	conj	O
are	VBP	cop	O
not	RB	neg	O
sufficient	JJ	conj	O
to	TO	mark	O
induce	VB	xcomp	O
Stat6	NN	compound	B-protein
activation	NN	dobj	O
in	IN	case	O
PBMCs	NNS	nmod	B-cell_type
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
evidence	NN	nsubjpass	O
of	IN	case	O
switch	NN	compound	O
recombination	NN	nmod	O
to	TO	case	O
epsilon	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
detected	VBN	conj	O
in	IN	case	O
isolated	VBN	amod	O
cases	NNS	nmod	O
of	IN	case	O
elevated	JJ	amod	O
IgE	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
SAC	NN	nmod	O
on	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
Jurkat	NN	compound	B-cell_line
cells	NNS	appos	I-cell_line
)	-RRB-	punct	O
induced	VBN	acl	O
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF-	NN	amod	B-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
H2O2	NN	conj	O
.	.	punct	O

The	DT	det	O
minimal	JJ	amod	O
region	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
tumor	NN	compound	I-DNA
necrosis	NN	compound	I-DNA
factor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TNF-alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
necessary	JJ	amod	O
for	IN	case	O
its	PRP$	nmod:poss	O
transcriptional	JJ	amod	O
induction	NN	nmod	O
by	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
and	CC	cc	I-cell_line
B	NN	conj	I-cell_line
lymphocyte	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
has	VBZ	aux	O
been	VBN	auxpass	O
localized	JJ	ROOT	O
between	IN	case	O
-52	CD	nummod	B-DNA
and	CC	cc	I-DNA
+89	CD	conj	I-DNA
nucleotides	NNS	nmod	I-DNA
(	-LRB-	punct	O
nt	NNS	appos	O
)	-RRB-	punct	O
relative	JJ	amod	O
to	TO	case	O
the	DT	det	O
gene	NN	nmod:poss	O
's	POS	case	O
transcriptional	JJ	amod	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Human	JJ	amod	O
IL-5	NN	compound	B-protein
promoter/enhancer-luciferase	NN	compound	O
gene	NN	compound	O
construct	NN	nsubjpass	O
transfected	VBN	acl	O
to	TO	case	O
T-cell	NN	compound	B-cell_line
clones	NNS	nmod	I-cell_line
was	VBD	auxpass	O
transcribed	VBN	ROOT	O
on	IN	case	O
either	CC	cc:preconj	O
TCR	NN	compound	B-protein
or	CC	cc	O
IL-2R	NN	conj	B-protein
stimulation	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
clearly	RB	advmod	O
downregulated	VBN	conj	O
by	IN	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
approximately	RB	advmod	O
500-bp	JJ	amod	B-DNA
human	JJ	amod	I-DNA
IL-5	NN	compound	I-DNA
gene	NN	compound	I-DNA
segment	NN	nsubj	I-DNA
located	JJ	amod	O
5	CD	dobj	B-DNA
'	''	punct	I-DNA
upstream	RB	amod	I-DNA
of	IN	case	O
the	DT	det	O
coding	VBG	amod	O
region	NN	nmod	O
contains	VBZ	ccomp	O
activation-inducible	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
elements	NNS	dobj	I-DNA
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
by	IN	case	O
GC	NN	nmod	O
.	.	punct	O

CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
costimulated	VBN	acl	O
with	IN	case	O
the	DT	det	O
A6H	NN	compound	B-protein
mAb	NN	nmod	I-protein
upregulated	VBD	ROOT	O
CD80	NN	dobj	B-protein
,	,	punct	O
CD86	NN	conj	B-protein
,	,	punct	O
CD71	NN	conj	B-protein
,	,	punct	O
interleukin-2	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL-2	NN	appos	I-protein
)	-RRB-	punct	I-protein
R	NN	compound	I-protein
alpha	NN	conj	I-protein
,	,	punct	O
IL-2R	NN	compound	B-protein
beta	NN	conj	I-protein
and	CC	cc	O
IL-2R	NN	compound	B-protein
gamma	NN	conj	I-protein
,	,	punct	O
while	IN	mark	O
no	DT	neg	O
corresponding	JJ	amod	O
up-regulation	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
molecules	NNS	nmod	I-protein
was	VBD	auxpass	O
seen	VBN	advcl	O
in	IN	case	O
CD8+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
low	JJ	amod	O
frequency	NN	nsubj	O
with	IN	case	O
which	WDT	nmod	O
these	DT	det	O
Ig-expressing	JJ	amod	B-cell_line
hybrids	NNS	nsubjpass	I-cell_line
are	VBP	auxpass	O
recovered	VBN	acl:relcl	O
,	,	punct	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
fact	NN	nmod	O
that	IN	mark	O
cell	NN	compound	O
fusions	NNS	nsubj	O
can	MD	aux	O
lead	VB	ccomp	O
to	TO	case	O
chromosome	NN	compound	O
loss	NN	nmod	O
,	,	punct	O
led	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
propose	VB	xcomp	O
that	IN	mark	O
this	DT	det	O
rare	JJ	amod	O
phenotype	NN	nsubj	O
was	VBD	cop	O
due	JJ	ccomp	O
to	TO	case	O
loss	NN	nmod	O
of	IN	case	O
a	DT	det	O
T-cell-derived	JJ	amod	B-protein
chromosome	NN	nmod	I-protein
encoding	VBG	acl	I-protein
a	DT	det	I-protein
factor	NN	dobj	I-protein
or	CC	cc	O
factors	NNS	conj	O
with	IN	case	O
gene	NN	compound	O
silencing	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

HS	NN	nsubj	B-DNA
II	CD	nummod	I-DNA
was	VBD	cop	O
weak	JJ	ROOT	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
absent	JJ	advcl	O
in	IN	case	O
Hela	NNP	nmod	B-cell_line
,	,	punct	O
and	CC	cc	O
greatly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
Jurkat	NN	nmod	B-cell_line
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
this	DT	det	O
region	NN	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
implicated	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
cis-activation	NN	nmod	O
of	IN	case	O
tal-1	NN	compound	B-DNA
promoter	NN	compound	I-DNA
1b	NN	nmod	I-DNA
in	IN	case	O
this	DT	det	O
cell	NN	compound	O
line	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
all-trans	JJ	amod	O
and	CC	cc	O
9-cis	JJ	conj	O
RA	NN	nsubj	O
inhibited	VBD	dep	O
virus	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
HIV-1	NN	compound	B-cell_line
IIIB-infected	JJ	amod	I-cell_line
monocytoid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
the	DT	det	O
co-stimulatory	JJ	amod	O
agent	NN	nmod	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	dep	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Prolonged	JJ	amod	O
corticosteroid	NN	compound	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
down-regulation	NN	nmod	O
of	IN	case	O
GcR	NN	nmod	B-protein
,	,	punct	O
while	IN	mark	O
the	DT	det	O
mean	JJ	amod	O
level	NN	nsubj	O
of	IN	case	O
GcR	NN	nmod	B-protein
in	IN	case	O
Cushing	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
was	VBD	cop	O
normal	JJ	advcl	O
.	.	punct	O

NF-kappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
degree	NN	nmod	O
of	IN	case	O
albuminuria	NN	nmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0.316	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
with	IN	case	O
thrombomodulin	NN	compound	B-protein
plasma	NN	compound	O
concentrations	NNS	conj	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0.33	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
indicative	JJ	amod	O
for	IN	case	O
albuminuria	NN	nmod:npmod	O
associated	JJ	amod	O
endothelial	JJ	amod	O
dysfunction	NN	nmod	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
IL-2R	NN	compound	B-protein
alpha	NN	nmod	I-protein
by	IN	case	O
TG	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
no	DT	neg	O
detectable	JJ	amod	O
NF-AT	NN	compound	B-protein
protein	NN	compound	O
expression	NN	nsubj	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
resting	VBG	amod	B-cell_type
eosinophils	NNS	nmod	I-cell_type
.	.	punct	O

Studies	NNS	nsubj	O
presented	VBN	csubj	O
here	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
overall	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
signal	NN	compound	O
transduction	NN	nsubj	O
begins	VBZ	ccomp	O
with	IN	case	O
a	DT	det	O
parallel	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
stimuli-specific	JJ	amod	O
pathways	NNS	nmod	O
through	IN	case	O
which	WDT	nmod	O
cytokines	NNS	nsubj	B-protein
(	-LRB-	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
oxidants	NNS	conj	O
(	-LRB-	punct	O
hydrogen	NN	compound	O
peroxide	NN	dep	O
and	CC	cc	O
mitomycin	NN	compound	O
C	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
phorbol	NN	compound	O
ester	NN	conj	O
(	-LRB-	punct	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	appos	O
)	-RRB-	punct	O
individually	RB	advmod	O
initiate	VBP	acl:relcl	O
signaling	NN	dobj	O
.	.	punct	O

CD14	NN	compound	B-protein
-mediated	JJ	amod	O
translocation	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
induced	VBN	acl	O
by	IN	case	O
lipopolysaccharide	NN	nmod	O
does	VBZ	aux	O
not	RB	neg	O
require	VB	ROOT	O
tyrosine	NN	compound	B-protein
kinase	NN	compound	I-protein
activity	NN	dobj	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
the	DT	det	O
presence	NN	dobj	O
in	IN	case	O
vaginal	JJ	amod	O
fluid	NN	nmod	O
of	IN	case	O
agent	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
indigenous	JJ	amod	O
bacteria	NNS	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
activate	VB	acl:relcl	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	dobj	I-DNA
,	,	punct	O
cytokine	NN	compound	B-protein
production	NN	conj	O
,	,	punct	O
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
with	IN	case	O
possible	JJ	amod	O
influence	NN	nmod	O
on	IN	case	O
vaginal	JJ	amod	O
physiology	NN	nmod	O
and	CC	cc	O
host	NN	compound	O
defense	NN	conj	O
.	.	punct	O

These	DT	det	O
alternative	JJ	amod	O
polyadenylation	NN	compound	O
events	NNS	nsubj	O
ensure	VBP	ROOT	O
the	DT	det	O
rapid	JJ	amod	O
accumulation	NN	dobj	O
of	IN	case	O
high	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
NF-ATc	NN	nmod	B-protein
necessary	JJ	amod	O
to	TO	mark	O
exceed	VB	xcomp	O
critical	JJ	amod	O
threshold	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
NF-ATc	NN	nmod	B-protein
for	IN	case	O
gene	NN	compound	O
induction	NN	nmod	O
in	IN	case	O
effector	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
PGG-Glucan	NN	nsubj	O
induced	VBD	ccomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
an	DT	det	O
NF-kappaB-like	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
in	IN	case	O
purified	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
neutrophils	NNS	nmod	I-cell_type
.	.	punct	O

Human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HTLV-1	NN	compound	O
)	-RRB-	punct	O
Tax	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
immortalization	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Cross	NN	compound	O
titration	NN	compound	O
analyses	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
9-cis	JJ	amod	O
RA	NN	nmod	O
and	CC	cc	O
D3	NN	conj	O
on	IN	case	O
HL60	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
differentiation	NN	nmod	O
were	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
boundaries	NNS	dobj	O
of	IN	case	O
the	DT	det	O
concentrations	NNS	nmod	O
of	IN	case	O
each	DT	det	O
agent	NN	nmod	O
,	,	punct	O
alone	RB	advmod	O
and	CC	cc	O
in	IN	case	O
combination	NN	conj	O
,	,	punct	O
that	WDT	nsubj	O
give	VBP	ccomp	O
rise	NN	dobj	O
to	TO	case	O
optimal	JJ	amod	O
neutrophil	NN	nmod	O
and	CC	cc	O
monocyte	NN	compound	O
differentiation	NN	conj	O
of	IN	case	O
HL60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Differentiation-associated	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
BZLF1	NN	compound	I-protein
transactivator	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
oral	JJ	amod	O
hairy	JJ	amod	O
leukoplakia	NN	nmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
these	DT	det	O
hypotheses	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
several	JJ	amod	O
tat	NN	compound	B-protein
mutants	NNS	dobj	I-protein
,	,	punct	O
including	VBG	case	O
two	CD	nummod	O
stop	JJ	compound	B-protein
codon	NN	compound	I-protein
mutants	NNS	nmod	I-protein
and	CC	cc	O
one	CD	nummod	O
deletion	NN	compound	B-protein
mutant	NN	conj	I-protein
using	VBG	acl	O
replication-competent	JJ	amod	B-DNA
HIV-1	NN	compound	I-DNA
constructs	NNS	dobj	I-DNA
carrying	VBG	acl	O
wild-type	JJ	amod	B-DNA
or	CC	cc	I-DNA
mutant	JJ	conj	I-DNA
LTRs	NNS	dobj	I-DNA
with	IN	case	O
modifications	NNS	nmod	O
in	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
and/or	CC	cc	I-DNA
Sp1	NN	conj	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

Maximal	JJ	amod	O
LPS	NN	compound	O
induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TF	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
required	VBD	ROOT	O
the	DT	det	O
two	CD	nummod	O
AP-1	NN	compound	B-protein
sites	NNS	dobj	O
and	CC	cc	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	conj	I-DNA
within	IN	case	O
the	DT	det	O
LPS	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Gel	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
using	VBG	acl	O
a	DT	det	O
synthetic	JJ	amod	B-DNA
E6	NN	compound	I-DNA
motif	NN	dobj	I-DNA
detected	VBD	ROOT	O
a	DT	det	O
B-cell-specific	JJ	amod	B-protein
complex	NN	dobj	I-protein
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
a	DT	det	O
ubiquitous	JJ	amod	O
band	NN	nmod	O
found	VBN	acl	O
also	RB	advmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
HeLa	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
mutations	NNS	nsubj	O
R217A	NN	dep	O
and	CC	cc	O
R294A	NN	conj	O
caused	VBD	ROOT	O
an	DT	det	O
increased	VBN	amod	O
binding	NN	compound	O
efficiency	NN	dobj	O
for	IN	case	O
antagonists	NNS	nmod	O
but	CC	cc	O
no	DT	neg	O
change	NN	conj	O
in	IN	case	O
agonist	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
IL-5	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
fundamentally	RB	advmod	O
involved	VBN	dep	O
in	IN	case	O
eosinophilic	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

She	PRP	nsubj	O
had	VBD	aux	O
generalized	VBN	ROOT	O
lymphadenopathy	NN	dobj	O
and	CC	cc	O
the	DT	det	O
bone	NN	compound	O
marrow	NN	nsubjpass	O
was	VBD	auxpass	O
infiltrated	VBN	conj	O
by	IN	case	O
lymphoma	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
at	IN	case	O
presentation	NN	nmod	O
.	.	punct	O

Granulocyte	NN	compound	O
DNA	NN	nsubj	O
from	IN	case	O
four	CD	nummod	O
patients	NNS	nmod	O
exhibited	VBD	ROOT	O
allele	NN	compound	O
loss	NN	dobj	O
on	IN	case	O
20q	NN	nmod	B-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
murine	JJ	amod	B-cell_line
FDC-P1-derived	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubjpass	I-cell_line
WT-19	NN	dep	B-cell_line
transfected	VBN	acl	O
with	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
GM-CSF	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	I-protein
beta	NN	conj	I-protein
subunits	NNS	nmod	I-protein
(	-LRB-	punct	O
GM-CSFRalpha	NN	dep	B-protein
and	CC	cc	I-protein
beta	NN	conj	I-protein
)	-RRB-	punct	O
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	ccomp	O
to	TO	mark	O
differentiate	VB	xcomp	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-protein
GM-CSF	NN	nmod	I-protein
(	-LRB-	punct	O
hGM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
gp41	NN	nsubj	B-protein
failed	VBD	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
NF-kappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
as	RB	advmod	O
much	JJ	mwe	O
as	IN	dep	O
no	DT	neg	O
NF-kappaB	NN	nmod	B-protein
bound	VBD	acl	O
to	TO	case	O
the	DT	det	O
main	JJ	amod	B-DNA
NF-kappaB-binding	JJ	amod	I-DNA
site	NN	nmod	I-DNA
2	CD	nummod	O
of	IN	case	O
the	DT	det	O
IL-10	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
after	IN	case	O
addition	NN	nmod	O
of	IN	case	O
gp41	NN	nmod	B-protein
.	.	punct	O

RXRs	NNS	nsubj	B-protein
heterodimerize	VBP	ROOT	O
with	IN	case	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25-dihydroxyvitamin	NN	compound	I-protein
D3	NN	nmod	I-protein
[	-LRB-	punct	I-protein
1	CD	nummod	I-protein
,	,	punct	I-protein
25	CD	nummod	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
]	-RRB-	punct	I-protein
receptor	NN	dep	I-protein
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
enabling	VBG	advcl	O
their	PRP$	nmod:poss	O
efficient	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
.	.	punct	O

Accumulating	VBG	amod	O
data	NNS	nsubj	O
from	IN	prep	O
a	DT	det	O
number	NN	pobj	O
of	IN	prep	O
laboratories	NNS	pobj	O
have	VBP	aux	O
recently	RB	advmod	O
indicated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
response	NN	nsubj	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	B-protein
to	TO	case	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
redox	NN	compound	O
homeostasis	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
may	MD	aux	O
play	VB	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
modulating	VBG	advcl	O
immune	JJ	amod	O
function	NN	dobj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
studies	NNS	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
signaling	NN	compound	O
pathways	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
this	DT	det	O
monocyte-specific	JJ	amod	O
response	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	acl:relcl	O
.	.	punct	O

The	DT	det	O
GATA-1	NN	compound	B-protein
nuclear	JJ	amod	O
bodies	NNS	nsubj	O
differed	VBN	ROOT	O
from	IN	case	O
previously	RB	advmod	O
described	VBN	amod	O
nuclear	JJ	amod	O
structures	NNS	nmod	O
and	CC	cc	O
there	EX	expl	O
was	VBD	conj	O
no	DT	neg	O
co-localization	NN	nsubj	O
with	IN	case	O
nuclear	JJ	amod	B-protein
antigens	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
RNA	NN	compound	O
processing	NN	nmod	O
or	CC	cc	O
other	JJ	amod	O
ubiquitous	JJ	amod	B-protein
(	-LRB-	punct	I-protein
Spl	NN	conj	I-protein
,	,	punct	I-protein
c-Jun	NN	conj	I-protein
and	CC	cc	I-protein
TBP	NN	conj	I-protein
)	-RRB-	punct	I-protein
or	CC	cc	I-protein
haemopoietic	JJ	amod	I-protein
(	-LRB-	punct	I-protein
NF-E2	NN	compound	I-protein
)	-RRB-	punct	I-protein
transcription	NN	compound	I-protein
factors	NNS	conj	I-protein
.	.	punct	O

G0S24	NN	nsubj	B-DNA
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
a	DT	det	O
set	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
(	-LRB-	punct	O
putative	JJ	amod	B-DNA
G0/G1	NN	compound	I-DNA
switch	NN	compound	I-DNA
regulatory	JJ	amod	I-DNA
genes	NNS	appos	I-DNA
)	-RRB-	punct	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
expressed	VBN	acl:relcl	O
transiently	RB	advmod	O
within	IN	case	O
1-2	CD	nummod	O
hr	NN	nmod	O
of	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
lectin	NN	nmod	B-protein
or	CC	cc	O
cycloheximide	NN	conj	O
to	TO	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Pretreatment	NN	nsubj	O
with	IN	case	O
IFN-gamma	NN	nmod	B-protein
potentiates	VBZ	ROOT	O
the	DT	det	O
IFN-alpha	NN	compound	B-protein
-induced	JJ	amod	O
protection	NN	dobj	O
,	,	punct	O
but	CC	cc	O
IFN-gamma	NN	nsubj	B-protein
alone	RB	advmod	O
does	VBZ	aux	O
not	RB	neg	O
have	VB	conj	O
any	DT	det	O
antiviral	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

No	DT	neg	O
upregulation	NN	nsubj	O
of	IN	case	O
megakaryocyte	NN	amod	B-protein
or	CC	cc	I-protein
lymphoid	JJ	conj	I-protein
markers	NNS	nmod	I-protein
occurred	VBD	ROOT	O
.	.	punct	O

Dimerization	NN	nsubj	O
among	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
has	VBZ	aux	O
become	VBN	ROOT	O
a	DT	det	O
recurrent	JJ	amod	O
theme	NN	xcomp	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
eukaryotic	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
mycotoxins	NNS	nsubj	O
alpha-zearalenol	NN	dep	O
and	CC	cc	O
zearalenone	NN	conj	O
both	DT	nsubj	O
exhibited	VBD	ROOT	O
full	JJ	amod	O
agonist	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
but	CC	cc	O
at	IN	case	O
lower	JJR	amod	O
potencies	NNS	conj	O
,	,	punct	O
with	IN	case	O
EC50	NN	compound	O
values	NNS	nmod	O
of	IN	case	O
1.8	CD	nummod	O
and	CC	cc	O
54	CD	conj	O
nM	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
compared	VBN	prep	O
with	IN	case	O
E2	NN	nmod	O
at	IN	case	O
0.5	CD	nummod	O
nM	NN	nmod	O
.	.	punct	O

Copyright	NN	compound	O
1999	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

The	DT	det	O
biological	JJ	amod	O
effects	NNS	nsubjpass	O
that	WDT	nsubj	O
follow	VBP	acl:relcl	O
from	IN	case	O
expression	NN	nmod	O
of	IN	case	O
TF	NN	nmod	B-protein
by	IN	case	O
vascular	JJ	amod	O
cells	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
resolved	VBN	ROOT	O
by	IN	case	O
analysis	NN	nmod	O
of	IN	case	O
function	NN	nmod	O
aided	VBN	acl	O
by	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
recombinant	JJ	amod	B-protein
full	JJ	amod	I-protein
length	NN	compound	I-protein
TF	NN	nmod	I-protein
and	CC	cc	O
truncated	VBN	amod	B-protein
surface	NN	compound	I-protein
domain	NN	conj	I-protein
of	IN	case	O
TF	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
IL-9	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
controlled	VBN	ccomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

This	DT	det	O
regulated	JJ	amod	O
interaction	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
coordination	NN	nmod	O
of	IN	case	O
lineage-specific	JJ	amod	O
effector	NN	compound	O
functions	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
lymphokine	NN	compound	B-protein
production	NN	nmod	O
with	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
characterized	VBN	ROOT	O
several	JJ	amod	O
29-kDa	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
rapidly	RB	advmod	O
phosphorylated	VBN	acl:relcl	O
following	VBG	case	O
exposure	NN	nmod	O
of	IN	case	O
intact	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
platelets	NNS	nmod	I-cell_type
to	TO	case	O
thrombin	NN	nmod	B-protein
.	.	punct	O

Cross-competition	JJ	compound	O
assays	NNS	nsubj	O
among	IN	case	O
the	DT	det	O
P-like	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
revealed	VBD	ROOT	O
element-specific	JJ	amod	B-protein
and	CC	cc	I-protein
common	JJ	conj	I-protein
complexes	NNS	dobj	I-protein
.	.	punct	O

Monitoring	VBG	csubj	O
DPD	NN	compound	B-protein
activity	NN	dobj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
management	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
experiencing	VBG	acl	O
severe	JJ	amod	O
toxicity	NN	dobj	O
secondary	JJ	amod	O
to	TO	case	O
FUra	NN	compound	O
chemotherapy	NN	nmod	O
.	.	punct	O

(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
Intrafollicular	JJ	amod	B-cell_type
CD57+	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
were	VBD	cop	O
negative	JJ	ROOT	O
for	IN	case	O
Bcl-6	NN	nmod	B-protein
,	,	punct	O
indicating	VBG	xcomp	O
heterogeneity	NN	dobj	O
of	IN	case	O
the	DT	det	O
intrafollicular	JJ	amod	B-cell_type
T-cell	NN	compound	I-cell_type
population	NN	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
MEL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
K562	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
acquired	VBD	ROOT	O
a	DT	det	O
macrophage-like	JJ	amod	O
morphology	NN	dobj	O
and	CC	cc	O
exhibited	VBD	conj	O
a	DT	det	O
complete	JJ	amod	O
failure	NN	dobj	O
to	TO	mark	O
generate	VB	acl	O
benzidine-positive	JJ	amod	B-cell_line
cells	NNS	dobj	I-cell_line
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
NFAT	NN	nsubj	B-protein
(	-LRB-	punct	O
-276	CD	nummod	B-DNA
to	TO	dep	I-DNA
-261	CD	appos	I-DNA
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
distal	JJ	amod	B-DNA
octamer	NN	compound	I-DNA
(	-LRB-	punct	O
-256	CD	nummod	B-DNA
to	TO	dep	I-DNA
-248	CD	appos	I-DNA
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
proximal	JJ	amod	B-DNA
octamer	NN	conj	I-DNA
(	-LRB-	punct	O
-75	CD	compound	B-DNA
to	TO	dep	I-DNA
-66	CD	appos	I-DNA
)	-RRB-	punct	O
sites	NNS	conj	O
not	RB	neg	O
only	RB	cc:preconj	O
act	VBP	ccomp	O
as	IN	case	O
enhancers	NNS	nmod	O
of	IN	case	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	O
stimulation	NN	nmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
have	VBP	conj	O
a	DT	det	O
silencing	NN	compound	O
effect	NN	dobj	O
on	IN	case	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
resting	VBG	amod	O
cells	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
a	DT	det	O
series	NN	nsubjpass	O
of	IN	case	O
Burkitt	NN	nmod:poss	B-cell_line
's	POS	case	I-cell_line
lymphoma	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
BL	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
were	VBD	auxpass	O
assayed	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
expression	NN	nmod	O
of	IN	case	O
tissue	NN	compound	B-protein
inhibitor	NN	nmod	I-protein
of	IN	prep	I-protein
metalloproteinases	NNS	dep	I-protein
(	-LRB-	punct	I-protein
TIMP	NNS	dep	I-protein
)	-RRB-	punct	I-protein
-1	CD	nummod	I-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
DNA	NN	compound	O
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
revealed	VBN	ROOT	O
as	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
possible	JJ	amod	O
factors	NNS	nmod	O
in	IN	mark	O
establishing	VBG	advcl	O
MNDA	NN	compound	B-protein
expression	NN	dobj	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IL-4R	NN	compound	B-protein
alpha	NN	compound	I-protein
cytoplasmic	JJ	amod	I-protein
domain	NN	nsubj	I-protein
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
activate	VB	xcomp	O
JAK-1	NN	dobj	B-protein
and	CC	cc	O
STAT6	NN	conj	B-protein
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
expression	NN	dobj	O
of	IN	case	O
IL-4	NN	compound	B-DNA
target	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
thus	RB	advmod	O
identifying	VBG	xcomp	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
IL-4	NN	compound	B-protein
signaling	NN	nsubj	O
can	MD	aux	O
proceed	VB	acl:relcl	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
JAK-3	NN	nmod	B-protein
and	CC	cc	O
gamma	NN	conj	B-protein
(	-LRB-	punct	I-protein
c	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-DNA
MHC	NN	compound	I-DNA
HLA-DRA	NN	compound	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
gene	NN	nmod	I-DNA
can	MD	aux	O
be	VB	auxpass	O
up-regulated	VBN	ROOT	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
Ig	NN	compound	O
cross-linking	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
phorbol	NN	compound	O
esters	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
12-O-tetradecanoyl	NN	compound	O
phorbol	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
TPA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
intense	JJ	amod	O
physical	JJ	amod	O
exercise	NN	nsubj	O
led	VBD	ccomp	O
not	RB	neg	O
only	RB	cc:preconj	O
to	TO	mark	O
increases	NNS	xcomp	O
in	IN	case	O
blood	NN	compound	O
hormone	NN	compound	O
concentrations	NNS	nmod	O
but	CC	cc	O
also	RB	advmod	O
to	TO	case	O
an	DT	det	O
increase	NN	conj	O
in	IN	case	O
the	DT	det	O
density	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
GATA-1	NN	compound	B-protein
activity	NN	nsubj	O
is	VBZ	cop	O
low	JJ	ccomp	O
in	IN	case	O
G1	NN	nmod	O
,	,	punct	O
peaks	VBZ	conj	O
in	IN	case	O
mid-S	NN	amod	O
phase	NN	nmod	O
,	,	punct	O
and	CC	cc	O
then	RB	advmod	O
decreases	VBZ	conj	O
in	IN	case	O
G2/M	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
these	DT	det	O
cytokines	NNS	nsubj	B-protein
predominantly	RB	advmod	O
activate	VBP	ccomp	O
an	DT	det	O
80	CD	nummod	B-protein
kDa	NN	compound	I-protein
STAT5	NN	compound	I-protein
isoform	NN	dobj	I-protein
in	IN	case	O
mature	JJ	amod	O
granulocytes	NNS	nmod	O
.	.	punct	O

Constitutive	JJ	amod	O
dephosphorylation	NN	ROOT	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
a	DT	det	O
member	NN	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
,	,	punct	O
NF-AT1	NN	appos	B-protein
,	,	punct	O
in	IN	case	O
Tax-expressing	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
type	NN	conj	I-cell_type
I	CD	nummod	I-cell_type
human	JJ	amod	I-cell_type
T-cell	NN	compound	I-cell_type
leukemia	NN	nmod:npmod	I-cell_type
virus-infected	JJ	amod	I-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

TAR	NN	compound	B-DNA
-independent	JJ	amod	O
transactivation	NN	ROOT	O
by	IN	case	O
Tat	NN	nmod	B-protein
in	IN	case	O
cells	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
CNS	NN	nmod	O
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dep	O
of	IN	case	O
HIV-1	NN	compound	O
gene	NN	compound	O
regulation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
activating	VBG	amod	O
region	NN	dobj	O
in	IN	case	O
the	DT	det	O
LMP1	NN	compound	B-protein
C-terminus	NN	nmod	B-protein
and	CC	cc	O
identify	VBP	conj	O
the	DT	det	O
JAK	NN	compound	B-protein
/STAT	NN	compound	B-protein
pathway	NN	dobj	O
as	IN	case	O
a	DT	det	O
target	NN	nmod	O
of	IN	case	O
this	DT	det	O
viral	JJ	amod	B-protein
integral	JJ	amod	I-protein
membrane	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
STAT	NN	compound	B-protein
activity	NN	nmod	O
by	IN	case	O
a	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
the	DT	det	O
T	NN	compound	O
cell	NN	compound	O
functional	JJ	amod	O
phenotype	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
distinct	JJ	conj	O
from	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
-activated	JJ	amod	O
Janus	NN	compound	B-protein
kinase	NN	compound	I-protein
-STAT	JJ	amod	B-protein
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
transcriptional	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
isolated	VBN	amod	B-DNA
human	JJ	amod	I-DNA
MCM	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

Transient-transfection	JJ	compound	O
experiments	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
plasmids	NNS	nsubj	B-DNA
containing	VBG	acl	O
446	CD	nummod	O
bp	NN	dobj	O
of	IN	case	O
c-fes	NN	compound	B-DNA
5'-flanking	JJ	amod	I-DNA
sequences	NNS	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
luciferase	NN	compound	O
reporter	NN	compound	O
gene	NN	nmod	O
were	VBD	cop	O
active	JJ	ccomp	O
exclusively	RB	advmod	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
resistance	NN	nmod	O
to	TO	case	O
host	NN	compound	O
defense	NN	compound	O
mechanisms	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	O
necrosis	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
TNF	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
and	CC	cc	O
Fas-mediated	JJ	amod	O
apoptosis	NN	conj	O
of	IN	case	O
transformed	VBN	amod	B-cell_type
or	CC	cc	O
virus-infected	JJ	conj	B-cell_type
cells	NNS	nmod	I-cell_type
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
critical	JJ	amod	O
component	NN	ROOT	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
disease	NN	nmod	O
.	.	punct	O

This	DT	det	O
minimal	JJ	amod	B-DNA
promoter	NN	nsubj	I-DNA
exhibits	VBZ	ROOT	O
B-cell-specific	JJ	amod	O
activity	NN	dobj	O
and	CC	cc	O
contains	VBZ	conj	O
SP1	NN	dobj	B-DNA
,	,	punct	I-DNA
ETS	NN	conj	I-DNA
,	,	punct	I-DNA
OCT	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
IKAROS/LYF-1	NN	compound	I-DNA
transcription	NN	compound	I-DNA
factor	NN	compound	I-DNA
motifs	NNS	conj	I-DNA
.	.	punct	O

All	DT	det	O
cases	NNS	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
remarkably	RB	advmod	O
poor	JJ	amod	O
prognosis	NN	dobj	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
mean	JJ	amod	O
survival	NN	nmod	O
of	IN	case	O
9.6	CD	nummod	O
+/-	CC	cc	O
6.6	CD	conj	O
months	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
found	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
conserved	VBN	amod	B-DNA
motif	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
several	JJ	amod	O
T-cell-expressed	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
[	-LRB-	punct	O
human	JJ	amod	B-protein
interleukin-2	NN	dep	I-protein
,	,	punct	I-protein
-4	CD	conj	I-protein
,	,	punct	I-protein
-5	CD	conj	I-protein
and	CC	cc	I-protein
-13	CD	conj	I-protein
and	CC	cc	O
human	JJ	amod	B-protein
and	CC	cc	I-protein
mouse	NN	conj	I-protein
granulocyte/macrophage-colony	NN	compound	I-protein
stimulating	NN	compound	I-protein
factor	NN	conj	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
]	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
with	IN	case	O
endometriosis	NN	nmod	O
,	,	punct	O
adenomyotic	JJ	amod	O
lesions	NNS	nsubj	O
showed	VBD	ROOT	O
identical	JJ	amod	O
steroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptor	NN	compound	I-protein
expression	NN	dobj	O
,	,	punct	O
proliferative	JJ	amod	O
activity	NN	conj	O
,	,	punct	O
bcl-2	NN	compound	B-protein
expression	NN	conj	O
and	CC	cc	O
leukocyte	NN	compound	O
subpopulations	NNS	conj	O
to	TO	case	O
eutopic	JJ	amod	O
endometrium	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
different	JJ	amod	O
aetiologies	NNS	dobj	O
for	IN	case	O
these	DT	det	O
disorders	NNS	nmod	O
.	.	punct	O

Human	JJ	amod	B-protein
myeloid	JJ	amod	I-protein
zinc	NN	compound	I-protein
finger	NN	compound	I-protein
protein	NN	nsubj	I-protein
(	-LRB-	punct	O
MZF-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
putative	JJ	amod	O
transcription	NN	compound	O
factor	NN	ROOT	O
containing	VBG	acl	O
13	CD	nummod	B-protein
zinc	NN	compound	I-protein
fingers	NNS	dobj	I-protein
,	,	punct	O
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	conj	O
that	IN	mark	O
it	PRP	nsubj	O
regulates	VBZ	ccomp	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
neutrophilic	JJ	amod	B-cell_type
granulocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
NFATd	NN	compound	B-DNA
element	NN	nsubj	I-DNA
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	dobj	I-protein
NFAT-1	NN	dep	B-protein
and	CC	cc	O
is	VBZ	cop	O
very	RB	advmod	O
active	JJ	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
is	VBZ	cop	O
only	RB	advmod	O
weakly	RB	advmod	O
active	JJ	ROOT	O
in	IN	case	O
one	CD	nummod	O
B	NN	compound	B-cell_line
clone	NN	nmod	I-cell_line
and	CC	cc	O
not	RB	neg	O
at	IN	case	O
all	DT	conj	O
in	IN	case	O
another	DT	nmod	O
.	.	punct	O

Footprinting	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
identical	JJ	amod	O
sequence	NN	compound	O
CCGAAACTGAAAAGG	NN	nsubjpass	O
,	,	punct	O
designated	VBN	acl	O
E6	NN	xcomp	B-DNA
,	,	punct	O
was	VBD	auxpass	O
protected	VBN	ccomp	O
by	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
or	CC	cc	O
HeLa	NN	compound	O
cells	NNS	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
possible	JJ	amod	O
involvement	NN	dobj	O
of	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
family	NN	compound	I-protein
members	NNS	nmod	O
extracellular-regulated	JJ	amod	B-protein
kinase	NN	dep	I-protein
1/2	CD	nummod	I-protein
(	-LRB-	punct	O
ERK1/2	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
c-	NN	amod	O
Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	conj	I-protein
(	-LRB-	punct	O
JNK	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	mark	O
mediating	VBG	acl	O
IL-6	NN	compound	B-protein
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
their	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	mark	O
enhancing	VBG	advcl	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	dobj	O
.	.	punct	O

Upon	IN	case	O
ligand-induced	JJ	amod	O
Mpl	NN	compound	O
homodimerization	NN	nmod	O
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
signaling	NN	compound	O
events	NNS	nsubjpass	O
for	IN	case	O
proliferation	NN	nmod	O
are	VBP	auxpass	O
mediated	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
JAK2	NN	compound	B-protein
/STAT5	NN	compound	B-protein
pathway	NN	nmod	O
,	,	punct	O
while	IN	mark	O
differentiation	NN	nsubj	O
might	MD	aux	O
occur	VB	advcl	O
through	IN	case	O
a	DT	det	O
prolonged	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
MAPK	NN	compound	B-protein
pathway	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
simian	JJ	amod	O
virus	NN	compound	O
40	CD	nummod	O
enhancer	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
MnlI-AluI	NN	compound	B-DNA
fragment	NN	nmod	I-DNA
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
sought	VBD	dep	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
modulation	NN	dobj	O
of	IN	case	O
GR	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
by	IN	case	O
fluticasone	NN	compound	O
propionate	NN	nmod	O
(	-LRB-	punct	O
FP	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
mild	JJ	amod	O
asthma	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Ten	CD	nummod	O
atopic	JJ	amod	O
asthmatic	JJ	amod	O
subjects	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	dep	O
with	IN	case	O
FP	NN	compound	O
250	CD	nummod	O
microg	NN	nmod	O
twice	RB	advmod	O
daily	RB	advmod	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

Cytokines	NNS	nsubj	B-protein
,	,	punct	O
IL-2	NN	appos	B-protein
,	,	punct	O
IL-4	NN	conj	B-protein
,	,	punct	O
IL-6	NN	conj	B-protein
,	,	punct	O
IL-7	NN	conj	B-protein
,	,	punct	O
IL-12	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-15	NN	conj	B-protein
are	VBP	cop	O
key	JJ	amod	O
regulators	NNS	nsubj	O
of	IN	case	O
human	JJ	amod	O
peripheral	JJ	amod	O
blood	NN	compound	O
T	NN	nmod	O
and	CC	cc	O
NK	NN	conj	O
cell	NN	compound	O
activation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
but	CC	cc	O
the	DT	det	O
precise	JJ	amod	O
mechanisms	NNS	conj	O
that	WDT	nsubj	O
give	VBP	acl:relcl	O
rise	NN	dobj	O
to	TO	case	O
their	PRP$	nmod:poss	O
differential	JJ	amod	O
activities	NNS	nmod	O
within	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
are	VBP	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
.	.	punct	O

Mechanisms	NNS	ROOT	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
lymphoid	JJ	amod	O
malignancies	NNS	nmod	O
:	:	punct	O
roles	NNS	dep	O
for	IN	case	O
genetic	JJ	amod	O
alterations	NNS	nmod	O
and	CC	cc	O
cytokine	NN	compound	B-protein
production	NN	conj	O
.	.	punct	O

The	DT	det	O
Tax	NN	compound	B-protein
protein	NN	nsubj	I-protein
of	IN	case	O
HTLV-I	NN	nmod	O
,	,	punct	O
a	DT	det	O
positive	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
activator	NN	appos	I-protein
of	IN	case	O
HTLV-I	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
viral	JJ	amod	O
oncogene	NN	ROOT	O
that	WDT	nsubj	O
also	RB	advmod	O
increases	VBZ	acl:relcl	O
transcription	NN	dobj	O
of	IN	case	O
cellular	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
including	VBG	case	O
GM-CSF	NN	nmod	B-protein
,	,	punct	O
IL-2R	NN	compound	B-protein
alpha	NN	conj	I-protein
and	CC	cc	O
IL-2	NN	conj	B-protein
.	.	punct	O

Signal	NN	compound	B-protein
transducers	NNS	nsubjpass	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	O
STATs	NNS	appos	B-protein
)	-RRB-	punct	O
are	VBP	auxpass	O
rapidly	RB	advmod	O
phosphorylated	VBN	ROOT	O
on	IN	case	O
tyrosine	NN	compound	O
residues	NNS	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
cytokine	NN	nmod	B-protein
and	CC	cc	O
growth	NN	compound	B-protein
factor	NN	compound	I-protein
stimulation	NN	conj	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Rhombotin-2	NN	nsubj	B-DNA
(	-LRB-	punct	O
RBTN-2	NN	appos	B-DNA
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
proto-oncogene	NN	ROOT	B-DNA
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
context	NN	dep	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Further	JJ	amod	O
evidence	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
translational	JJ	amod	O
suppression	NN	nmod	O
of	IN	case	O
TNF	NN	nmod	B-protein
is	VBZ	auxpass	O
given	VBN	ROOT	O
by	IN	case	O
experiments	NNS	nmod	O
using	VBG	acl	O
chloram-phenicol	JJ	amod	B-DNA
acetyltransferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
constructs	NNS	dobj	I-DNA
containing	VBG	acl	O
elements	NNS	dobj	O
of	IN	case	O
the	DT	det	O
TNF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
TNF	NN	compound	B-protein
translational	JJ	amod	O
regulation	NN	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
SRF	NN	nmod	B-protein
constitutively	RB	advmod	O
expressed	VBN	acl	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
are	VBP	cop	O
consistently	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
Zap	NN	nsubj	B-protein
and	CC	cc	O
other	JJ	amod	O
protein-tyrosine	JJ	amod	B-protein
kinases	NNS	conj	I-protein
were	VBD	cop	O
unable	JJ	ROOT	O
to	TO	mark	O
reconstitute	VB	xcomp	O
these	DT	det	O
signaling	NN	compound	O
pathways	NNS	dobj	O
when	WRB	advmod	O
expressed	VBN	advcl	O
at	IN	case	O
the	DT	det	O
same	JJ	amod	O
levels	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
bcl-2	NN	nmod	B-protein
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
on	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	acl:relcl	O
by	IN	case	O
bufalin	NN	nmod	O
.	.	punct	O

In	IN	case	O
T-	NN	compound	B-cell_line
and	CC	cc	I-cell_line
B-cell	NN	conj	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
E	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
gre	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
motifs	NNS	nsubj	I-DNA
were	VBD	cop	O
of	IN	case	O
major	JJ	amod	O
importance	NN	ROOT	O
for	IN	case	O
Akv	NN	compound	O
MLV	NN	compound	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
EA/S	NN	compound	B-DNA
motif	NN	nsubj	I-DNA
had	VBD	advcl	O
some	DT	det	O
effect	NN	dobj	O
.	.	punct	O

Signal	NN	compound	O
integration	NN	nsubj	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	conj	O
[	-LRB-	punct	O
see	VB	ROOT	O
comments	NNS	dobj	O
]	-RRB-	punct	O

Transfection	NN	compound	O
studies	NNS	nsubj	O
with	IN	case	O
reporter	NN	compound	B-DNA
constructs	NNS	nmod	I-DNA
and	CC	cc	O
various	JJ	amod	O
expression	NN	compound	O
vectors	NNS	conj	O
verified	VBD	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
relation	NN	nsubj	O
between	IN	case	O
circulating	VBG	amod	O
cortisol	NN	compound	O
concentrations	NNS	nmod	O
and	CC	cc	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
affinity	NN	conj	O
and	CC	cc	O
number	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
MF	NN	compound	O
individuals	NNS	nsubj	O
where	WRB	advmod	O
no	DT	neg	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
seen	VBN	acl:relcl	O
,	,	punct	O
transendothelial	JJ	amod	O
migration	NN	dobj	O
of	IN	case	O
48-hr	JJ	amod	O
filarial	JJ	amod	B-cell_type
antigen	NN	compound	I-cell_type
stimulated	JJ	amod	I-cell_type
T-cells	NNS	nmod	I-cell_type
from	IN	case	O
LP	NN	compound	O
individuals	NNS	nmod	O
was	VBD	ROOT	O
significantly	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0.01	CD	dep	O
)	-RRB-	punct	O
greater	JJR	amod	O
than	IN	case	O
migration	NN	nmod	O
of	IN	case	O
48-hr	JJ	amod	O
media-stimulated	JJ	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
.	.	punct	O

Sensitivity	NN	nsubj	O
against	IN	case	O
various	JJ	amod	O
enzyme	NN	compound	O
inhibitors	NNS	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
components	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
are	VBP	auxpass	O
shared	VBN	ccomp	O
by	IN	case	O
all	DT	det	O
three	CD	nummod	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

In	IN	case	O
three	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
PHP	NN	nmod	O
who	WP	nsubjpass	O
were	VBD	auxpass	O
subjected	VBN	acl:relcl	O
to	TO	case	O
parathyroidectomy	NN	nmod	O
,	,	punct	O
the	DT	det	O
calcitriol	NN	compound	O
number	NN	nsubj	O
came	VBD	ROOT	O
down	RP	advmod	O
to	IN	case	O
normal	JJ	nmod	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
most	RBS	advmod	O
active	JJ	amod	O
NFAT-like	JJ	amod	B-DNA
elements	NNS	nsubj	I-DNA
were	VBD	cop	O
located	JJ	ROOT	O
at	IN	case	O
the	DT	det	O
center	NN	nmod	O
of	IN	case	O
the	DT	det	O
DNase	NN	compound	B-DNA
I-hypersensitive	JJ	amod	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Thirty	CD	nummod	O
percent	NN	nsubj	O
of	IN	case	O
GC	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
naive	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
displayed	VBD	ROOT	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
742	CD	nummod	B-DNA
bp	NN	compound	I-DNA
region	NN	nmod	I-DNA
analyzed	VBN	acl	O
within	IN	case	O
the	DT	det	O
first	JJ	amod	O
intron	NN	nmod	O
of	IN	case	O
BCL-6	NN	nmod	B-protein
(	-LRB-	punct	O
overall	JJ	amod	O
frequency	NN	appos	O
:	:	punct	O
5	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-4	CD	dep	O
)	-RRB-	punct	O
/bp	NN	nummod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
study	VB	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
15-LO	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
and	CC	cc	O
sequenced	VBD	conj	O
the	DT	det	O
human	JJ	amod	B-DNA
15-LO	NN	compound	I-DNA
promoter	NN	compound	I-DNA
region	NN	dobj	I-DNA
.	.	punct	O

Heat-shock	NN	nsubj	O
and	CC	cc	O
cadmium	NN	conj	O
chloride	NN	conj	O
increase	VBP	ROOT	O
the	DT	det	O
vimentin	NN	compound	O
mRNA	NN	dobj	O
and	CC	cc	O
protein	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
U-937	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
IL-2	NN	nsubj	B-protein
and	CC	cc	O
IL-12	NN	conj	B-protein
synergistically	RB	advmod	O
induced	VBD	ROOT	O
IRF-1	NN	dobj	B-protein
,	,	punct	O
whereas	IN	dep	O
IFN-alpha	NN	nsubj	B-protein
and	CC	cc	O
IL-12	NN	conj	B-protein
did	VBD	parataxis	O
not	RB	neg	O
.	.	punct	O

Two	CD	nummod	O
stable	JJ	amod	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
established	VBN	ROOT	O
:	:	punct	O
R59Z	NN	compound	B-cell_line
activator	NN	compound	I-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
used	VBN	parataxis	O
to	TO	mark	O
induce	VB	xcomp	O
lytic	JJ	amod	O
EBV	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
constitutive	JJ	amod	O
manner	NN	nmod	O
by	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
the	DT	det	O
BZLF	NN	compound	B-protein
1	CD	nummod	I-protein
trans-activator	NN	nmod	I-protein
(	-LRB-	punct	O
Zta	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Monocytes	NNS	nsubj	O
of	IN	case	O
AIDS-GR	NN	compound	O
patients	NNS	nmod	O
had	VBD	ROOT	O
a	DT	det	O
receptor	NN	compound	O
Kd	NN	dobj	O
of	IN	case	O
10.5	CD	nummod	O
+/-	CC	cc	O
4.2	CD	conj	O
nmol/L	NN	nmod	O
that	WDT	nsubj	O
was	VBD	cop	O
higher	JJR	acl:relcl	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
the	DT	det	O
AIDS-C	NN	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
2.9	CD	nummod	O
+/-	CC	cc	O
0.8	CD	conj	O
nmol/L	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
normal	JJ	amod	O
subjects	NNS	conj	O
(	-LRB-	punct	O
2.0	CD	nummod	O
+/-	CC	cc	O
0.8	CD	conj	O
nmol/L	NN	dep	O
;	:	punct	O
P	NN	compound	O
<	ADD	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
Tax1	NN	nmod	B-protein
with	IN	case	O
NF-YB	NN	nmod	B-protein
was	VBD	cop	O
specific	JJ	ROOT	O
in	IN	mark	O
that	DT	mark	O
NF-YB	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
interact	VB	advcl	O
with	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
human	JJ	amod	B-protein
immunodeficiency	NN	compound	I-protein
virus	NN	compound	I-protein
Tat	NN	nmod	I-protein
,	,	punct	O
human	JJ	amod	B-protein
papillomavirus	NN	compound	I-protein
E6	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
Bicoid	NNP	conj	B-protein
,	,	punct	O
or	CC	cc	O
with	IN	case	O
the	DT	det	O
M7	NN	compound	B-protein
(	-LRB-	punct	I-protein
amino	NN	compound	I-protein
acids	NNS	compound	I-protein
29CP-AS	NN	amod	I-protein
)	-RRB-	punct	I-protein
Tax1	NN	compound	I-protein
mutant	NN	conj	I-protein
.	.	punct	O

Access	NN	nsubjpass	O
to	TO	case	O
this	DT	det	O
site	NN	nmod	O
is	VBZ	auxpass	O
blocked	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	B-DNA
silent	JJ	amod	I-DNA
c-myc	NN	compound	I-DNA
allele	NN	nmod	I-DNA
;	:	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	parataxis	O
that	IN	mark	O
the	DT	det	O
Nm23H2	NN	compound	B-protein
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
deregulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
translocated	VBN	amod	O
c-myc	NN	compound	B-DNA
allele	NN	nmod	I-DNA
in	IN	case	O
Burkitt	NN	nmod:poss	B-cell_line
's	POS	case	I-cell_line
lymphoma	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Further	RB	amod	O
dissection	NN	nsubj	O
of	IN	case	O
the	DT	det	O
317	CD	nummod	B-DNA
base	NN	compound	I-DNA
pair	NN	compound	I-DNA
region	NN	nmod	I-DNA
demonstrates	VBZ	ROOT	O
that	IN	mark	O
,	,	punct	O
whereas	IN	mark	O
all	DT	det	O
317	CD	nummod	B-DNA
base	NN	compound	I-DNA
pairs	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
expression	NN	nmod	O
in	IN	case	O
megakaryocytes	NNS	nmod	B-cell_type
,	,	punct	O
only	RB	advmod	O
the	DT	det	O
5	CD	nummod	B-DNA
'	CC	punct	I-DNA
62	CD	nummod	I-DNA
base	NN	compound	I-DNA
pairs	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
needed	VBN	parataxis	O
for	IN	case	O
erythroid-specific	JJ	amod	O
reporter	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
DFX	NN	compound	O
treatment	NN	nsubj	O
limits	VBZ	ccomp	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
activation	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	appos	I-protein
involved	VBN	acl	O
in	IN	case	O
both	CC	cc:preconj	O
TNF-alpha	NN	compound	B-protein
gene	NN	compound	O
transcription	NN	nmod	O
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
signalling	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	amod	O
0.005	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
replicative	JJ	amod	O
gene	NN	compound	O
expression	NN	ROOT	O
in	IN	case	O
tumour	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
AIDS-related	JJ	amod	O
non-Hodgkin	JJ	amod	O
's	POS	case	O
lymphoma	NN	nmod	O
in	IN	case	O
relation	NN	nmod	O
to	TO	case	O
CD4	NN	compound	B-protein
cell	NN	compound	O
number	NN	nmod	O
and	CC	cc	O
antibody	NN	compound	O
titres	NNS	conj	O
to	TO	case	O
EBV	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
ETS1	NN	nsubj	B-protein
,	,	punct	O
and	CC	cc	O
inducible	JJ	amod	O
NFkappaB	NN	conj	B-protein
and	CC	cc	O
AP1	NN	conj	B-protein
,	,	punct	O
cooperate	VBP	ccomp	O
as	IN	case	O
part	NN	nmod	O
of	IN	case	O
a	DT	det	O
higher	JJR	amod	O
order	NN	compound	O
transcriptional	JJ	amod	B-protein
complex	NN	nmod	I-protein
in	IN	case	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Neighbouring	VBG	amod	O
sequence	NN	compound	O
analysis	NN	nsubj	O
favours	VBZ	ROOT	O
a	DT	det	O
small	JJ	amod	O
deletion	NN	compound	O
model	NN	dobj	O
of	IN	case	O
slipped	JJ	amod	O
mispairing	NN	amod	O
events	NNS	nmod	O
during	IN	case	O
replication	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
led	VBD	ROOT	O
to	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
some	DT	nsubj	O
of	IN	case	O
the	DT	det	O
Rel/NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
proteins	NNS	nmod	I-protein
were	VBD	cop	O
key	JJ	amod	O
nuclear	JJ	amod	B-protein
factors	NNS	ccomp	I-protein
in	IN	case	O
functions	NNS	nmod	O
of	IN	case	O
accessory	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
Egr-1	NN	nmod	B-protein
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	nmod	O
and	CC	cc	O
restricts	VBZ	conj	O
differentiation	NN	dobj	O
of	IN	case	O
myeloblasts	NNS	nmod	B-cell_type
along	IN	case	O
the	DT	det	O
macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

RP1	NN	nsubjpass	B-DNA
,	,	punct	O
a	DT	det	O
new	JJ	amod	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
adenomatous	JJ	amod	B-DNA
polyposis	NN	compound	I-DNA
coli-binding	JJ	amod	I-DNA
EB1-like	JJ	amod	I-DNA
gene	NN	compound	I-DNA
family	NN	nmod	I-DNA
,	,	punct	O
is	VBZ	auxpass	O
differentially	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
ORF	NN	nsubj	B-DNA
does	VBZ	aux	O
not	RB	neg	O
contain	VB	ROOT	O
the	DT	det	O
characteristic	JJ	amod	O
DNA-binding	JJ	amod	B-DNA
domain	NN	dobj	I-DNA
found	VBN	acl	O
in	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
forkhead	NN	compound	B-protein
protein	NN	compound	I-protein
family	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nsubj	I-DNA
of	IN	case	O
many	JJ	amod	O
inducible	JJ	amod	B-DNA
T-cell	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
contain	VBP	ROOT	O
adjacent	JJ	amod	O
or	CC	cc	O
overlapping	VBG	conj	B-DNA
binding	VBG	amod	I-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
the	DT	dep	O
Ets	NN	nmod	B-protein
and	CC	cc	I-protein
NF-kappaB/NFAT	NN	conj	I-protein
families	NNS	dep	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
study	NN	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
alterations	NNS	nsubj	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
binding	NN	nmod	O
contribute	VBP	ccomp	O
to	TO	case	O
poor	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
glucocorticoid	NN	compound	O
therapy	NN	nmod	O
in	IN	case	O
asthma	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
paper	NN	nmod	O
plasma	NN	compound	O
membranes	NNS	nsubjpass	O
from	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
were	VBD	auxpass	O
covalently	RB	advmod	O
photolabeled	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
[	-LRB-	punct	O
125I	NN	nummod	O
]	-RRB-	punct	O
-aldosterone	JJ	amod	O
derivative	NN	nmod	O
.	.	punct	O

The	DT	det	O
X-inactivation	NN	compound	O
patterns	NNS	nsubjpass	O
of	IN	case	O
circulating	VBG	amod	O
PMNCs	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
lymphocytes	NNS	conj	I-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
individual	JJ	amod	O
granulocyte	NN	compound	B-cell_line
colonies	NNS	conj	I-cell_line
grown	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
from	IN	case	O
bone	NN	compound	O
marrow	NN	compound	O
cells	NNS	nmod	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

Both	DT	det	O
primers	NNS	nsubj	O
detected	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
copy	NN	dobj	O
of	IN	case	O
the	DT	det	O
adenovirus	NN	compound	B-DNA
type	NN	compound	I-DNA
2	CD	nummod	I-DNA
genome	NN	nmod	I-DNA
but	CC	cc	O
were	VBD	cop	O
less	RBR	advmod	O
sensitive	JJ	conj	O
for	IN	case	O
the	DT	det	O
group	NN	compound	O
B	NN	compound	O
type	NN	nmod	O
35	CD	nummod	O
.	.	punct	O

The	DT	det	O
Kd	NN	compound	O
value	NN	nsubj	O
for	IN	case	O
aldosterone	NN	nmod	O
was	VBD	cop	O
0.3	CD	nummod	O
nM	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
Bmax	NN	nsubj	O
=	JJ	conj	O
32	CD	nummod	O
pmol/mg	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
vaccination	NN	nsubj	O
with	IN	case	O
a	DT	det	O
CTL	NN	compound	O
epitope	NN	nmod	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
adenovirus	NN	compound	I-DNA
type	NN	compound	I-DNA
5	CD	nummod	I-DNA
E1A-region	NN	nmod	I-DNA
(	-LRB-	punct	O
Ad5E1A234-243	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
serve	VB	acl:relcl	O
as	IN	case	O
a	DT	det	O
target	NN	nmod	O
for	IN	case	O
tumor-eradicating	JJ	amod	B-cell_type
CTL	NN	nmod	I-cell_type
,	,	punct	O
enhances	VBZ	ccomp	O
rather	RB	advmod	O
than	IN	mwe	O
inhibits	VBZ	conj	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
Ad5E1A-expressing	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
paper	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
in	IN	case	O
blood	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
first	RB	advmod	O
investigated	VBN	ROOT	O
in	IN	case	O
fractions	NNS	nmod	O
of	IN	case	O
nucleated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
revealing	VBG	xcomp	O
predominant	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
Ah	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
monocyte	NN	compound	B-cell_type
fraction	NN	nmod	I-cell_type
.	.	punct	O

Molecular	JJ	amod	O
mechanisms	NNS	ROOT	O
of	IN	case	O
steroid	NN	compound	O
action	NN	nmod	O
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
type	NN	dep	O
of	IN	case	O
cross-talk	NN	nmod	O
between	IN	case	O
glucocorticoids	NNS	nmod	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
enhanced	VBN	amod	O
efficacy	NN	dobj	O
of	IN	case	O
local	JJ	amod	O
immunosuppression	NN	nmod	O
by	IN	mark	O
targeting	VBG	advcl	O
spleen	NN	dobj	O
with	IN	case	O
liposomal	JJ	amod	O
MPL	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
p50	NN	compound	B-protein
protein	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
of	IN	case	O
all	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
decrease	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
level	NN	nmod	O
in	IN	case	O
leukocytes	NNS	nmod	B-cell_type
may	MD	aux	O
be	VB	cop	O
related	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
type	NN	compound	O
II	CD	nummod	O
diabetes	NNS	nmod	O
in	IN	case	O
menopausal	JJ	amod	O
period	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
hypothesized	VBN	ROOT	O
that	IN	mark	O
such	JJ	amod	O
defects	NNS	nsubj	O
in	IN	case	O
fetal/neonatal	JJ	amod	O
T-cell	NN	compound	O
activation	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
due	JJ	ccomp	O
to	TO	case	O
lack	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
elements	NNS	nmod	I-protein
required	VBN	acl	O
for	IN	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
beta-casein	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
cytotoxic	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
CTLL-2	NN	appos	B-cell_line
,	,	punct	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
interleukin-2	NN	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
activates	VBZ	acl:relcl	O
STAT5	NN	dobj	B-protein
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
the	DT	det	O
RAR-selective	JJ	amod	O
antagonist	NN	nmod	O
and	CC	cc	O
9-cis	JJ	amod	O
RA	NN	conj	O
resulted	VBD	ROOT	O
in	IN	case	O
partial	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
and	CC	cc	I-cell_line
NB4	NN	conj	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
RAR	NN	compound	B-protein
antagonist	NN	nsubj	O
completely	RB	advmod	O
blocked	VBD	parataxis	O
all-trans	JJ	amod	O
RA-induced	JJ	amod	O
differentiation	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Type	NN	compound	B-protein
I	CD	nummod	I-protein
IFNs	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
IFN-alpha/beta	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
addition	NN	dep	O
to	TO	case	O
IL-12	NN	appos	B-protein
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
mouse	NN	conj	O
,	,	punct	O
Th	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
corresponding	JJ	amod	O
mutations	NNS	nsubj	O
in	IN	case	O
murine	JJ	amod	O
calcineurin	NN	nmod	B-protein
render	VBP	ccomp	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
signal	NN	compound	O
transduction	NN	compound	O
cascade	NN	compound	O
CsA	NN	dobj	O
resistant	JJ	amod	O
in	IN	case	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
initial	JJ	amod	O
changes	NNS	nsubjpass	O
are	VBP	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
eventual	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
TCR	NN	compound	B-protein
zeta	NN	compound	I-protein
chain	NN	nmod	I-protein
and	CC	cc	O
p56	NN	conj	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	conj	O
in	IN	case	O
cytotoxic	JJ	amod	O
function	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
successful	JJ	amod	O
generation	NN	nsubjpass	O
of	IN	case	O
surrogate	JJ	amod	B-protein
receptors	NNS	nmod	I-protein
on	IN	case	O
non-T	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
more	RBR	advmod	O
efficient	JJ	amod	O
TG	NN	compound	B-protein
presentation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
nNOS	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
predominant	JJ	amod	O
isoform	NN	ccomp	O
constitutively	RB	advmod	O
expressed	VBN	acl	O
in	IN	case	O
glia	NN	nmod	B-cell_type
.	.	punct	O

During	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
latent	JJ	amod	O
infection	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
six	CD	nummod	O
viral	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
antigens	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
EBNAs	NNS	appos	B-protein
)	-RRB-	punct	O
are	VBP	auxpass	O
expressed	VBN	ROOT	O
from	IN	case	O
one	CD	nmod	O
of	IN	case	O
two	CD	nummod	O
promoters	NNS	nmod	B-DNA
,	,	punct	O
Cp	NN	appos	B-DNA
or	CC	cc	O
Wp	NN	conj	B-DNA
,	,	punct	O
whose	WP$	nmod:poss	O
activities	NNS	nsubj	O
are	VBP	cop	O
mutually	RB	advmod	O
exclusive	JJ	conj	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
in	IN	case	O
mouse	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
its	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
found	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
B	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

This	DT	det	O
last	JJ	amod	O
site	NN	nsubj	O
closely	RB	advmod	O
resembles	VBZ	ROOT	O
the	DT	det	O
ME1a1	NN	compound	B-DNA
G3AG4AG3	NN	compound	I-DNA
motif	NN	dobj	I-DNA
previously	RB	advmod	O
shown	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
critical	JJ	amod	O
element	NN	xcomp	O
in	IN	case	O
the	DT	det	O
P2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
c-myc	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
CD27	NN	compound	B-protein
cross-linking	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
up-regulation	NN	nmod	O
of	IN	case	O
positive	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
domain	NN	compound	I-protein
I-binding	JJ	amod	I-protein
factor-1	NN	nmod	I-protein
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
PKC	NN	nmod	B-protein
by	IN	case	O
the	DT	det	O
isoquinoline	NN	compound	O
derivative	JJ	amod	O
H7	NN	nmod	O
abolishes	VBZ	ROOT	O
induction	NN	dobj	O
of	IN	case	O
M-CSF	NN	nmod	B-protein
by	IN	case	O
M-CSF	NN	nmod	B-protein
.	.	punct	O

When	WRB	advmod	O
considered	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
antioxidants	NNS	nsubj	O
exert	VBP	ccomp	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
by	IN	mark	O
impairing	VBG	advcl	O
translation	NN	dobj	O
and/or	CC	cc	O
by	IN	mark	O
causing	VBG	conj	O
degradation	NN	dobj	O
of	IN	case	O
newly	RB	advmod	O
translated	VBN	amod	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Long-lasting	JJ	amod	O
IL-2	NN	compound	B-protein
receptivity	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
high-level	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
IL-2	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
chain	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
at	IN	case	O
both	CC	cc:preconj	O
transcriptional	JJ	amod	O
and	CC	cc	O
posttranscriptional	JJ	conj	O
levels	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Abnormalities	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
cyclic	JJ	amod	O
adenosine	NN	compound	O
monophosphate	NN	compound	O
(	-LRB-	punct	O
cAMP	NN	compound	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
phosphorylation	NN	compound	O
system	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
recently	RB	advmod	O
reported	VBN	dep	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
bipolar	JJ	amod	O
disorder	NN	nmod	O
.	.	punct	O

No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
estrogen	NN	nmod	O
and	CC	cc	O
progesterone	NN	conj	O
status	NN	dep	O
,	,	punct	O
tumor	NN	compound	O
size	NN	conj	O
and	CC	cc	O
polyamine	NN	compound	O
concentrations	NNS	conj	O
.	.	punct	O

The	DT	det	O
HB9	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
3	CD	nummod	O
exons	NNS	nmod	B-DNA
spread	VBN	acl	O
over	IN	case	O
6	CD	nummod	O
kilobases	NNS	nmod	O
of	IN	case	O
DNA	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
proximal	JJ	amod	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
may	MD	aux	O
constitute	VB	ccomp	O
a	DT	det	O
minimal	JJ	amod	O
region	NN	dobj	O
responsible	JJ	amod	O
for	IN	case	O
CTL-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
perforin	NN	nmod	B-protein
.	.	punct	O

Passaging	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NPC	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
HK666	NN	nmod	I-cell_line
led	VBD	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
BZLF1	NN	nmod	B-DNA
,	,	punct	O
which	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
Zta	NN	dobj	B-protein
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
Qp	NN	compound	B-DNA
function	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
map	VBP	ROOT	O
the	DT	det	O
cis-acting	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
interleukin	NN	compound	O
responsiveness	NN	dobj	O
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
using	VBG	acl	O
a	DT	det	O
thymic	JJ	amod	B-cell_line
lymphoma-derived	JJ	amod	I-cell_line
hybridoma	NN	dobj	I-cell_line
(	-LRB-	punct	O
PC60	NN	appos	B-cell_line
)	-RRB-	punct	O
.	.	punct	O

All	DT	det	O
such	JJ	amod	O
events	NNS	nsubjpass	O
were	VBD	auxpass	O
abrogated	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
LY294002	NN	nmod	O
,	,	punct	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
PI3-kinase	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
chimeric	JJ	amod	B-protein
oncoprotein	NN	nsubj	I-protein
E2a-Pbx1	NN	dep	B-protein
results	VBZ	ROOT	O
from	IN	case	O
fusion	NN	nmod	O
of	IN	case	O
the	DT	dep	O
E2A	NN	nmod	B-DNA
and	CC	cc	I-DNA
PBX1	NN	conj	I-DNA
genes	NNS	dep	I-DNA
following	VBG	case	O
t	NN	nmod	B-DNA
(	-LRB-	punct	I-DNA
1	CD	nummod	I-DNA
;	:	punct	I-DNA
19	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
chromosomal	JJ	amod	I-DNA
translocations	NNS	conj	I-DNA
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
precursor	NN	compound	O
acute	JJ	amod	O
leukemias	NNS	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
first	JJ	amod	O
day	NN	nmod	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
,	,	punct	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
capacity	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
without	IN	case	O
alteration	NN	nmod	O
of	IN	case	O
the	DT	det	O
receptor-ligand	JJ	amod	O
affinity	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
on	IN	case	O
days	NNS	nmod	O
4	CD	nummod	O
and	CC	cc	O
12	CD	conj	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
receptor	NN	compound	O
sites	NNS	nmod	O
was	VBD	cop	O
normal	JJ	parataxis	O
again	RB	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
this	DT	det	O
C/EBP	NN	compound	B-RNA
epsilon	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
accumulation	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
require	VB	ROOT	O
synthesis	NN	dobj	O
of	IN	case	O
new	JJ	amod	O
protein	NN	compound	B-protein
factors	NNS	nmod	I-protein
because	IN	mark	O
9-cis	JJ	amod	O
RA	NN	nsubj	O
induced	VBD	advcl	O
C/EBP	NN	compound	B-RNA
epsilon	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
accumulation	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
5'-most	JJ	amod	B-DNA
distal	JJ	amod	I-DNA
CArG	NN	compound	I-DNA
sequences	NNS	nsubj	I-DNA
conferred	VBD	ROOT	O
TPA	NN	compound	O
inducibility	NN	dobj	O
.	.	punct	O

These	DT	det	O
lymphoid/DC	JJ	amod	B-cell_type
precursors	NNS	nsubj	I-cell_type
have	VBP	ROOT	O
little	JJ	amod	O
capacity	NN	dobj	O
to	TO	mark	O
form	VB	acl	O
myeloid	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
thymic	JJ	amod	B-cell_type
DC	NNS	nsubj	I-cell_type
are	VBP	cop	O
a	DT	det	O
lymphoid-related	JJ	amod	O
rather	RB	cc	O
than	IN	mwe	O
myeloid-related	JJ	amod	B-cell_type
lineage	NN	ccomp	I-cell_type
.	.	punct	O

For	IN	case	O
IL-2R	NN	compound	B-protein
and	CC	cc	O
signaling	NN	conj	O
pathway	NN	compound	O
molecule	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
peripheral	JJ	amod	O
blood	NN	compound	B-cell_type
lymphocytes	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
phytohemagglutinin	NN	nmod	B-protein
(	-LRB-	punct	O
PHA	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

An	DT	det	O
IL-2	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	nsubj	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-2	NN	compound	I-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
chain	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	cop	O
a	DT	det	O
composite	JJ	amod	B-DNA
element	NN	ROOT	I-DNA
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
Stat5	NN	dobj	B-protein
,	,	punct	O
Elf-1	NN	conj	B-protein
,	,	punct	O
HMG-I	NN	conj	B-protein
(	-LRB-	punct	I-protein
Y	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
a	DT	det	O
GATA	NN	compound	B-protein
family	NN	compound	I-protein
protein	NN	conj	I-protein
.	.	punct	O

NF-AT	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
reconstituted	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
using	VBG	xcomp	O
semi-purified	JJ	amod	B-protein
AP1	NN	compound	I-protein
proteins	NNS	dobj	I-protein
mixed	VBN	acl	O
with	IN	case	O
cytosol	NN	nmod	O
from	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
EGR1	NN	nmod	B-protein
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
stimulus-dependent	JJ	amod	O
CD44	NN	compound	B-protein
transcription	NN	nmod	O
in	IN	case	O
B	NN	compound	O
lymphocytes	NNS	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
GATA-2	NN	nsubj	B-protein
and	CC	cc	O
GATA-3	NN	compound	B-protein
proteins	NNS	conj	I-protein
also	RB	advmod	O
localized	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
nuclear	JJ	amod	O
bodies	NNS	nmod	O
in	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
co-expressing	VBG	acl	O
GATA-1	NN	compound	B-protein
and	CC	cc	I-protein
-2	CD	conj	I-protein
or	CC	cc	I-protein
GATA-1	NN	conj	I-protein
and	CC	cc	I-protein
-3	CD	conj	I-protein
gene	NN	compound	I-protein
products	NNS	dobj	I-protein
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
different	JJ	amod	O
set	NN	nsubj	O
of	IN	case	O
proteins	NNS	nmod	B-protein
recognize	VBP	ccomp	O
IL-2	NN	compound	B-DNA
and	CC	cc	I-DNA
IL-4	NN	conj	I-DNA
genes	NNS	dobj	I-DNA
.	.	punct	O

Whereas	IN	mark	O
anti-CD28	NN	nsubj	B-protein
together	RB	advmod	O
with	IN	case	O
PMA	NN	nmod	O
increased	VBD	advcl	O
the	DT	dep	O
DNA	NN	compound	O
binding	NN	dobj	O
and	CC	cc	O
trans-activation	NN	compound	O
activity	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
PMA-induced	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
AP-1	NN	nmod	B-protein
was	VBD	auxpass	O
significantly	RB	advmod	O
suppressed	VBN	ROOT	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
not	RB	neg	O
only	RB	cc:preconj	O
reveal	VBP	ROOT	O
that	IN	mark	O
Nmi	NN	nsubj	B-protein
can	MD	aux	O
potentiate	VB	ccomp	O
STAT	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	dobj	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
suggest	VBP	conj	O
that	IN	mark	O
it	PRP	nsubj	O
can	MD	aux	O
augment	VB	ccomp	O
coactivator	NN	compound	O
protein	NN	compound	O
recruitment	NN	dobj	O
to	TO	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
some	DT	det	O
members	NNS	nmod	O
of	IN	case	O
a	DT	det	O
group	NN	nmod	O
of	IN	case	O
sequence-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Distinct	JJ	amod	O
patterns	NNS	nsubjpass	O
of	IN	case	O
chromosome	NN	compound	B-DNA
1	CD	nummod	I-DNA
abnormalities	NNS	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
among	IN	case	O
the	DT	det	O
histologic	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
breast	NN	compound	O
carcinoma	NN	nmod	O
.	.	punct	O

Tissue-specific	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
interleukin-3	NN	nmod	B-protein
(	-LRB-	punct	O
IL-3	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
via	IN	case	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
located	JJ	amod	O
within	IN	case	O
315	CD	nummod	O
base	NN	compound	O
pairs	NNS	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
start	NN	nmod	I-DNA
.	.	punct	O

To	TO	mark	O
differentiate	VB	advcl	O
whether	IN	mark	O
the	DT	det	O
RA	NN	compound	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
RA	NN	compound	B-protein
receptors	NNS	nmod	I-protein
alpha	NN	dep	I-protein
,	,	punct	I-protein
beta	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
gamma	NN	conj	I-protein
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
RAR	NNS	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
reverse	JJ	amod	B-protein
transcriptase	NN	compound	I-protein
-polymerase	NN	amod	O
chain	NN	compound	O
reaction	NN	nmod	O
(	-LRB-	punct	O
RT-PCR	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
a	DT	det	O
more	RBR	advmod	O
sensitive	JJ	amod	O
and	CC	cc	O
specific	JJ	conj	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
(	-LRB-	punct	O
PCR	NN	appos	O
)	-RRB-	punct	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
developed	VBN	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
adenovirus	NN	compound	O
DNA	NN	dobj	O
.	.	punct	O

The	DT	det	O
HTLV-I	NN	compound	B-DNA
LTR	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
three	CD	nummod	O
conserved	VBN	amod	O
regulatory	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
known	VBN	acl	O
as	IN	case	O
21	CD	nummod	B-DNA
base	NN	compound	I-DNA
pair	NN	compound	I-DNA
repeats	NNS	nmod	I-DNA
which	WDT	nsubjpass	O
are	VBP	auxpass	O
required	VBN	acl:relcl	O
for	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
the	DT	det	O
transactivator	NN	compound	B-protein
protein	NN	compound	I-protein
tax	NN	nmod	B-protein
.	.	punct	O

It	PRP	nsubj	O
enables	VBZ	ROOT	O
rapid	JJ	amod	O
and	CC	cc	O
quantitative	JJ	conj	O
assessment	NN	dobj	O
of	IN	case	O
STAT-1	NN	compound	B-protein
phosphorylation	NN	nmod	O
on	IN	case	O
a	DT	det	O
discrete	JJ	amod	O
cell	NN	compound	O
basis	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
both	CC	cc:preconj	O
more	RBR	advmod	O
sensitive	JJ	conj	O
and	CC	cc	O
less	JJR	conj	O
time	NN	compound	O
consuming	JJ	conj	O
than	IN	prep	O
immunoblotting	NN	pobj	O
.	.	punct	O

Chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
expression	NN	compound	I-DNA
constructs	NNS	nsubjpass	I-DNA
containing	VBG	acl	O
regions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
collagenase-1	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
were	VBD	auxpass	O
stably	RB	advmod	O
or	CC	advmod	O
transiently	RB	advmod	O
transfected	VBN	ROOT	O
into	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
reporter	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
assessed	VBN	conj	O
at	IN	case	O
various	JJ	amod	O
times	NNS	nmod	O
after	IN	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
phorbol	NN	nmod:npmod	O
12-myristate	NN	nmod:npmod	O
13-acetate	NN	nmod:npmod	O
(	-LRB-	punct	O
PMA	NN	nmod:npmod	O
)	-RRB-	punct	O
-mediated	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
myeloid-associated	JJ	amod	B-RNA
growth	NN	compound	I-RNA
factor	NN	compound	I-RNA
receptor	NN	compound	I-RNA
transcripts	NNS	nmod	I-RNA
in	IN	case	O
CD34+	JJ	amod	B-cell_line
CB	NN	compound	I-cell_line
subsets	NNS	nmod	I-cell_line
does	VBZ	aux	O
not	RB	neg	O
discriminate	VB	ROOT	O
the	DT	det	O
various	JJ	amod	O
stages	NNS	dobj	O
of	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
exception	NN	nmod	O
of	IN	case	O
the	DT	det	O
M-CSF	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
although	IN	mark	O
CD45	NN	nsubjpass	B-protein
and	CC	cc	O
Lck	NN	conj	B-protein
are	VBP	auxpass	O
not	RB	neg	O
required	VBN	advcl	O
for	IN	case	O
Fas	NN	compound	B-protein
signaling	NN	nmod	O
,	,	punct	O
JNK	NN	compound	B-protein
activation	NN	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
transducing	VBG	acl	O
distal	JJ	amod	O
signals	NNS	dobj	O
that	WDT	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
apoptosis	NN	nmod	O
after	IN	case	O
Fas	NN	compound	B-protein
ligation	NN	nmod	O
.	.	punct	O

GR	NN	compound	B-protein
expression	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
rate-limiting	JJ	xcomp	O
for	IN	mark	O
initiating	VBG	advcl	O
the	DT	det	O
apoptotic	JJ	amod	O
pathway	NN	dobj	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
steroid	NN	compound	O
sensitivity	NN	nmod	O
and	CC	cc	O
GR	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
induction	NN	conj	O
of	IN	case	O
an	DT	det	O
integrated	VBN	amod	O
mouse	NN	compound	B-DNA
mammary	JJ	amod	I-DNA
tumor	NN	compound	I-DNA
virus	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MMTV	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
LTR	NN	compound	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
observed	VBN	conj	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
imply	VBP	ROOT	O
that	IN	mark	O
during	IN	case	O
persistent	JJ	amod	O
infection	NN	compound	O
Ad5	NN	nsubj	O
underwent	VBD	ccomp	O
spontaneous	JJ	amod	O
mutations	NNS	dobj	O
by	IN	case	O
sequence-specific	JJ	amod	O
breakage	NN	nmod	O
and	CC	cc	O
nonhomologous	JJ	amod	O
end-end	NN	conj	O
joining	VBG	amod	O
recombination	NN	compound	O
events	NNS	dep	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
inhibitory	JJ	amod	O
action	NN	dobj	O
of	IN	case	O
six	CD	nummod	O
flavonoids	NNS	nmod	O
on	IN	case	O
IkappaB	NN	compound	B-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
IKK	NN	appos	B-protein
)	-RRB-	punct	O
activity	NN	nmod	O
,	,	punct	O
an	DT	det	O
enzyme	NN	appos	O
recently	RB	advmod	O
found	VBN	acl	O
to	TO	mark	O
phosphorylate	VB	xcomp	O
critical	JJ	amod	O
serine	NN	compound	O
residues	NNS	dobj	O
of	IN	case	O
IkappaB	NN	nmod	O
for	IN	case	O
degradation	NN	nmod	O
.	.	punct	O

Paradoxically	RB	advmod	O
,	,	punct	O
APL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
express	VBP	ROOT	O
PML-RAR	NN	dobj	B-protein
,	,	punct	O
an	DT	det	O
aberrant	JJ	amod	O
form	NN	appos	O
of	IN	case	O
the	DT	det	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	compound	I-protein
type	NN	compound	I-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
RAR	NN	compound	B-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
leukemia-specific	JJ	amod	B-DNA
t	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
15	CD	nummod	I-DNA
;	:	punct	I-DNA
17	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
chromosomal	JJ	amod	I-DNA
translocation	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MHC	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	nsubj	I-DNA
encode	VBP	ROOT	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
proteins	NNS	dobj	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
antigenic	JJ	amod	O
peptide	NN	dobj	O
for	IN	case	O
presentation	NN	nmod	O
to	TO	case	O
T-cells	NNS	nmod	B-cell_type
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
potently	RB	advmod	O
up-regulates	VBZ	ROOT	O
the	DT	det	O
promoter	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
RANTES	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
chemokine	NN	appos	O
that	WDT	nsubj	O
blocks	VBZ	acl:relcl	O
HIV	NN	compound	O
infection	NN	dobj	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
the	DT	det	O
findings	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
role	NN	nmod	O
for	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
A/R	NN	compound	O
tolerance	NN	nmod	O
(	-LRB-	punct	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
PMN	NN	compound	B-cell_type
adhesion	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
perhaps	RB	advmod	O
by	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
GTP-cyclohydrolase	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
these	DT	det	O
stimuli	NNS	nmod	O
on	IN	case	O
endogenous	JJ	amod	O
IkappaB	NN	compound	B-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
IKK	NN	compound	B-protein
)	-RRB-	punct	O
signalsome	JJ	compound	O
activation	NN	nmod	O
and	CC	cc	O
IkappaB	NN	compound	B-protein
phosphorylation/proteolysis	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
investigated	VBD	conj	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
signalsome	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
IKK-alpha	NN	dep	B-protein
,	,	punct	O
IKK-beta	NN	conj	B-protein
,	,	punct	O
NF-kappaB-inducing	NN	amod	B-protein
kinase	NN	conj	I-protein
(	-LRB-	punct	O
NIK	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
IKK-gamma	NN	conj	B-protein
(	-LRB-	punct	O
NF-kappaB	NN	compound	B-protein
essential	JJ	amod	O
modulator	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
IKK	NN	nmod:npmod	B-protein
complex-associated	JJ	amod	I-protein
protein	NN	conj	I-protein
.	.	punct	O

Coactivation	NN	ROOT	O
by	IN	case	O
OCA-B	NN	nmod	B-protein
:	:	punct	O
definition	NN	dep	O
of	IN	case	O
critical	JJ	amod	O
regions	NNS	nmod	O
and	CC	cc	O
synergism	NN	conj	O
with	IN	case	O
general	JJ	amod	O
cofactors	NNS	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
mechanisms	NNS	nsubj	O
other	JJ	amod	O
than	IN	case	O
altered	JJ	amod	O
ligand	NN	nmod	O
or	CC	cc	O
DNA	NN	compound	O
binding	NN	conj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
lack	NN	nmod	O
of	IN	case	O
response	NN	nmod	O
to	TO	case	O
chemotherapy	NN	nmod	O
.	.	punct	O

C/EBP	NN	compound	B-protein
beta	NN	nsubj	I-protein
activated	VBD	ROOT	O
the	DT	det	O
TNF	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
in	IN	case	O
cotransfection	NN	compound	O
assays	NNS	nmod	O
and	CC	cc	O
bound	VBD	conj	O
to	TO	case	O
it	PRP	nmod	O
at	IN	case	O
a	DT	det	O
site	NN	nmod	O
which	WDT	nsubj	O
failed	VBD	acl:relcl	O
to	TO	mark	O
bind	VB	xcomp	O
the	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
protein	NN	compound	O
C/EBP	NN	compound	B-protein
alpha	NN	dobj	I-protein
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
inhibitory	JJ	amod	O
NLS	NN	compound	B-protein
peptide	NN	nsubj	O
interacts	VBZ	ccomp	O
in	FW	compound	O
vitro	FW	advmod	O
with	IN	case	O
a	DT	det	O
cytoplasmic	JJ	amod	B-protein
NLS	NN	compound	I-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
comprised	VBN	acl	O
of	IN	case	O
the	DT	det	O
Rch1/importin	NN	compound	B-protein
(	-LRB-	punct	I-protein
karyopherin	NN	compound	I-protein
)	-RRB-	punct	I-protein
-beta	NN	compound	I-protein
heterodimer	NN	nmod	I-protein
expressed	VBN	acl	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

An	DT	det	O
early	JJ	amod	O
biochemical	JJ	amod	O
event	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
through	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
IL-2R	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
tyrosine	NN	compound	O
phosphorylation	NN	ROOT	O
of	IN	case	O
several	JJ	amod	O
intracellular	JJ	amod	O
substrates	NNS	nmod	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
PU.1	NN	compound	B-protein
/Elf-1	NN	compound	B-protein
site	NN	nmod	O
or	CC	cc	O
the	DT	det	O
3	CD	nummod	B-DNA
'	``	punct	I-DNA
site	NN	conj	I-DNA
(	-LRB-	punct	O
FP4-3	NN	appos	B-DNA
'	''	punct	I-DNA
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
the	DT	det	O
c-fes	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
resulted	VBD	ROOT	O
in	IN	case	O
substantially	RB	advmod	O
reduced	VBN	amod	O
activity	NN	nmod	O
in	IN	case	O
transient	JJ	amod	O
transfections	NNS	nmod	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
implies	VBZ	ROOT	O
that	IN	mark	O
development	NN	nsubj	O
of	IN	case	O
anti-E.	JJ	amod	B-protein
chaffeensis	NN	compound	I-protein
antibody	NN	nmod	I-protein
in	IN	case	O
patients	NNS	nmod	O
can	MD	aux	O
result	VB	ccomp	O
in	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
major	JJ	amod	B-protein
proinflammatory	JJ	amod	I-protein
cytokines	NNS	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathophysiology	NN	nmod	O
of	IN	case	O
ehrlichiosis	NN	nmod	O
and	CC	cc	O
immune	JJ	amod	O
responses	NNS	conj	O
to	IN	case	O
it	PRP	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	O
HGFs	NNS	nmod	B-protein
,	,	punct	O
FL	NN	compound	B-cell_type
monocytic	JJ	amod	I-cell_type
progenitors	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
colony-forming	JJ	amod	B-cell_type
unit	NN	compound	I-cell_type
monocyte	NN	dep	I-cell_type
[	-LRB-	punct	O
CFU-M	NN	appos	B-cell_type
]	-RRB-	punct	O
)	-RRB-	punct	O
generate	VBP	ROOT	O
large	JJ	amod	O
colonies	NNS	dobj	O
exclusively	RB	advmod	O
composed	VBN	acl	O
of	IN	case	O
monocytes-macrophages	NNS	nmod	O
;	:	punct	O
these	DT	det	O
colonies	NNS	nsubj	O
are	VBP	cop	O
absent	JJ	parataxis	O
in	IN	case	O
FCS-	JJ	amod	O
clonogenic	JJ	amod	O
culture	NN	nmod	O
.	.	punct	O

One	CD	nummod	O
p21ras	NN	compound	B-protein
effector	NN	compound	O
pathway	NN	nsubj	O
involves	VBZ	ROOT	O
the	DT	det	O
MAP	NN	compound	B-protein
kinase	NN	compound	I-protein
ERK-2	NN	dobj	B-protein
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	conj	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
NFAT	NN	compound	B-protein
regulation	NN	nmod	O
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
Tax	NN	nsubj	B-protein
can	MD	aux	O
activate	VB	ROOT	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	dobj	O
that	WDT	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
E2F	NN	nmod	B-protein
that	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
induces	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
factors	NNS	nmod	O
required	VBN	acl	O
for	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

Consistent	JJ	advcl	O
with	IN	case	O
the	DT	det	O
diagnosis	NN	nmod	O
of	IN	case	O
PEL	NN	nmod	B-cell_line
,	,	punct	O
both	CC	cc:preconj	O
CRO-AP/3	NN	nsubj	B-cell_line
and	CC	cc	O
CRO-AP/5	NN	conj	B-cell_line
expressed	VBD	ROOT	O
indeterminate	JJ	amod	O
(	-LRB-	punct	O
i.e.	FW	dep	O
non-B	JJ	amod	O
,	,	punct	O
non-T	JJ	dep	O
)	-RRB-	punct	O
phenotypes	NNS	dobj	O
although	IN	mark	O
immunogenotypic	JJ	amod	O
studies	NNS	nsubj	O
documented	VBD	advcl	O
their	PRP$	nmod:poss	O
B-cell	NN	compound	B-cell_type
origin	NN	dobj	I-cell_type
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
reported	VBN	csubj	O
herein	RB	advmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
CD28	NN	compound	B-protein
cosignaling	NN	nmod	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
IL-2	NN	compound	B-protein
secretion	NN	nmod	O
in	IN	case	O
LP	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
are	VBP	cop	O
unique	JJ	ccomp	O
to	TO	case	O
that	DT	det	O
compartment	NN	nmod	O
and	CC	cc	O
differ	VBP	conj	O
from	IN	case	O
those	DT	nmod	O
seen	VBN	acl	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
class	NN	compound	B-protein
II	CD	nummod	I-protein
transactivator	NN	nsubj	I-protein
(	-LRB-	punct	O
CIITA	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
octamer-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
1/octamer-binding	JJ	amod	I-protein
factor	NN	compound	I-protein
1/Oct	CD	compound	I-protein
coactivator	NN	conj	I-protein
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
Bob1/OBF-1/OCA-B	NN	appos	B-protein
)	-RRB-	punct	O
represent	VBP	ROOT	O
two	CD	nummod	O
B	NN	nmod:npmod	B-protein
cell-specific	JJ	amod	I-protein
transcriptional	JJ	amod	I-protein
coactivators	NNS	dobj	I-protein
.	.	punct	O

The	DT	det	O
RAR	NN	compound	B-protein
alpha	NN	compound	I-protein
rearranged	JJ	amod	O
band	NN	nsubj	O
in	IN	case	O
the	DT	det	O
Southern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
a	DT	det	O
chimaeric	JJ	amod	B-protein
product	NN	conj	I-protein
of	IN	case	O
PML-RAR	NN	compound	B-protein
alpha	NN	nmod	I-protein
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
were	VBD	cop	O
strongly	RB	advmod	O
visible	JJ	ROOT	O
before	IN	case	O
ATRA	NN	compound	O
treatment	NN	nmod	O
,	,	punct	O
but	CC	cc	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
maximal	JJ	amod	O
basophilia	NN	nmod	O
both	DT	nsubjpass	O
of	IN	case	O
them	PRP	nmod	O
were	VBD	auxpass	O
markedly	RB	advmod	O
diminished	VBN	conj	O
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
effect	NN	nmod	O
on	IN	case	O
IL-2	NN	compound	B-protein
induction	NN	nmod	O
,	,	punct	O
cyclosporin	NN	compound	O
A	NN	nsubj	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
synergistic	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
JNK	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
competitive	JJ	amod	O
inhibitor	NN	nsubj	O
of	IN	case	O
Jun	NN	compound	B-protein
phosphorylation	NN	nmod	O
by	IN	case	O
JNK	NN	nmod	B-protein
inhibited	VBD	conj	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activation	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutant	NN	nsubj	O
of	IN	case	O
IKK2	NN	nmod	B-protein
inhibited	VBD	ROOT	O
LPS	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	nmod	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
IL-6	NN	compound	B-protein
signaling	NN	nsubj	O
leads	VBZ	ccomp	O
to	TO	case	O
marked	JJ	amod	O
increases	NNS	nmod	O
in	IN	case	O
the	DT	dep	O
synthesis	NN	nmod	O
and	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
Ig	NN	nmod	B-protein
in	IN	case	O
clonal	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
newly	RB	advmod	O
isolated	VBN	amod	B-cell_type
polyclonal	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
therefore	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
basal	JJ	amod	O
level	NN	compound	O
GR	NN	compound	B-protein
expression	NN	nsubj	O
is	VBZ	cop	O
inadequate	JJ	ccomp	O
to	TO	mark	O
mediate	VB	xcomp	O
glucocorticoid-induced	JJ	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
glucocorticoid-sensitive	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
that	IN	mark	O
positive	JJ	amod	O
autoregulation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
necessary	JJ	amod	O
component	NN	conj	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
,	,	punct	O
using	VBG	acl	O
highly	RB	advmod	O
enriched	JJ	amod	O
human	JJ	amod	B-protein
CD34+	NN	dobj	I-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
Lin-	NN	amod	B-cell_line
murine	JJ	amod	I-cell_line
bone	NN	compound	I-cell_line
marrow	NN	compound	I-cell_line
progenitor	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
demonstrates	VBZ	ROOT	O
a	DT	det	O
potent	JJ	amod	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
9-cis-RA	NN	nmod	O
on	IN	case	O
burst-forming	JJ	amod	O
unit-erythroid	JJ	compound	O
(	-LRB-	punct	O
BFU-E	NN	appos	O
)	-RRB-	punct	O
colony	NN	compound	O
formation	NN	nmod	O
regardless	RB	advmod	O
of	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
stimulating	NN	compound	O
growth	NN	nmod	O
.	.	punct	O

Among	IN	case	O
these	DT	det	O
hypersensitive	JJ	amod	B-DNA
sites	NNS	nmod	I-DNA
,	,	punct	O
two	CD	nummod	O
transcriptional	JJ	amod	B-DNA
control	NN	compound	I-DNA
elements	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
found	VBN	ROOT	O
,	,	punct	O
one	CD	xcomp	O
in	IN	case	O
the	DT	det	O
first	JJ	amod	B-DNA
intron	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
GATA-3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
other	JJ	conj	O
between	IN	case	B-DNA
8.3	CD	nummod	I-DNA
and	CC	cc	I-DNA
5.9	CD	conj	I-DNA
kilobases	NNS	nmod	I-DNA
5	CD	nummod	O
'	''	punct	O
from	IN	case	O
the	DT	det	O
GATA-3	NN	compound	B-DNA
transcriptional	JJ	amod	I-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

OCA-B	NN	nsubj	B-protein
stimulates	VBZ	ROOT	O
the	DT	det	O
transcription	NN	dobj	O
from	IN	case	O
an	DT	det	O
IgH	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
Oct-1	NN	nmod	B-protein
or	CC	cc	O
Oct-2	NN	conj	B-protein
but	CC	cc	O
shows	VBZ	conj	O
no	DT	neg	O
significant	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
octamer	NN	nmod:npmod	B-DNA
/	:	punct	O
Oct	NN	nmod:npmod	B-DNA
-dependent	JJ	amod	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
ubiquitously	RB	advmod	B-DNA
expressed	VBN	amod	I-DNA
histone	NN	compound	I-DNA
H2B	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
transcription	NN	conj	O
of	IN	case	O
USF-	NN	amod	B-DNA
and	CC	cc	I-DNA
Sp1-regulated	JJ	conj	I-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
structural	JJ	amod	O
motifs	NNS	dobj	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
this	DT	det	O
antiapoptotic	JJ	amod	O
effect	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
a	DT	det	O
panel	NN	dobj	O
of	IN	case	O
E2A-HLF	JJ	compound	B-protein
mutants	NNS	nmod	I-protein
and	CC	cc	O
programmed	VBD	conj	O
their	PRP$	nmod:poss	O
expression	NN	dobj	O
in	IN	case	O
IL-3-dependent	JJ	amod	B-cell_line
murine	JJ	amod	I-cell_line
pro-B	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
FL5.12	NN	compound	B-cell_line
line	NN	appos	I-cell_line
)	-RRB-	punct	O
,	,	punct	O
using	VBG	advcl	O
a	DT	det	O
zinc-inducible	JJ	amod	O
vector	NN	dobj	O
.	.	punct	O

The	DT	det	O
binding	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-protein
(	-LRB-	punct	I-protein
P	NN	appos	I-protein
)	-RRB-	punct	I-protein
(	-LRB-	punct	O
a	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
that	WDT	nsubj	O
specifically	RB	advmod	O
recognizes	VBZ	acl:relcl	O
the	DT	det	O
P	NN	compound	B-DNA
sequence	NN	dobj	I-DNA
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
P	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
was	VBD	auxpass	O
abolished	VBN	ROOT	O
when	WRB	advmod	O
oligonucleotides	NNS	nsubjpass	O
carrying	VBG	acl	O
base	NN	compound	O
substitutions	NNS	dobj	O
were	VBD	auxpass	O
used	VBN	advcl	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
NF	NN	compound	B-protein
(	-LRB-	punct	I-protein
P	NN	appos	I-protein
)	-RRB-	punct	I-protein
interaction	NN	nsubj	O
is	VBZ	cop	O
sequence-specific	JJ	ccomp	O
and	CC	cc	O
that	IN	mark	O
binding	NN	compound	O
specificity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
paralleled	VBD	conj	O
the	DT	det	O
sequence	NN	compound	O
requirements	NNS	dobj	O
for	IN	case	O
IL-4	NN	compound	B-protein
expression	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
two	CD	nummod	O
NF-kappaB-binding	JJ	amod	B-DNA
sites	NNS	nsubj	I-DNA
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
located	JJ	acl:relcl	O
between	IN	case	O
-3134	CD	nmod	B-DNA
and	CC	cc	I-DNA
-3059	CD	conj	I-DNA
,	,	punct	O
are	VBP	cop	O
critical	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
proIL-1beta	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
.	.	punct	O

Competition	NN	compound	O
assays	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
DR	NN	compound	B-DNA
units	NNS	nsubj	I-DNA
bound	VBD	ccomp	O
to	TO	case	O
factors	NNS	nmod	O
other	JJ	amod	O
than	IN	case	O
the	DT	det	O
12-bp	JJ	amod	B-DNA
insert	NN	nmod	I-DNA
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
prostaglandin	NN	compound	B-protein
E2	NN	nmod	I-protein
on	IN	case	O
Th0-type	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
:	:	punct	O
modulation	NN	dep	O
of	IN	case	O
functions	NNS	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
several	JJ	amod	O
HBD	NN	compound	B-protein
subfragments	NNS	dobj	I-protein
,	,	punct	O
the	DT	det	O
mAb	NN	compound	B-protein
18C7	NN	nummod	I-protein
epitope	NN	nsubj	I-protein
was	VBD	cop	O
located	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
HBD	NN	nmod	B-protein
from	IN	case	O
Thr729	NN	nmod	B-protein
to	TO	case	I-protein
Leu765	NN	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
bulk	NN	nsubj	O
of	IN	case	O
protein-DNA	JJ	amod	O
interactions	NNS	nmod	O
that	WDT	nsubj	O
underlies	VBZ	acl:relcl	O
the	DT	det	O
developmental	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
globin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
takes	VBZ	ccomp	O
place	NN	dobj	O
in	IN	case	O
the	DT	dep	O
gamma-	NN	compound	B-DNA
and	CC	cc	I-DNA
beta-globin	NN	conj	I-DNA
gene	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
GT	NN	compound	B-DNA
motifs	NNS	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
locus	NN	compound	I-DNA
LCR	NN	nmod	B-DNA
may	MD	aux	O
play	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
developmental	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
beta-globin	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
,	,	punct	O
perhaps	RB	advmod	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
probability	NN	dobj	O
of	IN	case	O
interaction	NN	nmod	O
of	IN	case	O
the	DT	det	O
LCR	NN	compound	B-protein
holocomplex	NN	nmod	I-protein
with	IN	case	O
the	DT	det	O
fetal	JJ	nmod	B-DNA
or	CC	cc	I-DNA
the	DT	det	I-DNA
adult	JJ	amod	I-DNA
globin	NN	compound	I-DNA
gene	NN	conj	I-DNA
.	.	punct	O

Using	VBG	advcl	O
Tax	NN	compound	B-protein
mutants	NNS	dobj	O
that	WDT	nsubj	O
fail	VBP	acl:relcl	O
to	TO	mark	O
activate	VB	xcomp	O
either	CC	cc:preconj	O
ATF	NN	compound	B-protein
-or	CD	dep	O
NF-kappaB-dependent	JJ	amod	B-DNA
promoters	NNS	dobj	I-DNA
and	CC	cc	O
different	JJ	amod	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
truncation	NN	compound	I-DNA
mutants	NNS	conj	I-DNA
of	IN	case	O
the	DT	det	O
E2F-1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
Tax	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
transcriptional	JJ	amod	O
control	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E2F1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
involves	VBZ	ccomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
the	DT	det	O
ATF	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	appos	I-DNA
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
E2F-1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
a	DT	det	O
cell-type-specific	JJ	amod	O
differential	JJ	amod	O
response	NN	dobj	O
:	:	punct	O
CREB	NN	nsubjpass	B-DNA
,	,	punct	I-DNA
CTF	NN	conj	I-DNA
,	,	punct	I-DNA
OTF-1	NN	conj	I-DNA
,	,	punct	I-DNA
OFT-2	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
genes	NNS	conj	I-DNA
were	VBD	auxpass	O
strongly	RB	advmod	O
induced	VBN	conj	O
1	CD	compound	O
to	TO	dep	O
4	CD	nummod	O
hours	NNS	nmod	O
after	IN	case	O
influenza	NN	compound	O
A	NN	compound	O
virus	NN	compound	O
infection	NN	nmod	O
in	IN	case	O
the	DT	det	O
monocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Mono	NN	compound	B-cell_line
Mac	NN	nmod	I-cell_line
6	CD	nummod	I-cell_line
,	,	punct	O
while	IN	mark	O
in	IN	case	O
freshly	RB	advmod	O
prepared	VBN	amod	O
human	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
no	DT	neg	O
significant	JJ	amod	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	advcl	O
.	.	punct	O

To	TO	aux	O
help	VB	advcl	O
elucidate	VB	xcomp	O
further	RB	advmod	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ZAP-70	NN	nsubj	B-protein
regulates	VBZ	acl:relcl	O
these	DT	det	O
initial	JJ	amod	O
events	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
dominant-negative	JJ	amod	O
mutant	JJ	amod	O
approach	NN	dobj	O
.	.	punct	O

Cobalt	NN	nmod:npmod	O
chloride-induced	JJ	amod	O
signaling	NN	nsubjpass	O
in	IN	case	O
endothelium	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
augmented	JJ	amod	O
adherence	NN	nmod	O
of	IN	case	O
sickle	JJ	amod	B-cell_type
red	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
transendothelial	JJ	amod	O
migration	NN	conj	O
of	IN	case	O
monocyte-like	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
PAF-receptor	NN	compound	O
antagonist	NN	nmod	O
.	.	punct	O

These	DT	nsubj	O
are	VBP	cop	O
essential	JJ	ROOT	O
for	IN	case	O
IL-2	NN	compound	B-protein
inducibility	NN	nmod	O
of	IN	case	O
PRRIII/CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
c-fos	NN	nmod	B-protein
had	VBD	ROOT	O
a	DT	det	O
negative	JJ	amod	O
influence	NN	dobj	O
on	IN	case	O
GR	NN	compound	B-protein
function	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
the	DT	det	O
cell-specific	JJ	amod	O
synergistic	JJ	amod	O
or	CC	cc	O
antagonistic	JJ	conj	O
activity	NN	nmod	O
of	IN	case	O
Jun	NN	nmod	B-protein
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
GR	NN	nmod	B-protein
;	:	punct	O
high	JJ	amod	O
basal	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
c-fos	NN	nmod	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
AP-1	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	conj	O
and	CC	cc	O
transcriptional	JJ	amod	O
activity	NN	conj	O
were	VBD	auxpass	O
observed	VBN	parataxis	O
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Complete	JJ	amod	O
suppression	NN	nsubjpass	O
of	IN	case	O
AP-1	NN	compound	B-protein
activity	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
Con	NN	nmod:npmod	B-cell_line
A-treated	JJ	amod	I-cell_line
,	,	punct	I-cell_line
proliferating	VBG	amod	I-cell_line
thymocytes	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
development	NN	ROOT	O
of	IN	case	O
functionally	RB	advmod	O
responsive	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
temporal	JJ	amod	O
control	NN	nsubjpass	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
and	CC	cc	O
c-Fos	NN	conj	B-protein
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	ccomp	O
through	IN	case	O
the	DT	det	O
ubiquitinylation	NN	compound	O
pathways	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ubiquitinylation	NN	nsubjpass	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
and	CC	cc	O
c-Fos	NN	conj	B-protein
may	MD	aux	O
in	IN	case	O
turn	NN	nmod	O
be	VB	auxpass	O
regulated	VBN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
the	DT	det	O
heterodimerization	NN	nmod	O
between	IN	case	O
them	PRP	nmod	O
and	CC	cc	O
the	DT	det	O
cooperation	NN	conj	O
between	IN	case	O
E220K	NN	nmod	B-protein
and	CC	cc	O
E3	NN	conj	O
mediated	JJ	amod	O
polyubiquitinylation	NN	conj	O
.	.	punct	O

The	DT	det	O
LTR	NN	nsubjpass	B-DNA
from	IN	case	O
SIVsmmPBj14	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
confer	VB	xcomp	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
kinetics	NNS	nmod	O
of	IN	case	O
virus	NN	compound	O
replication	NN	nmod	O
in	IN	case	O
cultured	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
Egr-1	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
observed	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
transcriptionally	RB	advmod	O
silent	JJ	xcomp	O
in	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
active	JJ	conj	O
in	IN	case	O
U-937	NN	nmod	B-cell_line
and	CC	cc	O
M1	NN	conj	B-cell_line
cells	NNS	dep	I-cell_line
,	,	punct	O
the	DT	det	O
latter	JJ	amod	O
two	CD	nsubjpass	O
being	VBG	auxpass	O
predetermined	VBN	parataxis	O
for	IN	case	O
macrophage	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
activated	VBN	advcl	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
leukemias	NNS	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
SCL	NN	nmod	B-protein
and	CC	cc	O
LYL-1	NN	conj	B-protein
is	VBZ	cop	O
low	JJ	ROOT	O
or	CC	cc	O
undetectable	JJ	conj	O
in	IN	case	O
normal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
populations	NNS	nmod	I-cell_type
.	.	punct	O

Lactobacilli	NN	ROOT	O
and	CC	cc	O
vaginal	JJ	amod	O
host	NN	compound	O
defense	NN	conj	O
:	:	punct	O
activation	NN	dep	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
,	,	punct	O
cytokine	NN	compound	B-protein
production	NN	conj	O
,	,	punct	O
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
resultant	JJ	amod	O
primer	NN	compound	B-DNA
products	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
analysed	VBN	ROOT	O
by	IN	case	O
denaturing	VBG	amod	O
polyacrylamide	NN	compound	O
gel	NN	compound	O
electrophoresis	NN	nmod	O
and	CC	cc	O
autoradiography	NN	conj	O
.	.	punct	O

Decreased	VBN	amod	O
Mn-SOD	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
glutathione	NN	nmod	O
and	CC	cc	O
a	DT	det	O
lower	JJR	amod	O
ratio	NN	conj	O
of	IN	case	O
reduced	VBN	amod	O
:	:	punct	O
oxidized	VBN	amod	O
glutathione	NN	nmod	O
.	.	punct	O

The	DT	det	O
latter	JJ	amod	O
mechanism	NN	nsubj	O
is	VBZ	cop	O
especially	RB	advmod	O
important	JJ	ROOT	O
because	IN	mark	O
evasion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
impending	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
prerequisite	NN	advcl	O
for	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
lymphoproliferative	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
c-fos	NN	compound	B-protein
and	CC	cc	I-protein
c-jun	NN	conj	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
AP-1	NN	compound	B-protein
binding	NN	compound	O
activity	NN	conj	O
during	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
of	IN	case	O
HL60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
phytohemagglutinin-stimulated	JJ	amod	B-cell_line
lymphocytes	NNS	conj	I-cell_line
.	.	punct	O

Liposomal	JJ	amod	O
transfection	NN	nsubj	O
of	IN	case	O
a	DT	det	O
double-stranded	JJ	amod	O
kappaB	NN	compound	O
phosphorothioate	NN	compound	O
oligonucleotide	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
the	DT	det	O
mutated	VBN	amod	O
form	NN	conj	O
,	,	punct	O
inhibited	VBD	ROOT	O
MCP-1	NN	compound	B-protein
secretion	NN	dobj	O
and	CC	cc	O
surface	NN	compound	O
expression	NN	conj	O
of	IN	case	O
ICAM-1	NN	nmod	B-protein
on	IN	case	O
activated	VBN	amod	O
endothelium	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0.05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Antigen	NN	compound	O
receptor	NN	compound	O
signals	NNS	nsubj	O
prolong	VBP	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
-DNA	NN	compound	O
interaction	NN	dobj	O
,	,	punct	O
probably	RB	advmod	O
by	IN	mark	O
functionally	RB	advmod	O
antagonizing	VBG	advcl	O
the	DT	det	O
IL-1	NN	compound	B-protein
-induced	JJ	amod	O
synthesis	NN	dobj	O
of	IN	case	O
a	DT	det	O
protein	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
transient	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
-DNA	NN	compound	O
interaction	NN	nmod	O
and	CC	cc	O
consequently	RB	advmod	O
synergistically	RB	advmod	O
enhance	VBP	conj	O
IL-1	NN	compound	B-protein
-induced	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nmod:npmod	I-protein
-dependent	JJ	amod	O
gene	NN	compound	O
transcription	NN	dobj	O
.	.	punct	O

When	WRB	advmod	O
used	VBN	advcl	O
at	IN	case	O
differentiation-inducing	JJ	amod	O
concentrations	NNS	nmod	O
,	,	punct	O
both	DT	det	O
topoisomerase	NN	compound	B-protein
inhibitors	NNS	nsubj	O
caused	VBD	ROOT	O
a	DT	det	O
great	JJ	amod	O
stimulation	NN	dobj	O
of	IN	case	O
AP-1	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
with	IN	case	O
maximum	JJ	amod	O
value	NN	nmod	O
at	IN	case	O
hour	NN	nmod	O
12	CD	nummod	O
in	IN	case	O
etoposide-treated	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
at	IN	case	O
hour	NN	conj	O
48	CD	nummod	O
in	IN	case	O
ICRF-193-treated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Selective	JJ	amod	O
DNA-binding	JJ	amod	O
activity	NN	ROOT	O
of	IN	case	O
interleukin-10-stimulated	JJ	amod	B-protein
STAT	NN	compound	I-protein
molecules	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
protein	NN	compound	O
footprint	NN	nsubj	O
was	VBD	cop	O
visible	JJ	ROOT	O
over	IN	case	O
this	DT	det	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
c-myb	NN	compound	B-DNA
5	CD	nummod	I-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
sequence	NN	nmod	I-DNA
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
unactivated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
has	VBZ	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
activator	NN	compound	I-protein
protein	NN	nmod	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	nummod	O
LPS-induced	JJ	amod	O
event	NN	ccomp	O
that	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
this	DT	det	O
response	NN	dobj	O
.	.	punct	O

Transactivation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
ICAM-I	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
by	IN	case	O
TaxI	NN	nmod	B-protein
was	VBD	auxpass	O
further	RB	advmod	O
shown	VBN	ROOT	O
by	IN	case	O
co-transfection	NN	nmod	O
of	IN	case	O
a	DT	det	O
CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
with	IN	case	O
the	DT	det	O
ICAM-I	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
a	DT	det	O
plasmid	NN	conj	B-DNA
expressing	VBG	acl	O
TaxI	NN	dobj	B-protein
.	.	punct	O

We	PRP	nsubj	O
then	RB	advmod	O
generated	VBD	ROOT	O
new	JJ	amod	O
donor	NN	compound	O
anti-pml/RAR-alpha	NN	compound	B-cell_line
CD4	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
+	CC	cc	I-cell_line
)	-RRB-	punct	I-cell_line
T-cell	NN	compound	I-cell_line
clones	NNS	dobj	I-cell_line
.	.	punct	O

In	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
with	IN	case	O
protein	NN	compound	O
extracts	NNS	nmod	O
of	IN	case	O
highly	RB	advmod	B-cell_line
polarized	VBN	amod	I-cell_line
Th2	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
from	IN	case	O
atopics	NNS	nmod	O
and	CC	cc	O
Th1	NN	compound	B-cell_line
clones	NNS	conj	I-cell_line
from	IN	case	O
controls	NNS	nmod	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
DNA-binding	JJ	amod	O
activities	NNS	dobj	O
at	IN	case	O
the	DT	det	O
two	CD	nummod	O
NFAT-binding	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
P0	NN	dep	B-DNA
and	CC	cc	O
P1	NN	conj	B-DNA
of	IN	case	O
the	DT	det	O
crucial	JJ	amod	O
proximal	JJ	amod	O
human	JJ	amod	O
IL-4	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

No	DT	neg	O
NF-IL-6	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
mature	JJ	amod	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
via	IN	case	O
Ag	NN	compound	B-protein
receptor	NN	compound	I-protein
cross-linking	NN	nmod	O
induces	VBZ	ROOT	O
transient	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
Egr-1	NN	nmod	B-protein
.	.	punct	O

Signaling	NN	compound	O
events	NNS	ROOT	O
induced	VBN	acl	O
by	IN	case	O
lipopolysaccharide-activated	JJ	amod	B-protein
toll-like	JJ	amod	I-protein
receptor	NN	nmod	I-protein
2	CD	nummod	I-protein
.	.	punct	O

The	DT	det	O
anaphylatoxins	NNS	nsubjpass	B-protein
C5a	NN	dep	B-protein
and	CC	cc	O
C3a	NN	conj	B-protein
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	O
production	NN	nmod	O
.	.	punct	O

After	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
APL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
AM580	NN	nmod	O
either	CC	dep	O
alone	RB	advmod	O
or	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
granulocyte	NN	compound	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
G-CSF	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
compound	NN	nsubj	O
induces	VBZ	ROOT	O
granulocytic	JJ	amod	O
maturation	NN	dobj	O
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
determination	NN	nmod	O
of	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
leukocyte	NN	compound	B-RNA
alkaline	NN	compound	I-RNA
phosphatase	NN	nmod	I-RNA
,	,	punct	I-RNA
CD11b	NN	conj	I-RNA
,	,	punct	I-RNA
CD33	NN	conj	I-RNA
,	,	punct	I-RNA
and	CC	cc	I-RNA
G-CSF	NN	compound	I-RNA
receptor	NN	compound	I-RNA
mRNA	NN	conj	I-RNA
,	,	punct	O
at	IN	case	O
concentrations	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
10-	CD	nmod:npmod	O
to	TO	dep	O
100-fold	RB	advmod	O
lower	JJR	acl:relcl	O
than	IN	case	O
those	DT	nmod	O
of	IN	case	O
ATRA	NN	nmod	O
necessary	JJ	amod	O
to	TO	mark	O
produce	VB	xcomp	O
similar	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

Tyrosine	NN	compound	B-protein
kinase	NN	compound	I-protein
-dependent	JJ	nsubj	O
,	,	punct	O
and	CC	cc	O
not	RB	neg	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
-dependent	JJ	conj	O
,	,	punct	O
pathways	NNS	nsubj	O
mediate	VBP	ROOT	O
CD23	NN	nmod:npmod	B-protein
-triggered	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
but	CC	cc	O
do	VBP	aux	O
not	RB	neg	O
participate	VB	conj	O
in	IN	case	O
the	DT	det	O
direct	JJ	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
raised	VBN	dep	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
could	MD	aux	O
diminish	VB	ccomp	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	mark	O
direct	VB	acl	O
leukocyte	NN	compound	O
traffic	NN	dobj	O
into	IN	case	O
inflamed	JJ	amod	O
tissues	NNS	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
endothelial-leukocyte	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	dep	I-protein
and	CC	cc	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
have	VBP	ROOT	O
important	JJ	amod	O
implications	NNS	dobj	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
germline	NN	compound	B-DNA
transcription	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
concomitant	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
V-J	NN	compound	O
recombination	NN	nmod	O
of	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
locus	NN	nmod	I-DNA
.	.	punct	O

NM23	NN	nsubjpass	B-protein
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
system	NN	nmod	O
of	IN	case	O
murine	JJ	amod	B-cell_line
melanoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
an	DT	det	O
inverse	JJ	amod	O
relationship	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	acl:relcl	O
between	IN	case	O
NM23	CD	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
ability	NN	conj	O
.	.	punct	O

When	WRB	advmod	O
data	NNS	nsubj	O
obtained	VBN	advcl	O
preoperatively	RB	advmod	O
and	CC	advmod	O
after	IN	case	O
12	CD	nummod	O
months	NNS	conj	O
were	VBD	auxpass	O
compared	VBN	advcl	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
out	IN	advmod	O
of	IN	advmod	O
23	CD	nummod	O
patients	NNS	nsubj	O
whose	WP$	nmod:poss	O
PBMCs	NNS	nsubj	B-cell_type
had	VBD	aux	O
experienced	VBN	acl:relcl	O
a	DT	det	O
drop	NN	dobj	O
in	IN	case	O
their	PRP$	nmod:poss	O
PHA	NN	compound	B-protein
-induced	JJ	amod	O
proliferation	NN	nmod	O
,	,	punct	O
14	CD	appos	O
(	-LRB-	punct	O
61	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	aux	O
developed	VBN	ccomp	O
metastatic	JJ	amod	O
disease	NN	dobj	O
within	IN	case	O
the	DT	det	O
subsequent	JJ	amod	O
24	CD	nummod	O
months	NNS	nmod	O
(	-LRB-	punct	O
i.e.	FW	advmod	O
36	CD	nummod	O
months	NNS	dep	O
after	IN	case	O
surgery	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
even	RB	advmod	O
at	IN	case	O
doses	NNS	nmod	O
as	RB	advmod	O
high	JJ	amod	O
as	IN	advmod	O
100	CD	nummod	O
U/ml	NN	dep	O
,	,	punct	O
IL-10	NN	nsubj	B-protein
inhibited	VBD	ROOT	O
TNF-alpha	NN	compound	B-protein
release	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
C.	FW	compound	O
albicans	FW	nmod	O
by	IN	case	O
only	RB	advmod	O
50	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
broad	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
gene	NN	compound	O
regulation	NN	nmod	O
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
evident	JJ	conj	O
whether	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
acts	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
messenger	NN	compound	O
system	NN	nmod	O
for	IN	case	O
germline	NN	compound	B-DNA
C	NN	compound	O
epsilon	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
receptors	NNS	nsubj	I-protein
are	VBP	cop	O
important	JJ	amod	O
regulators	NNS	ROOT	O
of	IN	case	O
erythroid	JJ	amod	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

One	CD	nummod	O
such	JJ	amod	O
example	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
excessive	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
``	``	punct	B-protein
normal	JJ	amod	I-protein
''	''	punct	I-protein
lymphokines	NNS	nmod	I-protein
of	IN	case	O
cytokines	NNS	nmod	B-protein
which	WDT	nsubj	O
accompanies	VBZ	acl:relcl	O
many	JJ	amod	O
lymphoproliferative	JJ	amod	O
diseases	NNS	dobj	O
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
by	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-protein
matrix	NN	compound	I-protein
protein	NN	nmod	I-protein
tenascin	NN	dep	B-protein
.	.	punct	O

Changes	NNS	ROOT	O
in	IN	case	O
PKC	NN	compound	B-protein
isoforms	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
alveolar	JJ	amod	I-cell_type
macrophages	NNS	nmod	I-cell_type
compared	VBN	case	O
with	IN	case	O
blood	NN	compound	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

BZLF1	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
and	CC	cc	O
the	DT	det	O
product	NN	conj	O
,	,	punct	O
an	DT	det	O
immediate-early	JJ	amod	B-DNA
gene	NN	appos	I-DNA
for	IN	case	O
EBV	NN	compound	O
replication	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
not	RB	neg	O
expressed	VBN	ROOT	O
in	IN	case	O
any	DT	nmod	O
of	IN	case	O
them	PRP	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
tumour	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
carried	VBD	ccomp	O
EBV	NN	compound	B-DNA
genomes	NNS	dobj	I-DNA
in	IN	case	O
a	DT	det	O
tightly	RB	advmod	O
latent	JJ	amod	O
form	NN	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
constitutive	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
Rev	NN	compound	B-protein
M10	NN	nmod	I-protein
did	VBD	aux	O
not	RB	neg	O
alter	VB	ROOT	O
the	DT	det	O
secretion	NN	dobj	O
of	IN	case	O
interleukin	NN	nmod	B-protein
2	CD	nummod	I-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
mitogen	NN	compound	O
stimulation	NN	nmod	O
of	IN	case	O
EL-4	NN	compound	B-cell_line
and	CC	cc	O
Jurkat	NN	conj	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	dobj	O
to	TO	mark	O
define	VB	advcl	O
these	DT	det	O
rearrangements	NNS	dobj	O
at	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TNF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-alpha	NN	nsubj	I-protein
controls	VBZ	ROOT	O
T-cell	NN	compound	O
activation	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
inducer	NN	conj	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV	NN	compound	O
)	-RRB-	punct	O
-1	CD	nummod	O
replication	NN	nmod	O
in	IN	case	O
chronically	RB	advmod	B-cell_type
infected	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
structure	NN	dobj	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
a	DT	det	O
gene	NN	nmod	O
represented	VBN	acl	O
by	IN	case	O
clone	NN	compound	B-DNA
pAT	NN	nmod	I-DNA
133	CD	nummod	I-DNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	acl:relcl	O
upon	IN	case	O
transition	NN	nmod	O
from	IN	case	O
a	DT	det	O
resting	JJ	amod	O
state	NN	nmod	O
(	-LRB-	punct	O
G0	NN	appos	O
)	-RRB-	punct	O
through	IN	case	O
the	DT	det	O
early	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
(	-LRB-	punct	O
G1	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Interferon	NN	compound	B-protein
gamma	NN	nsubj	I-protein
activated	VBD	ROOT	O
strongly	RB	advmod	O
c-fos	NN	dobj	B-DNA
and	CC	cc	O
weakly	RB	advmod	O
c-jun	NN	conj	B-DNA
and	CC	cc	O
AP1	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-protein
myeloid	JJ	amod	I-protein
nuclear	JJ	amod	I-protein
differentiation	NN	compound	I-protein
antigen	NN	nsubjpass	I-protein
(	-LRB-	punct	O
MNDA	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
specifically	RB	advmod	O
in	IN	case	O
maturing	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
the	DT	det	O
myelomonocytic	JJ	amod	O
lineage	NN	nmod	O
and	CC	cc	O
in	IN	case	O
monocytes	NNS	conj	B-cell_type
and	CC	cc	O
granulocytes	NNS	conj	B-cell_type
.	.	punct	O

B	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
contain	VBP	ROOT	O
signal	NN	compound	B-protein
transducer	NN	dobj	I-protein
and	CC	cc	I-protein
activator	NN	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	I-protein
STAT	NN	appos	I-protein
)	-RRB-	punct	I-protein
1	CD	nummod	I-protein
and	CC	cc	O
STAT3	NN	conj	B-protein
constitutively	RB	advmod	O
phosphorylated	VBN	acl	O
on	IN	case	O
serine	NN	compound	O
residues	NNS	nmod	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
this	DT	det	O
result	NN	nmod	O
,	,	punct	O
these	DT	det	O
cell	NN	compound	O
lines	NNS	nsubj	O
expressed	VBD	ROOT	O
increased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	B-RNA
encoding	VBG	acl	O
the	DT	det	O
AP-1	NN	compound	B-protein
proteins	NNS	dobj	I-protein
,	,	punct	O
c-Fos	NN	appos	B-protein
,	,	punct	O
Fra-1	NN	conj	B-protein
,	,	punct	O
c-Jun	NN	conj	B-protein
,	,	punct	O
JunB	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
JunD	NN	conj	B-protein
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
Jak	NN	compound	B-protein
kinases	NNS	nsubjpass	I-protein
Jak1	NN	dep	B-protein
and	CC	cc	O
Jak3	NN	conj	B-protein
and	CC	cc	O
the	DT	det	O
signal	NN	compound	O
transducer	NN	conj	O
and	CC	cc	O
activator	NN	conj	O
of	IN	case	O
transcription	NN	compound	B-protein
proteins	NNS	nmod	I-protein
Stat3	NN	dep	B-protein
and	CC	cc	O
Stat5	NN	conj	B-protein
are	VBP	auxpass	O
activated	VBN	advcl	O
in	IN	case	O
normal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
response	NN	dep	O
to	TO	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
this	DT	det	O
signaling	NN	compound	O
pathway	NN	nsubjpass	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ROOT	O
in	IN	case	O
HTLV-I-transformed	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

A	DT	det	O
second	JJ	amod	O
weak	JJ	amod	O
inducible	JJ	amod	O
complex	NN	nsubjpass	O
resembling	VBG	acl	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	dobj	I-protein
(	-LRB-	punct	O
NF-AT	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
binding	VBG	xcomp	O
to	TO	case	O
the	DT	det	O
hCLEO	NN	compound	B-DNA
region	NN	nmod	I-DNA
.	.	punct	O

GATA-3	NN	nsubj	B-protein
inhibits	VBZ	ROOT	O
Th1	NN	compound	B-protein
cytokines	NNS	dobj	I-protein
by	IN	case	O
a	DT	det	O
cell-intrinsic	JJ	amod	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
dependent	JJ	acl:relcl	O
on	IN	case	O
IL-4	NN	nmod	B-protein
and	CC	cc	O
that	WDT	nsubj	O
may	MD	aux	O
involve	VB	conj	O
repression	NN	dobj	O
of	IN	case	O
IL-12	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

The	DT	det	O
signal	NN	nsubjpass	O
is	VBZ	auxpass	O
subsequently	RB	advmod	O
propagated	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
Raf-1	NN	nmod	B-protein
,	,	punct	O
MEK	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
MAP	NN	compound	B-protein
kinases	NNS	conj	I-protein
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
their	PRP$	nmod:poss	O
increased	VBN	amod	O
autophosphorylation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
phosphorylation	NN	conj	O
in	FW	compound	O
situ	FW	advmod	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
basis	NN	nsubj	O
of	IN	case	O
GC	NN	compound	O
insensitivity	NN	nmod	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

IL-12	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	B-protein
immunoregulatory	JJ	amod	I-protein
cytokine	NN	ROOT	I-protein
that	WDT	nsubj	O
promotes	VBZ	acl:relcl	O
cell-mediated	JJ	amod	O
immune	JJ	amod	O
responses	NNS	dobj	O
and	CC	cc	O
the	DT	det	O
differentiation	NN	conj	O
of	IN	case	O
naive	JJ	amod	O
CD4+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
Th1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
relatively	RB	advmod	O
few	JJ	amod	O
IL-12	NN	compound	B-protein
target	NN	compound	O
genes	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	parataxis	O
.	.	punct	O

To	TO	mark	O
confirm	VB	advcl	O
the	DT	det	O
physiological	JJ	amod	O
relevance	NN	dobj	O
of	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
carried	VBD	ROOT	O
out	RP	prt	O
in	FW	amod	O
vivo	FW	dep	O
footprinting	NN	compound	O
experiments	NNS	dobj	O
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
that	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
IL-2R	NN	compound	B-protein
alpha	NN	compound	I-protein
expression	NN	nmod	O
correlated	VBD	ccomp	O
with	IN	case	O
occupancy	NN	nmod	O
of	IN	case	O
the	DT	det	O
GASd	NN	compound	B-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Separate	JJ	amod	O
epitopes	NNS	nsubjpass	B-protein
in	IN	case	O
VP22	NN	nmod	B-protein
were	VBD	auxpass	O
defined	VBN	ROOT	O
for	IN	case	O
T-cell	NN	compound	B-cell_line
clones	NNS	nmod	I-cell_line
from	IN	case	O
each	DT	nmod	O
of	IN	case	O
three	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O

Infection	NN	nsubj	O
with	IN	case	O
Theileria	FW	compound	O
annulata	FW	nmod	O
induces	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-protein
metalloproteinase	NN	nmod	I-protein
9	CD	nummod	I-protein
and	CC	cc	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-1	NN	conj	B-protein
in	IN	case	O
bovine	JJ	amod	B-cell_type
leucocytes	NNS	nmod	I-cell_type
.	.	punct	O

Comparison	NN	ROOT	O
of	IN	case	O
the	DT	det	O
transactivation	NN	compound	B-protein
domains	NNS	nmod	I-protein
of	IN	case	O
Stat5	NN	nmod	B-protein
and	CC	cc	O
Stat6	NN	conj	B-protein
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
mammary	JJ	amod	B-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
activation	NN	nsubj	O
(	-LRB-	punct	O
with	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
alone	RB	advmod	O
)	-RRB-	punct	O
specifically	RB	advmod	O
induces	VBZ	ccomp	O
differentiation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
CD34+	JJ	amod	I-cell_line
hemopoietic	JJ	amod	I-cell_line
progenitor	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
HPC	NN	appos	B-cell_line
)	-RRB-	punct	O
to	TO	case	O
mature	JJ	amod	B-cell_type
DC	NN	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
still	RB	advmod	O
lower	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
healthy	JJ	amod	O
subjects	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

They	PRP	nsubj	O
bind	VBP	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
respectively	RB	advmod	O
ATF-1	NN	dobj	B-protein
and	CC	cc	O
NF-Y	NN	conj	B-protein
proteins	NNS	dep	I-protein
.	.	punct	O

